Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,type I interferon signaling pathway (GO:0060337),0.8682557227644914,2.4275191027928504,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,cellular response to type I interferon (GO:0071357),0.8682557227644914,2.4275191027928504,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,defense response to symbiont (GO:0140546),0.7823052741621793,2.3861054171699045,0.0,0.0,0.0,24/92,5.02%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,defense response to virus (GO:0051607),0.7733449162555682,2.3715020648654863,0.0,0.0,0.0,25/100,5.02%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;CXCL10;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,negative regulation of viral process (GO:0048525),0.8027934887737923,2.3171847453319234,0.0,0.0,0.0,26/57,10.21%,RSAD2;OAS3;STAT1;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;PML;TRIM14;ZC3HAV1;BST2;ZFP36;TRIM21;CCL5;ILF3;SLPI;UBP1;N4BP1;PPIA;BANF1;SRPK1;PROX1;TNIP1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.8500971346548333,2.2897636787760463,0.0,0.0,0.0,10/36,1.54%,PARP14;ZBP1;NLRC5;AXL;HSPA1B;PARP9;IRGM;CASP4;CXCR4;WNT5A
prerank,regulation of viral genome replication (GO:0045069),0.7977998187462262,2.2831949070355138,0.0,0.0,0.0,27/56,10.39%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;ADAR;PKN2;TARBP2;LARP1;CCL5;ILF3;CNOT7;SLPI;N4BP1;PPIA;BANF1;VAPB;SRPK1;PROX1;TNIP1;STAU1
prerank,negative regulation of viral genome replication (GO:0045071),0.8144220298320997,2.248652389684821,0.0,0.0,0.0,20/40,10.21%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;RESF1;CCL5;ILF3;SLPI;N4BP1;BANF1;SRPK1;PROX1;TNIP1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.776460471103252,2.2042296168544797,0.0,0.0,0.0,8/48,0.89%,PARP14;OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15;NR1H2
prerank,negative regulation of innate immune response (GO:0045824),0.808846059924774,2.196080861079723,0.0,0.0,0.0,13/34,5.01%,OAS3;USP18;STAT2;TRAFD1;NLRC5;SAMHD1;ISG15;DHX58;NMI;TRIM21;USP15;CNOT7;SUSD4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7899370311345015,2.186063840166014,0.0,0.0,0.0,14/45,4.28%,OAS3;STAT1;SP100;OASL;IRF7;OAS2;PML;CAMK2D;TRIM25;B2M;CAMK2B;TRIM21;GBP2;HCK
prerank,cellular response to interferon-gamma (GO:0071346),0.7232237809211185,2.148732541861843,0.0,0.0,0.0,24/88,5.24%,OAS3;STAT1;GBP4;SP100;OASL;IRF7;OAS2;PML;GBP5;CCL7;DAPK3;CAMK2D;WNT5A;TRIM25;B2M;CAMK2B;GBP3;TRIM21;GBP2;CD47;HCK;CCL5;GBP7;CX3CL1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.8043771115665539,2.1094668093927265,0.0,7.708657589722355e-05,0.001,10/29,4.88%,OAS3;USP18;ZBP1;STAT2;NLRC5;SAMHD1;ISG15;WNT5A;CNOT7;HSP90AB1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.7649013908854239,2.074793158491322,0.0,0.00014316078380912945,0.002,14/38,7.30%,DDX60;OASL;GBP5;DHX58;IFI35;SASH1;NMI;ADAM8;USP15;CCL5;TLR8;LY86;POLR3B;DHX9
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.8074951894087657,2.0432751885887224,0.0,0.0004008501946655625,0.006,8/23,4.88%,PARP14;STAT1;NLRC5;PARP9;IRGM;NR1H2;SOCS1;HSP90AB1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.8804104320941633,2.0418172510549932,0.0,0.0003757970574989648,0.006,6/15,0.28%,OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15
prerank,positive regulation of innate immune response (GO:0045089),0.7816525360071396,2.0167332563712015,0.0,0.001178971160781066,0.02,11/30,7.30%,ZBP1;NLRC5;GBP5;IFI35;WNT5A;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9
prerank,response to interferon-gamma (GO:0034341),0.6889837148496267,1.997955678120675,0.0,0.001892903697031823,0.032,17/67,5.24%,STAT1;GBP4;SP100;GBP5;BST2;CCL7;DAPK3;WNT5A;GBP3;CD40;CXCL16;TRIM21;GBP2;CD47;CCL5;GBP7;CX3CL1
prerank,positive regulation of type I interferon production (GO:0032481),0.6643467331956818,1.96899185477342,0.0,0.0041667322866551885,0.07,22/73,12.25%,OAS3;STAT1;ZBP1;IRF7;OAS2;IFIH1;ISG15;DHX58;DHX33;NFKB2;CGAS;DHX36;TLR8;CTNNB1;NFKB1;POLR3B;DHX9;POLR3GL;POLR2K;RIOK3;PTPN11;PRKDC
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.8851123468539451,1.9643845281875636,0.0,0.004459458415654382,0.078,4/13,5.39%,PARP10;PARP9;NAMPT;NAPRT
prerank,protein ADP-ribosylation (GO:0006471),0.7528511410205387,1.9598928478148068,0.0,0.004676585604431562,0.086,7/28,4.18%,PARP14;PARP12;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.9077454708130802,1.9484118501463972,0.0,0.005329485542712592,0.1,5/11,0.46%,PARP14;PARP12;PARP10;PARP9;PARP11
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.690023258596167,1.9375640621331853,0.0,0.007102019753313769,0.132,13/49,16.43%,PARP14;PARP9;IL15;CRLF1;CD40;STAT3;CCL5;LYN;JAK2;PIBF1;FGFR3;IL18;ARL2BP
prerank,regulation of type I interferon production (GO:0032479),0.6447326406736618,1.9328796608769945,0.0,0.007641206835812283,0.147,23/84,9.95%,ZBP1;NLRC5;IRF7;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;DHX33;NFKB2;CGAS;TRIM21;IKBKE;DHX36;CTNNB1;NFKB1;POLR3B;CYLD;DHX9;POLR3GL;POLR2K;TRAF3
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.908051203796981,1.923900375636674,0.0,0.008633696500489037,0.175,2/10,2.19%,CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.908051203796981,1.923900375636674,0.0,0.008633696500489037,0.175,2/10,2.19%,CNGB1;CACNA2D4
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.813044577892257,1.9206541140137134,0.0,0.009019129379975155,0.186,6/18,4.65%,DDX60;OASL;DHX58;BIRC2;USP15;NOP53
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.8494628721356117,1.9187876600172964,0.0,0.00909070977187972,0.192,6/13,5.91%,STAT1;OASL;OAS2;CRLF1;STAT3;IL27
prerank,sensory perception of chemical stimulus (GO:0007606),-0.6742872910336806,-1.914479020278097,0.0,1.0,0.677,5/15,10.55%,GNAL;UBR3;ADCY3;SYT10;GNAS
prerank,positive regulation of interferon-beta production (GO:0032728),0.7209757446449244,1.8998979320929452,0.0,0.013718752351916233,0.289,9/33,7.30%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9
prerank,NAD biosynthetic process (GO:0009435),0.7806701289611879,1.8903750791725067,0.0,0.016201028701066482,0.335,4/20,5.39%,PARP10;PARP9;NAMPT;NAPRT
prerank,positive regulation of defense response to virus by host (GO:0002230),0.7578163917047539,1.8836545143873946,0.0,0.01781197235973588,0.371,5/24,2.93%,STAT1;PARP9;DTX3L;AIM2;CGAS
prerank,positive regulation of interferon-alpha production (GO:0032727),0.776862051898734,1.8825363356931142,0.0,0.01769377812390959,0.377,6/19,7.30%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,regulation of innate immune response (GO:0045088),0.6552640242353039,1.8819228319278325,0.0,0.01737017510217437,0.383,24/57,14.26%,USP18;TRAFD1;SAMHD1;PARP9;GBP5;DHX58;IFI35;BIRC2;NMI;TRIM21;ADAM8;CCL5;HSP90AB1;TLR8;ERAP1;POLR3B;DHX9;N4BP1;ABCE1;RIOK3;PTPN11;FCGR2B;BIRC3;IFNAR2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.8770155659226938,1.8726945831300075,0.0,0.020160406849356226,0.429,3/11,0.94%,IRF7;AXL;NOD2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6533139277685185,1.8627908785641147,0.0,0.02382195442583914,0.488,9/57,4.86%,PARP14;PARP9;IL15;CRLF1;SOCS1;CD40;STAT3;CCL5;CNOT7
prerank,response to interferon-beta (GO:0035456),0.754307525416557,1.8613082447200908,0.0,0.02360562257474979,0.493,7/22,4.79%,STAT1;IRGM;XAF1;BST2;AIM2;PNPT1;IKBKE
prerank,cellular response to virus (GO:0098586),0.7031203789719698,1.851895597033953,0.0,0.02792409126352668,0.558,13/30,18.20%,CXCL10;IFIH1;IRGM;CCL5;MAPK14;RIOK3;ZC3H12A;HSP90AA1;LGALS9;BAX;RRP1B;POU2F2;GBF1
prerank,erythrocyte development (GO:0048821),-0.7490100279110636,-1.8450777220725663,0.002898550724637681,1.0,0.911,7/10,23.81%,NCKAP1L;ZBTB7A;DMTN;ABCB10;ALAS1;LYAR;ALAS2
prerank,response to cadmium ion (GO:0046686),-0.5377678071908605,-1.8386593823041677,0.0,0.9638159700457917,0.918,10/26,5.66%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;EGFR;MAPK3
prerank,regulation of interferon-beta production (GO:0032648),0.6595825471420824,1.8335446635926833,0.0011534025374855825,0.038502716066560604,0.692,14/46,12.37%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9;TRAF3;RIOK3;RELB;PTPN11;REL
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8026613298345215,1.82506976831691,0.0014124293785310734,0.04383656616022113,0.741,4/14,4.27%,DDX60;OASL;DHX58;USP15
prerank,cellular response to interferon-beta (GO:0035458),0.8013509700610219,1.8219300503804539,0.0,0.04567186905470752,0.763,4/14,1.79%,STAT1;IRGM;AIM2;PNPT1
prerank,regulation of interferon-alpha production (GO:0032647),0.7304664001223291,1.8158154131486144,0.0012903225806451613,0.05000850599303297,0.794,6/23,7.30%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.8473917594564515,1.8154528480303895,0.00145985401459854,0.049056428585261685,0.796,4/11,6.02%,STAT1;WNT5A;SOX9;FGFR2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5969377421154659,-1.81445940279025,0.011406844106463879,0.909838969321958,0.953,12/18,22.37%,DLG4;GRIN1;PRKCZ;NLGN2;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;CUX2;SHANK1
prerank,response to interferon-alpha (GO:0035455),0.7722274452291225,1.8130763210625407,0.0,0.04982661140668445,0.805,5/16,2.38%,EIF2AK2;AXL;BST2;KLHL20;ADAR
prerank,detection of visible light (GO:0009584),0.7735150883115964,1.8052528812082205,0.0,0.05632400746636,0.844,2/16,2.19%,CNGB1;CACNA2D4
prerank,cellular response to cadmium ion (GO:0071276),-0.5394143073847413,-1.8021470575982945,0.0,0.80781995815296,0.971,10/24,5.66%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;EGFR;MAPK3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.8017369781329089,1.801463411173052,0.0,0.0587022840632457,0.859,4/13,7.30%,AXL;IFIH1;WNT5A;DHX9
prerank,regulation of defense response to virus by host (GO:0050691),0.693098864617524,1.7897436552675698,0.0,0.0697566480064745,0.899,7/30,7.30%,STAT1;PARP9;DTX3L;AIM2;CGAS;TARBP2;DHX9
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7239891188628899,-1.7871545975409888,0.01282051282051282,0.6637364376909319,0.981,3/10,17.00%,MAPK7;KLF4;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7239891188628899,-1.7871545975409888,0.01282051282051282,0.6637364376909319,0.981,3/10,17.00%,MAPK7;KLF4;MAP2K5
prerank,cellular response to zinc ion (GO:0071294),-0.6338332670310127,-1.7856407946025055,0.0176678445229682,0.5882087858358366,0.981,8/15,2.04%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,regulation of protein kinase C signaling (GO:0090036),0.7800385840741391,1.774346352602293,0.00273224043715847,0.08863480102259272,0.948,5/14,10.85%,WNT11;WNT5A;CD40;SPHK2;ADGRV1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7595247184324261,1.7697390160488,0.0,0.0937613658459917,0.961,4/15,2.47%,EIF2AK2;GBP5;USP50;DHX33
prerank,myoblast fusion (GO:0007520),-0.659190722372903,-1.7651840471735303,0.003257328990228013,0.6230362125407503,0.992,6/12,14.04%,CD81;KCNH1;JAM2;PTGFRN;CD9;ADGRB3
prerank,regulation of defense response (GO:0031347),0.5968807155627931,1.7647836231933214,0.001072961373390558,0.09908771393646174,0.97,22/76,14.83%,USP18;ZBP1;SAMHD1;PIK3AP1;CASP4;NOD2;DHX58;WNT5A;BIRC2;HCK;AREL1;ERAP1;BCL6;CYLD;N4BP1;TRAF3;APOE;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12
prerank,positive regulation of immune response (GO:0050778),0.6098839140828914,1.762667533409938,0.0011001100110011,0.10017246364692405,0.973,19/64,17.53%,RSAD2;IL15;NOD2;GBP5;IFI35;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9;SPHK2;RIOK3;XBP1;FCGR2B;STX4;MYB;LGALS9;PTPRC
prerank,maintenance of protein location in nucleus (GO:0051457),0.7251784851922048,1.7604180851101932,0.0013404825737265416,0.10143081886586437,0.977,10/20,11.54%,SP100;PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;BARD1;SUN2;TAF3
prerank,negative regulation of type I interferon production (GO:0032480),0.6409301606143065,1.755434518519072,0.0012165450121654502,0.10728524200496085,0.981,12/40,12.37%,NLRC5;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;IKBKE;CYLD;HAVCR2;RELB;REL
prerank,positive regulation of immune system process (GO:0002684),0.7609130947818835,1.7529955403676125,0.004155124653739612,0.10932621818661707,0.986,3/16,2.01%,RSAD2;IL15;PIK3CD
prerank,UV-damage excision repair (GO:0070914),-0.6540221563203784,-1.749483939240998,0.015432098765432098,0.646037744038584,0.996,6/12,18.88%,INO80;XPC;SIRT1;ACTR5;ERCC1;XPA
prerank,positive regulation of T cell migration (GO:2000406),0.7116347977854625,1.744804287980145,0.002680965147453083,0.12277892999571116,0.992,8/20,16.66%,CXCL10;DOCK8;WNT5A;CCL5;APP;OXSR1;AIF1;STK39
prerank,metanephric mesenchyme development (GO:0072075),0.8284189909711419,1.7444067853026852,0.0015337423312883436,0.12109319971578765,0.992,1/10,0.06%,STAT1
prerank,positive regulation of response to external stimulus (GO:0032103),0.5652327466812568,1.7393320004735815,0.0,0.12834364268488457,0.996,28/128,11.15%,DDX60;ZBP1;OASL;IL15;AGT;GBP5;DHX58;IFI35;WNT5A;SASH1;NMI;ADAM8;CD47;PTGER4;USP15;CCL5;TLR8;CX3CL1;LY86;LRSAM1;POLR3B;USF1;DHX9;APP;TNIP1;PPM1F;RIOK3;ABCC1
prerank,response to peptide (GO:1901652),0.6483529301081897,1.7373747610031145,0.006002400960384154,0.12985436569297565,0.996,8/33,9.48%,STAT1;STAT2;NOD2;IRS1;STAT3;CACNA1A;EIF2B2;PRNP
prerank,defense response to bacterium (GO:0042742),0.5721363488873334,1.73278397301043,0.0,0.13658279262203754,0.996,12/105,5.80%,OAS3;GBP4;OAS2;ISG15;IRGM;GALP;NOD2;NOD1;STAB2;GBP2;GBP7;SLPI
prerank,phospholipid homeostasis (GO:0055091),0.7982564126453664,1.7287460935321313,0.004491017964071856,0.14293027068265712,0.997,3/11,4.72%,ABCA1;ABCG1;TLCD2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.795240105577481,1.7280623970402147,0.0030075187969924814,0.14203458564316432,0.998,6/11,8.46%,WNT5A;SFRP2;RUNX1;YJEFN3;ETV6;YTHDF2
prerank,cellular response to leucine starvation (GO:1990253),-0.6906081870538598,-1.7278879327760692,0.005847953216374269,0.7003859634503974,0.998,5/10,7.58%,IMPACT;GCN1;RRAGD;RRAGB;LARS1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.7700537544293411,1.7269735050732689,0.00423728813559322,0.141940396799609,0.998,5/13,10.62%,MOV10;ZC3HAV1;PNPT1;CNOT7;ZC3H12A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.7463770436342392,1.7256111217361048,0.011142061281337047,0.14228565579197364,0.999,6/14,8.57%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.8152846914150528,1.7213226268622146,0.0014619883040935672,0.14934851102043514,0.999,3/10,6.02%,STAT1;SOX9;FGFR2
prerank,water transport (GO:0006833),0.7746978180234025,1.7188896543077175,0.002844950213371266,0.1515714798579158,0.999,3/12,9.06%,AQP11;AQP4;PDPN
prerank,cellular response to fluid shear stress (GO:0071498),-0.631750202853526,-1.7179510665930873,0.02348993288590604,0.6976506678547583,0.998,9/12,31.13%,MTSS1;ASS1;MAPK7;KLF4;MAP2K5;MEF2C;SREBF2;HAS2;HDAC3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6242851736127217,-1.7091678221488187,0.0113314447592068,0.689537267816637,0.998,7/12,15.02%,DOCK4;DOCK7;TPM1;ADAMTS1;IGFBP5;DOCK5;PRKG1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6497623195727412,1.708526721665328,0.0025031289111389237,0.17222682786957685,1.0,5/29,2.96%,STAT1;STAT2;IL15;STAT3;NMI
prerank,embryonic heart tube development (GO:0035050),0.7550427962939481,1.7085003608617961,0.008438818565400843,0.16966288163609827,1.0,2/14,2.78%,PITX2;ACVR1
prerank,lymphocyte chemotaxis (GO:0048247),0.6395447039084899,1.7079728991864134,0.0024009603841536613,0.16841691014679974,1.0,8/34,5.90%,CXCL10;CCL7;PIK3CD;CXCL16;ADAM8;CCL5;CX3CL1;CH25H
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6376642066024129,1.705738850710526,0.0036407766990291263,0.17159925245168417,1.0,5/32,8.64%,CXCL10;CXCL9;GALP;RNASE7;FAM3A
prerank,negative regulation of DNA binding (GO:0043392),0.6499611237999423,1.7054290158207095,0.005128205128205128,0.16972229619064355,1.0,5/28,4.05%,SP100;ILRUN;PER2;MAD2L2;SUMO3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5817737724200585,1.7044981311273206,0.0010741138560687433,0.16923036254077192,1.0,22/69,17.53%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;DHX9;TMEM106A;HMGB1;APP;SPHK2;HAVCR2;PSEN1;PTPN11;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5790314230767352,1.701550559172047,0.0010741138560687433,0.17391817248834723,1.0,23/73,17.53%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;ADAM8;DHX9;TMEM106A;HMGB1;APP;SPHK2;HAVCR2;PSEN1;PTPN11;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6233215479900671,1.7008962261493497,0.0011918951132300357,0.17289448326859783,1.0,12/42,16.66%,CXCL10;CXCL9;CCL7;CCL5;CX3CL1;ACKR3;CIB1;CCL14;GPR35;RBM15;OXSR1;STK39
prerank,myelin maintenance (GO:0043217),0.8032392036872946,1.6984039102876725,0.00303951367781155,0.1764289966384181,1.0,5/10,9.50%,CXCR4;CLU;DEGS1;EPB41L3;ABCD1
prerank,regulation of response to external stimulus (GO:0032101),0.5511538952003261,1.6966560442343235,0.0010362694300518134,0.17831062544464396,1.0,28/121,14.83%,USP18;ZBP1;SAMHD1;PIK3AP1;CNGB1;CASP4;NOD2;DHX58;CXCR4;WNT5A;BIRC2;CD55;HCK;CX3CL1;AREL1;ERAP1;BCL6;CYLD;N4BP1;P2RX4;TRAF3;CAMKMT;USP14;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12
prerank,regulation of T cell chemotaxis (GO:0010819),0.7850480713236143,1.6954332316714886,0.004451038575667656,0.17879254849399637,1.0,3/11,4.37%,CXCL10;WNT5A;CCL5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7358981507405308,1.691215573110231,0.002789400278940028,0.18618436673282046,1.0,7/16,11.03%,MOV10;ZFP36;TARDBP;PLEKHN1;DHX36;ZC3H12A;ZFP36L1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6294171935284019,-1.6911287367202283,0.025157232704402517,0.7384138720767391,1.0,6/12,23.39%,ZBTB1;PRKCQ;CCR2;CARD9;CLEC6A;IL1B
prerank,regulation of viral life cycle (GO:1903900),0.6874976582833365,1.6883572833078289,0.00784313725490196,0.19022163783220328,1.0,5/21,7.79%,AXL;TRIM14;TRIM25;TRIM21;PPIA
prerank,fluid transport (GO:0042044),0.7613626454556109,1.6796014655616265,0.005681818181818182,0.21040780891147168,1.0,3/12,9.06%,AQP11;AQP4;PDPN
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5701379312947019,1.6776188266895578,0.0,0.21302143414616426,1.0,25/72,17.60%,USP18;STAT1;ZBP1;AXL;SPPL2A;SOCS1;BIRC2;RBCK1;RUNX1;HSP90AB1;CFLAR;CYLD;ABCE1;RNF31;PTPN11;RACK1;SHARPIN;BIRC3;IFNAR2;JAK2;PIAS1;IRAK1;ELF1;PTPRC;CDC37
prerank,pyroptosis (GO:0070269),0.7245641962349133,1.6763703436964776,0.004103967168262654,0.2134151489536621,1.0,4/15,7.30%,ZBP1;CASP4;AIM2;DHX9
prerank,regulation of cytokine production (GO:0001817),0.5525751287218791,1.6756965151241843,0.0010277492291880781,0.21274752924287071,1.0,23/126,10.59%,IGF2BP1;ZBP1;EIF2AK2;IRF7;IFIH1;ISG15;IL15;AGT;ICOSLG;PIK3CD;IGF2BP3;TRIM21;CD47;PTGER4;CD276;BCL6;SNAI2;N4BP1;LYN;PPP1R11;MAPK14;TRAF3;CCDC88B
prerank,sensory perception of smell (GO:0007608),-0.6526353853562907,-1.6730333136120747,0.01834862385321101,0.7925443842880834,1.0,3/11,4.37%,UBR3;ADCY3;SYT10
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6368313896569372,-1.6690463586963986,0.015873015873015872,0.7636547031962305,1.0,7/12,20.54%,TGFB1;SIRT7;RBM4;AAAS;PTPN14;NEDD4;TPR
prerank,mesenchyme development (GO:0060485),0.7181946714316746,1.668642561401575,0.017094017094017096,0.2298900308492041,1.0,4/15,9.69%,WNT11;SFRP2;FGFR2;BMPR2
prerank,regulation of response to interferon-gamma (GO:0060330),0.7292937072976999,1.6629110366324835,0.01566951566951567,0.24374589547916792,1.0,4/14,4.88%,STAT1;PARP9;SOCS1;HSP90AB1
prerank,response to cytokine (GO:0034097),0.5401494694060509,1.6620243582462315,0.0,0.24346877299805947,1.0,31/141,12.37%,STAT1;SP100;EIF2AK2;CD274;ISG15;PML;XAF1;BST2;CXCR4;KLHL20;ADAR;CD40;CXCL16;STAT3;ASAH2;PTPN18;TRIM21;IKBKE;IGBP1;SRF;PTPN7;APP;LDLRAP1;ALDH1A2;GCH1;TIMP2;COL3A1;RELB;GGT7;PTPN11;REL
prerank,response to alcohol (GO:0097305),-0.5027825654706484,-1.6606157758434772,0.013761467889908258,0.7668711509017359,1.0,9/27,11.32%,CCR5;TGFB1;GRIN2A;GRIN2B;TGFBR3;GRIN1;ABCA2;CCL3;PMVK
prerank,positive regulation of response to stimulus (GO:0048584),0.6108852530831762,1.6597125197995066,0.005980861244019139,0.24726562155061296,1.0,12/40,14.67%,RSAD2;IFIH1;IL15;WNT5A;B2M;CGAS;DHX9;ECHDC3;YPEL3;IER5;FCGR2B;NSMCE1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6572915587920687,1.6583144071067468,0.010767160161507403,0.2485271206926487,1.0,4/25,5.24%,CXCL10;CXCL9;THY1;CX3CL1
prerank,positive regulation of viral genome replication (GO:0045070),0.6371021368629367,1.6569352663295989,0.01256281407035176,0.24993240011072917,1.0,12/29,11.55%,IFIT1;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;PPIA;VAPB;SRPK1;STAU1;HACD3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7118224562668048,1.6564301501182945,0.01867816091954023,0.24861822300961817,1.0,4/15,10.32%,RNF213;NPHP3;DACT1;SPEF1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5948357408852205,-1.656160885702386,0.027950310559006212,0.7473017935843901,1.0,8/13,26.08%,ABHD16A;MOGAT3;DGAT1;MGLL;ABHD12;FAAH;ABHD6;DGAT2
prerank,positive regulation of type 2 immune response (GO:0002830),0.7228024500348511,1.65425533740723,0.009749303621169917,0.2523442054115146,1.0,2/14,0.94%,RSAD2;NOD2
prerank,nerve growth factor signaling pathway (GO:0038180),0.7705763283738345,1.6500182705334359,0.014619883040935672,0.2626014164164618,1.0,4/10,13.18%,BDNF;MAGI2;RAPGEF2;RAPGEF1
prerank,thymus development (GO:0048538),-0.6044931905315828,-1.6460289044479866,0.017421602787456445,0.7633088362213337,1.0,3/13,6.66%,ZBTB1;FOXE1;FGF10
prerank,cellular response to dsRNA (GO:0071359),0.707006727734324,1.6455950615325246,0.00995732574679943,0.2731067260358777,1.0,6/15,10.61%,IFIH1;IFIT1;CGAS;DHX9;NPM1;RIOK3
prerank,innate immune response (GO:0045087),0.5243830327420957,1.6433042057116207,0.0,0.2771094823992366,1.0,38/217,12.37%,CXCL10;SP100;NLRC5;IRF7;IFIH1;IFIT1;ISG15;IRGM;PML;TRIM14;NOD2;BST2;DHX58;ALPK1;TRIM25;PIK3CD;B2M;ADAR;CD40;CXCL16;TRIM21;CYBB;HCK;TLR8;SLPI;TRIM39;CYLD;ATAD3A;RNASE7;LYN;HMGB1;APP;SRPK1;GCH1;IRAK4;TRIM26;RELB;REL
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6281278166059425,-1.641509671049312,0.03353658536585366,0.7496438278169198,1.0,7/11,30.03%,TGFB1;EFNB2;FZD7;MEF2C;SOX6;GREM1;BMP2
prerank,cellular response to chemokine (GO:1990869),0.5912077324559105,1.6379721789728512,0.002328288707799767,0.2911874949045026,1.0,11/46,12.51%,CXCL10;CXCL9;CCL7;DOCK8;CCL5;CX3CL1;ACKR3;ZC3H12A;LRCH1;CCL14;GPR35
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.7544998295740252,1.636570662576428,0.02118003025718608,0.29246072846437166,1.0,8/11,17.14%,DHX36;NCBP2;BARD1;ZFP36L1;AHCYL1;PAPOLA;NCBP1;ZC3H3
prerank,regulation of RNA metabolic process (GO:0051252),0.5683025202468661,1.6361873525056672,0.0,0.29070078064719923,1.0,12/59,11.86%,OAS3;IGF2BP1;OASL;OAS2;FASTK;IGF2BP3;HNRNPH1;YTHDF2;CLK3;HNRNPL;MITF;HNRNPH3
prerank,cellular response to copper ion (GO:0071280),-0.5690211521732642,-1.6312868089667247,0.02564102564102564,0.7678880776787275,1.0,8/16,2.04%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7512608120664429,1.6304216007625087,0.020833333333333332,0.3072036556982509,1.0,3/10,1.73%,NAMPT;NOD2;KDR
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7560493953127281,1.6303831799001929,0.0188953488372093,0.30416058198837176,1.0,3/11,7.75%,AGT;ABCG1;LIPC
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7364832383768338,1.6294316246254412,0.016591251885369532,0.3042473429052163,1.0,4/12,7.30%,IFIH1;IFIT1;CGAS;DHX9
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49234172359674,-1.6288960615725696,0.018867924528301886,0.7460593882588982,1.0,10/26,5.83%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC39A14;SLC39A7
prerank,monocyte differentiation (GO:0030224),-0.6613194196465746,-1.6283603763205616,0.019417475728155338,0.7157783722059813,1.0,4/10,6.15%,PPARG;MT1G;THOC5;PDE1B
prerank,protein heterooligomerization (GO:0051291),-0.5417689139342561,-1.6269667791640137,0.038910505836575876,0.6924844158712368,1.0,7/17,14.72%,GRIN2B;KCNC2;GRIN1;MAT2A;TMEM120A;CPSF7;FARSA
prerank,protein auto-ADP-ribosylation (GO:0070213),0.7506928036358947,1.626191762119102,0.011347517730496455,0.31261253944082235,1.0,3/12,0.46%,PARP12;PARP10;PARP11
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.698475540210915,1.626101832648515,0.02092050209205021,0.3097870516924133,1.0,3/15,8.82%,AGT;SOX9;GDNF
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6512956545602656,1.625694352071675,0.014267185473411154,0.3078708091652905,1.0,6/23,12.06%,AXL;CD274;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,reverse cholesterol transport (GO:0043691),0.7284337248012394,1.6240704075845833,0.014367816091954023,0.31019713716117164,1.0,5/13,12.38%,ABCA1;ABCG1;CLU;LIPC;APOE
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6119010185317341,-1.6233738117273258,0.02922077922077922,0.6813699480039677,1.0,6/13,13.56%,CHST1;OGA;MGAT3;CHST7;PGM3;CHST3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7284162340329927,1.6232812046505252,0.02463768115942029,0.30986109222594255,1.0,3/12,8.82%,AGT;SOX9;GDNF
prerank,lung development (GO:0030324),0.6051808372200074,1.6232544335480994,0.008706467661691543,0.3069683810447313,1.0,9/33,11.35%,WNT11;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,receptor signaling pathway via STAT (GO:0097696),0.6272046052982782,1.620599423011939,0.015424164524421594,0.31310217824282,1.0,4/25,2.96%,STAT1;STAT2;STAT3;NMI
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.545645662340153,-1.6205599121181873,0.03787878787878788,0.6692792015772526,1.0,9/17,19.48%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28
prerank,monocyte chemotaxis (GO:0002548),0.6206762018103976,1.619048146939143,0.008353221957040573,0.3154615399905775,1.0,5/32,5.24%,CALCA;FLT1;CCL7;CCL5;CX3CL1
prerank,protein homotetramerization (GO:0051289),0.5820445863590761,1.6162120788591436,0.007009345794392523,0.3227593319758087,1.0,12/49,13.86%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;ALDH1A2;TK1;HPRT1;ACOT13;SHMT1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4778314211689549,-1.6125406900447643,0.014084507042253521,0.6811186615074892,1.0,14/26,22.37%,DLG4;GRIN1;PRKCZ;NLGN2;SLC8A3;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;SLC8A2;CUX2;SHANK1
prerank,zinc ion homeostasis (GO:0055069),-0.47258035313770475,-1.611627172886014,0.030612244897959183,0.6608669537320845,1.0,10/28,5.83%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC39A14;SLC39A7
prerank,vitamin transport (GO:0051180),0.6217303808613336,1.6076392664863615,0.012391573729863693,0.35110579898032906,1.0,8/29,9.51%,SLC27A1;SLC2A6;SLC46A1;SLC19A1;SLC52A2;SLC35F3;PDPN;AMN
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5683243444282136,-1.6061067028480263,0.030303030303030304,0.6642788178006502,1.0,6/15,13.56%,CHST1;OGA;MGAT3;GNPDA1;CHST7;CHST3
prerank,negative regulation of DNA replication (GO:0008156),-0.5937093087221375,-1.603749980261574,0.02702702702702703,0.65241909848863,1.0,6/13,17.49%,WAPL;CDAN1;RAD17;S100A11;TERF1;TSPYL2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5371386139844623,-1.6033652554795754,0.01845018450184502,0.6327492106785437,1.0,12/18,29.04%,CACNG7;TSHZ3;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;CACNG2;CACNG3;CCL2;CACNG5;PTK2B
prerank,positive regulation of viral process (GO:0048524),0.5589020795851487,1.6029888028791264,0.00684931506849315,0.36520578630046185,1.0,17/60,11.55%,AXL;IFIT1;POLR2G;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;DHX9;MDFIC;PPIA;VAPB;POLR2K;SRPK1;STAU1;HACD3
prerank,regulation of interleukin-4 production (GO:0032673),-0.5062699521353449,-1.6027031292218643,0.029787234042553193,0.6156415838683363,1.0,12/21,26.58%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28;ZFPM1;FCER1G;LEF1
prerank,response to purine-containing compound (GO:0014074),0.67810444727312,1.6020279558839559,0.02631578947368421,0.36528385012069076,1.0,3/17,9.00%,STAT1;TRPM2;P2RX4
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.6275895830417686,1.598606602668278,0.012610340479192938,0.3747407630670759,1.0,5/26,3.47%,TRAFD1;ILRUN;DHX58;NMI;TRIM21
prerank,regulation of immune response (GO:0050776),0.5167043383879905,1.5956419598726195,0.0,0.38298193933638547,1.0,23/135,8.83%,RSAD2;IRF7;CLEC2D;SAMHD1;IL15;TREML2;DHX58;SPPL2A;PIANP;BIRC2;B2M;LAG3;CD40;GPR108;NPDC1;CD276;ERAP1;BCL6;N4BP1;SH2D1A;LAIR1;LYN;FCGR1A
prerank,genitalia development (GO:0048806),0.718618113693884,1.5945569790113685,0.029619181946403384,0.3842486113820684,1.0,3/12,12.23%,WNT5A;CHD7;PTPN11
prerank,response to zinc ion (GO:0010043),-0.4874363350633454,-1.5932404073932338,0.018433179723502304,0.6377747466842854,1.0,8/25,2.04%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,sarcomere organization (GO:0045214),0.6134794134546484,1.5917481979437724,0.01174934725848564,0.39221785056114183,1.0,3/27,3.83%,MYOZ2;CSRP1;ACTN2
prerank,erythrocyte differentiation (GO:0030218),-0.4208932167901134,-1.5911756113646247,0.006756756756756757,0.6270687254615351,1.0,19/44,23.81%,RPS14;UBA5;TGFBR3;NCKAP1L;CASP3;KMT2E;ID2;DMTN;PTPN2;ABCB10;ALAS1;JAK3;SLC25A5;LYAR;CDK5RAP3;ZFPM1;INHBA;HIPK2;ALAS2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7181512851010619,1.5908588235186718,0.020618556701030927,0.39218834480691966,1.0,4/12,9.16%,CXCL10;DOCK8;CCL5;APP
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5974571135300542,1.590810443524288,0.01877346683354193,0.38898883006910084,1.0,4/32,5.24%,CXCL10;CXCL9;THY1;CX3CL1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6765287544980646,1.5891348531911103,0.03305785123966942,0.39227645439077125,1.0,4/15,9.00%,KDR;MET;SMOC2;P2RX4
prerank,positive regulation of defense response (GO:0031349),0.5319965851889834,1.58615996777325,0.003194888178913738,0.4018098572078762,1.0,20/89,11.15%,ZBP1;IL15;AGT;GBP5;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CCL5;TLR8;CX3CL1;LRSAM1;POLR3B;DHX9;APP;TNIP1;RIOK3;ABCC1
prerank,regulation of coagulation (GO:0050818),-0.6141511075373758,-1.5854839653715045,0.04815864022662889,0.6323917536565096,1.0,5/11,28.77%,EPHB2;HS3ST5;F2R;CAV1;PROCR
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6763382708858614,1.584962195025091,0.019363762102351315,0.40351972222247384,1.0,6/16,8.51%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6350028125953046,1.580036566179202,0.04221635883905013,0.4203832906097864,1.0,3/20,2.90%,RSAD2;B2M;CD55
prerank,cytokine-mediated signaling pathway (GO:0019221),0.49090375453203366,1.5766664930276653,0.0,0.430756600717987,1.0,117/532,14.80%,IFIT3;RSAD2;OAS3;STAT1;STAT2;CXCL10;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;CXCL9;EDAR;PML;IL15;CRLF1;XAF1;NOD2;IFIT2;PSMB10;BST2;CCL7;CAMK2D;TNFSF9;IL15RA;IFI35;NOD1;SKP1;AIM2;IRS1;PSME2;SOCS1;TRIM25;BIRC2;PIK3CD;B2M;TNFRSF8;CAMK2B;SLC27A1;PSMA5;ADAR;CD40;SOD2;STAT3;BCL2L11;IL21R;PSME4;GRB10;TRIM21;MAP3K8;GBP2;IL17RC;HCK;CCL5;TXNDC17;JUNB;CX3CL1;CCND1;IL27;PSMA3;BCL6;NFKB1;MT3;CSF1;IL10RA;CSNK2B;HNRNPA2B1;TNFRSF17;PPIA;IL12RB2;PSMB9;ACKR3;SOCS5;FCGR1A;LEPR;RBX1;RORA;VAV1;IRF9;HSPA8;TRAF3;COMMD7;BTRC;HNRNPDL;PSMD2;CCL14;IRAK4;TRAF5;IL10RB;PIM1;TNFSF8;SOS1;TRIM26;PTPN11;PSME3;SOCS2;GPR35;LIMS1;PIK3CB;RAPGEF1;NUMBL;BIRC3;ST18;STX4;FYN;IFNAR2;IL1RAP;JAK2;AIP;IRS2;PSMA4;HSP90AA1;SOX2;TNIP2;MYD88
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7435988074184366,1.5753082895020183,0.01908957415565345,0.4331317779654735,1.0,1/10,0.46%,CNGB1
prerank,cell differentiation in spinal cord (GO:0021515),-0.631851017082453,-1.5736926578521961,0.06027397260273973,0.6637049481550324,1.0,7/10,31.04%,SOX13;ZC4H2;MDGA2;SOX4;MDGA1;SOX6;LHX1
prerank,male gonad development (GO:0008584),0.5790264556504258,1.5723719230136233,0.016766467065868262,0.4422632340859904,1.0,6/34,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,development of primary male sexual characteristics (GO:0046546),0.5796666810511567,1.5702902996965984,0.012091898428053204,0.44746519310973515,1.0,6/34,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,ncRNA 3'-end processing (GO:0043628),-0.5656771016049782,-1.5687950043294216,0.034482758620689655,0.6663292179914188,1.0,9/14,30.25%,ERI1;TRNT1;INTS12;INTS2;ELAC2;INTS6;TOE1;INTS5;INTS6L
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6011424318746076,1.567944112536429,0.02666666666666667,0.45387465841592306,1.0,4/30,2.89%,CD274;ISG15;NOD2;STAT3
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7120608911210631,1.5672204735018578,0.03392330383480826,0.4535413164842003,1.0,2/11,3.86%,SP100;MAD2L2
prerank,hyaluronan metabolic process (GO:0030212),0.624281679171296,1.564532893149616,0.02656042496679947,0.46195617709647024,1.0,6/23,3.12%,HAS3;HYAL1;SPAM1;STAB2;HYAL4;HAS1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.7372642392621092,1.5644045856982383,0.029985007496251874,0.4590282766296209,1.0,2/10,1.75%,PARP14;SOCS1
prerank,sprouting angiogenesis (GO:0002040),0.5599796394191427,1.5635037444264483,0.009248554913294798,0.4597037038668474,1.0,9/51,13.33%,RNF213;LOXL2;KDR;CDH13;YJEFN3;SRF;BMPER;VEGFD;NRP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4857614823461645,-1.5629448709611453,0.039301310043668124,0.6734095259160784,1.0,12/23,22.07%,TECR;HACD1;ELOVL5;DGAT1;FAR1;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.6093492932167841,-1.5621069365792846,0.04242424242424243,0.6598305241033904,1.0,6/10,19.20%,RCC2;CDC42;APC;RACGAP1;ECT2;KNSTRN
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.6132937243465825,1.5608456241405066,0.017241379310344827,0.46829323991804334,1.0,7/26,7.79%,NOL3;GPR37L1;SOD2;FBXO7;NME5;GPR37;PPIA
prerank,negative regulation of cartilage development (GO:0061037),0.716050560247624,1.5599135342695198,0.02865329512893983,0.4683980423544349,1.0,5/13,14.83%,WNT11;SOX9;SNAI2;PTPN11;ADAMTS12
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.565119108404695,1.5595183717501615,0.005917159763313609,0.466701986114977,1.0,6/40,3.63%,NOL3;TNFSF10;CLU;MLLT11;BCL2L11;FXN
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5851964689800284,1.5590133279300962,0.023752969121140142,0.46539310382919413,1.0,10/35,12.25%,STAT1;HSPA1B;ZFP36;STAT3;BRD1;LYN;MAPK14;ZFP36L1;LDB1;PRKDC
prerank,folic acid metabolic process (GO:0046655),0.6483568080929554,1.5585980562834993,0.021534320323014805,0.46357278016295184,1.0,4/18,5.41%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6484913985583393,1.5565598226366906,0.028727770177838577,0.46923969176655916,1.0,4/18,3.82%,SLAMF1;IFI35;NMI;ENPP3
prerank,ruffle organization (GO:0031529),0.660900044962752,1.5559607140222338,0.043115438108484005,0.46839050503880775,1.0,9/16,15.98%,CYFIP1;CARMIL1;PIP5K1A;AIF1L;PLEKHA1;CORO1B;RAC1;INPP5K;AIF1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5123636091684276,1.5556769671863109,0.0030959752321981426,0.46638334966572254,1.0,29/112,17.53%,OAS3;OAS2;IFIH1;NOD2;SLAMF1;ILRUN;WNT5A;CLU;ZFP36;TNFRSF8;STAT3;CD47;CX3CL1;DHX9;TMEM106A;HMGB1;APP;SPHK2;ZC3H12A;HAVCR2;PSEN1;PTPN11;ARFGEF2;JAK2;TLR2;DICER1;LGALS9;TLR3;PTPRC
prerank,pancreas development (GO:0031016),0.7152948814515137,1.555053576354262,0.03442879499217527,0.4659012099520499,1.0,6/12,15.35%,CCDC40;TCF7L2;NPHP3;MET;PROX1;SELENOT
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6847002756932367,1.5546712668493528,0.034782608695652174,0.4641282910428941,1.0,3/13,1.73%,NAMPT;NOD2;KDR
prerank,microtubule nucleation (GO:0007020),-0.5073174037690574,-1.5546512487127486,0.041044776119402986,0.6736131306258291,1.0,11/19,20.17%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;TUBGCP2;CCDC57;GOLGA2;TPX2;CLASP1
prerank,glycerol metabolic process (GO:0006071),0.7367466421800553,1.5533953081387009,0.03468208092485549,0.4663176211014774,1.0,4/10,6.34%,COQ2;TPI1;PDXP;COQ3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6773447032600832,1.5525554097935272,0.03333333333333333,0.46627974948987394,1.0,5/15,4.86%,TENT4A;POLR2G;ZFP36;AGO2;CNOT7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5100539576020471,-1.551653790261596,0.048327137546468404,0.6685543366835647,1.0,10/18,22.07%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,negative regulation of cell division (GO:0051782),-0.5975045545770801,-1.5513528436346344,0.03870967741935484,0.6539353196421938,1.0,8/11,32.34%,ZFYVE19;ORC6;MYC;VPS4A;E2F8;AURKB;CHMP4C;E2F7
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6100806468833215,1.5508330378639879,0.03333333333333333,0.4703355998887514,1.0,5/23,8.82%,AGT;PIK3CD;SOX9;SIRT6;GDNF
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.560374843736639,1.550468726471367,0.014840182648401826,0.46856724765600527,1.0,9/42,5.41%,PARP10;ISG15;SYCP1;UBE2L6;TRIM25;POLD4;CDKN2D;RFC4;RFC1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5835442071594139,1.5501493117390244,0.026381909547738693,0.4667051493898718,1.0,5/32,9.00%,CXCL10;CXCL9;THY1;CX3CL1;P2RX4
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6937151739318727,1.5500762668578134,0.03744798890429958,0.4638251424895729,1.0,4/13,4.62%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5565739029950304,-1.547564180894162,0.05442176870748299,0.653537123476022,1.0,2/13,0.30%,TGFB1;SYK
prerank,respiratory system development (GO:0060541),0.5812292006072368,1.5472833977023028,0.023779724655819776,0.472213884287786,1.0,9/32,11.35%,CHD7;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5423229992836998,1.5465774641659078,0.020179372197309416,0.47217153372323445,1.0,17/51,19.98%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;HMGB1;APP;TMED10;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6515041450687933,1.54623075416401,0.03302509907529723,0.47047760263424454,1.0,5/19,7.30%,IFIH1;PARP9;WNT5A;RUNX1;DHX9
prerank,regulation of activated T cell proliferation (GO:0046006),0.5969478520205043,1.5459296187145355,0.031630170316301706,0.4684903021781725,1.0,7/30,16.80%,CD274;ICOSLG;TNFSF9;HMGB1;PRNP;IL18;LGALS9
prerank,lamellipodium assembly (GO:0030032),0.5940572394198512,1.5450182977909293,0.027450980392156862,0.46937553544364036,1.0,11/26,14.01%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;SRGAP2;WHAMM;RAC1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6340280813739856,1.5415813361913988,0.023968042609853527,0.48067513078207547,1.0,4/19,5.41%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,amino acid import across plasma membrane (GO:0089718),-0.4626544517901363,-1.5409090866905375,0.0330188679245283,0.6645415678701819,1.0,7/24,16.15%,SLC1A2;SLC7A2;SLC16A2;SLC3A2;SLC7A5;SLC1A4;SLC1A1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7048087222571152,1.5397901666099092,0.03784570596797671,0.4853913467411629,1.0,3/11,5.48%,LMX1A;WNT5A;CTNNB1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6063522480398341,1.5392014819274187,0.028241335044929396,0.48472744291535313,1.0,6/26,8.82%,HSPA1B;EYA4;UNC5B;SNAI2;RET;GDNF
prerank,cellular response to alkaloid (GO:0071312),0.6373640914114257,1.5371292956884308,0.03146374829001368,0.49070961573921107,1.0,4/17,4.28%,CASP7;SLC8A1;CASP6;CRHBP
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6079969870064653,-1.534877302922838,0.04,0.6741531761665065,1.0,10/11,39.24%,ASAH1;SIRT1;EGR1;WNT4;BMP5;STAR;DGKQ;BMP2;NR1H4;FGFR4
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6672523113553457,1.5331044442043351,0.026462395543175487,0.5051358985358128,1.0,3/15,3.63%,NOL3;CLU;FXN
prerank,protein heterotetramerization (GO:0051290),-0.5578250339016754,-1.5309177004262042,0.04918032786885246,0.6754977793494177,1.0,4/13,14.72%,GRIN2B;GRIN1;CPSF7;FARSA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7375808703036839,1.5306327957610368,0.04725609756097561,0.5128505655629035,1.0,3/10,8.68%,AXL;RAPGEF2;LYN
prerank,defense response to protozoan (GO:0042832),0.699478763222635,1.530389393196248,0.044630404463040445,0.5106371906567675,1.0,4/12,5.16%,GBP4;CD40;GBP2;GBP7
prerank,respiratory tube development (GO:0030323),0.59012703032052,1.530192951651726,0.021518987341772152,0.5083566946589372,1.0,8/28,11.35%,CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,autophagy of nucleus (GO:0044804),-0.5287068879918003,-1.5294915490414833,0.05415162454873646,0.6668237521893398,1.0,6/16,12.81%,ATG5;ULK2;ATG2B;ATG2A;ATG9A;ATG3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6449266644421747,1.5285109146638982,0.037383177570093455,0.5127857207231157,1.0,5/17,9.86%,NOL3;SOD2;NME5;PPIA;UBQLN1
prerank,protein autoubiquitination (GO:0051865),0.5258226387949265,1.5281137922920114,0.009977827050997782,0.5115850609419241,1.0,14/61,8.78%,RNF213;DTX3L;NFX1;RNF4;TRIM21;RNFT1;BFAR;CNOT4;UBE2B;RNF11;UBE3A;LRSAM1;AMFR;RNF19B
prerank,secondary palate development (GO:0062009),0.6766672145351478,1.5280422169698908,0.03806734992679356,0.5086876111652654,1.0,4/14,7.94%,WNT11;WNT5A;CHD7;SMAD2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6898413322229646,1.5268945972175703,0.041116005873715125,0.5108241878872348,1.0,4/13,12.99%,GPR37L1;GPR37;MET;RACK1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7114915258305081,1.5257457797683789,0.043923865300146414,0.5127931447341293,1.0,3/11,8.30%,STAT1;STAT3;IL12RB2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5211423139432714,1.5252216516106423,0.008879023307436182,0.5120066869088742,1.0,10/63,7.18%,SP100;NOL3;TNFSF10;PML;AGT;ACVR1;FEM1B;CFLAR;TCF7L2;CYLD
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7085573703939403,1.5237765708651476,0.03458646616541353,0.5153961745351459,1.0,1/10,0.10%,SP100
prerank,regulation of superoxide anion generation (GO:0032928),-0.5402793432778451,-1.522761826424306,0.06859205776173286,0.6805400412853347,1.0,2/14,0.30%,TGFB1;SYK
prerank,response to exogenous dsRNA (GO:0043330),0.6339561802646627,1.521659596537368,0.04596100278551532,0.5220409726461523,1.0,4/18,7.30%,IFIH1;IFIT1;CGAS;DHX9
prerank,regulation of endothelial cell migration (GO:0010594),0.5013897245205591,1.5206129944827453,0.012711864406779662,0.523919605479874,1.0,19/85,14.01%,SP100;AGT;WNT5A;KDR;PIK3CD;NRP2;SASH1;RHOJ;BCAR1;SMOC2;BMPER;BMPR2;PROX1;ZC3H12A;RIN2;APOE;PIK3CB;NRP1;RAC1
prerank,amide transport (GO:0042886),0.5927210445676997,1.5191272128284539,0.03666245259165613,0.5274580128467613,1.0,13/26,22.55%,SLC27A1;AQP11;SLC46A1;SLC19A1;SLC14A2;ABCB9;PDPN;PLEKHA3;TAP1;ABCG2;GLTP;SLC5A6;CERT1
prerank,retinoic acid metabolic process (GO:0042573),0.676904298208271,1.5183358545464671,0.048295454545454544,0.5278295743781121,1.0,3/14,9.56%,BCO2;CYP26B1;ALDH1A2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5465372279361272,1.5166375852318268,0.01627906976744186,0.5323997967855137,1.0,12/44,11.03%,MOV10;ZC3HAV1;POLR2G;PNPT1;ZFP36;AGO2;YTHDF1;DHX36;CNOT7;YTHDF2;ZC3H12A;ZFP36L1
prerank,cellular response to retinoic acid (GO:0071300),0.5470211742223908,1.5156309330929663,0.01985981308411215,0.5337519594992705,1.0,11/42,15.53%,WNT11;WNT5A;BRINP3;SOX9;WNT7B;RET;LTK;LYN;SNW1;ZNF35;ADNP2
prerank,response to peptide hormone (GO:0043434),0.5407535548467275,1.5146948097269133,0.023014959723820484,0.5347679522874804,1.0,9/43,11.51%,STAT1;STAT2;IRS1;SLC27A1;STAT3;EIF2B2;ZFP36L1;EIF6;XBP1
prerank,neurotrophin signaling pathway (GO:0038179),0.6123417470382109,1.5141649886526543,0.04473684210526316,0.5340517875316696,1.0,7/21,13.18%,BDNF;MAGI2;RAPGEF2;BCAR1;SOS1;DDIT4;RAPGEF1
prerank,cellular response to interleukin-15 (GO:0071350),0.6776169286266824,1.5135707027324241,0.04398826979472141,0.5307485634626141,1.0,3/13,2.89%,IL15;IL15RA;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6776169286266824,1.5135707027324241,0.04398826979472141,0.5307485634626141,1.0,3/13,2.89%,IL15;IL15RA;STAT3
prerank,negative regulation of protein transport (GO:0051224),0.5973068217470037,1.5131565663526558,0.039318479685452164,0.5298169121254345,1.0,5/25,12.38%,RSAD2;RSC1A1;PPM1F;RHBDF2;APOE
prerank,regulation of cell projection organization (GO:0031344),0.6718099443804914,1.51203997310138,0.05028735632183908,0.5314209176793648,1.0,3/13,2.60%,MOV10;SPRY2;SEMA4D
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6194676550010529,1.5119713355403674,0.040897097625329816,0.5257463817157585,1.0,5/21,8.82%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6194676550010529,1.5119713355403674,0.040897097625329816,0.5257463817157585,1.0,5/21,8.82%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,maintenance of protein localization in organelle (GO:0072595),0.6301887234092549,1.5118983624317341,0.03382949932341001,0.5231818797681514,1.0,8/19,11.54%,PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;HK1;TAF3
prerank,oxoacid metabolic process (GO:0043436),0.5905563996462799,1.5117683663866106,0.025,0.5208118130056003,1.0,6/27,7.68%,TPST1;LIPT1;AGXT;GRHPR;THAP4;SULT6B1
prerank,positive regulation of chromosome organization (GO:2001252),0.6545028456001405,1.511571391769864,0.041726618705035974,0.5189248042041383,1.0,7/15,12.66%,PML;DHX36;RTEL1;FEN1;SIRT6;PPP1R10;DDX11
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5398692983338372,1.5097658445599897,0.02847380410022779,0.5243197211563334,1.0,15/45,19.98%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;APP;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6207656717337042,-1.508998736290258,0.058823529411764705,0.7248306358412074,1.0,4/10,10.08%,PTPN12;APOD;SNCA;PTPN2
prerank,myelination (GO:0042552),0.5329369060577951,1.5078723190058512,0.030303030303030304,0.5297921560610406,1.0,18/46,19.87%,PMP22;CXCR4;CNTNAP1;DEGS1;MYOC;EPB41L3;EIF2B2;B4GALT5;ABCD1;ARHGEF10;SCN2A;PLLP;ACER3;MPZ;NF1;SCN8A;EIF2B5;PLP1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.5628345624547944,-1.5067623086019128,0.06418918918918919,0.7201540348946611,1.0,3/12,4.91%,TGFB1;PPARG;ESR1
prerank,regulation of protein modification process (GO:0031399),0.5290266555636101,1.5052680337624995,0.02531645569620253,0.5386289068455432,1.0,17/50,19.54%,STAT2;PML;PLXNB2;SOCS1;NOP53;KDM4D;MT3;CCDC88A;LYN;PHIP;PUM3;NDUFS4;SPRED3;CORO1C;FNIP2;SPRED1;PIN1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6978575610368006,1.503834950195806,0.05623100303951368,0.542171439370908,1.0,5/10,12.99%,KDR;MLLT11;MYOC;ABCD1;RACK1
prerank,regulation of mitochondrial fission (GO:0090140),0.5977953923018589,1.5034341722984252,0.03756476683937824,0.5410888142404703,1.0,3/24,2.15%,STAT2;KDR;FIS1
prerank,negative regulation of chemokine production (GO:0032682),0.6588317262061493,1.502989269843312,0.061971830985915494,0.540102993674115,1.0,1/14,0.04%,OAS3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5600472992479469,1.5022651509017708,0.033373063170441,0.5405167948994987,1.0,3/35,1.40%,STAT1;FLT1;XDH
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.6259024213495767,1.5017692557642057,0.04551724137931035,0.539892468767846,1.0,4/18,8.82%,AGT;NOD2;FXN;GDNF
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6407290068531935,1.5009843096153934,0.05227882037533512,0.5405443888143923,1.0,5/17,15.98%,CXCL10;CCL5;HMGB1;CXCL17;AIF1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4978724270425071,1.5005452724619874,0.012644889357218124,0.5397437432364646,1.0,23/95,16.74%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;NFKB1;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;FCGR2B;TNIP2;MYD88;TLR2;TNIP3;IRAK1;UPF1;ACOD1
prerank,dendritic cell differentiation (GO:0097028),0.6055493193974602,1.5004376492734983,0.05026455026455026,0.5374092635736492,1.0,4/22,8.68%,AXL;TRPM2;BATF3;LYN
prerank,inner ear morphogenesis (GO:0042472),0.6128489357982818,1.4994045606850905,0.04768041237113402,0.5395051034956272,1.0,5/22,6.02%,CHD7;MYO3B;SOX9;TTC39C;FGFR2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.49850361456881204,1.4991482103417504,0.00755939524838013,0.5381773600739364,1.0,21/84,14.01%,AGT;WNT5A;KDR;PIK3CD;CD40;NRP2;SASH1;MAP2K3;BCAR1;MET;SMOC2;P2RX4;HMGB1;MAPK14;BMPR2;PROX1;ZC3H12A;RIN2;PIK3CB;NRP1;RAC1
prerank,regulation of T cell migration (GO:2000404),0.625709631353405,1.4981548234871436,0.057931034482758624,0.5397979611225946,1.0,5/18,10.70%,CXCL10;DOCK8;CCL5;APP;LRCH1
prerank,regulation of spindle assembly (GO:0090169),0.6000203097332896,1.4979257185384787,0.03571428571428571,0.5382227772409878,1.0,5/25,4.22%,HSPA1B;CHMP4B;CHMP1B;RNF4;DYNC1H1
prerank,cellular response to purine-containing compound (GO:0071415),0.7056855938474029,1.4967875672367443,0.052307692307692305,0.5404391892220802,1.0,2/10,3.73%,TRPM2;SLC8A1
prerank,mRNA stabilization (GO:0048255),0.5560917758232061,1.4954109706781458,0.02962085308056872,0.5438721340964247,1.0,11/40,15.57%,IGF2BP1;ZFP36;TARDBP;LARP1;DHX9;GDNF;MAPK14;TENT5A;TENT5C;MYD88;TAF15
prerank,modulation by symbiont of entry into host (GO:0052372),0.6417989370620243,1.4947501624773734,0.05955678670360111,0.5438184272204686,1.0,3/16,3.47%,TRIM14;TRIM25;TRIM21
prerank,pyruvate metabolic process (GO:0006090),-0.3753049799796322,-1.4939297176950583,0.008547008547008548,0.7610946733898079,1.0,17/52,11.05%,ENO1;VDAC1;SRR;PDHB;PFKL;GLO1;SLC16A1;PGAM1;PGAM4;PKM;PDHA1;HOGA1;PFKFB2;ME2;ENO2;PGK1;ME1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.659390093800814,1.493774688491745,0.051470588235294115,0.545380621197403,1.0,5/13,13.33%,KDR;SFRP2;CTNNB1;NOTCH4;NRP1
prerank,androgen receptor signaling pathway (GO:0030521),0.6896663086277787,1.4919816866457825,0.04682779456193353,0.5513178481829697,1.0,4/11,5.69%,DAXX;DDX5;PMEPA1;ARID1A
prerank,sympathetic nervous system development (GO:0048485),0.6468132556553103,1.4916704753203955,0.061196105702364396,0.550117526390964,1.0,6/15,17.97%,NRP2;CTNNB1;TFAP2B;GDNF;NRP1;NF1
prerank,multivesicular body assembly (GO:0036258),0.5748976407348779,1.4885179127764632,0.0392638036809816,0.5615734381590413,1.0,14/30,22.48%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;TSG101;CHMP1A;VPS36
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.543974851778158,-1.4882377982910555,0.07096774193548387,0.7710082667887754,1.0,7/12,34.85%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4924626088564146,1.4881593997862514,0.014767932489451477,0.5605156709846674,1.0,26/101,16.74%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;HCK;CCL5;NFKB1;LYN;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;PRKCE;TNIP2;MYD88;IL18;TNIP3;IRAK1;UPF1;ACOD1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6891189109776387,1.4878511802454635,0.05722460658082976,0.5591033218823757,1.0,1/12,0.04%,OAS3
prerank,negative regulation of viral release from host cell (GO:1902187),0.6677161923865349,1.4866549404692804,0.05196629213483146,0.5617760560288229,1.0,4/13,11.99%,PML;TRIM21;CHMP3;TRIM26
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5331537230428627,-1.4865014833562367,0.059800664451827246,0.763591538454998,1.0,4/15,13.40%,TGFB1;IRAK3;TGFB2;JAK3
prerank,regulation of postsynapse organization (GO:0099175),-0.42830671270832976,-1.48576445831827,0.03980099502487562,0.7525185600317505,1.0,12/28,11.72%,PDLIM5;IL1RAPL1;CFL1;ARHGAP44;SRCIN1;HOMER1;PPFIA2;TANC2;SHANK3;ABHD17B;ABHD17C;ZDHHC15
prerank,mRNA destabilization (GO:0061157),0.5454809354003713,1.485550905412479,0.024793388429752067,0.5639172101541516,1.0,16/38,19.03%,MOV10;ZFP36;TARDBP;YTHDF1;PLEKHN1;DHX36;YTHDF2;ZC3H12A;ZFP36L1;DIS3L2;MEX3D;TUT7;UPF1;METTL14;DCPS;RC3H2
prerank,chordate embryonic development (GO:0043009),0.5192873504124782,1.4855077897429647,0.022909507445589918,0.561420425753605,1.0,10/55,10.19%,WNT11;EGFL8;WNT5A;CHD7;FGFR2;WNT7B;DACT1;ALDH1A2;PROX1;KIAA1217
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6973180252793114,1.4840238144308762,0.059748427672955975,0.5654135156541568,1.0,3/10,6.03%,ACTN2;PDXP;CARMIL1
prerank,DNA dealkylation (GO:0035510),0.7043074419120027,1.481571129010915,0.06554878048780488,0.5708522748654715,1.0,5/10,14.40%,ASCC3;ALKBH1;MPG;ASCC2;ALKBH2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7043074419120027,1.481571129010915,0.06554878048780488,0.5708522748654715,1.0,5/10,14.40%,ASCC3;ALKBH1;MPG;ASCC2;ALKBH2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5228184626497189,1.4809487664038623,0.035046728971962614,0.5709904011173317,1.0,5/48,5.24%,CXCL10;CXCL9;CAMK2D;THY1;CX3CL1
prerank,base conversion or substitution editing (GO:0016553),0.6897953191819235,1.4807281399287322,0.04457652303120357,0.5692447390601142,1.0,2/11,2.38%,APOBEC1;ADAR
prerank,connective tissue development (GO:0061448),0.5496411579150916,1.4804524888136061,0.041312272174969626,0.5679208269631487,1.0,13/35,18.89%,NAMPT;HYAL1;DDRGK1;ARID5B;SOX9;ITGB8;SCX;XBP1;COL11A2;SOX5;SH3PXD2B;SPTLC2;CREB3L2
prerank,"phototransduction, visible light (GO:0007603)",0.641052177305196,1.479670021798073,0.05131761442441054,0.568826839897754,1.0,1/14,0.46%,CNGB1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5924554424960055,1.4789826873994936,0.04258064516129032,0.5693504372089078,1.0,6/25,12.25%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6003303715892998,1.4782396445671577,0.0563564875491481,0.5698876184986137,1.0,10/22,21.18%,XDH;GADD45G;SASH1;ZC3H12A;MAP3K4;MINK1;PRMT1;RELL1;MFHAS1;GADD45A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5918896504949317,1.4778940798049214,0.04974489795918367,0.5688183236106401,1.0,10/25,14.81%,CHMP4A;CHMP4B;CHMP1B;MVB12A;RILP;LEPROT;CHMP3;LEPROTL1;LYST;DENND10
prerank,positive regulation of immune effector process (GO:0002699),0.5776385489953848,1.4767910994837603,0.052096569250317665,0.5714210627274563,1.0,2/27,1.29%,DDX60;DHX58
prerank,histone monoubiquitination (GO:0010390),0.5763479050959706,1.4765388057739632,0.05222929936305733,0.5701096428135427,1.0,7/24,11.49%,DTX3L;SKP1;RNF40;UBE2E1;RING1;WAC;RYBP
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6773274414185049,1.4756690002488992,0.07598784194528875,0.5714101468642518,1.0,6/11,18.17%,ARHGEF7;PDPN;KANK1;CORO1B;RREB1;CORO1C
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5365730968863772,1.4756564618735954,0.03571428571428571,0.5688972017229471,1.0,13/42,14.01%,KDR;UTRN;CDH13;THY1;CX3CL1;CSF1;MYOC;CIB1;PPM1F;RIN2;LIMS1;NRP1;RAC1
prerank,response to retinoic acid (GO:0032526),0.5113046174771739,1.4741164159020697,0.020361990950226245,0.57342157199848,1.0,14/59,13.02%,WNT11;TMEM161A;WNT5A;RARG;BRINP3;CDKN2D;SOX9;WNT7B;RET;CTSH;LTK;LYN;SNW1;ZNF35
prerank,regulation of lymphocyte migration (GO:2000401),-0.5852621294608524,-1.4740417270012873,0.07079646017699115,0.7890095407491036,1.0,4/10,13.13%,STK10;WASL;JAM2;AKT1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5678211828907531,1.4738952195104469,0.04701397712833545,0.5718306182546322,1.0,10/26,15.36%,AIM2;PSME2;USP50;STAT3;EPHA4;LYN;PSME3;FYN;APH1A;APH1B
prerank,organophosphate biosynthetic process (GO:0090407),0.5514693260308309,1.4738017193010227,0.04642857142857143,0.5698058912069555,1.0,11/37,11.00%,TPI1;ITPKC;MOCS3;PCYT2;AGPAT5;PIP5K1A;PPIP5K1;NFS1;GNPAT;MOCOS;TPK1
prerank,regulation of response to biotic stimulus (GO:0002831),0.571809600039228,1.4725670822832844,0.04218362282878412,0.5728802649929594,1.0,11/28,16.15%,SAMHD1;DHX58;BIRC2;CD55;CX3CL1;ERAP1;N4BP1;TRAF3;FCGR2B;BIRC3;LRP8
prerank,cell proliferation in forebrain (GO:0021846),-0.592122587501415,-1.4717659222314452,0.07961783439490445,0.7848570013366032,1.0,5/10,7.78%,NUMB;DOCK7;PCM1;AKNA;CEP120
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5443203036951585,-1.4716411300970216,0.07042253521126761,0.7716096436188571,1.0,8/13,40.07%,KCND3;KCNT2;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,multivesicular body organization (GO:0036257),0.5616730564095515,1.4694870719807827,0.044063647490820076,0.5842919021717238,1.0,14/31,22.48%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;TSG101;CHMP1A;VPS36
prerank,endosome organization (GO:0007032),0.5429773298135812,1.4687069772687806,0.027122641509433963,0.5852850451500035,1.0,13/41,13.62%,DNAJC13;USP50;SNX33;WASHC4;RILP;SNX10;TMEM9;VPS11;HOOK2;RAB22A;HOOK1;ARFGEF2;HOOK3
prerank,regulation of T cell proliferation (GO:0042129),0.5091712185682672,1.4684083013541847,0.027808676307007785,0.5841302320417242,1.0,11/61,11.62%,CD274;IL15;TNFSF9;SDC4;CCL5;IL27;CD276;NCK1;NCK2;CCDC88B;TNFSF8
prerank,mesoderm formation (GO:0001707),0.6257734760349407,1.467309201795367,0.048678720445062586,0.586581789732843,1.0,5/17,9.69%,ITGA2;ITGA3;SMAD2;SCX;BMPR2
prerank,nuclear membrane organization (GO:0071763),0.6026359825158198,1.4642812313892806,0.05756358768406961,0.5979535915705655,1.0,4/19,9.97%,CHMP4B;TOR1AIP1;TARDBP;UBXN2B
prerank,regulation of lymphocyte activation (GO:0051249),0.6643639749894588,1.4638614036767805,0.0725925925925926,0.5973614113422744,1.0,3/12,8.02%,THEMIS2;CCL5;DCAF15
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5585796376682842,-1.463017937934379,0.06153846153846154,0.7952978184486802,1.0,7/11,34.85%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,protein import (GO:0017038),0.4844559234324192,1.4628332502562345,0.024731182795698924,0.5995023007527076,1.0,29/84,17.56%,CLU;FIS1;RANBP6;RAB8B;SNX33;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;GDAP1;NXT1;RPAIN;ABCD1;PEX2;PPP1R10;SAMM50;HSPA4;IPO8;APOE;TNPO2;HSP90AA1;NUP155;RANBP17;PEX5;PEX13;ATAD1;NUP88
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5504406160324261,1.4620201929959709,0.057571964956195244,0.6007337177991678,1.0,5/30,3.59%,PARP14;SOCS1;SEMA4D;THY1;SFRP2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5787821695072269,-1.4617758181424114,0.09287925696594428,0.7868618573605812,1.0,5/10,22.83%,MTMR4;MTMR1;MTMR9;ABCA3;PHB2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5863940354238976,-1.4616950457128943,0.0729483282674772,0.7740616011918363,1.0,7/10,28.04%,TGFB1;CST3;DPP4;TNFRSF1B;FAP;EMILIN1;CHADL
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5048684532400789,-1.4615815805816363,0.05179282868525897,0.7618761574314115,1.0,8/16,32.71%,SLC39A14;PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,regulation of interleukin-10 production (GO:0032653),0.5262749247910161,1.4600844552688566,0.0461361014994233,0.6069143710080457,1.0,5/44,4.00%,CD274;ISG15;NOD2;STAT3;CD47
prerank,lysine catabolic process (GO:0006554),0.6571599416911897,1.4599140585394024,0.06329113924050633,0.602690057391281,1.0,6/12,15.62%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,lysine metabolic process (GO:0006553),0.6571599416911897,1.4599140585394024,0.06329113924050633,0.602690057391281,1.0,6/12,15.62%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4918201703710794,1.459737428497884,0.01733477789815818,0.6009901684289163,1.0,14/72,9.32%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;SOX9;MYDGF;MYOC;LYN;ROR2;INSR
prerank,sterol transport (GO:0015918),0.6037868712507451,1.4577398046692789,0.06,0.6077891076616591,1.0,8/19,20.93%,LDLRAP1;STARD3;NPC1;NPC2;OSBP;LDLR;OSBPL2;MSR1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3752148859283679,-1.4577090826639638,0.024,0.7656985391422275,1.0,21/46,23.30%,GRM3;CDH2;GRIK1;CACNG7;TSHZ3;DGKZ;HOMER1;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;GRM8;CLN3;UNC13A;CACNG2;SYT1;CACNG3;MEF2C;MAPK8IP2;CCL2
prerank,regulation of presynapse organization (GO:0099174),-0.47271624675193563,-1.4569551434776888,0.07264957264957266,0.7449632035198492,1.0,11/18,29.95%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,regulation of presynapse assembly (GO:1905606),-0.47271624675193563,-1.4569551434776888,0.07264957264957266,0.7449632035198492,1.0,11/18,29.95%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,positive regulation of chemokine production (GO:0032722),0.5207789287958108,1.4559003752826911,0.03416856492027335,0.6137166175423204,1.0,10/44,17.23%,OAS3;EIF2AK2;WNT5A;HMGB1;APP;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6446859325606765,1.4549542627648384,0.08357348703170028,0.615615624892216,1.0,6/13,11.37%,LTV1;LSG1;RRS1;ABCE1;NPM1;EIF6
prerank,protein homooligomerization (GO:0051260),0.4791992725067796,1.4549341579406578,0.013555787278415016,0.6131605827496416,1.0,21/114,12.68%,RNF213;SAMHD1;SYCP1;GBP5;PNPT1;TRPM2;B2M;ATL1;MLKL;SOD2;AQP11;RBMX;AQP4;TRMT61B;ALDH1A2;TK1;RS1;G3BP2;HPRT1;POLQ;ACOT13
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4708005556455896,1.4538691149821665,0.006224066390041493,0.6154652246066379,1.0,24/121,16.43%,PARP14;PARP9;IL15;AGT;CRLF1;SEMA4D;CD40;ACVR1;STAT3;CCL5;EPHA4;DOK7;CSPG4;LYN;FCGR1A;PRNP;PTPN11;NRP1;JAK2;PIBF1;FGFR3;IL18;LRP8;ARL2BP
prerank,cholesterol efflux (GO:0033344),0.6018294808987927,1.453842149584802,0.05858310626702997,0.6130840115085424,1.0,7/20,16.64%,ABCA1;ABCG1;APOE;NPC1;NPC2;SOAT2;SOAT1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.611964273215291,1.4527602530970574,0.07378129117259552,0.6153254172158389,1.0,5/18,8.62%,NOL3;SOD2;NME5;PPIA;NONO
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5716885912054476,1.4525630091352848,0.05449936628643853,0.6137633172936939,1.0,6/24,8.51%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5516747733353661,1.450711467207693,0.04846938775510204,0.619596408758562,1.0,5/29,7.18%,TNFSF10;PML;AGT;RET;CYLD
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6191469055339469,1.4502611651401478,0.05540540540540541,0.6191565913447201,1.0,3/17,0.95%,EIF2AK2;NOD2;TAOK3
prerank,cellular response to gamma radiation (GO:0071480),-0.492065295179569,-1.4500707607650891,0.06882591093117409,0.7618253731092652,1.0,7/17,22.29%,MAP3K20;XRCC5;KDM1A;TP53;HRAS;YAP1;CRYAB
prerank,cochlea morphogenesis (GO:0090103),0.7044947255647747,1.4496221208764777,0.05293276108726753,0.6194859163420002,1.0,2/10,5.43%,MYO3B;SOX9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6837276199562469,1.4494119488300488,0.0945945945945946,0.6179880301942604,1.0,5/10,14.62%,CLU;HSP90AB1;SORL1;RB1;HSP90AA1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6794150383706397,1.4484423537602653,0.07544378698224852,0.620013447923583,1.0,2/11,2.49%,IGF2BP1;IGF2BP3
prerank,insulin secretion (GO:0030073),0.5992687839847072,1.4461376191911626,0.07712765957446809,0.6278930124346339,1.0,4/19,8.11%,CLTRN;GAL;SNX19;RAB11B
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5271091317542892,-1.4458452652070235,0.07348242811501597,0.7675209383169896,1.0,5/14,15.41%,DYRK1A;NIPBL;SAP30BP;ZBTB7B;ING2
prerank,positive regulation of T cell activation (GO:0050870),0.5020304465303272,1.4458175818163108,0.035437430786267994,0.6269162901787717,1.0,22/62,21.34%,CD274;IL15;NOD2;DOCK8;THY1;CD47;CCL5;CD276;NCK1;NCK2;CCDC88B;XBP1;AIF1;FLOT2;LGALS9;MDK;PTPRC;SIRPA;LCK;VCAM1;CD46;RHOH
prerank,regulation of monocyte chemotaxis (GO:0090025),0.577553829973126,1.4456116303804105,0.06844106463878327,0.6254442007943555,1.0,6/24,15.98%,CXCL10;CCL5;LYN;HMGB1;CXCL17;AIF1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4837827745616631,1.445301730188629,0.021739130434782608,0.6245316494837744,1.0,8/75,5.48%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6365887139956963,1.4443492208857613,0.07396870554765292,0.6265194958919706,1.0,4/13,9.05%,SP100;NUP153;MDFIC;BARD1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.651074607839861,1.4441815344395998,0.0824891461649783,0.6247475567886924,1.0,7/13,16.47%,PIK3AP1;UNC93B1;PIK3R4;IRAK4;TNIP2;MYD88;IRAK1
prerank,positive regulation of heart contraction (GO:0045823),-0.47739955029792974,-1.4439769883128453,0.08812260536398467,0.7634677928259609,1.0,14/19,49.37%,ATP2A2;TGFB2;TRPM4;SCN3B;CHGA;RYR2;KCNQ1;ATP1A2;APLN;ADM;EDN3;EDN2;NPPA;EDN1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6211311061837778,1.4431984452453905,0.06938775510204082,0.6268236880927134,1.0,6/16,12.29%,PARP9;DTX3L;MAD2L2;KDM4D;PRKDC;SHLD1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5719378395780663,1.4428513498292797,0.07058823529411765,0.6261241497388137,1.0,4/25,2.90%,NOD2;WNT5A;B2M;CD55
prerank,regulation of inflammatory response (GO:0050727),0.46198934062499103,1.442543521956891,0.0060790273556231,0.6250076200943958,1.0,42/190,17.23%,USP18;ZBP1;PIK3AP1;IL15;CASP4;AGT;AOAH;NOD2;IFI35;WNT5A;BIRC2;NMI;ENPP3;CD47;PTGER4;HCK;CCL5;CX3CL1;AREL1;BCL6;CYLD;DHX9;APP;RORA;TNIP1;ABCC1;APOE;CXCL17;RB1;VAMP2;SHARPIN;BIRC3;JAK2;MYD88;ADAMTS12;DAGLA;TLR2;PPARD;IL18;ACOD1;MDK;TLR3
prerank,in utero embryonic development (GO:0001701),0.5699358884795858,1.442483344610809,0.06914212548015365,0.6229013129968082,1.0,4/25,6.47%,EGFL8;CHD7;FGFR2;WNT7B
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6812968275965894,1.4420349457642465,0.07692307692307693,0.6227543086079423,1.0,4/10,16.66%,WNT5A;CCL5;OXSR1;STK39
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6092567394321668,1.4399550178583742,0.07123655913978495,0.6303407270414707,1.0,3/19,1.53%,HSPA1B;CHMP4B;CHMP1B
prerank,regulation of angiogenesis (GO:0045765),0.45513960807211706,1.4393262280329608,0.005070993914807302,0.6308701375026143,1.0,29/192,11.51%,STAT1;CXCL10;SP100;PML;FLT1;HYAL1;WNT5A;SPRY2;KDR;PIK3CD;AGO2;CD40;MECP2;SASH1;SFRP2;RUNX1;COL4A2;YJEFN3;CTNNB1;RHOJ;MYDGF;ITGB8;HTATIP2;CTSH;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,response to interleukin-1 (GO:0070555),0.49175415144627943,1.439280549167995,0.029882604055496264,0.6286830473196967,1.0,21/73,16.80%,CCL7;HYAL1;GBP3;CD40;GBP2;CD47;CCL5;RBMX;CX3CL1;SOX9;IGBP1;NFKB1;APP;ZC3H12A;CCL14;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;LGALS9
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6499651277806578,1.4391034790035584,0.08175182481751825,0.6270715784022426,1.0,2/12,5.43%,NOD2;SOX9
prerank,lipid droplet formation (GO:0140042),0.6800724985763194,1.4385464555806136,0.07863501483679525,0.6271398516672028,1.0,2/10,2.68%,AUP1;CDS1
prerank,lipid homeostasis (GO:0055088),0.4968390705613016,1.4371853178877576,0.050335570469798654,0.6308882863979399,1.0,21/57,21.72%,ACOXL;ABCA1;USF2;ABCG1;PNPLA2;TLCD2;FBXW7;USF1;ABHD8;ABCD1;THADA;XBP1;APOE;IRS2;ACOX1;PNPLA3;NR1D2;DDX3X;ADCK1;ZBTB20;PNPLA8
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4618054503141296,1.4371689351271781,0.0070921985815602835,0.6286407409360214,1.0,41/175,15.07%,STAT1;EDAR;PSMB10;CCL7;TNFSF9;HYAL1;AIM2;PSME2;BIRC2;ZFP36;TNFRSF8;PSMA5;GBP3;CD40;PSME4;GBP2;CRHBP;CCL5;TXNDC17;CX3CL1;PSMA3;DHX9;TNFRSF17;PSMB9;TRAF3;COMMD7;CIB1;ZC3H12A;ZFP36L1;PSMD2;CCL14;TRAF5;TNFSF8;PSME3;LIMS1;BIRC3;ST18;JAK2;PSMA4;ADAMTS12;INPP5K
prerank,regulation of interleukin-1 beta production (GO:0032651),0.49481036390117566,1.4361593394635457,0.04333694474539545,0.6308287491548673,1.0,20/66,20.02%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;CX3CL1;TMEM106A;APP;GIT1;ZC3H12A;PANX1;JAK2;MYD88;LGALS9;CD33;RIPK2;TYROBP;SIRPA
prerank,B cell mediated immunity (GO:0019724),0.6702583765430694,1.4360241152508413,0.08052708638360176,0.629242698502997,1.0,4/10,15.92%,MSH2;TLR8;FCGR2B;CD27
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.31838825361855544,-1.435473124144423,0.0,0.7874243246752379,1.0,32/87,18.92%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;RPL31;RPL36A;RPLP2;SEC61A1;RPL7;RPL39;RPS9;RPS18;RPL37;SEC61B;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;RPL38;RPL34;RPL18
prerank,neutrophil migration (GO:1990266),0.5007600652457498,1.4354126897163024,0.0335195530726257,0.6296982137684485,1.0,10/58,13.15%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA;CCL14;IRAK4;PIP5K1C
prerank,regulation of interferon-gamma production (GO:0032649),0.4909144538198681,1.4353110738031867,0.029411764705882353,0.6279230522021145,1.0,12/71,12.06%,AXL;CD274;ISG15;CD47;TLR8;IL27;CD276;IL12RB2;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.5075276078896861,1.4342564993751787,0.051627384960718295,0.6305227798382146,1.0,12/50,13.36%,HSPA1B;ISG15;DTX3L;SPRY2;PER2;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,regulation of leukocyte migration (GO:0002685),-0.48680950616585184,-1.4334616890197127,0.09420289855072464,0.7845658942683144,1.0,6/16,18.47%,CD81;NCKAP1L;HMOX1;RAC2;HOXA7;ANXA1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6335638397143003,1.433342197324318,0.08908045977011494,0.6324065380949245,1.0,3/13,12.23%,PER2;MAD2L2;PSEN1
prerank,neutrophil chemotaxis (GO:0030593),0.5068674939074094,1.4332084254746424,0.03881278538812785,0.6306516781056033,1.0,7/53,7.79%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,renal system development (GO:0072001),0.5041579447585982,1.4325807948267912,0.03468208092485549,0.631357080437949,1.0,7/52,10.70%,STAT1;AGT;GREB1L;TFAP2B;NPHP3;PROX1;IFT27
prerank,regulation of cholesterol esterification (GO:0010872),0.685092128149357,1.4324491655750586,0.07993966817496229,0.6296652556061985,1.0,3/10,12.38%,AGT;ABCG1;APOE
prerank,protein targeting to lysosome (GO:0006622),0.5823707810355453,1.4323022124437208,0.08068783068783068,0.6280535166098414,1.0,8/20,15.19%,CLU;LAMP2;GNPTAB;GGA3;NAGPA;HSPA8;SORL1;HGS
prerank,regulation of DNA metabolic process (GO:0051052),-0.3704308512403006,-1.4322403220383353,0.05555555555555555,0.7783599228421264,1.0,17/44,19.59%,XRCC5;MPV17;NBN;SIRT7;UBE2V2;KDM1B;POLH;TERF2IP;PARG;YLPM1;KPNA1;WDR18;THOC1;TOM1L1;KPNA2;MYC;RADX
prerank,protein alkylation (GO:0008213),0.5769589148419627,1.4318305029413647,0.07224334600760456,0.6279296901738812,1.0,9/22,17.45%,PRMT2;METTL21A;GSPT1;EEF2KMT;CAMKMT;FAM98B;ETF1;PRMT1;PRMT3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6210775973608234,1.4310459140800451,0.08232118758434548,0.6291322483457138,1.0,3/16,2.35%,NR1H2;PNPLA2;SLC27A1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6120624926876438,1.430384962888999,0.07565337001375516,0.6298801318614923,1.0,8/16,22.48%,CHMP4A;CHMP4B;LEPROT;LEPROTL1;VPS28;CHMP5;TMEM50A;VPS36
prerank,gene silencing by miRNA (GO:0035195),0.5438392198184653,1.429446055504605,0.0640096618357488,0.6320236071067566,1.0,12/32,17.03%,MOV10;ZFP36;ZC3H7A;ADAR;AGO2;TARBP2;CNOT7;NOTCH4;EIF6;ZC3H7B;DICER1;PRKRA
prerank,negative regulation of myoblast differentiation (GO:0045662),0.649970221123475,1.4292450765145945,0.08142857142857143,0.6307026190084849,1.0,4/13,5.46%,EID2B;PRICKLE1;SOX9;SRA1
prerank,translesion synthesis (GO:0019985),0.5153389423464859,1.4289623771745694,0.05835240274599542,0.6297552778570998,1.0,9/42,5.41%,PARP10;ISG15;UBE2L6;TRIM25;POLE2;POLD4;MAD2L2;RFC4;RFC1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4580940650793788,1.4289512554751922,0.011375387797311272,0.6276133844927891,1.0,33/132,16.61%,IRGM;TRIM14;MOV10;ZC3HAV1;DTX3L;IRS1;PNPT1;PNPLA2;SNX33;TRIM21;ADAM8;CNOT7;SH3GLB1;VPS11;DACT1;ENTPD5;HMGB1;APP;INSR;ABCD1;ZSWIM8;SNX9;ZC3H12A;PSEN1;APOE;SVIP;PIK3CB;BAD;IRS2;HSP90AA1;TMEM59;PHKG2;UPF1
prerank,postreplication repair (GO:0006301),0.5080315815063767,1.4277147870833287,0.05377574370709382,0.6309110655049982,1.0,10/45,6.00%,PARP10;ISG15;MSH2;UBE2L6;TRIM25;POLD4;UBE2B;RFC4;RFC1;WDR33
prerank,T cell migration (GO:0072678),0.6323084347421654,1.4276905393976589,0.09295774647887324,0.6288666847228582,1.0,3/13,2.73%,CXCL10;PIK3CD;CXCL16
prerank,positive regulation of translational initiation (GO:0045948),0.586065743930289,1.427265928800407,0.07378129117259552,0.6286298621791419,1.0,8/18,20.49%,POLR2G;YTHDF1;LARP1;CCL5;YTHDF2;MTOR;EIF2B5;DDX3X
prerank,regulation of endothelial cell proliferation (GO:0001936),0.47361537090874184,1.4267379502209458,0.037037037037037035,0.6288216898259196,1.0,26/88,23.62%,STAT1;XDH;WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;EGFL7;BMPR2;PROX1;VEGFD;APOE;NRP1;AGGF1;NF1;ACVRL1;SPARC;F3;FGF2;AKT3;STAT5A;VASH1;PTPRM;ANG
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5467361896771651,-1.4265604705976742,0.10197368421052631,0.7906862799127142,1.0,7/11,25.02%,EXOSC10;LARP7;EXOSC5;EXOSC3;TENT4B;FBL;PARN
prerank,DNA geometric change (GO:0032392),0.5636381704730223,1.4265085148442949,0.06459948320413436,0.6277389551067868,1.0,11/24,15.24%,ASCC3;DHX36;MCM9;RTEL1;DHX9;HNRNPA2B1;HMGB1;HMGB3;ZRANB3;DDX11;RECQL5
prerank,regulation of chromatin binding (GO:0035561),0.6663787702575517,1.4257204757256596,0.0990990990990991,0.6291330124381987,1.0,7/10,20.14%,PARP9;DTX3L;KDM4D;CDT1;DDX11;HMBOX1;BTAF1
prerank,RNA metabolic process (GO:0016070),0.45692334900362264,1.4257013800124037,0.009202453987730062,0.6271089962957102,1.0,46/127,19.33%,APOBEC1;TP53RK;POLR2G;PNPT1;XRN2;ADAR;AGO2;HNRNPH1;RBMX;DHX36;RNASEH2A;NCBP2;NOL9;HNRNPK;RBMS2;DDX20;ALKBH1;HNRNPM;DHX9;HNRNPA2B1;RNASEH2C;POLR2K;HNRNPL;DDX24;ZC3H12A;HNRNPH3;HNRNPA1;DDX54;ATXN1;PAPOLA;RNASE1;DUSP11;DDX39B;RBM3;RBM39;NCBP1;RNASEH2B;LAGE3;HNRNPA3;DICER1;METTL14;TBRG4;RBPMS;FASTKD2;WTAP;HNRNPF
prerank,negative regulation of neuron death (GO:1901215),0.47452112653946726,1.424617765840783,0.01263157894736842,0.6300074186634397,1.0,19/93,12.39%,CHMP4A;CHMP4B;CRLF1;MSH2;UNC5B;BDNF;SOD2;FBXO7;ADAM8;NENF;MT3;NRBP2;CSF1;AGAP2;GDNF;MAG;SORL1;APOE;PPARGC1A
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5445155573526835,1.424373898079885,0.0625,0.6289014540631325,1.0,12/30,12.68%,DDRGK1;NOP53;HSP90AB1;UBXN1;CAMLG;TRIM39;N4BP1;UCHL5;WAC;RYBP;USP14;SVIP
prerank,positive regulation of binding (GO:0051099),0.4718256241869774,1.4238516861354409,0.032397408207343416,0.6289940154762697,1.0,41/84,27.56%,PARP9;DTX3L;TRIB3;B2M;TRIM21;KDM4D;CDT1;TCF7L2;EDF1;AMFR;DHX9;RAPGEF2;DACT1;BAMBI;MET;HMGB1;APP;MEN1;PSEN1;APOE;DDX11;SPPL3;NCBP1;RPL11;HMBOX1;STK3;PIN1;RIPK2;PLAUR;USP33;IDE;CAPRIN2;SIRT2;ADD2;NVL;LRP1;TXN;TIAM1;MED25;FKBP1A;NMD3
prerank,regulation of phosphorylation (GO:0042325),0.4652494453063305,1.423498181120809,0.012552301255230125,0.6284335652543763,1.0,38/120,19.73%,STAT2;NLRC5;PML;NUP37;PLXNB2;SOCS1;ANKLE2;MCM7;SLC2A6;CCL5;NUP153;NOP53;CDKN2D;KDM4D;RAE1;CCDC88A;LYN;BARD1;APP;PRKAG1;PHIP;EIF6;STAP1;LDB2;LDB1;PSEN1;DYNLL1;NRP1;NUP155;DSCAM;NDUFS4;PTGES3;NUP88;CORO1C;FNIP2;TESK1;PIN1;NUP133
prerank,dicarboxylic acid transport (GO:0006835),0.5415757870846543,1.423467241029185,0.0663265306122449,0.6264490864141717,1.0,7/28,9.06%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;PDPN
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5507254446194552,1.4233102682121783,0.07818411097099622,0.6250724318883225,1.0,6/27,6.90%,AGT;NR1H2;ABCA1;ABCG1;NFKB1;CSF1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5847508027582058,-1.4232183197357542,0.08504398826979472,0.7945971084095359,1.0,5/10,12.77%,EMC2;EMC3;EMC8;MMGT1;EMC9
prerank,positive regulation of catalytic activity (GO:0043085),0.5295744969176618,1.4229075178565596,0.0624263839811543,0.6247736364663632,1.0,13/37,15.76%,NOD2;MSH2;AZIN2;FXN;MT3;MAPK14;CIB1;PSEN1;CHTOP;STX4;APH1A;PHACTR4;NHEJ1
prerank,gonad development (GO:0008406),0.5155613983286101,1.4227817376645517,0.05357142857142857,0.6232689599639343,1.0,6/41,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6726269073649784,1.4226055074250417,0.08284023668639054,0.6219197384925882,1.0,2/10,1.16%,MTHFR;DHFR
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.48538223515460366,1.422302024841331,0.030601092896174863,0.6212255006999554,1.0,15/69,12.39%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;CX3CL1;MT3;NRBP2;AGAP2;NONO;GDNF;MAG;APOE;PPARGC1A
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4024616099673644,-1.4222349364941966,0.054945054945054944,0.7873945510779887,1.0,13/32,20.73%,APOD;RCC2;DMTN;CLASP2;JAG1;SRC;SEMA3E;NEXMIF;ACER2;HOXA7;MAP4K4;ITGB1BP1;DUSP22
prerank,heterocycle biosynthetic process (GO:0018130),0.620795344572455,1.4216661586100745,0.07402031930333818,0.6219387909676201,1.0,4/14,10.53%,MOCS3;NFS1;GCH1;MOCOS
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5316886607255793,1.4210734868768997,0.053987730061349694,0.6224836732128386,1.0,14/36,16.33%,DDRGK1;AQP11;USP25;NOP53;HSP90AB1;UBXN1;CAMLG;TRIM39;N4BP1;UCHL5;WAC;RYBP;RPL11;OPHN1
prerank,regulation of vasoconstriction (GO:0019229),0.5538458075465102,1.4196701567584622,0.06361323155216285,0.6265993621141046,1.0,4/27,9.69%,AGT;PER2;ZDHHC21;BMPR2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6433067426618558,1.4187671562638584,0.10117302052785923,0.6285994797808224,1.0,4/12,11.25%,APOBEC1;RESF1;DNMT1;SETDB2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.464977815606144,1.4182363656433303,0.017616580310880828,0.6287542863300695,1.0,26/114,14.43%,STAT1;EDAR;PSMB10;TNFSF9;AIM2;PSME2;BIRC2;TNFRSF8;PSMA5;CD40;PSME4;TXNDC17;PSMA3;TNFRSF17;PSMB9;TRAF3;COMMD7;PSMD2;TRAF5;TNFSF8;PSME3;LIMS1;BIRC3;ST18;JAK2;PSMA4
prerank,cellular response to UV-A (GO:0071492),-0.5562075449637528,-1.418021398482209,0.10543130990415335,0.793670347963627,1.0,7/11,36.28%,MMP1;CERS1;MMP2;OPN3;PPID;MME;TIMP1
prerank,response to UV-B (GO:0010224),0.6616397898058402,1.416716968906786,0.08649468892261002,0.6332915849658253,1.0,2/12,1.27%,MSH2;HYAL1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.48399013985369105,1.416147380847401,0.03373231773667029,0.6336719789530669,1.0,19/68,17.70%,IFIH1;NOD2;WNT5A;STAT3;TLR8;DHX9;TMEM106A;HMGB1;APP;SPHK2;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.44618830683770033,1.4159372817094293,0.007099391480730223,0.6325146268806935,1.0,66/186,24.22%,RNF213;WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;GRB10;TMEM170B;SFRP2;MAD2L2;PRICKLE1;SOX9;PFDN5;PSMA3;TCF7L2;HMGXB4;NPHP3;SNAI2;BICC1;AMFR;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;APCDD1;PSMD2;SCYL2;MDFI;PSME3;APOE;LZTS2;RACK1;CXXC4;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD9;STK3;PSMD8;PSMF1;WWOX;STK11;PSMB6;PSMD12;PSMC2;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;PSMA2;AXIN1;TLE5;KREMEN1
prerank,inflammatory response (GO:0006954),0.4489847441024139,1.415735015682342,0.007063572149344097,0.6314767287897194,1.0,34/195,12.93%,CXCL10;TPST1;CXCL9;SIGLEC1;CCL7;HYAL1;NOD1;CXCR4;PIK3CD;NFX1;CD40;STAT3;FPR3;ADAM8;CYBB;PTGER4;CRHBP;CCL5;TACR1;CX3CL1;TAC1;NFKB1;TMIGD3;PTGER3;HMGB1;TAC4;C3AR1;IL17D;CCL14;IL10RB;ABCF1;RELB;REL;FCGR2B
prerank,response to organophosphorus (GO:0046683),0.604796362810103,1.4147392435773558,0.09690444145356662,0.6336975621226068,1.0,1/16,0.06%,STAT1
prerank,negative regulation of immune effector process (GO:0002698),0.6341500265531156,1.4142121004964359,0.09455587392550144,0.6339191320575764,1.0,5/13,15.47%,CD55;ENPP3;CD47;HAVCR2;CD300A
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4994874706295898,1.414103499730051,0.05131128848346636,0.6323855800495238,1.0,15/52,12.66%,ZBTB17;ATP6V0D1;YIF1A;KLHDC3;SRPRA;HYOU1;GOSR2;MYDGF;CUL7;GFPT1;VAPB;XBP1;PDIA6;EXTL3;DDX11
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5059678403780996,-1.4128280731100162,0.08868501529051988,0.804381300832728,1.0,6/13,18.27%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,negative regulation of lipid storage (GO:0010888),0.5759745647720906,1.4127887437162887,0.07352941176470588,0.6361979426329688,1.0,5/19,4.76%,NR1H2;ABCA1;ABCG1;PNPLA2;OSBPL8
prerank,negative regulation of catalytic activity (GO:0043086),0.5634613732364909,1.412603180693904,0.08310991957104558,0.6349788519979365,1.0,4/24,8.10%,IFIT1;PARP9;MT3;CAND1
prerank,histone H2B ubiquitination (GO:0033523),0.6596055914606228,1.4122840513153987,0.09316770186335403,0.6344899401817213,1.0,4/10,9.88%,DTX3L;RNF40;UBE2E1;WAC
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.45645781614023195,1.4122011326590929,0.009155645981688708,0.6329236675240482,1.0,39/149,16.80%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;RBCK1;TRIM21;ADAM8;RHEBL1;CX3CL1;CFLAR;NFKB1;DHX9;PPIA;RNF31;APP;CIB1;NPM1;TRAF5;RTKN2;RNF25;IL1RAP;PRKCH;MYD88;TLR2;IL18;IRAK1;FLOT2;LGALS9
prerank,determination of bilateral symmetry (GO:0009855),0.5625953768073911,1.411842299217109,0.08062418725617686,0.6325753235537714,1.0,4/24,6.86%,PITX2;ODAD2;NPHP3;KIF3B
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4533984486343019,1.4105987085949832,0.02158273381294964,0.6357334702230106,1.0,29/136,13.61%,SP100;NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;MAD2L2;ID3;BHLHE40;TCF7L2;TMIGD3;CYLD;PRNP;MEN1;TRAF3;ARRB2;PROX1;COMMD7;BTRC;ZC3H12A;SIK1;TAF3;PIM1;MDFI;HAVCR2;PAXIP1;RB1;PTCH1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.5295271160661943,1.4103967043237218,0.07923169267707082,0.6347642780758985,1.0,10/33,18.57%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC;MTURN;PRMT1;ACVR2A;HOXA5
prerank,regulation of extracellular matrix organization (GO:1903053),0.599850781146984,1.4102748357481778,0.10052910052910052,0.6333494935313829,1.0,8/15,23.31%,AGT;RUNX1;AEBP1;RB1;RIC1;DDR2;ANGPTL7;NOTCH1
prerank,regulation of p38MAPK cascade (GO:1900744),0.5189984212639724,1.4093425322166426,0.07938388625592417,0.6353814766383112,1.0,15/35,21.18%,XDH;GADD45G;SASH1;CYLD;ZC3H12A;DUSP10;MAP3K4;DLG1;MINK1;PRMT1;LGALS9;RELL1;MFHAS1;PER1;GADD45A
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6113523153565332,1.4091872194068737,0.08446866485013624,0.6321113367898183,1.0,5/15,11.03%,ZFP36;AGO2;DHX36;CNOT7;ZFP36L1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6113523153565332,1.4091872194068737,0.08446866485013624,0.6321113367898183,1.0,5/15,11.03%,ZFP36;AGO2;DHX36;CNOT7;ZFP36L1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5199495455873878,1.4073523797333973,0.06159420289855073,0.6379964695111896,1.0,12/37,11.49%,PML;DDRGK1;NOP53;HSP90AB1;UBXN1;CAMLG;TRIM39;CSNK2A2;N4BP1;UCHL5;WAC;RYBP
prerank,positive regulation of neuron migration (GO:2001224),-0.5524552222295703,-1.4069848039723838,0.12302839116719243,0.8180863340946142,1.0,7/11,13.59%,NIPBL;SHTN1;KIF20B;SEMA6A;DAB2IP;NSMF;ARHGEF2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5971422753825304,1.4049355741639582,0.08594815825375171,0.6467273178706805,1.0,2/16,1.75%,PARP14;SOCS1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.631857787715642,1.4049291049114863,0.10416666666666667,0.644797905558547,1.0,4/13,4.86%,POLR2G;ZFP36;AGO2;CNOT7
prerank,RNA splicing (GO:0008380),0.47067884378583924,1.4049120988826442,0.03249475890985325,0.642898316743526,1.0,35/95,17.98%,NOL3;TARDBP;MAGOHB;TXNL4A;PRPF18;NCBP2;RRAGC;CDK12;NONO;BCAS2;RNPC3;SRPK1;RSRC1;RNPS1;WDR83;HNRNPH3;PPARGC1A;USP39;SNRPD2;SNRPD1;DBR1;DDX39B;SNRPG;NCBP1;DHX16;GEMIN2;SF3B4;SRSF7;NRDE2;SRSF4;DDX47;DDX23;SNRNP48;SLU7;SCNM1
prerank,mesonephros development (GO:0001823),-0.5436276026329812,-1.4048211203336207,0.1,0.8166725254998509,1.0,7/11,35.74%,FGF10;ZBTB16;PAX8;OSR1;BMP4;GATA3;BMP7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6356153220394407,1.4037212079009647,0.09010339734121123,0.6439995428516994,1.0,4/12,11.81%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6356153220394407,1.4037212079009647,0.09010339734121123,0.6439995428516994,1.0,4/12,11.81%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5988488029605311,1.4033257512667745,0.08310626702997276,0.6439166315686055,1.0,4/17,13.32%,EIF2AK2;FGFR2;HPSE;NELL1
prerank,regulation of translational initiation (GO:0006446),0.4793634622535772,1.403252891796845,0.052980132450331126,0.6422667115319423,1.0,24/63,20.49%,POLR2G;EIF4A2;AGO2;YTHDF1;LARP1;CCL5;NCBP2;EIF4EBP2;ALKBH1;YTHDF2;NCK1;EIF2B2;NCK2;EIF4H;NPM1;EIF4G3;EIF1B;NCBP1;EIF4B;EIF2B5;EIF5;CSDE1;GLE1;DDX3X
prerank,midbody abscission (GO:0061952),0.6001696301639585,1.4023956271788307,0.08609271523178808,0.6441429992001898,1.0,3/17,1.53%,CHMP4A;CHMP4B;CHMP1B
prerank,nucleoside salvage (GO:0043174),0.6641242052579852,1.4021795556641048,0.08682634730538923,0.6431415374782876,1.0,5/10,15.04%,DCK;TK1;TK2;HPRT1;UCKL1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6645023207917045,1.4020589076434473,0.10541310541310542,0.6417635335542085,1.0,3/10,16.80%,CD274;PRNP;LGALS9
prerank,lamellipodium organization (GO:0097581),0.5269659048192227,1.4019383730764217,0.08354755784061697,0.6403611421006156,1.0,11/29,16.70%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;WHAMM;RAC1;SNX1
prerank,regulation of viral release from host cell (GO:1902186),0.5785803619238806,1.4015151084571726,0.0847457627118644,0.6403375539829224,1.0,8/21,21.53%,PML;TRIM25;TRIM21;CHMP3;TRIM26;TRIM62;TRIM13;TSG101
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5603346667933505,1.4007180425914794,0.0858974358974359,0.6421067627071656,1.0,7/22,16.95%,SOCS1;LAG3;RUNX1;BCL6;NFATC2;DUSP10;MDK
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.5101241496279436,1.3992308819771164,0.09344660194174757,0.646807537428959,1.0,13/38,17.46%,XDH;TRIB3;OTUD3;NOP53;PPP2R5C;MAGI2;ARRB2;CIB1;PLEKHA1;RACK1;PIK3CB;INPP5K;PHLDA3
prerank,nucleocytoplasmic transport (GO:0006913),0.5118949530679183,1.3989786328729064,0.06330597889800703,0.6459239266548971,1.0,16/40,15.44%,PHAX;NCBP2;LSG1;DDX20;NXT1;HTATIP2;NPM1;RSRC1;HNRNPA1;ATXN1;SNRPD2;SNRPD1;GEMIN7;SNRPG;NCBP1;GEMIN2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5380776954321016,-1.398865562727853,0.09846153846153846,0.8316107869794763,1.0,6/11,20.39%,TGFB1;CASP8;ID2;RIPK1;PF4;IL34
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4255626939924759,-1.39870527293572,0.07589285714285714,0.8217997575456557,1.0,12/24,21.74%,CDH2;CTNNA1;OLFM2;RBM4;CTNNA2;CDC42;CAMK1;BNIP2;BOC;ABL1;MEF2C;TCF3
prerank,granulocyte chemotaxis (GO:0071621),0.494040558960057,1.3987001320325783,0.04431818181818182,0.6452843319025053,1.0,7/55,7.79%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,positive regulation of vasculature development (GO:1904018),0.46111837540187833,1.3982653617047565,0.032873806998939555,0.6453339568728891,1.0,17/94,11.51%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SMOC2;ZC3H12A;VEGFD;XBP1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5355349699636931,-1.3974199705096102,0.10862619808306709,0.8171564087375803,1.0,4/12,15.41%,NIPBL;SAP30BP;ZBTB7B;ING2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.48904787010097145,-1.3973060837321347,0.09574468085106383,0.807472173723136,1.0,5/16,7.58%,GPR137C;GPR137B;RRAGD;RRAGB;LARS1
prerank,stress granule assembly (GO:0034063),0.5625887803617695,1.39677759139146,0.09959623149394348,0.6499276154809457,1.0,9/20,24.18%,YTHDF1;DYNC1H1;YTHDF2;EIF2S1;OGFOD1;CSDE1;DDX3X;G3BP1;UBAP2L
prerank,epithelial cell migration (GO:0010631),0.5118535786564073,1.3950426342631481,0.08160779537149818,0.6555806742785399,1.0,4/37,3.97%,STAT1;LOXL2;CDH13;PKN2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6267027133136543,1.3947000661508615,0.10349854227405247,0.6552230473637507,1.0,3/12,1.77%,NR1H2;ABCA1;ABCG1
prerank,positive regulation of T cell proliferation (GO:0042102),0.4887053678935197,1.3929533805825787,0.06451612903225806,0.6609663653988287,1.0,10/55,10.59%,CD274;IL15;ICOSLG;TNFSF9;CCL5;CD276;NCK1;HMGB1;NCK2;CCDC88B
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.546177148964223,1.3915207420889208,0.062261753494282084,0.6653569220469863,1.0,6/27,8.57%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5976227082502862,1.3914473147799824,0.11051930758988016,0.663792505050992,1.0,4/17,5.68%,SASH1;CD55;CX3CL1;LY86
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6114743964365673,1.3913581110416477,0.11576011157601115,0.6622853748938196,1.0,6/14,21.10%,CCL7;WNT5A;CCL5;OXSR1;STK39;CCL4
prerank,positive regulation of dendrite development (GO:1900006),-0.5698892868562464,-1.3912049259789934,0.09831460674157304,0.8229431149837081,1.0,5/10,12.06%,COBL;ALK;DAB2IP;ZDHHC15;VLDLR
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5372110791690533,-1.3907620155517864,0.10610932475884244,0.8146893055614494,1.0,8/12,31.80%,WASL;AKT1;NBL1;BMP5;CCN3;GREM1;DUSP1;PLCB1
prerank,DNA double-strand break processing (GO:0000729),-0.46628265312480577,-1.3904409163199514,0.10566037735849057,0.8064666953476763,1.0,10/18,25.15%,NBN;UBE2V2;EXD2;SLX4;DNA2;BRCA1;RNF138;SETMAR;MRE11;RAD50
prerank,response to sterol (GO:0036314),-0.5543910657146586,-1.390412312922419,0.11337209302325581,0.7971655662976259,1.0,6/11,11.32%,CCR5;TGFB1;ABCA2;INSIG1;CCL3;PMVK
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5104803037383994,1.3901805700293712,0.06758304696449026,0.6654737785576003,1.0,6/40,9.43%,GBP4;STAB2;GBP2;GBP7;RNASE7;PPP1R11
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5058864010838143,1.3898905382010236,0.06777645659928656,0.6648338271016715,1.0,9/35,12.53%,ESR2;DAXX;DDX5;EGLN2;PMEPA1;UBE3A;ARID1A;NR3C1;DDX54
prerank,regulation of ERAD pathway (GO:1904292),0.6362109421538302,1.3896898175932206,0.11487481590574374,0.6637684019244439,1.0,5/11,12.98%,AQP11;USP25;RNFT1;UBXN1;RNF185
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6087290657831549,1.3894270372612993,0.10359712230215827,0.6629651235720502,1.0,5/14,13.33%,KDR;PIK3CD;MYO1C;VEGFD;NRP1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.31187085859406954,-1.3892424635220624,0.0,0.7926251219935002,1.0,33/91,18.92%,TRAM1;RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;SSR1;RPL31;RPL36A;RPLP2;SEC61A1;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;SIL1;SRP19;UBA52;RPS25;RPS27A;RPL38;RPL34;RPL18
prerank,positive regulation of peptidase activity (GO:0010952),0.5482409791700827,1.3889816223745948,0.09491978609625669,0.6631039081587337,1.0,12/20,27.59%,PSME2;DDRGK1;CTSH;PSME3;APH1A;APH1B;TANK;VCP;PSENEN;GRN;VSIR;PRELID1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.613230708399896,1.3889072616420164,0.10795454545454546,0.6615651767239504,1.0,5/12,19.07%,IRGM;FYCO1;INSR;JMJD4;UVRAG
prerank,regulation of AMPA receptor activity (GO:2000311),-0.41791230846028726,-1.3882183611904024,0.06542056074766354,0.7872541422569572,1.0,17/25,29.73%,CACNG7;SHISA9;NLGN2;SHISA6;CACNG8;SHANK3;GSG1L;PRRT1;SHISA7;CACNG2;CACNG3;MEF2C;SHANK1;MAPK8IP2;CACNG5;ADRB2;SHISA8
prerank,cholesterol transport (GO:0030301),0.4995010250404195,1.3880651472327086,0.07719298245614035,0.6634712751971138,1.0,16/45,22.54%,ABCA1;ABCG1;CLU;LIPC;LDLRAP1;STARD3;APOE;NPC1;NPC2;OSBP;SOAT2;SOAT1;LDLR;OSBPL2;MSR1;ABCA5
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.45451464776344164,1.3877483027408926,0.034736842105263156,0.6629143604738962,1.0,27/104,15.26%,PKMYT1;IRGM;TRIB3;SLC27A1;CCNJ;THY1;SLC8A1;CCND2;CDKN2D;CCND1;CDK12;ETAA1;CCNT2;CAB39;CNPPD1;MTCP1;MNAT1;CIB1;MAP2K2;RB1;TELO2;CCNI;ACTB;SERTAD1;EZH2;HGS;CALM3
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5018935364504281,1.387488696314802,0.07838479809976247,0.6621717651311584,1.0,4/41,3.83%,CLTRN;KCNMB3;CTSS;ACTN2
prerank,positive regulation of double-strand break repair (GO:2000781),0.5074342999353667,1.3874022992622377,0.07109004739336493,0.6606913674686956,1.0,11/39,12.66%,PARP9;DTX3L;TIMELESS;ACTR2;MAD2L2;KDM4D;SLF2;ARID2;PRKDC;SHLD1;DDX11
prerank,mesonephric tubule development (GO:0072164),0.6007478357140934,1.3872348136731651,0.08913649025069638,0.6596359883842251,1.0,2/15,6.02%,WNT11;FGFR2
prerank,plasma membrane tubulation (GO:0097320),0.6092587596021313,1.3863050345445749,0.10841654778887304,0.6617882540776642,1.0,5/13,13.51%,CHMP4A;SNX33;FNBP1L;SNX9;WHAMM
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6566789325224749,1.3850723581951214,0.10309278350515463,0.6651971703011083,1.0,5/11,11.00%,ENPP3;SLC25A19;DCK;NT5C3A;TPK1
prerank,positive regulation of cytokine production (GO:0001819),0.4358412179705172,1.384899152827718,0.00501002004008016,0.6641244406892817,1.0,49/292,12.43%,ZBP1;EIF2AK2;IRF7;IFIH1;HSPA1B;CD274;ISG15;IL15;AGT;NOD2;GBP5;DHX58;NOD1;WNT5A;PIK3CD;DHX33;CD40;NFKB2;STAT3;CGAS;RUNX1;PTGER4;DHX36;TLR8;CTNNB1;IL27;CD276;NFKB1;POLR3B;DHX9;TMEM106A;IL12RB2;POLR3GL;HMGB1;APP;RORA;POLR2K;MAPK14;SPHK2;TMED10;CCDC88B;HPSE;IL17D;XBP1;SORL1;HAVCR2;PTPN11;PRKDC;CXCL17
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4918641447118662,1.3847191556792218,0.06802721088435375,0.662986561749309,1.0,11/49,17.23%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;TLR3
prerank,negative regulation of viral transcription (GO:0032897),0.6320038225884828,1.3847103607689883,0.09577464788732394,0.6612367080060952,1.0,4/13,6.96%,TRIM14;ZFP36;TRIM21;UBP1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5875795591349158,1.3843512360056915,0.11142061281337047,0.6609248426462734,1.0,11/15,33.95%,MET;SMOC2;P2RX4;FGF2;NOTCH1;SEMA5A;FGF1;PRKD1;PRKD2;LGMN;TMSB4X
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.4339276598980083,1.3840169734596153,0.0,0.6605767447834956,1.0,113/509,17.23%,DDX60;OASL;EIF2AK2;AXL;PIK3AP1;EDAR;WNT11;TNFSF10;TRIM14;AGT;NOD2;BST2;FLT1;UNC5B;DHX58;IFI35;NOD1;TRIB3;WNT5A;SPRY2;ALPK1;IRS1;KDR;TRIM25;MIOS;BIRC2;PIK3CD;FIS1;GPR37L1;DHX33;SEMA4D;CD40;CDH13;KITLG;CANT1;SASH1;CGAS;BCL2L11;NMI;TGFA;RBCK1;LRP2;TRIM21;ADAM8;USP15;CCL5;SIAH1;OSBPL8;IKBKE;DHX36;HSP90AB1;CX3CL1;RRAGC;SOX9;MYDGF;FGFR2;CFLAR;TCF7L2;GPR37;RET;TSPAN6;TMEM106A;MYOC;RAPGEF2;TMEM9B;RNF31;LYN;MET;P2RX4;HMGB1;APP;ROR2;INSR;VAV1;SPHK2;HPSE;ADGRV1;IRAK4;FGF9;TRAF5;RTKN2;NEK6;PTPN11;REL;LAMTOR3;MIER1;RACK1;LIMS1;PIK3CB;BAD;AKAP13;SHARPIN;BIRC3;RAC1;FYN;JAK2;IRS2;HSP90AA1;SOX2;TNIP2;MYD88;TLR2;BMF;CD27;FGFR3;IL18;IRAK1;LGALS9;MIB2;ZDHHC13;BAX;RUNDC3A;TLR3
prerank,error-free translesion synthesis (GO:0070987),-0.4431959993152969,-1.3837102335725404,0.08294930875576037,0.7960499210885382,1.0,14/22,19.67%,RPA1;RFC2;POLH;UBB;RCHY1;NPLOC4;RFC3;UBC;UFD1;UBA52;RPS27A;RPA3;RFC5;POLD1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6044418892320577,1.3836577962991836,0.11576011157601115,0.6602899486900768,1.0,7/15,22.02%,AGT;NFKB1;CSF1;PRKCH;IL18;MSR1;MAPK9
prerank,regulation of stem cell proliferation (GO:0072091),0.575712921135969,1.3836150874024615,0.10540915395284327,0.6586954660527554,1.0,1/17,0.13%,EIF2AK2
prerank,regulation of phosphate metabolic process (GO:0019220),0.5944466619892704,1.3828678702354429,0.09919571045576407,0.6600648627736241,1.0,6/16,12.23%,MCM7;SMG7;IGBP1;BARD1;SMG5;PSEN1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.44152530977198284,-1.3821127716744763,0.08936170212765958,0.7935140143232826,1.0,8/20,20.05%,ITGAV;CASP3;GSK3B;CASP9;APPL1;DCC;BAK1;FAS
prerank,cellular response to ionizing radiation (GO:0071479),-0.3546363029993664,-1.3817714068548204,0.034013605442176874,0.7860087311121295,1.0,18/47,19.97%,MAP3K20;XRCC5;INO80;NIPBL;RHNO1;SPIDR;SIRT1;EEF1D;HUS1;KDM1A;TP53;CDKN1A;HRAS;RAD1;YAP1;NET1;ECT2;RAD51AP1
prerank,negative regulation of viral life cycle (GO:1903901),0.5985721689426838,1.3811834650832564,0.1172316384180791,0.6655828098591291,1.0,5/15,11.99%,BST2;LY6E;PPIA;GSN;TRIM26
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6312713526994589,1.3803031878893917,0.11189801699716714,0.6675465185150856,1.0,2/12,1.63%,RER1;GPAA1
prerank,endothelial cell migration (GO:0043542),0.510180237360714,1.3798756713748461,0.08323424494649227,0.6676421184436041,1.0,3/37,2.75%,STAT1;LOXL2;CDH13
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.49371309928755364,1.379342615036029,0.08129175946547884,0.6681837817193442,1.0,14/50,17.23%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;APP;RTKN2;LIMS1;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,regulation of nuclear division (GO:0051783),0.5654635321443715,1.3786828853373605,0.11492734478203434,0.6693137800664455,1.0,4/20,6.30%,PKMYT1;DAPK3;PDXP;CUL7
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.44371176244029964,1.3786769353943356,0.011122345803842264,0.6675768660830335,1.0,34/182,12.99%,PARP14;PARP10;PARP9;MOV10;APOBEC1;ABCC2;XDH;KDR;DDRGK1;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;CNOT7;HSP90AB1;FBXW7;NFKB1;WDR54;PTRH2;ITGB8;DNMT1;APP;LRPAP1;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;RACK1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.57353404719576,1.3786210416463076,0.0965034965034965,0.6660547931941652,1.0,6/16,17.09%,ESR2;DDX5;EGLN2;ARID1A;DDX54;TRIP4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5491491593566222,1.3776651960703417,0.08634020618556701,0.6683545735899175,1.0,8/24,12.38%,PSME2;UBE3A;EPHA4;CTSC;UCHL5;USP14;PSME3;APOE
prerank,epidermal cell differentiation (GO:0009913),0.49187105940883324,1.3764973375784848,0.07060185185185185,0.671862178044589,1.0,5/41,6.64%,PITX2;CLIC4;WNT5A;CTNNB1;PIP5K1A
prerank,positive regulation of epithelial cell migration (GO:0010634),0.45053734485264507,1.376126631024756,0.04343220338983051,0.6716255477684022,1.0,24/92,17.21%,AGT;HYAL1;WNT5A;KDR;PIK3CD;NRP2;SASH1;SOX9;CTSH;BCAR1;SMOC2;BMPR2;PROX1;PPM1F;ZC3H12A;RIN2;PRKCE;PIK3CB;NRP1;RAC1;RREB1;MTOR;RAB11A;IQSEC1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6039940964499753,1.3760418751134385,0.12772133526850507,0.6702731975762265,1.0,3/13,3.32%,NR1H2;CLU;AQP11
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6604323772939802,1.3757890953664043,0.11596385542168675,0.6696540881922679,1.0,3/10,8.54%,PCGF5;MECP2;DNMT3A
prerank,sterol homeostasis (GO:0055092),0.4694341434422657,1.37540950841181,0.05945945945945946,0.6695262684721971,1.0,19/65,19.03%,NR1H2;ABCA1;ABCG1;LIPC;RORA;LDLRAP1;ABCD1;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B
prerank,neuromuscular process controlling balance (GO:0050885),-0.5072596477623961,-1.3742706194472398,0.13245033112582782,0.8068127774585725,1.0,7/12,29.53%,CDH23;NRXN1;MYO7A;CLN3;SHANK1;CLRN1;TIFAB
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4743096267020729,-1.371901561527708,0.10256410256410256,0.7984319117098204,1.0,8/16,25.19%,APOD;RCC2;DMTN;CLASP2;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4743096267020729,-1.371901561527708,0.10256410256410256,0.7984319117098204,1.0,8/16,25.19%,APOD;RCC2;DMTN;CLASP2;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,lipid droplet organization (GO:0034389),0.550091434973784,1.3707757234816027,0.11125827814569536,0.6874736206806902,1.0,7/22,24.29%,AUP1;CDS1;PPIA;FAF2;PNPLA3;ZFYVE1;BSCL2
prerank,protein targeting to peroxisome (GO:0006625),0.5148521705854218,1.370692000368156,0.08439897698209718,0.686032379550825,1.0,10/29,17.38%,FIS1;RAB8B;PEX7;LONP2;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4789448174423311,1.370639436427283,0.0673289183222958,0.6845135351849696,1.0,13/54,13.36%,HSPA1B;ISG15;SPRY2;PER2;TRIM21;CTNNB1;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,negative regulation of cytokine production (GO:0001818),0.4433641237068444,1.3700798197146116,0.024489795918367346,0.685284242411138,1.0,29/163,14.73%,NLRC5;AXL;IFIH1;CD274;ISG15;SLAMF1;UBE2L6;ILRUN;DHX58;TRIM25;ZFP36;PTGER4;IKBKE;TLR8;CX3CL1;CYLD;N4BP1;HMGB1;PPP1R11;PRNP;ABCD1;ZC3H12A;HAVCR2;CHID1;FCGR2B;RAC1;CD84;PIBF1;NPTN
prerank,embryonic hemopoiesis (GO:0035162),0.618646863383575,1.3695942354209183,0.12922173274596183,0.6857280718220325,1.0,3/12,5.65%,KDR;KITLG;KMT2A
prerank,megakaryocyte differentiation (GO:0030219),-0.541869678377189,-1.3689329250093427,0.1188118811881188,0.8016088481938094,1.0,3/11,33.48%,UBA5;ZFPM1;TAL1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5488586874994479,1.3689143706907876,0.09881422924901186,0.6868496505202507,1.0,8/23,20.99%,IFI35;NMI;CYLD;TSPAN6;ZC3H12A;UACA;DDX3X;ADIPOR1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4534775175889362,1.3683938850107324,0.04935622317596566,0.6873127374068089,1.0,21/85,15.78%,NOD2;HYAL1;ZFP36;B2M;SGPP2;TGFA;AQP11;SFRP2;LAMC1;SOX9;FGFR2;TCF7L2;PEX2;ZFP36L1;FGF9;PRKDC;DUSP10;LIMS1;BAD;SOX2;MCC
prerank,regulation of cellular component biogenesis (GO:0044087),0.5011438683182575,1.368300571581081,0.10023584905660378,0.6859599825528481,1.0,10/39,14.62%,PARP10;IRGM;AGT;VPS11;RAPGEF2;HSPA8;PTPN11;APOE;RAPGEF1;HSP90AA1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5664455686766562,1.3682510565281183,0.11804613297150611,0.6844567814445448,1.0,5/18,14.38%,STAT1;STAT3;PTPN11;ST18;JAK2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5260546003879935,1.3678953293733507,0.09359605911330049,0.6843960337532999,1.0,11/29,17.03%,ZC3H7A;ADAR;AGO2;TARBP2;SRRT;HNRNPA2B1;SMAD2;ZC3H7B;TUT7;DICER1;PRKRA
prerank,blood circulation (GO:0008015),0.48441942877833094,1.3676747177365434,0.07525655644241733,0.6836590942861267,1.0,5/49,10.25%,STAT1;CXCL10;TBC1D8;CYB5R3;C3AR1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.6296220029301051,1.367450149743503,0.13069016152716592,0.6828931252903299,1.0,4/11,12.98%,AUP1;RNF5;POMT2;RNF185
prerank,positive regulation of protein binding (GO:0032092),0.4736424096570922,1.3672359718399159,0.08793686583990981,0.6821736928139939,1.0,28/56,27.56%,DTX3L;TRIB3;BDNF;B2M;TRIM21;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;MEN1;PSEN1;APOE;SPPL3;RPL11;STK3;PIN1;RIPK2;USP33;IDE;CAPRIN2;ADD2;NVL;LRP1;TIAM1;FKBP1A;NMD3
prerank,response to cholesterol (GO:0070723),-0.4685675773131905,-1.3671167463430356,0.10600706713780919,0.8000412141137713,1.0,8/17,11.32%,CCR5;TGFB1;GRAMD1A;LRP6;GRAMD1B;ABCA2;CCL3;PMVK
prerank,central nervous system neuron development (GO:0021954),0.590750812982633,1.3669000499045376,0.11275167785234899,0.6818787502044383,1.0,5/15,18.66%,HSP90AB1;RAPGEF2;B4GALT5;HSP90AA1;GBA2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6323422027332053,1.366528450384977,0.10028653295128939,0.6817777067163098,1.0,2/12,0.58%,CHMP4A;CHMP4B
prerank,eosinophil migration (GO:0072677),0.6081716215626015,1.3660339557267982,0.12921348314606743,0.6805849452778935,1.0,3/14,5.24%,CCL7;CCL5;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.6081716215626015,1.3660339557267982,0.12921348314606743,0.6805849452778935,1.0,3/14,5.24%,CCL7;CCL5;CX3CL1
prerank,positive regulation of inflammatory response (GO:0050729),0.4587217866598623,1.365898514083254,0.047872340425531915,0.6794931706393658,1.0,14/86,11.15%,ZBP1;IL15;AGT;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CX3CL1;DHX9;APP;TNIP1;ABCC1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5136616976642174,1.3657063649474719,0.08926417370325694,0.6785230835246657,1.0,11/35,14.30%,CLU;B2M;RAB21;HNRNPK;LDLRAP1;MKLN1;LRPAP1;PIK3CB;RAC1;SMAP1;SNAP91
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4849063833343058,1.3655071945391561,0.07990867579908675,0.6776441652923861,1.0,13/47,14.55%,TRIB3;SLC27A1;ACADL;FBXW7;NFKB1;SNAI2;RAPGEF2;PROX1;ZC3H12A;SIK1;CLK2;FYN;ERLIN2
prerank,actin filament bundle organization (GO:0061572),-0.3885418747489757,-1.3649400963013771,0.060240963855421686,0.8000561146721237,1.0,7/33,7.60%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5647754704705791,1.3636835209242995,0.09814323607427056,0.6835554575704511,1.0,6/19,13.11%,XDH;SPRY2;ADAMTS3;MYO1C;SMOC2;PIK3CB
prerank,early endosome to late endosome transport (GO:0045022),0.5690812631579643,1.3632285153310788,0.11228533685601057,0.6838867837102403,1.0,12/20,26.25%,RILP;HOOK2;STX8;KIF16B;HOOK1;ANKRD27;HOOK3;WDR91;BECN1;EEA1;PTPN23;SNF8
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.43675516321363955,1.362111122329295,0.024390243902439025,0.6869337443547499,1.0,32/150,16.08%,AXL;PIK3AP1;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OSBPL8;HSP90AB1;CX3CL1;MYDGF;FGFR2;TCF7L2;RET;MYOC;MET;P2RX4;INSR;VAV1;HPSE;FGF9;PTPN11;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;FGFR3;IL18
prerank,protein import into peroxisome membrane (GO:0045046),0.5381113772823486,1.3619366525103227,0.10242587601078167,0.686008668208533,1.0,8/22,17.38%,FIS1;RAB8B;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5368225155673092,1.3603934648409732,0.10925449871465295,0.6908960326013084,1.0,10/24,19.12%,KDR;THY1;DUSP3;MYOC;PPM1F;LIMS1;NRP1;RAC1;IQSEC1;TSC1
prerank,regulation of blood circulation (GO:1903522),0.5007027767361178,1.3600359537519364,0.10462287104622871,0.6907198563699257,1.0,4/34,7.01%,AGT;CAMK2D;PER2;TMIGD3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.47698495403353336,1.3598183826675612,0.08720271800679502,0.6899088023539348,1.0,14/50,17.60%,PKMYT1;CCNJ;CCND2;HSP90AB1;CDKN2D;CCND1;CCNT2;CNPPD1;MNAT1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,homocysteine metabolic process (GO:0050667),0.6232393217465817,1.3597693616256108,0.1297134238310709,0.6884335828155109,1.0,1/11,0.30%,MTHFR
prerank,regulation of axon guidance (GO:1902667),0.6446261899930007,1.3597585373947805,0.12788906009244994,0.6868326609573528,1.0,5/10,15.21%,TUBB2B;YTHDF1;ZSWIM8;NRP1;MYCBP2
prerank,regulation of fibroblast proliferation (GO:0048145),0.48921345185737014,1.3591498472616819,0.08525345622119816,0.6877567943330413,1.0,7/45,9.55%,PARP10;AGT;WNT5A;MORC3;CTNNB1;DHX9;PEX2
prerank,regulation of chemokine production (GO:0032642),0.5018755085880913,1.359074309434038,0.09501187648456057,0.6864175075067741,1.0,9/36,17.23%,EIF2AK2;WNT5A;SNAI2;APP;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.438136514955821,1.3581189382544139,0.04361370716510903,0.6886567985484059,1.0,18/100,9.32%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;NOP53;SOX9;PPP2R5C;MYDGF;PIP5K1A;MYOC;ENTPD5;LYN;ROR2;INSR
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4552382766193017,1.3579752679762607,0.046462513199577615,0.6875991946001584,1.0,24/93,15.95%,EIF2AK2;EDAR;NOD2;TAOK3;SLAMF1;XDH;GADD45G;SASH1;TRAF4;WNT7B;TPD52L1;HMGB1;APP;TRAF3;ZC3H12A;TRAF5;FCGR2B;MAP3K4;MINK1;STK25;TAOK2;MTURN;CD27;PRMT1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6213760327034084,1.3576658511489141,0.11840228245363767,0.6872743608455512,1.0,3/12,8.68%,BST2;CSF1;LYN
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5054366557055077,1.3568725955249092,0.10353535353535354,0.688924376725038,1.0,14/33,26.55%,SP100;EVL;APOE;DUSP10;MCC;CORO1C;SVBP;ACVRL1;ADIPOR1;VASH1;PTPRM;PTPN23;PFN2;PTEN
prerank,hyaluronan catabolic process (GO:0030214),0.5670636454843399,1.356383249373343,0.12849162011173185,0.6894243395456521,1.0,4/18,2.90%,HYAL1;SPAM1;STAB2;HYAL4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.48649433280262144,1.355326709153526,0.08313817330210772,0.692231802186257,1.0,10/43,16.08%,STAT1;CDH13;CCL5;CX3CL1;DNMT1;LDLRAP1;FGF9;BMPR1A;AIF1;IL18
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5019361390617781,1.3552256057366572,0.10083036773428232,0.6910836982300773,1.0,7/36,9.34%,WNT11;MOV10;WNT5A;AGO2;CTNNB1;TCF7L2;PLCB3
prerank,cellular response to lipid (GO:0071396),0.4308738774350334,1.354960860361656,0.017189079878665317,0.6905965050814387,1.0,39/191,16.74%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;ADCY5;BRINP3;SOX9;NFKB1;WNT7B;RET;LTK;LYN;HMGB1;RORA;MAPK14;SPHK2;GIT1;ZC3H12A;SNW1;XBP1;STAP1;NR3C1;LCOR;UBE2L3;ZNF35;TNIP2;MYD88;ADNP2;TNIP3;IRAK1;UPF1;ACOD1
prerank,nucleotide catabolic process (GO:0009166),0.5925685460609117,1.353655202360551,0.11002785515320335,0.6945223628102464,1.0,2/16,1.40%,SAMHD1;XDH
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4419804074634198,1.3535218008962342,0.0506198347107438,0.6934192050133279,1.0,24/113,14.80%,NOD2;HYAL1;WNT5A;KDR;PIK3CD;CDH13;NRP2;TGFA;LAMC1;PLXNB3;SOX9;MYDGF;FGFR2;TCF7L2;EGFL7;BMPR2;PROX1;VEGFD;FGF9;XBP1;BAD;NRP1;RREB1;AGGF1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.45670719596965476,1.3519065550746945,0.07290533188248095,0.6987390198204738,1.0,28/73,21.76%,EIF2AK2;PSMB10;PSME2;PSMA5;KITLG;PSME4;RUNX1;DHX36;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PRKDC;PSME3;PSMA4;MYB;PUS7;METTL14;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2
prerank,mitotic cytokinetic process (GO:1902410),0.5604120838474593,1.3514987490076766,0.10741687979539642,0.698894928566373,1.0,3/20,1.53%,CHMP4A;CHMP4B;CHMP1B
prerank,secondary alcohol metabolic process (GO:1902652),0.4862612201464864,1.3510115839181343,0.11511627906976744,0.6992948172160115,1.0,16/42,23.32%,ABCA1;ABCG1;CH25H;IDH1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;IDH3A;ABCA5;CLN6
prerank,Golgi to endosome transport (GO:0006895),0.5734025782265387,1.3505120663090393,0.11875843454790823,0.6998346823793096,1.0,9/16,19.42%,KLHL20;AP2A1;DOP1B;KIF16B;RAB14;CORO7;VPS13A;GBF1;VPS13C
prerank,regulation of mRNA metabolic process (GO:1903311),0.6257795640507368,1.3496899597297358,0.14477611940298507,0.70175461018086,1.0,5/11,15.41%,SRPK3;DHX9;SLTM;SRPK1;NCBP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49062452043558574,1.3496530562394857,0.10849056603773585,0.7002635349316044,1.0,17/41,25.49%,THY1;CD47;CCL5;CX3CL1;PODXL;MEGF10;PTPRU;MDK;LCK;PLAUR;CITED2;GCNT2;PIEZO1;JAK1;MAGI1;PTPN23;TNF
prerank,regulation of protein acetylation (GO:1901983),-0.5261346506296811,-1.3496334980690818,0.11805555555555555,0.8516710197725639,1.0,6/12,14.48%,TERF2IP;SIRT1;GSK3B;CAMK1;FAM161A;RAPGEF3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5559108126835043,1.3495619479155423,0.136986301369863,0.6990864339685811,1.0,6/19,11.94%,PML;MSH2;AEN;SNW1;DYRK2;DDIT4
prerank,lipoxygenase pathway (GO:0019372),-0.48931735798203857,-1.3494994638628868,0.14634146341463414,0.8436485271742235,1.0,3/14,4.64%,HPGD;LTC4S;ALOX5AP
prerank,neuron projection regeneration (GO:0031102),0.6351102048749057,1.3492214243909595,0.13696612665684832,0.6990044124472085,1.0,3/10,7.97%,DHFR;GAP43;MAPK8IP3
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5865936482075633,1.3485764532935374,0.12689655172413794,0.7000673967409768,1.0,5/15,12.73%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,histone exchange (GO:0043486),-0.36129161611076843,-1.3482268227823389,0.06779661016949153,0.840266775943867,1.0,21/37,32.39%,CENPO;ZNHIT1;KNL1;CENPA;ITGB3BP;SPTY2D1;CENPL;MIS18BP1;CENPK;CENPU;CENPC;DMAP1;CENPX;CENPQ;VPS72;CENPH;ANP32E;CENPI;MIS18A;CENPW;RNF8
prerank,embryonic eye morphogenesis (GO:0048048),0.6269717553210884,1.3479353913404253,0.14814814814814814,0.7010819454447355,1.0,3/11,7.88%,RARG;FBN1;MFAP5
prerank,regulation of microtubule nucleation (GO:0010968),0.6446646240787008,1.3478917889156075,0.13742690058479531,0.6996734901831716,1.0,4/10,10.43%,HSPA1B;MECP2;ARHGEF7;GIT1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5492085322708626,1.3477105782616634,0.1266490765171504,0.6988284415942025,1.0,8/21,14.68%,AIM2;BIRC2;USP50;MT3;PSMB9;BIRC3;FYN;SOX2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4711063692349885,1.3473249747597875,0.08564814814814815,0.6988048774299841,1.0,13/45,16.06%,PARP9;ZC3H7A;TDRD7;LARP1;TCOF1;CYFIP1;NOLC1;APP;PUM3;MATR3;ZC3H7B;RBM3;MEX3D
prerank,natural killer cell activation (GO:0030101),0.5403286573117686,1.3466697268207481,0.10779220779220779,0.6999471579437408,1.0,3/23,3.02%,AXL;PIK3CD;IL21R
prerank,muscle tissue development (GO:0060537),0.589829587629147,1.3460668896952939,0.14676258992805755,0.7010139849481897,1.0,4/13,17.97%,SRPK3;CSRP1;PTCH1;NF1
prerank,protein methylation (GO:0006479),0.49140333562926236,1.345944608845155,0.10163551401869159,0.7000038805761304,1.0,14/40,17.49%,PRMT2;METTL21A;GSPT1;NTMT1;NSD3;SETD3;EEF2KMT;CAMKMT;FAM98B;EZH2;ETF1;PRMT1;PRMT3;ATPSCKMT
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5724034327851777,1.3457791329705269,0.11234396671289876,0.6990976359566778,1.0,6/17,17.15%,CLU;FIS1;SOD2;TIMM50;BAD;BAX
prerank,regulation of protein kinase B signaling (GO:0051896),0.42599575723626576,1.3454205481553396,0.019250253292806486,0.6990534639207261,1.0,42/193,16.08%,AXL;PIK3AP1;XDH;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OTUD3;NOP53;OSBPL8;HSP90AB1;CX3CL1;PPP2R5C;MYDGF;FGFR2;TCF7L2;RET;MAGI2;MYOC;MET;P2RX4;INSR;VAV1;ARRB2;CIB1;HPSE;PLEKHA1;FGF9;PTPN11;RACK1;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;INPP5K;FGFR3;IL18
prerank,lipid translocation (GO:0034204),0.5393812261016018,1.345187526940009,0.13520749665327977,0.6983421552805875,1.0,6/21,15.86%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4502766017923316,1.3443881678349372,0.05825242718446602,0.7001853017212182,1.0,12/88,6.30%,IGF2BP1;EIF2AK2;TM4SF20;DAPK3;DHFR;RGP1;IGF2BP3;LARP1;ILF3;DHX36;CNOT7;NFKB1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5180946507569769,-1.3441296431256686,0.13142857142857142,0.8475959654244896,1.0,7/11,36.02%,ALG10B;TREM2;NOS1AP;AKAP6;LRRC55;RNF207;KCNIP2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40484089548320046,-1.343255971590162,0.10256410256410256,0.8425921690478952,1.0,11/26,22.15%,GPR137B;MAFB;RARA;PTPN2;CCL3;TMEM178A;CEACAM1;HOXA7;MYC;ZFPM1;INHBA
prerank,mRNA catabolic process (GO:0006402),0.4850608150691122,1.3429116533942183,0.09207459207459208,0.704867777294978,1.0,20/44,24.03%,HSPA1B;PNPT1;ZFP36;XRN2;DDX5;XRN1;DCP2;YTHDF2;DIS3L2;EXOSC9;NUDT16;TUT7;UPF1;LSM5;ERN1;EXOSC4;AGO4;RNH1;ZFP36L2;PDE12
prerank,positive regulation of angiogenesis (GO:0045766),0.43798040901161805,1.3415543283879248,0.04512067156348373,0.7090651592108901,1.0,19/108,11.51%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SIRT6;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5232349825843929,-1.3410432572666846,0.13056379821958458,0.8429864530664863,1.0,4/11,23.35%,PRKCQ;NFKBID;CARD9;CLEC6A
prerank,response to gamma radiation (GO:0010332),-0.40297643629444746,-1.3403961217154776,0.1,0.837431189094659,1.0,12/24,28.31%,MAP3K20;XRCC5;DCUN1D3;FANCD2;KDM1A;TP53;HRAS;YAP1;MYC;CRYAB;LIG4;TSPYL5
prerank,intracellular cholesterol transport (GO:0032367),0.5826122022388154,1.340067672642572,0.12112676056338029,0.7139186505904187,1.0,8/15,19.13%,ABCA1;ABCG1;LDLRAP1;NPC1;NPC2;OSBP;LDLR;OSBPL2
prerank,intracellular sterol transport (GO:0032366),0.6015387590554271,1.3400491735313145,0.12794117647058822,0.7123934546082963,1.0,6/13,19.13%,ABCA1;ABCG1;NPC1;NPC2;OSBP;OSBPL2
prerank,myofibril assembly (GO:0030239),0.47980306666283645,1.3387802653537768,0.11318553092182031,0.7161383831777324,1.0,4/42,6.10%,MYOZ2;CSRP1;ACTN2;CFLAR
prerank,nuclear body organization (GO:0030575),0.6061122251493726,1.3377219842072106,0.1339155749636099,0.719296030880285,1.0,2/12,2.06%,PML;USP50
prerank,T cell homeostasis (GO:0043029),-0.5322410195994042,-1.3363648220781934,0.13677811550151975,0.8452401545200038,1.0,8/10,42.40%,NCKAP1L;AKT1;JAK3;FAS;PMAIP1;FOXP3;FADD;RIPK3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.462663056875281,1.3349496034757977,0.08080808080808081,0.7295539762659052,1.0,12/61,9.60%,PML;EYA4;TMEM161A;MECP2;APLF;DHX36;RTEL1;DHX9;SIRT6;SMOC2;HMGB1;PPP1R10
prerank,cholesterol homeostasis (GO:0042632),0.4580492077554867,1.3342573403929698,0.08971553610503283,0.7308402062928,1.0,18/64,19.03%,NR1H2;ABCA1;ABCG1;LIPC;RORA;LDLRAP1;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B
prerank,positive regulation of endocytosis (GO:0045807),0.4801327828697085,1.3342505329726777,0.1095890410958904,0.7292638582654911,1.0,12/45,14.77%,AXL;CLU;B2M;RAB21;HNRNPK;LDLRAP1;ANKFY1;STAP1;APOE;VPS28;DAB2;TFR2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.506779627115357,1.3339787722032677,0.13614457831325302,0.7289837957572479,1.0,11/29,18.26%,TRAPPC3;COG3;GOLGA5;COPE;GOSR2;COG8;COG2;VTI1B;NAPA;COPB2;GOSR1
prerank,histone H2A monoubiquitination (GO:0035518),0.5691713763022961,1.3334517152196665,0.13031550068587106,0.7295714228073789,1.0,5/17,11.49%,PCGF5;SKP1;PCGF6;RING1;RYBP
prerank,protein polyubiquitination (GO:0000209),0.4176800991494126,1.3322383998386131,0.01001001001001001,0.7331213835324322,1.0,102/297,22.84%,RNF213;HERC6;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;SASH1;FBXO7;PSME4;ANAPC5;RBCK1;TRIM21;BFAR;RNF5;SIAH1;UBE2B;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;RNF114;AMFR;SPSB1;FBXW8;DCAF15;PSMB9;ANAPC4;RNF31;RNF19B;UBE2E3;RBX1;BARD1;UBE2E1;TRAF3;ARIH1;BTRC;PSMD2;CDC16;TRAF5;CDC27;PSME3;NPEPPS;SMURF1;FBXL14;UBE2L3;FBXL19;MYLIP;SHARPIN;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;NHLRC3;HECTD2;ANAPC2;LMO7;RNF166;MIB2;FBXL5;UBE2K;HECTD1;TRIM62;TRIM2;WWP1;PSMD7;RFFL;PSMD9;RC3H2;UBE2V1;PSMD8;FBXO30;SPOP;PSMF1;MKRN1;RNF216;PSMB6;UNKL;ANKRD39;PSMD12;PSMC2;HUWE1;STUB1;SMURF2;UBR2;FBXW2;PSMD4;PELI1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.559744830975393,1.332089113965277,0.15214384508990317,0.7322117009656497,1.0,8/18,19.70%,BCL2L11;RNFT1;NCK1;XBP1;FCGR2B;RNF185;BAX;ERN1
prerank,neuron fate commitment (GO:0048663),-0.48021837231545855,-1.332018632024726,0.13588850174216027,0.8544118754699493,1.0,9/14,44.51%,MYT1L;ID2;POU3F2;SHH;PAX6;DLL4;ISL1;EPOP;DLL1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5239355105578984,-1.33130919359317,0.14375,0.8413153480598495,1.0,4/10,16.84%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5239355105578984,-1.33130919359317,0.14375,0.8413153480598495,1.0,4/10,16.84%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,regulation of endopeptidase activity (GO:0052548),0.45304595926213614,1.3309874616360629,0.08096280087527352,0.7354666334674318,1.0,11/59,15.36%,AGT;PSME2;BIRC2;SERPINC1;PSMA3;PSMB9;TIMP2;PSME3;BIRC3;APH1A;APH1B
prerank,cellular response to interleukin-1 (GO:0071347),0.4283847019269876,1.330698471302913,0.03991811668372569,0.735093750112535,1.0,50/143,21.76%,NOD2;PSMB10;CCL7;HYAL1;NOD1;SKP1;PSME2;PSMA5;GBP3;CD40;PSME4;MAP3K8;GBP2;CD47;CCL5;RBMX;CX3CL1;SOX9;PSMA3;NFKB1;PSMB9;RBX1;BTRC;ZC3H12A;PSMD2;CCL14;IRAK4;PSME3;ST18;IL1RAP;PSMA4;TNIP2;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;PSMD7;PSMD9;UBE2V1;PSMD8;TAB3;TANK;RIPK2;SIRPA;PSMF1;CCL4;PSMB6;PSMD12;PSMC2
prerank,negative regulation of cell growth (GO:0030308),0.43244202811070853,1.3306502526081503,0.06548856548856549,0.7336987078192316,1.0,26/121,13.25%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;MAG;SERTAD2;RB1;ENPP1;RACK1;FGF13;APBB1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5192534669826547,1.3305928384406815,0.13533834586466165,0.7323895895078101,1.0,4/26,9.68%,RSAD2;IFI35;HMGB1;WDFY1
prerank,male meiosis I (GO:0007141),-0.4489499315614127,-1.33051349125979,0.125,0.8364919678279071,1.0,9/16,45.29%,ING2;FOXJ3;DDX4;SYCP3;BRDT;HSF2BP;SLC25A31;TDRD9;MOV10L1
prerank,skeletal muscle organ development (GO:0060538),0.518143404817051,1.3301884350432462,0.12323491655969192,0.7325558858598888,1.0,2/26,6.10%,MYOZ2;CFLAR
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5608990370807816,1.3298177031221454,0.14304993252361672,0.7325623326868232,1.0,4/18,16.08%,ICOSLG;TNFSF9;HMGB1;IL18
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.46092237774445766,1.3296191469189362,0.096,0.7319078211763993,1.0,18/55,20.63%,TNFSF10;PML;AGT;FIS1;BCL2L11;SIAH1;TRIM39;CYLD;TPD52L1;RACK1;BAD;BMF;BAX;CRADD;BECN1;BCAP31;WWOX;LCK
prerank,cellular response to cytokine stimulus (GO:0071345),0.416220988660538,1.3295858092737476,0.0,0.7304723932020903,1.0,91/416,16.82%,STAT1;STAT2;CXCL10;GBP4;AXL;IFIT1;IRGM;CRLF1;GBP5;CCL7;DAPK3;HYAL1;DOCK8;CXCR4;AIM2;WNT5A;SOCS1;PNPT1;PIK3CD;ZFP36;GBP3;CD40;STAT3;BCL2L11;ASAH2;PTPN18;GRB10;GBP2;CD47;CRHBP;HCK;CCL5;RBMX;JUNB;GBP7;CX3CL1;SOX9;CCND1;BCL6;NFKB1;CSF1;IL10RA;AQP4;DHX9;RO60;IL12RB2;SOCS5;LEPR;PTPN7;RORA;LDLRAP1;VAV1;HSPA8;CIB1;ZC3H12A;LRCH1;ZFP36L1;CCL14;IRAK4;IL10RB;XBP1;PIM1;SOS1;PTPN11;SOCS2;PIK3CB;RAPGEF1;NUMBL;SHMT1;STX4;FYN;IFNAR2;IL1RAP;JAK2;HSP90AA1;SOX2;ADAMTS12;INPP5K;CRK;TLR2;OXSR1;AIF1;IL18;LRP8;IRAK1;PTPN9;UPF1;STK39;ACOD1;LGALS9;CSK
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5871439705713067,1.329477068961481,0.15121255349500715,0.7294041935075146,1.0,5/13,12.91%,ENTPD3;ENPP3;ENTPD6;ENTPD5;ENPP1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6028457399004237,1.328904195697753,0.15198863636363635,0.7301294399463434,1.0,9/13,28.64%,SIRT6;HMGB1;MDK;ITGA4;FGF2;AKT3;PDPK1;SP1;PLCG1
prerank,retinal metabolic process (GO:0042574),0.6069657867895594,1.3288744664716245,0.1447178002894356,0.728706930581701,1.0,2/12,7.89%,BCO2;RDH11
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5679578958846321,1.3273801818520572,0.1460823373173971,0.7335494867963268,1.0,2/15,1.22%,AGT;CAMK2D
prerank,regulation of necroptotic process (GO:0060544),0.536099144506007,1.327362471807803,0.13938618925831203,0.7320770325811264,1.0,9/23,17.60%,ZBP1;BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37
prerank,protein localization to nucleus (GO:0034504),0.4365935627113554,1.3271372092941127,0.05907172995780591,0.7315431485094898,1.0,28/102,17.56%,PML;TOR1AIP2;TOR1AIP1;SKP1;RANBP6;STAT3;GBP2;CHCHD10;NUP153;NOP53;KPNB1;MORC3;CSE1L;PRICKLE1;NXT1;RRS1;RPAIN;SUPT7L;TAF8;PPP1R10;TAF3;IPO8;TNPO2;NUP155;RPL11;ARL2BP;RANBP17;NUP88
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6235002898595996,1.3248054509136005,0.13884785819793205,0.7401065923139613,1.0,4/10,14.84%,NR1H2;SLC45A3;ABCD1;LPGAT1
prerank,negative regulation of angiogenesis (GO:0016525),0.43738852173786996,1.324394865879645,0.07379679144385026,0.7402654653262102,1.0,8/84,5.48%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,negative regulation of translation (GO:0017148),0.4439633431278385,1.323905858307349,0.08467309753483387,0.7407367051130679,1.0,12/87,5.70%,IGF2BP1;EIF2AK2;DAPK3;DHFR;IGF2BP3;AGO2;YTHDF1;LARP1;ILF3;DHX36;CNOT7;EIF4EBP2
prerank,regulation of programmed cell death (GO:0043067),0.42501438472439573,1.323827968103361,0.04435483870967742,0.7395413546991204,1.0,21/161,6.22%,STAT1;CXCL10;AGT;DAPK3;TNFSF9;DAXX;CLU;BIRC2;RARG;TMEM219;ACTN1;TARDBP;BCL2L11;ACTN2;CASP6;RSL1D1;NOP53;OSGIN1;SOX9;SRA1;BCL6
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5501560845949315,1.3232652442688702,0.14227642276422764,0.7403196802429571,1.0,2/18,0.68%,SAMHD1;AOAH
prerank,regulation of feeding behavior (GO:0060259),0.6169559489640111,1.323117185186259,0.1608187134502924,0.7393410431620329,1.0,3/11,14.71%,STAT3;LEPR;CFAP20
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5905786313192094,1.3231046261609711,0.15655853314527504,0.7378706210672537,1.0,3/14,3.83%,GAL;ATP1B3;ACTN2
prerank,carboxylic acid metabolic process (GO:0019752),0.49776715160035806,1.3230687702724824,0.1362530413625304,0.7365040179394097,1.0,8/33,15.89%,LIPT1;AGXT;GRHPR;ST6GAL1;CYB5R3;ST3GAL1;GNE;GLUD1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5082373020836697,1.322982973713219,0.14880201765447668,0.7353526278144823,1.0,7/26,14.03%,MYOZ2;RCAN1;CHERP;PRNP;CIB1;DYRK2;SPPL3
prerank,positive regulation of kinase activity (GO:0033674),0.4300443546623019,1.3227215631909552,0.06907216494845361,0.7349617306293942,1.0,21/107,10.38%,AXL;FLT1;KDR;DAXX;LCP2;CACUL1;EPHA4;TRAF4;FGFR2;MAP2K3;CSF1;RET;EPHA6;AGAP2;RAPGEF2;LTK;MET;ROR2;INSR;PRKAG1;SNX9
prerank,ether lipid biosynthetic process (GO:0008611),0.6334142451985432,1.3224617884925691,0.1619190404797601,0.7345621142008769,1.0,5/10,15.91%,PEX7;LPCAT2;GNPAT;CHPT1;PEDS1
prerank,epithelial structure maintenance (GO:0010669),0.6130024471479766,1.3220200204218953,0.1422087745839637,0.7348281019689908,1.0,1/11,0.94%,NOD2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.49536697514178946,1.3217548921216145,0.11302211302211303,0.7343522064707081,1.0,8/32,11.94%,PML;MSH2;MYBBP1A;DDX5;AEN;SNW1;DYRK2;DDIT4
prerank,protein tetramerization (GO:0051262),0.4572561324734008,1.321252935561345,0.09090909090909091,0.7349440464613088,1.0,12/67,13.86%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;ALDH1A2;TK1;HPRT1;ACOT13;SHMT1
prerank,response to cAMP (GO:0051591),0.49351586144062926,1.320527494535838,0.11189634864546526,0.7365335419887413,1.0,8/37,16.38%,STAT1;CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K;NDUFS4
prerank,retina homeostasis (GO:0001895),0.5303686705677579,1.3205239223356642,0.1395045632333768,0.735038592927431,1.0,5/23,15.27%,CNGB1;B2M;POTEF;ACTB;CCDC66
prerank,carboxylic acid transmembrane transport (GO:1905039),0.476838418564759,1.3203383797215786,0.1408284023668639,0.7343273499934965,1.0,14/40,23.00%,SLC27A1;SLC38A2;SLC38A1;SLC19A1;SLC38A3;SLC38A6;SLC25A10;SLC7A6;ABCC1;SLC36A4;ABCC5;SLC7A7;SLC5A6;SLC25A30
prerank,histone H2A ubiquitination (GO:0033522),0.5565602638788707,1.3203102682523382,0.14030261348005502,0.7329651725161652,1.0,5/17,11.49%,DTX3L;SKP1;UBE2B;RING1;RYBP
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.48285427132589975,1.3201093307906147,0.11471610660486674,0.7322935440123843,1.0,10/40,13.78%,CLU;B2M;RAB21;HNRNPK;MAGI2;INSR;LDLRAP1;ARRB2;SCYL2;DAB2
prerank,regulation of vasculature development (GO:1901342),0.5198064101536596,1.3199344202674426,0.11621966794380588,0.7315353765118311,1.0,4/26,9.46%,SP100;CTNNB1;HTATIP2;BMPER
prerank,regulation of RNA export from nucleus (GO:0046831),0.6144879548546608,1.319875595822127,0.14516129032258066,0.7302802218189446,1.0,4/11,16.18%,NUP153;NCBP2;DHX9;NRDE2
prerank,tRNA wobble base modification (GO:0002097),0.5735020891719624,1.3195324010276728,0.1555232558139535,0.7301979276919401,1.0,4/14,6.79%,TRMT9B;MOCS3;ADAT2;ALKBH1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5124931398656574,1.3177769494190428,0.12797992471769135,0.7362920419228947,1.0,6/29,7.58%,DTX3L;TRIB3;ARRDC4;FEM1B;FBXW7;DCUN1D4
prerank,sphingoid metabolic process (GO:0046519),0.6102964228087779,1.3173109759291088,0.15593705293276108,0.7368962745268589,1.0,3/12,10.01%,SGPP2;ASAH2;SPHK2
prerank,regulation of mRNA catabolic process (GO:0061013),0.43049225924784046,1.317134321552082,0.04890738813735692,0.7361103725085935,1.0,42/121,23.70%,IGF2BP1;MOV10;ZC3HAV1;PSMB10;PSME2;PNPT1;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;DHX36;CNOT7;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;HSPA8;ZC3H12A;ZFP36L1;PSMD2;PSME3;EXOSC9;PSMA4;UPF1;PCBP4;PSMD7;PSMD9;RC3H2;SET;PSMD8;PSMF1;PSMB6;PSMD12;PRKCD;PSMC2;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2
prerank,protein targeting to membrane (GO:0006612),0.43960572360099465,1.3170419034959575,0.08690987124463519,0.7349989169387753,1.0,16/83,9.55%,CHMP4A;CHMP4B;GOLGA7;FIS1;RAB8B;MYO1C;AQP11;RTP4;ZDHHC21;SRPRA;ZDHHC20;GDAP1;VPS37A;NACA;ABCD1;PEX2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5861365143606385,1.3164707615112783,0.14157973174366617,0.7360781720836543,1.0,4/12,12.25%,CCND1;PLK3;WAC;PRKDC
prerank,positive regulation of heart rate (GO:0010460),-0.4574550091830595,-1.3162094291672504,0.15018315018315018,0.8859760040132644,1.0,4/17,13.24%,ATP2A2;TPM1;TRPM4;SCN3B
prerank,regulation of transferase activity (GO:0051338),0.5619218116064036,1.3152040461819654,0.1628222523744912,0.739983832467178,1.0,4/17,12.19%,NLRC5;FEM1B;LDB2;LDB1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5018254945711598,1.3146371315453067,0.13177339901477833,0.7408217640905901,1.0,7/27,16.23%,CAMK2D;FXYD4;UTRN;FXYD6;FXYD5;DLG1;SCN1B
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5221690712973721,-1.3144871118065866,0.159375,0.8847749447898299,1.0,5/10,14.70%,UBAC2;UBE2J1;INSIG1;UBE2G2;YOD1
prerank,negative regulation of protein secretion (GO:0050709),0.48466581827280764,1.314336125677545,0.12725090036014405,0.7405766996772853,1.0,2/38,1.61%,RSAD2;IRS1
prerank,peroxisomal membrane transport (GO:0015919),0.4997035198549737,1.3142436738884067,0.12827225130890052,0.7395388430543985,1.0,9/27,17.38%,FIS1;RAB8B;PEX7;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,Rac protein signal transduction (GO:0016601),0.5451810428531819,1.3141668303233862,0.14873837981407703,0.738396161948269,1.0,13/18,29.02%,CDH13;CYFIP1;HACD3;RAC1;DBNL;AIF1;NCKAP1;RHOH;FARP2;BRK1;TIAM1;WASF1;HACE1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5589385020333612,1.3140732365505152,0.14167812929848694,0.7373726300343264,1.0,7/18,14.81%,DNAJC13;RAB21;VPS11;CHMP3;MAP2K2;DAB2;DENND10
prerank,protein localization to synapse (GO:0035418),-0.4953281704431016,-1.3136202562396428,0.1289308176100629,0.8801372092696683,1.0,7/12,22.37%,DLG4;NRXN2;NLGN2;NRXN1;ZDHHC15;ZDHHC12;SHANK1
prerank,regulation of monocyte differentiation (GO:0045655),0.577254920912353,1.3133208529108447,0.16643159379407615,0.7391010821100505,1.0,3/14,11.03%,IRF7;CSF1;ZFP36L1
prerank,protein K11-linked ubiquitination (GO:0070979),0.5157546838730362,1.3125447038200306,0.15931372549019607,0.7410019045494978,1.0,10/27,12.73%,UBE2W;CDC26;RNF4;ANAPC5;UBE2B;ANAPC4;UBE2E3;CDC16;CDC27;UBE2L3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.441549916151734,1.3121143638070596,0.0989247311827957,0.7414922971019705,1.0,18/76,17.28%,NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;TMIGD3;CYLD;TRAF3;ARRB2;G3BP2;COMMD7;ZC3H12A;HAVCR2;MTURN;IRAK1;ACOD1;ANXA4
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6207912377951539,1.3119649594601897,0.14890510948905109,0.7406766344025127,1.0,3/10,9.75%,PFKM;GFPT1;HK1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5404742607242606,1.311608853040183,0.15579227696404793,0.7406803421197306,1.0,7/19,14.01%,KDR;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4450412158824504,1.3114651034578455,0.09529025191675794,0.73986162830611,1.0,15/66,15.78%,STAT1;XDH;B2M;AQP11;SFRP2;FBXW7;SOX9;FGFR2;SNAI2;NFIB;PEX2;APOE;DUSP10;SOX2;MCC
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4894095622662461,1.311241913792632,0.13209876543209875,0.7393443982027752,1.0,6/31,11.81%,MOCS3;FDFT1;NFS1;GCH1;MOCOS;DHRS11
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4755787504747633,1.310734283578432,0.13136094674556212,0.7401309669553334,1.0,17/37,25.39%,IRGM;SPRY2;S1PR2;TNKS1BP1;CAB39;APP;DDIT4;INPP5K;CALM3;UBE2K;SPRED3;SPRED1;RIPK2;AXIN1;CALM2;WNK3;SIRT2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5753979411675589,1.3106322598323272,0.1659513590844063,0.739092793762163,1.0,2/13,0.58%,CHMP4A;CHMP4B
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4703322461878173,-1.310306513384316,0.1610738255033557,0.8855989150152747,1.0,3/14,6.15%,ATP1B1;DMD;ANK3
prerank,positive regulation of protein kinase activity (GO:0045860),0.41935301934481856,1.309215001752949,0.059959349593495935,0.7436120013536704,1.0,38/148,16.15%,IRGM;CALCA;AGT;TAOK3;DAXX;CLU;SLC27A1;LCP2;CCL5;HSP90AB1;CACUL1;ETAA1;EPHA4;TRAF4;PAK3;CAB39;DOK7;MAP2K3;CSF1;AGAP2;MTCP1;RAPGEF2;CCDC88A;FCGR1A;INSR;PRNP;PRKAG1;TNIK;SNX9;CIB1;MAP2K2;TELO2;MINK1;HSP90AA1;EZH2;CALM3;TAOK2;LRP8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5926370682706066,1.3090107374713627,0.16101694915254236,0.7429793181019558,1.0,5/13,12.99%,DDRGK1;BFAR;ATF6B;NCK1;RACK1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.45975772062553955,1.3068976214733186,0.10638297872340426,0.7504162796475153,1.0,11/54,13.64%,HSPA1B;CASP4;SPPL2A;BIRC2;RBCK1;CFLAR;CYLD;RNF31;RACK1;SHARPIN;BIRC3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.5345582048441702,1.3066616721592965,0.17108753315649866,0.7499386807805367,1.0,6/19,15.62%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6055786280666328,1.306424412003908,0.1808972503617945,0.7480175636920773,1.0,4/11,11.37%,ZFP36;AGO2;NOTCH4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6055786280666328,1.306424412003908,0.1808972503617945,0.7480175636920773,1.0,4/11,11.37%,ZFP36;AGO2;NOTCH4;EIF6
prerank,protein insertion into ER membrane (GO:0045048),-0.35943849212850365,-1.3062182383625691,0.08839779005524862,0.8944137295943091,1.0,19/37,23.41%,TRAM1;EMC2;CCDC47;EMC3;EMC8;CYB5A;HMOX1;GET3;UBE2J2;SEC61G;MMGT1;EMC9;SEC61B;UBL4A;WDR83OS;OTOF;EMC6;STX1A;ALDH3A2
prerank,cellular response to peptide (GO:1901653),0.45411726195292035,1.306089822079177,0.11235955056179775,0.7479937444636247,1.0,17/56,17.68%,CASP4;NOD2;NOD1;TIMELESS;EPHA4;CACNA1A;APP;PRNP;ZFP36L1;ABCC1;XBP1;PSEN1;DDX11;FCGR2B;FYN;ITGA4;CHMP5
prerank,RNA processing (GO:0006396),0.4197008171037602,1.3060113388471586,0.046511627906976744,0.7469009547989348,1.0,56/176,18.81%,NOL3;APOBEC1;TENT4A;XRN2;ADAR;TARDBP;MAGOHB;PRPF18;HNRNPH1;NCBP2;NOL9;RRAGC;HNRNPK;CDK12;RBMS2;DDX20;HNRNPA2B1;NONO;BCAS2;RNPC3;SRPK1;HNRNPL;TSEN2;RSRC1;RNPS1;HNRNPH3;PPARGC1A;DDX54;USP39;ATXN1;SNRPD2;SNRPD1;DUSP11;AURKAIP1;DDX39B;SNRPG;RBM3;RBM39;NCBP1;DHX16;GEMIN2;SF3B4;SRSF7;NRDE2;TUT7;SRSF4;DDX47;DICER1;DDX23;SNRNP48;TSEN34;SLU7;SCNM1;LSM5;RBPMS;FASTKD2
prerank,regulation of myotube differentiation (GO:0010830),0.5145286374740674,1.3056903614952822,0.1514360313315927,0.7467896390932952,1.0,11/24,23.57%,BDNF;MMP14;MAPK14;SIK1;XBP1;ATP11A;SMYD1;HDAC1;PIEZO1;NOTCH1;HDAC4
prerank,myeloid cell development (GO:0061515),-0.4356844338186563,-1.305681482828846,0.1263537906137184,0.8888128675650233,1.0,7/18,16.90%,NCKAP1L;DMTN;SRC;ABCB10;ALAS1;FOXP1;LYAR
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4935757444942257,1.3049772805827509,0.1383108935128519,0.7483476856647066,1.0,6/31,15.47%,CD274;SDC4;LST1;LYN;FCGR2B;CD300A
prerank,positive regulation of cell motility (GO:2000147),0.41280151619345223,1.3048694137617913,0.029233870967741934,0.7473802438813314,1.0,48/205,17.40%,WNT11;FLT1;CCL7;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;FAM83H;CARMIL1;PODXL;SNAI2;CSF1;RET;ELP6;MAPRE1;MYOC;CTSH;BCAR1;PDPN;ROR2;INSR;CIB1;PPM1F;SUN2;XBP1;RACK1;DAB2;STX4;CFAP20;MIEN1;SPAG9;SEMA3D;AIF1;MGAT5;MDK;CBLL1;CAVIN1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5152627958132997,1.3041940360164856,0.1320049813200498,0.74873767776795,1.0,6/26,9.60%,CDC25B;PKN2;DUSP3;SMOC2;APP;PPP1R10
prerank,coenzyme A biosynthetic process (GO:0015937),0.6104309843335379,1.3041188105784969,0.15251798561151078,0.7448113673537299,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6104309843335379,1.3041188105784969,0.15251798561151078,0.7448113673537299,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6104309843335379,1.3041188105784969,0.15251798561151078,0.7448113673537299,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,cAMP-mediated signaling (GO:0019933),0.5116888528737409,1.303966214534415,0.14658385093167703,0.744012244539617,1.0,4/24,8.09%,PDE7B;GAL;SOX9;RAPGEF2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5606066951026398,1.3036168957722187,0.1597222222222222,0.7439644241444922,1.0,4/16,9.73%,GPR37L1;PLCB3;BMPR2;KLK1
prerank,negative regulation of defense response to virus (GO:0050687),0.6224368525208087,1.3027560035419916,0.1646153846153846,0.7461293408084815,1.0,3/10,7.36%,ILRUN;TARBP2;TSPAN6
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5551487076156896,1.3025731680680983,0.15782122905027932,0.7455064368079152,1.0,4/17,11.01%,STAT1;MAML2;SNW1;NOTCH4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6034544992178351,1.3022860129037086,0.1796759941089838,0.7453570056257078,1.0,3/11,9.03%,CD274;RUNX1;HMGB1
prerank,relaxation of muscle (GO:0090075),0.5849509900652032,1.302058367965159,0.17682020802377416,0.7448554276006422,1.0,5/13,16.85%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,regulation of viral entry into host cell (GO:0046596),0.5004467289865806,1.3018589768628972,0.13578680203045684,0.7442458156579869,1.0,8/30,18.12%,TRIM14;TRIM25;TRIM21;LY6E;GSN;TRIM26;LGALS9;TRIM62
prerank,adipose tissue development (GO:0060612),0.6023605199597846,1.3017238861088887,0.17099236641221374,0.7434544018613534,1.0,5/11,18.47%,NAMPT;ARID5B;XBP1;SH3PXD2B;SPTLC2
prerank,regulation of viral transcription (GO:0046782),0.4777596580644211,1.3012865595798848,0.12206572769953052,0.7438462003556668,1.0,9/39,9.35%,TRIM14;POLR2G;ZFP36;TRIM21;TARBP2;UBP1;DHX9;MDFIC;POLR2K
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5487612022546117,1.301128025995837,0.16044260027662519,0.7431010551895117,1.0,5/16,16.64%,PPCS;SLC25A1;SCD5;GCDH;ACAT1
prerank,ether lipid metabolic process (GO:0046485),0.5761211161013959,1.3002879909220413,0.1623108665749656,0.7451172781348601,1.0,7/14,21.18%,TMEM86B;PEX7;GNPAT;PEDS1;PAFAH1B1;PLA2G6;NCEH1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5459664701026529,1.2997400153605128,0.1814569536423841,0.7460132172600444,1.0,2/16,1.22%,AGT;CAMK2D
prerank,negative regulation of cellular component movement (GO:0051271),0.5597014730979313,1.2991787237667038,0.16432584269662923,0.7470108646103931,1.0,2/15,2.34%,SP100;ACTN1
prerank,T cell receptor signaling pathway (GO:0050852),0.41210814601059137,1.299045826364869,0.061855670103092786,0.7461844761323053,1.0,45/138,21.76%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;PSMB9;BCAR1;NCK1;RNF31;EIF2B2;BTRC;ZC3H12A;PSMD2;PSME3;PIK3CB;SPPL3;FYN;PSMA4;CSK;PTPRC;PAG1;PSMD7;EIF2B5;PSMD9;EIF2B3;RC3H2;PSMD8;DENND1B;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMD12;PSMC2
prerank,regulation of cell population proliferation (GO:0042127),0.4019126264199046,1.2989696730107543,0.001,0.7451298549905481,1.0,115/691,13.10%,IFIT3;STAT1;STAT2;CXCL10;EIF2AK2;HSPA1B;CXCL9;NAMPT;PML;IL15;AGT;CRLF1;FLT1;SLAMF1;SGK2;SGK3;IFI35;TFAP2C;IRS1;KDR;ZBTB17;CLU;BIRC2;RARG;GAREM1;DDRGK1;TIMELESS;TNFRSF8;GDF9;SOD2;MECP2;CDH13;KITLG;STAT3;NMI;TGFA;CDC25B;ECRG4;AQP11;S1PR2;SFRP2;FXN;RUNX1;CD47;NACC1;HCK;CCND2;TMEM115;CNOT7;TIPIN;JUNB;CDKN2D;OSGIN1;CACUL1;CX3CL1;SOX9;CHERP;CTNNB1;PPP2R5C;P3H1;FGFR2;BCL6;TCF7L2;TFAP2B;CSF1;TMIGD3;CSNK2B;TBC1D8;MAGI2;FRZB;MEIS3;RAPGEF2;CTSH;CCDC88A;IL12RB2;ARID2;BAMBI;LTK;LYN;GDNF;PDPN;SCX;APP;NCK2;ROR2;INSR;ALDH1A2;MEN1;BMPR2;PROX1;PHIP;CIB1;NPM1;CDK10;FAM98B;DNAJA3;CTCF;ZFP36L1;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;KLF10;THAP12;NOP2;PRKDC;CAPNS1;RPS6;TSPO;LIMS1;CGREF1;CAPN1
prerank,sensory perception (GO:0007600),-0.3438424737611198,-1.2988272238336984,0.07801418439716312,0.9098238748813801,1.0,25/45,32.66%,GNAL;OPRM1;CDH23;GNAS;WHRN;PENK;CHRNA7;MYO7A;CCR2;KCNA2;PTGES;SCN9A;NTSR2;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1;TTC8;CLRN1;USH2A;PNOC;ALOXE3;PDYN;KCNK4
prerank,regulation of fatty acid oxidation (GO:0046320),0.5514514311104145,1.2986511976008948,0.16432584269662923,0.7451508328469296,1.0,5/16,12.39%,LONP2;ACADL;SOX9;ABCD1;PPARGC1A
prerank,regulation of cartilage development (GO:0061035),0.5425622234397497,1.298545159433329,0.15691489361702127,0.7441586364782663,1.0,6/18,16.95%,WNT11;SOX9;SCX;BMPR2;SOX5;MDK
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.47048582372845194,-1.2976143137028313,0.17407407407407408,0.9072309028033801,1.0,7/14,25.37%,CD81;CARD11;IKBKG;CD226;TESPA1;NECTIN2;RPS3
prerank,membrane lipid catabolic process (GO:0046466),-0.5174471028667734,-1.2975428725413907,0.17888563049853373,0.8997226531302251,1.0,5/10,25.13%,PDXDC1;FUCA1;SMPDL3B;SMPD2;PPT1
prerank,regulation of cell growth (GO:0001558),0.4105914209814482,1.2963632728356873,0.04233870967741935,0.7519026017142251,1.0,48/204,16.20%,HSPA1B;WNT11;PML;AGT;ESR2;BST2;SGK2;SGK3;CAMK2D;HYAL1;CXCL16;KIF26A;MMP14;SFRP2;FXN;MAD2L2;DDX49;EGLN2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;ATAD3A;FRZB;ST7L;BCAR1;BMPR2;SPHK2;OGFR;EI24;CIB1;SLIT3;ARHGEF11;SOCS2;SERTAD2;RB1;ENPP1;RACK1;APBB1;EXOSC9;PRDM11;NCBP1;ADNP2;TAOK2;CHPT1;MTOR
prerank,positive regulation of leukocyte migration (GO:0002687),0.5067706210562128,1.2962396086365642,0.1576923076923077,0.7510365688180765,1.0,6/27,16.95%,THY1;ADAM8;CSF1;AIF1;JAM3;MDK
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4403176735438124,1.2961369452749454,0.09737417943107221,0.7500645550446005,1.0,20/67,16.11%,AXL;FLT1;KDR;NRP2;ELMO2;CYBB;CYFIP1;BCAR1;NCK1;NCK2;MAPK14;VAV1;VEGFD;PIK3CB;NRP1;RAC1;FYN;HSP90AA1;CRK;BAIAP2
prerank,positive regulation of cartilage development (GO:0061036),0.5586251552585791,1.2958657741266906,0.1592442645074224,0.7498222409490455,1.0,8/17,22.89%,LOXL2;SOX9;SCX;BMPR2;SOX5;MDK;ACVRL1;PKDCC
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6007912994172706,1.2953596567829326,0.18541996830427893,0.7505231273620916,1.0,4/10,13.32%,RGP1;EPHA4;RIC1;NELL1
prerank,ureteric bud development (GO:0001657),0.5409191944378151,1.2952880377119782,0.1655450874831763,0.7494849483599328,1.0,2/17,6.02%,WNT11;FGFR2
prerank,AMP metabolic process (GO:0046033),0.5840993059521256,1.2952640749495645,0.1927007299270073,0.7482284178679449,1.0,5/13,18.93%,XDH;AK4;AK3;ADSL;AMPD3
prerank,import into cell (GO:0098657),0.4720338686423005,1.2944448204303178,0.12903225806451613,0.7502513389411587,1.0,8/41,6.98%,SLC27A1;LRP2;SLC38A1;SLC46A1;SLC19A1;LRSAM1;SLC11A2;IL10RA
prerank,regulation of protein ubiquitination (GO:0031396),0.4237494122930397,1.2936738488166208,0.07223942208462332,0.7522813895686756,1.0,25/108,16.03%,HSPA1B;ISG15;SPRY2;PER2;DAXX;BIRC2;SASH1;HSP90AB1;FBXW7;PRICKLE1;UBE3A;UBXN1;CAMLG;N4BP1;UBQLN1;ARRB2;PRR7;VPS28;PAXIP1;UBE2L3;HDAC8;BIRC3;HSP90AA1;MYCBP2;SPRTN
prerank,regulation of establishment of planar polarity (GO:0090175),0.4286043501876091,1.2929663657959252,0.08886509635974305,0.7539934692097269,1.0,22/88,14.43%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;NPHP3;PSMB9;DACT1;ROR2;ARRB2;SPEF1;AP2S1;PSMD2;PSME3;SMURF1;RAC1;PSMA4
prerank,proteoglycan biosynthetic process (GO:0030166),0.4897377304748805,1.292943412170132,0.15012106537530268,0.7527611699027921,1.0,7/31,12.27%,EXT1;XYLT2;CANT1;FAM20B;BMPR2;CSGALNACT2;EXTL3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5201451981354513,1.292857786771407,0.17438692098092642,0.7517587498993101,1.0,6/21,18.36%,AGXT;LPIN2;LDHD;CYP26B1;PPARD;ACOX1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5090560669134987,1.292741035247652,0.14694894146948942,0.7509099544606885,1.0,6/29,16.80%,CXCL10;CCL5;HMGB1;CXCL17;AIF1;LGALS9
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5052265068883911,1.2919927246786918,0.16944801026957637,0.7526586504348307,1.0,12/25,23.84%,AUP1;UBE2W;RNF5;POMT2;NGLY1;LONP1;RNF185;KLHL15;STUB1;CUL3;VCP;HDAC6
prerank,macrophage activation (GO:0042116),0.49160015975018045,1.291840001004155,0.15012106537530268,0.7519554497648795,1.0,9/34,15.98%,IFI35;CLU;NMI;CX3CL1;TMEM106A;APP;JAK2;CRTC3;AIF1
prerank,cellular response to heat (GO:0034605),0.48832274751312693,1.2904630031261255,0.14819277108433734,0.7562511556017347,1.0,13/35,24.51%,HSPA1B;DAXX;DHX36;HSP90AB1;IER5;TRPV4;HSP90AA1;SLU7;HSBP1;STUB1;SUMO1;VCP;YWHAE
prerank,regulation of anoikis (GO:2000209),0.5291263249858791,1.2896010348950375,0.16644295302013423,0.7584901572849194,1.0,8/19,24.76%,MYBBP1A;PTRH2;SNAI2;SIK1;MCL1;NOTCH1;TLE5;PIK3CA
prerank,response to tumor necrosis factor (GO:0034612),0.4295587729645167,1.2894134439786624,0.08907741251325557,0.7579114007513162,1.0,21/91,15.07%,CCL7;HYAL1;ZFP36;GBP3;CD40;CXCL16;GBP2;CRHBP;CCL5;CX3CL1;IGBP1;DHX9;GCH1;CIB1;ZC3H12A;ZFP36L1;CCL14;GGT7;JAK2;ADAMTS12;INPP5K
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5571620299369081,1.288891575114377,0.17337031900138697,0.7586461091633423,1.0,1/16,0.24%,CD274
prerank,negative regulation of gene expression (GO:0010629),0.4089566011969668,1.2886993614869933,0.013026052104208416,0.758114987882982,1.0,69/302,18.78%,PARP14;IGF2BP1;EIF2AK2;HSPA1B;PARP10;PARP9;MOV10;ABCC2;DAPK3;DHFR;XDH;KDR;PNPT1;ZFP36;DDRGK1;IGF2BP3;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;PTGER4;LARP1;ILF3;DHX36;CNOT7;FBXW7;NFKB1;PTRH2;ITGB8;DCP2;N4BP1;YTHDF2;DNMT3A;DNMT1;APP;PPP1R11;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;FCGR2B;RACK1;SHMT1;DIS3L2;PATL2;EZH2;NPTN;BMPR1A;NUDT16;SLC24A3;TIPARP;FLOT2;ENC1;PUS7;DICER1;LGALS9;MRPL13;LSM5;HDAC1;CAPRIN1;HINFP;TERF2;ASB1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.43731995460257833,1.288579774863869,0.12081984897518878,0.7572845674538365,1.0,11/74,10.17%,NOL3;HSPA1B;TNFSF10;EYA4;UNC5B;ACVR1;CFLAR;TCF7L2;SNAI2;GDNF;PHIP
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5670708940048034,1.2884283472046076,0.18376068376068377,0.7566152911205825,1.0,5/14,15.63%,ENTPD3;ENTPD6;NUDT5;ENTPD5;NUDT16
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.43006069708023953,1.2882944239174379,0.09839572192513368,0.7558184863576495,1.0,30/80,21.25%,RER1;ARF3;KIF26A;KIF3C;COG3;ERGIC3;COPE;TMEM115;TAPBP;KIF2C;ARF5;KIF3B;TMED10;KDELR1;SCFD1;RINT1;NAPA;KIF2A;ARF4;ATP9B;KLC2;ERGIC2;TMED3;COPB2;GBF1;GOLPH3L;UVRAG;RAB1A;TMED7;ERGIC1
prerank,pre-miRNA processing (GO:0031054),0.5632297815548867,1.2880377830430196,0.19021739130434784,0.7555430500450283,1.0,6/14,17.03%,ADAR;AGO2;TARBP2;TUT7;DICER1;PRKRA
prerank,regulation of vasculogenesis (GO:2001212),0.5676435561491373,1.287165692723458,0.16852367688022285,0.7577135514339454,1.0,4/14,11.74%,XDH;KDR;RAPGEF2;RIN2
prerank,regulation of translation (GO:0006417),0.4094036003979652,1.2869858539274754,0.042682926829268296,0.7570813630895405,1.0,51/173,20.49%,IGF2BP1;EIF2AK2;DAPK3;DHFR;PLXNB2;EIF4A2;IGF2BP3;YTHDF1;LARP1;ILF3;DHX36;CNOT7;NCBP2;GSPT1;TCOF1;CYFIP1;ZCCHC4;ALKBH1;DHX9;NOLC1;EIF2B2;APP;EIF4H;NPM1;PUM3;EIF6;PRKDC;UPF3A;RACK1;EIF4G3;SHMT1;EIF1B;PATL2;RBM3;ETF1;NCBP1;MTOR;ENC1;UPF1;PUS7;METTL14;MRPL13;CAPRIN1;EIF4B;TSC1;OGFOD1;EIF5;CSDE1;GLE1;MTG2;DDX3X
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5737606601922184,1.2866663537664462,0.1806543385490754,0.7570753057032478,1.0,1/13,0.17%,AXL
prerank,positive regulation of vasoconstriction (GO:0045907),-0.47448050725092605,-1.2866485210373626,0.15483870967741936,0.9371209828474132,1.0,10/13,52.58%,TRPM4;F2R;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A;ADRA1A;ADRA1B
prerank,visual perception (GO:0007601),0.437070916027828,1.2864445157071573,0.1073326248671626,0.7566551966658207,1.0,12/84,15.32%,CABP4;CNGB1;EYA4;CACNA2D4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4080762159642655,1.2847429377024997,0.025150905432595575,0.7623986603229489,1.0,52/234,16.80%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;ESR2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;ARID5B;RBCK1;TRIM21;ADAM8;IKBKE;RHEBL1;CX3CL1;CTNNB1;CFLAR;LPAR5;NFKB1;SRF;DHX9;PPIA;TFDP1;RNF31;APP;CRTC1;CIB1;NPM1;TRAF5;RTKN2;TRIM26;PPARGC1A;BUD31;RNF25;IL1RAP;PRKCH;MYD88;CRTC3;TLR2;IL18;LRP8;IRAK1;FLOT2;LGALS9
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4981496532763416,1.2846242047978833,0.17380352644836272,0.7615772266799551,1.0,7/28,12.29%,PARP9;DTX3L;ACTR2;MAD2L2;KDM4D;PRKDC;SHLD1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.43055629429872194,1.2845535303337527,0.10599571734475374,0.7605526668441686,1.0,33/78,25.91%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;UBQLN2;NOP53;PRICKLE1;DET1;SIRT6;SOCS5;RNF19B;RBX1;PLK3;UBQLN1;ARIH1;RACK1;DAB2;PIAS1;HECTD1;BCAP31;USP5;RNF180;HSPBP1;NUB1;STUB1;DNAJB2;SUMO1;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,RNA catabolic process (GO:0006401),0.45484475288044723,1.284160244100725,0.13856812933025403,0.7609017874059615,1.0,20/46,24.09%,HSPA1B;PNPT1;ZFP36;XRN2;RNASEH2A;DCP2;FEN1;RNASEH2C;YTHDF2;DIS3L2;NCBP1;RNASEH2B;NUDT16;LSM5;ERN1;RNASEH1;AGO4;RNH1;ZFP36L2;RNASE3
prerank,somite development (GO:0061053),0.5910207787592281,1.2836189888314051,0.17665130568356374,0.7618602955428927,1.0,4/11,22.37%,SFRP2;PTCH1;MTHFD1;PPP2R3A
prerank,regulation of cell division (GO:0051302),0.4334186151026198,1.283572183378103,0.11637931034482758,0.7607561591809858,1.0,23/72,19.58%,ESRRB;SFRP2;PRPF40A;PDXP;FGFR2;SH3GLB1;KLHL13;ZFYVE26;PIK3R4;PLK3;GIT1;CIB1;KLHL9;RACK1;AHCTF1;MLLT3;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1;SMYD5
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5018801398178482,1.2834084947202227,0.176158940397351,0.7601061654438296,1.0,9/25,21.91%,HSPA1B;DNAJB4;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.41740163582265116,1.2832422755249098,0.08677685950413223,0.7594704094907162,1.0,8/110,4.30%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;S1PR2;PTGER4;ADCY5
prerank,protein monoubiquitination (GO:0006513),0.47110702704459084,1.2831782356758976,0.15758293838862558,0.7584565332878025,1.0,9/36,9.88%,DTX3L;TRIM25;UBE2W;RNF40;TRIM21;UBE2B;RBX1;UBE2E1;WAC
prerank,'de novo' posttranslational protein folding (GO:0051084),0.48445997517427525,1.2831327255929896,0.16666666666666666,0.7573246994788353,1.0,10/30,21.91%,HSPA1B;DNAJB4;ENTPD5;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,positive regulation of protein depolymerization (GO:1901881),0.5816693578873166,1.2828438945692031,0.17496229260935142,0.7572773786182093,1.0,4/11,18.82%,PDXP;TRPV4;STMN2;CFL2
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5981190854522804,1.2824632673375533,0.18168389955686853,0.7576818568999083,1.0,6/11,24.95%,RAB21;VPS11;SORL1;DAB2;MSN;PTPN23
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5571232944099365,1.2823681059177525,0.1861777150916784,0.7567748825817864,1.0,4/15,8.32%,ACVR1;CSNK2B;MAGI2;DACT1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.512942983440547,1.2822394796695755,0.1658291457286432,0.7560391360125049,1.0,7/24,12.99%,NR1H2;CLU;AQP11;USP25;UBXN1;XBP1;RACK1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5554514505507209,1.282162030621437,0.17688022284122562,0.7550939238041467,1.0,5/15,14.80%,NOD2;GBP5;STAT3;IL17D;MYD88
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6108668174968022,1.282098716388811,0.20303030303030303,0.7540858864782831,1.0,3/10,11.56%,HSPA1B;DNAJB6;SORL1
prerank,response to copper ion (GO:0046688),-0.41024481819431247,-1.281668216188615,0.12083333333333333,0.9491594434101877,1.0,10/20,9.23%,MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SNCA;ATP5F1D
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5569565911987687,1.2814706778907379,0.18653576437587657,0.7553964461024723,1.0,6/14,20.36%,XDH;SPRY2;NOTCH4;SPRED3;SPRED1;ZEB1
prerank,apoptotic mitochondrial changes (GO:0008637),0.47035545863097195,1.2813786567921532,0.15621156211562115,0.7545296341002784,1.0,7/32,13.15%,IFIT2;CLU;FIS1;SOD2;TIMM50;NDUFS1;BAD
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4422675199925731,1.281203825769256,0.12416851441241686,0.7539891106988306,1.0,16/63,17.90%,PML;CHEK2;CNOT4;CNOT7;CCND1;TNKS1BP1;TFDP1;PLK3;WAC;TFDP2;PRKDC;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5198930127873649,-1.2810468564190638,0.1833810888252149,0.9437295823338597,1.0,6/10,22.73%,APOD;WASL;AKT1;RIPOR2;CD200R1;CD200
prerank,determination of left/right symmetry (GO:0007368),0.4747713518508951,1.2807275082986114,0.16242424242424242,0.7546257127369481,1.0,5/36,6.86%,PITX2;ODAD2;CCDC40;NPHP3;KIF3B
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5034068900809311,-1.2799971620834432,0.1762820512820513,0.9405208701928215,1.0,5/11,22.63%,AGBL4;ATG5;AGTPBP1;ICMT;LCMT1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5083349881464923,1.279771261448022,0.15514993481095177,0.7570613222174679,1.0,11/23,24.77%,IRGM;S1PR2;TNKS1BP1;CAB39;APP;CALM3;UBE2K;RIPK2;AXIN1;CALM2;WNK3
prerank,regulation of smooth muscle contraction (GO:0006940),0.5338465369283659,1.2794955270543253,0.16508795669824086,0.7569415772520175,1.0,4/20,7.29%,DAPK3;ZDHHC21;SETD3;SRF
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5559437967485309,1.2794860524710228,0.17945007235890015,0.7557046697904726,1.0,5/14,14.43%,IRS1;ARPP19;SLC45A3;PPARGC1A;IRS2
prerank,protein complex oligomerization (GO:0051259),0.4286491651387824,1.2793549310864172,0.11324786324786325,0.7549395439142427,1.0,13/85,11.65%,RNF213;NOL3;PNPT1;ATL1;AQP11;RBMX;TRMT61B;TMEM120B;TWNK;RS1;G3BP2;ZC3H12A;POLQ
prerank,negative regulation of DNA recombination (GO:0045910),0.4588604333652121,1.2785182348114745,0.15542857142857142,0.7570432765460454,1.0,10/43,12.53%,MSH2;POLR2G;DAXX;CGAS;MAD2L2;RTEL1;POLR2K;POLQ;SHLD1;ZRANB3
prerank,cytosolic transport (GO:0016482),0.4203160894035757,1.2784745909217028,0.09014675052410902,0.7559555249232776,1.0,49/108,25.54%,VPS51;RGP1;KLHL20;RILP;GOSR2;AP2A1;VPS53;TBC1D23;HOOK2;VPS54;DOP1B;BAIAP3;STX8;KIF16B;HOOK1;STX16;RAB14;ARL1;ANKFY1;ANKRD27;CORO7;VPS50;TMEM87A;VPS52;RIC1;VTI1B;HOOK3;PREPL;SPAG9;VPS26A;SNX1;VPS13A;LAMP1;GBF1;GOSR1;WDR91;BECN1;VPS13C;VPS35;SNX2;STX6;RAB29;EEA1;RBSN;DENND2A;PTPN23;CCDC91;DCTN1;TBC1D17
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5163621069150848,1.2780506889046976,0.17772215269086358,0.7563571193839641,1.0,9/24,22.89%,LOXL2;SOX9;SNAI2;PTPN11;ADAMTS12;SOX5;MDK;ACVRL1;PKDCC
prerank,endothelial cell differentiation (GO:0045446),0.5707679213674391,1.2778911927424002,0.19097744360902255,0.7557137798710861,1.0,4/12,10.07%,KDR;EDF1;BMPR2;PROX1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.49360522392922435,1.2777384280234358,0.1592920353982301,0.7550162493044547,1.0,5/27,9.38%,NOD2;FLT1;IRS1;AGAP2;PIK3R4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4139424775548027,1.2770612671920578,0.0945945945945946,0.7566080497760896,1.0,30/122,16.80%,NLRC5;NAMPT;NOD2;IRS1;PLXNB2;KDR;PPP1R3E;YTHDF1;ZCCHC4;CDT1;NFKB1;DHX9;TMEM106A;SMOC2;INSR;NPM1;EIF6;XBP1;DYRK2;LDB1;PRKDC;UPF3A;STN1;JAK2;IRS2;RBM3;TLR2;PRMT1;MTOR;METTL14
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.498755262041188,1.276792757260075,0.17271589486858574,0.7564891760654064,1.0,13/27,28.91%,NAA50;KAT8;SGF29;KAT7;RUVBL2;KAT6A;KAT5;KAT2B;RUVBL1;EP300;BRD8;ATAT1;NAT8
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.43479816215684514,1.276767486154341,0.1252676659528908,0.7553619749691692,1.0,19/76,17.23%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;CYLD;TSPAN6;APP;ZC3H12A;RTKN2;LIMS1;DLG1;UACA;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.40463315351628587,1.2760953210642005,0.04923076923076923,0.7567511942675597,1.0,63/161,25.95%,WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;PRICKLE1;SOX9;PFDN5;PSMA3;TCF7L2;NPHP3;SNAI2;BICC1;AMFR;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;PSMD2;SCYL2;PSME3;APOE;LZTS2;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD9;STK3;PSMD8;PSMF1;STK11;PSMB6;PSMD12;PSMC2;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;PSMA2;AXIN1;TLE5;KREMEN1;DACT3;LRP4;INVS;PSMD1;PSMD11
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6034747907183919,1.2756867888701535,0.19133034379671152,0.7571058051745811,1.0,2/10,1.59%,XDH;SPRY2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.43413488475045936,-1.274536099402928,0.13945578231292516,0.9563575960346958,1.0,7/17,18.47%,ARRB1;BCL3;PTPN22;CACTIN;KLF4;MAP2K5;ANXA1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.3813880221312226,-1.2741741717793107,0.16037735849056603,0.9500419862208476,1.0,14/25,25.37%,CARD11;TRAF2;PNP;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;IL1B;CD80;IL1A;RPS3
prerank,negative regulation of defense response (GO:0031348),0.4309733076035693,1.2740160979938162,0.1342134213421342,0.7625551700345496,1.0,21/77,21.67%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;RORA;APOE;CXCL17;RB1;SHARPIN;PPARD;ACOD1;MFHAS1;TNFAIP8L2;SIRPA;MAPKBP1;VPS35;PRKCD
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.46352737495956137,1.273939082654716,0.12689173457508732,0.7616088200247866,1.0,13/49,15.95%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;WDR5;CIB1;EIF6;RBM15;MTURN;PRMT1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5399925415597077,1.2737974910215313,0.18944519621109607,0.7609385673336081,1.0,7/18,17.83%,CABYR;CCDC40;ADCY10;NPHP3;AQP4;ODAD4;SPAG17
prerank,cellular response to interleukin-6 (GO:0071354),0.48794018700919056,1.2733819137505342,0.19172932330827067,0.7614521572445908,1.0,6/26,14.38%,STAT1;STAT3;NFKB1;PTPN11;ST18;JAK2
prerank,regulation of multicellular organismal development (GO:2000026),0.49937803645533657,1.2732673141718942,0.15355805243445692,0.7606800527436823,1.0,6/25,11.03%,OAS2;DHX36;SCX;INSR;HPSE;RAB14
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4262964662322684,1.2731412928281856,0.1302475780409042,0.759910455075569,1.0,23/84,19.54%,IGF2BP1;EIF2AK2;DAPK3;DHFR;CLU;IGF2BP3;LARP1;ILF3;DHX36;CNOT7;GGA3;PRNP;SORL1;APOE;RACK1;SHMT1;PATL2;ENC1;PUS7;MRPL13;CAPRIN1;TSC1;PIN1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.45585271725224163,-1.2720526977703066,0.16279069767441862,0.9513476375167867,1.0,7/15,21.68%,ABHD16A;HOGA1;ABHD12;SARDH;GGT5;PRODH;ALDH4A1
prerank,regulation of macrophage differentiation (GO:0045649),-0.4447200376643775,-1.2719785097519662,0.14950166112956811,0.9441018831168002,1.0,7/15,22.15%,CASP8;ID2;RIPK1;PTPN2;PF4;IL34;INHBA
prerank,mononuclear cell differentiation (GO:1903131),0.5070439831034278,1.2712774560462237,0.1866840731070496,0.7662102045513955,1.0,6/24,14.04%,AXL;TRPM2;BATF3;LYN;RELB;IKZF1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4303906263964038,1.271097433323287,0.12144420131291028,0.7658022436616013,1.0,25/70,21.76%,EIF2AK2;PSMB10;PSME2;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PRKDC;PSME3;PSMA4;MYB;PUS7;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2
prerank,mitochondrial fission (GO:0000266),0.537218573049619,1.2709748246830705,0.16555407209612816,0.765099334399788,1.0,8/16,23.69%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;SLC25A46;OPA1;DNM3
prerank,relaxation of cardiac muscle (GO:0055119),0.5676363386706851,1.2709625934275486,0.20648967551622419,0.763928340141046,1.0,5/13,16.85%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,regulation of stem cell differentiation (GO:2000736),0.42214061746653264,1.2706978055678622,0.11288604898828541,0.7636615777825878,1.0,33/89,23.70%,EIF2AK2;PSMB10;PSME2;ESRRB;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;GDNF;PSMD2;LDB1;PRKDC;PSME3;PSMA4;MYB;BMPR1A;PUS7;PSMD7;PSMD9;PSMD8;SMYD5;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;NOTCH1;ZFP36L2;PSMA2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3411542869436161,-1.2706072558109578,0.11560693641618497,0.9420488283552206,1.0,8/37,10.46%,IL1RAPL1;CD164;ADGRL1;FAT4;CADM3;NECTIN1;ALCAM;TENM3
prerank,synaptonemal complex organization (GO:0070193),0.5498576093016287,1.2701498283199144,0.18093922651933703,0.7633783386179934,1.0,2/15,10.06%,SYCP1;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.5498576093016287,1.2701498283199144,0.18093922651933703,0.7633783386179934,1.0,2/15,10.06%,SYCP1;TEX11
prerank,ncRNA metabolic process (GO:0034660),0.47361789275014243,1.2699121349912494,0.15393794749403342,0.7631587073528443,1.0,9/37,17.03%,AGO2;DTD1;TARBP2;BCDIN3D;MEPCE;DTD2;TUT7;DICER1;PRKRA
prerank,response to muramyl dipeptide (GO:0032495),0.5788585694844441,1.269576301230389,0.19821162444113263,0.7632011332346655,1.0,2/12,1.44%,NOD2;NOD1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5747840731680329,1.2690332566718887,0.19130434782608696,0.7641430953333262,1.0,4/12,14.83%,XDH;SPRY2;PIK3CB;ADAMTS12
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.596014716979932,1.2687593671572317,0.2131837307152875,0.7639712438156733,1.0,3/11,7.30%,ZFP36;STAT3;DHX9
prerank,ribonucleoprotein complex assembly (GO:0022618),0.41132019314121365,1.268544621086507,0.07430340557275542,0.7636930249340533,1.0,54/132,23.52%,NOL3;SRPK3;PWP2;TXNL4A;PRPF18;ERAL1;TARBP2;MDN1;NOP53;HSP90AB1;DDX20;RRS1;PPAN;DHX9;SRPK1;TGS1;EIF4H;EIF6;EIF3A;CELF6;NOP2;PRKDC;USP39;DENR;SNRPD2;SNRPD1;SART1;GEMIN7;CLNS1A;HSP90AA1;DDX39B;SNRPG;NCBP1;GEMIN2;RPL23A;RPL11;DICER1;PTGES3;DDX23;RSL24D1;RPL24;EIF4B;RPL3;MRPS11;SNUPN;EIF5;SRSF5;RPL5;SF3A2;RPL6;SRSF10;SART3;SNRPD3;LSM4
prerank,negative regulation of phagocytosis (GO:0050765),0.5390740527756473,1.2684775819377165,0.18733153638814015,0.7627592905313805,1.0,8/17,20.02%,CD47;HMGB1;FCGR2B;RACK1;CD300A;TLR2;CD300LF;SIRPA
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5696854527882971,1.2684530286123747,0.1951219512195122,0.7616567274243358,1.0,3/14,4.00%,DDRGK1;BCL2L11;BFAR
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.39883614159113767,-1.2684313521860464,0.17256637168141592,0.943628698043158,1.0,11/22,20.62%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;GTF2H3;XPA;GTF2H4
prerank,B cell proliferation (GO:0042100),0.5375684809410628,1.2682984715767813,0.19021739130434784,0.761145276133899,1.0,2/17,2.63%,GAPT;CD40
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.43886172084539654,1.2682158415340719,0.1341330425299891,0.7602564750195197,1.0,14/62,12.63%,NOL3;TMEM161A;CLU;SOD2;SFRP2;HYOU1;CDKN2D;NME5;SNAI2;PPIA;ACKR3;RTKN2;XBP1;ARMC10
prerank,outflow tract septum morphogenesis (GO:0003148),0.5060919970048791,1.2673413950448935,0.17922077922077922,0.7624797624644399,1.0,7/24,15.05%,NRP2;ACVR1;LRP2;FGFR2;BMPR2;NRP1;BMPR1A
prerank,regulation of mitotic spindle organization (GO:0060236),0.4784321691311785,1.2667249169271715,0.17261904761904762,0.7637365881659929,1.0,6/35,11.39%,HSPA1B;CHMP4B;CHMP1B;DYNC1H1;RAE1;CHMP3
prerank,endocrine system development (GO:0035270),0.5130974793546137,1.266543123962917,0.1800518134715026,0.7633292411693198,1.0,6/21,17.97%,WNT11;TG;DKK3;SOX2;MDK;NF1
prerank,histone H3-K4 methylation (GO:0051568),0.4925035985390348,1.2655572986427939,0.1734820322180917,0.7660776644844306,1.0,7/26,14.76%,DPY30;RBBP5;KMT2A;MEN1;WDR5;PAXIP1;TET2
prerank,positive regulation of mRNA processing (GO:0050685),0.5099344582328118,1.2654789723282411,0.18453188602442333,0.7651550595741351,1.0,8/21,15.80%,RBMX;DHX36;NCBP2;SNW1;DAZAP1;RBM3;NCBP1;SF3B4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.40717630540035166,-1.2650281421841696,0.16666666666666666,0.949980747233921,1.0,11/21,24.01%,CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DCN;BCAN;UGDH;CSPG5
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4917581942663361,1.2649602652231242,0.18963337547408343,0.7660055591047342,1.0,6/28,12.33%,CLU;DDRGK1;OSBPL7;FBXW7;CTSC;SMURF1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.48983180325715336,-1.2641090786675422,0.20481927710843373,0.9466688192762985,1.0,5/10,14.61%,ZBTB1;TRPM4;TNFRSF1B;CCR2;WAS
prerank,regulation of mitotic nuclear division (GO:0007088),0.443060757573493,1.2640150880101422,0.14555555555555555,0.7686318165427131,1.0,11/55,14.41%,PKMYT1;DAPK3;TGFA;CHEK1;PDXP;CUL7;CDK5RAP2;INSR;PHIP;ANAPC15;AURKAIP1
prerank,regulation of cholesterol storage (GO:0010885),0.5513374210646915,1.2635866748998792,0.2122905027932961,0.7691360084777666,1.0,3/15,1.77%,NR1H2;ABCA1;ABCG1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.44804819048282013,1.2634977983502176,0.1541095890410959,0.7682722346418149,1.0,13/48,18.29%,PML;MSH2;CHEK2;BCL2L11;AEN;IKBKE;SNW1;DYRK2;DDIT4;PRKDC;BAX;PHLDA3;FNIP2
prerank,protein stabilization (GO:0050821),0.40378993890329345,1.2634795147147648,0.07092198581560284,0.767131742870597,1.0,44/168,19.98%,HSPA1B;IRGM;ZSWIM7;CLU;FKBPL;GOLGA7;CHEK2;RAB21;ATP1B3;LAMP2;COG3;OTUD3;UBE2B;NOP53;HSP90AB1;MORC3;SEC16A;FBXW7;P3H1;EPHA4;MT3;CAMLG;TRIM39;CDC37L1;CCT4;CCT7;CCT3;BAG1;PPARGC1A;TELO2;HSP90AA1;TNIP2;RPL11;FLOT2;PRKRA;PTGES3;LAMP1;CDC37;IFT46;STK3;TSC1;PIN1;AAK1;TYROBP
prerank,positive regulation of cell adhesion (GO:0045785),0.42504892900625185,1.2634444730405001,0.13137893593919653,0.7660851924085065,1.0,16/74,14.38%,FBLN2;HYAL1;SFRP2;ADAM8;CD47;CCL5;EPHA4;RET;MEGF10;CIB1;DUSP26;PPM1F;LIMS1;RAC1;STX4;JAK2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5181895746961191,1.2632629892041585,0.18617021276595744,0.7656160913338433,1.0,4/20,9.86%,HSPA1B;DAXX;HSP90AB1;UBQLN1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.43486834673737457,1.2630309081467965,0.14905450500556172,0.765283615250636,1.0,15/59,20.69%,MCAT;PER2;OSBPL7;CH25H;LIPC;OSBPL3;ALDH1A2;XBP1;CYP27A1;OSBPL9;OSBP;OXSM;OSBPL2;ELOVL4;CYP39A1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5909588373977721,1.262678032272076,0.20209580838323354,0.7655649232531851,1.0,2/10,5.48%,WNT5A;CTNNB1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5320728281198961,1.2626697642113014,0.18900804289544235,0.7644049030971524,1.0,5/18,12.73%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,negative regulation of apoptotic process (GO:0043066),0.39557716641714424,1.2623490369085093,0.01,0.7644779227593447,1.0,74/444,12.70%,RNF213;IFIT3;NOL3;AXL;HSPA1B;WNT11;CRLF1;MSH2;UNC5B;WNT5A;SPRY2;COMP;KDR;BDNF;BIRC2;DDRGK1;KLHL20;SEMA4D;SOD2;ASAH2;LRP2;ANKLE2;FXN;ADAM8;BFAR;HCK;CCND2;CDKN2D;CX3CL1;SOX9;HNRNPK;CTNNB1;AREL1;MYDGF;CFLAR;IGBP1;TMBIM4;NFKB1;MT3;NRBP2;PTRH2;TFAP2B;SNAI2;CSNK2A2;ATAD3A;AGAP2;HTATIP2;CTSH;LTK;GDNF;BARD1;PDPN;SCX;PLK3;DNAJB6;PHIP;CIB1;NPM1;ZC3H12A;NUAK2;MAG;XBP1;PIM1;CBX4;NAA35;BAG1;ARHGAP10;PSEN1;PRKDC;APOE;PPARGC1A;SOCS2;DFFA;RB1
prerank,replicative senescence (GO:0090399),0.5763419610481774,1.2619678652607502,0.19336219336219337,0.7647792452454227,1.0,2/12,4.45%,CHEK2;CHEK1
prerank,regulation of protein localization to cell surface (GO:2000008),0.4730056295767169,1.2612166187921534,0.17427884615384615,0.7666013295936009,1.0,16/33,25.76%,BDNF;SNX33;ACTN2;HSP90AB1;CTNNB1;RAB11B;LEPROT;LEPROTL1;STX4;GBF1;TYROBP;TM9SF4;RAB11FIP5;COMMD1;TNF;TMEM35A
prerank,response to lipopolysaccharide (GO:0032496),0.40828753180187066,1.260605940190948,0.0826530612244898,0.7677974527438962,1.0,26/138,16.80%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;SLPI;NFKB1;HMGB1;MAPK14;GCH1;GIT1;ZC3H12A;XBP1;STAP1;GGT7;JAK2;TNIP2;MYD88;TNIP3;IRAK1;UPF1;ACOD1;LGALS9
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4044333467993649,1.2602208430497324,0.07222787385554426,0.7682321646806547,1.0,41/170,18.50%,IGF2BP1;ZUP1;TRIM14;IGF2BP3;TARDBP;TRIM21;CGGBP1;SLC8A1;TAPBP;HNRNPK;AFF1;TRIM39;RO60;GDNF;APP;KIF16B;MKLN1;PROX1;ZC3H12A;MARF1;CTCF;ZFP36L1;HNRNPDL;TRIM26;NKAP;PSEN1;APOE;PRDM4;NELL1;POGZ;SOX2;PRDM11;ADNP2;NPAT;AIF1;PCBP4;PTPRC;ZNF445;ZNF513;LDLR;HINFP
prerank,regulation of stem cell population maintenance (GO:2000036),0.5382067908012788,1.2599373334824975,0.19640387275242047,0.7682251010606811,1.0,4/18,15.00%,LOXL2;ESRRB;WDR43;ZC3H13
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3356870942852844,-1.2589044228929356,0.10059171597633136,0.9607893411914454,1.0,17/38,24.80%,CENPO;ASF1A;HAT1;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;HIRA;CENPK;CENPU;CENPC;CENPX;ATRX;ASF1B;CENPQ;CENPH
prerank,protein localization to mitochondrion (GO:0070585),0.5862388110073598,1.2585532757902154,0.19133034379671152,0.7726433471237737,1.0,2/11,9.75%,ISG15;HK1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5414464078595209,1.2585147365391982,0.21662125340599456,0.7716305048809075,1.0,3/17,2.90%,MSH2;STAT3;CD55
prerank,angiogenesis involved in wound healing (GO:0060055),0.5764816163262765,1.2582720734941517,0.20520231213872833,0.7713906762504869,1.0,3/11,10.73%,KDR;SRF;HPSE
prerank,DNA modification (GO:0006304),-0.3983694629214185,-1.257196395036212,0.14410480349344978,0.9603303668754745,1.0,10/22,17.17%,PARP2;PARP1;TERF2IP;EXOSC5;OGG1;EXOSC3;NEIL1;PARP3;NEIL3;TERF1
prerank,regulation of cellular component movement (GO:0051270),0.4395417141371972,1.2571412866501406,0.15375854214123008,0.7748839994056482,1.0,9/49,9.84%,SP100;DAPK3;ACTN1;YTHDF1;PKN2;IGBP1;LYN;PDPN;ZSWIM8
prerank,myeloid dendritic cell activation (GO:0001773),0.5668968868583959,1.2562710130123917,0.212481426448737,0.7772092343903312,1.0,3/12,9.03%,SLAMF1;BATF3;HMGB1
prerank,regulation of cardiac conduction (GO:1903779),0.43591052836090544,1.2561029046593983,0.18057142857142858,0.7766594175725595,1.0,9/54,11.05%,AGT;ASPH;FXYD4;ATP1B3;SLC8A1;ITPR1;NPPC;FXYD6;AHCYL1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5093582105240895,1.2560550122873098,0.20990873533246415,0.7756481634217622,1.0,7/21,11.83%,KDR;PTGER4;SOX9;MT3;CTSH;ZFP36L1;MAP2K2
prerank,regulation of DNA binding (GO:0051101),0.44406760176481463,1.2555289507735004,0.16374269005847952,0.7765608358971448,1.0,8/44,11.86%,SP100;ILRUN;SUMO3;CDT1;EDF1;CSNK2B;HMGB1;MDFI
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.4281669666917085,-1.2555124225575653,0.16304347826086957,0.9599459776508629,1.0,9/15,23.39%,ANP32B;GSK3B;CAMK1;RAPGEF3;TP53;BAG3;TPR;RBM22;IL1B
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4263531769035805,1.2552756724150351,0.1368653421633554,0.7764080741782842,1.0,27/72,21.76%,PSMB10;SKP1;PSME2;BIRC2;PSMA5;NFKB2;PSME4;PSMA3;PSMB9;BTRC;PSMD2;RELB;PSME3;REL;BIRC3;PSMA4;IRAK1;DICER1;TLR3;COPS8;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4782853682594447,-1.2550687167011203,0.18032786885245902,0.9546674311949722,1.0,7/12,20.13%,SYT2;RIMS1;RIMS3;UNC13A;SYT8;RIMS2;SYT1
prerank,regulation of amyloid fibril formation (GO:1905906),0.5481379185067148,1.2550563071598269,0.19642857142857142,0.7760713700975304,1.0,6/15,12.39%,CLU;PFDN5;APP;PSEN1;APOE;PFDN4
prerank,regulation of receptor binding (GO:1900120),0.5893215880857796,1.254975695950816,0.22122571001494767,0.7752451820182761,1.0,2/10,2.21%,BDNF;B2M
prerank,endochondral bone morphogenesis (GO:0060350),0.5819544155746245,1.2548808311144637,0.19117647058823528,0.7744712082506284,1.0,5/11,16.07%,COL13A1;SCX;BMPR2;TRPV4;FGFR3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.463477303812759,-1.254571396168101,0.18095238095238095,0.9498748005141393,1.0,3/12,4.96%,TGFB1;AR;SELENOS
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5015810370920228,1.2540289705126293,0.19023136246786632,0.7766367193140667,1.0,7/24,8.75%,B2M;TAPBPL;TAPBP;ERAP1;ABCB9;SEC24D;SEC23A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.48790062706740034,1.253908681518768,0.18098958333333334,0.7759546287022303,1.0,3/25,2.95%,TNFSF10;MLLT11;BCL2L11
prerank,fatty acid beta-oxidation (GO:0006635),0.44116018427745873,1.2538127683282674,0.15711009174311927,0.7751320624316971,1.0,16/51,21.21%,MCAT;ACOXL;ACADL;ECI2;AUH;ABCD1;PEX2;ACADS;GCDH;PPARD;HADHA;ACAT1;ACOX1;HADH;ABCD4;DECR2
prerank,icosanoid biosynthetic process (GO:0046456),-0.49598973003093727,-1.253248028664392,0.1908831908831909,0.9484081401301367,1.0,2/10,4.64%,LTC4S;ALOX5AP
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4628865690264274,1.2529448573378459,0.17726161369193155,0.7774995831090888,1.0,4/38,6.10%,SP100;TNFSF10;FEM1B;CFLAR
prerank,regulation of trans-synaptic signaling (GO:0099177),0.46724293369612285,1.2524106552027627,0.1814903846153846,0.7784331295243432,1.0,14/33,25.21%,BDNF;GRIK3;EIF4EBP2;ABR;CACNA1A;IQSEC2;GRID1;LRP8;NLGN3;BCR;LRRC4;GRIK4;GRIK2;GRIK5
prerank,cytoplasmic translational initiation (GO:0002183),0.5292405783022954,1.2512669186727978,0.18989071038251365,0.7817833319687555,1.0,8/17,21.57%,EIF4A2;EIF4H;EIF3A;DENR;EIF4B;EIF2B3;EIF5;EIF3I
prerank,cellular response to nitrogen compound (GO:1901699),0.5187954606523808,1.2511834002214095,0.20639147802929428,0.7809256718389896,1.0,6/20,18.99%,DAXX;TIMELESS;RIOK3;DDX11;RTF2;DDI2
prerank,cellular response to growth factor stimulus (GO:0071363),0.40482978813199844,1.2511341604829445,0.07723577235772358,0.7799931302752758,1.0,44/151,20.41%,FLT1;HYAL1;WNT5A;SPRY2;KDR;CPNE3;ZFP36;GAREM1;ACVR1;HAS1;LRP2;CCL5;DUSP3;SOX9;CTNNB1;MAP2K3;SNAI2;MAGI2;RAPGEF2;BCAR1;MAPK14;BMPR2;CIB1;ZFP36L1;GAS1;PTPN11;NR3C1;RACK1;LIMS1;RAPGEF1;NRP1;CORO1B;ADAMTS12;BMPR1A;INPP5K;SOX5;STMN2;PDE3A;ACVR2A;DSTYK;ERN1;ACVRL1;WWOX;APPL2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5401184866205446,1.2509407567975213,0.20714285714285716,0.7795525239760128,1.0,4/15,11.94%,BDNF;BCAR1;SOS1;DDIT4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.35939247394992485,-1.2508637335794264,0.15920398009950248,0.951178709899747,1.0,13/29,20.62%,RPA1;PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;RPA3;GTF2H3;XPA;GTF2H4
prerank,myelination in peripheral nervous system (GO:0022011),0.5484699561686305,1.2503281955767191,0.2198581560283688,0.7807789784302837,1.0,5/13,17.97%,CNTNAP1;MYOC;ARHGEF10;DICER1;NF1
prerank,alcohol catabolic process (GO:0046164),0.5880650643439338,1.2499423221138035,0.21363636363636362,0.7811553344203629,1.0,3/10,12.38%,MT3;CYP27A1;APOE
prerank,regulation of histone modification (GO:0031056),0.5588197755479669,1.2499124418387453,0.2040520984081042,0.7801080636679544,1.0,2/13,10.77%,MTHFR;SETD5
prerank,regulation of cytoplasmic transport (GO:1903649),0.5796736075725822,1.2497159257879045,0.20474777448071216,0.7797216194392482,1.0,4/11,14.81%,DNAJC13;CHMP3;MAP2K2;DENND10
prerank,double-strand break repair (GO:0006302),0.39749917114291444,1.2486506250635263,0.0851063829787234,0.7828031658683198,1.0,39/158,15.76%,SAMHD1;PARP9;TENT4A;DTX3L;ZSWIM7;SEM1;CHEK2;APLF;POLM;MAD2L2;AP5Z1;POLB;HELQ;TNKS1BP1;KDM4D;HERC2;UBXN1;MCM9;BRIP1;RAD51C;FEN1;ERCC4;XRCC3;ACTR8;HMGB1;BARD1;ZFYVE26;CIB1;POLQ;PRKDC;PAXIP1;APBB1;NSMCE2;DCLRE1A;NSMCE1;GEN1;RMI1;RECQL5;NHEJ1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4328938584075024,-1.2481327969744698,0.16727272727272727,0.9555016982404864,1.0,8/15,28.70%,PTTG1IP;SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;PRKN
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3675148373239647,-1.2480645345648238,0.15566037735849056,0.9488005955851634,1.0,7/26,12.61%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1;CCR2
prerank,lymphocyte mediated immunity (GO:0002449),0.5639064777005359,1.247865031225834,0.24393723252496433,0.7847983640273773,1.0,2/12,2.90%,MSH2;CD55
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.46400821993171043,1.2473450886072641,0.18951132300357568,0.7857208288910612,1.0,12/32,21.64%,SLC27A1;CSNK2B;CSNK2A2;LPIN2;CEPT1;ABHD3;CHPT1;PCYT1A;PCTP;SLC44A1;CHKA;PCYT1B
prerank,immunoglobulin mediated immune response (GO:0016064),0.5779337751585599,1.247314444242682,0.21407185628742514,0.7847127460007415,1.0,4/10,15.92%,GAPT;TLR8;FCGR2B;CD27
prerank,positive regulation of cell population proliferation (GO:0008284),0.39007135743883176,1.2472835222725611,0.017,0.7836870736652789,1.0,86/423,16.95%,STAT1;NAMPT;IL15;AGT;CRLF1;NOD2;BST2;FLT1;SLAMF1;HYAL1;WNT5A;IRS1;KDR;GAREM1;DDRGK1;GDF9;MECP2;CDH13;KITLG;TGFA;CDC25B;AQP11;S1PR2;SFRP2;FXN;LAMC1;CD47;NACC1;HCK;CCL5;CCND2;CNOT7;TIPIN;CACUL1;CX3CL1;SOX9;FGFR2;TCF7L2;TFAP2B;CSF1;TBC1D8;DHX9;MEGF10;MEIS3;CTSH;IL12RB2;SIRT6;BAMBI;LYN;GDNF;SCX;INSR;PROX1;PHIP;CIB1;NPM1;HPSE;FAM98B;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;PIM1;NOP2;CAPNS1;RPS6;CAPN1;BAD;CHTOP;STX4;IRS2;PRKCH;SERTAD1;EZH2;BMPR1A;ACER3;PRMT1;AIF1;FGFR3;IL18;NDUFS4;TCIRG1;RBPJ;MDK
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.40306772757382897,1.246992339905583,0.09007164790174002,0.7837339202624708,1.0,24/140,15.35%,CHRNA9;CALCA;CXCR4;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;GNA15;TAC1;CACNA1A;PTGER3;ACKR3;P2RX4;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4394216884872104,1.2465620820916288,0.16591422121896163,0.7842604799493433,1.0,6/46,6.24%,STAT1;CDH13;CCL5;CX3CL1;CTNNB1;TCF7L2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.41786626235228674,1.2462940398288138,0.13822894168466524,0.7829721664442575,1.0,22/78,16.52%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;SEC24D;KIF3B;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;DYNLL1;FCGR2B;KIF2A;SEC24A;KLC2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.41786626235228674,1.2462940398288138,0.13822894168466524,0.7829721664442575,1.0,22/78,16.52%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;SEC24D;KIF3B;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;DYNLL1;FCGR2B;KIF2A;SEC24A;KLC2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.45118482884858985,-1.2462622865570414,0.20655737704918034,0.9489181346856554,1.0,5/13,11.04%,CD81;SAR1A;GCC2;SAR1B;INSIG1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3975110076333495,1.2461107615785765,0.08787878787878788,0.7825201736212554,1.0,65/193,23.38%,RNF213;ISG15;UBE2L6;DTX3L;TRIM25;CDC26;FBXO7;ANAPC5;RNF40;BFAR;RNF5;CNOT4;SIAH1;UBQLN2;UBE2B;RNF11;AREL1;RNF114;AMFR;SPSB1;ANAPC4;RNF19B;RBX1;PPP1R11;UBE2E1;UBQLN1;ARIH1;ELOC;BTRC;CDC16;CDC27;XBP1;LONP1;RNF149;SMURF1;FBXL14;UBE2L3;RNF185;ANAPC15;MYLIP;UBE4B;UBR4;UBA1;ANAPC2;RNF166;UBE2K;BIRC6;KLHL15;RFFL;WDR91;PSMD9;RC3H2;PTTG1;PSMF1;USP33;PSMC2;NUB1;UBQLN4;STUB1;SMURF2;ADRM1;CUL3;FEM1C;FEM1A;KCTD21
prerank,microtubule-based transport (GO:0099111),0.5662239480544724,1.2459052695299857,0.2253922967189729,0.7821785776010771,1.0,3/12,6.18%,CABYR;CCDC40;ADCY10
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5439456662102828,1.245740385219418,0.20027247956403268,0.7817014502711801,1.0,6/15,18.15%,NR1H2;SLC27A1;FBXW7;SIK1;SREBF1;LDLR
prerank,presynapse organization (GO:0099172),0.5913806537925943,1.2455616439969062,0.22693997071742314,0.7813243211869457,1.0,3/10,16.25%,WNT5A;LRRTM3;NLGN3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4212668413587518,1.2455583555206335,0.14859002169197397,0.7802053769054712,1.0,23/75,23.62%,WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;SIRT6;HMGB1;EGFL7;BMPR2;PROX1;VEGFD;NRP1;AGGF1;MDK;ITGA4;F3;FGF2;AKT3;STAT5A;PDPK1;ANG
prerank,regulation of B cell activation (GO:0050864),0.49090074639224324,1.245513042307256,0.1976284584980237,0.7792631901232214,1.0,5/25,14.78%,THEMIS2;NOD2;ZFP36L1;FCGR2B;TNIP2
prerank,cellular response to misfolded protein (GO:0071218),0.5169677821383597,1.2451385839473506,0.19489247311827956,0.7796695124578811,1.0,9/20,23.70%,AUP1;UBE2W;RNF5;POMT2;RNF185;KLHL15;STUB1;CUL3;VCP
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5433091817372101,1.2439966951729993,0.20972222222222223,0.7829959694562988,1.0,3/15,7.09%,SAT1;DDC;SMOX
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3756915554697696,-1.2437442268656373,0.14678899082568808,0.9527536960842763,1.0,9/24,18.64%,TGFB1;NUMB;RHOQ;DMTN;TMBIM1;GDI1;ABI3;ITGB1BP1;PICALM
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5568515274613981,1.2433236497539844,0.2099125364431487,0.7844842766241705,1.0,6/12,13.36%,CTNNB1;FEN1;CTCF;DDX11;RB1;HDAC8
prerank,SNARE complex assembly (GO:0035493),0.5960247527544678,1.2432383881349356,0.21189024390243902,0.7836621305711746,1.0,5/10,19.07%,CLTRN;VAMP1;VAMP2;VAMP4;UVRAG
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.38055564864314867,-1.24319272646518,0.14678899082568808,0.9484025122130825,1.0,7/23,16.74%,NCKAP1L;MPP1;C5AR2;RAC2;DPP4;RIPOR2;C1QBP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4625592101265071,1.2430315620989083,0.1957547169811321,0.7833721171781859,1.0,5/33,8.26%,AGT;TGFA;DOK1;FBXW7;CCDC88A
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3551568304442201,-1.2430074164138292,0.13372093023255813,0.9425269370833858,1.0,14/33,24.33%,APOD;PPARG;PDCD4;HMOX1;TPM1;IGFBP5;TRIB1;PRKG1;CDKN1A;CDKN1B;MEF2C;TNFAIP3;EFEMP2;IGFBP3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.506415857312263,1.2427419753644098,0.20286085825747724,0.7833495935810563,1.0,8/20,17.45%,TRIB3;SLC27A1;ACADL;FBXW7;ASXL3;SIK1;ERLIN2;PRMT3
prerank,diterpenoid metabolic process (GO:0016101),0.4341772572133737,1.2423371700720756,0.16252821670428894,0.7838468079822883,1.0,9/55,13.05%,BCO2;SDC3;SDC4;LRP2;RDH11;AGRN;AKR1B10;APOE;ALDH1A1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.596764524979306,1.2420123957080387,0.21649484536082475,0.7840852819892238,1.0,5/10,22.89%,LOXL2;SOX9;SOX5;ACVRL1;PKDCC
prerank,cellular defense response (GO:0006968),0.44695638447158115,1.2419532492995051,0.18906064209274673,0.7832053212325244,1.0,2/40,0.33%,LGALS3BP;CXCL9
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3963810845507857,1.2419524207016182,0.07452165156092648,0.7820983586524403,1.0,63/208,22.10%,STAT1;EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;WNT5A;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;TRAF4;CFLAR;TRIM39;TSPAN6;TMEM106A;TMEM9B;RNF31;RORA;TRAF3;SPHK2;TNIP1;RIOK3;ZC3H12A;IRAK4;TRAF5;NEK6;REL;MIER1;AKAP13;SHARPIN;BIRC3;TNIP2;MYD88;TNIP3;IRAK1;LGALS9;MIB2;ZDHHC13;CXXC5;TRIM62;TFG;UBE2V1;TAB3;TANK;RIPK2;PER1;TRIM13;ZFAND6;MAPKBP1;OPTN;RHOH;LITAF;ROR1;S100A13;GOLT1B
prerank,protein modification by small protein conjugation (GO:0032446),0.38848337227279284,1.2419076638303352,0.023,0.7811710515915413,1.0,91/361,18.78%,RNF213;IFIH1;ISG15;TRIM14;DTX3L;NUP37;SKP1;UBE2W;NFX1;DDRGK1;KLHL20;TMEM129;UVSSA;HLTF;CUL5;ARRDC4;FBXO7;RNF40;MOCS3;TRIM21;SUMO2;SUMO3;CNOT4;NUP153;UBE2B;TNFAIP1;FBXW7;AREL1;HERC2;CUL7;VPS11;TRIM39;UBE2M;DET1;AMFR;KLHL13;DCUN1D4;SPSB1;FBXW8;DCAF15;CAND1;RAE1;UCHL3;UBE2E3;RBX1;BARD1;UBA2;PEX2;UBE2E1;ZSWIM8;WAC;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;CDC16;RNF103-CHMP3;CDC27;TRIM26;PRKDC;SMURF1;KLHL9;UBE2L3;RACK1;MYLIP;RNF25;NSMCE2;NUP155;MYCBP2;RNF103;PIAS1;LZTR1;UBA1;PIAS2;LMO7;ENC1;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;NUP88;BIRC6;CAND2;TRIM62;WWP1;PCNP;MGRN1;ASB1
prerank,autophagy of peroxisome (GO:0030242),0.5686435044819984,1.2417828095077126,0.22108345534407028,0.78055340938063,1.0,5/12,17.00%,NBR1;PIK3R4;MAP1LC3B;RB1CC1;PEX5
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5342698600643858,1.241445459411432,0.1977715877437326,0.7807636316423251,1.0,6/15,15.96%,IRS1;SLC45A3;LDLRAP1;PRKCE;IRS2;PPARD
prerank,negative regulation of T cell differentiation (GO:0045581),0.5838054140160058,1.241280066362055,0.2166172106824926,0.7803339967059881,1.0,4/10,23.40%,LAG3;MDK;GLI3;IRF1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5221339764187075,1.2410568115755218,0.2096317280453258,0.7801164747179358,1.0,5/15,11.76%,ENTPD3;ENTPD6;ENTPD5;AK4;CMPK2
prerank,autonomic nervous system development (GO:0048483),0.5290134413853017,1.2409767214602556,0.20357634112792297,0.7793115773300582,1.0,6/17,17.97%,KIF26A;TFAP2B;GDNF;NRP1;PHACTR4;NF1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3814517754889687,-1.2408123474120762,0.15352697095435686,0.9447729484687135,1.0,6/22,12.61%,STIM1;GRM3;CAP2;EDNRB;PALM;CCR2
prerank,nucleic acid metabolic process (GO:0090304),0.41506667566321503,1.2406828192669859,0.16266375545851527,0.7793501680898249,1.0,23/69,19.33%,POLR2G;XRN2;HNRNPH1;RBMX;NCBP2;HNRNPK;HNRNPM;FEN1;HNRNPA2B1;POLR2K;HNRNPL;DDX24;HNRNPA1;DDX54;ENPP1;DNASE2;DUSP11;RECQL5;NCBP1;HNRNPA3;METTL14;WTAP;HNRNPF
prerank,regulation of cholesterol transport (GO:0032374),0.5032274059615874,1.2401894135775915,0.21635883905013192,0.7801751285261584,1.0,4/20,13.00%,NR1H2;YJEFN3;NFKB1;TSPO
prerank,B cell receptor signaling pathway (GO:0050853),-0.350272805986868,-1.2400327432145013,0.1092896174863388,0.9412497813817694,1.0,6/32,3.78%,NFAM1;SYK;CD38;SH2B2;NCKAP1L;LAT2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5680700598353684,1.2394922789442637,0.23547400611620795,0.7817845527632958,1.0,4/11,17.86%,SLC18A2;ABCD1;FYN;ABCB7
prerank,chemical homeostasis (GO:0048878),0.42734963800105497,1.2393521776941903,0.15436241610738255,0.7812502829763425,1.0,19/61,21.72%,ACOXL;USF2;PNPLA2;AQP11;TLCD2;FBXW7;USF1;ABHD8;AQP4;THADA;IRS2;SLC4A2;ACOX1;PNPLA3;NR1D2;DDX3X;ADCK1;ZBTB20;PNPLA8
prerank,regulation of neuron apoptotic process (GO:0043523),0.4101115828494099,1.2388700681195446,0.13011542497376705,0.7820382381509082,1.0,24/96,19.06%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;EGLN2;CTNNB1;MT3;NRBP2;TFAP2B;AGAP2;GDNF;PRNP;MAG;APOE;PPARGC1A;AKT1S1;MDK;BAX;NF1;RETREG1;TRIM2;SET
prerank,retinoid metabolic process (GO:0001523),0.42084225912059636,1.2388444128059948,0.1791845493562232,0.7810187618049534,1.0,11/71,13.05%,BCO2;SDC3;SDC4;LRP2;RDH11;CYP26B1;ALDH1A2;AGRN;AKR1B10;APOE;ALDH1A1
prerank,regulation of cell aging (GO:0090342),0.5715740844638497,1.2385507526018755,0.21839080459770116,0.781093834107448,1.0,3/11,11.88%,PNPT1;RSL1D1;NEK6
prerank,response to iron ion (GO:0010039),0.5648588819935021,1.2380120258429996,0.22286541244573083,0.7821274948886684,1.0,4/12,14.77%,B2M;FXN;SLC11A2;TFR2
prerank,peripheral nervous system development (GO:0007422),0.49321122672084444,1.2375376402721106,0.2178988326848249,0.7828540098792827,1.0,5/23,18.02%,PMP22;BDNF;GDNF;NF1;SCN8A
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5151795886664309,1.2371164451462517,0.22356091030789826,0.7834419138439244,1.0,4/19,14.43%,IRS1;PNPLA2;ABCD1;IRS2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5439325949334868,1.2369264926221826,0.2034139402560455,0.7831304473268612,1.0,2/14,8.40%,ADAM8;PTGER3
prerank,protein kinase A signaling (GO:0010737),0.5563585481657681,1.2357906910315273,0.2237960339943343,0.786657387746987,1.0,1/12,0.59%,GAL
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4683319443166129,1.2357737220083915,0.2034956304619226,0.785630293923099,1.0,7/30,8.51%,TMEM161A;CLU;SFRP2;CDKN2D;RTEL1;SNAI2;ACKR3
prerank,extracellular transport (GO:0006858),0.5648344840386166,1.2356280814691825,0.22364672364672364,0.7850676011707282,1.0,3/12,6.18%,CABYR;CCDC40;ADCY10
prerank,miRNA metabolic process (GO:0010586),0.5108059933536969,1.2353387195157974,0.2297650130548303,0.785069812366668,1.0,7/20,17.03%,AGO2;TARBP2;BCDIN3D;DIS3L2;TUT7;DICER1;PRKRA
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4101494975443118,1.2347019088249558,0.15319148936170213,0.7864459660610245,1.0,23/87,19.33%,HYAL1;POLR2G;ZFP36;HNRNPH1;CCL5;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;RAB14;ZFP36L1;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;DSTYK;SPRED1;HNRNPF
prerank,actin filament bundle assembly (GO:0051017),-0.351476618080915,-1.234490268033812,0.14534883720930233,0.9573810290924133,1.0,7/33,7.60%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.44564616566626514,-1.234242239084573,0.19444444444444445,0.9518223391396086,1.0,4/14,12.48%,XRCC5;TERF2IP;PINX1;NABP2
prerank,regulation of autophagosome assembly (GO:2000785),0.4621907689396753,1.234176378445023,0.19546027742749053,0.7873476333940295,1.0,5/33,6.32%,CHMP4A;CHMP4B;UBQLN2;LRSAM1;SH3GLB1
prerank,histone ubiquitination (GO:0016574),0.4926638159397222,1.2340871345209472,0.22649006622516557,0.7866009634976773,1.0,5/21,9.88%,DTX3L;RNF40;UBE2B;UBE2E1;WAC
prerank,ribosomal large subunit assembly (GO:0000027),0.4842423099178789,1.2337594911789216,0.20897435897435898,0.7868447049189313,1.0,14/24,22.13%,MDN1;NOP53;RRS1;PPAN;DHX30;NOP2;RPL23A;RPL11;RSL24D1;RPL24;FASTKD2;RPL3;RPL5;RPL6
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.49078416046662715,-1.2331815859705961,0.22822822822822822,0.9497603907717665,1.0,6/10,27.15%,VDAC1;BIN1;FKBP1B;CBARP;ADRA2A;SESTD1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.43050011213872036,1.2330841233658065,0.19031531531531531,0.7882974764436447,1.0,19/54,23.51%,KDR;CD40;MECP2;MAP2K3;CSNK2B;P2RX4;HMGB1;MAPK14;APOE;SH3BP1;NF1;ACVRL1;GADD45A;FGF2;AKT3;ATP5F1B;STAT5A;VASH1;PDPK1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4980031446096647,1.2329276943064884,0.1994750656167979,0.7878188921788709,1.0,9/21,21.83%,PGD;PGM2L1;PGLS;HK1;RPIA;DERA;RPE;TKT;TALDO1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5652326946165096,1.2318694651749456,0.21796759941089838,0.7908538546519391,1.0,4/11,11.25%,RESF1;SIRT6;DNMT1;SETDB2
prerank,regulation of glycogen metabolic process (GO:0070873),0.5557664662233555,1.231499828259722,0.23467862481315396,0.7912273565811537,1.0,5/12,20.67%,PPP1R3E;PPP1R3D;RUBCNL;INPP5K;PPP1R3B
prerank,tRNA metabolic process (GO:0006399),0.5086504864181618,1.2310638257693496,0.2222222222222222,0.7918678020185917,1.0,7/17,17.06%,TRPT1;DTD1;AARS1;ADAT1;DTD2;YARS2;RPP30
prerank,receptor catabolic process (GO:0032801),0.4820955067297868,1.2305474270157317,0.20332480818414322,0.7928532869420485,1.0,11/24,19.16%,MVB12A;AP2A1;SH3GLB1;KIF16B;PIK3R4;AP2S1;SMURF1;MYLIP;UVRAG;SNX25;BECN1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4168142641551545,1.2305402259783391,0.16052060737527116,0.791797753399642,1.0,31/76,25.91%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;FBXW7;PRICKLE1;DET1;SOCS5;RNF19B;RBX1;ARIH1;SMURF1;RACK1;DAB2;PIAS1;HECTD1;USP5;RNF180;HSPBP1;NUB1;STUB1;DNAJB2;SUMO1;VCP;AXIN1;BBS7;SIRT2;RAD23A;DDA1
prerank,regulation of kinase activity (GO:0043549),0.40593712647339897,1.2300514862771497,0.1487778958554729,0.7925233162603169,1.0,22/89,19.14%,NLRC5;AXL;FLT1;KDR;RBL1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;ROR2;INSR;LDB2;LDB1;RB1;IRS2;FGFR3;PLCE1;DSTYK;NPRL2;CAMKK2
prerank,positive regulation of ossification (GO:0045778),0.4500027179120366,1.2292996282609847,0.19806763285024154,0.7943292600730448,1.0,9/39,15.05%,ISG15;WNT5A;ACVR1;SLC8A1;BMPR2;ADGRV1;PTPN11;NELL1;BMPR1A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5663995588673466,1.2291109354238061,0.24362606232294617,0.7940147114794749,1.0,2/11,2.35%,NR1H2;SLC27A1
prerank,positive regulation of chemotaxis (GO:0050921),0.442142838791159,1.2288740274716463,0.18501170960187355,0.7938678090727072,1.0,11/43,16.95%,KDR;CDH13;MET;SMOC2;P2RX4;PPM1F;NRP1;STX4;DSCAM;AIF1;MDK
prerank,positive regulation of cell migration (GO:0030335),0.3858293661370775,1.2287542398359634,0.07142857142857142,0.7932256578506618,1.0,59/253,17.53%,WNT11;FLT1;CCL7;HYAL1;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;AGO2;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;SYDE1;SOX9;FAM83H;CARMIL1;ARHGEF7;PODXL;SNAI2;CSF1;RET;ELP6;MAPRE1;MYOC;RAPGEF2;CTSH;BCAR1;PDPN;ROR2;INSR;BMPR2;CIB1;PPM1F;SUN2;XBP1;PRKCE;RACK1;NRP1;DAB2;STX4;RREB1;MIEN1;SPAG9;SEMA3D;AIF1;MTOR;RAB11A;MGAT5;MDK;CBLL1;PTPRC
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5188065508179683,1.2285567910611805,0.22601839684625494,0.7929273960355936,1.0,6/19,16.80%,PIK3AP1;NMI;PRKCE;TNIP3;IRAK1;LGALS9
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3865528560826289,1.2285317696206064,0.037,0.7919668066055362,1.0,120/341,23.70%,RNF213;PML;PSMB10;UBE2L6;DTX3L;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;UBAP1;CDC26;RNF4;FBXO7;PSME4;ANAPC5;RBCK1;RNF40;FEM1B;BFAR;RNF5;MVB12A;CNOT4;SIAH1;UBQLN2;UBE2B;TNFAIP1;RNF11;KCTD17;FBXW7;CTNNB1;AREL1;PPP2R5C;PSMA3;UBXN1;RNF114;AMFR;SPSB1;PSMB9;ANAPC4;RNF19B;RBX1;VPS37A;PPP1R11;UBE2E1;ZSWIM8;UBQLN1;UBXN2B;ARRB2;ARIH1;ELOC;BTRC;UBXN11;RNF122;PSMD2;CDC16;CDC27;XBP1;RNF149;PSME3;SMURF1;FBXL14;VPS28;UBE2L3;FBXL19;RNF185;ANAPC15;MYLIP;SHARPIN;ZRANB1;UBE4B;PSMA4;NHLRC3;APPBP2;UBR4;UBA1;ATE1;ANAPC2;GID4;RNF166;UBE2K;BIRC6;KLHL15;TRIM2;WWP1;PCNP;PSMD7;RFFL;WDR91;PSMD9;RC3H2;PSMD8;PTTG1;ZFAND2A;SPOP;PSMF1;TRIM13;RNF216;PSMB6;TSG101;USP33;PSMD12;PSMC2;NUB1;HUWE1;UBQLN4;STUB1;SMURF2;ADRM1;PSMD4;PELI1;CUL3;FEM1C;FEM1A;KCTD21;KAT5;MAEA;PSMA2;VCP
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5755136835013887,1.2285151517486899,0.2188449848024316,0.7909669914537745,1.0,3/10,10.61%,DHX58;TSPAN6;RIOK3
prerank,regulation of interleukin-6 production (GO:0032675),0.40708267479131144,1.2280695920066003,0.1708595387840671,0.7916360322930164,1.0,23/96,17.70%,IFIH1;NOD2;SLAMF1;WNT5A;STAT3;CD47;TLR8;CX3CL1;DHX9;TMEM106A;HMGB1;APP;SPHK2;ZC3H12A;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4259754334389415,1.2277570703422147,0.19260918253079506,0.7917437009387943,1.0,7/57,4.39%,TNFSF10;KDR;FIS1;MLLT11;BCL2L11;FBXO7;CHCHD10
prerank,zinc ion transport (GO:0006829),0.5042158850866678,1.2276952803873438,0.22451612903225807,0.790945675328134,1.0,5/21,10.95%,TRPM2;SLC30A1;SLC30A5;MT3;SLC30A6
prerank,regulation of actin filament depolymerization (GO:0030834),0.5519119977825075,1.2275408292511945,0.22819767441860464,0.7904784620273184,1.0,6/12,28.44%,PDXP;PLEKHH2;SH3BP1;CFL2;PIK3CA;SEMA5A
prerank,tRNA modification (GO:0006400),0.4263107245927197,1.2269587206257377,0.15765765765765766,0.7916791344644859,1.0,21/62,21.54%,TPRKB;TRMT9B;OSGEP;MOCS3;BCDIN3D;ADAT2;TRMT1;TRMT13;ALKBH1;AARS1;TRMT61B;THADA;WDR4;DUS2;PUS7;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;PUS10
prerank,diol metabolic process (GO:0034311),0.5148234017730525,1.2269506240255008,0.21372031662269128,0.7906636294653165,1.0,7/19,21.53%,SGPP2;ASAH2;SPHK2;GCH1;HSP90AA1;PRKG2;PLPP2
prerank,amino sugar metabolic process (GO:0006040),0.5771142776677669,1.2269128695965978,0.24071322436849926,0.7897777683744556,1.0,5/10,14.55%,ST6GAL1;GFPT1;ST3GAL1;GNE;SLC35A3
prerank,negative regulation of DNA metabolic process (GO:0051053),0.48502598255923063,1.2263982399316253,0.2131979695431472,0.7906116239593846,1.0,10/24,20.21%,MSH2;KMT2A;RTEL1;ERCC4;BMPR2;ZRANB3;DFFA;DACH1;TERF2;ACVRL1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5477426933244719,1.2259914124376843,0.22905027932960895,0.7910781256952233,1.0,6/13,16.59%,IRS1;PPP1R3E;INSR;DYRK2;IRS2;PHKG2
prerank,neuron cell-cell adhesion (GO:0007158),-0.43083302755578357,-1.2256589359548231,0.19927536231884058,0.9743473048999846,1.0,4/14,8.48%,ASTN1;NRXN2;NLGN2;NRXN1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5523569619431805,1.2255650837571446,0.23760932944606414,0.791697766279643,1.0,5/12,18.20%,MCM2;MCM7;MCM4;GINS2;GINS4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.451807465224206,-1.2252825346922565,0.22580645161290322,0.9695123002865219,1.0,7/12,39.39%,GRIN1;RAB27A;TLR4;ZNF205;ADGRB1;MMP8;SLC5A3
prerank,negative regulation of T cell proliferation (GO:0042130),0.47452744212954934,1.2248710551513744,0.1951219512195122,0.793259409270379,1.0,3/28,9.48%,CD274;SDC4;PRNP
prerank,skeletal system development (GO:0001501),0.3919064300533291,1.2247099209481678,0.11812627291242363,0.7927954093443327,1.0,19/148,7.78%,WNT11;EXT1;COL13A1;HYAL1;WNT5A;COMP;DDRGK1;CHD7;MMP14;PTGER4;TCOF1;SOX9;P3H1;FGFR2;ITGB8;ANKH;FBN1;FRZB;MYOC
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.4520551019180885,-1.2244590408043463,0.2123076923076923,0.9664677038638937,1.0,7/12,24.01%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4770167542763306,1.2235089942699626,0.22,0.7964710440336525,1.0,8/24,22.01%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,focal adhesion assembly (GO:0048041),0.5038543468364087,1.2234962773063387,0.2222222222222222,0.7954784741563292,1.0,9/21,17.17%,ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;PIP5K1A;WHAMM;TAOK2;BCR
prerank,central nervous system myelination (GO:0022010),0.5629507305538062,1.2233991316842314,0.24005891016200295,0.7947886320167727,1.0,5/11,21.47%,CLU;CNTNAP1;B4GALT5;PLP1;TENM4
prerank,regulation of centrosome cycle (GO:0046605),0.5051741932567667,1.2232771256313724,0.22588832487309646,0.7941996319006406,1.0,8/21,17.68%,CHMP4B;CHMP1B;XRCC3;NPM1;CEP131;CHMP3;GEN1;CHMP5
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4540256878260461,1.2231941339087637,0.20024420024420025,0.7934724116511476,1.0,11/37,15.63%,PNPT1;XRN2;ENTPD3;ENTPD6;RNASEH2A;NUDT5;RNASEH2C;ENTPD5;NCBP1;RNASEH2B;NUDT16
prerank,mitochondrial genome maintenance (GO:0000002),-0.4733985856173554,-1.2228181099018605,0.2356687898089172,0.9669253010409071,1.0,4/11,6.40%,MPV17;SLC25A4;PARP1;SLC25A36
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.45694970308813054,1.222711476220142,0.20359281437125748,0.7942285627722143,1.0,11/32,22.50%,DHFR;ESRRB;CDT1;BACH1;TFDP1;TFDP2;RB1;NPAT;HINFP;ORC1;CDK16
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4798993647826266,-1.2224686947839782,0.20771513353115728,0.9493837432060069,1.0,6/10,17.78%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,t-circle formation (GO:0090656),-0.4798993647826266,-1.2224686947839782,0.20771513353115728,0.9493837432060069,1.0,6/10,17.78%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4798993647826266,-1.2224686947839782,0.20771513353115728,0.9493837432060069,1.0,6/10,17.78%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,regulation of mitotic cell cycle (GO:0007346),0.3929222765288757,1.2223143822286724,0.10274669379450661,0.7946868260497881,1.0,36/171,13.12%,PKMYT1;PSMB10;DAPK3;SKP1;PSME2;PSMA5;CDC26;ASAH2;PSME4;CDC25B;ANAPC5;RNF40;PKN2;BRINP3;DUSP3;SRA1;PDXP;PSMA3;CUL7;CYLD;PSMB9;ANAPC4;SMOC2;APP;UBE2E1;BTRC;CDK10;PSMD2;CDC16;SIK1;GAS1;CDC27;NEK6;PSME3;RB1;ANAPC15
prerank,regulation of cell-substrate adhesion (GO:0010810),0.44368509903179065,1.222236683774833,0.1990686845168801,0.7939565729885688,1.0,15/42,19.12%,FBLN2;THY1;CX3CL1;PDPN;PPM1F;LIMS1;PIK3CB;RAC1;JAK2;MINK1;TBCD;NF1;CORO1C;VIT;TSC1
prerank,protein ubiquitination (GO:0016567),0.38053720905914773,1.2220041051989317,0.021,0.7937843849960244,1.0,122/471,19.15%,RNF213;HERC6;ISG15;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;NFX1;KLHL20;PSMA5;RNF4;TMEM129;UVSSA;SASH1;HLTF;CUL5;ARRDC4;FBXO7;PSME4;RBCK1;RNF40;TRIM21;RNFT1;BFAR;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;HERC2;CUL7;VPS11;TRIM39;DET1;RNF114;AMFR;KLHL13;SPSB1;FBXW8;DCAF15;CAND1;PSMB9;UCHL3;RNF31;RNF19B;UBE2E3;RBX1;BARD1;PEX2;UBE2E1;ZSWIM8;WAC;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;RNF122;PSMD2;CDC16;RNF103-CHMP3;CDC27;TRIM26;PRKDC;PSME3;NPEPPS;SMURF1;FBXL14;KLHL9;UBE2L3;FBXL19;RNF185;RACK1;MYLIP;RNF25;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;NHLRC3;MYCBP2;RNF103;HECTD2;LZTR1;UBA1;LMO7;RNF166;ENC1;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;BIRC6;CAND2;TRIM62;TRIM2;WWP1;PCNP;PSMD7;MGRN1;ASB1;PSMD9;RC3H2;UBE2V1;PSMD8
prerank,mRNA metabolic process (GO:0016071),0.40737110062120163,1.2218081058214292,0.15112540192926044,0.7935104696675658,1.0,36/90,24.16%,HSPA1B;PNPT1;ZFP36;DDX5;PRPF18;NCBP2;DCP2;HNRNPA2B1;YTHDF2;NONO;PPARGC1A;USP39;DIS3L2;PCF11;AURKAIP1;SNRPG;NCBP1;GEMIN2;NUDT16;SF3B4;SRSF7;SRSF4;LSM5;TBRG4;ERN1;SRSF5;PCBP3;SF3A2;TCERG1;AGO4;SRSF2;SNRPD3;RNH1;ZFP36L2;RNASE4;SON
prerank,metal ion homeostasis (GO:0055065),-0.3187885097142933,-1.2216994057437647,0.13815789473684212,0.9462344479407346,1.0,11/40,12.43%,SLC12A6;SLC12A2;GRIN1;ANK3;TMTC2;SNCA;COX11;FAM20A;LETM1;WFS1;SELENON
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.40750801553919186,1.2214067397196897,0.16595289079229122,0.794030073758918,1.0,20/85,14.43%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;MAGI2;PSMB9;ROR2;ARRB2;AP2S1;PSMD2;PSME3;SMURF1;RAC1;PSMA4
prerank,proteasomal protein catabolic process (GO:0010498),0.38759480436455857,1.221281661474569,0.09109311740890688,0.793479563304933,1.0,74/201,23.70%,PML;PSMB10;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;RNF4;PSME4;RBCK1;FEM1B;BFAR;RNF5;SIAH1;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;AREL1;PPP2R5C;PSMA3;UBXN1;SPSB1;PSMB9;RBX1;ZSWIM8;UBXN2B;ARRB2;BTRC;UBXN11;RNF122;PSMD2;PSME3;SMURF1;FBXL19;RNF185;SHARPIN;UBE4B;PSMA4;NHLRC3;APPBP2;ATE1;GID4;ENC1;UBE2K;TRIM2;WWP1;PCNP;PSMD7;RFFL;SOCS6;PSMD9;DDI2;PSMD8;ZFAND2A;SPOP;PSMF1;TRIM13;RNF216;PSMB6;PSMD12;PSMC2;HUWE1;STUB1;SMURF2;PSMD4;PELI1;CUL3;FEM1C;KAT5;MAEA;PSMA2;VCP
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3995654323071965,-1.2212562223679868,0.18461538461538463,0.9420382309152546,1.0,4/18,4.91%,TGFB1;TMBIM6;RPS26;ESR1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4010302140530318,1.2211925192328883,0.15958549222797927,0.7927817334699949,1.0,20/101,15.26%,IRGM;NOD2;FLT1;WNT5A;SLC27A1;CD40;ADAM8;CCND2;CCND1;ETAA1;CAB39;TPD52L1;MTCP1;RAPGEF2;PROX1;CIB1;MAP2K2;TELO2;EZH2;CALM3
prerank,negative chemotaxis (GO:0050919),-0.345303508452905,-1.2210159674467211,0.14012738853503184,0.9369414562881482,1.0,19/33,28.97%,SEMA4C;UNC5C;ITGAV;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;RHOA;SEMA3E;ITGB3;NTN1;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,regulation of cellular component organization (GO:0051128),0.3941518669675986,1.2209955304719489,0.12949640287769784,0.7925118499208945,1.0,35/135,17.71%,IRGM;AGT;SGK2;SGK3;CAMK2D;WNT5A;SEMA4D;CDH13;STK38L;MAD2L2;EGLN2;ATAD3A;RAPGEF2;BCAR1;RAB5C;HSPA8;SSRP1;OGFR;AP2S1;SETD5;ARHGEF11;PTPN11;APOE;SOCS2;RAPGEF1;STON1;HSP90AA1;MLLT3;TAOK2;CHPT1;MTOR;OPHN1;STON2;CAMSAP2;PLCE1
prerank,phospholipid transport (GO:0015914),0.43405173562745436,1.220942212407468,0.19173363949483352,0.7916804359261568,1.0,15/52,19.78%,ATP10A;ABCA1;ABCG1;ATP8A1;OSBPL8;PITPNM1;ABCC1;APOE;ATP11A;NPC2;ATP9B;MTTP;LDLR;OSBPL2;PCTP
prerank,lipid catabolic process (GO:0016042),0.5046855786719817,1.220880079220233,0.2222222222222222,0.7908823732150372,1.0,4/18,8.34%,ACADL;MT3;LIPC;HSD11B1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5565833128643054,1.2205633068168555,0.2376237623762376,0.7910885035105583,1.0,4/14,14.83%,SOX9;SNAI2;PTPN11;ADAMTS12
prerank,peptide catabolic process (GO:0043171),0.4820027006573916,1.2203185378339791,0.22533333333333333,0.7909427731754496,1.0,9/23,24.88%,ERAP1;CPQ;CTSH;GGT7;NPEPPS;CHAC2;IDE;TRHDE;ECE1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4451726342697666,-1.2202098143501372,0.18960244648318042,0.9341692695493662,1.0,6/13,22.07%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,sulfur compound transport (GO:0072348),0.4639936484581063,1.2200087950336131,0.21455457967377667,0.7910602507660034,1.0,14/27,26.18%,SLC27A1;SLC26A1;SLC25A19;SLC35F3;SLC25A10;SLC13A4;ABCG2;SLC5A6;MGST1;SLC6A6;SLC25A30;SLC26A7;SLC36A1;SLC25A26
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.43777609479250174,1.219534193317315,0.21136363636363636,0.7918562843892252,1.0,9/51,16.95%,CXCL10;CCL5;CSF1;HMGB1;VEGFD;CXCL17;AIF1;LGALS9;MDK
prerank,negative regulation of growth (GO:0045926),0.3975265198693408,1.219526835723688,0.15392561983471073,0.7908616790095138,1.0,25/121,13.25%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;PNPT1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;SERTAD2;RB1;ENPP1;RACK1;APBB1
prerank,DNA replication initiation (GO:0006270),0.44370120814880293,1.2193274215394079,0.1880952380952381,0.7906099426646862,1.0,6/37,6.00%,MCM2;LRWD1;POLE2;MCM7;MCM4;CDT1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.5613881335459094,1.2189908404540184,0.24320457796852646,0.7909384890212574,1.0,3/12,14.02%,CLTRN;BAIAP3;STX4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5027374722779095,1.2186455043860804,0.2601307189542484,0.7912070162955441,1.0,9/20,20.12%,PML;CAMK2D;FIS1;KCTD17;THADA;PSEN1;BAX;BCAP31;TGM2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.40857469931210516,1.2186250698105323,0.1655982905982906,0.7902671653493016,1.0,28/86,19.80%,CLU;HCK;EVL;CX3CL1;PDXP;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;APP;NCK2;PROX1;SNX9;PSEN1;AKAP9;APOE;RB1;SYNPO;TRPV4;PRKCE;RAC1;BAIAP2;BAIAP2L1;STMN2;CFL2;NUMA1;NCKAP1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.41956650894370795,1.2185188671984535,0.17467248908296942,0.7896825822785076,1.0,19/67,18.90%,FBLN2;UTRN;CDH13;CX3CL1;CARMIL1;ARHGEF7;CSF1;MYOC;CIB1;PPM1F;LIMS1;NRP1;RAC1;JAK2;RREB1;CRK;MDK;VIT;TESK1
prerank,vitamin D metabolic process (GO:0042359),0.5456000636344449,1.2184071347870395,0.24606580829756797,0.7890764274780224,1.0,1/13,3.40%,LRP2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.46608144679280683,1.218138829424689,0.23809523809523808,0.7890285573471412,1.0,11/29,18.77%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPIA;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,regulation of histone methylation (GO:0031060),0.550792685919609,1.217415415206272,0.23469387755102042,0.7907524240335785,1.0,3/13,13.46%,MTHFR;AASS;CHTOP
prerank,response to glucocorticoid (GO:0051384),0.4814602048784785,1.217407656649803,0.2358974358974359,0.7897782875222661,1.0,6/26,12.73%,ZFP36;BCL2L11;ZFP36L1;SLIT3;NR3C1;UBE2L3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4993970560939458,1.217274918697881,0.2369109947643979,0.789250318876579,1.0,7/19,20.66%,KDR;TRPM2;FIS1;PRNP;PTPRC;BCAP31;VCAM1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4971279228793851,1.216420858053285,0.2359249329758713,0.7914753986603357,1.0,7/20,17.31%,CLU;HSP90AB1;HSPA4;LONP1;PSMG2;HSP90AA1;PTGES3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.2856938488624796,-1.2160544786174545,0.09090909090909091,0.9445639807674246,1.0,28/72,21.55%,GRIN2A;GRIN2B;DLG4;CACNG7;PRKCZ;TSHZ3;RGS14;NLGN2;EPHB2;SLC8A3;FLOT1;CACNG8;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS3;CCR2;SHISA7;RIMS2;ZDHHC12;CACNG2;KCTD13;PLK2;SYT1;CACNG3;SLC8A2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4796130024842048,1.2152210625029172,0.2256020278833967,0.7950657590469553,1.0,4/26,1.59%,IFIH1;NOD2;NOD1;ALPK1
prerank,endoderm development (GO:0007492),0.5412296268161962,1.2149621974835798,0.2613480055020633,0.7950690874732387,1.0,2/13,9.37%,LAMC1;KIF16B
prerank,positive regulation of T cell differentiation (GO:0045582),0.4504073687889032,1.2139118134621947,0.2258852258852259,0.7980825894729408,1.0,12/36,21.84%,TNFSF9;SOCS1;ADAM8;BCL6;XBP1;NKAP;DUSP10;SART1;MDK;CD46;RHOH;GLI3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.40651743278848307,1.2136170306453755,0.1791845493562232,0.7981403733797652,1.0,22/79,16.52%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;SEC24D;KIF3B;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;DYNLL1;FCGR2B;KIF2A;SEC24A;KLC2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.44197217844489045,-1.2132959778901176,0.2326388888888889,0.9440494407175353,1.0,7/15,18.13%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.44197217844489045,-1.2132959778901176,0.2326388888888889,0.9440494407175353,1.0,7/15,18.13%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4072060107722129,1.2131996496566726,0.1611170784103115,0.79873829871966,1.0,34/85,25.91%,HSPA1B;TRIB3;CLU;DDRGK1;RNFT1;SUMO2;NOP53;OSBPL7;FBXW7;PRICKLE1;DET1;SOCS5;RNF19B;RBX1;ARIH1;RNF185;RACK1;DAB2;PIAS1;HECTD1;USP5;RNF180;HSPBP1;PSMC2;NUB1;STUB1;DNAJB2;SUMO1;TMTC3;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,peptidyl-lysine modification (GO:0018205),0.39917404360955033,1.2128077732955727,0.1673728813559322,0.7993296611936956,1.0,41/99,27.02%,IFIH1;LIPT1;LOXL2;NUP37;METTL21A;SENP3;SUMO2;SUMO3;NUP153;SENP5;RAE1;UBA2;VIPAS39;USPL1;NSMCE2;NUP155;GCSH;PIAS1;PIAS2;ATPSCKMT;NUP88;NUP133;NUP43;SENP7;SUMO1;SENP2;HDAC4;KAT5;HDAC6;KAT2B;PLOD3;LOX;NUP205;TRIM28;EEF1AKMT1;SIRT2;PIAS4;SEH1L;EYA1;NUP188;EP300
prerank,intracellular pH reduction (GO:0051452),-0.33454595809984816,-1.2127435292180573,0.16279069767441862,0.9403099062061006,1.0,10/33,13.09%,ATP6V0A1;ATP6V1H;ATP6V1E1;DMXL1;ATP6V1C1;ATP6V1D;GPR89B;GPR89A;DMXL2;ATP6V1A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.409875841131839,1.2120283758322237,0.18446601941747573,0.8011829189916637,1.0,16/72,17.90%,SP100;PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;PAXIP1;E2F4;MYO6;PRMT1;PCBP4;BAX;CRADD
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.47671434784788363,1.2109699132586687,0.2146341463414634,0.8043412105821449,1.0,6/26,14.11%,TPI1;GBGT1;B4GALT5;SCCPDH;TNIP1;ALG11
prerank,mitochondrion morphogenesis (GO:0070584),0.5551822148594008,1.210569346637538,0.2617246596066566,0.8048540631302368,1.0,3/11,9.52%,PNPT1;FIS1;SLIRP
prerank,vasodilation (GO:0042311),0.5393771816353676,1.210100006281111,0.25,0.8055957277974798,1.0,1/13,2.70%,SOD2
prerank,sulfur amino acid metabolic process (GO:0000096),0.475622535098392,1.2090336616740363,0.21794871794871795,0.8086863844217406,1.0,8/24,23.07%,MTHFR;SMS;MSRA;GCLC;MTHFD1;GADL1;MMUT;TXN2
prerank,negative regulation of blood pressure (GO:0045776),0.5369032376453123,1.2088424482710092,0.26906474820143883,0.8084029658026293,1.0,2/13,9.69%,GPR37L1;BMPR2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3764690908045803,1.2086791395802667,0.025025025025025027,0.8080450963185657,1.0,113/476,20.37%,STAT1;SP100;IRF7;PARP9;WNT11;PML;AGT;LHX2;NR1H2;HAS3;ESR2;DTX3L;WNT5A;TRIM45;ESRRB;PRMT2;RNF4;TEAD2;CHEK2;ACVR1;STAT3;MLLT11;ARID1B;RUNX1;MAD2L2;USP21;ILF3;NCOA1;MRPL12;SERTAD3;SOX9;CTNNB1;KMT2A;ARID1A;NSD3;ZXDC;TCF4;SMARCC2;NFKB1;EDF1;SETD3;MT3;TFAP2B;NFATC2;MAP2K3;RET;MDFIC;RAI1;SMAD2;CDK5RAP2;BAMBI;NFIB;POU3F1;SCX;RORA;ELF4;WAC;MED12;PHIP;BTRC;RGMB;NPM1;FOXK1;DNM2;CTCF;NOTCH4;RYBP;ARHGEF11;MITF;MAP2K2;ZNF423;ILF2;PSEN1;APOE;PPARGC1A;BRPF1;APBB1;CASZ1;SMARCA1;KDM8;SOX2;RREB1;MYB;CREB5;INPP5K;PRDM11;MLLT3;TAF15;NPAT;PPARD;BRD7;KAT8;MED16;ELF1;TRIP4;TNNI2;ENY2;CAND2;HDAC1;HINFP;CREB3L2;ZKSCAN3;PSMD9;UBE2V1;CAMKK2;SS18L1;SEC14L2;POU3F3;MED24;NR1D2;ACVRL1;ZFP90;SPIN1
prerank,bile acid metabolic process (GO:0008206),0.46593989385126316,1.2082341010933133,0.22418136020151133,0.8087765712943847,1.0,10/27,20.69%,OSBPL7;CH25H;OSBPL3;CYP27A1;NPC1;OSBPL9;OSBP;GBA2;OSBPL2;CYP39A1
prerank,activation of protein kinase B activity (GO:0032148),0.4571984672142939,1.208021239800016,0.22540473225404734,0.8086115564966337,1.0,8/29,16.20%,WNT5A;OSBPL8;MT3;PPIA;CCDC88A;INSR;IL18;MTOR
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5516656811859313,1.2067575820023895,0.2556818181818182,0.8105776028036719,1.0,6/12,14.28%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5516656811859313,1.2067575820023895,0.2556818181818182,0.8105776028036719,1.0,6/12,14.28%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5516656811859313,1.2067575820023895,0.2556818181818182,0.8105776028036719,1.0,6/12,14.28%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4000335103652438,1.20666143514649,0.1522198731501057,0.8099287596422188,1.0,40/100,25.91%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;HSP90AB1;PRICKLE1;UBXN1;CAMLG;TRIM39;DET1;N4BP1;UCHL5;SOCS5;RNF19B;RBX1;WAC;ARIH1;RYBP;RACK1;DAB2;PIAS1;RPL11;HECTD1;TLK2;USP5;RNF180;HSPBP1;NUB1;UBQLN4;STUB1;DNAJB2;SUMO1;VCP;BBS7;COMMD1;SIRT2;RAD23A;DDA1
prerank,RNA methylation (GO:0001510),0.42222103716752524,1.206542244182813,0.21714922048997773,0.8093560319894681,1.0,23/60,20.62%,BCDIN3D;MRM2;ZCCHC4;MEPCE;TFB2M;TRMT13;TRMT61B;THADA;TGS1;DIMT1;NOP2;TRMT10C;RBM15;ZC3H13;METTL14;CBLL1;THUMPD3;TYW3;GTPBP3;BUD23;WTAP;METTL1;TARBP1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5526191240328533,1.206533302583926,0.26029411764705884,0.80838660034425,1.0,5/11,16.80%,PIK3CD;RAPGEF2;LYN;PIK3CB;LGALS9
prerank,fatty acid oxidation (GO:0019395),0.4194093021108342,1.2063240224539655,0.18665158371040724,0.808115726655516,1.0,16/57,20.99%,MCAT;ACADL;ECI2;AUH;ABCD1;PEX2;PPARGC1A;ACADS;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;ADIPOR1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3859600081936104,1.2062896499388782,0.11616161616161616,0.8072590928022124,1.0,71/173,27.31%,TRAPPC3;YIF1A;CD55;TGFA;COG3;DYNC1H1;ERGIC3;COPE;TMEM115;HYOU1;SEC16A;GOSR2;ANK1;CNIH3;COG8;DYNC1LI2;ACTR1A;NRBP2;TMED5;SEC24D;CTSC;SEC23A;VAPB;TMED10;TRAPPC12;COG2;CAPZB;KDELR1;SCFD1;DYNLL1;WHAMM;VTI1B;NAPA;MIA2;VAMP4;NRBP1;SEC24A;ARF4;TMED1;ERGIC2;TMED3;DCTN3;COPB2;GBF1;GOSR1;CNIH1;TFG;BCAP31;RAB1A;TMED7;ERGIC1;GOLT1A;TRAPPC6A;RAB2A;F8;CUL3;RAB29;CNIH4;ANK2;BCAP29;DCTN1;TBC1D20;SEC22B;ARCN1;DYNC1LI1;KDELR2;COG1;COG7;CAPZA2;SPTBN1;COPB1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5078738891159343,1.2060885062651252,0.23983739837398374,0.8070829523643037,1.0,9/16,26.33%,CLU;SRF;LRPAP1;APOE;HDAC1;IFNGR1;HMGCR;TNF;LRP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.4814342653579282,-1.2058473968032115,0.24850299401197604,0.9612134468379947,1.0,2/10,4.96%,SIRT7;SELENOS
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4747557174099699,1.205830147251375,0.24625,0.8070602797111511,1.0,9/26,14.28%,ANAPC5;CDK5RAP2;ANAPC4;CDC16;CDC27;NEK6;RB1;ANAPC15;NSMCE2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.5119830177616554,1.205514127367799,0.23056300268096513,0.8072348831012613,1.0,6/18,15.36%,ABCG1;LDLRAP1;PSEN1;APOE;APH1A;APH1B
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4070391383686618,-1.2047881780683545,0.18596491228070175,0.9595499059688621,1.0,8/17,21.50%,EMC2;EMC3;EMC8;GET3;MMGT1;EMC9;UBL4A;EMC6
prerank,cytoplasmic translation (GO:0002181),-0.2698892224439692,-1.204276959208734,0.09615384615384616,0.9557243043936374,1.0,32/91,19.72%,RPS12;RPL13;RPS14;DRG1;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;TMA7;FTSJ1;RPL22L1;RPL31;RPL36A;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;UBA52;RPS25;RPS27A;RPL38;RPL34;RPL18;GSPT2
prerank,lymphocyte migration (GO:0072676),0.4558465241095031,1.2036733999166933,0.2366504854368932,0.8132039035171047,1.0,6/32,11.13%,CCL7;ADAM8;CCL5;CX3CL1;RET;CCL14
prerank,regulation of gene expression (GO:0010468),0.37239231598756184,1.202969074502714,0.008,0.8148005671653793,1.0,178/903,17.38%,PARP14;IGF2BP1;HSPA1B;PARP10;PARP9;WNT11;ZUP1;PML;TRIM14;MOV10;THAP7;ABCC2;ESR2;ICOSLG;DAPK3;XDH;WNT5A;MYBBP1A;TFAP2C;SPRY2;KDR;FASTK;DAXX;CLU;ESRRB;PIK3CD;NFX1;DDRGK1;ZC3H7A;SAP30L;IGF2BP3;AGO2;TARDBP;ZFPL1;TEAD2;NFKB2;CHEK2;MECP2;STAT3;ZFP37;CHD7;SLC38A2;TDRD7;TRIM21;RBL1;SFRP2;CGGBP1;RUNX1;SLC8A1;HNRNPH1;BHLHE40;LARP1;NKX6-2;SRRT;DHX36;CNOT7;MZF1;NFXL1;FBXW7;SERTAD3;TAPBP;SOX9;PFDN5;HNRNPK;ZNF2;CD276;NSD3;ZSCAN26;BCL6;NFKB1;AFF1;EDF1;ZBTB38;BACH1;MT3;PTRH2;ITGB8;TRIM39;NFATC2;SNAI2;CSF1;SAP30;RO60;CTSH;YTHDF2;NONO;LYN;ACTR8;GDNF;POU3F1;CLK3;SCX;DNMT1;APP;RORA;INSR;MAPK14;HNRNPL;PRKAG1;TRAF3;PROX1;PPM1F;ZC3H12A;DNM2;FAM98B;MARF1;CTCF;ZFP36L1;HNRNPDL;NAB1;SETDB2;HCFC2;FGF9;RYBP;MITF;MAP2K2;GSN;HNRNPH3;ZNF423;TRIM26;NKAP;HAVCR2;STAP1;LDB1;PSEN1;NR3C1;EPHX2;REL;APOE;PPARGC1A;RB1;UBE2L3;PRDM4;ATXN1;RACK1;LIMS1;ZNF35;PIK3CB;APBB1;MATR3;NELL1;CLK2;ZC3H7B;POGZ;CASZ1;ASCC2;EZH2;SOX2;RREB1;MYD88;MBNL2;MYB;BMPR1A;PRDM11;HGS;MYCBP;ZNHIT3;ADNP2;TLR2;TDG;GTF2IRD1;NPAT;SLC24A3;AIF1;TIPARP;RPL11;MTOR;DENND4A;FLOT2;ZBTB4;RBPJ;DICER1;LGALS9;TRIP4;PCBP4;TLR3;RRP1B;TULP3
prerank,epithelial to mesenchymal transition (GO:0001837),0.42213514684473435,1.2029240014627731,0.21820303383897316,0.8139727422578803,1.0,9/47,13.01%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;CUL7;SNAI2;NOTCH4;LIMS1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4014337020402498,1.2024775554805212,0.1702127659574468,0.8147329270248874,1.0,29/94,23.55%,PML;CASP4;TRIB3;MYBBP1A;CHEK2;CUL5;MLLT11;BCL2L11;DDX5;ITPR1;IKBKE;PPM1F;DIABLO;PRKDC;SCN2A;BAD;BAX;FNIP2;STK24;ERN1;ERO1A;DDX3X;STK11;JMY;MCL1;PRKCD;BCL2L2;CUL3;ARL6IP5
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5275325671014223,1.2022408486430127,0.258493353028065,0.8145993859681472,1.0,2/13,3.73%,CAMK2D;SLC8A1
prerank,regulation of steroid metabolic process (GO:0019218),0.474059941366885,1.202212899611461,0.24621212121212122,0.8136879636813646,1.0,9/23,24.97%,ABCG1;ACADL;RORA;EPHX2;APOE;PANK2;TTC39B;STUB1;ACADVL
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.43835965874821675,-1.2018746207016153,0.21107266435986158,0.9595813862512984,1.0,7/14,21.63%,NFKBIA;FAF1;KEAP1;NFKBIE;NFKBIB;PSMD10;CCDC22
prerank,sensory perception of taste (GO:0050909),-0.47035717281450246,-1.2007308844505975,0.25149700598802394,0.9581891482447212,1.0,6/10,52.72%,PKD2L1;PKD1L3;ASIC3;TAS1R3;TAS1R1;ASIC1
prerank,regulation of centrosome duplication (GO:0010824),0.4588378748598658,1.2006596343025142,0.24150485436893204,0.8184664375647128,1.0,10/29,17.68%,CHMP4B;CHMP1B;XRCC3;NPM1;CEP131;CHMP3;CEP295;TMEM67;GEN1;CHMP5
prerank,ribosome assembly (GO:0042255),0.42816494154085216,1.2005240171287188,0.20093457943925233,0.8179919470296672,1.0,22/47,22.13%,PWP2;SBDS;ERAL1;MDN1;NOP53;RRS1;PPAN;NPM1;EIF6;NOP2;MRPS2;RPL23A;RPL11;DHX37;RSL24D1;RPL24;RPL3;MRPS11;MRPL22;DDX3X;RPL5;RPL6
prerank,negative regulation of cell death (GO:0060548),0.4005257389067518,1.2000416065574016,0.19682539682539682,0.8189035435188553,1.0,17/88,15.53%,HSPA1B;WNT11;CHMP4A;CHMP4B;CLU;NENF;MT3;CSF1;NCK1;LRPAP1;SPEF1;SORL1;SRGAP2;PPARGC1A;DUS2;FYN;ADNP2
prerank,positive regulation of protein acetylation (GO:1901985),-0.44450968423419457,-1.199612954925161,0.2348993288590604,0.9567839630602212,1.0,5/12,14.48%,DIP2B;TERF2IP;CAMK1;FAM161A;RAPGEF3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5352305629354543,1.1989442475090382,0.25604551920341395,0.8220814056078934,1.0,4/12,14.43%,IRS1;ABCD1;PPARGC1A;IRS2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.42323141378426404,1.1988744538845058,0.22650056625141562,0.8213561564615399,1.0,13/54,17.90%,PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,negative regulation of response to external stimulus (GO:0032102),0.3904686536567429,1.1986115329366245,0.1922675026123302,0.821361484030691,1.0,27/105,22.01%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;DUSP3;EPHA4;RORA;APOE;CXCL17;RB1;SHARPIN;CRK;PPARD;ACOD1;CERS2;MFHAS1;TNFAIP8L2;RTN4RL1;SIRPA;MAPKBP1;VPS35;PRKCD;FGF2
prerank,monosaccharide transmembrane transport (GO:0015749),0.5220728159655141,1.1985760199666213,0.2585969738651995,0.8205090472242853,1.0,3/16,15.59%,SLC2A6;SLC45A3;SLC2A9
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3882628271867536,1.198554765872446,0.1568627450980392,0.8195980839357512,1.0,24/124,12.33%,WNT11;MOV10;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;AGO2;PSME4;SFRP2;PRICKLE1;CTNNB1;AP2A1;PSMA3;TCF7L2;FRZB;PSMB9;ROR2;PLCB3;ARRB2;AP2S1;PSMD2;PSME3;SMURF1
prerank,regulation of protein localization to nucleus (GO:1900180),0.4305784562187489,1.1983462527602335,0.23368920521945433,0.8193537738099651,1.0,4/43,4.05%,PARP9;ILRUN;DTX3L;SUMO3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3774215001280976,-1.198247051944496,0.18779342723004694,0.9563286341533659,1.0,9/20,21.75%,RPGRIP1L;RNF157;GRK3;SNCA;RGS14;GRK2;CRY1;GPRASP1;YWHAB
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5741447223597884,1.1979865511235026,0.2583081570996979,0.8196818327739785,1.0,5/10,15.10%,CAMK2B;NETO1;APP;NPTN;SYNGR1
prerank,cellular response to interleukin-2 (GO:0071352),-0.44236999237459207,-1.1977331154491868,0.23796033994334279,0.9471157432830591,1.0,3/11,13.40%,SYK;STAT5B;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.44236999237459207,-1.1977331154491868,0.23796033994334279,0.9471157432830591,1.0,3/11,13.40%,SYK;STAT5B;JAK3
prerank,positive regulation of JNK cascade (GO:0046330),0.40867266957413656,1.1976304336888604,0.2023681377825619,0.8200549816784317,1.0,17/70,15.92%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;TRAF4;WNT7B;TPD52L1;HMGB1;APP;TRAF3;TRAF5;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5500106884004166,1.1975717864072315,0.2543604651162791,0.8192900431800777,1.0,5/12,14.43%,IRS1;PPP1R3E;INSR;DYRK2;IRS2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.510731364335527,1.1966203539361397,0.2545201668984701,0.8219729543143462,1.0,9/17,24.61%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR;PTPRC;CD33;PPP1R12A;CALM2
prerank,regulation of cellular senescence (GO:2000772),0.45871350515768816,1.1955587206804588,0.22942643391521197,0.8249104817851546,1.0,12/28,23.09%,PNPT1;B2M;CGAS;RBL1;RSL1D1;YPEL3;NEK6;EEF1E1;TERF2;ZKSCAN3;AKT3;VASH1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5372081491435359,1.195264687585662,0.2654232424677188,0.8250857205319078,1.0,6/13,16.96%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,inorganic anion transport (GO:0015698),0.41415506619040476,1.1951872779880601,0.20457142857142857,0.824376028786248,1.0,16/53,23.27%,CLIC4;SLC26A1;ENPP3;CLCN2;CLCN6;SLC25A10;TTYH1;ANO10;ENPP1;SLC13A4;ANO5;CLCN1;GLRA1;CLIC1;SLC25A30;SLC26A7
prerank,plasma membrane invagination (GO:0099024),0.46442820371249455,1.194975227451602,0.2521419828641371,0.8241870783315175,1.0,11/29,20.93%,SNX33;GULP1;FCGR1A;SNX9;ARHGAP25;GSN;FCGR2B;SH3BP1;AIF1;MYH9;MSR1
prerank,vesicle organization (GO:0016050),0.4289164050743828,1.1944546749059413,0.231651376146789,0.8251539570231909,1.0,12/46,13.62%,DNAJC13;USP50;SNX33;WASHC4;SNX10;VPS11;HOOK2;RAB22A;HOOK1;FNBP1L;ARFGEF2;HOOK3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.489568749082318,1.1939150392233842,0.2506493506493506,0.8262058254560852,1.0,8/20,19.60%,KPNB1;ACADL;LDLRAP1;EPHX2;APOE;SREBF1;TTC39B;SEC14L2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.47015955276961846,1.1938407509120808,0.24474660074165636,0.8255101264600383,1.0,7/26,14.84%,NR1H2;TRIB3;ACADL;SLC45A3;EIF6;ERLIN2;LPGAT1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.49907384825151785,1.192695747458196,0.2708618331053352,0.8289295704116213,1.0,5/18,17.97%,PARP10;MORC3;PEX2;CD300A;NF1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4330649541480504,1.1926170725779017,0.23684210526315788,0.8282299039982892,1.0,10/43,20.02%,CD274;SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,telomere maintenance via recombination (GO:0000722),0.5510237559186304,1.1925722753866965,0.2773722627737226,0.827408121530579,1.0,4/11,14.28%,TPRKB;ERCC4;XRCC3;NSMCE2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4625972927450305,1.1925616552016638,0.26059850374064836,0.8264717901509381,1.0,7/31,12.73%,TRIB3;SKP1;ARRDC4;FBXW7;DCUN1D4;BTRC;UBE2L3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.27690915938548355,-1.1921985216642048,0.0851063829787234,0.9636218150875273,1.0,20/70,14.81%,TGFB1;CASP8;CASP8AP2;TRAF2;BLOC1S2;ITGAV;CASP3;RIPK1;GSK3B;TGFB2;DAB2IP;CASP9;ACVR1B;TRADD;RNF41;TNFRSF1B;APPL1;HIPK1;DEDD2;DCC
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5726004769081152,1.1919378328370136,0.2600574712643678,0.8278720125266767,1.0,2/10,5.26%,TGFA;FBXW7
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.48865505430058065,1.1918935073859491,0.2570659488559892,0.8271069387995283,1.0,9/19,19.32%,CAMK2B;DHX36;CUL7;FBXW8;CUX1;DBNL;LRP8;CAPRIN1;SS18L1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4745220887078363,-1.1917462366115459,0.25846153846153846,0.9597661062943625,1.0,4/10,17.00%,IRAK3;MAPK7;KLF4;MAP2K5
prerank,regulation of microtubule polymerization (GO:0031113),-0.3215358357738584,-1.1916056556315242,0.15723270440251572,0.9548544824672032,1.0,9/40,9.52%,PAK1;DYRK1A;FES;DRG1;PRUNE1;CLIP1;TUBB4A;SNCA;ARL2
prerank,negative regulation of translational initiation (GO:0045947),0.5298452262319399,1.1914703321386553,0.25142857142857145,0.8277236692560886,1.0,3/13,5.70%,AGO2;LARP1;EIF4EBP2
prerank,regulation of protein processing (GO:0070613),0.47902843270855733,1.191408404293075,0.2516469038208169,0.8269688592469231,1.0,5/21,15.14%,ADAM8;RUNX1;PRNP;GAS1;TMEM59
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5534216072853175,1.1911673296317782,0.274310595065312,0.8269118812326434,1.0,4/11,11.80%,SNX33;ACTN2;LEPROT;LEPROTL1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.2601956999546843,-1.1908892309992296,0.09302325581395349,0.9522435656027034,1.0,24/107,12.61%,STIM1;ATP1B1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;TPT1;TMCO1;SLC39A14;SLC39A7;ATP2A2;CCL13;SLC10A7;SLC8A3;ATP2C1;CCL15;SLC39A12;CCL3;CHRNA7;CCR2
prerank,regulation of T cell activation (GO:0050863),0.4301652392156298,1.1908440374575482,0.23892773892773891,0.8271029130042626,1.0,12/42,20.63%,TNFSF9;THY1;CD47;CCL5;DUSP3;IL27;CCDC88B;TNFSF8;PAG1;TNFAIP8L2;SIRPA;LCK
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.38594575338116294,1.190527528629685,0.16191446028513237,0.8273394751646307,1.0,48/158,22.84%,EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;CFLAR;TSPAN6;TMEM106A;TMEM9B;RNF31;IRAK4;TRAF5;NEK6;REL;MIER1;AKAP13;SHARPIN;BIRC3;TNIP2;MYD88;IRAK1;LGALS9;MIB2;ZDHHC13;CXXC5;TRIM62;TFG;UBE2V1;TAB3;RIPK2;TRIM13;LITAF;ROR1;S100A13;GOLT1B;GPRC5B;PELI1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3942910800165091,-1.1905120170697334,0.22519083969465647,0.9482307967893207,1.0,6/17,15.14%,COX15;COX10;NDUFA4;COX8A;COX6C;COX7B
prerank,amino acid transmembrane transport (GO:0003333),0.42498352895587443,1.1904863485478174,0.24393063583815028,0.8265250748591646,1.0,13/45,21.94%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;SFXN2;SLC25A12;SLC36A4;SFXN1;SLC7A7;MFSD12;SLC6A6
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5686000077220779,1.1902936858299042,0.26666666666666666,0.8262277634783107,1.0,3/10,16.66%,CAMK2D;PRKCE;STK39
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5641934593945053,1.190247408694068,0.2931297709923664,0.8254294990376168,1.0,3/10,15.41%,DHX36;NCBP2;NCBP1
prerank,negative regulation of proteolysis (GO:0045861),0.4434627244162343,1.1898655378530925,0.2512254901960784,0.8259145104286773,1.0,8/34,15.14%,TM4SF20;TRIM21;EPHA4;CST7;PRNP;TIMP2;GAS1;TMEM59
prerank,regulation of nervous system development (GO:0051960),0.43594261725743105,1.189335991367937,0.2388955582232893,0.8269187892972777,1.0,7/37,8.46%,PER2;BHLHE40;NKX6-2;CX3CL1;CTNNB1;NPHP3;YTHDF2
prerank,steroid metabolic process (GO:0008202),0.39889826405078627,1.1891542020067472,0.1967391304347826,0.826645821422053,1.0,11/72,13.83%,LRP2;HSD17B7;DHRS4;HSD11B1;FDFT1;CYP26B1;STARD3;DHRS11;CYP27A1;TSPO;NPC1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.49708212720347156,1.1889236213058798,0.2717391304347826,0.8265687705736935,1.0,7/18,23.31%,CXCR4;TMEM98;SLC45A3;MDK;NF1;TENM4;NOTCH1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.430918862353167,-1.1887803642072945,0.24193548387096775,0.9491781393410232,1.0,7/13,24.01%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,glycogen biosynthetic process (GO:0005978),0.5402517603108994,1.188314197356149,0.25783475783475784,0.826862022039352,1.0,3/12,7.83%,PER2;PGM2L1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.5402517603108994,1.188314197356149,0.25783475783475784,0.826862022039352,1.0,3/12,7.83%,PER2;PGM2L1;PGM1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4033550444666684,1.188294480792333,0.22489082969432314,0.8259751313522673,1.0,20/70,21.72%,NR1H2;TMEM86B;SLC27A1;PLA2G12A;CSNK2B;CSNK2A2;LIPC;LPIN2;CEPT1;LPCAT2;ABHD3;CHPT1;PCYT1A;PLA2G4E;PCTP;SLC44A1;PLA2G6;CHKA;PCYT1B;PNPLA8
prerank,positive regulation of cell junction assembly (GO:1901890),0.41420366053381846,1.1882332818415249,0.21753607103218647,0.8252299698635263,1.0,13/56,16.25%,AGT;KDR;BDNF;CLSTN1;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1;IL1RAP;CLSTN3;NLGN3
prerank,establishment of protein localization to organelle (GO:0072594),0.40393333249248836,1.1880579931677715,0.21271929824561403,0.8249434228054537,1.0,24/72,20.41%,RANBP6;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;LRSAM1;NXT1;IL10RA;RPAIN;PPP1R10;HK1;IPO8;NEURL1B;TNPO2;NUP155;RAB11A;RANBP17;LAMP1;NUP88;CD68;NUP133;APPL2
prerank,B cell activation (GO:0042113),-0.27939949289723626,-1.1876824406849336,0.14130434782608695,0.9482647389065404,1.0,25/68,23.05%,NFAM1;GPR183;CASP8;KLF6;LAT2;DCAF1;CTPS1;ZBTB7A;BANK1;EPHB2;LYL1;PTPN2;FCRL1;DNAJB9;JAK3;SLC25A5;CD86;ADGRG3;BTK;MEF2C;CHRNA4;RASGRP1;TCF3;PHB2;CLCF1
prerank,regulation of telomere maintenance (GO:0032204),0.4726931678682701,1.1872160134710028,0.2358974358974359,0.8272609759040634,1.0,10/26,18.77%,PML;DHX36;RTEL1;ERCC4;SIRT6;PPP1R10;SMG5;HDAC8;UPF1;TERF2
prerank,protein polymerization (GO:0051258),0.4127733890010711,1.1871841880006664,0.2258426966292135,0.8264160050664502,1.0,16/55,19.66%,CHMP4A;CHMP4B;GAS7;TPPP3;CHMP3;CORO7;GSN;TRPV4;FGF13;RAC1;JAK2;AIF1;UBE2K;GPX4;PIN1;TTC17
prerank,regulation of platelet aggregation (GO:0090330),-0.41113500170284056,-1.1868619956700486,0.2204724409448819,0.9462200044073464,1.0,7/17,17.41%,SYK;PRKCQ;DMTN;CEACAM1;CD9;PRKG1;F11R
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5143623104930525,1.186738766919742,0.2550335570469799,0.8270211461363577,1.0,8/16,22.12%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,response to progesterone (GO:0032570),0.4914722167541241,1.1859073813969556,0.27595628415300544,0.8291593219789861,1.0,3/18,5.51%,CATSPER4;ABHD2;UBE3A
prerank,B cell activation involved in immune response (GO:0002312),0.52610332366061,1.1857667990946583,0.2746478873239437,0.8287046081834073,1.0,2/13,0.99%,GAPT;MSH2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5191726155319902,1.1853375365143568,0.27521613832853026,0.8293211844266862,1.0,5/15,17.74%,SNX33;ADAM8;SNX9;APOE;SH3D19
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.46622251844230267,1.1852048052654673,0.24937027707808565,0.828892701155676,1.0,8/24,15.07%,IRS1;PPP1R3E;PPP1R3D;INSR;DYRK2;ENPP1;IRS2;INPP5K
prerank,cell-substrate junction assembly (GO:0007044),0.44448334042888127,1.1851692882276557,0.2633495145631068,0.8280747195243932,1.0,7/33,6.64%,ACTN1;THY1;LAMC1;ACTN2;PEAK1;ARHGEF7;PIP5K1A
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4505878472770514,-1.185092053896583,0.2913907284768212,0.9478956479333714,1.0,4/12,11.50%,DPYSL3;CTPS1;UMPS;CRMP1
prerank,tRNA wobble uridine modification (GO:0002098),0.51688363599481,1.1850038259011586,0.2728592162554427,0.8277464476171151,1.0,3/14,6.12%,TRMT9B;MOCS3;TRMU
prerank,protein autoprocessing (GO:0016540),0.5120467596342525,1.1849207953585004,0.27770360480640854,0.8271051897992354,1.0,2/17,3.63%,CASP4;FXN
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4654688810931628,1.184643204633091,0.26455026455026454,0.8271713657613488,1.0,6/26,14.62%,CLU;HSP90AB1;TMEM106A;P2RX4;INSR;HSP90AA1
prerank,Rho protein signal transduction (GO:0007266),-0.29563064155617313,-1.1835474682143288,0.18,0.9483032851948515,1.0,20/53,20.88%,CFL1;ARHGAP5;ROCK1;PLEKHG5;ARHGDIB;SHTN1;ARHGEF1;EPS8;CDC42;COL1A2;RHOU;RHOA;RIPOR1;WAS;CDC42EP1;ARHGEF3;CDC42EP2;NTN1;RTKN;TAX1BP3
prerank,modified amino acid transport (GO:0072337),0.507011776111234,1.1830814088579569,0.2616033755274262,0.8319957664577081,1.0,6/15,21.85%,SLC46A1;SLC19A1;PDPN;CTNS;SLC5A6;MGST1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.43323934589180746,1.1829309786719906,0.2386780905752754,0.8316484800177243,1.0,9/38,14.62%,CLU;CD47;HSP90AB1;P2RX4;INSR;ZC3H12A;RAC1;JAK2;HSP90AA1
prerank,positive regulation of axonogenesis (GO:0050772),0.42747632346031594,1.1827625652083624,0.2488479262672811,0.8313099943212184,1.0,6/43,4.62%,PLXNA3;PLXNB2;BDNF;SEMA4D;RUFY3;PLXNB3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4297780674888315,1.182690286581665,0.25381903642773207,0.8306031966967768,1.0,11/39,19.01%,CAMK2D;FXYD4;UTRN;NETO1;FXYD6;FXYD5;PRKCE;FGF13;SCN1B;STK39;GLRX
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38023578375953715,1.1825708957394834,0.16480162767039674,0.8301011734822161,1.0,24/142,16.04%,CHRNA9;CALCA;CXCR4;WNT5A;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;TAC1;CACNA1A;PTGER3;ACKR3;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT;HCRTR1
prerank,dendritic spine morphogenesis (GO:0060997),-0.41431118509780224,-1.1823884456246287,0.24290220820189273,0.9476000701935143,1.0,6/15,10.23%,WASL;DLG4;CDC42;EPHB2;SHANK3;EPHB1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.32955059151769545,-1.1821980018424207,0.19161676646706588,0.9432078755761795,1.0,9/33,15.67%,GPR137B;MAFB;TRAF6;CAMK4;CCL3;UBASH3B;TMEM178A;CEBPB;CCR1
prerank,rRNA catabolic process (GO:0016075),-0.41724338725562077,-1.182047890378276,0.251063829787234,0.9387016960556358,1.0,7/16,14.36%,EXOSC7;EXOSC10;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5513168293291871,1.1815555513109182,0.273542600896861,0.8328620456758172,1.0,6/11,16.96%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,receptor internalization (GO:0031623),-0.30288349131823517,-1.1813367056476547,0.15,0.9365015210722443,1.0,15/44,21.20%,SYK;CALCRL;CD81;ARRB1;GRK3;SNCA;TFRC;GRK2;RAB31;CEACAM1;CD9;SAG;PICALM;NEDD4;CAV1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.46084226673536044,1.181214882038313,0.26889714993804215,0.8331568806017126,1.0,8/26,22.01%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,macromolecule catabolic process (GO:0009057),0.45932739432490993,1.1812123521779043,0.24469413233458176,0.8322180109902689,1.0,14/26,23.32%,MVB12A;SIAH1;LRSAM1;SH3GLB1;UCHL3;KIF16B;PIK3R4;SMURF1;MTOR;UVRAG;SNX25;BECN1;IDE;CLN6
prerank,neurogenesis (GO:0022008),-0.31243464894636863,-1.1811856912900645,0.2064516129032258,0.9320798507643083,1.0,12/43,13.27%,BTBD1;LPAR1;TRAK2;FAT4;SPOCK1;WDR62;CIT;RYK;TGFB2;EPHB1;METTL3;CLN5
prerank,regulation of chemotaxis (GO:0050920),0.44461398270042474,1.1811215089723963,0.25870646766169153,0.8316039501967796,1.0,10/30,15.98%,CXCR4;YTHDF1;DUSP3;P2RX4;ZSWIM8;PPM1F;USP14;STX4;MYCBP2;AIF1
prerank,protein oxidation (GO:0018158),0.5532136938565203,1.1809103617149812,0.29545454545454547,0.8314781566234097,1.0,1/11,0.54%,LOXL2
prerank,regulation of MAP kinase activity (GO:0043405),0.3944060200416153,1.1807692970367567,0.2082018927444795,0.8310669738696187,1.0,19/92,16.47%,AGT;NOD2;FLT1;TRIB3;SPRY2;CD40;ADAM8;CDK12;TPD52L1;PAQR3;LYN;SORL1;APOE;PIK3CB;EZH2;INPP5K;HGS;CD300A;IRAK1
prerank,negative regulation of macrophage activation (GO:0043031),0.5028282942538427,1.1805981594570625,0.27548209366391185,0.8307586314088301,1.0,6/16,18.15%,CX3CL1;CST7;ZC3H12A;FCGR2B;PTPRC;LDLR
prerank,cell part morphogenesis (GO:0032990),0.525330244177761,1.1803830291164652,0.2831858407079646,0.8306161207832274,1.0,3/13,9.52%,PNPT1;FIS1;SLIRP
prerank,positive regulation of neuron projection development (GO:0010976),0.39250426050403114,1.1803506247014035,0.2167019027484144,0.8297994456770302,1.0,25/85,18.35%,WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;DHX36;CX3CL1;P3H1;RET;MAGI2;RAPGEF2;LTK;LYN;ROR2;APOE;RAPGEF1;NPTN;DBNL;LRP8;SCN1B;STMN2;MDK;FUT9;CAPRIN1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3297261735923907,-1.1803375416803168,0.19597989949748743,0.9302038373547129,1.0,13/29,36.29%,BLMH;HOGA1;SARDH;KMO;PRODH;IL4I1;ALDH4A1;DDO;GOT2;IDO2;CBS;THNSL2;DAO
prerank,mitotic metaphase plate congression (GO:0007080),0.42616478989171164,1.1800541669728477,0.24263038548752835,0.8299720646598459,1.0,16/51,19.23%,CHMP4A;CHMP4B;CHMP1B;KPNB1;KIF2C;CDT1;RRS1;CHMP3;PIBF1;MIS12;RAB11A;CHAMP1;RMDN1;CHMP5;BECN1;NDC80
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.36505640525813493,1.1800411403277304,0.006,0.8290948253006483,1.0,257/1082,20.37%,STAT1;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;WNT11;PITX2;NAMPT;PML;GAL;AGT;LHX2;LMX1A;NR1H2;HAS3;NOD2;ESR2;DTX3L;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;TRIM45;ESRRB;PRMT2;RARG;DDRGK1;DHX33;AGO2;RBM14;RNF4;TEAD2;CD40;NFKB2;CHEK2;CDH13;ACVR1;STAT3;MLLT11;ARID1B;ACTR2;RBL1;SFRP2;ELK3;RUNX1;MAD2L2;USP21;RBMX;CHCHD10;KLF15;CHEK1;ILF3;DHX36;MZF1;JUNB;UBTF;NCOA1;CX3CL1;MRPL12;SERTAD3;SOX9;CTNNB1;PAXBP1;PFKM;KMT2A;ARID1A;CCNT2;ZNF76;MYDGF;FGFR2;NSD3;ZXDC;TCF7L2;TCF4;SMARCC2;NFKB1;CREBRF;ASXL3;EDF1;ZBTB38;SETD3;THAP3;ACTR3;MT3;USF1;TFAP2B;NFATC2;MAP2K3;RET;UBP1;SRF;DHX9;MDFIC;RAI1;MRTFA;HTATIP2;SMAD2;GLIS3;MEIS3;ATF6B;CDK5RAP2;TFDP1;LPIN2;NCK1;BAMBI;LMO2;MET;NFIB;GDNF;ATF1;METTL23;POU3F1;HMGB1;SCX;APP;NCK2;RORA;CRTC1;MAML2;ELF4;AGRN;MEN1;BMPR2;BPTF;WAC;MED12;PROX1;PHIP;TNIP1;BTRC;RGMB;NPM1;FOXK1;ZC3H12A;MAX;DNM2;CTCF;SNW1;NOTCH4;TFDP2;GALR1;RYBP;XBP1;ARHGEF11;IER5;MITF;ECD;MAP2K2;KLF10;ZNF423;ICE2;LDB2;LDB1;ILF2;PSEN1;PRKDC;NR3C1;REL;APOE;PPARGC1A;SERTAD2;BRPF1;PRDM4;E2F4;APBB1;HDAC8;ST18;DAB2;POGZ;MYO6;WDR43;CASZ1;SMARCA1;BCL11B;KDM8;SERTAD1;SOX2;RREB1;TET2;TFR2;TNIP2;DDX39B;MYB;CREB5;BMPR1A;INPP5K;PRDM11;CRTC3;CAMTA2;MLLT3;TLR2;TAF15;SMARCD2;MEF2A;NPAT;ARF4;PPARD;IL18;IER2;TNIP3;MTOR;LAGE3;LMO7;SREBF1;CCNK;ZBED4;RBPJ;BRD7;KAT8;MED16;ELOF1;ELF1;CHCHD2;TRIP4;MPND;PELP1;TLR3;RRP1B;TNNI2;POU2F2;ENY2;ZBTB49;MED10;ZNF513;PTOV1;CAND2;ACVR2A;FOSL2;HDAC1;HINFP;HOXA5;GABPB1;GABPB2;CREB3L2;ZKSCAN3;PSMD9;UBE2V1;CAMKK2;CCDC62;SS18L1;BEX1;PIN1;SEC14L2;KAT7;RIPK2;POU3F3;MED24;PER1;NR1D2;ACVRL1;ZFP90;WWOX;SPIN1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4373319919356128,-1.1800140720743932,0.23102310231023102,0.9264483595287248,1.0,6/13,21.75%,GOPC;NFKBIA;KEAP1;NFKBIE;DBN1;YWHAB
prerank,import into nucleus (GO:0051170),0.40268707512335733,1.1799179258858483,0.21820175438596492,0.828638423199605,1.0,25/73,20.41%,RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;DDX20;NXT1;RPAIN;HTATIP2;PPP1R10;HNRNPA1;IPO8;SNRPD2;SNRPD1;TNPO2;GEMIN7;NUP155;SNRPG;GEMIN2;RANBP17;NUP88;SNUPN;NUP133;APPL2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5240873903276058,1.1798528127096266,0.28270042194092826,0.8270209097553751,1.0,6/14,19.97%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,heme catabolic process (GO:0042167),0.5240873903276058,1.1798528127096266,0.28270042194092826,0.8270209097553751,1.0,6/14,19.97%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5578015953315352,1.1797265515493354,0.29112081513828236,0.8265380639070848,1.0,3/10,11.01%,MAD2L2;PPM1F;NOTCH4
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.40972735292510876,1.1789396754884318,0.23804226918798665,0.8286367153317219,1.0,15/56,19.51%,NOD2;NOD1;ALPK1;CTSS;TLR8;UNC93B1;HMGB1;TRAF3;IRAK4;MYD88;TLR2;IRAK1;TLR3;LACC1;TAB3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4738351452306994,1.1783601913402404,0.261455525606469,0.8298405208739599,1.0,8/21,15.07%,CNKSR3;PAQR3;NCK1;NCK2;PPM1F;DDIT4;RACK1;INPP5K
prerank,regulation of cell migration (GO:0030334),0.36597857552118435,1.1779809022142993,0.078,0.830357151852668,1.0,81/382,17.19%,WNT11;BST2;FLT1;CCL7;SGK3;PLXNA3;CLIC4;SPRY2;PLXNB2;KDR;CPNE3;PIK3CD;DDRGK1;CAMK2B;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;SASH1;STAT3;MYO1C;SPATA13;THY1;MMP14;SFRP2;RUFY3;CCL5;PLXNB3;DUSP3;OSGIN1;CX3CL1;FAM83H;EPHA4;CARMIL1;PODXL;ARHGAP4;SNAI2;CSF1;RET;TMIGD3;MAGI2;ELP6;MAPRE1;MYOC;CTSH;BCAR1;ARID2;PDPN;KANK1;ROR2;INSR;TBCCD1;CIB1;PPM1F;SUN2;FGF9;XBP1;SORL1;MITF;SRGAP3;SRGAP2;LDB2;LDB1;DUSP10;RACK1;DAB2;RAC1;STX4;MINK1;AMOTL2;KIF2A;IGSF10;MIEN1;SPAG9;SEMA3D;AIF1;MGAT5;PTPRU;MDK;CBLL1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.40620468777137997,1.1779557425684801,0.22209821428571427,0.829531994820279,1.0,31/60,29.58%,MOV10;MECP2;DHX36;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;SRF;MED12;PAXIP1;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;ATF7IP;CDKN2A;PTEN;AGO1;MED25;AGO3;SUB1;MED26;CSF1R;MED13
prerank,regulation of secretion (GO:0051046),0.5270133300995551,1.1778281125359327,0.290414878397711,0.8290914473157192,1.0,1/13,0.18%,OAS2
prerank,mesenchyme morphogenesis (GO:0072132),0.49404822290379213,1.1775343033971295,0.26458036984352773,0.8292638564153723,1.0,6/17,23.31%,ACVR1;SOX9;SMAD2;BMPR1A;ACVRL1;NOTCH1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3940153067135008,1.1774098636846904,0.21734475374732334,0.8287867277628874,1.0,11/76,12.51%,CALCA;AGT;FPR3;ACTN2;TACR1;GNA15;GNA14;PTGER3;C3AR1;HTR2A;GPR35
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.44330577470451876,1.1773668702085818,0.2467222884386174,0.82805261924847,1.0,9/36,14.33%,TAOK3;DUSP3;IGBP1;CYLD;PPIA;DACT1;MEN1;DUSP10;DLG1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4417836846110233,1.1769127818134226,0.26252983293556087,0.8287711095174363,1.0,9/34,14.28%,TGFA;ANAPC5;ANAPC4;INSR;PHIP;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.35436125243319494,-1.1768525651501942,0.21428571428571427,0.9331766516155194,1.0,6/24,11.84%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36653035552790014,-1.1767606180346375,0.19642857142857142,0.9286149780044696,1.0,13/20,28.97%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,mitotic nuclear membrane organization (GO:0101024),0.41072549514469003,1.1766399772993026,0.23772321428571427,0.8279086313175278,1.0,13/51,16.89%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;PPP2R2A;IST1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.41072549514469003,1.1766399772993026,0.23772321428571427,0.8279086313175278,1.0,13/51,16.89%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;PPP2R2A;IST1
prerank,carbohydrate derivative transport (GO:1901264),0.4977043342752401,1.1765218353629276,0.28187919463087246,0.827447816752019,1.0,4/18,4.38%,ABCG1;SLC15A3;SLC15A2;SLC25A19
prerank,maturation of LSU-rRNA (GO:0000470),0.4605676189496014,1.1762264460744958,0.2718078381795196,0.8276240262306194,1.0,9/26,17.87%,DDX18;RSL1D1;LAS1L;RPL7L1;EIF6;NOP2;ZNHIT3;RPL10A;WDR12
prerank,carnitine shuttle (GO:0006853),-0.4587504230588245,-1.1762157369173933,0.26229508196721313,0.9257109937404422,1.0,8/11,38.41%,CPT2;THRSP;CPT1A;ACACB;PRKAG2;PRKAA2;CPT1B;MID1IP1
prerank,muscle organ development (GO:0007517),0.4148433139321799,1.1761633771990863,0.2465753424657534,0.8269358315752304,1.0,5/54,5.01%,CXCL10;MEF2B;UTRN;ITGB1BP2;COPRS
prerank,vasculature development (GO:0001944),0.4955068097386016,1.1760372805557537,0.2937062937062937,0.8264886475144634,1.0,6/16,24.76%,FBXW7;BMPR2;NOTCH4;ACVRL1;STK11;PIK3CA
prerank,pinocytosis (GO:0006907),0.557920051056678,1.1760094592228545,0.29809104258443464,0.8256753320797278,1.0,2/10,6.03%,SNX33;CARMIL1
prerank,bile acid and bile salt transport (GO:0015721),0.4645305303012912,1.1759967177850992,0.2757731958762887,0.8248131472587097,1.0,4/24,6.37%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,negative regulation of signal transduction (GO:0009968),0.3699702732594364,1.1756467499215484,0.1228600201409869,0.8251100847007128,1.0,53/249,15.61%,AGT;SLAMF1;XDH;SPRY2;IRS1;SOCS1;BDNF;DLK2;ACVR1;KIF26A;ASAH2;PTPN18;GRB10;KIF7;MMP14;SFRP2;CD47;CRHBP;CCL5;SIAH1;GPR108;CX3CL1;FBXW7;HMGXB4;SNAI2;CSNK2A2;FRZB;DACT1;YTHDF2;NCK1;LYN;SOCS5;LEPROT;EGFL7;KANK1;CYP26B1;LRPAP1;BTRC;DKK3;APCDD1;MDFI;DDIT4;RB1;ENPP1;RACK1;PIK3CB;CXXC4;PTCH1;EZH2;ADAMTS12;INPP5K;HGS;PHACTR4
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.44931002893385225,1.1755669928238428,0.2605042016806723,0.8245064359053678,1.0,10/30,19.79%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TNIP3;TLR3;CD300LF;TANK
prerank,histone lysine methylation (GO:0034968),0.44056681222538874,1.1753740171514724,0.2784503631961259,0.8242970567943777,1.0,10/33,16.12%,DPY30;RBBP5;KMT2A;SETD3;MEN1;WDR5;SETDB2;PAXIP1;EZH2;SMYD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.43939068870753006,1.1743611619273155,0.26941747572815533,0.8270144738345124,1.0,8/34,13.33%,FLT1;SPRY2;KDR;MAP2K3;MAPK14;VEGFD;GAS1;NRP1
prerank,canonical Wnt signaling pathway (GO:0060070),0.3966511454688502,1.174287975492105,0.2376237623762376,0.8263592476177235,1.0,8/68,7.62%,WNT11;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB
prerank,cation transmembrane transport (GO:0098655),0.42929499826786177,1.1741372093551559,0.261271676300578,0.8259986503123534,1.0,11/44,22.43%,TRPM5;TRPM2;TRPM6;SLC25A19;TRPM3;SFXN2;TRPM7;SLC36A4;SFXN1;MFSD12;ABCC9
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4457846708652771,1.1735943350714426,0.28214731585518105,0.8270780971297172,1.0,13/30,22.93%,BLZF1;GOLGA7;SEC16A;GGA3;AMN;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;OPTN;RAB10
prerank,chromatin remodeling at centromere (GO:0031055),-0.32893138223129065,-1.1734071973544768,0.1875,0.9318317040158095,1.0,13/31,24.80%,CENPV;CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH
prerank,cholesterol metabolic process (GO:0008203),0.4003281704077833,1.1725111245377104,0.2475355969331873,0.8301343354652586,1.0,22/68,23.82%,ABCA1;ABCG1;HSD17B7;CH25H;MT3;FDFT1;LDLRAP1;STARD3;CYP27A1;APOE;GGPS1;PPARD;SOAT2;SOAT1;IDI1;EBP;GBA2;HMGCS1;ABCA5;HMGCR;CLN6;SNX17
prerank,cellular response to glucose starvation (GO:0042149),0.43145902236437006,1.1724060909828775,0.24737456242707118,0.8295930637852881,1.0,10/41,12.13%,MYBBP1A;KPTN;SH3GLB1;PIK3R4;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;HNRNPA1
prerank,regulation of apoptotic process (GO:0042981),0.3650980989211152,1.1722197715876084,0.037,0.8293459815610489,1.0,112/676,13.78%,IFIT3;STAT1;ZBP1;CXCL10;NOL3;AXL;HSPA1B;WNT11;TNFSF10;AGT;IFIT2;DAPK3;TNFSF9;WNT5A;SPRY2;COMP;KDR;DAXX;CLU;BIRC2;PRMT2;RARG;GADD45G;DDRGK1;KLHL20;TNFRSF8;TMEM219;ACTN1;TARDBP;SEMA4D;MLLT11;BCL2L11;LRP2;ANKLE2;SFRP2;PLEKHN1;FXN;ACTN2;CASP6;BFAR;EGLN2;HCK;SIAH1;CCND2;RSL1D1;NOP53;OSGIN1;CX3CL1;SOX9;SRA1;HNRNPK;CTNNB1;AREL1;MYDGF;ARHGEF7;CFLAR;BCL6;TMBIM4;NFKB1;DDX20;MT3;TFAP2B;ATAD3A;FRZB;PPIA;HTATIP2;CTSH;ABR;BCAR1;LTK;GDNF;HMGB1;BARD1;PDPN;SCX;PLK3;VAV1;SPHK2;PHIP;PRR7;CIB1;NPM1;DIABLO;DNM2;PHLDA1;NUAK2;DNAJA3;RNPS1;RNF122;GAS1;RYBP;XBP1;ARHGEF11;PIM1;CBX4;NAA35;SOS1;BAG1;ARHGAP10;PSEN1;PRKDC;SOCS2;AKT1S1;DFFA;RPS6;RACK1;BAD;AKAP13;APBB1;TIAM2;BIRC3;DAB2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.42972105567489205,1.1715942828089858,0.2635933806146572,0.8306042562450662,1.0,13/37,23.18%,FIS1;BCL2L11;SIAH1;NCK1;RACK1;BAD;BMF;BAX;BECN1;BCAP31;LCK;FBH1;NACC2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5540635836064987,1.171421396364691,0.30597014925373134,0.8303250930369608,1.0,3/10,17.44%,ABCA1;APOE;ZDHHC8
prerank,ganglion development (GO:0061548),0.5440620833896701,1.170433337583149,0.27485380116959063,0.8330615970042418,1.0,3/11,13.33%,NRP2;CTNNB1;NRP1
prerank,negative regulation of binding (GO:0051100),0.39571990889615505,1.1703698786323724,0.23085339168490154,0.8324062083553982,1.0,15/81,14.38%,SP100;IFIT1;IFIT2;ILRUN;SUMO3;SLPI;DACT1;LRPAP1;SORL1;MDFI;DDX11;RACK1;DAB2;ACTB;JAK2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.40193495813721164,-1.1699869507717462,0.22761194029850745,0.9400115940670036,1.0,10/16,29.83%,NAPEPLD;SIRT1;ZBTB7B;VSTM2A;SOX13;FLCN;FTO;FNDC5;TFE3;METRNL
prerank,regulation of autophagosome maturation (GO:1901096),0.5164950441969455,1.1698222282987851,0.2812051649928264,0.8334813094946769,1.0,2/13,3.92%,IRGM;FYCO1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.35942874998475105,-1.1694934112890598,0.20982142857142858,0.9371704662073169,1.0,10/23,18.88%,PARP1;XPC;COPS2;UBB;UBC;GPS1;UBA52;COPS6;RPS27A;XPA
prerank,negative regulation of secretion by cell (GO:1903531),0.4308247982904069,1.169292235470098,0.2526564344746163,0.8345183757059446,1.0,4/38,12.38%,RSAD2;SLC30A1;RHBDF2;APOE
prerank,endothelial cell proliferation (GO:0001935),0.49767239592511725,1.1688382132489503,0.2862849533954727,0.8352742957381594,1.0,6/17,20.21%,LOXL2;BMPER;BMPR2;DLG1;ERN1;ACVRL1
prerank,ncRNA transcription (GO:0098781),0.5176712950821153,1.1680713741483084,0.27180232558139533,0.8373028410227439,1.0,9/13,23.62%,SNAPC2;RPAP2;USPL1;CAVIN1;POLR1G;BRF1;SPIN1;GTF3C1;ANG
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5502297520347599,1.1676700723980755,0.3103975535168196,0.8378664401291667,1.0,5/10,20.41%,GRB10;RSC1A1;ENPP1;INPP5K;APPL2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4309652028658334,1.1676674653506631,0.2811764705882353,0.8369784391245546,1.0,7/35,17.06%,PDE7B;GAL;SOX9;RAPGEF2;APOE;PDE3A;NUDT4
prerank,ureteric bud morphogenesis (GO:0060675),0.5054878365428105,1.1675718108524877,0.30422535211267604,0.8364238759844986,1.0,2/16,8.82%,WNT11;GDNF
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4488636730837524,1.1670651544829767,0.2733990147783251,0.8374080988661267,1.0,4/29,9.07%,NR1H2;TMEM86B;PLA2G12A;LPCAT2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.45654722240358375,1.166534530741368,0.27560050568900124,0.838479361372224,1.0,11/25,23.47%,TXNL4A;BCAS2;WDR83;DBR1;GEMIN2;SF3B4;SRSF4;DDX23;SLU7;SRSF10;TRA2B
prerank,negative regulation of immune system process (GO:0002683),0.49502489970776165,1.1663957413849255,0.28125,0.8380547981797686,1.0,5/16,12.93%,SOX9;LYN;IL17D;COL3A1;FCGR2B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.37226405889284375,1.165994932933203,0.18559837728194725,0.838530376601961,1.0,12/152,6.61%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;GPR37L1;S1PR2;PTGER4;ADCY5;GNA15;GNA14;GPR37
prerank,nuclear membrane reassembly (GO:0031468),0.40570646889779705,1.1658744010334334,0.2564102564102564,0.8380766879795148,1.0,14/54,16.89%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;UBXN2B;CHMP3;REEP3;AHCTF1;NUP155;PPP2R2A;IST1
prerank,negative regulation of ATPase activity (GO:0032780),0.4826964771781178,1.1656617441345996,0.28512960436562074,0.8380025722487695,1.0,2/16,9.61%,IFIT1;THADA
prerank,positive regulation of MAPK cascade (GO:0043410),0.3730936803479503,1.1654280929576681,0.13682092555331993,0.8379542552846995,1.0,45/245,16.80%,EIF2AK2;NOD2;TAOK3;FLT1;CCL7;SLAMF1;SPRY2;KDR;GAREM1;GPR37L1;DHX33;CD40;ADAM8;CCL5;CX3CL1;FBXW7;MYDGF;FGFR2;MT3;GPR37;RET;TPD52L1;TMEM106A;RAPGEF2;ACKR3;HMGB1;APP;ROR2;INSR;BMPER;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE;NRP1;EZH2;SOX2;STK25;TAOK2;MTURN;FGFR3;IRAK1;LGALS9
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5522485185505296,1.165338259024444,0.29357798165137616,0.8373638902766497,1.0,2/10,6.61%,GPR37L1;GPR37
prerank,regulation of dendrite development (GO:0050773),-0.3078876424778055,-1.165076762876139,0.18235294117647058,0.9487031728587958,1.0,12/37,14.81%,SDC2;COBL;ALK;CSMD3;BCL11A;GSK3B;DAB2IP;NSMF;ZDHHC15;VLDLR;ADGRB3;DCC
prerank,regulation of GTPase activity (GO:0043087),0.3733676775920087,1.1649018979341288,0.1656441717791411,0.8381095272253224,1.0,51/177,21.16%,WNT11;CCL7;PLXNA3;RASA4;DOCK8;RGP1;PLXNB2;SEMA4D;CD40;THY1;CCL5;PLXNB3;CX3CL1;EPHA4;ARHGEF7;RAPGEF6;RAPGEF2;RAP1GAP;AGRN;VAV1;SNX9;STMN3;LRCH1;CCL14;SRGAP2;FGD6;RGS16;CHN1;SIPA1L1;ARHGAP11A;RACK1;LIMS1;RIC1;RAPGEF1;ASAP3;EZH2;CRK;SH3BP1;OCRL;TBC1D2;RRP1B;NF1;CPEB2;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,negative regulation of cell motility (GO:2000146),0.37824876327493184,1.1647666177924818,0.22033898305084745,0.837702359790381,1.0,29/108,21.59%,WNT11;BST2;CLIC4;THY1;SFRP2;PLXNB3;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;MITF;SRGAP3;SRGAP2;DUSP10;CRK;PTPRU;NF1;DACH1;STK24;SINHCAF;PIN1;RAP2A;ACVRL1;MCTP1;CITED2
prerank,camera-type eye development (GO:0043010),0.46153192693785844,1.1646955395613656,0.30038022813688214,0.8370843551611973,1.0,2/25,7.50%,PITX2;FBN1
prerank,cellular lipid catabolic process (GO:0044242),0.4518556571078036,1.1646714950135695,0.2749360613810742,0.8362944412583465,1.0,4/27,8.37%,AOAH;ACADL;MT3;LPIN2
prerank,filopodium assembly (GO:0046847),0.48588120623499204,1.1644753170445217,0.2764456981664316,0.8361378371991091,1.0,5/16,12.65%,SPATA13;S1PR2;SPEF1;SRGAP2;FGD6
prerank,spliceosomal complex assembly (GO:0000245),0.41391538270957257,1.1634266054821119,0.2547699214365881,0.8391501899253427,1.0,11/46,15.41%,NOL3;SRPK3;TXNL4A;SRPK1;CELF6;USP39;SNRPD2;SNRPD1;DDX39B;SNRPG;NCBP1
prerank,regulation of peptide hormone secretion (GO:0090276),0.40002409614002604,1.162831046423099,0.26537216828478966,0.8404156960553382,1.0,9/67,8.39%,PER2;CHD7;CRHBP;CCL5;ITPR1;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3968886430996266,1.1627190067827573,0.25517993456924754,0.8399102595237968,1.0,28/67,25.95%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD9;PSMD8;TAP1;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,negative regulation of complement activation (GO:0045916),0.5393888249111993,1.1625898234212784,0.31555555555555553,0.8395063132815974,1.0,2/10,5.01%,CD55;SUSD4
prerank,regulation of protein transport (GO:0051223),0.4507390883798036,1.1622768189151096,0.2619974059662776,0.8397082951704231,1.0,14/27,26.75%,P3H1;GAPVD1;HSPA8;PPM1F;SCFD1;RHBDF2;LLGL1;STXBP5L;SNX12;TNF;NDFIP1;PTPN1;CHP1;DNAJA1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3585321035960464,-1.1622217184789367,0.23923444976076555,0.9547992788288373,1.0,6/25,10.29%,APOD;RCC2;ROCK1;DMTN;CLASP2;SRC
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5510486074879608,1.1621117236836551,0.29709035222052066,0.839406679353021,1.0,3/10,16.66%,CAMK2D;PRKCE;STK39
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4778739482536092,1.1621024031011833,0.28950863213811423,0.8385556352786223,1.0,4/21,5.82%,ZFP36;CNOT4;CNOT7;TNKS1BP1
prerank,regulation of neuron death (GO:1901214),0.396660012262952,1.1619826467691678,0.2402938090241343,0.8381032292258846,1.0,18/82,14.25%,CHMP4A;CHMP4B;WNT5A;DAXX;CLU;NENF;EGLN2;CCL5;RILPL1;CSF1;PRNP;SORL1;DDIT4;PPARGC1A;AKT1S1;FCGR2B;EIF2S1;FYN
prerank,positive regulation of dendritic spine development (GO:0060999),0.48023576744691704,1.1618731550847339,0.2866323907455013,0.8376118137750483,1.0,7/20,18.35%,CAMK2B;DHX36;PSEN1;APOE;DBNL;LRP8;CAPRIN1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4606448221016468,1.1618171078943558,0.30299089726918077,0.8369365500487917,1.0,8/24,16.38%,COQ10B;SDHAF4;MT3;GFPT1;LEPR;PPARGC1A;NDUFS1;NDUFS4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4563836627915028,1.161779423450899,0.27525252525252525,0.8362039371080839,1.0,9/28,20.63%,NOD2;THY1;CD47;CCDC88B;PRKDC;TNIP2;TYROBP;SIRPA;LCK
prerank,negative regulation of cell cycle (GO:0045786),-0.27026565902778743,-1.1616513103141106,0.16883116883116883,0.9522083197008462,1.0,29/73,27.10%,TGFB1;PTPRK;HPGD;PDCD4;BRINP1;BTG2;RPS6KA2;NUDT6;RUNX3;APC;NR2F2;CEBPA;SIPA1;BTG1;PPP1R13B;INCA1;SCRIB;BRINP2;TSPYL2;HEXIM1;CDKN1B;NLRP2B;INHBA;NR4A1;CDK5RAP1;FOXC1;HTRA2;NUPR1;GMNC
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.45502234251350404,1.1616393865525416,0.2645962732919255,0.8358177305596293,1.0,3/27,7.30%,AGT;WNT5A;DHX9
prerank,endothelial tube morphogenesis (GO:0061154),0.5561482007795042,1.161502195332117,0.30030959752321984,0.8354700286408681,1.0,4/10,20.21%,CTNNB1;CSNK2B;RBPJ;ACVRL1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.48373899960084604,1.161456490303356,0.29110512129380056,0.8347548394909294,1.0,6/19,16.95%,AXL;MMP14;XBP1;PRKDC;CD27;MDK
prerank,RNA modification (GO:0009451),0.4105905085991631,1.161370801681674,0.23146067415730337,0.8341978872557972,1.0,12/54,12.21%,TRMT9B;ADAR;BCDIN3D;ADAT2;MRM2;MEPCE;TRMT1;ALKBH1;AARS1;PUS7L;WDR4;NOP2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5415120630015895,1.1602014075294353,0.29878048780487804,0.8374376456185612,1.0,1/11,3.51%,RTP4
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3658087677615121,1.160072271042725,0.1282565130260521,0.8370521646936567,1.0,107/314,23.70%,PML;PSMB10;SKP1;AUP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;CUL5;PSME4;ANAPC5;RBCK1;ECRG4;FEM1B;BFAR;RNF5;SIAH1;UBQLN2;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;AREL1;PPP2R5C;PSMA3;UBXN1;AMFR;SPSB1;PSMB9;ANAPC4;TMUB2;RBX1;UBE2E1;ZSWIM8;UBQLN1;UBXN2B;ARRB2;FAM8A1;BTRC;UBXN11;RNF122;PSMD2;CDC16;RNF103-CHMP3;CDC27;FAF2;PSME3;SMURF1;FBXL14;RB1;FBXL19;RNF185;ANAPC15;SHARPIN;UBE4B;ANKZF1;PSMA4;TMEM67;ERLIN2;NHLRC3;AMN1;APPBP2;RNF103;ANAPC2;GID4;FBXL5;UBE2K;KLHL15;TRIM2;WWP1;PCNP;PSMD7;STT3B;RFFL;PSMD9;PSMD8;PTTG1;ZFAND2A;SPOP;PSMF1;TRIM13;RNF216;PSMB6;PSMD12;PSMC2;HUWE1;HSP90B1;STUB1;SMURF2;UBR2;PSMD4;PELI1;DNAJB2;CUL3;FEM1C;FEM1A;KAT5;MAEA;PSMA2;VCP
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.45888409145029335,1.159610086214281,0.2935196950444727,0.8378664939527439,1.0,7/26,17.23%,IRF7;BIRC2;GPR108;BIRC3;TLR2;FLOT2;TLR3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5267034503656378,1.159562964850421,0.27485380116959063,0.8371660577745231,1.0,5/11,23.37%,TIMELESS;TIPIN;ZRANB3;FBH1;LIG3
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4270053923624627,-1.159534215790031,0.27147766323024053,0.9555549765710503,1.0,7/15,23.12%,TGFB1;CST3;CLASP2;DPP4;FAP;CLASP1;DDR1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.47277633509917893,1.1594427434897323,0.2812071330589849,0.8367394366895208,1.0,4/21,10.35%,TUBD1;KIF7;UCHL5;PDCL
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5047965314951007,1.1593352445341596,0.29819694868238555,0.8362700839690054,1.0,4/14,14.43%,IRS1;LONP2;ABCD1;IRS2
prerank,cellular response to superoxide (GO:0071451),0.5595209920336818,1.1587529226440507,0.3094890510948905,0.8374978470622961,1.0,3/10,14.31%,SOD2;MT3;PRDX2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.45645945780575836,1.158522096941506,0.2916666666666667,0.8374515010570105,1.0,13/26,27.61%,ATP1B3;ACTN2;CAB39;NETO1;AKAP9;VAMP2;DLG1;STK39;KCNS1;YWHAE;ANK2;ITGB1;CACNA1D
prerank,positive regulation of GTPase activity (GO:0043547),0.3699226954331409,1.1583917295472388,0.17925478348439072,0.8370698286409104,1.0,59/188,21.16%,WNT11;CCL7;DOCK8;RGP1;TBC1D1;SEMA4D;CD40;THY1;CCL5;CX3CL1;SYDE1;ARHGEF7;PIP5K1A;TBC1D8;RAPGEF6;RAPGEF2;ABR;RAP1GAP;SYDE2;AGRN;SIPA1L2;TBC1D8B;SNX9;ARHGAP25;CCL14;SRGAP2;ARHGEF10;RGS16;SIPA1L1;ARHGAP11A;RACK1;LIMS1;RIC1;RAPGEF1;TIAM2;ASAP3;EZH2;SH3BP1;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;NF1;CORO1C;SIPA1L3;ARAP1;TSC1;ARHGAP24;PIN1;ARHGAP42;SGSM1;TBC1D4;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3300530214498256,-1.1580019476604446,0.25365853658536586,0.9565801019410322,1.0,7/29,8.81%,GPR183;CD38;CD81;NCKAP1L;SASH3;EPHB2;TFRC
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3756685185705726,1.1578320231203616,0.21797520661157024,0.8381626579413513,1.0,37/119,20.92%,PIGW;SOCS1;ARF3;PIK3CD;SLC27A1;CDS1;ITPKC;SYNJ1;PITPNM1;SBF1;PIP5K1A;PIGV;SOCS5;PIK3R4;PI4KB;EFR3A;CDIPT;RAB14;PLEKHA1;SOCS2;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;INPP5K;MTMR14;PGAP2;OCRL;PIGQ;SOCS6;PIGB;PGAP3;PI4KA;SOCS4;SOCS7;SACM1L
prerank,regulation of mRNA processing (GO:0050684),0.43937617474249663,1.1578108902058366,0.28992628992628994,0.8373822553707104,1.0,11/32,17.60%,SRPK3;HNRNPK;DHX9;SLTM;SRPK1;ZFP36L1;AHCYL1;PAPOLA;RBM39;NCBP1;CWC22
prerank,membrane protein proteolysis (GO:0033619),0.42266642138781313,1.1576235020590502,0.26215895610913403,0.8371690264064888,1.0,13/37,18.22%,SPPL2A;RBMX;ERAP1;NFKB1;RET;CTSH;PSEN1;NAPSA;SPPL3;APH1A;APH1B;MYH9;HM13
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.45750443421626275,1.1572842091193103,0.2755498059508409,0.8375140035597711,1.0,13/25,25.42%,PLXNB3;EVL;KANK1;RAP1GAP;CDK10;ODF2L;CAPZB;STAP1;TESK1;ARHGAP24;PRKCD;EVI5L;PFN2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.49697569195697,1.1569499180056906,0.3013513513513513,0.8378356130717242,1.0,4/16,11.62%,TNFSF9;IL27;LST1;TNFSF8
prerank,positive regulation of viral life cycle (GO:1903902),0.47305952793792067,1.1567623475664257,0.28350515463917525,0.8376884234918335,1.0,1/22,0.17%,AXL
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5084083869159524,1.1565867889334527,0.3196022727272727,0.8374623936213648,1.0,7/14,14.97%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,negative regulation of endocytosis (GO:0045806),0.45844983776683323,1.1565204838218832,0.28681177976952626,0.8368353606714447,1.0,6/24,15.47%,NR1H2;SNX33;LRSAM1;RUBCN;RAC1;CD300A
prerank,centromere complex assembly (GO:0034508),-0.3120326604629563,-1.156351920794724,0.22289156626506024,0.9580611786363074,1.0,16/36,24.80%,CENPV;CENPO;CENPE;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPF;CENPC;DLGAP5;CENPX;CENPQ;CENPH
prerank,nitrogen compound transport (GO:0071705),0.37394385022240867,1.1556911588817878,0.20781893004115226,0.839013921525454,1.0,34/141,22.55%,ZG16;ABCC2;CHMP1B;SLC18A2;ARRDC4;SLC38A2;LRP2;SLC38A1;SLC15A3;SLC15A2;RILP;SLC52A2;ARRDC2;SLC38A3;SLC35F3;PDPN;SLC7A6;AMN;ABCC1;CHMP3;CMTM6;VAMP2;DENND10;SLC25A47;SLC25A45;MYH9;FLVCR1;ABCG2;SLC44A1;SLC7A7;SLC6A6;CHMP1A;HSP90B1;CERT1
prerank,positive regulation of phospholipase activity (GO:0010518),0.4695527140031633,1.1555616919022214,0.28763440860215056,0.8386191841005529,1.0,9/22,23.51%,FLT1;CCL5;FGFR2;ARL1;ARF4;FGFR3;ABL2;FGF2;PDPK1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46757586152972014,1.1553361469459829,0.29683377308707126,0.8385528119775743,1.0,8/21,18.22%,SPPL2A;RBMX;ERAP1;PSEN1;SPPL3;APH1A;MYH9;HM13
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.42438806852095207,1.1553182615101896,0.28042959427207637,0.8377697488118352,1.0,16/40,26.82%,PML;CLU;FBXW7;UBE3A;TRIM39;CSNK2A2;SMURF1;RPL11;RPL5;NUB1;UBQLN4;AXIN1;COMMD1;RAD23A;PTEN;UFL1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4046937930694736,1.154613433031933,0.26136363636363635,0.8394460944608204,1.0,12/55,16.74%,AGT;BCO2;XDH;MT3;DHRS4;MAPK14;SPHK2;ZC3H12A;EIF6;RAC1;ARF4;ACOD1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4297910941861345,-1.154533857250963,0.27945205479452057,0.9602381477766067,1.0,6/12,32.84%,ANXA6;UBASH3B;FKBP1B;MTLN;PTK2B;RYR2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4876417384177816,1.1542228763658677,0.30294906166219837,0.83994443692605,1.0,6/17,19.60%,ABCG1;KPNB1;APOE;ERLIN2;SREBF1;SEC14L2
prerank,positive regulation of tissue remodeling (GO:0034105),0.5485527772747255,1.1540585636650393,0.31790123456790126,0.839684309481288,1.0,1/10,0.61%,IL15
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.32537878414206045,-1.1539969227179956,0.2023121387283237,0.957522349807648,1.0,10/33,13.44%,CSTF3;CSTF2;FIP1L1;PABPN1;MAZ;SNRPE;SYMPK;SNRPF;CPSF7;CPSF4
prerank,regulation of heart contraction (GO:0008016),0.37927698219631917,1.153844966459858,0.23698193411264612,0.8395611790589881,1.0,12/90,11.05%,AGT;ASPH;CAMK2D;FXYD4;ATP1B3;SLC8A1;ITPR1;TMIGD3;NPPC;FXYD6;P2RX4;AHCYL1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.461065609144731,1.1532703635575554,0.28777923784494086,0.8406957880908617,1.0,9/23,25.49%,CCL5;IL10RA;IL10RB;JAK2;PIBF1;NOTCH1;CRLF3;OCIAD1;TNF
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.39939815303309695,1.1527766354467825,0.25277161862527714,0.8398795446383274,1.0,20/61,23.08%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,vesicle coating (GO:0006901),0.39939815303309695,1.1527766354467825,0.25277161862527714,0.8398795446383274,1.0,20/61,23.08%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,COPII vesicle coating (GO:0048208),0.39939815303309695,1.1527766354467825,0.25277161862527714,0.8398795446383274,1.0,20/61,23.08%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.476790632122719,1.1526277866231454,0.2991913746630728,0.8395379726708655,1.0,5/20,16.66%,CAMK2D;ACTN2;CAB39;PRKCE;STK39
prerank,positive regulation of microtubule polymerization (GO:0031116),0.45344048308227647,1.152505939406802,0.3018867924528302,0.8391414171096345,1.0,8/28,14.01%,HSPA1B;MECP2;MAPRE1;CDK5RAP2;MET;GIT1;AKAP9;RAC1
prerank,renal absorption (GO:0070293),0.53747785969333,1.1523110864657136,0.30505952380952384,0.8389903786814964,1.0,3/10,11.84%,MAGED2;SLC15A2;GSN
prerank,embryonic appendage morphogenesis (GO:0035113),-0.43578545178873734,-1.1522296499116491,0.25,0.9597342746855695,1.0,3/12,8.68%,FBXW4;LRP6;TGFB2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.47707383523409375,1.1519391224265452,0.307797537619699,0.8393881872454094,1.0,9/18,22.74%,RGP1;VPS11;DACT1;RIC1;NELL1;HSP90AA1;WDR91;VPS35;MSN
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.41866366549368067,1.1513679881019743,0.29694835680751175,0.8405370409960665,1.0,11/41,16.15%,AGT;BDNF;TGFA;FBXW7;EPHA4;DOK7;FCGR1A;PRNP;STAP1;FYN;LRP8
prerank,negative regulation of endothelial cell migration (GO:0010596),0.42035860661143254,1.1512688500258605,0.273164861612515,0.8400483240758282,1.0,12/36,23.31%,SP100;MECP2;CSNK2B;HMGB1;APOE;SVBP;ACVRL1;GADD45A;FGF2;VASH1;PTPRM;NOTCH1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4056894106736246,1.150926616964692,0.27662037037037035,0.8404559558907502,1.0,16/48,19.54%,CLU;AZIN2;MAD2L2;HSP90AB1;RILP;PFDN5;NFKB1;AGAP2;PRNP;AZIN1;APOE;PFDN4;CD84;FLOT2;LDLR;PIN1
prerank,mesenchymal cell differentiation (GO:0048762),0.4041777703862756,1.150481629599523,0.2526690391459075,0.8411304050910363,1.0,11/51,14.41%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;FGFR2;CUL7;SNAI2;NOTCH4;LIMS1;RANBP3L
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.49492911945492996,1.1494475242187783,0.3089430894308943,0.84392032808923,1.0,5/15,15.96%,NR1H2;SLC45A3;PPARGC1A;LPGAT1;PPARD
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.44181092938479793,1.1493316922001255,0.31683168316831684,0.8434854072434947,1.0,4/27,12.51%,CALCA;GNA15;C3AR1;GPR35
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4883928502449579,1.1491799938616707,0.3044654939106901,0.8431396324283081,1.0,7/18,17.64%,MTHFR;SMS;SLC25A12;MSRA;FOLH1;MTHFD1;GADL1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5318886162314008,1.1490411347108274,0.2794759825327511,0.8427765109039916,1.0,5/12,18.15%,CLU;PFDN5;APOE;PFDN4;LDLR
prerank,dopaminergic neuron differentiation (GO:0071542),0.47597977884120624,1.1488282512410424,0.28356164383561644,0.8426493791223475,1.0,2/19,5.48%,LMX1A;CTNNB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3170156744530728,-1.1486249943775877,0.16891891891891891,0.9687561225307405,1.0,13/39,15.94%,TRAK2;WASL;MYO1G;BICDL1;NDE1;HTT;PPFIA2;TANC2;FBXW11;MYO7A;MYO1B;MYO5B;CLN3
prerank,protein mannosylation (GO:0035268),0.46417354632516084,1.147479523247314,0.29450261780104714,0.8466290153165567,1.0,7/22,18.03%,DPY19L4;TMTC1;POMT1;POMT2;CRPPA;TMTC4;DPY19L1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4596451627139703,1.147384343211527,0.29743589743589743,0.8461216247619099,1.0,5/25,11.67%,EXT1;HAS3;HAS1;CSGALNACT2;B3GALNT1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5424123217498654,1.1467838440938203,0.31343283582089554,0.8474258581255076,1.0,4/10,14.43%,IRS1;SLC45A3;PRKCE;IRS2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4620147385618725,1.1459803388067822,0.2955729166666667,0.8494215052920815,1.0,3/22,9.05%,SP100;MDFIC;BARD1
prerank,endomembrane system organization (GO:0010256),0.36579890754686606,1.1459695865716204,0.2209889001009082,0.848615003565641,1.0,49/178,20.04%,DNAJC13;VPS51;TOR1AIP2;BLZF1;USP50;TJAP1;ATL1;SNX33;COG3;GOLGA5;GOLGA8B;TLCD2;WASHC4;SEC16A;SNX10;ARHGEF7;CUL7;VPS11;TMED5;HOOK2;RAB22A;FBXW8;DOP1B;RAB43;VAPB;HOOK1;UBXN2B;TMED10;TRAPPC12;COG2;ARL1;SUN2;ARHGAP21;ARFGEF2;REEP3;HOOK3;PLEKHM2;NUP155;SYNGR1;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;SERP1;OSBPL2;RAB1A;GORASP2;VPS18
prerank,gland development (GO:0048732),0.3985283692227919,1.145497846154346,0.2698768197088466,0.8494073344206792,1.0,11/59,11.51%,WNT11;GFER;ARID5B;SOX9;FGFR2;MET;TG;PROX1;DKK3;NOTCH4;XBP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5354780484987265,1.1453148834309552,0.30434782608695654,0.8492238045230971,1.0,6/11,25.69%,PRR7;GSN;ST18;LGALS9;PLAUR;PIH1D1
prerank,regulation of protein export from nucleus (GO:0046825),0.4541375405999082,1.1446767924319678,0.31352718078381797,0.8505929893881029,1.0,3/23,9.05%,SP100;TCF7L2;BARD1
prerank,telomere maintenance via telomerase (GO:0007004),0.44217988793608587,1.1443427322781394,0.3042944785276074,0.8509573375092861,1.0,10/28,18.77%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,regulation of tissue remodeling (GO:0034103),0.48454258149214496,1.1442013001455573,0.30955585464333785,0.8506261182097042,1.0,7/18,20.43%,IL15;RUNX1;SYT7;LEPR;IL18;MDK;DDR2
prerank,regulation of double-strand break repair (GO:2000779),0.417115502722184,1.1439462994159078,0.29369797859690844,0.8506540213061415,1.0,9/39,12.66%,PML;TIMELESS;ACTR2;CHEK1;RTEL1;SLF2;SIRT6;PPP4R2;DDX11
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4197595180328832,1.1437825393576246,0.2867132867132867,0.8504365315823562,1.0,11/42,12.40%,TIMELESS;CGAS;ACTR2;MAD2L2;CHEK1;RTEL1;ARID2;SIRT6;POLQ;SHLD1;PPP4R2
prerank,aminoglycan biosynthetic process (GO:0006023),0.40650679434332637,1.1434362146726877,0.2818181818181818,0.8507936669938759,1.0,5/49,3.12%,EXT1;XYLT2;SDC3;SDC4;HAS1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.47652910782535773,1.1429660888178894,0.29882044560943644,0.8516477058285047,1.0,5/19,12.91%,TPST1;SLC26A1;SULT6B1;SLC26A2;ENPP1
prerank,response to amino acid (GO:0043200),-0.3214686327997136,-1.1429414330335403,0.20652173913043478,0.9856737017548836,1.0,11/31,16.44%,TMBIM6;GRIN1;RRAGD;RRAGB;GLRB;LARS1;NSMF;GLRA3;SLC38A9;CAPN2;LAMTOR2
prerank,regulation of interleukin-8 production (GO:0032677),0.39327833628978826,1.1417217966315203,0.26460859977949286,0.8552174411573161,1.0,17/69,21.31%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;TLR3;ANXA4;PTPRC;RAB1A;CD33;MAPKBP1;F3
prerank,cellular response to UV (GO:0034644),-0.2598410532007188,-1.1415240549872523,0.2191780821917808,0.9862866582847983,1.0,29/76,21.11%,ZBTB1;PTPRK;IMPACT;MMP1;PARP1;INO80;USP28;YY1;RHNO1;XPC;SIRT1;ACTR5;NSMCE3;CASP9;TAF1;METTL3;KDM1A;TP53;CERS1;CDKN1A;ERCC1;BAK1;XPA;MYC;USP47;POLD1;NEDD4;SMPD1;COPS9
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5396681832130013,1.1413270493629968,0.3398496240601504,0.8558003849990782,1.0,2/10,4.42%,THAP7;KLF15
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.46546506031706236,1.1402200850240125,0.2994791666666667,0.858838276975951,1.0,4/21,10.07%,LRP2;CX3CL1;CTNNB1;PROX1
prerank,nucleosome organization (GO:0034728),0.3936652974718686,1.140181369400014,0.25984251968503935,0.8581449352654478,1.0,12/55,10.98%,DAXX;BRD2;NAP1L2;SOX9;ARID1A;SMARCC2;SMARCE1;ARID2;BPTF;CHAF1B;NPM1;CTCF
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4441561229604435,1.1401080846455323,0.30378096479791394,0.857591482159886,1.0,7/27,15.07%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,quinone biosynthetic process (GO:1901663),0.5034836794782392,1.1398731180142962,0.3218884120171674,0.857603483570527,1.0,3/14,6.34%,COQ2;COQ10B;COQ3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.43892064644864176,1.1397416576683312,0.29397590361445786,0.8572104929764579,1.0,9/29,19.79%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TLR3;CD300LF;TANK
prerank,negative regulation of cell population proliferation (GO:0008285),0.35412266752760874,1.1395812760421353,0.146,0.8569524751808848,1.0,66/351,17.03%,IFIT3;EIF2AK2;HSPA1B;PARP10;PML;IFI35;WNT5A;PER2;ZBTB17;RARG;B2M;TNFRSF8;SOD2;CDH13;NMI;AQP11;SFRP2;TMEM115;CNOT7;MORC3;CDKN2D;SOX9;CHERP;CTNNB1;PPP2R5C;P3H1;TFAP2B;TMIGD3;CSNK2B;MAGI2;FRZB;RAPGEF2;TFDP1;ARID2;LYN;PDPN;APP;NCK2;ROR2;PEX2;ALDH1A2;MEN1;BMPR2;PROX1;CIB1;NPM1;CDK10;DNAJA3;CTCF;KLF10;THAP12;DUSP10;CGREF1;NELL1;ST18;DIS3L2;JAK2;SOX2;HGS;CD300A;MCC;AIF1;EEF1E1;BRD7;PTPRU;PRKRA
prerank,regulation of JNK cascade (GO:0046328),0.37558467318176214,1.1393439778417795,0.2625523012552301,0.8570208478371183,1.0,23/101,15.92%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;DUSP3;TRAF4;WNT7B;CYLD;TPD52L1;MAPK8IP3;DACT1;HMGB1;APP;MEN1;TRAF3;TRAF5;DUSP10;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,autophagosome maturation (GO:0097352),0.4310376145988345,1.139280560438012,0.30597014925373134,0.8563998202851466,1.0,9/32,13.59%,LAMP2;VPS33A;LIX1;RUBCNL;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,sensory perception of light stimulus (GO:0050953),0.3862020686344431,1.1391338301329346,0.26849894291754756,0.8561023243761603,1.0,11/87,15.32%,CABP4;CNGB1;EYA4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,skeletal muscle contraction (GO:0003009),0.4885606151190124,1.1385348237000434,0.33064516129032256,0.8573383573195273,1.0,5/19,22.04%,TNNC1;STAC3;TNNI2;RCSD1;MYH14
prerank,photoreceptor cell development (GO:0042461),-0.40943815672739253,-1.1384711464686084,0.27491408934707906,0.9937844244503775,1.0,10/14,50.54%,MYO7A;DCX;MFSD2A;CEP290;RP1;RORB;AHI1;TH;CDHR1;TOPORS
prerank,negative regulation of organelle assembly (GO:1902116),0.4160584401457655,1.1384405927444903,0.30097087378640774,0.8568504353257979,1.0,7/35,12.01%,CHMP4A;CHMP4B;RBM14;CDK5RAP2;CDK10;ODF2L;SCFD1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.477025513479968,1.1383497360857016,0.30294906166219837,0.8563235324759307,1.0,5/17,10.51%,SFRP2;CCL5;PODXL;RET;CIB1
prerank,granulocyte differentiation (GO:0030851),-0.37147158553343484,-1.137701516017889,0.2669039145907473,0.9917820842445905,1.0,9/18,17.32%,CBFA2T3;LBR;RXRA;JAGN1;RARA;CDK4;CEBPA;E2F1;CDKN1A
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2786181220271387,-1.137452965669343,0.19791666666666666,0.9880428738928807,1.0,26/68,20.62%,CSTF3;CSTF2;POLR1A;FIP1L1;PABPN1;ERCC3;TBP;TTF1;ERCC2;PRMT5;MAZ;SNRPE;SYMPK;TAF1D;SNRPF;CPSF7;POLR2F;CPSF4;POLR1C;TAF1A;POLR1H;GTF2H3;POLR2A;CLP1;MTERF2;GTF2H4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.36942582680796193,1.1372285149916745,0.26959247648902823,0.8593255236263965,1.0,22/95,15.24%,SAMHD1;ZSWIM7;MCM2;SEM1;MCM7;AP5Z1;MCM4;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;GINS2;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3825746108110824,1.136968743144406,0.278494623655914,0.8594193181857089,1.0,30/84,23.70%,PSMB10;PSME2;PSMA5;CDC26;PSME4;ANAPC5;ECRG4;PSMA3;PSMB9;ANAPC4;UBE2E1;PSMD2;CDC16;CDC27;PSME3;RB1;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD9;PSMD8;PTTG1;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;CUL3;PSMA2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.34940834648513935,1.1364507621760145,0.017,0.8604208644319514,1.0,345/1668,18.59%,STAT1;STAT2;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;PITX2;MYOZ2;SIM1;NAMPT;LOXL2;GAL;MOV10;THAP7;SP110;LHX2;LMX1A;NR1H2;NOD2;CC2D1B;IRF2BP1;ESR2;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;ZNF483;TFAP2C;PER2;GMEB2;CCNL1;ZBTB17;ESRRB;BRD2;ZFP36;RARG;NFX1;HTATSF1;DDRGK1;BBX;AGO2;RBM14;RNF4;TEAD2;SEMA4D;ZBTB2;CD40;NFKB2;SOD2;MECP2;CDH13;ACVR1;STAT3;ARID1B;ARID5B;ZFP37;TGFA;BATF3;ACTR2;RBL1;DDX5;SFRP2;ZNF471;ELK3;MTA3;CGGBP1;RUNX1;PCGF6;MAD2L2;ID3;NACC1;BHLHE40;ZHX3;NKX6-2;RBMX;KLF15;CIC;CCNL2;NOP53;GATAD2A;DHX36;BRWD3;MZF1;JUNB;ZSCAN12;NCOA1;CX3CL1;ZNF23;SOX9;SRA1;HNRNPK;CTNNB1;CCND1;CDK12;PAXBP1;PFKM;KMT2A;ZNF2;ARID1A;CCNT2;TRAK1;ZNF76;MYDGF;MBD2;ZSCAN22;FGFR2;IGBP1;ZSCAN26;BCL6;ZXDC;TCF7L2;TCF4;SMARCC2;SMARCE1;NFKB1;ZBTB43;CREBRF;ASXL3;ZBTB38;SETD3;THAP3;BRIP1;BACH1;ZSCAN29;DDX20;ACTR3;USF1;TFAP2B;NFATC2;SNAI2;SAP30;UBP1;SRF;DHX9;ETV6;MTA2;RAI1;TADA2A;IKZF2;MRTFA;HTATIP2;SMAD2;GLIS3;MED13L;MEIS3;ATF6B;TFDP1;DACT1;LPIN2;SIRT6;RPAP2;NCK1;DNMT3A;LMO2;AEBP1;AASS;MET;SLTM;NFIB;GDNF;ATF1;ELP2;HOXA9;METTL23;POU3F1;HMGB1;SCX;DACH2;APP;LCORL;NCK2;RORA;CRTC1;MAML2;TADA2B;ELF4;HR;PLK3;PEX2;MAPK14;AGRN;IRF9;MNAT1;MEN1;BMPR2;LIN9;ZSCAN20;BPTF;NR2C1;MED12;PROX1;NCOA5;PHIP;ELOC;TNIP1;KDM3B;DUSP26;NPM1;FOXK1;ZC3H12A;MAX;DNAJA3;CTCF;SNW1;NOTCH4;ZBTB5;HCFC2;TFDP2;GALR1;XBP1;TAF3;IER5;MITF;SKIL;CBX4;ECD;MDFI;HMGB3;CUX1;KLF10;NKAP;UXT;RELB;TEF;LDB2;LDB1;NOP2;PSEN1;PRKDC;NR3C1;REL;APOE;PPARGC1A;LCOR;HOXB6;RB1;FBXL19;PRDM4;ATXN1;MIER1;ZNF35;E2F4;APBB1;HDAC8;BUD31;PGBD1;PTCH1;ST18;ZBTB21;DBX2;TIAL1;DAB2;POGZ;MYO6;MED29;IKZF1;CASZ1;SMARCA1;BCL11B;ZNF418;DLG1;MYPOP;EZH2;SOX2;RREB1;TET2;TFR2;TNIP2;MYB;CREB5;ZBTB34;POU6F1;BMPR1A;CRTC3;ZBTB24;CAMTA2;ERF;SOX5;CRK;KLF16;TLR2;SMARCD2;PIAS1;GTF2IRD1;MEF2A;NPAT;ARF4;RCOR3;CARF;PPARD;MED27;KDM7A;PROX2;IL18;IER2;TNIP3;PIAS2;LAGE3;LMO7;SREBF1;CCNK;ZBED4;ZBTB4;RBPJ;BRD7;DICER1;KAT8;MED16;ELF1;HMBOX1;CHCHD2;ID4;MPND;BAX;PELP1;TLR3;ANXA4;RRP1B;ZNF445;LRRFIP1;POU2F2;ENY2;ZBTB49;CXXC5;MED10;ZNF513;DACH1;PTOV1;HSBP1;ACVR2A;FOSL2;FNIP2;HDAC1;HINFP;HOXA5;GABPB1;GABPB2;CTBP1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3307238539204245,-1.136336224659107,0.2578947368421053,0.9874095048185373,1.0,12/28,17.56%,MAP3K20;NBN;USP28;CEP63;RHNO1;DONSON;HUS1;RAD17;CLSPN;E2F1;STK33;RAD1
prerank,nuclear migration (GO:0007097),-0.4142867368053669,-1.136222478804277,0.26732673267326734,0.983152932920228,1.0,7/13,12.07%,DOCK7;PCM1;CEP120;TMEM201;FBXW11;SYNE3;CLMN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.38982549281110584,1.135976378042529,0.28324324324324324,0.8611983159744783,1.0,18/68,21.16%,MTHFR;DHFR;SLC25A19;SLC46A1;SLC19A1;SLC52A2;CYB5R3;AMN;TPK1;ABCC1;ENPP1;SHMT1;PANK2;MCCC1;MTHFD1;ABCD4;SLC5A6;MMUT
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4496026422278445,1.135972869242685,0.3036935704514364,0.860379973195296,1.0,7/23,17.15%,BCL2L11;SAMM50;HSPA4;BAD;HSP90AA1;BMF;BAX
prerank,protein destabilization (GO:0031648),0.42974764798751736,1.1358732527394693,0.2989949748743719,0.8598962853465202,1.0,9/32,14.40%,IRGM;TRIM21;GGA3;CTSH;PRNP;PEX2;BTRC;GSN;KDM8
prerank,regulation of mitochondrial fusion (GO:0010635),-0.44452676145451214,-1.1357614352377758,0.3165680473372781,0.9802699952310456,1.0,7/11,33.12%,VAT1;TFRC;ZDHHC6;MUL1;PRKN;BNIP3;PID1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.44740465159263276,-1.1349751647903874,0.3177842565597668,0.9787366878871017,1.0,7/11,33.91%,ZFPM2;JAG1;TGFB2;SOX4;BMP4;HEY2;GATA3
prerank,glycerolipid metabolic process (GO:0046486),0.525178792094465,1.1346551075084874,0.3308931185944363,0.8632691993949835,1.0,5/11,20.03%,PDXP;PIP5K1A;DGKB;DGKA;PNPLA3
prerank,protein sumoylation (GO:0016925),0.4023596230816886,1.134165071518409,0.2800925925925926,0.8641356096227176,1.0,21/49,26.92%,IFIH1;NUP37;SUMO2;SUMO3;NUP153;RAE1;UBA2;NSMCE2;NUP155;PIAS1;PIAS2;NUP88;NUP133;NUP43;SUMO1;NUP205;TRIM28;PIAS4;SEH1L;EYA1;NUP188
prerank,keratinocyte differentiation (GO:0030216),0.43010437175447536,1.1338783006230324,0.30855018587360594,0.8642540662650502,1.0,3/29,6.64%,CLIC4;WNT5A;PIP5K1A
prerank,regulation of protein phosphorylation (GO:0001932),0.3562506717193676,1.1337687093242792,0.18693467336683417,0.8638148083312747,1.0,47/256,15.07%,STAT2;IRGM;PML;XDH;PLXNB2;KDR;SOCS1;DAXX;TARDBP;SEMA4D;CD40;CCND2;NOP53;SOX9;CCND1;PPP2R5C;KDM4D;MYDGF;MT3;PPIA;PAQR3;CCDC88A;LYN;LEPR;APP;INSR;BMPER;PRNP;MEN1;TNIK;PHIP;MOB1B;CIB1;NPM1;ZC3H12A;VEGFD;FGF9;PPP2R5D;PRKDC;RACK1;DAB2;RAC1;FYN;RB1CC1;HSP90AA1;NPTN;INPP5K
prerank,positive regulation of signaling (GO:0023056),-0.2988521529308211,-1.1336805800691552,0.23214285714285715,0.9792942541193379,1.0,15/37,23.92%,INPP5F;DLG4;HOMER1;SNCA;RIMS1;NSF;RIMS3;VAMP3;SCRIB;RIMS2;CDKN2AIP;KCTD13;SYT1;NMU;CD80
prerank,positive regulation of cell death (GO:0010942),0.39480484066488886,1.133555748001592,0.30112359550561796,0.8636953408320694,1.0,13/59,14.25%,WNT5A;DAXX;CLU;RARG;MT3;HTATIP2;PRNP;PRR7;ZC3H12A;DDIT4;FCGR2B;EIF2S1;FYN
prerank,epithelium development (GO:0060429),0.3692594565597958,1.1333624990354552,0.2751817237798546,0.8635472231603366,1.0,14/107,14.38%,STAT1;KDR;TIMELESS;CASP6;SOX9;FGFR2;WNT7B;SNAI2;DACT1;ALDH1A2;PROX1;HNRNPH3;PTCH1;JAK2
prerank,regulation of interleukin-12 production (GO:0032655),0.40213070983548005,1.1333585217950857,0.30180180180180183,0.862730985548212,1.0,15/47,24.26%,SLAMF1;CD40;CD47;TLR8;HMGB1;MAPK14;PIBF1;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5;LILRA5
prerank,RNA interference (GO:0016246),0.47715397290340833,1.1332129178144774,0.32845744680851063,0.862407287340603,1.0,10/17,28.30%,AGO2;TARBP2;DHX9;NRDE2;DICER1;PRKRA;AGO4;TSN;AGO1;AGO3
prerank,positive regulation of cell cycle (GO:0045787),0.39321850636643785,1.1331949716628165,0.293007769145394,0.8616503388230734,1.0,11/62,10.07%,CDC25B;TRIM21;PKN2;CCND2;CHEK1;DUSP3;CCND1;FGFR2;SMOC2;APP;PROX1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4140601833236554,1.1327620298411978,0.29239766081871343,0.8623620657999276,1.0,2/42,0.60%,IRGM;GALP
prerank,positive regulation of phagocytosis (GO:0050766),0.40615481629792416,1.1327059308544385,0.27880184331797236,0.8617378613648538,1.0,11/47,20.41%,IL15;IL15RA;C4B;CD47;TUB;STAP1;FCGR2B;PTPRC;CD300LF;SIRPA;APPL2
prerank,regulation of response to stress (GO:0080134),0.5409715736059741,1.1326620772014209,0.34575260804769004,0.8610746494211173,1.0,3/10,9.95%,SLC38A2;CRHBP;MLC1
prerank,negative regulation of response to stimulus (GO:0048585),0.3915153611268721,1.131933352396827,0.29799107142857145,0.8627401587163385,1.0,20/60,22.56%,NR1H2;CLU;ACVR1;KIF26A;AQP11;RBL1;THY1;LYN;SOCS5;COL3A1;GGT7;FCGR2B;TERF2;ZKSCAN3;VPS13C;APPL2;MCTP1;AKT3;PIM3;ERBB3
prerank,anion transmembrane transport (GO:0098656),0.3867599691725854,1.1318730304066327,0.2883977900552486,0.8621536809627538,1.0,22/67,23.55%,SLC25A22;SLC27A1;SLC25A19;SLC25A1;SLC19A1;SLC35B1;SLC25A10;ABCC1;SFXN2;SLC35B4;SLC13A4;SLC35A3;SLC25A12;SLC36A4;SFXN1;SLC35C2;ABCC5;SLC5A6;MFSD12;SLC1A3;SLC25A30;ARL6IP5
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.360846065412719,-1.1318449347341746,0.2672811059907834,0.9818950646149541,1.0,7/21,16.59%,TGFB1;ROCK1;SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,regulation of glucose import (GO:0046324),0.4306130088474038,1.1315593849808876,0.3225806451612903,0.8624053336923226,1.0,8/30,14.43%,IRS1;ARPP19;GRB10;OSBPL8;INSR;PTPN11;ENPP1;IRS2
prerank,xenobiotic transport (GO:0042908),0.48020357346222825,1.1313009967580239,0.3155737704918033,0.8624858315526511,1.0,5/17,20.24%,ABCC2;SLC15A2;ABCC1;ABCG2;ABCC5
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3568548904581588,1.1312796108039178,0.23272357723577236,0.8617298016819798,1.0,48/163,21.76%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;NFATC2;PSMB9;BCAR1;NCK1;RNF31;EIF2B2;BTRC;ZC3H12A;PSMD2;PLEKHA1;PSME3;PIK3CB;SPPL3;FYN;PSMA4;BLNK;CSK;PTPRC;PAG1;PSMD7;EIF2B5;PSMD9;EIF2B3;RC3H2;PSMD8;DENND1B;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMD12;PSMC2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4195730617225266,1.1310619541926923,0.32077764277035237,0.8617137161962968,1.0,3/33,3.63%,NOL3;CLU;FXN
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4002811401999374,1.1308818659317958,0.3042505592841163,0.8615141600768804,1.0,15/56,16.29%,HYAL1;MECP2;CDC25B;ANAPC5;CCND2;CCND1;RAD51C;TFDP1;ANAPC4;CDC16;CDC27;RB1;NSMCE2;AIF1;RAB11A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.40278705201071346,1.1307914528905771,0.30011587485515645,0.8610053207381149,1.0,7/47,7.97%,EIF2AK2;NOD2;TAOK3;IGBP1;NBR1;PPIA;MAPK8IP3
prerank,positive regulation of ATPase activity (GO:0032781),0.4114285991916112,1.13055952299443,0.3011904761904762,0.8609719363444338,1.0,7/41,13.46%,MSH2;TOR1AIP2;TOR1AIP1;ATP1B3;DHX9;DYNLL1;CHTOP
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5294413097462418,1.1304923168902887,0.3284457478005865,0.860391570269563,1.0,3/11,9.96%,ATL1;VAPB;VCPIP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3572903881631809,1.130441656541541,0.19859578736208625,0.8597621003018345,1.0,63/259,16.87%,CNGB1;PMP22;CEP19;ATP6V0D1;BBIP1;RAB8B;CDH13;B9D2;SPATA13;ACTR2;S1PR2;CEP162;ACTN2;PARVB;RILP;CYFIP1;SNX10;RILPL1;TTC39C;CARMIL1;ARHGEF7;ACTR3;PIP5K1A;NPHP3;KIF3B;AIF1L;RAPGEF6;RAPGEF2;CCDC88A;MKS1;CFAP54;TNIK;FNBP1L;SPEF1;WDR35;CEP131;TMEM138;EXOC6;SRGAP2;FXYD5;GSN;DYNLT2B;FGD6;DYNLL1;NRP1;WHAMM;RAC1;DZIP1;TMEM67;PIBF1;MINK1;CFAP20;INPP5K;CCDC66;BBS2;ARF4;AIF1;RAB11A;OPHN1;CEP89;DYNC2H1;WDR19;OCRL
prerank,positive regulation of hydrolase activity (GO:0051345),0.3665289031993357,1.1298673044854914,0.2510330578512397,0.8609137983986483,1.0,39/137,21.16%,WNT11;CCL7;DOCK8;RGP1;SEMA4D;CD40;THY1;CCL5;CX3CL1;ARHGEF7;RAPGEF6;RAPGEF2;CTSH;RAP1GAP;AGRN;SNX9;CCL14;SRGAP2;RGS16;ARHGAP11A;RACK1;LIMS1;RIC1;RAPGEF1;ASAP3;EZH2;CALM3;SH3BP1;TBC1D2;NF1;FNTA;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,organelle transport along microtubule (GO:0072384),-0.32273122085270345,-1.1296981587474195,0.2268041237113402,0.9857668006957768,1.0,10/31,15.94%,TRAK2;BICDL1;NDE1;HTT;CDC42;TMEM201;FBXW11;UBB;RHOT1;CLN3
prerank,DNA replication checkpoint signaling (GO:0000076),0.4772861724490427,1.1296323114554587,0.3271428571428571,0.8608891349382637,1.0,3/16,6.00%,TIMELESS;TIPIN;CDT1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.49364977207249117,1.1291840313068418,0.33475783475783477,0.8616239042942775,1.0,4/14,9.93%,PNPT1;MRPL12;TFB2M;TWNK
prerank,regulation of oxidoreductase activity (GO:0051341),0.5077043145042794,1.1291753178771768,0.3261494252873563,0.8608352292541509,1.0,2/13,6.59%,NOD2;MT3
prerank,response to ethanol (GO:0045471),-0.4016513753821334,-1.1286307234633859,0.2781456953642384,0.9853700494733005,1.0,3/14,3.93%,GRIN2A;GRIN2B;GRIN1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3689589061625597,1.1285284718203767,0.2781875658587987,0.862248377578045,1.0,26/91,17.53%,DNAJC13;RAB8B;CDH13;RAB21;HCK;RAB12;CPLX1;SYT7;RAB11B;RAB5C;AP2S1;CHMP3;GAS1;MAP2K2;SCFD1;RINT1;VAMP2;NRP1;STON1;STX4;DENND10;RAB11A;OPHN1;STXBP5L;STON2;PTPRC
prerank,skeletal muscle tissue development (GO:0007519),0.4253388001682308,1.127903721863597,0.2971639950678175,0.86361083539774,1.0,2/32,6.10%,MYOZ2;CFLAR
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4253427806695713,1.127732859027708,0.317103620474407,0.8633880350163008,1.0,11/32,19.80%,ACTR2;CYFIP1;CARMIL1;ARHGEF7;ACTR3;CORO1B;RAC1;RREB1;PLCE1;CORO1C;NCKAP1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5318821087193767,1.1272359247850636,0.3430232558139535,0.8643163108041294,1.0,3/10,16.28%,ISG15;DIS3L2;TUT7
prerank,neutrophil activation (GO:0042119),0.5143329392627438,1.127041066708369,0.34620886981402005,0.8641815515858606,1.0,2/12,4.37%,IL15;CCL5
prerank,negative regulation of nervous system development (GO:0051961),0.4729536200308888,1.1270407140082939,0.3401360544217687,0.863373331149438,1.0,8/17,25.49%,B2M;SLIT1;SORL1;HOOK3;TLR2;APPL2;NOTCH1;TNF
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5033633519786154,1.1269299378105002,0.3398328690807799,0.8629369124044143,1.0,1/13,0.31%,CLTRN
prerank,negative regulation of histone modification (GO:0031057),0.49183750693832295,1.1268519928547367,0.3273231622746186,0.8624291938229576,1.0,5/14,19.06%,THAP7;AASS;SPHK2;CTBP1;SET
prerank,myelin assembly (GO:0032288),0.5360299984586634,1.1266093678691629,0.336322869955157,0.8624248896425293,1.0,3/10,8.22%,PMP22;CNTNAP1;EPB41L3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4532592070992904,1.1263947359775677,0.32671957671957674,0.8623934837543096,1.0,10/21,26.51%,EXT1;XYLT2;HPSE;EXTL3;HS3ST4;HS6ST1;XYLT1;HS6ST2;EXT2;GLCE
prerank,homotypic cell-cell adhesion (GO:0034109),0.41170391279088464,1.1262400826654726,0.3125,0.862129583519023,1.0,13/39,22.29%,CSRP1;ACTN1;MYL9;MEGF10;PPIA;MEGF11;TJP2;PIK3CB;ACTB;FIBP;MYH9;STXBP3;CLIC1
prerank,aminoglycan metabolic process (GO:0006022),0.528027907145921,1.1262330900478592,0.3432624113475177,0.8613511158087197,1.0,1/10,0.90%,XYLT2
prerank,nucleosome assembly (GO:0006334),0.42578370765239437,1.1261018313699358,0.32965686274509803,0.8609852009124066,1.0,6/31,10.56%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1
prerank,superoxide anion generation (GO:0042554),0.510236005950937,1.1260887341928267,0.34195402298850575,0.8602176258112176,1.0,2/13,4.69%,CYBB;TAFA4
prerank,regulation of transmembrane transport (GO:0034762),0.42969959017721343,1.1259262947566813,0.30566037735849055,0.8599539345661115,1.0,5/31,16.85%,CLTRN;TRIB3;PIM1;ACTB;KCNJ2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3526179962203853,1.1258208706642292,0.20724346076458752,0.8595531494531609,1.0,79/248,24.22%,WNT11;PSMB10;DAPK3;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;UBE2B;PRICKLE1;SOX9;PFDN5;CTNNB1;FGFR2;PSMA3;TCF7L2;NFKB1;TMEM9;NPHP3;SNAI2;BICC1;AMFR;CYLD;FRZB;PSMB9;DACT1;BAMBI;USP34;RBX1;KANK1;BTRC;DKK3;PSMD2;SCYL2;PSEN1;PSME3;APOE;LZTS2;PLEKHA4;DAB2;CTNND2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD9;STK3;PSMD8;PIN1;PSMF1;DDX3X;STK11;PSMB6;USP8;PSMD12;PSMC2;GLI3;SMURF2;RUVBL2;PSMD4;GPRC5B;CUL3;LIMD1;XIAP;CHD8;PSMA2;VCP;AXIN1;CAPRIN2;TLE5;KREMEN1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4737542882253723,1.125810112285576,0.3130081300813008,0.858804824500291,1.0,5/18,9.12%,TNFAIP1;ITGA3;MYOC;MET;KANK1
prerank,cation transport (GO:0006812),0.35858586351699123,1.1255050039368057,0.23732251521298176,0.85903310189593,1.0,20/167,13.09%,TRPM5;CATSPER4;CNGB1;KCNMB3;TRPM2;TRPM6;SLC18A2;LRP2;SLC8A1;PANX2;SLC11A2;KCNS3;SLC7A6;KCNA4;TRPM3;PANX1;ANO10;KCNK3;SCN2A;FGF13
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4183137691699802,1.1254935960546475,0.29064039408866993,0.8582671747804725,1.0,15/36,22.93%,BLZF1;GOLGA7;RILPL1;GGA3;AMN;NECTIN3;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;GORASP2;OPTN;RAB10
prerank,diol biosynthetic process (GO:0034312),0.4935540567608632,1.1254246751268828,0.32878581173260574,0.8577101274831702,1.0,6/15,18.47%,DHFR;ASAH2;SPHK2;GCH1;ACER3;SPTLC2
prerank,eye morphogenesis (GO:0048592),0.47016740035654925,1.125297135769151,0.31544502617801046,0.8573826638329598,1.0,4/19,7.88%,RARG;STAT3;FBN1;MFAP5
prerank,negative regulation of transport (GO:0051051),0.3979495503232825,1.1252059911094148,0.29954954954954954,0.8568690614179839,1.0,25/51,30.64%,NR1H2;BST2;SNX33;LRSAM1;RSC1A1;PPM1F;FCGR2B;RACK1;RUBCN;TLR2;SIRPA;MCTP1;ERBB3;ARL6IP5;SNX12;SYT11;NDFIP1;PTEN;PIP4P2;CTTNBP2NL;MTMR2;RAB7A;LILRB1;PRKD1;LGALS3
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.42365364436815933,1.125011252331275,0.3105076741440378,0.8567258529195939,1.0,10/35,15.94%,PLXNA3;PLXNB2;SEMA4D;NRP2;PLXNB3;MET;NRP1;RAC1;SH3BP1;SEMA3D
prerank,positive regulation of vasculogenesis (GO:2001214),0.5326731386295724,1.1245104919860538,0.327893175074184,0.8577013023464647,1.0,3/10,11.74%,KDR;RAPGEF2;RIN2
prerank,microtubule polymerization (GO:0046785),-0.3297348048610091,-1.1244959594670063,0.2679425837320574,0.996943684049191,1.0,16/28,28.50%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;HDGFL3;TUBGCP2;CCDC57;GOLGA2;TPX2;CLASP1;CKAP5;CSNK1D;MAP7D3;NDEL1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5085505004500966,1.1244751422471841,0.32794117647058824,0.8570348638803928,1.0,3/12,8.63%,CTSS;CTSH;LMO2
prerank,receptor recycling (GO:0001881),0.5384731272073304,1.1242479234181644,0.35259259259259257,0.8570079528400472,1.0,3/10,12.78%,RAB11B;SORL1;ARFGEF2
prerank,protein transport (GO:0015031),0.34868418518942534,1.123903372228346,0.19019019019019018,0.8573611443231847,1.0,92/332,19.92%,ZG16;ABCA1;BLZF1;CHMP1B;ABCG1;ARF3;CLU;TBC1D1;GOLGA7;ATP6V0D1;RAB8B;SNX33;ARRDC4;RAB21;LRP2;LAMP2;RAB12;RILP;AP2A1;STX7;LRSAM1;ARRDC2;HERC2;ARF5;GGA3;TMED5;KIF3B;VPS33A;IL10RA;TBC1D8;UNC93B1;RAB22A;RAB43;RAB11B;RAB5C;STX8;AMN;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;DNM2;VIPAS39;TMEM167A;RAB14;ARL1;CHMP3;RAB24;SCFD1;APOE;NEURL1B;CMTM6;RIC1;ARL5C;VAMP2;NAPA;NAPB;MYO6;STX4;FAM91A1;MIA2;TFR2;VAMP4;DENND10;BBS2;PREPL;ARF4;VPS26A;RAB32;TBCK;TCIRG1;SNX1;MTTP;TBC1D2;ATP6V1B2;TMED1;VAMP5;ATP6V1G1;TMED3;SLU7;COPB2;MYH9;SVBP;GOLPH3L;ATP6V1G2;RAB5B;RAB1A;SGSM1;TBC1D4;SGSM3
prerank,cellular response to amyloid-beta (GO:1904646),0.41640084573195096,1.1238953492603208,0.31286894923258557,0.8566003171390593,1.0,9/35,14.25%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,cardiac muscle cell differentiation (GO:0055007),0.464404875768667,1.123862833740279,0.3452054794520548,0.8559419239218462,1.0,4/21,13.24%,ACVR1;SLC8A1;SIK1;AKAP13
prerank,regulation of microtubule-based process (GO:0032886),-0.30443017724406846,-1.123809865521616,0.26519337016574585,0.994936905829925,1.0,9/36,11.95%,MACF1;ROCK1;MAP6;TPPP;MARK4;KLHL42;CLASP2;GSK3B;APC
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4130136088573459,-1.12366917560554,0.29180327868852457,0.9909194429973054,1.0,3/13,3.63%,ATP1B1;SLC12A2;ATP1B2
prerank,protein K48-linked ubiquitination (GO:0070936),0.39576131343809534,1.1235264787384989,0.29942857142857143,0.8562813558556875,1.0,10/54,9.60%,DTX3L;RNF4;BFAR;RNF5;UBE2B;UBE3A;AMFR;UBE2E3;RBX1;UBE2E1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3876291415761153,1.1235092155847743,0.3067552602436323,0.8555566117342702,1.0,21/63,22.25%,RGP1;STAT3;MT3;IL10RA;MET;LEPR;TIMP2;FOXK1;SORL1;RIC1;RUBCN;NELL1;EIF4G3;BMF;NRDE2;MTOR;ZKSCAN3;TAB3;TLK2;MCL1;RRAGA
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3810590287793025,-1.1232442139369376,0.2631578947368421,0.9880783724832273,1.0,8/17,22.55%,PPARG;PDCD4;TPM1;PRKG1;CDKN1A;CDKN1B;MEF2C;EFEMP2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4778250354050876,1.1226517438404757,0.3495702005730659,0.8577644554058759,1.0,7/16,17.98%,DDX5;HNRNPM;DHX9;RBM17;RSRC1;SLU7;SCNM1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3441304267293825,-1.12219399326085,0.25688073394495414,0.9877695068100378,1.0,5/22,8.56%,ROCK1;NCKAP1L;CRY2;PTPA;GSK3B
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.33336446622069416,-1.1221105534252165,0.25668449197860965,0.9835980353987303,1.0,14/30,24.01%,ARSB;CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DSEL;NDNF;DCN;BCAN;UGDH;CSPG5
prerank,tyrosine metabolic process (GO:0006570),0.5137144681216153,1.1219463106469743,0.33810888252148996,0.8593642456450239,1.0,1/11,4.40%,THAP4
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3914539931687608,1.121936370784006,0.3042986425339366,0.8586066702741006,1.0,21/54,22.64%,PAK1IP1;MDN1;RSL1D1;NOP53;LAS1L;RRS1;PPAN;NPM1;EIF6;NOP2;NOP16;RPL23A;RPL11;RPL10A;WDR12;RSL24D1;RPL24;RPL3;RPL5;RPL6;LTO1
prerank,ganglioside biosynthetic process (GO:0001574),0.49284978130327967,1.1211829906015465,0.3286118980169972,0.8603434573497114,1.0,4/15,9.76%,ST6GALNAC4;ST6GALNAC6;B4GALT5;ST3GAL1
prerank,regulation of protein binding (GO:0043393),0.3679876047068288,1.1210690094191997,0.28914405010438415,0.8599414036120756,1.0,23/114,14.03%,IFIT1;IFIT2;DTX3L;TRIB3;B2M;TRIM21;SLPI;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;LDLRAP1;MEN1;LRPAP1;SORL1;PSEN1;DDX11;RACK1;DAB2;ACTB;SPPL3
prerank,negative regulation of transferase activity (GO:0051348),0.4353226283070873,1.1208558675932203,0.3224592220828105,0.8598601416426783,1.0,7/28,15.07%,DTX3L;ZFP36;EIF4A2;ERCC4;MEN1;IRS2;INPP5K
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.43686718307980404,1.1203579663936607,0.3117206982543641,0.8607301356114774,1.0,5/26,9.26%,TGFA;FBXW7;SOCS5;APP;NCK2
prerank,response to ketone (GO:1901654),0.4433198802452862,1.1201820715020532,0.331151832460733,0.8605345304142022,1.0,4/24,11.17%,CATSPER4;ABHD2;UBE3A;SLIT3
prerank,endocardial cushion development (GO:0003197),0.4501747766272497,1.119755801690897,0.32793522267206476,0.861203181498892,1.0,6/21,23.31%,ACVR1;SOX9;BMPR2;BMPR1A;ACVRL1;NOTCH1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.48161107737087666,1.1196042292719692,0.3384615384615385,0.8609384526638296,1.0,7/16,14.97%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3929556429724894,1.1193022503273593,0.3094972067039106,0.8611652812073499,1.0,6/54,3.12%,EXT1;XYLT2;SDC3;HYAL4;SDC4;HAS1
prerank,apoptotic DNA fragmentation (GO:0006309),0.4721649256172127,1.1189258947227623,0.34965034965034963,0.8616184244246975,1.0,5/16,16.76%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,COPII-coated vesicle budding (GO:0090114),0.3822197475440887,1.1184910839595328,0.29637760702524696,0.8622592130442069,1.0,21/68,23.08%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;VAPB;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,response to thyroid hormone (GO:0097066),0.5013139931333608,1.1180428289569238,0.34553440702781846,0.8629875596767737,1.0,3/13,8.63%,CTSS;CTSH;LMO2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4834103212537174,1.1180271718990493,0.34146341463414637,0.8622502945257896,1.0,2/17,7.75%,NR1H2;LIPC
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4427464013696535,1.117837544821142,0.3502604166666667,0.8621179837078926,1.0,5/25,7.36%,PML;HSP90AB1;EPHA4;TRIM39;CSNK2A2
prerank,regulation of JUN kinase activity (GO:0043506),-0.3091752349673572,-1.1176444318409247,0.2621951219512195,0.9964238764937848,1.0,9/33,10.41%,PAK1;TRAF2;PDCD4;TRAF6;MAP3K11;PTPN22;DVL3;DAB2IP;MAPK8IP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49180669342821093,1.1172150477256155,0.3370165745856354,0.8634069432842703,1.0,3/14,9.50%,ACOXL;ECI2;ABCD1
prerank,organic acid transport (GO:0015849),0.36443957565015817,1.1169711127574355,0.28662420382165604,0.8634993303462503,1.0,14/94,9.40%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC46A1;NCOA1;SLC19A1;SLCO1B1;SLC38A3;SLC25A10;PDPN;SLC7A6
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.388348672029166,1.1169371033973132,0.32733408323959506,0.8628291428256387,1.0,6/57,2.15%,TNFSF10;ASPH;NOD1;AIM2;USP50;FIS1
prerank,cellular response to interleukin-7 (GO:0098761),0.4745379872479833,1.1168467821823973,0.3423545331529093,0.8616039245936349,1.0,5/17,14.43%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4745379872479833,1.1168467821823973,0.3423545331529093,0.8616039245936349,1.0,5/17,14.43%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.49610771334011394,1.1167150153803935,0.34626436781609193,0.8612688852998337,1.0,7/13,25.76%,SNX33;HSP90AB1;STX4;TYROBP;TM9SF4;TNF;TMEM35A
prerank,response to unfolded protein (GO:0006986),0.3937263701169011,1.1166154348384711,0.3313885647607935,0.860815017501428,1.0,15/48,21.23%,HSPA1B;DAXX;ERP44;HSP90AB1;DNAJB4;HSPA8;HSPA4;HSPB3;HSP90AA1;DNAJC4;BAX;HSPA14;STT3B;ERN1;OPTN
prerank,cellular response to oxygen-containing compound (GO:1901701),0.35118547629764085,1.1163435513202575,0.22322322322322322,0.8609684411663898,1.0,53/291,16.94%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;BRINP3;DHX36;RRAGC;SOX9;PDXP;NFKB1;WNT7B;MT3;RET;RAPGEF2;LTK;LYN;P2RX4;HMGB1;RORA;MAPK14;GIT1;ZC3H12A;SNW1;ZFP36L1;GLRA2;XBP1;STAP1;AKAP9;LCOR;LAMTOR3;ZNF35;RAPGEF1;SHMT1;ACTB;TNIP2;MYD88;INPP5K;ERCC6L2;ADNP2;TLR2;TNIP3;MTOR;IRAK1;UPF1;ACOD1;PDE3A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3882688579370593,1.1162679505111357,0.29379157427937913,0.8604421528758764,1.0,14/63,17.53%,CD274;IL15;CD40;CCL5;CD276;NFATC2;NCK1;NCK2;CCDC88B;IRS2;CHRNB2;AIF1;IL18;PTPRC
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4107653208821365,1.1156965831906016,0.3146341463414634,0.8616138810052106,1.0,14/37,23.10%,NOD2;GBP5;STAT3;ABCD1;MAPK14;ZC3H12A;IL17D;CHID1;MYD88;SIRPA;PER1;APPL2;PLD3;ADCY7
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.39363799699117186,-1.1155812434781025,0.30716723549488056,1.0,1.0,3/15,11.84%,UBR3;TGFB2;BRCA1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4274561229982129,-1.1155385797322088,0.3270440251572327,0.9957783366536491,1.0,4/12,6.15%,ATP1B1;DMD;ATP1B2;ANK3
prerank,positive regulation of bone mineralization (GO:0030501),0.42046525226266296,1.1155368014079372,0.32709113607990015,0.8613715935325678,1.0,7/35,15.05%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A
prerank,regulation of cell-matrix adhesion (GO:0001952),0.38810377102610855,1.115492013531251,0.2987598647125141,0.8607676858572898,1.0,16/64,19.12%,DAPK3;UTRN;CDH13;THY1;PEAK1;DUSP3;CX3CL1;CSF1;MYOC;CIB1;LDB1;PIK3CB;MINK1;NF1;CORO1C;TSC1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.439097646138821,-1.115321432030572,0.3074433656957929,0.9922524775275305,1.0,3/11,9.02%,EPN1;E2F2;SEMA6A
prerank,regulation of hormone secretion (GO:0046883),-0.3889856401695609,-1.11531376563753,0.3,0.9879178950889157,1.0,4/15,21.01%,SCG5;VAMP3;ANXA1;OSM
prerank,regulation of programmed necrotic cell death (GO:0062098),0.46507691779831956,1.1152116427504644,0.3545816733067729,0.8609445833203438,1.0,10/20,22.84%,BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37;STUB1;PELI1
prerank,glial cell development (GO:0021782),0.4404441305694634,1.1151233958203968,0.32858990944372574,0.8604929410349226,1.0,9/25,18.98%,MT3;EIF2B2;MXRA8;APP;TLR2;MDK;NF1;EIF2B5;EIF2B3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3733098430759012,1.1145826230058296,0.31646932185145316,0.8615354833355627,1.0,19/72,20.56%,POLR2G;HNRNPH1;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;RAB14;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;SPRED1;HNRNPF;FGFRL1
prerank,response to axon injury (GO:0048678),0.46153933311924356,1.1145798601809014,0.34354194407456723,0.8607803633555666,1.0,4/18,9.00%,DHFR;GAP43;MAPK8IP3;P2RX4
prerank,positive regulation of interleukin-17 production (GO:0032740),0.45639472129127295,1.1145652546937848,0.3276762402088773,0.8600666340388565,1.0,2/22,0.94%,IL15;NOD2
prerank,postsynaptic membrane organization (GO:0001941),-0.38230370285351717,-1.1144954418183175,0.28523489932885904,0.9869174636314954,1.0,5/17,8.86%,DLG4;NRXN2;NLGN2;NRXN1;SHANK3
prerank,pre-replicative complex assembly (GO:0036388),0.38200137603345463,1.113889025471625,0.30965593784683687,0.8615229238176267,1.0,23/64,22.73%,PSMB10;PSME2;MCM2;PSMA5;PSME4;MCM7;MCM4;CDT1;PSMA3;PSMB9;PSMD2;PSME3;ORC3;PSMA4;PSMD7;PSMD9;PSMD8;ORC1;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4615518249868426,1.1138651575805272,0.3280212483399734,0.8608320119081312,1.0,5/20,16.18%,MOV10;AGO2;CNOT7;EIF6;NRDE2
prerank,negative regulation of cell migration (GO:0030336),0.3565143741114339,1.113729224534599,0.2930856553147575,0.8605204510005288,1.0,36/137,22.01%,WNT11;BST2;CLIC4;HAS1;THY1;SFRP2;PLXNB3;EVL;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;COL3A1;MITF;SRGAP3;SRGAP2;DUSP10;RAC1;BMPR1A;MCC;PTPRU;NF1;DACH1;CORO1C;STK24;SINHCAF;RAP2A;ACVRL1;ADIPOR1;MCTP1;CITED2;FGF2
prerank,regulation of adaptive immune response (GO:0002819),0.4671630409287977,1.1136622886404992,0.34986595174262736,0.8599957138801207,1.0,1/18,0.14%,IRF7
prerank,cell-matrix adhesion (GO:0007160),0.37236705849694535,1.113478541948113,0.285563751317176,0.8598369583465792,1.0,21/95,17.43%,SIGLEC1;COL13A1;ITGA2;ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;ITGA3;PIP5K1A;ITGB8;MKLN1;HPSE;COL3A1;WHAMM;RAC1;ADAMTS12;TAOK2;NID2;BCR;ITGA4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5382016912740868,1.1133808761134516,0.34285714285714286,0.8593863442445466,1.0,3/10,15.74%,CD40;LYN;BTLA
prerank,regulation of histone acetylation (GO:0035065),0.4197648608931481,1.1131223530135743,0.3366093366093366,0.8595043672039813,1.0,11/33,19.06%,THAP7;CHEK1;KMT2A;TADA2A;TADA2B;SETD5;PPARGC1A;PAXIP1;BRD7;CTBP1;SET
prerank,regulation of amyloid-beta formation (GO:1902003),0.41354857538071793,1.1122461233342986,0.3105590062111801,0.8616600139079734,1.0,9/34,12.38%,ABCG1;CLU;EPHA4;GGA3;PRNP;TMED10;SORL1;LRRTM3;APOE
prerank,fatty acid biosynthetic process (GO:0006633),0.3792717262031898,1.1116715953348963,0.3164277839029768,0.8627779511509155,1.0,16/63,21.21%,MCAT;ABHD2;ASAH2;DEGS1;FADS3;LIPC;SCD5;ABCD1;XBP1;HACD3;EPHX2;ABHD3;OXSM;GPX4;ELOVL4;DECR2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4140857142891109,1.110662141211724,0.33251231527093594,0.8654094585625222,1.0,16/33,28.71%,IRS1;PIK3CD;LTK;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;NYAP2;NF1;ERBB3;PIK3CA;SIRT2;PTEN;PIK3R5;HTR2B;PIK3R1
prerank,negative regulation of cell projection organization (GO:0031345),0.3948422827249174,1.110307999763973,0.32606199770378874,0.8658240812016137,1.0,16/48,17.89%,SPRY2;EPHA4;MT3;RAPGEF2;PAQR3;KANK1;PRNP;CIB1;MAG;APOE;TRPV4;MYLIP;FYN;PTPN9;STMN2;ITM2C
prerank,ubiquinone metabolic process (GO:0006743),0.4776458588073983,1.1102577488120513,0.3564493758668516,0.8652217600297314,1.0,3/15,6.34%,COQ2;COQ10B;COQ3
prerank,rRNA methylation (GO:0031167),0.453101191051239,1.1101617875070349,0.3577981651376147,0.8647410330931579,1.0,9/22,20.26%,MRM2;MRM3;ZCCHC4;TFB2M;DIMT1;NOP2;METTL15;BUD23;EMG1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4910940314608634,1.1098036357201861,0.34225352112676055,0.8651463603837279,1.0,3/15,12.38%,ABCG1;LIPC;APOE
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3642332898337835,1.1095815728689513,0.3220338983050847,0.8651487217431206,1.0,34/94,22.84%,NOD2;PSMB10;NOD1;SKP1;PSME2;PSMA5;PSME4;MAP3K8;PSMA3;NFKB1;PSMB9;RBX1;BTRC;PSMD2;IRAK4;PSME3;ST18;IL1RAP;PSMA4;TNIP2;MYD88;IRAK1;PSMD7;PSMD9;UBE2V1;PSMD8;TAB3;RIPK2;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PELI1
prerank,snRNA processing (GO:0016180),-0.38407696524413387,-1.109548115041392,0.32131147540983607,1.0,1.0,8/16,30.25%,INTS10;INTS12;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.35286046262510384,1.1092141220917602,0.27579162410623087,0.8655678999881936,1.0,38/172,16.87%,ETNK1;ETNK2;ARF3;CPNE3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PCYT2;PITPNM1;SBF1;AGPAT5;PIP5K1A;ABHD8;CSNK2B;CSNK2A2;LPIN2;CEPT1;LPCAT2;PIK3R4;PI4KB;GNPAT;DGKB;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;ABHD3;INPP5K;MTMR14;CHPT1;DGKA;OCRL
prerank,regulation of cell cycle process (GO:0010564),0.3662098903281068,1.109085243107416,0.3043933054393305,0.8652148045808128,1.0,28/104,19.54%,PKMYT1;DAPK3;DYNC1H1;CHEK1;TIPIN;SOX9;CTNNB1;PRPF40A;PDXP;CUL7;SH3GLB1;CSNK2A2;KLHL13;YTHDF2;ZFYVE26;PIK3R4;PLK3;GIT1;KLHL9;AHCTF1;CALM3;NUDT16;RAB11A;BIRC6;NUMA1;UVRAG;BECN1;PIN1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3415143336688736,-1.108914625257217,0.29515418502202645,0.9991343472422303,1.0,7/23,12.06%,INPP5F;MTMR4;MTMR1;INPP5B;MTMR9;SYNJ2;MTMR10
prerank,negative regulation of centrosome duplication (GO:0010826),0.503597706730281,1.1089098024217083,0.3398496240601504,0.8650629267671917,1.0,6/11,23.88%,RBM14;CDK5RAP2;NPM1;TMEM67;MDM1;KAT2B
prerank,glutamate receptor signaling pathway (GO:0007215),-0.2936852766076966,-1.108795013050229,0.2246376811594203,0.995336520423598,1.0,7/37,6.08%,GRM3;GRIN2A;GRIN2B;GRIK1;GRIN1;HOMER1;HOMER3
prerank,positive regulation of lipid localization (GO:1905954),0.5169308553433816,1.1087684382134455,0.3323615160349854,0.8648036623341534,1.0,3/11,10.62%,IKBKE;NFKB1;ZC3H12A
prerank,macrophage activation involved in immune response (GO:0002281),0.48709694816693505,1.1085391949239338,0.35520684736091296,0.8648150569798633,1.0,2/13,2.96%,IFI35;NMI
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5116824018790209,1.1084618194953018,0.35365853658536583,0.8643275532452971,1.0,2/10,6.59%,GRB10;MT3
prerank,positive regulation of transport (GO:0051050),0.37159146658355074,1.1083431323064703,0.3241525423728814,0.8639430318185783,1.0,17/85,17.19%,IL15;SGK2;IL15RA;CD47;DYNC1H1;CHCHD10;KMT2A;TUB;MLC1;APOE;FCGR2B;DAB2;ACTB;TFR2;INPP5K;BAX;CBLL1
prerank,collagen fibril organization (GO:0030199),0.36589003015383814,1.1081620404915644,0.30728051391862954,0.8637658844416357,1.0,15/88,12.55%,LOXL2;COL13A1;P4HA1;ADAMTS3;COL9A1;COL4A2;COL14A1;P3H1;COL5A3;COL8A1;COL22A1;SCX;COL3A1;ADAMTS2;COL11A2
prerank,negative regulation of programmed cell death (GO:0043069),0.34914233632468905,1.1080375711943629,0.187,0.8634365477904214,1.0,53/355,12.48%,IFIT3;NOL3;AXL;HSPA1B;WNT11;WNT5A;SPRY2;COMP;KDR;BIRC2;DDRGK1;KLHL20;SEMA4D;LRP2;ANKLE2;FXN;BFAR;HCK;CCND2;CX3CL1;SOX9;HNRNPK;CTNNB1;AREL1;MYDGF;CFLAR;TMBIM4;NFKB1;MT3;TFAP2B;ATAD3A;HTATIP2;CTSH;LTK;MET;GDNF;BARD1;PDPN;SCX;PLK3;PHIP;CIB1;NPM1;NUAK2;XBP1;PIM1;CBX4;NAA35;BAG1;ARHGAP10;PSEN1;PRKDC;SOCS2
prerank,oligodendrocyte development (GO:0014003),0.47948910622694185,1.1079922712539758,0.3495702005730659,0.862850939770603,1.0,6/15,19.87%,CNTNAP1;EIF2B2;B4GALT5;EIF2B5;EIF2B3;PLP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.46767118265540575,1.1077468538727064,0.3310719131614654,0.8629161641766334,1.0,3/16,5.43%,TRIB3;ACADL;SOX9
prerank,negative regulation of leukocyte activation (GO:0002695),0.47164990046964267,1.107449979886909,0.3638968481375358,0.863175095030811,1.0,6/15,18.74%,ZC3H12A;HAVCR2;FCGR2B;CD84;CD300A;CD300LF
prerank,negative regulation of cellular process (GO:0048523),0.34338030942269454,1.1070736899265574,0.151,0.8636697800190131,1.0,79/521,13.25%,IFIT3;SP100;EIF2AK2;HSPA1B;WNT11;PML;CHMP4B;NR1H2;ESR2;BST2;PLXNA3;HYAL1;IFI35;PLXNB2;ZBTB17;CLU;RARG;TNFRSF8;ACTN1;SEMA4D;SOD2;CDH13;NMI;AQP11;SFRP2;GNG4;PLXNB3;TMEM115;CNOT7;CDKN2D;OSGIN1;SERTAD3;CHERP;CTNNB1;PPP2R5C;P3H1;BCL6;PODXL;MT3;TFAP2B;TMIGD3;CSNK2B;MAGI2;TMEM98;FRZB;RAPGEF2;ST7L;ARID2;NCK1;LYN;PDPN;APP;NCK2;ROR2;ALDH1A2;MEN1;BMPR2;SPHK2;LRPAP1;PROX1;SPEF1;EI24;CIB1;NPM1;CDK10;DNAJA3;CTCF;NOTCH4;SLIT3;SRGAP2;KLF10;THAP12;SERTAD2;RB1;ENPP1;FCGR2B;RACK1;CGREF1;APBB1
prerank,microglial cell activation (GO:0001774),0.45689188891980764,1.1069381348196434,0.34469200524246396,0.8633697167905279,1.0,7/21,20.38%,CLU;CX3CL1;APP;JAK2;AIF1;TYROBP;IFNGR1
prerank,response to chemokine (GO:1990868),0.49310374584432154,1.1068191323798406,0.342143906020558,0.8630129579256561,1.0,5/13,16.66%,DOCK8;ZC3H12A;LRCH1;OXSR1;STK39
prerank,negative regulation of cellular component organization (GO:0051129),0.3762939712396012,1.1068002045993377,0.3187294633077766,0.862324217497129,1.0,15/74,13.20%,HSPA1B;SPRY2;CLU;SNX33;NOP53;CARMIL1;LRSAM1;RTEL1;HSPA8;DNAJB6;RIOK3;DNM2;SORL1;SVIP;RUBCN
prerank,cellular response to calcium ion (GO:0071277),0.3793592260131053,1.1065726573457941,0.3155021834061135,0.862306481047475,1.0,10/67,10.85%,CAMK2D;CLIC4;RASA4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5161999562042923,1.106476665561743,0.34328358208955223,0.8618728801576258,1.0,4/11,19.98%,LYN;FCGR2B;CD300A;TYROBP
prerank,regulation of filopodium assembly (GO:0051489),-0.2983460710394755,-1.1062656167953804,0.30718954248366015,1.0,1.0,11/38,11.26%,MYO10;WASL;DPYSL3;ARHGAP44;PPP1R16B;FXR2;CDC42;RHOQ;DMTN;PALM;GPM6A
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4245188360290508,1.1061083964348886,0.3525,0.8623747680422164,1.0,5/27,11.45%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,O-glycan processing (GO:0016266),0.3886520798541305,1.1060059096512593,0.341545352743561,0.8619668868370342,1.0,12/54,19.24%,ST6GALNAC4;GALNT15;GALNT7;ST6GAL1;GCNT4;B4GALT5;ST3GAL1;XXYLT1;GALNT1;GXYLT1;GALNT13;GALNT14
prerank,long-term synaptic potentiation (GO:0060291),-0.3500647710414857,-1.1058883019870898,0.2863636363636364,0.9978507082412338,1.0,6/21,8.20%,GRIN2A;GRIN2B;PRKCZ;TSHZ3;RGS14;SLC8A3
prerank,negative regulation of reproductive process (GO:2000242),-0.36467963594361,-1.1055746000948372,0.326007326007326,0.9948243860362144,1.0,4/17,7.93%,SULF1;PAEP;ARHGDIB;WDR77
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4268060325566257,1.1055690319278741,0.3556701030927835,0.862730003951829,1.0,7/28,15.07%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,embryonic organ development (GO:0048568),0.38300597205097986,1.1054567643857018,0.3281423804226919,0.862378527461293,1.0,9/61,8.82%,COL13A1;KDR;TEAD2;KITLG;KMT2A;FGFR2;WNT7B;TBC1D23;GDNF
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4220753199417945,1.1052715406441018,0.3399503722084367,0.8622118944476707,1.0,3/29,1.61%,NOD2;FLT1;IRS1
prerank,macroautophagy (GO:0016236),0.36036324343384085,1.1047635293775508,0.30520833333333336,0.8631293913732961,1.0,28/118,16.79%,CHMP4A;CHMP4B;ILRUN;MVB12A;LAMP2;VPS33A;NBR1;CSNK2B;LIX1;RUBCNL;CSNK2A2;TOMM5;VPS37A;PIK3R4;PRKAG1;UBQLN1;EI24;VIPAS39;CHMP3;VPS28;MAP1LC3B;DYNLL1;VTI1B;RB1CC1;HGS;MTMR14;TCIRG1;TOMM40
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3885472166538252,1.104741097465134,0.33916083916083917,0.8624596185590021,1.0,10/47,12.38%,AGT;NR1H2;TCOF1;CYFIP1;NFKB1;CSF1;NOLC1;APP;PUM3;APOE
prerank,DNA replication (GO:0006260),0.36290526113502636,1.1046878970411536,0.31027253668763105,0.8618803004115818,1.0,20/105,9.97%,MCM2;TIMELESS;POLE2;POLD4;MCM7;CHEK1;TIPIN;RNASEH2A;MCM4;POLG2;POLB;RFC4;RFC1;MCM9;BRIP1;RPAIN;FEN1;BARD1;WDHD1;PTMS
prerank,DNA-dependent DNA replication (GO:0006261),0.35538048960524676,1.1043901029993481,0.2826530612244898,0.8621393667772428,1.0,43/128,23.83%,PSMB10;PSME2;MCM2;LRWD1;PSMA5;POLE2;PSME4;POLD4;MCM7;MCM4;POLG2;POLB;RFC4;RFC1;CDT1;PSMA3;RPAIN;PSMB9;WDHD1;TWNK;PSMD2;PSME3;ORC3;GINS2;PSMA4;RECQL5;DDX23;GINS4;PSMD7;PSMD9;PSMD8;PRIM1;ORC1;PSMF1;GINS3;PSMB6;PSMD12;PSMC2;SSBP1;PSMD4;POLG;PSMA2;TEFM
prerank,phosphate ion homeostasis (GO:0055062),0.5222668595265263,1.104018186267615,0.3672566371681416,0.8626260184694401,1.0,2/10,12.91%,TFAP2B;ENPP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3973153679185068,1.103968261247519,0.34213685474189676,0.8620591782586509,1.0,10/40,16.95%,LOXL2;CTNNB1;TCF7L2;SMAD2;BAMBI;PDPN;DAB2;EZH2;MTOR;MDK
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3489728791352747,1.1039207960111204,0.27134146341463417,0.8614744788845099,1.0,62/190,24.87%,STAT1;IFI35;XDH;TRIB3;NMI;OTUD3;UBE2B;NOP53;ITPR1;DUSP3;PPP2R5C;TRIM39;MAP2K3;MAGI2;CYLD;TSPAN6;LYN;RORA;MAPK14;ARRB2;TNIP1;CIB1;RIOK3;ZC3H12A;ARHGAP25;PLEKHA1;RTKN2;DDIT4;AKT1S1;RACK1;PIK3CB;UACA;INPP5K;SH3BP1;TNIP3;PDE3A;PHLDA3;NF1;SPRED1;MGRN1;RFFL;NPRL2;TSC1;NPRL3;TANK;PER1;DDX3X;PLAUR;ADIPOR1;MAPKBP1;MCL1;RHOH;UBR2;CD22;BCL2L2;LIMD1;CGNL1;UBR1;USP10;CD2AP;PHLPP2;FNIP1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.45444363154303974,1.1038082036744374,0.34395750332005315,0.8611507142771727,1.0,2/19,0.90%,EXT1;XYLT2
prerank,protein localization to microtubule organizing center (GO:1905508),0.47595028017349794,1.1037775833128127,0.3475274725274725,0.860513963715538,1.0,9/15,27.47%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;BBS4;CEP83;CEP192;CCDC14
prerank,protein targeting to ER (GO:0045047),-0.2414544567568893,-1.1036616555323338,0.17777777777777778,0.9979559641703896,1.0,36/99,18.92%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;SGTB;RPS17;RPL8;RPL21;GET3;SPCS3;RPL31;RPL36A;RPLP2;SEC61G;SEC61A1;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;SRPRB;RPL38;RPL34;RPL18
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.40641639254014106,1.1036557076671218,0.3528693528693529,0.8601787648339962,1.0,14/35,26.60%,SOCS1;CCL5;IL10RA;LEPROT;IL10RB;JAK2;HGS;PTPRC;ADIPOR1;NOTCH1;CRLF3;OCIAD1;TNF;DOT1L
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4473306270050324,1.103628859390255,0.36675461741424803,0.8595285735845372,1.0,7/21,20.02%,DHX36;SRF;MED12;MITF;PAXIP1;MED16;MED24
prerank,positive regulation of cellular respiration (GO:1901857),-0.4285479627373406,-1.1035571352630005,0.3413173652694611,0.9941637113177029,1.0,3/11,6.64%,PINK1;ISCU;IFNAR1
prerank,protein processing (GO:0016485),0.36509999776209817,1.1035560955864419,0.3050314465408805,0.8590703691475883,1.0,20/102,16.62%,CASP4;CTSS;PRSS12;ADAMTS3;MMP14;FXN;LONP2;CTSH;AEBP1;PCSK7;KLK1;SPCS1;PSEN1;PITRM1;PTCH1;SPPL3;APH1A;APH1B;SPRTN;METAP2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4535496807446588,1.1035167513781248,0.35834411384217335,0.8584690527324128,1.0,7/22,17.04%,THY1;DUSP3;SH2D1A;PRNP;FCGR2B;CD300A;UBASH3A
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5063400708446238,1.1030127146099533,0.36470588235294116,0.85937024405645,1.0,4/11,20.99%,SOCS1;LEPROT;HGS;ADIPOR1
prerank,regulation of cilium movement (GO:0003352),0.5222544473197238,1.1028281187202646,0.3583815028901734,0.8592431317583172,1.0,2/10,5.18%,ODAD2;CCDC40
prerank,organic substance transport (GO:0071702),0.35689981561652107,1.102577558963448,0.3153526970954357,0.8593480825809097,1.0,19/121,13.28%,ZG16;ABCA1;CHMP1B;ABCG1;SLC18A2;ARRDC4;LRP2;ATP8A1;RILP;SLC19A1;ARRDC2;SLCO1B1;ABCB9;SLC35F3;ABCD1;AMN;CHMP3;CMTM6;VAMP2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4634102922955671,1.1024572260159118,0.357429718875502,0.858988704408709,1.0,8/18,23.51%,FLT1;SIRT6;HMGB1;MDK;ITGA4;FGF2;AKT3;PDPK1
prerank,gliogenesis (GO:0042063),-0.39251048444072784,-1.1021902473293486,0.32936507936507936,0.9951295350094428,1.0,6/15,22.42%,CDH2;TGFB2;METTL3;CD9;ANXA1;METRN
prerank,rRNA modification (GO:0000154),0.4580166865951133,1.1018300519319972,0.375,0.8602441872203941,1.0,5/21,10.00%,MRM2;ZCCHC4;TFB2M;GAR1;DIMT1
prerank,bile acid biosynthetic process (GO:0006699),0.43374321259296067,1.1017245243118179,0.33806451612903227,0.8598499278197502,1.0,8/24,20.69%,OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;OSBPL2;CYP39A1
prerank,regulation of intracellular protein transport (GO:0033157),-0.31471729798419296,-1.1016514622221407,0.26256983240223464,0.9930326597569195,1.0,9/32,12.90%,TGFB1;OAZ2;SIRT7;OAZ1;PCM1;GCC2;KIF20B;ZFAND1;RIPOR1
prerank,positive regulation of autophagy (GO:0010508),0.3662561388196434,1.1016406320303411,0.33512931034482757,0.8594055510116754,1.0,14/81,13.15%,IRGM;TRIM14;KDR;FBXO7;TRIM21;LARP1;SH3GLB1;HMGB1;PLK3;WAC;ZC3H12A;SVIP;PIK3CB;BAD
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.3744615000202151,-1.10132036382908,0.3029197080291971,0.9902299831871411,1.0,3/15,19.04%,QDPR;KMO;IL4I1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3931463179134017,-1.1007806756295224,0.3125,0.9882655040802054,1.0,4/14,13.94%,TMBIM6;SELENOS;HERPUD1;CREB3
prerank,lipid biosynthetic process (GO:0008610),0.369805781885663,1.100673010957919,0.3261802575107296,0.8617670298937948,1.0,18/77,20.74%,MCAT;PCYT2;AGPAT5;PIP5K1A;ACSL5;LIPC;FDFT1;SCD5;GNPAT;XBP1;DHRS11;GGPS1;PAM;SREBF1;ACSS2;OXSM;ELOVL4;SRD5A1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4402811779228892,1.1006314053014716,0.3437908496732026,0.8611882819429284,1.0,13/24,27.30%,FBXW7;CTNNB1;TFAP2B;PRNP;BAX;NF1;TYROBP;MCL1;TNF;CDK5R1;SRPK2;GRN;CDK5
prerank,photoperiodism (GO:0009648),0.4210755524460386,1.1005261668209056,0.3516209476309227,0.8608021540269182,1.0,5/28,11.45%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,primary neural tube formation (GO:0014020),0.4216656701163157,1.1000248154615164,0.3548795944233207,0.8617385032939336,1.0,4/30,5.34%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.37479362573462144,1.0998563437151614,0.3225108225108225,0.8615759122058856,1.0,10/65,8.26%,AGT;SPRY2;CDH13;TGFA;MVB12A;DOK1;DUSP3;ARHGEF7;WDR54;CCDC88A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49812084878241836,1.0997834596991864,0.3633633633633634,0.8611011670225636,1.0,3/12,7.13%,KLF15;PODXL;MAGI2
prerank,protein-containing complex assembly (GO:0065003),0.3470514416229549,1.0996686409053293,0.2660642570281124,0.8607408101104976,1.0,46/259,13.76%,NOL3;PML;TRAPPC3;SKP1;AIM2;GPAA1;TEAD2;CD40;TGFA;RBBP5;LAMC1;MDN1;CHCHD10;SEC16A;TSPAN4;CX3CL1;TAPBP;SOX9;CTNNB1;GOSR2;KMT2A;CNIH3;TCF7L2;SKAP2;SEC24D;DET1;CSNK2B;CTSC;DHX9;PPP6R3;CAND1;SEC23A;RBX1;MNAT1;MEN1;TMED10;SNX9;SAMM50;ZC3H12A;MITF;SCFD1;PPARGC1A;BAD;VAMP2;PYGO1;NAPA
prerank,programmed necrotic cell death (GO:0097300),0.46881957695230503,1.0994761026716924,0.35555555555555557,0.8606736246608339,1.0,6/18,17.23%,ALKBH7;MLKL;CYLD;ITPK1;TRPM7;TLR3
prerank,stress-activated MAPK cascade (GO:0051403),0.38376199102416414,1.0993935493116025,0.3333333333333333,0.8602268697651743,1.0,21/61,22.02%,NOD2;NOD1;SKP1;ZFP36;MAP3K8;PTGER4;NFKB1;MAP2K3;MAPK14;BTRC;ZFP36L1;MINK1;TNIP2;TAOK2;IRAK1;LGALS9;UBE2V1;TAB3;RIPK2;MAP4K2;MAPK9
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.503368990499039,1.0989624645480618,0.3735632183908046,0.860935741485462,1.0,5/12,17.53%,RUNX1;LYN;CD300A;ELF1;PTPRC
prerank,protein K48-linked deubiquitination (GO:0071108),0.4420384055349298,1.098801100193071,0.3465982028241335,0.8607721227253442,1.0,9/23,21.61%,USP50;USP25;OTUD3;USP34;VCPIP1;USP37;USP5;USP8;USP33
prerank,positive regulation of histone methylation (GO:0031062),0.4297422148453715,1.0984990020823475,0.3449612403100775,0.8610201852791667,1.0,8/24,14.97%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;CHTOP;MYB
prerank,regulation of osteoblast differentiation (GO:0045667),0.36700598984474314,1.0983750158766368,0.33653846153846156,0.8607043993972057,1.0,16/82,15.05%,SEMA4D;ACVR1;DDX5;ZHX3;SOX9;FGFR2;WNT7B;SNAI2;NBR1;BAMBI;MEN1;BMPR2;NELL1;PTCH1;RANBP3L;BMPR1A
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3396826573576202,1.0974116877895166,0.143,0.863189738474439,1.0,158/807,16.79%,STAT1;SP100;IRF7;PARP9;WNT11;MYOZ2;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;IRF2BP1;ESR2;TRIB3;WNT5A;MYBBP1A;TFAP2C;PER2;DAXX;PRMT2;ZFP36;RARG;NFX1;TIMELESS;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;DDX5;SFRP2;ELK3;MTA3;CGGBP1;RUNX1;PCGF6;MAD2L2;ID3;NACC1;BHLHE40;EID2B;ZHX3;NKX6-2;CIC;ILF3;NOP53;GATAD2A;CNOT7;MZF1;PRICKLE1;SOX9;PFDN5;CTNNB1;CCND1;MBD2;FGFR2;IGBP1;BCL6;TCF7L2;SMARCC2;SMARCE1;NFKB1;ZBTB38;BACH1;DDX20;MT3;TFAP2B;SNAI2;SAP30;ETV6;MDFIC;MTA2;SMAD2;GLIS3;DACT1;SIRT6;DNMT3A;NONO;AEBP1;AASS;HMGB1;PLK3;PEX2;MEN1;HSPA8;RING1;BPTF;NR2C1;PROX1;NCOA5;COMMD7;BTRC;DUSP26;PPM1F;FOXK1;MAX;DKK3;DNAJA3;CTCF;SNW1;NOTCH4;ZBTB5;NAB1;SETDB2;HCFC2;TFDP2;TAF3;MITF;SKIL;CBX4;MDFI;CUX1;KLF10;ZNF423;NKAP;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;ATXN1;MIER1;LIMS1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;IKZF1;ZMYND15;DLG1;KDM8;MYPOP;EZH2;SOX2;RREB1;RBM15;MYB;POU6F1;INPP5K;PRDM11;ERF;GTF2IRD1;MEF2A;RCOR3;PPARD;GCLC;ZBTB4;RBPJ;BRD7;DICER1;KAT8;BAHD1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.49369843574355227,1.0973783817530158,0.3751783166904422,0.8625826468999813,1.0,7/13,27.39%,CDK5RAP2;XRCC3;ANAPC15;GEN1;NDC80;DYNC1LI1;MAD2L1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.35370610898906235,-1.0971793031960717,0.3168724279835391,0.9982530956642148,1.0,4/20,7.72%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.42011993064597614,1.0971114722605244,0.3444857496902107,0.8627181400049457,1.0,3/31,1.93%,HSPA1B;DAXX;UBE2W
prerank,histone H3 acetylation (GO:0043966),0.40030964779438244,1.097098136968549,0.34813084112149534,0.8620448649310696,1.0,17/40,24.70%,JADE3;BRD1;KAT14;TADA2A;SUPT7L;WDR5;LDB1;BRPF1;SGF29;KAT7;PER1;ING5;TADA1;KAT6A;KAT2B;JADE2;YEATS2
prerank,regulation of neuron differentiation (GO:0045664),-0.25498472570417285,-1.0967708719040505,0.2222222222222222,0.9955574222325486,1.0,24/76,22.48%,IMPACT;ZFHX3;ZFHX2;ROCK1;ALK;MOSMO;BIN1;REST;BRINP1;MMD2;ID2;RHOA;ARHGEF2;BRINP2;NRCAM;HOXD3;ZC4H2;ECT2;NBL1;CDK5RAP3;NREP;MEF2C;TCF3;DISP3
prerank,striated muscle tissue development (GO:0014706),0.4192857228990219,1.096248729973448,0.3412204234122042,0.8639872405030553,1.0,3/29,9.69%,MYOZ2;CFLAR;BMPR2
prerank,regulation of protein secretion (GO:0050708),0.35463683902391374,1.0962210615259291,0.3267429760665973,0.863333189315998,1.0,16/119,13.25%,RSAD2;PER2;ABCG1;ADAM8;CCL5;ITPR1;P3H1;TFAP2B;SYT7;KCNS3;PPIA;CACNA1A;TMED10;RHBDF2;APOE;APBB1
prerank,cartilage development (GO:0051216),0.38972990398413054,1.095689804749195,0.35266821345707655,0.8643498788503876,1.0,12/49,16.07%,HYAL1;DDRGK1;RUNX1;SOX9;ITGB8;SNX19;NFIB;SCX;COL11A2;TRPV4;SOX5;FGFR3
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.35972214892514287,1.0954921652722378,0.33880903490759756,0.8642770965875777,1.0,22/118,13.48%,STAT2;SP100;FMNL2;SEMA4D;RUFY3;CTNNB1;EPHA4;FGFR2;PAK3;BCL6;HTATIP2;GDNF;ZMYM3;BMPER;INF2;TNIK;PHIP;PHLDB1;CAPZB;CHN1;SIPA1L1;ZRANB1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3711487824731406,-1.0954160208596404,0.30337078651685395,0.9964165445296114,1.0,8/17,32.91%,PDE3B;ALK;AKT1;IL1B;ADRA2A;APOC1;MFSD2A;HCAR2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37176230163873164,1.095145343957552,0.34627831715210355,0.8647187929655396,1.0,28/70,25.95%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD9;PSMD8;TAP1;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,tube closure (GO:0060606),0.41809955652409836,1.0951238278637185,0.35353535353535354,0.8640721150433475,1.0,4/31,5.34%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.39913356652667215,1.0949843368469079,0.35697115384615385,0.863811430152328,1.0,7/40,15.05%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.4286745766543685,-1.0948844807887534,0.3352941176470588,0.9943536222601597,1.0,5/11,22.32%,ASF1A;HAT1;HIRA;ATRX;ASF1B
prerank,RNA stabilization (GO:0043489),0.4144510574211496,1.0942206628463826,0.348780487804878,0.8656093051894875,1.0,7/33,15.57%,PHAX;LARP1;DHX36;GDNF;TENT5A;TENT5C;TAF15
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4452094325641654,1.0940865703327822,0.33422818791946307,0.8653535781976768,1.0,7/22,16.59%,PSMB10;PSMA5;PSME4;PSMA3;PSMB9;PSMA4;ENC1
prerank,positive regulation of cellular senescence (GO:2000774),0.5179309809759386,1.0940628304422721,0.3785488958990536,0.8647258900043671,1.0,4/10,16.73%,B2M;CGAS;YPEL3;EEF1E1
prerank,response to hydroxyurea (GO:0072710),0.5140565806805953,1.0940247736328175,0.37370753323485967,0.8641273500312995,1.0,5/11,19.75%,TIMELESS;DDX11;RTF2;DDI2;KAT7
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.48492867991368,1.093775560849999,0.36530324400564174,0.8642130267584932,1.0,4/13,14.55%,NFKB1;DKK3;APOE;ERLIN2
prerank,basement membrane organization (GO:0071711),0.48501941722730224,1.09359709483245,0.36363636363636365,0.864092193827433,1.0,5/14,21.00%,CTSS;LAMB2;NID2;FLRT2;NTN4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.35214131081266165,1.0935286781487243,0.3288659793814433,0.8635690600143728,1.0,15/113,10.41%,ISG15;CLTRN;ABCA1;GBP5;CLU;USP50;DHX33;BCL2L11;CHD1L;CDT1;SH3GLB1;SLF2;ERCC4;RBX1;TPPP3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3417223004135981,1.0934267990131799,0.197,0.8631539217448098,1.0,121/497,20.49%,IGF2BP1;EIF2AK2;WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;DAPK3;DHFR;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;IGF2BP3;MECP2;ARID5B;SFRP2;ELK3;MTA3;PCGF6;ID3;NACC1;BHLHE40;LARP1;EID2B;ZHX3;NKX6-2;CIC;ILF3;GATAD2A;DHX36;CNOT7;PRICKLE1;SOX9;PFDN5;CTNNB1;MBD2;BCL6;TCF7L2;SMARCC2;SMARCE1;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;MEN1;BMPR2;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;CTCF;SNW1;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ATXN1;ENPP1;RACK1;LIMS1;ZBTB21;SHMT1;IKZF1;ZMYND15;KDM8;PATL2;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ENC1;ZBTB4;RBPJ;BRD7;PUS7;KAT8;BAHD1;HMBOX1;ID4;MRPL13;DACH1;HDAC1;WWP1;CAPRIN1;HINFP;CTBP1;ZKSCAN3;SET;TSC1;KAT7;POU3F3;PER1;NR1D2;BTAF1;ACVRL1;SFMBT1;ZEB1;BCOR;DDX3X
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.36524543441527485,1.093269993175639,0.32196162046908317,0.8629362676723311,1.0,30/87,23.70%,PSMB10;SKP1;PSME2;PRMT2;PSMA5;PSME4;RBL1;CDKN2D;PSMA3;PSMB9;DACT1;RBX1;ZFP36L1;PSMD2;PSME3;RB1;DLG1;PSMA4;BRD7;PSMD7;PSMD9;PSMD8;WEE1;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;ZFP36L2;PSMA2
prerank,protein targeting (GO:0006605),0.3524038733277911,1.0921514145754356,0.3256544502617801,0.8659450252101598,1.0,26/118,17.60%,GOLGA7;FIS1;MYO1C;FBXO7;AQP11;RTP4;LAMP2;ZDHHC21;SRPRA;LONP2;ZDHHC20;TRAK1;GDAP1;TOMM5;VPS37A;NACA;SPCS1;FUT10;SORL1;TSPO;PITRM1;AIP;TAOK2;RPL11;TOMM40;CDC37
prerank,calcium ion import across plasma membrane (GO:0098703),0.4931504343278765,1.091770908206219,0.3711484593837535,0.8664932689303174,1.0,3/14,12.88%,TRPM2;SLC8A1;TRPV4
prerank,recombinational repair (GO:0000725),0.36411473138343936,1.0914187815483731,0.3463626492942454,0.8669280801266118,1.0,18/77,15.24%,SAMHD1;ZSWIM7;SEM1;AP5Z1;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,protein trimerization (GO:0070206),0.4782651408801842,1.0913884918945982,0.3555240793201133,0.8655961399804033,1.0,2/14,2.61%,PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),0.4782651408801842,1.0913884918945982,0.3555240793201133,0.8655961399804033,1.0,2/14,2.61%,PNPT1;MLKL
prerank,regulation of cell cycle phase transition (GO:1901987),0.3643812695236949,1.0911845389866786,0.3344017094017094,0.8655316038945904,1.0,28/91,21.76%,PSMB10;SKP1;PSME2;PSMA5;CDC26;PSME4;ANAPC5;FBXW7;PSMA3;TRIM39;PSMB9;ANAPC4;UBE2E1;BTRC;PSMD2;CDC16;CDC27;PSME3;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2
prerank,positive regulation of cellular protein localization (GO:1903829),0.37237535984058756,1.0910316348164137,0.3391494002181025,0.8653165269449093,1.0,18/69,21.15%,PARP9;DTX3L;DDRGK1;SNX33;HSP90AB1;CDT1;CCDC88A;TRAPPC12;VPS28;STX4;FYN;TESK1;NUMA1;NDC80;KAT7;TYROBP;TM9SF4;ENTR1
prerank,regulation of inclusion body assembly (GO:0090083),0.5035792149888423,1.09085510671072,0.39020771513353114,0.8651713363791188,1.0,2/11,9.90%,HSPA1B;DNAJB6
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.33598008043903715,1.090816053404906,0.072,0.8645972506262425,1.0,302/1646,17.12%,STAT1;STAT2;SP100;IRF7;PARP9;WNT11;PITX2;SIM1;PML;LOXL2;CALCA;AGT;THAP7;SP110;LHX2;LMX1A;CIART;NR1H2;HAS3;CC2D1B;IRF2BP1;ESR2;DAPK3;DHFR;DTX3L;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;MYBBP1A;ZNF483;TFAP2C;PER2;GMEB2;DAXX;CCNL1;ZBTB17;TRIM45;ESRRB;PRMT2;BRD2;NFX1;HTATSF1;TIMELESS;BBX;SAP30L;ZFPL1;RNF4;TEAD2;ZBTB2;NFKB2;CHEK2;SOD2;MECP2;ACVR1;STAT3;MLLT11;ARID1B;ARID5B;ZFP37;TGFA;BATF3;CHD7;DDX5;SFRP2;ZNF471;ELK3;MTA3;RUNX1;PCGF6;MAD2L2;ID3;USP21;NACC1;BHLHE40;EID2B;ZHX3;NKX6-2;KLF15;CIC;SRRT;CCNL2;ILF3;GATAD2A;DHX36;BRWD3;CNOT7;MZF1;NFXL1;JUNB;ZSCAN12;NCOA1;MRPL12;SERTAD3;PRICKLE1;ZNF23;SOX9;SRA1;PFDN5;HNRNPK;CTNNB1;KMT2A;ZNF2;ARID1A;CCNT2;TRAK1;ZNF76;MBD2;ZSCAN22;CDT1;NSD3;ZSCAN26;BCL6;ZXDC;TCF7L2;TCF4;SMARCC2;SMARCE1;NFKB1;ZBTB43;CREBRF;EDF1;ZBTB38;SETD3;BRIP1;BACH1;ZSCAN29;MT3;USF1;TFAP2B;NFATC2;MAP2K3;SNAI2;RET;SAP30;UBP1;SRF;DHX9;ETV6;MDFIC;RAI1;TADA2A;IKZF2;HTATIP2;SMAD2;GLIS3;MED13L;MEIS3;ATF6B;CDK5RAP2;TFDP1;BAMBI;NONO;SLTM;NFIB;ACTR8;ATF1;ELP2;HOXA9;POU3F1;HMGB1;SCX;DACH2;LCORL;RORA;INSR;POLR2K;TADA2B;ELF4;HR;MAPK14;IRF9;MNAT1;MEN1;LIN9;HSPA8;ZSCAN20;RING1;BPTF;WAC;NR2C1;MED12;PROX1;PHIP;ELOC;COMMD7;BTRC;RGMB;KDM3B;NPM1;PPM1F;FOXK1;MAX;DNM2;DKK3;SETD5;CTCF;SNW1;NOTCH4;ZBTB5;NAB1;SETDB2;HCFC2;TFDP2;RYBP;ARHGEF11;MITF;CBX4;MAP2K2;HMGB3;CUX1;KLF10;ZNF423;NKAP;UXT;RELB;TEF;LDB1;ILF2;NOP2;PSEN1;NR3C1;REL;APOE;PPARGC1A;LCOR;HOXB6;BRPF1;RB1;UBE2L3;FBXL19;ATXN1;LIMS1;ZNF35;E2F4;APBB1;PGBD1;ST18;ZBTB21;DBX2;TIAL1;MED29;IKZF1;CASZ1;SMARCA1;BCL11B;ZNF418;ASCC2;ZMYND15;KDM8;MYPOP;EZH2;SOX2;RREB1;RBM15;MYB;CREB5;ZBTB34;POU6F1;INPP5K;PRDM11;ZBTB24;CAMTA2;MLLT3;MYCBP;ERF;SOX5;ZNHIT3;CRK;KLF16;TAF15;SMARCD2;PIAS1;GTF2IRD1;MEF2A;NPAT;RCOR3;CARF;PPARD;MED27;KDM7A;PROX2;GCLC;PIAS2;DENND4A;SREBF1;CCNK;ZBTB4;RBPJ;BRD7;KAT8;BAHD1;MED16;ELF1;HMBOX1;TRIP4;ID4
prerank,cellular protein catabolic process (GO:0044257),0.3757563701961606,1.0906709032694053,0.34448160535117056,0.8643622260982926,1.0,14/59,16.41%,CTSS;CHEK2;RNF5;RAB12;AP2A1;CTSC;RSPRY1;CTSH;AP2S1;LONP1;MYLIP;AFG1L;ADAMTS12;TCIRG1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3836983293357976,-1.0904462814875169,0.31899641577060933,1.0,1.0,8/15,24.01%,UST;VCAN;CSGALNACT1;BGN;DSEL;DCN;BCAN;CSPG5
prerank,protein-DNA complex assembly (GO:0065004),0.35376906529871965,1.0902627702466676,0.34057971014492755,0.8649501759511352,1.0,23/116,12.45%,PSMB10;PSME2;DAXX;MCM2;BRD2;PSMA5;PSME4;NAP1L2;MCM7;MCM4;CHD1L;SOX9;CDT1;PSMA3;TCF4;PSMB9;RBX1;MNAT1;CHAF1B;NPM1;PSMD2;PSME3;ORC3
prerank,phosphorylation (GO:0016310),0.3421874149784032,1.0896689229311043,0.244,0.8661258871560247,1.0,98/384,19.14%,EIF2AK2;WNT11;TAOK3;DAPK3;GLYCTK;SGK2;SGK3;RSKR;CAMK2D;TP53RK;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;STAT3;HASPIN;CDC25B;STK38L;PKN2;HCK;CHEK1;ILF3;GNPTAB;IKBKE;PEAK1;MORC3;CDK12;MKNK1;PAK3;NRBP2;RET;GMFB;FAM20B;LTK;LYN;CLK3;NADK;APP;INSR;PIK3R4;SRPK1;BMPR2;HK1;PRKAG1;DGKB;CERKL;CDK19;SPHK2;DGKK;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;FGGY;DYRK2;NEK6;PRKDC;PRKCE;PIK3CB;CLK2;FYN;JAK2;PRKCH;MINK1;FAM20C;PANK2;BMPR1A;STK25;NRBP1;TAOK2;OXSR1;MTOR;TBCK;IRAK1;STK39;CSK;DGKA;BCR;SNRK;BIRC6;PRKG2;ACVR2A;DGKI;FNIP2;COPS8;CTBP1;MARK1;BRSK1;NEK7;STK24;STK3;CAMKK2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3408199840871347,1.089590037756984,0.217,0.8656669553546669,1.0,103/417,20.44%,WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;EIF4A2;MECP2;ARID5B;SFRP2;ELK3;MTA3;PCGF6;ID3;NACC1;BHLHE40;EID2B;ZHX3;NKX6-2;CIC;ILF3;GATAD2A;CNOT7;PRICKLE1;SOX9;PFDN5;CTNNB1;MBD2;BCL6;TCF7L2;SMARCC2;SMARCE1;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;MEN1;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;CTCF;SNW1;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ATXN1;LIMS1;ZBTB21;IKZF1;ZMYND15;KDM8;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ZBTB4;RBPJ;BRD7;KAT8;BAHD1;HMBOX1;ID4;DACH1;HDAC1;WWP1;HINFP;CTBP1;ZKSCAN3;SET;KAT7;POU3F3;PER1;NR1D2;BTAF1;SFMBT1;ZEB1;BCOR
prerank,positive regulation of ERAD pathway (GO:1904294),0.4733815538346481,1.0891129761284586,0.3641703377386197,0.8664746547436949,1.0,4/13,12.98%,RNFT1;UBQLN2;UBQLN1;RNF185
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3375247497911511,1.088723024176316,0.188,0.8670207505982177,1.0,102/572,15.04%,STAT1;SP100;IRF7;PARP9;MYOZ2;LOXL2;THAP7;NR1H2;IRF2BP1;ESR2;TRIB3;TFAP2C;PER2;ZFP36;RARG;NFX1;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;DDX5;MTA3;CGGBP1;RUNX1;MAD2L2;ID3;BHLHE40;NOP53;GATAD2A;MZF1;SOX9;CCND1;MBD2;FGFR2;IGBP1;BCL6;TCF7L2;NFKB1;BACH1;DDX20;TFAP2B;SNAI2;SAP30;SRF;ETV6;MTA2;SMAD2;GLIS3;DACT1;SIRT6;DNMT3A;AEBP1;AASS;NFIB;HMGB1;PLK3;PEX2;MEN1;BPTF;NR2C1;PROX1;NCOA5;DUSP26;MAX;DNAJA3;CTCF;SNW1;NOTCH4;ZBTB5;HCFC2;TAF3;MITF;SKIL;CBX4;MDFI;CUX1;KLF10;NKAP;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;ATXN1;MIER1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;DLG1;MYPOP;EZH2;SOX2;RREB1;MYB;POU6F1
prerank,positive regulation of cellular component movement (GO:0051272),0.43564163189603905,1.088508768963827,0.38113695090439276,0.867031981378574,1.0,7/24,20.86%,TUBB2B;LYN;PDPN;CFAP20;CAVIN1;CCDC25;STK11
prerank,negative regulation of neurogenesis (GO:0050768),0.41201140763697586,1.0882211054356252,0.36996336996337,0.8672559629011874,1.0,14/34,26.55%,B2M;THY1;RUFY3;RAPGEF2;MAG;SORL1;HOOK3;NF1;APPL2;NOTCH1;LINGO1;LRP4;TNF;PTEN
prerank,regulation of protein localization to cell periphery (GO:1904375),0.45698800945862195,1.088205433171077,0.3753351206434316,0.8665967375472537,1.0,6/18,13.99%,MMP14;STX7;STX8;LDLRAP1;VTI1B;ACTB
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3474025392259323,1.0880543342190856,0.31910569105691056,0.8663780222778507,1.0,36/138,20.78%,AXL;FLT1;KDR;BDNF;LCP2;HCK;EPHA4;FGFR2;CSF1;RET;NPPC;EPHA6;BCAR1;LTK;LYN;MET;ROR2;INSR;BMPR2;GFRA2;STAP1;PIK3CB;RAPGEF1;FYN;JAK2;FGFR3;BLNK;PTPRU;MPZL1;ACVR2A;POLR1G;NPR2;PTPRF;DDR2;LCK;YES1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.43591686559667464,1.087731187819209,0.3748395378690629,0.8666894828361088,1.0,6/22,16.67%,BDNF;MAGI2;RAPGEF2;CIB1;RAPGEF1;STMN2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.34012805308195554,1.0876194835688608,0.27054108216432865,0.8663536726472257,1.0,51/308,16.20%,EIF2AK2;LOXL2;IL15;AGT;ABCA1;CXCR4;WNT5A;PER2;ESRRB;PIK3CD;GADD45G;SLC27A1;AGO2;ACVR1;GRB10;MAD2L2;PTGER4;DYNC1H1;ACADL;SYDE1;SOX9;CTNNB1;SMAD2;SIRT6;BAMBI;GDNF;B4GALT5;LEPR;PDPN;SCX;BMPR2;LRPAP1;CCDC88B;XBP1;SORL1;PTPN11;SHLD1;APOE;PPARGC1A;PAXIP1;BAD;DAB2;JAK2;PRKCH;EZH2;RREB1;BMPR1A;INPP5K;SOX5;IL18;MTOR
prerank,negative regulation of telomere maintenance (GO:0032205),-0.38758601415477395,-1.0875528335894378,0.31800766283524906,1.0,1.0,7/15,17.78%,PARP1;NBN;TERF2IP;SLX4;PINX1;TERF1;ERCC1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3460945907036323,1.0874957871631603,0.3268641470888662,0.8660394337925079,1.0,38/159,19.48%,CLTRN;CHMP4A;CHMP4B;CLU;NUP153;HSP90AB1;CCDC40;NSG2;TCF4;CSNK2B;DHX9;FMOD;SMAD2;NCK1;NCK2;VAMP1;SNX9;EIF4H;SAMM50;AP2S1;HSPA4;CHMP3;LONP1;VAMP2;AHCTF1;POGZ;TBCC;PSMG2;HSP90AA1;MIS12;VAMP4;TBCD;PTGES3;EIF4B;OTUD6B;UVRAG;COX7A2;GPX4
prerank,intestinal lipid absorption (GO:0098856),0.5031253093323045,1.0873056646203951,0.3916184971098266,0.8659334003634211,1.0,2/11,18.15%,SOAT2;LDLR
prerank,bone morphogenesis (GO:0060349),0.4840789116842864,1.0872486273490498,0.36046511627906974,0.8654076302814678,1.0,4/14,16.07%,FGFR2;CYP26B1;BMPR2;FGFR3
prerank,mitochondrial transcription (GO:0006390),0.5051756170007228,1.0872018895485631,0.38438880706921946,0.8648697970210744,1.0,6/10,26.05%,MRPL12;TFB2M;TWNK;TEFM;TFAM;SLC25A33
prerank,hemopoiesis (GO:0030097),0.35699523027797225,1.0868198789000614,0.3411513859275053,0.865362365943296,1.0,16/87,11.45%,FLT1;WNT5A;KDR;SBDS;KITLG;SFRP2;RUNX1;YJEFN3;KMT2A;FGFR2;ETV6;MFAP5;YTHDF2;FUT10;NOTCH4;RTKN2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.44478630422419796,1.0866067714563132,0.3837837837837838,0.865356302479181,1.0,4/19,8.09%,NANS;GMPPB;MPI;GFPT1
prerank,N-terminal protein amino acid modification (GO:0031365),0.47836974848680147,1.0865760665241122,0.3708513708513709,0.8647618521846862,1.0,4/14,16.62%,NAA50;NTMT1;NAA35;METAP2
prerank,negative regulation of cell differentiation (GO:0045596),0.3443812959892376,1.0861894060965016,0.30425963488843816,0.8652975568531648,1.0,32/181,14.97%,NR1H2;ABCA1;XDH;TRIB3;WNT5A;SPRY2;ABCG1;ESRRB;SEMA4D;SFRP2;MAD2L2;EID2B;SOX9;SRA1;NPHP3;SNAI2;NBR1;YTHDF2;BAMBI;HOXA9;RORA;MEN1;ADGRV1;NOTCH4;PTPN11;RB1;ENPP1;PTCH1;RANBP3L;SOX2;ADAMTS12;MYB
prerank,positive regulation of glucose import (GO:0046326),0.43871319984069024,1.0861875244666594,0.34411384217335056,0.8646149042468778,1.0,6/21,14.43%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.367841784109296,1.0859228477303724,0.3475409836065574,0.8647652382667098,1.0,33/74,27.02%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;RBPJ;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;CITED2;PSMD12;PSMC2;PSMD4;LIMD1;NOTCH1;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;HIGD1A;EP300
prerank,cellular response to hormone stimulus (GO:0032870),0.3697304584936415,1.0858604445417028,0.37102085620197583,0.864278271802594,1.0,13/69,12.73%,CTSS;STAT3;CRHBP;NCOA1;SRA1;CTSH;LMO2;ZFP36L1;SLIT3;XBP1;NR3C1;SOCS2;UBE2L3
prerank,nuclear export (GO:0051168),0.36761106108245023,1.085559971923022,0.3542116630669546,0.8645039944305466,1.0,22/80,17.94%,PHAX;MAGOHB;NUP153;WASHC4;NCBP2;CSE1L;LSG1;RAE1;RNPS1;HNRNPA1;SMURF1;ATXN1;ZC3H11A;CHTOP;RANBP3L;DDX39B;NUP155;NCBP1;SRSF7;SRSF4;RANBP17;SLU7
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.45887113178187205,1.0849630359139601,0.38140161725067384,0.8656577841998163,1.0,4/18,6.81%,MECP2;CDC25B;CCND1;RAD51C
prerank,histone H3 deacetylation (GO:0070932),0.4642207538113902,1.0848582438102246,0.3598901098901099,0.8652993388469827,1.0,9/15,25.39%,PER2;SIRT6;HDAC8;HDAC1;PER1;HDAC2;HDAC4;SMARCAD1;SIRT2
prerank,regulation of cell junction assembly (GO:1901888),0.42567501914288436,1.084709241055197,0.3660377358490566,0.865083026855558,1.0,8/27,15.18%,MYO1C;RUNX1;SNAI2;RAPGEF2;SETD5;RAPGEF1;PRKCH;CHRNB2
prerank,regulation of sensory perception of pain (GO:0051930),-0.4281948535336189,-1.0846087563648625,0.3504273504273504,1.0,1.0,6/11,29.47%,ZFHX2;CCL3;MGLL;F2R;ACP3;CCN3
prerank,regulation of mRNA stability (GO:0043488),0.3508591118494247,1.0843235359295291,0.3219814241486068,0.8656350364085246,1.0,46/145,24.03%,IGF2BP1;PSMB10;PSME2;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;LARP1;DHX36;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;GDNF;HSPA8;NPM1;ZFP36L1;PSMD2;TENT5A;PSME3;TENT5C;EXOSC9;PSMA4;TAF15;MEX3D;METTL14;PCBP4;TBRG4;PSMD7;PSMD9;RC3H2;SET;PSMD8;PSMF1;PSMB6;PSMD12;PRKCD;PSMC2;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2;PDE12
prerank,generation of neurons (GO:0048699),0.34251739740854276,1.0841501315050026,0.3155778894472362,0.865546562667528,1.0,39/190,19.83%,WNT11;LHX2;LMX1A;WNT5A;PER2;PLXNB2;TUBB2B;RUNX1;BHLHE40;CX3CL1;CTNNB1;NGRN;WNT7B;NRBP2;RAPGEF2;DTNB;YTHDF2;MET;DDIT4;LDB1;FGF13;NRP1;RAC1;SMARCA1;DNER;LRP12;ADNP2;IER2;OPHN1;PEX13;ITM2C;DCDC2;PAFAH1B1;FUT9;MARK1;BRSK1;MAP1B;PIN1;CCK
prerank,mitotic sister chromatid segregation (GO:0000070),0.36060760416813503,1.0840772173066326,0.35578947368421054,0.8651135497045914,1.0,25/98,19.45%,CHMP4A;CHMP4B;TENT4A;CHMP1B;HASPIN;NAA50;KPNB1;KIF2C;WRAP73;CSNK2B;RRS1;CSNK2A2;NCAPG2;CHMP3;RB1;POGZ;DIS3L2;PIBF1;MIS12;RAB11A;CHMP5;SET;BECN1;NDC80;PDS5B
prerank,phospholipid translocation (GO:0045332),0.4157116820995662,1.0837289434996735,0.36523929471032746,0.8655223095454386,1.0,6/28,15.86%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.44270433163251627,1.0831421535992676,0.3828647925033467,0.8667047168054873,1.0,6/22,17.74%,SNX33;ADAM8;TIMP2;SNX9;APOE;SH3D19
prerank,regulation of protein import into nucleus (GO:0042306),-0.2961001308895036,-1.0828154036648792,0.3090909090909091,1.0,1.0,13/36,22.72%,TGFB1;APOD;EFCAB7;UFM1;CABP1;PIK3R2;ZIC1;UBR5;ECT2;DMAP1;BAG3;TPR;RBM22
prerank,negative regulation of T cell activation (GO:0050868),0.40041568387612475,1.082778681171428,0.3615751789976134,0.8671617095445692,1.0,5/35,12.93%,CD274;SDC4;DUSP3;HAVCR2;FCGR2B
prerank,embryonic skeletal system development (GO:0048706),0.40152586397793766,1.0827635007552736,0.36996336996337,0.8665148435253326,1.0,4/35,10.19%,WNT11;WNT5A;HOXA9;KIAA1217
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3098309439783965,-1.0826982773363882,0.29743589743589743,1.0,1.0,8/29,11.85%,PAK1;UBA5;CBFB;ESR1;KANK2;UFM1;BRCA1;GPAM
prerank,negative regulation of macroautophagy (GO:0016242),0.41389159896172667,1.0826193203227445,0.3684210526315789,0.8663076817096464,1.0,8/26,19.12%,CHMP4A;CHMP4B;NRBP2;SCFD1;RUBCN;MTOR;FEZ2;TSC1
prerank,negative regulation of peptidase activity (GO:0010466),0.3836999739984221,1.0823722419403532,0.36009174311926606,0.86637877523783,1.0,5/47,10.32%,AGT;SERPINC1;UBXN1;CST7;TIMP2
prerank,zinc ion transmembrane transport (GO:0071577),0.4371553109826074,1.0819308274042192,0.3868520859671302,0.8671011774259462,1.0,6/22,19.49%,TRPM2;SLC30A1;SLC30A5;SLC30A6;SLC39A10;SLC39A3
prerank,RNA transport (GO:0050658),0.3715747325539493,1.0819038374373522,0.3463626492942454,0.8664904976346542,1.0,18/71,16.30%,PNPT1;ZFP36;MAGOHB;NUP153;NCBP2;HNRNPA2B1;RAE1;RNPS1;ZFP36L1;RBFOX1;HNRNPA1;ZC3H11A;CHTOP;DDX39B;NUP155;NCBP1;SRSF7;SRSF4
prerank,cellular component maintenance (GO:0043954),0.4873873726105744,1.0816333241786509,0.3815987933634992,0.8666056409104613,1.0,4/12,14.25%,ITGA3;INSR;PRNP;FYN
prerank,protein targeting to mitochondrion (GO:0006626),0.3768586110165032,1.0815501565208516,0.3767441860465116,0.8661688791698731,1.0,14/52,17.56%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;SAMM50;HSPA4;TSPO;PITRM1;AIP;HSP90AA1;TOMM40;MIPEP
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.44475683615178263,1.0812315310785459,0.390646492434663,0.8664660115489523,1.0,3/22,6.02%,B2M;CD55;STX7
prerank,negative regulation of cellular protein localization (GO:1903828),0.4004370436530569,1.0806527937887442,0.3717791411042945,0.8675648498461749,1.0,7/34,11.80%,ILRUN;SNX33;ACTN2;CDT1;LEPROT;UBXN2B;LEPROTL1
prerank,organic anion transport (GO:0015711),0.363831992386685,1.0804115843772175,0.37199124726477023,0.8676140284133758,1.0,16/76,20.24%,CA4;CYB5R2;SLCO1C1;SLC2A6;SLC25A19;SLC19A1;SLC52A2;SLCO1B1;SLC35B1;SLC35B4;CA2;SLC35A3;SLC4A2;SLC35C2;ABCG2;ABCC5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.30776472822946666,-1.0801994238961194,0.30392156862745096,1.0,1.0,15/29,32.12%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.30776472822946666,-1.0801994238961194,0.30392156862745096,1.0,1.0,15/29,32.12%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4937992573536624,1.08010522508638,0.375186846038864,0.8678919613380555,1.0,7/12,28.71%,BCL2L11;XBP1;BAX;ERN1;ATF6;PTPN1;PIK3R1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4257032956918953,1.0794602151381303,0.37962962962962965,0.8691841976738186,1.0,5/25,14.62%,CLU;HSP90AB1;P2RX4;INSR;HSP90AA1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33423127396490065,1.0790811588695033,0.182,0.8697220202419438,1.0,170/834,18.59%,STAT1;CXCL10;NLRC5;IRF7;HELZ2;PITX2;NAMPT;GAL;LMX1A;NR1H2;NOD2;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;ESRRB;RARG;DDRGK1;AGO2;RBM14;RNF4;CD40;NFKB2;CDH13;ACVR1;STAT3;ACTR2;RBL1;SFRP2;ELK3;RUNX1;RBMX;KLF15;DHX36;MZF1;JUNB;NCOA1;CX3CL1;SOX9;CTNNB1;CDK12;PAXBP1;PFKM;KMT2A;CCNT2;ZNF76;MYDGF;MEPCE;FGFR2;TCF7L2;TCF4;NFKB1;CREBRF;ASXL3;ZBTB38;SETD3;THAP3;ACTR3;USF1;TFAP2B;UBP1;SRF;DHX9;MRTFA;HTATIP2;SMAD2;GLIS3;MEIS3;ATF6B;TFDP1;LPIN2;NCK1;LMO2;MET;NFIB;GDNF;ATF1;METTL23;HMGB1;SCX;APP;NCK2;RORA;CRTC1;MAML2;ELF4;AGRN;MEN1;BMPR2;BPTF;MED12;PROX1;PHIP;TNIP1;NPM1;ZC3H12A;MAX;SNW1;NOTCH4;TFDP2;GALR1;XBP1;IER5;MITF;ECD;KLF10;LDB2;LDB1;PRKDC;NR3C1;REL;PPARGC1A;PAXIP1;PRDM4;E2F4;APBB1;HDAC8;ST18;DAB2;POGZ;MYO6;CASZ1;SMARCA1;BCL11B;SOX2;RREB1;TET2;TFR2;TNIP2;MYB;BMPR1A;CRTC3;CAMTA2;TLR2;SMARCD2;MEF2A;NPAT;ARF4;PPARD;IL18;IER2;TNIP3;LAGE3;LMO7;SREBF1;CCNK;ZBED4;RBPJ;KAT8;MED16;ELF1;CHCHD2;MPND;PELP1;TLR3;RRP1B;POU2F2;ZBTB49;MED10;ZNF513;PTOV1;ACVR2A;FOSL2;HDAC1;HINFP;HOXA5;GABPB1;GABPB2
prerank,transition metal ion transport (GO:0000041),0.40564146153845043,1.07897622146733,0.3645083932853717,0.8693647208949187,1.0,14/35,25.64%,SLC30A1;SLC30A5;MT3;SLC11A2;TTYH1;TFR2;SLC31A1;TRPC4;SLC31A2;COX17;TRPC1;SLC30A9;CP;ATP7B
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3799783458479972,1.0789331275044485,0.3654937570942111,0.8688136928222169,1.0,12/51,14.01%,WNT11;CD47;EVL;CX3CL1;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;SYNPO;NRP1;RAC1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.433722411616542,1.0789292758191291,0.37772087067861715,0.868140916106555,1.0,3/22,9.00%,AGT;CAMK2D;P2RX4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4657781461172535,1.0788605055466598,0.3767123287671233,0.8676859545850549,1.0,3/15,11.23%,KDR;CDH13;VEGFD
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4175593889845645,1.0787910360682864,0.3717146433041302,0.8672089478669455,1.0,3/28,4.68%,CASP4;TRIB3;ITPR1
prerank,positive regulation of cell aging (GO:0090343),0.5009487741659832,1.078652718156206,0.39069767441860465,0.8669522456478205,1.0,4/11,16.73%,B2M;CGAS;YPEL3;EEF1E1
prerank,proteoglycan metabolic process (GO:0006029),0.41984984418757193,1.0786203784912458,0.3858764186633039,0.8663637312301754,1.0,10/26,23.72%,CANT1;FAM20B;BMPR2;CSGALNACT2;HPSE;HS3ST4;ADAMTS12;XYLT1;CHST11;CHST12
prerank,fatty acid catabolic process (GO:0009062),0.3644535187875839,1.078527462561821,0.37032967032967035,0.8659679494477395,1.0,19/67,21.16%,MCAT;ABHD2;ACADL;ECI2;MCEE;AUH;LPIN2;ABCD1;PEX2;ACADS;ABHD3;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;MMUT
prerank,regulation of protein localization (GO:0032880),0.37824370004474545,1.0783420318438013,0.3775055679287305,0.865877882343964,1.0,13/58,14.62%,TRIM14;TRIM25;TRIM21;RSL1D1;HSP90AB1;FBXW7;DNAJB6;PPM1F;RAB14;RACK1;PLEKHM2;DLG1;HSP90AA1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.46589281986022246,1.0780869719779873,0.37445573294629897,0.8659911949287533,1.0,7/15,22.47%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.42438761878206827,1.077929665875743,0.38571428571428573,0.8658184556403637,1.0,8/26,15.07%,ZFP36;GAREM1;DUSP3;SOX9;SNAI2;ZFP36L1;PTPN11;INPP5K
prerank,protein neddylation (GO:0045116),0.4820149858485602,1.077202907205322,0.3878437047756874,0.8673458524801133,1.0,3/13,9.03%,UBE2M;DCUN1D4;RBX1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.43637252120133957,1.0770993440064518,0.36610608020698576,0.8669937389384782,1.0,3/22,10.01%,NOD2;WNT5A;SPHK2
prerank,positive regulation of transferase activity (GO:0051347),0.34811255004915226,1.076844006704907,0.35612244897959183,0.8671307676264086,1.0,22/142,9.32%,AXL;FLT1;DTX3L;TRIB3;KDR;ARRDC4;HSP90AB1;POLG2;RFC4;FBXW7;CTNNB1;EPHA4;FGFR2;RET;CCT4;EPHA6;DCUN1D4;HNRNPA2B1;LTK;MET;ROR2;INSR
prerank,positive regulation of stem cell differentiation (GO:2000738),0.4618392215893199,1.076766193121076,0.37714285714285717,0.8667046177718108,1.0,3/16,15.50%,DHX36;SOX9;SOX5
prerank,nitric oxide metabolic process (GO:0046209),0.4756053119852276,1.076713631402196,0.3940677966101695,0.8662083272964234,1.0,3/14,10.29%,CYB5B;CYB5R3;GCH1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5090540025855341,1.0765917221204375,0.3911764705882353,0.8658962836758097,1.0,4/10,17.03%,AGO2;TARBP2;DICER1;PRKRA
prerank,cellular senescence (GO:0090398),0.41624118175790836,1.076159473787752,0.3838509316770186,0.8665814114401813,1.0,9/27,23.12%,PML;ECRG4;SRF;MAPK14;NSMCE2;TERF2;PRKCD;OPA1;KAT6A
prerank,dendrite morphogenesis (GO:0048813),-0.3037919989190288,-1.0761472854463283,0.33727810650887574,1.0,1.0,10/35,11.81%,SDC2;WASL;DLG4;MAP6;CTNNA2;CDC42;EPHB2;SHANK3;EPHB1;CHRNA7
prerank,peroxisome organization (GO:0007031),0.4161336502497972,1.0760291509972004,0.3723404255319149,0.8663099267106629,1.0,5/25,9.55%,FIS1;PEX7;LONP2;ABCD1;PEX2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.34916979353637584,1.0760033125385602,0.34547346514047866,0.8657169720836937,1.0,25/110,17.15%,EIF2AK2;IRGM;ABCA1;CLU;BCL2L11;HCK;NOP53;CDT1;SH3GLB1;SLF2;HSPA8;RIOK3;SORL1;GSN;PTPN11;APOE;SVIP;RB1;RACK1;NAPA;NAPB;HSP90AA1;BMF;PEX5;BAX
prerank,regulation of neuron projection arborization (GO:0150011),0.4611465489586122,1.0759011125147728,0.401673640167364,0.8653605465032826,1.0,2/15,1.54%,MOV10;WNT5A
prerank,regulation of defense response to virus (GO:0050688),0.47443833021788034,1.0757168586851293,0.38028169014084506,0.8652129961988171,1.0,3/14,9.95%,ILRUN;DHX9;TRAF3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3536945522768713,1.0754726463673432,0.362303664921466,0.865288540288767,1.0,15/95,10.09%,EXT1;XYLT2;HAS3;HYAL1;SDC3;SDC4;HAS1;FMOD;B4GALT1;B4GALT4;CSPG4;B4GALT5;AGRN;ST3GAL1;CSGALNACT2
prerank,sodium ion homeostasis (GO:0055078),0.4367795836136036,1.0752589223847921,0.392904073587385,0.8652951489956204,1.0,3/21,6.72%,ATP1B3;SLC8A1;TFAP2B
prerank,calcium-mediated signaling (GO:0019722),0.35583048941155865,1.075119495238492,0.3644067796610169,0.8650398195703285,1.0,12/93,9.48%,IRGM;CXCR4;KDR;TRPM2;FIS1;RCAN1;SLC8A1;PPP1R9A;SAMD14;ACKR3;P2RX4;PRNP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4499939863063912,1.0750914482024725,0.3715469613259669,0.8644529005453332,1.0,8/17,25.39%,SPRY2;DDIT4;INPP5K;CALM3;SPRED3;SPRED1;CALM2;SIRT2
prerank,snRNA 3'-end processing (GO:0034472),-0.355005529244255,-1.074974280072109,0.3250883392226148,1.0,1.0,12/19,34.94%,EXOSC7;EXOSC5;INTS12;EXOSC3;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L;USB1;EXOSC8
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4460547974939056,1.0749125970492983,0.3839779005524862,0.8643567617528872,1.0,4/18,10.25%,FPR3;BCAR1;LYN;C3AR1
prerank,regulation of membrane depolarization (GO:0003254),0.4523455707385068,1.0748123483717298,0.4002695417789757,0.8640164064206814,1.0,3/18,16.23%,CAMK2D;ABCD1;SCN1B
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31271088819665915,-1.0744806532411795,0.37089201877934275,1.0,1.0,12/26,20.62%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;ERCC1;GTF2H3;XPA;GTF2H4
prerank,bicellular tight junction assembly (GO:0070830),-0.28065143424612515,-1.074019136674892,0.35074626865671643,1.0,1.0,22/46,35.27%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3392007506765429,-1.0737815278163438,0.336322869955157,1.0,1.0,8/22,24.66%,SORBS1;PPARG;AKT1;CREBL2;CREB1;DISP3;IL1B;EEF1A2
prerank,triglyceride catabolic process (GO:0019433),0.4479601719712991,1.073720277730602,0.3915343915343915,0.8668038836684295,1.0,2/19,7.75%,PNPLA2;LIPC
prerank,regulation of epithelial cell migration (GO:0010632),0.380084081073326,1.0734936578196668,0.3741339491916859,0.8668577880051133,1.0,15/51,18.17%,HYAL1;SASH1;EVL;SOX9;RHOJ;CTSH;BMPER;BMPR2;PPM1F;DUSP10;PRKCE;RREB1;MCC;RAB11A;CORO1C
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3793063785443536,1.0731746416878296,0.3737259343148358,0.8671731005204559,1.0,5/47,11.56%,AGT;SERPINC1;MT3;TIMP2;SORL1
prerank,atrioventricular valve development (GO:0003171),0.4739763731731146,1.0727870586824761,0.39092240117130306,0.8677061837514287,1.0,4/14,15.05%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,regulation of monooxygenase activity (GO:0032768),-0.33980131954171533,-1.0725099042851907,0.32432432432432434,1.0,1.0,13/23,24.02%,WASL;LYPLA1;EGFR;SNCA;DDAH1;NOSTRIN;AKT1;POR;CAV1;SPR;IL1B;NOS1AP;IL1A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.501808362291551,1.0724968207860472,0.3788546255506608,0.8679266776229783,1.0,3/11,13.92%,UQCRQ;UQCR10;CYC1
prerank,B cell homeostasis (GO:0001782),0.5116240514809811,1.0724949171131137,0.411144578313253,0.8672713168482592,1.0,3/10,8.68%,GAPT;CAMLG;LYN
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4192815831721668,1.072174662803037,0.39570164348925413,0.8676022161897702,1.0,7/25,22.95%,AGT;DOK1;CCDC88A;RBPJ;ARAP1;PLAUR;PDE6H
prerank,positive regulation of cellular process (GO:0048522),0.33466986652339215,1.0721724333747558,0.25,0.8669473394039624,1.0,99/565,16.07%,NAMPT;IL15;CRLF1;FLT1;SLAMF1;IL15RA;HYAL1;WNT5A;IRS1;KDR;ZFP36;GAREM1;DDRGK1;GDF9;MECP2;CXCL16;KITLG;TGFA;CDC25B;AQP11;TRIM21;S1PR2;MMP14;SFRP2;FXN;ADAM8;DDX49;CD47;NACC1;DYNC1H1;HCK;CCL5;CCND2;CHEK1;DHX36;CNOT7;HSP90AB1;TIPIN;CACUL1;CX3CL1;SOX9;CCND1;EPHA4;FGFR2;MT3;TFAP2B;CSF1;TBC1D8;SRF;TUB;MEIS3;CTSH;IL12RB2;BAMBI;LYN;GDNF;CST7;P2RX4;PDPN;SCX;INSR;MLC1;PROX1;PHIP;ECHDC3;PRR7;CIB1;DUSP26;NPM1;ZC3H12A;FAM98B;ZFP36L1;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;NOP2;CAPNS1;FCGR2B;RPS6;CAPN1;CHTOP;RAC1;STX4;EXOSC9;IRS2;SERTAD1;EZH2;NSMCE1;NCBP1;ADNP2;TLR2;ACER3;PRMT1;AIF1;FGFR3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.48662237756779314,1.0720730808936523,0.3789004457652303,0.8666050484291892,1.0,3/11,16.66%,ACTN2;CAB39;STK39
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.24949200145150585,-1.0715459510740264,0.2571428571428571,1.0,1.0,23/87,17.41%,TGFB1;ZMIZ2;PTPRK;USP9X;HPGD;PXN;TGFBR3;PRKCZ;TWSG1;SIRT1;TGFB2;COL1A2;UBB;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;RPS27A;F11R
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.515799895353921,1.0711844811879556,0.40337423312883436,0.8680730483753866,1.0,6/10,25.49%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.515799895353921,1.0711844811879556,0.40337423312883436,0.8680730483753866,1.0,6/10,25.49%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,regulation of cell death (GO:0010941),0.3547944556248344,1.0710287641361698,0.3747346072186836,0.8679063595544892,1.0,17/94,15.71%,HSPA1B;WNT11;CHMP4B;CLU;CCL5;RILPL1;MT3;NCK1;LRPAP1;SPEF1;PRR7;ZC3H12A;SRGAP2;DUS2;NOA1;ADNP2;ACER3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4633495299963171,1.070983100890724,0.3959731543624161,0.8673911269637797,1.0,6/15,16.74%,CDH13;PTPN18;MVB12A;WDR54;RHBDF2;RBPJ
prerank,ubiquinone biosynthetic process (GO:0006744),0.46641777218603064,1.0709522269648222,0.3900709219858156,0.8668210049549994,1.0,3/15,6.34%,COQ2;COQ10B;COQ3
prerank,stem cell differentiation (GO:0048863),-0.2942730970631709,-1.0709187388116497,0.3137254901960784,1.0,1.0,11/39,17.33%,LRP6;BATF;FBXL17;JARID2;TGFB2;NELFB;GPM6A;HMGA2;TP53;EEF1AKMT4-ECE2;FOXO4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2634857358672194,-1.0702320499280271,0.29310344827586204,1.0,1.0,16/57,11.36%,DLGAP1;GRIN2A;GRIN2B;LRRC7;DLG4;CACNG7;SHISA9;GRIN1;OPRM1;DAPK1;DLG3;NLGN2;SHISA6;CACNG8;GSG1L;PRRT1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4402264327418005,1.0701482607531263,0.3803921568627451,0.868667520236517,1.0,5/21,10.56%,MECP2;CDC25B;CCND1;RAD51C;NPM1
prerank,regulation of cellular response to stress (GO:0080135),0.3494898932263881,1.0701412285324168,0.36649214659685864,0.8680318063271986,1.0,27/115,18.18%,HSPA1B;CAMK2D;NUP37;PNPT1;CAMK2B;SLC38A2;CRHBP;NUP153;RSL1D1;HSP90AB1;AMFR;RAE1;ABCD1;HSPA8;DNAJB6;NPM1;CHORDC1;NEK6;BAG1;AKT1S1;HSP90AA1;NUP155;MTOR;CHCHD2;PTGES3;NUP88;HSBP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3465908183678691,1.070116159239321,0.36585365853658536,0.8674488000571448,1.0,24/151,13.33%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;CX3CL1;FBXW7;FGFR2;MT3;RAPGEF2;ACKR3;HMGB1;APP;ROR2;BMPER;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE;NRP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.491590065619681,1.0700455721554225,0.3792134831460674,0.8670202667467619,1.0,4/11,17.81%,DHFR;GCH1;HSP90AA1;PRKG2
prerank,axon guidance (GO:0007411),0.3424836883862551,1.070018615286075,0.34277047522750254,0.8664389113880959,1.0,42/201,16.33%,PLXNA3;UNC5B;CXCR4;WNT5A;PLXNB2;BDNF;PIK3CD;SEMA4D;NRP2;GRB10;DOK1;SIAH1;GAP43;PLXNB3;EVL;CYFIP1;EPHA4;RET;DOK6;DOK5;EPHA6;NFIB;GDNF;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;CHN1;PIK3CB;NRP1;RAC1;FYN;IRS2;NPTN;DSCAM;SEMA3D;DSCAML1;SCN1B;OPHN1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3441477432277318,-1.0699694026231565,0.35555555555555557,1.0,1.0,3/22,3.13%,PDE3B;APOD;ALK
prerank,inhibitory synapse assembly (GO:1904862),0.5009677785768922,1.0698957320075455,0.39705882352941174,0.8661590745168816,1.0,5/11,21.79%,WNT5A;FGF13;LGI2;CBLN4;GABRB2
prerank,acylglycerol homeostasis (GO:0055090),0.4438433374822596,1.0693559242364041,0.3877005347593583,0.8671730935340128,1.0,6/20,21.72%,LIPC;RORA;APOE;APOC4;IL18;PNPLA8
prerank,apical protein localization (GO:0045176),-0.4261166222009675,-1.0693191746581132,0.3775811209439528,1.0,1.0,2/10,1.41%,ATP8B1;GOPC
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3629672699907241,1.06905173037646,0.37794432548179874,0.867496522456279,1.0,14/77,12.70%,NOL3;CLU;BDNF;ACVR1;ASAH2;FXN;CX3CL1;CFLAR;TCF7L2;CSNK2A2;PHIP;RTKN2;PSME3;RB1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3350311223282566,-1.0687065608561517,0.336322869955157,1.0,1.0,8/23,16.96%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3350311223282566,-1.0687065608561517,0.336322869955157,1.0,1.0,8/23,16.96%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3913629402683756,1.068458209396677,0.4004914004914005,0.8686496434991341,1.0,8/38,9.48%,AGT;THY1;EPHA4;DOK7;FCGR1A;APP;NCK2;PRNP
prerank,regulation of blood coagulation (GO:0030193),-0.31698405236777283,-1.068458164277319,0.3444976076555024,1.0,1.0,10/27,28.29%,DMTN;EPHB2;VTN;ENPP4;FAP;F2R;CAV1;THBD;CD34;ST3GAL4
prerank,brain development (GO:0007420),0.34225145305524757,1.068191047929164,0.36419753086419754,0.8688041954271686,1.0,33/136,18.71%,VPS51;CXCR4;PLXNB2;GRIN2D;PAFAH1B3;SYNJ1;PHGDH;CIC;PITPNM1;UBE3A;TBC1D23;MEIS3;RAPGEF2;CDK5RAP2;NFIB;BPTF;PROX1;DNAJC30;SCYL2;DDIT4;PTPN11;ATXN1;PTCH1;SMARCA1;CTNS;POU6F1;BBS2;DSCAML1;NDUFS4;DHX37;NF1;PAFAH1B1;UTP3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33314491507021604,1.0681898376053467,0.31763527054108215,0.868151519432089,1.0,60/327,15.71%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;SERTAD3;PFDN5;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;NONO;ACTR8;RORA;INSR;DNM2;NAB1;HCFC2;RALY;RYBP;MITF;ZNF423;LDB1;NR3C1;PPARGC1A;RB1;UBE2L3;ATXN1;ZNF35;APBB1;CASZ1;ASCC2;EZH2;SOX2;RREB1;MYB;MYCBP;ZNHIT3;GTF2IRD1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.43133410964078744,-1.0680476596695248,0.382089552238806,1.0,1.0,2/10,1.85%,PPP3R1;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),-0.43133410964078744,-1.0680476596695248,0.382089552238806,1.0,1.0,2/10,1.85%,PPP3R1;PPP3CC
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.47890044264312837,1.0677890731189648,0.39372325249643364,0.8687271670737607,1.0,3/13,12.91%,TPST1;SULT6B1;ENPP1
prerank,negative regulation of immune response (GO:0050777),0.33920672101757,1.0677195966514994,0.3671399594320487,0.8683020871799191,1.0,19/154,12.93%,TRAFD1;CALCA;RXFP2;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;COL3A1;HAVCR2;RHBDF2;FCGR2B
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3630815888811729,-1.0676236512508905,0.3308270676691729,1.0,1.0,3/16,14.92%,PPP1R16B;HMOX1;JCAD
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3561744976629993,1.0675954385683293,0.3760504201680672,0.8680693190582162,1.0,17/83,15.78%,DHFR;ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;CDT1;BACH1;TFDP1;PLK3;MNAT1;MAX;TFDP2;RB1;USP37;NPAT
prerank,regulation of phagocytosis (GO:0050764),0.37383650700646487,1.0673745852276557,0.37485970819304154,0.8681302246389629,1.0,12/53,20.12%,IL15;IL15RA;CD47;HCK;SYT7;TUB;FCGR2B;RACK1;TLR2;PTPRC;SIRPA;TGM2
prerank,actin nucleation (GO:0045010),0.4299710975141466,1.0673021798825095,0.38836265223274696,0.8676749063328479,1.0,7/21,22.47%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,blood vessel diameter maintenance (GO:0097746),0.3964734493775703,1.067239813056593,0.37775061124694376,0.8672150018195245,1.0,2/34,1.61%,AGT;PER2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.37087940534003266,1.0669808725419168,0.3865638766519824,0.8673591697156087,1.0,11/62,11.37%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;LYN;HOXA9;WDR5;EIF6
prerank,positive regulation of cation channel activity (GO:2001259),0.39037289712253775,1.0669642351867956,0.38636363636363635,0.8667611124120459,1.0,7/40,17.49%,GAL;CTSS;ACTN2;CALM3;NLGN3;STAC3;ATPSCKMT
prerank,cognition (GO:0050890),0.3827778403614062,1.0667020145567578,0.3825581395348837,0.8669091605038188,1.0,13/42,18.27%,CHD7;CYFIP1;PTCHD1;DOP1B;METTL23;APP;LINS1;SETD5;CTNS;CHRNB2;MAGT1;NF1;SOBP
prerank,regulation of neutrophil migration (GO:1902622),-0.42689745800448625,-1.0666280777368913,0.35646687697160884,1.0,1.0,3/10,6.49%,NCKAP1L;MPP1;RAC2
prerank,Golgi organization (GO:0007030),0.34921881934893584,1.066590490254622,0.39057591623036647,0.8665803203707115,1.0,39/112,23.17%,VPS51;BLZF1;TJAP1;COG3;GOLGA5;GOLGA8B;SEC16A;GOSR2;ARHGEF7;CUL7;TMED5;FBXW8;RAB43;PLK3;STX16;VCPIP1;UBXN2B;TMED10;TRAPPC12;COG2;ARL1;ARHGAP21;VTI1B;PLEKHM2;VAMP4;STK25;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;RAB1A;GORASP2;TMED7;OPTN;HUWE1;RAB2A;STX6;RAB29
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4566506700089185,1.0662536352815932,0.40612516644474034,0.8669563107108403,1.0,5/16,15.24%,MCM2;MCM7;MCM4;TWNK;RECQL5
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.47803946797412694,1.0660026526590418,0.4116022099447514,0.8670529123735428,1.0,4/14,14.80%,ZFP36;TARDBP;MAPK14;MYD88
prerank,calcium ion import into cytosol (GO:1902656),0.4783155117794008,1.0657195670178514,0.4044943820224719,0.8672452381460862,1.0,3/15,12.88%,TRPM2;SLC8A1;TRPV4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33113099126041934,1.0656319480015488,0.302,0.8668864444192053,1.0,68/366,15.71%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;TCOF1;SERTAD3;CYFIP1;PFDN5;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;CCDC88A;NOLC1;NONO;ACTR8;APP;RORA;INSR;DNM2;PUM3;NAB1;HCFC2;RYBP;MITF;ZNF423;LDB1;NR3C1;PPARGC1A;ORC3;RB1;UBE2L3;ATXN1;ZNF35;APBB1;CASZ1;ASCC2;EZH2;SOX2;RREB1;MYB;USP37;RBM3;MYCBP;ZNHIT3;GTF2IRD1
prerank,neural tube closure (GO:0001843),0.39937048749842907,1.0648914571685988,0.38957816377171217,0.8685055144044085,1.0,4/34,5.34%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,positive regulation of macrophage migration (GO:1905523),0.44764511952870056,1.0647479637637347,0.3943472409152086,0.8682890497447521,1.0,6/19,16.95%,CCL5;CX3CL1;CSF1;P2RX4;CXCL17;MDK
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4711988112686143,1.064664933446957,0.3895522388059702,0.8679093715588212,1.0,6/13,21.77%,BCL2L11;BAD;BMF;BAX;RHOT2;VDAC2
prerank,tight junction assembly (GO:0120192),-0.26876174241189277,-1.064363605844465,0.30303030303030304,1.0,1.0,23/49,35.27%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;LSR;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,response to organonitrogen compound (GO:0010243),0.39083020081737935,1.0642872413450344,0.38941176470588235,0.8683644928147833,1.0,13/38,25.08%,DHFR;TRPM2;RNF5;RRAGC;GLRA2;RNF185;MTOR;KAT7;GLRA1;KYNU;IRF5;VCP;HLCS
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4269316452614742,1.0642045146318464,0.4007832898172324,0.8679741390566813,1.0,5/22,12.02%,ABCG1;CLU;EPHA4;LYN;LRRTM3
prerank,vasculogenesis (GO:0001570),0.3970069460062821,1.0641434221962867,0.3997539975399754,0.8675173090262497,1.0,5/32,9.11%,KDR;CUL7;WNT7B;ITGB8;EGFL7
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.47493769152644993,1.063909402573396,0.423728813559322,0.8675532862816616,1.0,6/12,22.15%,PCGF5;CDYL;RBM15;LRIF1;SMCHD1;PCGF3
prerank,piRNA metabolic process (GO:0034587),-0.35136640483872955,-1.0638413093895331,0.3584905660377358,1.0,1.0,10/19,48.31%,TEX15;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,negative regulation of JNK cascade (GO:0046329),0.40702692451670613,1.0636003905535234,0.3909313725490196,0.8678585266934669,1.0,6/31,12.59%,TAOK3;DUSP3;CYLD;DACT1;MEN1;DUSP10
prerank,regulation of humoral immune response (GO:0002920),0.3811191945936353,1.0635702196107546,0.36616454229432216,0.8673106154628185,1.0,7/44,16.14%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,activation of protein kinase A activity (GO:0034199),-0.36114860000538196,-1.0635571377150292,0.380327868852459,1.0,1.0,4/16,6.53%,ADCY9;PRRC1;ADCY3;PRKACB
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.42105894257063103,1.063333474891962,0.404551201011378,0.8673778662780801,1.0,7/26,18.47%,ASAH2;CYB5B;CYB5R3;SPHK2;GCH1;ACER3;SPTLC2
prerank,regulation of cellular response to heat (GO:1900034),0.35892195618080786,1.062903916032743,0.3861920172599784,0.8680477773848532,1.0,21/77,20.35%,HSPA1B;CAMK2D;NUP37;CAMK2B;NUP153;HSP90AB1;RAE1;HSPA8;DNAJB6;CHORDC1;IER5;BAG1;AKT1S1;HSP90AA1;NUP155;MTOR;PTGES3;NUP88;HSBP1;NUP133;NUP43
prerank,regulation of cell morphogenesis (GO:0022604),0.40282787339861764,1.062731089081038,0.3982947624847747,0.8679489692459486,1.0,9/30,17.74%,MOV10;FMNL2;PDPN;ZMYM3;PHIP;CAPZB;ZRANB1;ZMYM6;SH3D19
prerank,pentose-phosphate shunt (GO:0006098),0.4866590173201783,1.0624895375052748,0.40634441087613293,0.8680482122322044,1.0,7/11,21.83%,PGD;PGLS;RPIA;DERA;RPE;TKT;TALDO1
prerank,peptidyl-tyrosine modification (GO:0018212),0.36787408923068843,1.062325538512484,0.401123595505618,0.8678880742825366,1.0,8/56,9.32%,TPST1;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3690515797140413,1.062102747532569,0.39603960396039606,0.8679235651396475,1.0,17/51,19.80%,TAOK3;BDNF;CNTNAP1;GAS7;EPB41L3;TNIK;DNM2;ANKRD27;SRGAP2;MINK1;DBNL;TAOK2;SNX1;NYAP2;DICER1;DTNBP1;NCKAP1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3999095041481201,1.0617840129687803,0.3910411622276029,0.8682134177574214,1.0,11/33,18.77%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;STN1;HSP90AA1;PTGES3;TERF2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3725389687940163,1.0614598246026383,0.3947065592635213,0.8685198405676419,1.0,18/50,23.70%,TUBD1;KIF7;FGFR2;UCHL5;RORA;PDCL;BTRC;GAS1;RACK1;PTCH1;TULP3;DCDC2;MGRN1;GLI3;HERC4;KCTD21;TTC23;VCP
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.44788405207673343,1.0614257055108747,0.4005602240896359,0.8679676910409989,1.0,6/16,15.80%,RBMX;SNW1;DAZAP1;RBM3;NCBP1;SF3B4
prerank,positive regulation of translation (GO:0045727),0.35065397985285757,1.061294167384717,0.38675213675213677,0.8677462148513161,1.0,23/94,18.81%,POLR2G;PLXNB2;AGO2;YTHDF1;LARP1;CCL5;DHX36;ZCCHC4;NGRN;RCC1L;DHX9;YTHDF2;NPM1;EIF6;PRKDC;TRMT10C;UPF3A;RBM3;MTOR;METTL14;JMJD4;EIF2B5;FASTKD2
prerank,supramolecular fiber organization (GO:0097435),0.3320256522697908,1.061052562591138,0.344,0.8678539446361965,1.0,63/333,14.44%,LOXL2;CALCA;COL13A1;UBE2L6;B2M;P4HA1;ACTN1;KATNAL1;ADAMTS3;COL9A1;MYO1C;ELMO2;RHOF;MAD2L2;COL4A2;RUFY3;DYNC1H1;PPP1R9A;SIAH1;COL14A1;EVL;HSP90AB1;KIF2C;P3H1;CARMIL1;GGA3;COL5A3;HOOK2;COL8A1;COL22A1;SAMD14;STMN4;CCDC88A;BCAR1;SCX;APP;BFSP1;PLK3;HOOK1;DNAJB6;TPPP3;CIB1;STMN3;CCDC88B;ARHGAP25;COL3A1;SORL1;CORO7;GSN;FAT1;TMOD3;ADAMTS2;COL11A2;TRPV4;FGF13;CLIP2;WHAMM;HOOK3;CORO1B;MYO6;RAC1;DLG1;APH1A
prerank,protein localization to Golgi apparatus (GO:0034067),0.41579485487427437,1.0609599661434486,0.4167725540025413,0.8674855063887573,1.0,11/27,21.23%,GBP5;PAQR3;TMED10;ARL1;SORL1;ARL5C;VPS13D;VPS13A;GBF1;VPS13C;OPTN
prerank,intraciliary retrograde transport (GO:0035721),0.47987136203243264,1.060542239541251,0.4178470254957507,0.868089546112583,1.0,7/12,26.83%,WDR35;DYNC2LI1;DYNLT2B;DYNC2H1;WDR19;IFT140;IFT43
prerank,body fluid secretion (GO:0007589),-0.37616031875532097,-1.0604198967975635,0.37037037037037035,1.0,1.0,10/15,48.71%,ZBTB7B;GUCA1B;GPAT4;NPR1;APLN;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,protein localization to organelle (GO:0033365),0.34317205175193577,1.060166095413885,0.3817427385892116,0.8685889545786498,1.0,30/133,19.21%,ISG15;GBP5;TOR1AIP1;AUP1;DDRGK1;GBP2;LAMP2;COG3;SNX10;FAM83H;DHX9;TUB;CNTLN;PAQR3;APP;TRAM2;PRNP;WDR35;ARL1;SORL1;ZNF423;VAMP2;BBS2;RPL11;RAB11A;TULP3;LAMP1;GBF1;SERP1;CD68
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4569705299993569,1.0596454704865672,0.39196675900277006,0.869525830376426,1.0,2/15,3.86%,DTX3L;MAD2L2
prerank,response to estrogen (GO:0043627),0.4045893970497156,1.0596381909975001,0.4057788944723618,0.8689125930675429,1.0,4/31,5.46%,TRIM25;RBBP5;CRHBP;SRA1
prerank,cellular component assembly (GO:0022607),0.33929664727826137,1.0594955698587025,0.3417085427135678,0.86870771189032,1.0,52/253,16.65%,SYCP1;PML;HAS3;WNT5A;GPAA1;TEAD2;CD40;HAS1;YTHDF1;LAMC1;PARVB;MDN1;CHCHD10;TLCD2;TSPAN4;CCDC40;TAPBP;SOX9;CYFIP1;RHOJ;KMT2A;STX7;SKAP2;DET1;AIF1L;YTHDF2;MNAT1;VCPIP1;TEX11;CHAF1B;SPEF1;SNX9;MITF;GSN;LRRTM3;PPARGC1A;LIMS1;VAMP2;CORO1B;BSN;ACTB;RAC1;IL1RAP;STK25;SH3BP1;AIF1;BAIAP2;LLGL1;NLGN3;OPHN1;BAIAP2L1;WDR19
prerank,protein deacylation (GO:0035601),-0.3260094289502008,-1.0594783309434548,0.3333333333333333,1.0,1.0,7/23,10.83%,LYPLA1;SIRT7;SIRT1;LYPLAL1;ABHD17B;SIRT5;ABHD17C
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.43722657694654987,1.0593044657470265,0.4233289646133683,0.8686527892501644,1.0,6/20,17.03%,ZC3H7A;AGO2;TARBP2;ZC3H7B;DICER1;PRKRA
prerank,mRNA transport (GO:0051028),0.350008801806334,1.0592043921354901,0.3836477987421384,0.8683083788836359,1.0,30/101,20.94%,NUP37;ZFP36;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;ZFP36L1;SMG5;UPF2;ZC3H11A;CHTOP;DDX39B;NUP155;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5
prerank,telomere maintenance (GO:0000723),0.37630455044007527,1.0589619423452676,0.40022805017103763,0.8684267097472373,1.0,9/50,14.28%,SP100;TPRKB;POLD4;RTEL1;ERCC4;XRCC3;PRKDC;STN1;NSMCE2
prerank,negative regulation of protein processing (GO:0010955),0.48531922535253114,1.0586058215400773,0.4017216642754663,0.8688252286310472,1.0,4/12,23.89%,PRNP;GAS1;TMEM59;SNX12
prerank,signal transduction in response to DNA damage (GO:0042770),-0.26627732190776376,-1.0585239588264816,0.3629032258064516,1.0,1.0,18/49,17.56%,MAP3K20;NBN;USP28;CEP63;BCL3;RHNO1;BATF;NDRG1;CASP9;DONSON;HUS1;RAD17;TP53;CLSPN;ACER2;E2F1;STK33;RAD1
prerank,nitric oxide biosynthetic process (GO:0006809),0.4756117679943911,1.0583461841323942,0.39565217391304347,0.8689612964477086,1.0,3/13,10.29%,CYB5B;CYB5R3;GCH1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.45320975709752054,1.0581899621402437,0.4104372355430183,0.8687572763818519,1.0,5/16,11.62%,DHX36;RTEL1;HNRNPA2B1;ERCC4;SMG5
prerank,barbed-end actin filament capping (GO:0051016),-0.344273367837186,-1.058127081810476,0.37349397590361444,1.0,1.0,3/18,12.96%,ADD1;EPS8;CAPG
prerank,actin filament capping (GO:0051693),-0.344273367837186,-1.058127081810476,0.37349397590361444,1.0,1.0,3/18,12.96%,ADD1;EPS8;CAPG
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.39094191304884096,1.0579036497839478,0.40625,0.8690115221470961,1.0,12/39,20.79%,SOCS1;PIK3CD;ITPKC;SOCS5;PI4KB;EFR3A;SOCS2;PIK3CB;SOCS6;PI4KA;SOCS4;SOCS7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4555840201180817,1.0578685879025824,0.382228490832158,0.8684880751702951,1.0,2/16,3.73%,CAMK2D;SLC8A1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3833842914675824,-1.0577632727989112,0.37184115523465705,1.0,1.0,7/15,20.10%,FLOT1;EHD1;CAMK1;TREM2;RIPOR2;RAPGEF3;ADAM9
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.35144013612392155,1.05771567226478,0.38788522848034007,0.868314748282334,1.0,19/93,15.07%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;CNKSR3;PAQR3;NCK1;APP;NCK2;PPM1F;DDIT4;AKAP9;RACK1;HSP90AA1;INPP5K
prerank,liver development (GO:0001889),0.40169502388595507,1.0576284066224708,0.408812729498164,0.8679222991269473,1.0,7/32,11.51%,GFER;ARID5B;CCDC40;NPHP3;MET;PROX1;XBP1
prerank,atrial septum morphogenesis (GO:0060413),0.5008226581369145,1.0574821360105586,0.3996983408748115,0.8677154057651099,1.0,2/10,9.69%,ACVR1;BMPR2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.35410554929641136,1.0574448770461755,0.39572192513368987,0.86720315371215,1.0,27/88,19.42%,BLOC1S4;GOLGA7;KLHL20;AP2A1;AP1S1;DOP1B;APP;KIF16B;HSPA8;DNM2;RAB14;EXOC6;SORL1;CORO7;SCFD1;ARFGEF2;VAMP2;NAPA;STX4;SNAP23;HGS;LLGL1;VPS13A;SH3D19;GBF1;DTNBP1;VPS13C
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.313363821636755,-1.0573991537041154,0.36619718309859156,1.0,1.0,15/27,28.70%,PAK2;RHPN2;CLASP2;SHANK3;WAS;F11R;WASF2;CLASP1;SHANK1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28;PRKN
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4722422502805863,1.0571081372150486,0.39568345323741005,0.8675803224493276,1.0,2/13,2.79%,ESR2;ABHD2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3493962040824467,1.0567253676361636,0.3964248159831756,0.8680463288205771,1.0,21/98,17.85%,AGT;NR1H2;XDH;SLCO1C1;CCL5;MT3;CSF1;MAGI2;DHRS4;INSR;MAPK14;ARRB2;ZC3H12A;SCYL2;IL10RB;APOE;PPARD;ACOD1;CHCHD2;ATAD1;GHITM
prerank,plasma membrane organization (GO:0007009),0.3614516791108836,1.056556254820007,0.39043381535038935,0.867929265153387,1.0,12/61,14.02%,CHMP4A;CXCR4;SNX33;TLCD2;DEGS1;SYT7;EPB41L3;ABCD1;FNBP1L;SNX9;WHAMM;STX4
prerank,extracellular matrix assembly (GO:0085029),0.42490424023386175,1.0561617185527692,0.41145139813581894,0.8684328035270599,1.0,3/23,3.80%,HAS3;HAS1;LAMB2
prerank,muscle cell differentiation (GO:0042692),-0.30353939899860183,-1.0551579610320243,0.34269662921348315,1.0,1.0,13/32,21.94%,SEMA4C;DMD;NINJ1;NEBL;SPEG;MRTFB;KDM1A;WNT5B;GLMN;TMEM204;MTLN;MEF2C;NEB
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3610915748827133,1.0550554961449579,0.3938730853391685,0.8711233212903983,1.0,17/69,15.45%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;TMEM67;ERLIN2;RNF103
prerank,regulation of receptor recycling (GO:0001919),-0.3532279106042291,-1.0550257426356295,0.35294117647058826,1.0,1.0,5/16,15.56%,INPP5F;SNCA;NSF;VAMP3;SCRIB
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.37155853384526144,1.0549044356681878,0.3986095017381228,0.8709245803961644,1.0,17/49,22.72%,FIS1;BCL2L11;SIAH1;CYLD;UBQLN1;RTKN2;RACK1;BAD;BMF;BAX;BECN1;BCAP31;DDX3X;LCK;PLAUR;MCL1;BCL2L2
prerank,synapse assembly (GO:0007416),0.3624423015419403,1.0548454743823472,0.39562841530054643,0.8704813879609595,1.0,14/67,16.25%,SLITRK6;PCDHB13;WNT5A;PLXNB2;BDNF;PCDHB16;SDK1;LRRTM3;FGF13;DNER;LGI2;DBNL;DSCAM;NLGN3
prerank,skin development (GO:0043588),0.36138823135042913,1.0544439014739542,0.39759036144578314,0.8710727974790493,1.0,7/65,11.30%,CLIC4;WNT5A;ITGA3;PIP5K1A;COL5A3;MET;COL3A1
prerank,cellular copper ion homeostasis (GO:0006878),0.46687935083202947,1.0541924447567355,0.399702823179792,0.8711977195278406,1.0,6/14,25.64%,APP;PRNP;COX19;SLC31A1;SLC31A2;ATP7B
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3517105778075021,1.054163996557921,0.40631808278867104,0.870649079357693,1.0,18/74,21.92%,LOXL2;SPRY2;SFRP2;MAD2L2;CTNNB1;SMAD2;BAMBI;PDPN;PHLDB1;DAB2;EZH2;MTOR;MDK;SPRED3;SPRED1;USF3;ADIPOR1;GCNT2
prerank,morphogenesis of an epithelium (GO:0002009),0.41063668145279963,1.0538337182767261,0.4092664092664093,0.8709676206460013,1.0,3/25,6.02%,TIMELESS;SOX9;FGFR2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4976411178730278,1.0538126836069868,0.42208774583963693,0.8697648965760549,1.0,4/11,10.66%,MEPCE;CCT4;CCT7;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4976411178730278,1.0538126836069868,0.42208774583963693,0.8697648965760549,1.0,4/11,10.66%,MEPCE;CCT4;CCT7;CCT3
prerank,tRNA aminoacylation (GO:0043039),0.3845598030667921,1.0534497068386608,0.38814993954050786,0.8702137852921151,1.0,10/37,18.75%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;YARS2;EEF1E1;PPA1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.38205791053205546,1.053339177287652,0.40162037037037035,0.8699197938686765,1.0,11/44,16.39%,HCK;EVL;CARMIL1;NCK1;NCK2;SNX9;GSN;PRKCE;WHAMM;BAIAP2;BAIAP2L1
prerank,toxin transport (GO:1901998),0.4960973338403297,1.0528596768701783,0.3975720789074355,0.8706341052375298,1.0,5/10,31.20%,ANTXR1;ANTXR2;RAB29;ADAM10;RAB40B
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4441803208609047,1.0527415560857092,0.4176548089591568,0.8703689894829348,1.0,2/16,4.60%,AOAH;PGM2L1
prerank,respiratory electron transport chain (GO:0022904),0.47025146791859174,1.052652080820304,0.41739130434782606,0.8700144576320502,1.0,4/14,14.86%,SLC25A22;NDUFA5;PPARGC1A;SLC25A12
prerank,chromatin assembly (GO:0031497),0.3832882632200038,1.0521325559999264,0.4121071012805588,0.8709195512591816,1.0,7/38,10.98%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1;CTCF
prerank,regulation of ossification (GO:0030278),0.38825607622766106,1.0518016583495642,0.4146341463414634,0.8712659751007781,1.0,10/36,16.95%,WNT5A;ACVR1;SOX9;NBR1;ANKH;BMPR2;PTPN11;ENPP1;RBPJ;MDK
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3990926419703134,1.0517812545317595,0.4108433734939759,0.8707015318352601,1.0,10/31,23.54%,CD40;HMGB1;MAPK14;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.47611567411396394,1.0514833394053211,0.4029197080291971,0.8709845805009554,1.0,4/12,15.04%,DCK;TK1;TK2;UCKL1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.45989313060600967,1.0514418492077517,0.4235127478753541,0.8704891459514116,1.0,2/14,5.02%,SLAMF1;TLR8
prerank,microtubule polymerization or depolymerization (GO:0031109),0.415789388072896,1.0501709505992338,0.4084507042253521,0.8737547139375502,1.0,9/24,19.54%,KIF2C;STMN4;TPPP3;STMN3;TRPV4;FGF13;KIF2A;STMN2;PIN1
prerank,positive regulation of receptor internalization (GO:0002092),0.4294071272315404,1.0498133263340828,0.420844327176781,0.874174361848467,1.0,5/22,17.38%,MAGI2;INSR;ARRB2;SCYL2;ATAD1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.38785492477813527,1.0495840104842207,0.423444976076555,0.874245560430925,1.0,7/39,12.94%,PWP2;LTV1;NOB1;ERAL1;NPM1;RIOK3;RPS6
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.34994763569241244,-1.0493313668323723,0.34210526315789475,1.0,1.0,6/18,8.56%,APOD;CTNNA1;POLR1A;UFM1;CABP1;GSK3B
prerank,tryptophan catabolic process (GO:0006569),-0.39272493005452336,-1.0493020213867215,0.37012987012987014,1.0,1.0,5/11,39.83%,KMO;IL4I1;AFMID;IDO2;KYAT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3797283117855908,1.049257413550828,0.41037735849056606,0.8745978808400077,1.0,10/43,16.15%,IRS1;SOCS1;GRB10;NCK1;KANK1;SORL1;PTPN11;ENPP1;INPP5K;GKAP1
prerank,positive regulation of insulin secretion (GO:0032024),0.3868752554902535,1.0492467529007061,0.41350710900473936,0.8740053480212175,1.0,10/36,20.32%,CLTRN;TCF7L2;BAIAP3;MYRIP;BAD;STX4;IRS2;GLUD1;PSMD9;PLA2G6
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3447607105064853,1.0490036365297473,0.3936279547790339,0.8741043121172318,1.0,34/128,18.92%,PKMYT1;SKP1;CHEK2;ARPP19;CDC25B;DYNC1H1;BACH1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP152;CEP131;CEP70;AKAP9;TUBB4B;DYNLL1;KDM8;HSP90AA1;MASTL;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,membrane organization (GO:0061024),0.33034434294446685,1.048877107990114,0.40421263791374124,0.8738327693324661,1.0,47/227,15.19%,CHMP4A;CHMP4B;TOR1AIP2;TOR1AIP1;CHMP1B;WNT5A;AZIN2;TGFA;ACTR2;LRP2;RTP4;SYNJ1;TLCD2;AP2A1;SH3GLB1;ACTR3;GAPVD1;CCDC88A;TIMM50;LPCAT2;VAPB;LDLRAP1;HSPA8;UBXN2B;ARRB2;FNBP1L;SNX9;AP2S1;NECAP1;DNM2;SUN2;CHMP3;ARPC5;PIP5K1C;VAMP2;REEP3;VTI1B;NAPA;DAB2;NPC1;ACTB;SNAP23;VAMP4;PLEKHA3;NUP155;SYNGR1;HGS
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4367400126235102,1.0484975174519087,0.43087248322147653,0.8743601810090688,1.0,4/18,12.02%,ABCG1;CLU;EPHA4;LRRTM3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.4736832089838989,1.0482930922372558,0.4035608308605341,0.8742958104977572,1.0,1/12,1.22%,CAMK2D
prerank,regulation of ruffle assembly (GO:1900027),0.4094504082954131,1.047839719521886,0.3820816864295125,0.8750318102268756,1.0,5/23,12.08%,EVL;P2RX4;KANK1;DEF8;STAP1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3345421549488315,1.0473252063323026,0.3943089430894309,0.8759769929075136,1.0,33/166,16.80%,NR1H2;IRS1;PLXNB2;CLU;SLC27A1;PPP1R3E;ARPP19;YTHDF1;CCL5;HSP90AB1;ZCCHC4;CDT1;DHX9;SLC45A3;SMOC2;P2RX4;INSR;NPM1;EIF6;DYRK2;LDB1;PRKDC;PPARGC1A;UPF3A;STN1;IRS2;HSP90AA1;LPGAT1;RBM3;PRMT1;MTOR;SREBF1;METTL14
prerank,axon extension (GO:0048675),0.41520985656832504,1.047053609798881,0.4117647058823529,0.8761578871578933,1.0,9/23,19.08%,NRP2;HSP90AB1;CYFIP1;SLIT3;SLIT1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,regulation of primary metabolic process (GO:0080090),0.33715583305058816,1.0470389497076116,0.40309278350515465,0.8755789525443537,1.0,44/126,25.95%,HELZ2;PSMB10;PSME2;PSMA5;PSME4;NCOA1;PSMA3;EDF1;RUBCNL;PSMB9;FDFT1;TGS1;PSMD2;AZIN1;PSME3;APOE;GGPS1;IRS2;PSMA4;PPARD;SREBF1;IDI1;LDLR;PSMD7;CERS2;PSMD9;PSMD8;NR1D2;PSMF1;ADIPOR1;PSMB6;TNFAIP8L3;PSMD12;PSMC2;HMGCS1;PSMD4;HMGCR;PSMA2;NCOR2;PRKAB2;BBS4;PLPP1;PSMD1;PSMD11
prerank,central nervous system neuron axonogenesis (GO:0021955),0.4714274480701635,1.0469511207969198,0.4233576642335766,0.8752198302678768,1.0,5/12,15.21%,HSP90AB1;B4GALT5;HSP90AA1;CHRNB2;MYCBP2
prerank,response to UV-A (GO:0070141),-0.3751206938396189,-1.0461400918206762,0.3782894736842105,1.0,1.0,7/14,27.11%,MMP1;EGFR;AKT1;CERS1;MMP2;OPN3;PPID
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4272440964583,1.045987498996161,0.40329218106995884,0.8775212744737052,1.0,7/19,23.31%,RUNX1;FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,copper ion homeostasis (GO:0055070),0.44266058464041225,1.0455394061301189,0.4133148404993065,0.8782370156593415,1.0,8/17,25.64%,APP;PRNP;COX19;SLC31A1;SLC31A2;XIAP;COMMD1;ATP7B
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.3855856826182335,-1.045486204985331,0.42011834319526625,1.0,1.0,4/12,12.77%,SMARCA4;ZBTB7A;SIRT1;FOXP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.36854927324027154,1.045458169773328,0.42075892857142855,0.8778590974524113,1.0,12/47,15.96%,ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;ZC3H12A;ZFP36L1;XBP1;PIM1;RREB1;PPARD
prerank,anterograde axonal transport (GO:0008089),0.38823107683981845,1.0449327434354345,0.4303030303030303,0.8787813658508327,1.0,7/37,12.16%,BLOC1S4;RAB21;TRAK1;KIF3B;MAPK8IP3;AP3M2;AP3S2
prerank,regulation of axonogenesis (GO:0050770),0.3721431927942874,1.0446483849942465,0.4152445961319681,0.8790130641211492,1.0,11/51,13.46%,PLXNA3;PLXNB2;THY1;RUFY3;PLXNB3;EPHA4;PAK3;MAG;CHN1;SIPA1L1;TIAM2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.40751745474534645,-1.0444883416409179,0.37333333333333335,1.0,1.0,4/11,16.83%,ARRB1;GRK3;GRK2;SAG
prerank,regulation of muscle contraction (GO:0006937),0.40286391703989427,1.0444628396544264,0.40175219023779724,0.8789437984098746,1.0,3/26,5.30%,DAPK3;MYL9;TNNC1
prerank,protein modification by small protein removal (GO:0070646),0.3297242732369172,1.044402474155017,0.4046184738955823,0.8785086181340989,1.0,81/252,24.19%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;SENP3;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;SENP5;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;COPS7B;TRAF3;VCPIP1;ARRB2;JOSD2;TNIP1;ATXN7;FOXK1;ZC3H12A;OTUD1;PSMD2;USP14;PSME3;USPL1;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;BABAM2;COPS8;PSMD7;PSMD9;OTUD6B;PSMD8;BECN1;NFRKB;MBD6;PSMF1;USP5;PSMB6;USP8;USP33;PSMD12;PSMC2;SENP8;COPS7A;SENP7;SMURF2;ADRM1;PSMD4;SENP2;PSMA2;VCP;KAT2B;ACTL6A;USP32;USP10
prerank,mitotic cell cycle phase transition (GO:0044772),0.3347200377305244,1.044248518402931,0.38306451612903225,0.8783495991985744,1.0,42/203,15.03%,PKMYT1;CHMP4B;SKP1;CHEK2;ACVR1;CUL5;ARPP19;CDC25B;CCNJ;DYNC1H1;CCND2;GSPT1;CDKN2D;CACUL1;CCND1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;MAX;DNM2;PHLDA1;NEDD1;CEP152;CEP131;CDC16;CDC27;CEP70;AKAP9;RB1;TUBB4B;DYNLL1;CCNI;KDM8;HSP90AA1;MASTL;USP37
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36290111859632584,1.0440898155484897,0.43246311010215666,0.8781978461047488,1.0,20/53,23.70%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;BCKDK;AZIN1;PSME3;PSMA4;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2
prerank,sterol metabolic process (GO:0016125),0.35829075984846753,1.0438344089582596,0.4119601328903654,0.8783348394685917,1.0,17/60,23.32%,ABCA1;ABCG1;CH25H;CYP26B1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;CYP39A1;ABCA5;HMGCR;CLN6
prerank,"phagocytosis, engulfment (GO:0006911)",0.3910842490193638,1.043739254563337,0.40481927710843374,0.8779997625248702,1.0,13/36,21.34%,GULP1;XKR7;MEGF10;FCGR1A;ARHGAP25;GSN;FCGR2B;RAC1;SH3BP1;AIF1;MYH9;MSR1;RHOH
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.28505034805318163,-1.043531852033585,0.3413173652694611,1.0,1.0,13/39,17.86%,RCC2;SPOCK1;CORO2B;DMTN;JAG1;RHOA;SEMA3E;NEXMIF;ACER2;HOXA7;FZD7;MAP4K4;ITGB1BP1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4221619548387667,1.043487692127672,0.4260869565217391,0.8781198365936026,1.0,4/25,9.00%,CDH13;ITPR1;TMBIM4;P2RX4
prerank,cellular response to hydroxyurea (GO:0072711),0.49631373940652207,1.043303191850593,0.4528023598820059,0.8780824360602674,1.0,4/10,18.99%,TIMELESS;DDX11;RTF2;DDI2
prerank,regulation of lipid storage (GO:0010883),0.41846950508299235,1.0430013097171664,0.4230769230769231,0.8783510589955964,1.0,5/22,10.62%,ALKBH7;IKBKE;FBXW7;NFKB1;ZC3H12A
prerank,endocytic recycling (GO:0032456),0.36983061295935654,1.0426553248017856,0.43657142857142855,0.8787406269717384,1.0,20/50,24.95%,VPS51;VPS53;DENND1A;RAB11B;RAB14;ANKRD27;VPS50;VPS52;CMTM6;VPS26A;DENND1B;ENTR1;VPS35;ACAP2;STX6;VPS39;SNX17;SNX12;ARL4C;PTPN23
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2810334273062813,-1.042491791057966,0.4025157232704403,1.0,1.0,14/40,21.74%,IMPACT;REST;BRINP1;MMD2;RHOA;ARHGEF2;BRINP2;NRCAM;HOXD3;ZC4H2;ECT2;NBL1;MEF2C;TCF3
prerank,histone modification (GO:0016570),0.3413715146279073,1.0424314643889117,0.4329896907216495,0.8787876660154021,1.0,42/109,28.81%,EYA4;PRMT2;RBM14;MTA3;NAA50;USP21;UBE2B;NTMT1;NSD3;MT3;MTA2;ATXN7;MIER1;EZH2;RCOR3;PRMT1;EYA2;KAT8;ENY2;HDAC1;SGF29;PRKCD;HUWE1;RUVBL2;HDAC2;KAT6A;HDAC4;KAT5;HDAC6;HLCS;SIRT2;EYA3;EHMT2;RUVBL1;EYA1;UFL1;EP300;UBE2N;BRD8;HDAC5;USP22;NEK11
prerank,protein O-linked glycosylation (GO:0006493),0.34385776199604073,1.0419320704393176,0.4170168067226891,0.8796315776836192,1.0,22/96,19.24%,ST6GALNAC4;TMTC1;POMT1;TRAK1;POMT2;GALNT15;GALNT7;ST6GAL1;GCNT4;GALNTL6;B4GALT5;ST3GAL1;XXYLT1;B3GLCT;GALNT18;CRPPA;TET2;GALNT1;TMTC4;GXYLT1;GALNT13;GALNT14
prerank,cellular response to chemical stress (GO:0062197),0.34616911394659794,1.0418944375954609,0.44293193717277485,0.8791166826008139,1.0,20/96,17.01%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;TRPV4;EIF2S1;STX4;PRDX2;ADNP2;MSRA;AIF1;CHCHD2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.38879083129573816,1.041585712489407,0.41544117647058826,0.8794228084433555,1.0,9/34,22.01%,NOD2;FLT1;IRS1;PIK3R4;RUBCN;FGFR3;WDR91;TNFAIP8L3;FGF2
prerank,dendritic cell chemotaxis (GO:0002407),0.46122501942415245,1.0415036177831423,0.4230769230769231,0.8790562306806979,1.0,4/14,9.03%,CXCR4;TRPM2;CCL5;HMGB1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.46713340530864605,1.0410071628231938,0.41620111731843573,0.8798864293042289,1.0,4/13,18.65%,DDX5;EEF1E1;SPRED3;SPRED1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4428714615101481,1.040934861988944,0.4251412429378531,0.8795067799192996,1.0,7/16,22.63%,HASPIN;NAA50;MAU2;RB1;POGZ;PDS5B;PDS5A
prerank,positive regulation of cell projection organization (GO:0031346),0.34096548168005575,1.0408728949843324,0.4156378600823045,0.8790669874455951,1.0,28/115,18.35%,PLXNA3;WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;CX3CL1;P3H1;CARMIL1;CUL7;RET;MAGI2;FBXW8;RAPGEF2;LTK;LYN;ROR2;CUX1;APOE;RAPGEF1;TIAM2;NPTN;SCN1B;STMN2;MDK;FUT9;CAPRIN1
prerank,regulation of neurogenesis (GO:0050767),0.360140233717579,1.040856853082386,0.4284090909090909,0.8784926102991053,1.0,11/55,13.62%,PER2;B2M;LRP2;BHLHE40;CX3CL1;CTNNB1;YTHDF2;SNW1;SORL1;NUMBL;HOOK3
prerank,mitotic recombination (GO:0006312),0.44560548499251584,1.0405847974293279,0.40716180371352784,0.8786927363979085,1.0,4/15,15.02%,TPRKB;XRCC3;NSMCE2;GEN1
prerank,cellular response to fatty acid (GO:0071398),0.48558404721798004,1.0404206484251795,0.4296407185628742,0.8785696774425382,1.0,2/12,10.62%,IRS1;ZC3H12A
prerank,apical junction assembly (GO:0043297),-0.2619664844892187,-1.0403385608928561,0.3779527559055118,1.0,1.0,27/53,35.27%,CTNNA1;PAK2;ARL2;APC;PRKCI;RHOA;F11R;ECT2;MARVELD2;VCL;STRN;CLDN14;PECAM1;WDR1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;RHOC;MPP7;CLDN5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.40782907113809497,1.040247329311373,0.43312101910828027,0.8784558299717184,1.0,6/25,15.26%,CAMK2D;AKAP9;CTNNA3;FGF13;DLG1;CALM3
prerank,regulation of TORC1 signaling (GO:1903432),-0.2950934813622404,-1.04023549036845,0.4074074074074074,1.0,1.0,6/33,7.58%,GPR137C;GPR137B;RRAGD;RRAGB;CASTOR2;LARS1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44936066387711043,1.040167290844324,0.4475806451612903,0.8780711078512059,1.0,4/17,9.48%,THY1;DUSP3;SH2D1A;PRNP
prerank,embryonic organ morphogenesis (GO:0048562),0.3799350321062255,1.0400129455804221,0.42502951593860683,0.8779147063154933,1.0,6/42,8.87%,RARG;ACVR1;FGFR2;FBN1;MFAP5;HOXA9
prerank,homeostasis of number of cells (GO:0048872),-0.3933207301699491,-1.0396894132930554,0.40476190476190477,1.0,1.0,5/12,21.14%,NAPEPLD;CX3CR1;CARD9;OCIAD2;F2R
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.35733180945434145,1.0395891400495993,0.4077669902912621,0.8785607769859132,1.0,17/66,20.49%,HYAL1;PSME2;PRMT2;RBL1;CCND2;CDKN2D;CCND1;TFDP1;DACT1;PSME3;RB1;DLG1;AIF1;BRD7;WEE1;APPL2;DDX3X
prerank,positive regulation of DNA repair (GO:0045739),0.3703939203529355,1.0395017370038886,0.4287383177570093,0.8781948122923905,1.0,20/46,28.20%,EYA4;TMEM161A;TIMELESS;SLF2;DHX9;HMGB1;DDX11;ZCWPW1;EYA2;BABAM2;SLF1;SMCHD1;TIGAR;XRCC1;TRIM28;EYA3;FMN2;EYA1;UBE2N;BABAM1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41103413839719777,1.0393980596928567,0.4325,0.877912517714903,1.0,8/26,24.86%,CLTRN;ADCY5;BAIAP3;STX4;PLA2G6;PIM3;CDK16;CFTR
prerank,lymphocyte differentiation (GO:0030098),0.35308713073719333,1.0393421750368903,0.4264232008592911,0.8774900248757445,1.0,17/68,21.34%,AXL;MSH2;PIK3CD;CHD7;LEPR;RELB;IKZF1;LMBR1L;NHEJ1;BLNK;ITGA4;PTPRC;KAT7;LCK;VCAM1;TPD52;RHOH
prerank,external encapsulating structure organization (GO:0045229),0.32799548932700495,1.0390691798859457,0.4236602628918099,0.8776674530705152,1.0,38/205,18.18%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ADAMTS12;ST7;ADAMTS6;NID2;JAM3;ITGA4;COL15A1;NF1;VIT
prerank,cellular response to mechanical stimulus (GO:0071260),0.37263593390293187,1.0390059625038737,0.4218390804597701,0.8772450209110225,1.0,16/46,24.67%,TNFRSF8;CD40;PTGER4;CHEK1;TLR8;SOX9;NFKB1;BAD;MYD88;TLR3;CRADD;GADD45A;PIEZO1;TLR7;IRF1;MAP2K4
prerank,cellular protein modification process (GO:0006464),0.32163490724813654,1.038851151933717,0.311,0.8770885618902874,1.0,256/982,22.39%,PARP14;EIF2AK2;PARP10;PARP9;ISG15;WNT11;LIPT1;LOXL2;ZC3HAV1;TAOK3;PSMB10;DAPK3;GLYCTK;UBE2L6;SGK2;SGK3;RSKR;CAMK2D;MACROD1;TP53RK;SKP1;FBXL16;GPAA1;PSME2;FASTK;PNPLA2;DCAF17;PIK3CD;BRD2;KLHL20;CAMK2B;PSMA5;CHEK2;ACVR1;CUL5;MAPK6;HASPIN;RCN1;FBXO7;PSME4;CDC25B;PTPN18;USP25;RBBP5;SERPINC1;LAMC1;LAMB2;STK38L;FEM1B;PKN2;ART4;COG3;HCK;CHEK1;ILF3;IKBKE;PEAK1;MORC3;FBXW7;TNC;CDK12;PPP2R5C;P3H1;PDXP;SBF1;MPI;MKNK1;PAK3;PTAR1;PSMA3;CUL7;SETD3;MT3;NRBP2;UBE2M;DUSP29;CSF1;RET;NAGPA;KLHL13;FBN1;SPSB1;FBXW8;GMFB;SEPHS1;FAM20B;CAND1;RAB11B;PSMB9;SIRT6;UCHL3;TIMM50;LTK;LYN;NGLY1;SOCS5;B4GALT5;MXRA8;CLK3;PTPN7;RBX1;APP;INSR;PIK3R4;LRRC41;SRPK1;UBE2E1;MEN1;BMPR2;ST3GAL1;COPS7B;WDR5;PRKAG1;CDK19;WSB2;TNIK;ELOC;DAD1;BTRC;DUSP26;PPM1F;ASB7;FUT10;CDK10;NUAK2;CDK20;PSMD2;BCKDK;COL3A1;SIK1;PDIA6;PIM1;B3GALNT1;PPP2R5D;DYRK2;NEK6;ASB10;PRKDC;PSME3;APOE;PPP4R2;FBXL14;KLHL9;SOCS2;GGCX;DUSP10;KTN1;UBE2L3;FBXL19;PRKCE;DUSP16;CLK2;NPC1;DCAF4;RPN1;DUSP11;FYN;JAK2;PSMA4;PRKCH;MINK1;FAM20C;BMPR1A;STK25;NRBP1;TAOK2;ARF4;ATE1;OXSR1;MSRA;TIPARP;MTOR;RAB11A;TBCK;LMO7;IRAK1;PTPN9;METAP2;STK39;CSK;PPP2R2A;PTPRU;SPARCL1;FBXL5;ASB3;BCR;JMJD4;ST8SIA1;PTPRC;SNRK;BIRC6;PRKG2;GAD1;ACVR2A;FNIP2;FUT9;COPS8;DUSP8;PSMD7;STT3B;CTBP1;MARK1;ASB1;SERP1;BRSK1;SOCS6;NEK7;PSMD9;GLRX;STK24;STK3;CAMKK2;PSMD8;OGFOD1;PTPRB;UBL5;PIGK;FBXO30;AAK1;ERN1;ERO1A;RAB1A;TGM2;ACVRL1;PSMF1;PTPRF;APLP2;PPP2R5A;TLK2;LCK;YES1;DDOST;STK11;LHPP;MAP4K2;PSMB6;CDK9;SUMF1;PSMD12;PRKCD;ABL2;PSMC2;ASB13;NUB1;SENP8;GCNT2;MAPK9;DCAF5;COPS7A;AKT3;HSP90B1;PIM3;CDK8;MMP15;PPP2R3A;RAB2A
prerank,negative regulation of response to wounding (GO:1903035),0.4280193034555209,1.038568522422195,0.4229195088676671,0.8772748783067862,1.0,9/19,26.88%,EPHA4;GIT1;CRK;MDK;CERS2;RTN4RL1;FGF2;PTPRS;AJAP1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3865355412726192,1.038375375640407,0.4427020506634499,0.8771959131670097,1.0,16/35,27.32%,HSP90AB1;CSNK2B;MAGI2;PPP6R3;PPP1R11;MASTL;CALM3;CD300A;MTOR;TSC1;HSP90B1;PPP1R12A;CALM2;TIPRL;BOD1;FKBP1A
prerank,positive regulation of neuron death (GO:1901216),0.3749500905569401,1.038311772608008,0.42742857142857144,0.8767818654007781,1.0,12/46,17.97%,WNT5A;DAXX;CLU;CTNNB1;TFAP2B;PRNP;DDIT4;FCGR2B;EIF2S1;FYN;BAX;NF1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3871828306177627,1.0382425873221388,0.42298578199052134,0.8763621841862334,1.0,5/33,8.20%,HYAL1;DDRGK1;CCND2;CCND1;TFDP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3930833660581391,1.0381928516672236,0.4432234432234432,0.8758996888526295,1.0,7/31,14.41%,SEMA4D;SOX9;NBR1;BAMBI;MEN1;PTCH1;RANBP3L
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.46475520486837113,1.038028951682306,0.4243281471004243,0.8757757708573631,1.0,4/13,13.91%,NOL9;RPS21;RRS1;KRI1
prerank,coenzyme A metabolic process (GO:0015936),0.4664578973318027,1.037527299663247,0.4452247191011236,0.8765826171856704,1.0,6/14,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,mitochondrial translation (GO:0032543),0.33721921242346875,1.0375246649085654,0.42513089005235605,0.8759923918019948,1.0,27/104,19.26%,MRPL36;IARS2;ERAL1;MRPS30;MTIF3;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS22;MRPS23;MRPS2;AURKAIP1;NOA1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;FASTKD2;MRPS11;MRPL40;MRPL22
prerank,DNA recombination (GO:0006310),0.3795359820066633,1.0375169383125682,0.4266826923076923,0.8754112177936497,1.0,9/37,15.24%,MSH2;RTEL1;RAD51C;RPAIN;XRCC3;HMGB1;HMGB3;GEN1;RECQL5
prerank,response to reactive oxygen species (GO:0000302),-0.24721915266192562,-1.037481006019062,0.40350877192982454,1.0,1.0,10/54,7.79%,PTPRK;APOD;MPV17;PXN;EGFR;APTX;MAPK3;HMOX1;TPM1;SIRT1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4229969405136736,-1.0373153558676536,0.4154727793696275,1.0,1.0,6/10,26.06%,HMOX1;HOXA7;CD200R1;CD200;BMP5;EMILIN1
prerank,synaptic vesicle cycle (GO:0099504),0.3905671322013846,1.037256611603977,0.4233055885850178,0.8755673335080493,1.0,14/30,28.46%,SLC18A2;CPLX1;SYT7;PIP5K1C;VAMP2;SLC32A1;BRSK1;PCLO;RAB3A;DNAJC5;PLD2;CDK5;CPLX2;SYNDIG1
prerank,dopamine metabolic process (GO:0042417),-0.34177833571981614,-1.0371395025302925,0.4095940959409594,1.0,1.0,11/18,36.29%,SNCAIP;SNCA;TGFB2;MAOA;MAOB;DRD2;MOXD1;PRKN;DRD3;LRTOMT;DAO
prerank,ion transport (GO:0006811),0.33876740954199575,1.0370790209147014,0.41995841995842,0.875459157269133,1.0,20/111,16.48%,CNGB1;SLC25A22;AQP11;SLC26A1;SLC8A1;SLC15A3;SLC15A2;PANX2;SLC12A5;LASP1;SLC25A10;TRPM3;PANX1;SLC26A2;ANO10;TSPO;CTNS;CHRNB2;SLC24A3;SLC4A2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3713779505582044,1.0369589781590234,0.4231651376146789,0.875198959480585,1.0,10/44,15.47%,AGT;SPRY2;PAQR3;LYN;SORL1;APOE;DUSP10;PIK3CB;INPP5K;CD300A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.34843146529262864,-1.0369096166386025,0.3622641509433962,1.0,1.0,6/17,18.27%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,sphingosine metabolic process (GO:0006670),0.44558610068637233,1.0367459013804938,0.422972972972973,0.8752226990447751,1.0,6/17,21.53%,SGPP2;ASAH2;SPHK2;ACER3;SPTLC2;PLPP2
prerank,negative regulation of anoikis (GO:2000811),0.45371432159143177,1.0367103056926112,0.4378531073446328,0.8747241235642571,1.0,6/14,27.56%,PTRH2;SNAI2;MCL1;NOTCH1;PIK3CA;ITGB1
prerank,tRNA methylation (GO:0030488),0.38775207582834864,1.0364727722205465,0.43847072879330945,0.8747837251640066,1.0,12/34,22.69%,BCDIN3D;TRMT1;TRMT13;TRMT61B;THADA;TRMT10C;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;TRDMT1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4617359324639067,1.0362794708051593,0.44047619047619047,0.8747495952529291,1.0,2/13,4.83%,RGPD1;KPNB1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.37489083534453055,1.0358580715339245,0.43187066974595845,0.8753651515024784,1.0,16/48,23.10%,PPCS;SLC26A1;ADCY5;ADCY10;SLC25A16;NPPC;SLC26A2;ADSL;PANK2;ACAT1;AMPD3;NPR2;AK5;DCAKD;PPCDC;ADCY7
prerank,positive regulation of proteolysis (GO:0045862),0.35558902824025834,1.035550887247345,0.4261744966442953,0.8756549292478376,1.0,18/55,23.32%,ASPH;SNX33;ADAM8;CTSC;CTSH;TNIP1;SNX9;BTRC;ZC3H12A;APOE;BAD;AURKAIP1;IST1;SH3D19;TANK;STUB1;HDAC2;CLN6
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3963065912191536,1.0355478585849214,0.44125,0.8750683906689168,1.0,14/27,24.60%,ZC3H12C;XRN1;ZC3H12A;RNASE1;PCF11;NUDT16;DICER1;RPP30;TRIR;ERN1;RNASEH1;RNASE4;PDE12;NHP2
prerank,pseudouridine synthesis (GO:0001522),0.46162231040282664,1.0353833442389029,0.45314685314685316,0.8749325839936397,1.0,5/13,24.60%,PUS7L;GAR1;PUS7;PUS10;NHP2
prerank,ncRNA catabolic process (GO:0034661),-0.30139772763459927,-1.0352837526856078,0.395,1.0,1.0,10/28,18.85%,EXOSC7;EXOSC10;RBM7;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2;TENT4B;NUDT16L1
prerank,proteolysis (GO:0006508),0.32437657108887274,1.0348695328306434,0.41708542713567837,0.8757909123954484,1.0,46/252,18.45%,CASP4;CASP7;ADAM33;SPPL2A;LAP3;CTSS;ADAMTS3;USP25;MMP14;TMPRSS5;CASP6;LONP2;UBE3A;ERAP1;CUL7;RET;CPQ;CTSC;RSPRY1;NLN;CTSH;DPP3;AEBP1;PCSK7;SPCS1;ADGRV1;LONP1;PSEN1;NPEPPS;CAPN1;PITRM1;PTCH1;NAPSA;SPPL3;APH1A;ADAMTS12;APH1B;CAPN5;HTRA3;SPRTN;LRP8;METAP2;FOLH1;MIPEP;HM13;SVBP
prerank,heterochromatin assembly (GO:0031507),0.4239946198264796,1.0347279397541913,0.4343163538873995,0.8755955705124839,1.0,10/20,26.02%,ZNFX1;MBD2;NRDE2;BAHD1;HDAC1;SMCHD1;SIRT2;CDKN2A;EZH1;HELLS
prerank,extracellular structure organization (GO:0043062),0.32597060699309377,1.033887730078082,0.44343434343434346,0.8773115396789455,1.0,38/204,18.18%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ADAMTS12;ST7;ADAMTS6;NID2;JAM3;ITGA4;COL15A1;NF1;VIT
prerank,Wnt signaling pathway (GO:0016055),0.3390459090581628,1.0338472107453693,0.4392819429778247,0.8768285269012119,1.0,12/92,10.42%,WNT11;SKP1;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB;USP34;RBX1;BTRC
prerank,regulation of protein localization to membrane (GO:1905475),0.40389564869979283,1.0333392374644481,0.4275092936802974,0.8777029450539346,1.0,8/28,14.25%,MMP14;STX7;STX8;LDLRAP1;GSN;VTI1B;ACTB;FYN
prerank,cellular response to arsenic-containing substance (GO:0071243),0.45287369240595043,1.0328931856435037,0.43370165745856354,0.8783616311673004,1.0,7/15,23.70%,DAXX;DHX36;ZC3H12A;HNRNPA1;CPEB2;DDX3X;VCP
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3247662680701665,1.0326830968831373,0.4174174174174174,0.8783870753539242,1.0,60/336,12.66%,IRF7;SAMHD1;PML;TAOK3;MSH2;DTX3L;MACROD1;ALKBH7;TIMELESS;CHEK2;CGAS;BCL2L11;POLE2;PSME4;APLF;RBBP5;MCM7;CHEK1;UBE2B;NOP53;IKBKE;CHD1L;POLB;RFC4;CCND1;ETAA1;BCL6;HERC2;MCM9;ZBTB38;BACH1;RTEL1;NFATC2;ALKBH1;RAD51C;SLF2;CHCHD6;RPAIN;FEN1;ERCC4;XRCC3;LYN;BARD1;POLK;PLK3;MAPK14;WDHD1;MNAT1;MEN1;WAC;VCPIP1;CIB1;NPM1;ZC3H12A;POLQ;DYRK2;PSEN1;PRKDC;ZRANB3;DDX11
prerank,cellular amide metabolic process (GO:0043603),0.33850363916990883,1.0326092107396505,0.46290491118077326,0.8780131265770716,1.0,26/102,21.99%,MTHFR;DHFR;ACOT9;ASAH2;NSMAF;SLC46A1;SLC19A1;ACBD6;ABCB9;NLN;ST6GAL1;AEBP1;ST3GAL1;ACOT13;GNE;SHMT1;PANK2;MCCC1;MIPEP;MTHFD1;SGPL1;OXSM;PLA2G4E;SLC5A6;PLPP2;NIT1
prerank,regulation of lipid kinase activity (GO:0043550),0.47773281804599366,1.032543096530869,0.44269340974212035,0.8776132582624054,1.0,4/11,20.42%,RBL1;RB1;WDR91;PPP2R5A
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2979014403640934,-1.0325195164998417,0.4362745098039216,1.0,1.0,10/28,22.72%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;ECT2;DMAP1;BAG3;TPR;RBM22
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.45535662672078,1.0325158541851096,0.4540229885057471,0.8770981441899082,1.0,5/14,17.87%,DDX18;NOL9;RPL7L1;ZNHIT3;WDR12
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.38248173690394915,1.0324077612230702,0.4306049822064057,0.8768104050439316,1.0,4/35,11.28%,PCDHB13;CDH13;CDH9;PCDHB16
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.41624256703752216,1.0322103255583013,0.42231075697211157,0.8768063811862171,1.0,8/22,25.49%,CCL5;IL10RA;IL10RB;MGAT5;NOTCH1;CRLF3;OCIAD1;TNF
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3733159808014076,-1.0321901075907736,0.42295081967213116,1.0,1.0,8/13,30.92%,SHISA9;SHISA6;CLN3;SHISA7;SLC8A2;PPFIA3;SHISA8;SLC4A10
prerank,response to growth factor (GO:0070848),0.37771727613506845,1.0321414590798714,0.4444444444444444,0.876408405129575,1.0,9/41,15.05%,CPNE3;ACVR1;LRP2;CTNNB1;BMPR2;CIB1;RACK1;SOX2;BMPR1A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.39374117248803286,-1.0319287322865587,0.39197530864197533,1.0,1.0,3/12,11.61%,GPR183;MFNG;LFNG
prerank,organelle organization (GO:0006996),0.32071239232837406,1.031896376875233,0.42,0.8765127034588522,1.0,115/388,23.26%,CHMP4A;CHMP4B;VPS51;TOR1AIP2;MTFR2;CCL7;FMNL2;BLZF1;CHMP1B;AUP1;KLHL20;TJAP1;ATL1;YTHDF1;CNTNAP1;THY1;COG3;PEX7;GOLGA5;GOLGA8B;CHCHD10;LONP2;BRWD3;POLG2;SEC16A;SPRYD3;PRPF40A;ANK1;STX7;ARHGEF7;TFB2M;CUL7;ARHGAP4;VPS11;TMED5;ATAD3A;FBXW8;PPIA;DOP1B;RAB43;YTHDF2;ZMYM3;VAPB;ABCD1;MAST3;PEX2;TWNK;UBXN2B;TNIK;FNBP1L;PHIP;TMED10;TRAPPC12;ATXN7;COG2;DNAJA3;RAB14;ARL1;CHMP3;LONP1;FAF2;CAPZB;ARHGAP21;ARHGAP10;APOE;PPARGC1A;FGD6;NCKIPSD;ZRANB1;AFG1L;VPS13D;PLEKHM2;STX4;ZMYM6;RAB32;DYNC2H1;MDK;CHCHD2;TMED1;CHMP5;PLCE1;SH3D19;TMED3;RHOT2;FMNL3;GBF1;GABPB1;GOLPH3L;MARK1;SIPA1L3;NUMA1;RANBP9;VPS13C;TTC17;RAB1A;GORASP2;PNPLA3;VPS18;ABCD4;ADCK1;TMED7;OPTN;MTX1;CHMP1A;HUWE1;ATP5F1B;RAB2A;SSBP1;PRDX3;PTCD2;OPA1;PAK5;RAB29;LIMD1;PCLO
prerank,negative regulation of mRNA processing (GO:0050686),0.4371010179817728,1.0317009223310647,0.43356643356643354,0.8764549016443869,1.0,6/15,17.13%,RBMX;BARD1;RNPS1;SRSF7;SRSF4;PCBP4
prerank,entry into host (GO:0044409),0.45344129366743324,1.0316275242417972,0.4226190476190476,0.8760647093445271,1.0,4/13,8.69%,CXCR4;CTNNB1;PPIA;MET
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3385016295696986,1.0313740359669985,0.43198338525441327,0.8762188987880009,1.0,24/109,15.36%,PIGW;ARF3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PITPNM1;SBF1;PIP5K1A;PLCB3;PIK3R4;PI4KB;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;LPGAT1;PLEKHA3;INPP5K;MTMR14
prerank,cellular response to pH (GO:0071467),0.4321124848587794,1.0312826730844047,0.4316069057104914,0.8758859611442807,1.0,2/17,8.11%,HYAL1;RAB11B
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4057679579011823,1.0311591019807669,0.4454203262233375,0.8756483663943866,1.0,6/27,11.83%,ZFP36;AGO2;STAT3;DDX5;DHX9;MAP2K2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4520892959420081,1.030887794559879,0.42424242424242425,0.8758603656140168,1.0,4/13,15.96%,SOX9;SRF;NFIB;PPARD
prerank,positive regulation of telomere maintenance (GO:0032206),0.3878361231245765,1.0307035303677268,0.4546553808948005,0.8757844146614595,1.0,6/31,9.60%,PML;DHX36;RTEL1;HNRNPA2B1;SIRT6;PPP1R10
prerank,myotube differentiation (GO:0014902),-0.35307569019960305,-1.0303532273317728,0.39759036144578314,1.0,1.0,5/17,25.17%,KCNH1;JAM2;ADGRB3;MEF2C;NOS1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2633970348548451,-1.0300943203903457,0.3875,1.0,1.0,13/40,20.67%,SIRT7;UBE2V2;POLH;FXR2;PARG;CASP9;HMGA2;CRY1;ING2;BCLAF1;MYC;RADX;ABL1
prerank,DNA duplex unwinding (GO:0032508),0.3648215478856134,1.0298295712377619,0.4413793103448276,0.8777067715002765,1.0,10/50,9.93%,ASCC3;MCM2;MCM7;MCM4;CHD1L;MCM9;RTEL1;DHX9;RBX1;TWNK
prerank,mesenchymal to epithelial transition (GO:0060231),-0.41606917704587826,-1.0293154029949243,0.43034055727554177,1.0,1.0,5/10,33.91%,SALL1;FZD7;PAX8;BMP4;GATA3
prerank,chromatin remodeling (GO:0006338),0.33437464576386605,1.0291998987250666,0.43478260869565216,0.8788801609882241,1.0,26/100,17.14%,GATAD1;DAXX;ARID1B;CHD1L;SOX9;ARID1A;KDM4D;MBD2;SMARCC2;SMARCE1;NUDT5;MTA2;TADA2A;ACTR8;TADA2B;BPTF;NPM1;HCFC2;RB1;ACTB;SMARCA1;MYB;SMARCD2;BAHD1;INO80C;MPND
prerank,response to amyloid-beta (GO:1904645),0.3723607083873919,1.0291931799005374,0.4275782155272306,0.8783093277229398,1.0,9/44,14.25%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3578203822262772,1.028791850959095,0.42937219730941706,0.8788218217670151,1.0,29/59,29.58%,MOV10;MECP2;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;MED12;MITF;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;CDKN2A;PTEN;AGO1;MED25;SETX;AGO3;JUN;MED26;CSF1R;MED13
prerank,carbohydrate catabolic process (GO:0016052),-0.2802005147071531,-1.0281762509516859,0.4166666666666667,1.0,1.0,10/38,10.73%,ENO1;PFKL;PGAM1;PGAM4;MANBA;MAN2B1;PKM;PFKFB2;ENO2;PGK1
prerank,response to organic cyclic compound (GO:0014070),0.36258574602373983,1.0281631923904913,0.4392735527809308,0.8800316351754056,1.0,12/52,17.23%,DHFR;TRPM2;STAT3;CCL5;CDKN2D;CTNNB1;GGT7;SOCS2;CHRNB2;TIPARP;IL18;TLR3
prerank,rRNA transcription (GO:0009303),0.4288556580414217,1.0275537992686437,0.4450474898236092,0.8811287081311554,1.0,10/17,23.62%,TCOF1;GTF3C5;TAF1B;GTF3C3;CAVIN1;POLR1G;BRF1;SPIN1;GTF3C1;ANG
prerank,extracellular matrix organization (GO:0030198),0.32172590937952045,1.0274380813442539,0.43029087261785354,0.880852247362567,1.0,52/276,18.18%,LOXL2;HAS3;COL13A1;CTSS;ITGA2;COMP;KDR;P4HA1;ADAMTS3;COL9A1;HAS1;MMP14;ADAM8;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;P3H1;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;SCX;APP;AGRN;GFOD2;TIMP2;COL3A1;GSN;ADAMTS2;CAPNS1;COL11A2;CAPN1;ADAMTS12;ST7;ADAMTS6;NID2;JAM3;SH3PXD2B;FLRT2;ITGA4;COL15A1;NF1;VIT
prerank,negative regulation by host of viral transcription (GO:0043922),0.4663211882216998,1.0271786810757968,0.44412607449856734,0.8809639024737662,1.0,6/12,23.97%,TARDBP;CCL5;INPP5K;HDAC1;CCL4;TFAP4
prerank,homologous chromosome segregation (GO:0045143),0.42226210795932895,1.0271685297789301,0.42633637548891784,0.8804039846354192,1.0,1/20,0.40%,SYCP1
prerank,negative regulation of biosynthetic process (GO:0009890),0.43951705588418377,1.0271488046879131,0.4405797101449275,0.8798781947850867,1.0,3/16,9.50%,SLC18A2;ASXL3;ABCD1
prerank,positive regulation of cell differentiation (GO:0045597),0.32161852233616334,1.0271244992009987,0.43543543543543545,0.8793611113831835,1.0,48/237,16.97%,LOXL2;AGT;KDR;ZFP36;CDS1;KITLG;ACVR1;SFRP2;MEDAG;ZHX3;BRINP3;DHX36;AAMDC;HSP90AB1;SOX9;CTNNB1;TCF4;NFKB1;WNT7B;CSF1;SRF;FRZB;SMAD2;RAPGEF2;BAMBI;GDNF;PDPN;MAPK14;BMPR2;ZC3H12A;ZFP36L1;XBP1;RIN2;NELL1;DAB2;RANBP3L;PRKCH;EZH2;BMPR1A;SOX5;SPAG9;MEF2A;PPARD;IL18;SMYD1;MTOR;MDK;PCP4
prerank,regulation of macrophage cytokine production (GO:0010935),-0.37662089220122974,-1.0270585491793423,0.41839762611275966,1.0,1.0,4/13,8.68%,TGFB1;IRAK3;SIRT1;TGFB2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3799570452285251,1.0258936546638335,0.43803680981595094,0.8822204720969045,1.0,8/36,7.79%,BDNF;ASAH2;CX3CL1;TRIM39;CYLD;CSNK2A2;TPD52L1;PPIA
prerank,positive regulation of protein phosphorylation (GO:0001934),0.32048976717497674,1.0257731821357845,0.4364364364364364,0.8819557155396982,1.0,59/348,15.26%,IRGM;IL15;AGT;SPRY2;KDR;DAXX;BDNF;DDRGK1;GDF9;SEMA4D;CD40;ACVR1;LCP2;S1PR2;SFRP2;MAD2L2;CCND2;HSP90AB1;CACUL1;CX3CL1;SOX9;CCND1;TNKS1BP1;TRAF4;MYDGF;CAB39;MT3;MAP2K3;CSF1;CSNK2B;AGAP2;PPIA;MTCP1;RAPGEF2;CSPG4;LYN;LEPR;APP;INSR;PRNP;BMPR2;PRKAG1;TNIK;SNX9;CIB1;VEGFD;FGF9;PTPN11;AKAP9;RACK1;NRP1;DAB2;RAC1;JAK2;RB1CC1;HSP90AA1;NPTN;BMPR1A;CALM3
prerank,regulation of cellular respiration (GO:0043457),0.42500874335113786,1.0257668352199945,0.42857142857142855,0.8813916719686152,1.0,8/17,27.59%,PNPT1;NOP53;IL10RB;NOA1;IDE;VCP;TRAP1;PRELID1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.347116119298977,1.025604572103575,0.4372955288985823,0.8812775372890598,1.0,23/70,16.11%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;ACTB;RAC1;FYN;HSP90AA1;MYH2;CRK;BAIAP2
prerank,myoblast differentiation (GO:0045445),0.44506384420575595,1.02549556622761,0.4330935251798561,0.8810052887432356,1.0,4/14,18.50%,DDX5;TCF7L2;RB1;HINFP
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3889879179416934,1.0250114434338282,0.43964421855146124,0.8817415076114438,1.0,3/29,3.86%,SPRY2;SFRP2;MAD2L2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.35946792301245317,1.0249338114266833,0.47058823529411764,0.8813597360844861,1.0,20/55,23.70%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2
prerank,chromatin organization (GO:0006325),0.3296723620802361,1.0249084019636943,0.4527720739219713,0.8808510476367436,1.0,30/132,17.14%,LOXL2;GATAD1;HMGN3;DAXX;LRWD1;CHD1L;SOX9;ARID1A;KDM4D;SMARCC2;SMARCE1;NUDT5;MTA2;TADA2A;TADA2B;BPTF;NPM1;SETD5;SETDB2;HCFC2;DDX11;RB1;HDAC8;SMARCA1;EZH2;SOX2;MYB;SMARCD2;INO80C;MPND
prerank,regulation of leukocyte activation (GO:0002694),-0.363822639628006,-1.0247529702299927,0.375886524822695,1.0,1.0,6/14,16.95%,GPR137B;MYO18A;PLSCR1;MIF;PJA2;SHPK
prerank,regulation of immune effector process (GO:0002697),0.3723919132257717,1.0246737807182278,0.4386792452830189,0.8809346247819855,1.0,7/41,16.14%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,dorsal/ventral pattern formation (GO:0009953),0.42478789143963175,1.0246174747040684,0.4404283801874163,0.8805077496924245,1.0,7/20,23.96%,ACVR1;MDFI;PTCH1;BMPR1A;DSCAML1;ACVRL1;LMX1B
prerank,protein autophosphorylation (GO:0046777),0.329216730141985,1.0242551861795437,0.4447852760736196,0.8809332124257513,1.0,32/157,16.66%,EIF2AK2;TAOK3;FLT1;DAPK3;CAMK2D;KDR;CAMK2B;CHEK2;HCK;PEAK1;CDK12;EPHA4;MKNK1;FGFR2;HTATIP2;LYN;INSR;TNIK;SIK1;PIM1;MAP2K2;NEK6;CLK2;JAK2;MINK1;STK25;TAOK2;OXSR1;FGFR3;MTOR;IRAK1;STK39
prerank,regulation of tube diameter (GO:0035296),-0.3789014096621424,-1.0237060692497901,0.431438127090301,1.0,1.0,2/13,3.76%,ROCK1;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.3789014096621424,-1.0237060692497901,0.431438127090301,1.0,1.0,2/13,3.76%,ROCK1;GCLM
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36463858368007185,1.023692416379356,0.43148357870894677,0.8819690522388167,1.0,10/48,20.89%,ISG15;TLR8;IL27;CD276;IL12RB2;IL18;LGALS9;TLR3;PDE4B;EBI3
prerank,regulation of platelet activation (GO:0010543),-0.3141072901489755,-1.0235342145505557,0.40310077519379844,1.0,1.0,7/21,26.18%,SYK;PRKCQ;TXK;PDGFRA;THBD;TLR4;FCER1G
prerank,cellular response to hypoxia (GO:0071456),0.32937505980754317,1.0233467707066595,0.4524793388429752,0.8823539620799149,1.0,47/126,26.54%,PSMB10;PSME2;PSMA5;PSME4;ADAM8;EGLN2;NOP53;HYOU1;PSMA3;BACH1;MT3;PSMB9;RBX1;RORA;PLK3;UBQLN1;ELOC;ZFP36L1;PSMD2;AK4;PSME3;SCN2A;NPEPPS;BAD;PSMA4;MTOR;CPEB2;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;STUB1;PSMD4;LIMD1;TIGAR;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;FMN2;HIGD1A;BNIP3L
prerank,glycolytic process (GO:0006096),-0.29837961969951393,-1.022816435509862,0.40703517587939697,1.0,1.0,8/28,10.73%,ENO1;PFKL;PGAM1;PGAM4;PKM;PFKFB2;ENO2;PGK1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3395815001229592,1.022700855573875,0.44253490870032225,0.8836274530291137,1.0,25/87,20.02%,AGT;SPRY2;DUSP3;IGBP1;DUSP29;PPIA;CNKSR3;PAQR3;LYN;TNIP1;DUSP26;SORL1;APOE;DUSP10;PIK3CB;DLG1;INPP5K;CD300A;SPRED3;PTPRC;NF1;SPRED1;RANBP9;PIN1;SIRPA
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3978732833385426,-1.0226999348390957,0.4036697247706422,1.0,1.0,3/11,12.46%,TGFB1;TGFB2;EFNB2
prerank,regulation of calcium ion import (GO:0090279),0.4111935278557136,1.0223332806532612,0.43373493975903615,0.884056343383137,1.0,5/21,14.25%,SLC30A1;CTNNB1;PRNP;SPHK2;FYN
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3434913725892998,1.0218696545705355,0.4547413793103448,0.8847606162620073,1.0,22/73,24.21%,MYBBP1A;TFAP2C;MECP2;MYO1C;CGGBP1;DNMT3A;DNMT1;POLR2K;SPHK2;CTCF;TAF1B;ACTB;EZH2;TDG;POLR1G;TAF1C;SMYD5;TASOR;HDAC4;HDAC6;KAT2B;POLR1F
prerank,cellular response to glucose stimulus (GO:0071333),0.3939073125129092,1.0217847535872255,0.45883777239709445,0.8844189541068856,1.0,11/30,27.09%,CLTRN;RAB11B;XBP1;RACK1;SELENOT;ERN1;ZBTB20;RAB11FIP5;TRA2B;KCNB1;PTPRN
prerank,regulation of complement activation (GO:0030449),0.37358545023544676,1.0215411026743384,0.4292508917954816,0.8844884810981468,1.0,5/40,10.25%,CLU;C4B;CD55;SUSD4;C3AR1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.4255705782018956,1.0213508332837027,0.451568894952251,0.884417579566961,1.0,4/19,9.16%,SLCO1C1;NFKB1;TMEM106A;APP
prerank,negative regulation of bone mineralization (GO:0030502),-0.38386789096363855,-1.021079165539647,0.44274809160305345,1.0,1.0,5/13,16.59%,SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,transport across blood-brain barrier (GO:0150104),0.33944698041108046,1.02104109293392,0.4336468129571578,0.8847102227609401,1.0,13/83,11.15%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;LRP2;SLC38A1;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3446490944326198,1.0209283012577102,0.45617740232312565,0.8844596362681918,1.0,19/84,17.23%,PIK3AP1;CTSS;BIRC2;NMI;TLR8;UNC93B1;HMGB1;PIK3R4;TRAF3;TNIP1;IRAK4;BIRC3;TNIP2;MYD88;TLR2;TNIP3;IRAK1;LGALS9;TLR3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3591551603576642,1.0207741199850935,0.4478114478114478,0.8842955193369516,1.0,10/55,10.73%,HYAL1;SPAM1;SDC3;STAB2;HYAL4;SDC4;FMOD;CSPG4;AGRN;HPSE
prerank,wound healing (GO:0042060),-0.24483692218006625,-1.020062940339641,0.3942307692307692,1.0,1.0,12/62,10.54%,PAK1;DST;MACF1;AHNAK2;MYOF;HMOX1;FGF10;TPM1;SCARB1;TGFB2;ANXA6;PLEC
prerank,cell cycle G2/M phase transition (GO:0044839),0.3348907189936912,1.0199958157683493,0.4552929085303186,0.8858723588962263,1.0,33/129,18.92%,PKMYT1;SKP1;CHEK2;ARPP19;CDC25B;DYNC1H1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP152;CEP131;CEP70;AKAP9;TUBB4B;DYNLL1;KDM8;HSP90AA1;MASTL;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.342800628115614,1.0199389687566214,0.4487594390507012,0.8854599550729563,1.0,15/78,17.60%,PKMYT1;CCNJ;CCND2;CDKN2D;CCND1;CCNT2;CNPPD1;MNAT1;MEN1;PROX1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,peptidyl-asparagine modification (GO:0018196),-0.28503605566274004,-1.0198674522695497,0.4444444444444444,1.0,1.0,11/31,19.96%,ALG5;DPM1;UBE2J1;TUSC3;HIF1AN;UGGT2;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,response to fatty acid (GO:0070542),0.43615205062150675,1.0197508803569337,0.46675712347354137,0.8854228220162425,1.0,2/17,5.43%,IRS1;SOX9
prerank,non-motile cilium assembly (GO:1905515),-0.2885289814941643,-1.019352548548696,0.3712871287128713,1.0,1.0,17/30,33.52%,RPGRIP1L;PCM1;IFT88;VANGL2;IFT57;BBS1;TMEM216;RPGRIP1;BBS10;FUZ;TMEM17;TTC8;CSNK1D;CEP250;TMEM107;CCDC13;CEP290
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3269598378138129,1.0192051520955236,0.433502538071066,0.8863734345413541,1.0,52/168,22.22%,HELZ2;POLR2G;ZFP36;XRN2;RPL36;DDX5;MAGOHB;SMG7;CNOT4;CNOT7;NCBP2;GSPT1;RPL22;XRN1;TNKS1BP1;RPS21;DCP2;ZC3H12A;RNPS1;ZFP36L1;SMG5;UPF2;UPF3A;RPS6;DIS3L2;EXOSC9;PATL2;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;TUT7;UPF1;PPP2R2A;RPL10A;RPS15A;DCPS;PAN3;RPL24;RPL37A;RC3H2;RPL3;CSDE1;RPL29;RPL5;MTPAP;EXOSC4;RPL6;PYM1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3584797967020496,1.0189839949948645,0.43398392652123996,0.8864026046803792,1.0,8/48,10.51%,KDR;CD40;RHOJ;MAP2K3;P2RX4;HMGB1;MAPK14;CIB1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.432260003049518,1.0188949743057258,0.44613259668508287,0.886073460452422,1.0,2/17,7.63%,CLTRN;UNC13D
prerank,vascular transport (GO:0010232),0.33990189679401506,1.018122592392945,0.45310853530031614,0.8876750323241561,1.0,13/81,11.15%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;LRP2;SLC38A1;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,antibacterial humoral response (GO:0019731),0.441937879522214,1.0179642931853585,0.4788732394366197,0.8875037864177292,1.0,6/16,24.24%,SLPI;RNASE7;PLA2G6;ANG;RNASE3;CAMP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3758992221130502,1.0179481894945892,0.45145631067961167,0.8869712666024229,1.0,6/38,10.62%,STAT1;TRIM39;RORA;TNIP1;RIOK3;ZC3H12A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.48219793570225505,1.0175805651577106,0.46326836581709147,0.8873893044776252,1.0,4/10,20.16%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,motile cilium assembly (GO:0044458),0.4687320665664473,1.0172574292412855,0.47246376811594204,0.887691243143127,1.0,3/12,13.03%,CCDC40;SPATA6;E2F4
prerank,nuclear transport (GO:0051169),0.4278912741163589,1.017036408373126,0.46153846153846156,0.887691368102789,1.0,4/16,10.86%,NXT1;BANF1;NPM1;RSRC1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3755079979660919,1.016992652736197,0.46332945285215366,0.8872461762392171,1.0,11/41,22.01%,TRPM2;GRIN2D;SLC8A1;ITPR1;CHERP;HTR2A;TRPV4;PTPRC;ERO1A;LCK;FGF2
prerank,ncRNA export from nucleus (GO:0097064),0.3773535512647444,1.016864757381276,0.4680337756332931,0.8870146289906429,1.0,11/36,20.35%,NUP37;PHAX;NUP153;NCBP2;RAE1;NPM1;NUP155;NUP88;TSC1;NUP133;NUP43
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.34372947771756934,1.0166746670276,0.45038167938931295,0.8869787287469394,1.0,23/71,16.11%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;ACTB;RAC1;FYN;HSP90AA1;MYH2;CRK;BAIAP2
prerank,cytoskeleton organization (GO:0007010),0.32890106129639113,1.016237016877607,0.44824016563146996,0.8876248410425289,1.0,32/114,19.30%,CCL7;FMNL2;LRCH3;KLHL20;CNTNAP1;THY1;RHOF;BRWD3;SPRYD3;PRPF40A;ANK1;ARHGAP4;EPB41L3;ZMYM3;MAST3;TNIK;PHIP;CAPZB;ARHGAP10;APOE;FGD6;NCKIPSD;ZRANB1;RAC1;ZMYM6;MDK;PLCE1;SH3D19;FMNL3;MARK1;SIPA1L3;RANBP9
prerank,regulation of cellular biosynthetic process (GO:0031326),0.39777939898562653,1.0159598763623685,0.44707347447073476,0.8878480645221314,1.0,10/28,21.28%,CD47;CCL5;EIF6;MITF;RAC1;CTNS;JAK2;SIRPA;ADIPOR1;MFSD12
prerank,thyroid hormone generation (GO:0006590),0.4869786192390718,1.0151384522968194,0.48323170731707316,0.889512447458583,1.0,2/10,9.81%,CPQ;TG
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3414376113302613,1.0151237473639052,0.44919786096256686,0.88897363399829,1.0,20/76,19.80%,DYNC1H1;HCK;EVL;CX3CL1;PDXP;CARMIL1;KATNBL1;NCK1;NCK2;PROX1;SNX9;STAP1;SYNPO;PRKCE;NRP1;BAIAP2;BAIAP2L1;CFL2;NUMA1;NCKAP1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.35539891377845384,1.0150659974200937,0.47184684684684686,0.8885614332137309,1.0,5/52,7.01%,MTHFR;DHFR;SLC46A1;SLC19A1;IDH1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.35673670056102835,1.0150130999890918,0.47861271676300576,0.8881244696509127,1.0,19/50,23.70%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2
prerank,Notch signaling pathway (GO:0007219),0.3523520758199069,1.0147923844251372,0.4597315436241611,0.8881593166676095,1.0,12/59,16.95%,STAT1;DTX3L;SNAI2;MAML2;SNW1;NOTCH4;ZNF423;PSEN1;APH1A;APH1B;RBPJ;MDK
prerank,response to calcium ion (GO:0051592),0.3290255955509033,1.0145938071300762,0.4533195020746888,0.8881131453392084,1.0,16/102,15.91%,KCNMB3;CAMK2D;CLIC4;RASA4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1;AHCYL1;SLC25A12;CALM3;MEF2A;CARF
prerank,regulation of endocytosis (GO:0030100),0.3495226183908172,1.0144911083342367,0.4550499445061043,0.8878436917432089,1.0,25/61,26.35%,CDH13;SNX33;LRSAM1;RAB5C;LRPAP1;AP2S1;APOE;RUBCN;STON1;DAB2;TFR2;OPHN1;CBLL1;STON2;RAB5B;MCTP1;ABL2;CD22;SNX17;SNX12;PACSIN1;SYT11;PTPN1;LRP1;CALY
prerank,pulmonary valve morphogenesis (GO:0003184),-0.34391485599242594,-1.0143184057049506,0.43846153846153846,1.0,1.0,8/17,37.01%,JAG1;TGFB2;SMAD6;ROBO1;BMP4;HEY1;HEY2;HEYL
prerank,macrophage migration (GO:1905517),0.4589159980151272,1.0140717592539523,0.4630969609261939,0.8884272660998336,1.0,4/13,12.43%,CCL5;TAFA4;P2RX4;CXCL17
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3590696327936382,1.0138967475936307,0.4600456621004566,0.8883486846360906,1.0,14/48,18.72%,MYBBP1A;MYO1C;ARID1B;CHEK1;ARID1A;POLR2K;SPHK2;SERTAD2;TAF1B;ACTB;SERTAD1;ELOF1;POLR1G;TAF1C
prerank,establishment of spindle localization (GO:0051293),0.4481941435849236,1.0133921643760337,0.4715909090909091,0.8891553830431772,1.0,4/14,16.21%,DYNC1H1;KPNB1;MAP4;LLGL1
prerank,primary miRNA processing (GO:0031053),0.47561149936753655,1.0129435165913352,0.46015037593984964,0.8898390047016853,1.0,3/10,7.94%,SRRT;HNRNPA2B1;SMAD2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.34065404544991956,1.0127913183960362,0.4538545059717698,0.889674488557678,1.0,23/73,16.11%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;ACTB;RAC1;FYN;HSP90AA1;MYH2;CRK;BAIAP2
prerank,regulated exocytosis (GO:0045055),0.3247135470640324,1.0124004337013905,0.49542217700915564,0.8901976138558019,1.0,23/173,13.59%,LGALS3BP;CLTRN;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CRHBP;CPLX1;SYT7;CDC37L1;ISLR;RAB11B;LYN;SYT3;APP;SCCPDH;TMED10;VEGFD;CHID1;PIP5K1C;VAMP2;VTI1B
prerank,lipoprotein transport (GO:0042953),-0.39988739396139655,-1.0122374108206302,0.41643835616438357,1.0,1.0,1/10,1.74%,PPARG
prerank,regulation of microtubule-based movement (GO:0060632),0.46885191194696435,1.0121068752424545,0.44894894894894893,0.8904049284699544,1.0,4/11,23.84%,IGBP1;DYNLT2B;LAMP1;HDAC6
prerank,regulation of organelle assembly (GO:1902115),0.34345628192084543,1.0120105249366986,0.4666666666666667,0.8900832201703673,1.0,30/72,28.66%,TBC1D1;RNF4;HCK;UBQLN2;RABEP2;VPS11;TBC1D8;CYLD;TRAPPC12;NPM1;GSN;DYNC2LI1;DYNLT2B;CEP295;TBC1D2;DCDC2;NPRL2;NPRL3;SGSM3;TSG101;MSN;IFT140;TBC1D2B;TBC1D20;TBC1D17;STX18;TBC1D15;PDCD6IP;CEP76;TBC1D9B
prerank,microvillus organization (GO:0032528),0.46071929701205366,1.0118633811568365,0.4585635359116022,0.8899118899407812,1.0,6/13,19.65%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3409263946102751,1.0116446550335472,0.4810400866738895,0.8899331002638087,1.0,31/76,27.32%,BIRC2;FBXW7;PRICKLE1;UBE3A;DCUN1D4;UBA2;UBQLN1;TNIP1;ZC3H12A;PAXIP1;UBE2L3;BIRC3;MYCBP2;PIAS1;SPRTN;TANK;RIPK2;HSPBP1;HUWE1;DCUN1D5;STUB1;CUL3;SENP2;XIAP;HDAC4;AXIN1;COMMD1;NDFIP1;PIAS4;GNL3;FKBP1A
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.48321333149777035,1.0114851771596598,0.46106870229007635,0.8897768705259219,1.0,2/10,5.48%,CX3CL1;CTNNB1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.34004630235745864,1.0113066074481423,0.47198275862068967,0.889683152731421,1.0,23/80,22.22%,PLXNB2;ABCG1;CLU;YTHDF1;NSMAF;ZCCHC4;EPHA4;SPHK2;NPM1;EIF6;LRRTM3;PRKDC;UPF3A;RACK1;RBM3;MTOR;METTL14;PLA2G6;IFNGR1;DDX3X;RPL5;PRKCD;PYM1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4793416921976431,1.0113005624891707,0.4519940915805022,0.8891324676653533,1.0,3/10,10.01%,CHEK1;KMT2A;SPHK2
prerank,regulation of lipase activity (GO:0060191),-0.3794817015953815,-1.0112849187835395,0.4387755102040816,1.0,1.0,4/13,14.47%,SNCA;PCSK6;RHOA;LPL
prerank,fatty acid elongation (GO:0030497),-0.36887999500203394,-1.0111553477347164,0.4166666666666667,1.0,1.0,6/13,22.07%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2877676918904388,-1.0109967935340143,0.4117647058823529,1.0,1.0,11/29,22.07%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;SCD;ACSBG1;ACSL4;ELOVL6
prerank,positive regulation of vacuole organization (GO:0044090),0.47344036568315645,1.010779983210143,0.4594594594594595,0.8899599290717568,1.0,2/10,6.32%,LRSAM1;SH3GLB1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3712501599771117,1.0105372141022178,0.4628501827040195,0.8900515678738544,1.0,7/39,11.01%,NOD2;STAT3;TM2D3;ENHO;MAML2;SNW1;NOTCH4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.43689468430014533,1.0105236289801478,0.4535367545076283,0.8895177221794124,1.0,3/14,8.42%,TIMELESS;ACTR2;ARID2
prerank,microvillus assembly (GO:0030033),0.4535543268520325,1.010478426552737,0.4684065934065934,0.8890607586730227,1.0,6/14,19.65%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,arachidonic acid secretion (GO:0050482),-0.398217678189936,-1.010390444397772,0.43558282208588955,1.0,1.0,7/10,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonate transport (GO:1903963),-0.398217678189936,-1.010390444397772,0.43558282208588955,1.0,1.0,7/10,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3823262580785542,1.010186795720701,0.46540880503144655,0.8892737422841702,1.0,3/30,2.74%,FLT1;KDR;SBDS
prerank,microtubule anchoring (GO:0034453),-0.3751611955726124,-1.010119949343153,0.4341317365269461,1.0,1.0,5/12,20.17%,PCM1;GCC2;CLASP2;BCCIP;CLASP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.28602094620352203,-1.0100917920912047,0.42857142857142855,1.0,1.0,13/32,20.17%,DYRK1A;FKBP4;TUBB4A;SNCA;CLASP2;HDGFL3;APC;ARHGEF2;CLIP3;TTBK2;TPX2;APC2;CLASP1
prerank,negative regulation of kinase activity (GO:0033673),-0.24419100203285884,-1.010083390731862,0.42696629213483145,1.0,1.0,17/62,13.62%,CEP85;TAB1;PPM1E;DEPTOR;LRP6;PRKRIP1;GSKIP;PAK2;SNCA;QARS1;TSC2;DBNDD2;CEP43;UBASH3B;AKT1;CEACAM1;TRIB1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2163856506570857,-1.0100578702837362,0.45,1.0,1.0,30/128,18.15%,TGFB1;ZMIZ2;PTPRK;USP9X;HPGD;PXN;TGFBR3;RUNX2;PDCD4;PRKCZ;MAPK3;TWSG1;SIRT1;TGFB2;COL1A2;UBB;BMP6;ACVR1B;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;GDF1;RPS27A;F11R;ACVR1C
prerank,bone development (GO:0060348),0.37099958983940046,1.0100238241653046,0.463855421686747,0.8891602996251065,1.0,11/39,17.53%,SBDS;PTGER4;P3H1;FGFR2;MYOC;CYP26B1;AKAP13;RANBP3L;FGFR3;SH3PXD2B;PTPRC
prerank,positive regulation of reproductive process (GO:2000243),0.38786159728276937,1.0098336912369936,0.4769038701622971,0.8891032433998084,1.0,8/31,22.27%,AGO2;TACR1;SYDE1;TAC4;PDE3A;GLRA1;LHFPL2;SMURF2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.35087121286824996,-1.009724597639224,0.4586206896551724,1.0,1.0,6/16,20.12%,TOP2B;SLX4;FANCM;TOP2A;EME2;CENPX
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.38823114122859703,1.0095178588902611,0.45665445665445664,0.889403295051818,1.0,8/29,18.15%,NR1H2;SLC27A1;SLC45A3;APOE;LPGAT1;MTOR;SREBF1;LDLR
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4426386477133908,1.0093255403565693,0.4905109489051095,0.8893289227302679,1.0,5/14,12.91%,ENPP3;AK4;AK3;CMPK2;ENPP1
prerank,protein localization to cell surface (GO:0034394),0.396158804513703,1.0091506788903692,0.47424042272126815,0.8892489040785222,1.0,7/26,19.61%,WNT11;CTNNB1;GGA3;SMURF1;JAM3;PTPRU;PIGK
prerank,calcium ion transport into cytosol (GO:0060402),0.4091244005208994,1.0091043079051794,0.45618556701030927,0.8888151833861945,1.0,3/21,3.73%,TRPM2;GRIN2D;SLC8A1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2881106720025751,-1.0087699374221013,0.4439252336448598,1.0,1.0,13/32,18.18%,POLR1A;MAPK3;ERCC3;TBP;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,electron transport chain (GO:0022900),0.43937439867498784,1.0082998110240446,0.47419804741980476,0.8904346831385048,1.0,7/15,27.21%,NDUFA5;ENOX2;PPARGC1A;SDHB;NDOR1;UQCRFS1;SDHA
prerank,regulation of cell killing (GO:0031341),0.43149920884002224,1.008273436357072,0.4675141242937853,0.8899421861549142,1.0,2/16,2.90%,WNT5A;CD55
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4466372036488828,1.0080969626269372,0.4841040462427746,0.889868980323191,1.0,3/12,10.62%,STAT3;BCDIN3D;ZC3H12A
prerank,organelle fusion (GO:0048284),0.40566460660790005,1.0080229699571088,0.4521276595744681,0.8895052764357941,1.0,9/22,23.21%,FIS1;GDAP1;VPS11;STX4;MIGA2;BAX;VPS18;OPA1;EEA1
prerank,superoxide metabolic process (GO:0006801),0.3850182606854136,1.0077296342180087,0.4528763769889841,0.8897107733843763,1.0,4/29,6.59%,SOD2;CYBB;TAFA4;MT3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3631089497669831,1.0077135847759169,0.45961995249406173,0.8891920408977915,1.0,15/46,20.02%,SPRY2;DUSP3;DUSP29;CNKSR3;LYN;TNIP1;DUSP26;DUSP10;DLG1;SPRED3;PTPRC;SPRED1;RANBP9;PIN1;SIRPA
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3768461639881901,1.0076049552288167,0.47619047619047616,0.8889043464204731,1.0,8/33,16.75%,PRMT2;RBL1;CDKN2D;DACT1;PLK3;RB1;DLG1;BRD7
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.36190324974358107,1.00755632504978,0.46412037037037035,0.8884647945204681,1.0,17/48,19.32%,CARMIL1;ARHGEF7;CUL7;FBXW8;MYOC;CIB1;CUX1;PRKDC;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CAPRIN1;TESK1;SS18L1
prerank,neuron projection organization (GO:0106027),0.4382002233709489,1.0074399240404177,0.4759887005649718,0.8882248292786621,1.0,5/15,12.23%,APP;INSR;PRNP;ABCD1;PSEN1
prerank,regulation of myoblast differentiation (GO:0045661),0.3814374575761403,1.0074110080177998,0.46748466257668714,0.88773305239766,1.0,9/32,17.09%,EID2B;SOX9;SRA1;MAPK14;ZFP36L1;RANBP3L;SMYD1;FLOT2;TRIP4
prerank,regulation of fibroblast migration (GO:0010762),0.40765990567657934,1.0073305314919359,0.46772068511198944,0.88740332577115,1.0,9/20,22.01%,HAS1;ARHGEF7;PRKCE;RAC1;CORO1C;RFFL;APPL2;DDR2;FGF2
prerank,negative regulation of axon extension (GO:0030517),-0.278706198770027,-1.0071877873152175,0.4263157894736842,1.0,1.0,9/30,13.01%,SEMA4C;DIP2B;SEMA4G;SEMA4A;CDKL3;SEMA6A;SEMA4B;SEMA3E;SEMA5B
prerank,limb morphogenesis (GO:0035108),-0.3243781069030606,-1.00699711766054,0.4117647058823529,1.0,1.0,4/20,8.68%,FBXW4;LRP6;NIPBL;TGFB2
prerank,positive regulation of apoptotic process (GO:0043065),0.31463993376947846,1.0068057732926055,0.49799599198396793,0.8882545496568671,1.0,48/293,13.46%,ZBP1;TNFSF10;IFIT2;DAPK3;MYBBP1A;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;PTRH2;TRIM39;TFAP2B;FRZB;TPD52L1;ABR;HMGB1;BARD1;PRNP;VAV1;SPHK2;PRR7;ZC3H12A;DIABLO;DNM2;PHLDA1;RNPS1;RNF122;SIK1;RYBP;ARHGEF11;SOS1;PSEN1;RPS6;RACK1;BAD;AKAP13;APBB1;TIAM2
prerank,apoptotic cell clearance (GO:0043277),-0.28939563627925036,-1.0066214025297666,0.4153846153846154,1.0,1.0,13/30,20.94%,ITGAV;XKR6;RAC2;RHOBTB2;SCARB1;RARA;XKR4;TREM2;RHOBTB1;TYRO3;ITGB3;ANXA1;NR1H3
prerank,positive regulation of DNA binding (GO:0043388),-0.28094271811862814,-1.0062622542357174,0.4263157894736842,1.0,1.0,5/31,8.73%,TGFB1;PPARG;NIBAN2;TRAF6;PINX1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3151632688958078,-1.006215889586527,0.43231441048034935,1.0,1.0,10/21,25.61%,COX16;PET100;COX15;COX10;TIMM21;SCO1;SURF1;COA3;COA6;COX18
prerank,lipid oxidation (GO:0034440),0.45404484248360166,1.0061807077637848,0.4765840220385675,0.8894688787997116,1.0,3/12,20.99%,PPARGC1A;ACOX1;ADIPOR1
prerank,lysosome organization (GO:0007040),0.37078349811939665,1.0061744898648517,0.46432889963724305,0.8889263773875513,1.0,10/36,20.04%,ABCA1;GNPTAB;VPS33A;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18
prerank,peptide hormone secretion (GO:0030072),0.3947148737962474,1.006061034663839,0.46446700507614214,0.8886762937306921,1.0,2/26,7.92%,GAL;SNX19
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.2767267814078306,-1.0060397988292724,0.4262295081967213,1.0,1.0,13/34,18.92%,TGFB1;ASXL1;ZFPM2;RUNX1T1;SIRT1;TRIO;ANKRD26;FOXO1;CCDC85B;E2F1;BBS12;YAP1;FLCN
prerank,isotype switching (GO:0045190),0.47657892150640024,1.0056851568749157,0.4595419847328244,0.8891484592703424,1.0,1/10,0.99%,MSH2
prerank,regulation of macrophage migration (GO:1905521),-0.4031663295812262,-1.004835127824765,0.4444444444444444,1.0,1.0,6/10,29.04%,CD81;CX3CR1;CD200R1;CD200;EMILIN1;PTK2B
prerank,protein deubiquitination (GO:0016579),0.3173645505048169,1.0047704991342004,0.5070281124497992,0.891061728983331,1.0,74/242,24.19%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;TRAF3;VCPIP1;ARRB2;JOSD2;TNIP1;ATXN7;FOXK1;ZC3H12A;OTUD1;PSMD2;USP14;PSME3;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;ENY2;BABAM2;PSMD7;PSMD9;OTUD6B;PSMD8;BECN1;NFRKB;MBD6;PSMF1;USP5;PSMB6;USP8;USP33;PSMD12;PSMC2;SENP8;SMURF2;ADRM1;PSMD4;PSMA2;VCP;KAT2B;ACTL6A;USP32;USP10
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3195322174732468,-1.0044849372821745,0.4152542372881356,1.0,1.0,9/21,25.37%,NFAM1;CD81;CARD11;IKBKG;FOXP1;CD226;TESPA1;NECTIN2;RPS3
prerank,MAPK cascade (GO:0000165),0.3149405759265822,1.0043170411875588,0.49198396793587174,0.8917290740896443,1.0,70/295,19.30%,TAOK3;RGL3;PSMB10;RASA4;SKP1;IRS1;KDR;PSME2;GOLGA7;ZFP36;CAMK2B;PSMA5;KITLG;TGFA;PSME4;MAP3K8;ACTN2;PTGER4;CCL5;SOX9;FGFR2;PSMA3;NFKB1;MT3;RET;RAPGEF2;PAQR3;CTSH;PSMB9;MET;GDNF;PTPN7;RBX1;MEN1;GFRA2;TNIK;BTRC;WDR83;ZFP36L1;PSMD2;FGF9;MAP2K2;SOS1;PSME3;LAMTOR3;FGF13;PIK3CB;RASAL1;FYN;DLG1;JAK2;IRS2;PSMA4;MINK1;TNIP2;TAOK2;MEF2A;FGFR3;IL18;LGALS9;CSF2RA;PRKG2;NF1;PSMD7;SPRED1;FNTA;PSMD9;CAMKK2;PSMD8;RANBP9
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.39657807320517524,1.0042484780932808,0.4722921914357683,0.8913449547069768,1.0,5/26,10.71%,HYAL1;CCND2;CCND1;TFDP1;CDK10
prerank,acylglycerol catabolic process (GO:0046464),0.3819477623645988,1.0039638946638307,0.47762998790810157,0.891526587162117,1.0,5/30,14.84%,PNPLA2;ABHD2;LIPC;LYPLA2;DAGLA
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.37883106050376564,1.0035778127186277,0.48058252427184467,0.8920042885684865,1.0,7/34,18.34%,NOD2;WNT5A;SPHK2;XBP1;STX4;PTPRC;LACC1
prerank,lytic vacuole organization (GO:0080171),0.3775976453686932,1.0033547009795092,0.4646840148698885,0.8920652004673377,1.0,9/32,20.04%,ABCA1;GNPTAB;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18
prerank,regulation of trophoblast cell migration (GO:1901163),0.44392680590341077,1.0032599043726682,0.461212976022567,0.8917836169341955,1.0,2/14,5.33%,AGO2;SYDE1
prerank,regulation of fat cell differentiation (GO:0045598),0.33941340518115287,1.0029957007039496,0.4831704668838219,0.8919557287446858,1.0,14/74,12.91%,TRIB3;WNT5A;ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;TAF8;RORA;ZC3H12A;ZFP36L1;XBP1;ENPP1
prerank,cellular response to inorganic substance (GO:0071241),0.41474705365864256,1.002842184079291,0.4768211920529801,0.8918465027708014,1.0,6/21,18.99%,TIMELESS;ADCY10;MT3;DDX11;RTF2;DDI2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.3210891737328024,-1.002717563730432,0.4524714828897338,1.0,1.0,11/21,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;PLTP;ABCA3;NR1H3;ABCA7;CAV1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.33114517789064285,1.0026042071662418,0.48214285714285715,0.8919431063410808,1.0,33/96,24.66%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;DDX39B;NUP155;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP;SRSF2;MAGOH;NUP205;EIF4E
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4083997727890689,1.0025779763281966,0.48756906077348067,0.8914385644774317,1.0,6/20,16.08%,HSP90AB1;ENTPD5;P2RX4;APP;C3AR1;IL18
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.31065274473768467,1.0024562503061754,0.51,0.8912083588146575,1.0,85/390,17.83%,AXL;NAMPT;FLT1;POLR2G;IRS1;KDR;BDNF;ATP6V0D1;NRP2;STAT3;ELMO2;LCP2;ACTR2;ZNF106;GRB10;CYBB;COL4A2;HNRNPH1;HCK;NCBP2;CYFIP1;AP2A1;EPHA4;FGFR2;ARHGEF7;PAK3;ACTR3;HNRNPM;CSF1;RET;EPHA6;RAPGEF2;BCAR1;NCK1;LTK;LYN;MET;NCK2;ROR2;INSR;POLR2K;KIF16B;MAPK14;VAV1;GFRA2;PHIP;GIT1;AP2S1;RAB14;VEGFD;FGF9;ARPC5;SOS1;DDIT4;STAP1;HNRNPA1;PSEN1;PTPN11;SOCS2;CHN1;SIPA1L1;PIK3CB;RAPGEF1;NRP1;TIAL1;ACTB;RAC1;FYN;JAK2;IRS2;APH1A;HSP90AA1;APH1B;NCBP1;CRK;FGFR3;BAIAP2;TCIRG1;BLNK;FLRT2;ATP6V1B2;FIBP;GIGYF1;MPZL1;ATP6V1G1
prerank,regulation of small molecule metabolic process (GO:0062012),0.3905531914319814,1.002445021674501,0.4703030303030303,0.8906729833666448,1.0,11/28,24.97%,ACADL;RORA;FOXK1;BCKDK;EPHX2;APOE;PANK2;TTC39B;ADIPOR1;NCOR2;ACADVL
prerank,polyol metabolic process (GO:0019751),0.3607470331314465,1.0023702078474377,0.4861111111111111,0.8903253147047802,1.0,11/46,18.89%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,regulation of B cell apoptotic process (GO:0002902),0.45553955522065515,1.0022948545663752,0.47533632286995514,0.8899674521589791,1.0,3/12,14.43%,BCL6;LYN;IRS2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4061946827643881,1.0021287900170843,0.4762550881953867,0.8898468223342112,1.0,2/21,3.73%,CAMK2D;SLC8A1
prerank,protein K63-linked ubiquitination (GO:0070534),0.3646756693419078,1.0017326398698083,0.47238542890716806,0.8904062896525128,1.0,8/41,11.40%,RNF4;TRIM21;BFAR;RNF5;UBE2B;UBE2E3;TRAF3;TRAF5
prerank,RNA export from nucleus (GO:0006405),0.3299559497346702,1.0016109586695334,0.49269311064718163,0.8902025463361074,1.0,34/100,24.66%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;HNRNPA1;UPF2;ZC3H11A;CHTOP;DDX39B;NUP155;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP;SRSF2;MAGOH;NUP205;EIF4E
prerank,negative regulation of histone acetylation (GO:0035067),0.4666900432462879,1.0014929936186348,0.5060240963855421,0.8899809721843063,1.0,1/11,0.66%,THAP7
prerank,positive regulation of filopodium assembly (GO:0051491),-0.30214416238252073,-1.0013007462405508,0.46543778801843316,1.0,1.0,7/24,14.12%,WASL;DPYSL3;CDC42;RHOQ;PALM;GPM6A;RIPOR2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2572687426797925,-1.0011755508631408,0.47023809523809523,1.0,1.0,23/42,31.14%,TOMM20;DNAJC15;TIMM21;AIFM1;SEC61G;AKT2;SEC61A1;SEC61B;PEX26;GRPEL1;PAM16;CHCHD4;ZFAND2B;TIMM17A;GRPEL2;ROMO1;PEX12;PEX1;HSPD1;SEC62;RTN2;SEC63;PEX6
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3504643178104657,1.0010918534201159,0.4954233409610984,0.8904813535436125,1.0,10/57,12.25%,TAOK3;CHEK2;CHEK1;NOP53;TIPIN;CCND1;TRIM39;WAC;RINT1;PRKDC
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4093494846853101,1.00107518614291,0.4751958224543081,0.8894131342564071,1.0,3/19,9.35%,POLR2G;DAXX;POLR2K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4093494846853101,1.00107518614291,0.4751958224543081,0.8894131342564071,1.0,3/19,9.35%,POLR2G;DAXX;POLR2K
prerank,response to muscle stretch (GO:0035994),0.4314236305889379,1.0008092014798886,0.47406340057636887,0.8895515241731919,1.0,3/15,11.84%,SLC8A1;CTNNB1;GSN
prerank,calcium ion import (GO:0070509),0.38428895832401216,1.000630903514405,0.4610630407911001,0.8895026209439971,1.0,10/28,27.61%,SLC8A1;CACNA1A;MCUR1;TRPV4;MICU2;TRPC4;SMDT1;MICU3;SLC25A23;CACNA1D
prerank,protein localization to cell junction (GO:1902414),-0.3177348558277605,-1.000364023137274,0.4067796610169492,1.0,1.0,5/22,7.99%,KIF3A;DLG4;NECTIN1;PAK2;NLGN2
prerank,positive regulation of nervous system process (GO:0031646),-0.32991966532539285,-0.9995283546339956,0.43089430894308944,1.0,1.0,8/18,21.84%,TPPP;NLGN2;RIMS1;RNF10;TNFRSF1B;RIMS2;EGR2;NCMAP
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.4262303043974959,0.9993802531690086,0.48079658605974396,0.8922787408978892,1.0,7/15,19.70%,UBQLN2;SCYL2;PIK3CB;DAB2;SMAP1;SNAP91;AAK1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3474555892766177,0.9989940956251089,0.4982857142857143,0.89275038173562,1.0,20/54,21.44%,KATNAL1;DYNC1H1;KPNB1;HOOK2;CCDC88A;PLK3;HOOK1;CIB1;STMN3;CCDC88B;TRPV4;CLIP2;HOOK3;DLG1;RAB11A;CLIP4;CAMSAP2;NUMA1;FIGN;CRIPT
prerank,positive regulation of mitochondrial fission (GO:0090141),0.41496077461496583,0.9988462224723423,0.4669365721997301,0.8925965837827962,1.0,2/18,2.15%,KDR;FIS1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.41138210145731846,0.9984462791713196,0.48408488063660476,0.8931151940127996,1.0,7/20,21.03%,ATIC;HPRT1;AK4;AK3;ADSL;AMPD3;LHPP
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.37081259070296335,0.9978195226672316,0.4775212636695018,0.8942374128569266,1.0,7/35,10.53%,SPRY2;TNFAIP1;ITGA3;MYOC;MET;KANK1;STMN3
prerank,organelle fission (GO:0048285),0.398352269936188,0.9976729547208164,0.47793190416141235,0.8940402451291689,1.0,10/24,26.77%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;CORO1C;OPA1;DNM3;WASHC5;DNM1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3883189228769648,0.9975730746236124,0.46894803548795944,0.8937399516319131,1.0,3/28,1.44%,IRGM;NOD2;NOD1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.30479437125161857,-0.9974708027406759,0.47058823529411764,1.0,1.0,4/23,7.16%,TGFB1;TGFBR3;TPM1;ID2
prerank,cellular response to radiation (GO:0071478),-0.2645931788190787,-0.9972895696118051,0.42441860465116277,1.0,1.0,13/40,19.97%,INO80;RHNO1;SPIDR;SIRT1;EEF1D;NSMCE3;HUS1;TP53;CDKN1A;RAD1;NET1;ECT2;RAD51AP1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24472440953264524,-0.9971480924803574,0.44329896907216493,1.0,1.0,17/59,13.13%,TAB1;NFKBIA;CARD11;TRAF2;ROCK1;NKIRAS1;TICAM2;BCL3;TRAF6;IKBKG;RIPK1;DAB2IP;UBB;IRAK1BP1;TRADD;UBC;AKT1
prerank,negative regulation of cell development (GO:0010721),0.3950692620464704,0.9970648484119521,0.47081218274111675,0.8945627805700213,1.0,5/25,13.62%,B2M;FBXW7;FBN1;SORL1;HOOK3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2959251842624977,-0.9969671308509995,0.4808510638297872,1.0,1.0,8/26,15.37%,SMARCA4;CRY2;ZBTB7A;SIRT1;KANK2;BRCA1;FOXP1;CRY1
prerank,regulation of receptor internalization (GO:0002090),0.3732900907825776,0.9964637645438724,0.45443645083932854,0.8955966418240145,1.0,7/35,11.13%,WDR54;MAGI2;INSR;MKLN1;ARRB2;LRPAP1;SCYL2
prerank,platelet aggregation (GO:0070527),0.3740206474906775,0.9964008326107836,0.48588957055214727,0.8952137723674929,1.0,11/33,24.11%,CSRP1;ACTN1;MYL9;PPIA;PIK3CB;ACTB;FIBP;MYH9;STXBP3;CLIC1;FLNA
prerank,histone acetylation (GO:0016573),0.34187216105359686,0.9962012540266054,0.48812095032397407,0.8952055509601587,1.0,30/69,28.95%,JADE3;NAA50;EP400;BRD1;KAT14;TADA2A;SUPT7L;WDR5;BRPF1;APBB1;KAT8;SGF29;KAT7;PER1;RUVBL2;ING5;TADA1;KAT6A;KAT5;KAT2B;ACTL6A;JADE2;YEATS2;ZZZ3;RUVBL1;EP300;CHD5;BRD8;BRPF3;YEATS4
prerank,platelet degranulation (GO:0002576),0.32622847780068226,0.9960827612291347,0.5,0.8949585326805806,1.0,14/118,13.59%,LGALS3BP;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CDC37L1;ISLR;LYN;APP;SCCPDH;VEGFD;CHID1;VTI1B
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3667171008497128,-0.996003564323651,0.46601941747572817,1.0,1.0,4/13,12.61%,GRM3;EDNRB;PALM;CCR2
prerank,cilium movement (GO:0003341),0.35785201786242743,0.9959833622181671,0.47171945701357465,0.8946711167114267,1.0,8/47,14.23%,ODAD2;CABYR;CCDC40;ADCY10;CFAP54;SPEF1;ODAD4;CFAP73
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34552743742119885,0.9958038022485267,0.48053392658509453,0.894593600802177,1.0,9/62,9.35%,NUP37;POLR2G;ZFP36;AGO2;STAT3;NUP153;DHX9;RAE1;POLR2K
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3945389550470195,0.9954893119852197,0.4884318766066838,0.8943625257005747,1.0,8/23,27.02%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3945389550470195,0.9954893119852197,0.4884318766066838,0.8943625257005747,1.0,8/23,27.02%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,sulfur compound biosynthetic process (GO:0044272),-0.21785259944192786,-0.9951533023026453,0.42857142857142855,1.0,1.0,39/104,25.45%,CHSY1;CHST1;UST;ST3GAL6;METTL16;VCAN;GCLM;CSGALNACT1;B3GNT2;GSS;MAT2A;SLC10A7;CHST7;CHST15;ST3GAL3;B4GALT3;PAPSS2;CHST3;GSTO1;BGN;GSTA3;SLC35B2;GGT5;DSEL;HAGH;GGCT;GSTM1;CDO1;SLC35B3;DCN;BCAN;GSTA4;ACAN;GSTO2;UGDH;CSPG5;HPGDS;ST3GAL2;B3GNT7
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.41769562481336875,0.9951055208395799,0.4939106901217862,0.8947651810732995,1.0,2/18,4.28%,IRS1;CRHBP
prerank,polyol biosynthetic process (GO:0046173),0.42839557561039476,0.9950868474710705,0.4673913043478261,0.8942715774614752,1.0,4/16,15.71%,ITPKC;PPIP5K1;CYP27A1;ACER3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.369579983527966,0.9950753545454469,0.47129186602870815,0.8937503156245358,1.0,6/36,6.51%,TIMELESS;CHEK2;CHEK1;TIPIN;CDT1;BRIP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.38983440944389236,0.9949828335949371,0.48226018396846254,0.8934452232541973,1.0,5/26,13.11%,DHFR;GDNF;GCH1;APOE;PIK3CB
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.37201956815777504,-0.9945973609395337,0.4633333333333333,1.0,1.0,6/13,23.13%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.35267414910878914,0.9944415907879589,0.48522727272727273,0.8942776377494616,1.0,9/53,12.38%,PSME2;DDRGK1;OSBPL7;HSP90AB1;FBXW7;UCHL5;USP14;PSME3;APOE
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4188729181189639,0.9943564368779336,0.4736111111111111,0.8939719827947468,1.0,4/18,14.03%,DHX33;UBTF;POLR2K;WDR43
prerank,cellular sodium ion homeostasis (GO:0006883),0.4274689265533324,0.9943120122183289,0.4843962008141113,0.8935367625230513,1.0,2/15,3.73%,ATP1B3;SLC8A1
prerank,calcium ion transmembrane transport (GO:0070588),0.335560682179252,0.9942526485341551,0.5052631578947369,0.8931437274430654,1.0,15/86,15.96%,TRPM5;TRPM2;CACNA2D4;GRIN2D;TRPM6;SLC8A1;CACNA1A;P2RX4;MCUR1;TRPM3;MCOLN2;TRPV4;MICU2;TRPM7;SLC24A3
prerank,regulation of spindle organization (GO:0090224),0.41746807205147024,0.9940100234309546,0.47192513368983957,0.8932366249110846,1.0,3/18,8.18%,RNF4;DYNC1H1;RAE1
prerank,regulation of microglial cell activation (GO:1903978),0.4314770461302253,0.9940078215536152,0.4805013927576602,0.8926974213884689,1.0,5/15,18.15%,CX3CL1;CST7;STAP1;PTPRC;LDLR
prerank,long-term memory (GO:0007616),-0.31029437041258806,-0.9936723322818788,0.451063829787234,1.0,1.0,6/19,16.69%,SGK1;RASGRF1;RGS14;CAMK4;CALB1;PJA2
prerank,regulation of hydrolase activity (GO:0051336),0.336558747017456,0.9930497967114607,0.5172031076581576,0.8947372548300428,1.0,17/71,18.30%,PLXNA3;PLXNB2;PLXNB3;EPHA4;RAPGEF6;RAP1GAP;VAV1;STMN3;FGD6;CHN1;SIPA1L1;CFAP73;CRK;TDG;OCRL;NF1;PAFAH1B1
prerank,transcription by RNA polymerase III (GO:0006383),0.3799770568110953,0.9928299483841875,0.48481012658227846,0.8948051796677139,1.0,10/27,20.51%,SNAPC2;RO60;GTF3C5;POLR3GL;POLR2K;SNAPC5;ICE2;GTF3C3;BRF1;SNAPC4
prerank,activin receptor signaling pathway (GO:0032924),0.4335809621270227,0.9927926328940003,0.4957627118644068,0.8943539439244347,1.0,2/15,7.94%,ACVR1;SMAD2
prerank,regulation of mitochondrion organization (GO:0010821),0.3568201568894773,0.9925941131543001,0.4873271889400922,0.8943170465194284,1.0,6/47,12.39%,STAT2;FIS1;FBXW7;CSNK2A2;INF2;PPARGC1A
prerank,dendritic cell migration (GO:0036336),0.42612497607483046,0.9925060801401481,0.4993342210386152,0.8940240207458351,1.0,4/16,9.03%,CXCR4;TRPM2;CCL5;HMGB1
prerank,cellular macromolecule catabolic process (GO:0044265),0.3477402739388059,0.9924523009240755,0.46835443037974683,0.8936167531596226,1.0,8/49,8.72%,PNPT1;XRN2;CHEK2;RNF5;RNASEH2A;RAB12;RNASEH2C;NGLY1
prerank,organic hydroxy compound transport (GO:0015850),0.36447769584263695,0.9918623934266629,0.4963855421686747,0.8946373242058882,1.0,4/36,6.37%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,mRNA export from nucleus (GO:0006406),0.3261512524588017,0.9914311868188337,0.5156576200417536,0.8952055160737147,1.0,35/102,24.66%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;DDX39B;NUP155;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;ENY2;SLU7;DDX19A;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP;SRSF2;MAGOH;NUP205;EIF4E
prerank,negative regulation of cyclase activity (GO:0031280),-0.3578671238735781,-0.9913834399332857,0.4745762711864407,1.0,1.0,4/14,12.61%,GRM3;EDNRB;PALM;CCR2
prerank,negative regulation of nuclear division (GO:0051784),0.46718266334096803,0.991203015958498,0.48863636363636365,0.89533918951062,1.0,5/11,29.46%,CHEK1;AURKAIP1;TOM1L2;FBXO5;NME6
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.32789771478618623,0.9904635113805202,0.5127388535031847,0.8966937371164255,1.0,25/88,21.76%,PSMB10;SKP1;FBXL16;PSME2;PSMA5;CUL5;PSME4;FBXW7;PSMA3;PSMB9;RBX1;BTRC;PSMD2;PSME3;FBXL14;PSMA4;AMN1;FBXL5;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2
prerank,positive regulation of TOR signaling (GO:0032008),-0.26273166003295534,-0.9904486847963828,0.475,1.0,1.0,13/40,19.52%,GPR137C;GPR137B;NCKAP1L;RRAGD;RRAGB;LARS1;SEC13;GOLPH3;TREM2;SLC38A9;LAMTOR2;FLCN;MLST8
prerank,organelle assembly (GO:0070925),0.31016978150819646,0.9897503129952825,0.555,0.8980326643575223,1.0,111/384,24.63%,IRGM;CNGB1;CHMP4A;CHMP4B;CHMP1B;AUP1;CEP19;ATP6V0D1;BBIP1;RAB8B;RBM14;CDS1;B9D2;ACTR2;YTHDF1;CEP162;MVB12A;DYNC1H1;GOLGA8B;UBQLN2;RILP;SNX10;RILPL1;TTC39C;STX7;ACTR3;NPHP3;KIF3B;MAPRE1;RAB43;YTHDF2;MKS1;VPS37A;UBQLN1;UBXN2B;CFAP54;FNBP1L;NPM1;WDR35;CEP131;TMEM138;CHMP3;EXOC6;GSN;NEK6;TMOD3;DYNLT2B;VPS28;MAP1LC3B;SYNPO;DYNLL1;E2F4;CCDC61;POGZ;EIF2S1;DZIP1;RB1CC1;TMEM67;PATL2;PIBF1;CFAP20;MIS12;DBNL;HGS;CCDC66;BBS2;ARF4;RAB11A;RAB32;DHX37;CEP89;DYNC2H1;WDR19;OCRL;IST1;SH3PXD2B;CHMP5;DCDC2;GBF1;IFT46;NEK7;BECN1;MRPL22;OGFOD1;CSDE1;RAB1A;GORASP2;DDX3X;STARD9;G3BP1;TRAPPC14;TSG101;HAUS3;CHMP1A;TRAPPC6A;FARP2;VPS36;MAPRE3;ZFYVE1;IFT140;LIMD1;NOTCH1;LSM4;HDAC6;FLNA;UBAP2L;BSCL2;EXOC2;BBS7;BBS4;CEP83
prerank,negative regulation of protein catabolic process (GO:0042177),0.35636225236831753,0.9894921360182642,0.4793875147232038,0.8981643813286128,1.0,9/40,13.32%,RGP1;AZIN2;MAD2L2;RILP;AGAP2;TIMP2;AZIN1;RIC1;NELL1
prerank,axonogenesis (GO:0007409),0.3150223535609376,0.989349878612111,0.542713567839196,0.8980118716723858,1.0,49/237,16.33%,SLITRK6;UNC5B;CXCR4;WNT5A;BDNF;PIK3CD;ATL1;SEMA4D;NRP2;GRB10;DOK1;SIAH1;EVL;HSP90AB1;CYFIP1;EPHA4;FGFR2;PAK3;RET;DOK6;DOK5;EPHA6;GDNF;B4GALT5;APP;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;PIK3CB;APBB1;NRP1;ACTB;FYN;IRS2;HSP90AA1;NPTN;TAOK2;DSCAM;SEMA3D;BAIAP2;DSCAML1;LLGL1;SCN1B;NLGN3;OPHN1
prerank,cellular response to BMP stimulus (GO:0071773),0.3397767124796264,0.9889053829432396,0.48272017837235226,0.8986529970984042,1.0,12/66,15.05%,GDF9;ACVR1;DDX5;USP15;SOX9;SMAD2;SCX;BMPR2;RGMB;SMURF1;ADAMTS12;BMPR1A
prerank,epithelial cell morphogenesis (GO:0003382),0.4192891545755695,0.9888194973045916,0.48048452220726784,0.8983197149125447,1.0,5/17,18.80%,RILPL1;COL22A1;MET;COL15A1;SIPA1L3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3677925762228082,0.9887582178957736,0.49166666666666664,0.8979420006096104,1.0,13/32,21.67%,ANKLE2;HSP90AB1;MAGI2;PPIA;DUSP26;SPPL3;CALM3;CD300A;MTOR;PPP1R7;PIN1;PPP2R5A;PRKCD
prerank,response to laminar fluid shear stress (GO:0034616),0.4647862423520274,0.9887377062449422,0.5095729013254786,0.8974624109117272,1.0,1/10,1.02%,ABCA1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3439647383155575,0.9885934288879854,0.5038503850385039,0.8973331761116021,1.0,6/66,3.68%,NOD2;TAOK3;FLT1;CD40;SASH1;ADAM8
prerank,regulation of vacuole organization (GO:0044088),-0.31414924146599044,-0.9885863978283045,0.41568627450980394,1.0,1.0,6/20,16.37%,ENO1;LAPTM4B;IFT88;ENO2;RAB1B;MTM1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.24668542476545877,-0.9883717559671997,0.4852941176470588,1.0,1.0,16/49,19.33%,CST3;RCC2;SLC39A14;GMIP;DAB2IP;ARL2;EGLN1;URI1;MAPK7;NEIL1;ZCCHC9;TMED2;ECM1;F11R;HRAS;CAMK2A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3123380687202057,0.9882073428677541,0.5271084337349398,0.8977967846708804,1.0,70/264,18.25%,SRPK3;POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;DDX20;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;SRPK1;HNRNPL;TGS1;HSPA8;RBM17;RSRC1;RNPS1;SNW1;WDR83;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;SNRPD2;SNRPD1;SART1;PAPOLA;BUD31;GEMIN7;CLNS1A;DBR1;EFTUD2;PCF11;RBM15;DDX39B;SNRPG;PRPF40B;NCBP1;DHX16;GEMIN2;SF3B4;SRSF7;SRSF4;HNRNPA3;METTL14;CWF19L1;DDX46;CWC22;DDX23;SNRPB2;SNRNP48;DCPS;SLU7;SCNM1;LSM5
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.38603178155219364,0.9880637297066658,0.5006257822277848,0.8976529980517934,1.0,11/29,29.44%,LARP1;GDNF;TENT5A;TENT5C;TAF15;FUS;NOCT;EIF4ENIF1;HNRNPU;SLC11A1;PABPC1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4161544424644412,0.9879536643448723,0.49506346967559944,0.8974145483054202,1.0,5/16,18.77%,DHFR;GCH1;APOE;PIK3CB;TERF2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.43096817134862575,0.9878805206934459,0.4958217270194986,0.8970785880594404,1.0,6/15,19.70%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34;ERN1
prerank,phagosome acidification (GO:0090383),-0.29021380978110745,-0.9874078113000752,0.43842364532019706,1.0,1.0,6/26,13.09%,ATP6V0A1;ATP6V1H;ATP6V1E1;ATP6V1C1;ATP6V1D;ATP6V1A
prerank,protein-containing complex disassembly (GO:0032984),0.34446775925897655,0.9872700070640922,0.5284738041002278,0.8981542132642728,1.0,11/54,13.59%,LAMP2;CTNNB1;VPS33A;LIX1;RUBCNL;HSPA8;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,motor neuron axon guidance (GO:0008045),0.4261001650542584,0.9872055124340613,0.49722222222222223,0.8977802255513095,1.0,4/15,14.01%,EPHA4;SLIT1;CHN1;RAC1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2640609299739873,-0.9871189375161481,0.49056603773584906,1.0,1.0,5/41,3.68%,SLC12A6;ATP1B1;SLC12A2;ATP1B2;KCNJ10
prerank,cardiac muscle cell development (GO:0055013),-0.32179252476216913,-0.9863698231830559,0.4620938628158845,1.0,1.0,10/20,34.57%,PDLIM5;SORBS2;CXADR;FHOD3;PDGFRA;PDGFRB;MYH11;HEY2;OBSL1;MYL2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3521243851073329,0.9862901074926582,0.5023148148148148,0.8996001553049021,1.0,13/48,20.35%,NUP37;PNPT1;SLC2A6;NUP153;RUBCNL;RAE1;PRKAG1;EIF6;NOA1;NUP155;NUP88;NUP133;NUP43
prerank,regulation of neuron projection development (GO:0010975),0.3167984364001891,0.9862847769097414,0.5400202634245187,0.8990709727501794,1.0,43/163,18.84%,WNT5A;PLXNB2;BDNF;CAMK2B;FBXO7;RETREG3;RUFY3;PLXNB3;CX3CL1;P3H1;EPHA4;PAK3;MT3;RET;MAGI2;EFHC2;RAPGEF2;PAQR3;CCDC88A;LTK;LYN;KANK1;ROR2;CIB1;MAG;PSEN1;APOE;TRPV4;CHN1;SIPA1L1;RAPGEF1;MYLIP;NPTN;RTN4IP1;SCN1B;PTPN9;STMN2;MDK;CAMSAP2;ITM2C;FUT9;MARK1;BRSK1
prerank,regulation of chromosome organization (GO:0033044),-0.31345818351327775,-0.9861861438675688,0.47641509433962265,1.0,1.0,5/22,7.74%,WAPL;XRCC5;CENPV;TERF2IP;YLPM1
prerank,modulation by symbiont of host process (GO:0044003),-0.39271075607969763,-0.9861731902287478,0.4340175953079179,1.0,1.0,7/10,17.31%,ENO1;MRC1;UBB;PGK1;UBC;UBA52;RPS27A
prerank,regulation of exocytosis (GO:0017157),0.34858440694487897,0.9859254951589974,0.4894366197183099,0.8994663073048497,1.0,11/46,16.42%,RAB8B;RAB21;RAB12;CPLX1;UNC13D;CADPS2;CHMP3;RAB2B;VAMP2;STX4;STXBP5L
prerank,axon development (GO:0061564),0.33479185265300077,0.9859092047601327,0.5126315789473684,0.8989769388976316,1.0,21/78,19.95%,SLITRK6;DHFR;ATL1;GAP43;FGFR2;PAK3;MAPK8IP3;APP;APBB1;ACTB;TAOK2;BAIAP2;DSCAML1;LLGL1;CAMSAP2;SVBP;BRSK1;MAP1B;CCK;PLP1;RTN4RL1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4625216751572568,0.9857323662725679,0.5049786628733998,0.8989239950342924,1.0,2/11,9.00%,CDH13;P2RX4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4257697357607416,0.9857201141055766,0.5100401606425703,0.8984115067407544,1.0,6/16,24.79%,DDRGK1;SEC16A;GBF1;BCAP31;ANK2;BCAP29
prerank,macrophage differentiation (GO:0030225),0.43689778727722794,0.9856785394848075,0.49145299145299143,0.8979878964718584,1.0,2/13,6.90%,IL15;CSF1
prerank,inositol phosphate metabolic process (GO:0043647),0.35448384734931465,0.9855772013175776,0.49942196531791905,0.8976890090749843,1.0,11/46,18.89%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.39180863130604515,-0.9854096729722003,0.45857988165680474,1.0,1.0,3/10,6.08%,STIM1;HOMER1;HOMER3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3210290347975183,-0.9849584414102422,0.462882096069869,1.0,1.0,4/20,7.72%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,positive regulation of transmembrane transport (GO:0034764),0.4423843951934646,0.984933631452953,0.5071633237822349,0.8987758234429141,1.0,4/13,13.39%,AZIN2;ACSL5;AZIN1;CA2
prerank,cellular response to organic substance (GO:0071310),0.3260091355289899,0.9846225785482245,0.5202913631633714,0.8990605963760838,1.0,25/116,18.22%,CXCR4;CPNE3;ACVR1;STAT3;ASAH2;PTPN18;LRP2;CCL5;NCOA1;CTNNB1;PTPN7;LDLRAP1;BMPR2;CIB1;SLIT3;PTPN11;SOCS2;RACK1;BMPR1A;INPP5K;TIPARP;IL18;PTPN9;DCPS;ACVR2A
prerank,phospholipid metabolic process (GO:0006644),-0.233837934237785,-0.9846130946224017,0.48936170212765956,1.0,1.0,23/71,22.56%,PLCB2;MBOAT1;PLAAT3;CLN8;SMPD3;ABCA2;PLBD1;GPAM;PLPPR4;AGPAT4;PLCD1;ABHD12;LPL;ACP6;AGPAT2;PLPP3;PIP4K2A;PLA2G15;FITM2;SMPD1;SMPD2;LGALS13;PLA2G3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.314469591838209,-0.9844762120464458,0.44680851063829785,1.0,1.0,9/21,20.62%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.314469591838209,-0.9844762120464458,0.44680851063829785,1.0,1.0,9/21,20.62%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.37659246706269717,-0.9844346014982063,0.4674922600619195,0.9979727301928446,1.0,5/11,13.59%,CASP8;SLC25A4;YBX3;RIPK1;ARHGEF2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4637022095090276,0.9843157053359063,0.5220588235294118,0.8992965099486526,1.0,3/11,20.74%,BMPR1A;LGALS9;CD46
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3292340845027947,0.984258230689912,0.5123258306538049,0.8989131465914983,1.0,30/80,25.54%,VPS51;RGP1;GOSR2;VPS53;TBC1D23;VPS54;BAIAP3;STX16;ARL1;ANKFY1;VPS50;TMEM87A;VPS52;RIC1;VTI1B;PREPL;SPAG9;VPS26A;SNX1;GBF1;GOSR1;VPS35;SNX2;STX6;RAB29;SNX12;RBSN;DENND2A;DCTN1;TBC1D17
prerank,positive regulation of protein import (GO:1904591),-0.2794554791916052,-0.984009442696167,0.47761194029850745,0.9966761634839938,1.0,10/30,22.72%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;ECT2;DMAP1;BAG3;TPR;RBM22
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.41444716624077493,0.9839069653882778,0.4964131994261119,0.899290061499883,1.0,5/17,12.38%,CLU;GGA3;PRNP;SORL1;APOE
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.40230301279637215,0.9837531960637987,0.5110821382007823,0.8991415468097546,1.0,3/20,13.52%,BCKDK;SIK1;CLK2
prerank,iron ion homeostasis (GO:0055072),0.3412391582244885,0.9835851519967643,0.5088495575221239,0.8990577468375394,1.0,13/58,18.23%,SKP1;ATP6V0D1;B2M;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1
prerank,receptor-mediated endocytosis (GO:0006898),0.31926065335640746,0.9835816798980797,0.5314109165808445,0.8985297193551132,1.0,29/132,14.77%,DNAJC13;STAB2;CXCL16;LRP2;HYOU1;AP2A1;AP1S1;ACKR3;FCGR1A;INSR;LDLRAP1;PI4KB;AMN;ARRB2;FNBP1L;SNX9;AP2S1;DNM2;SORL1;RABEPK;APOE;FCGR2B;PIP5K1C;DAB2;MASP1;LMBR1L;SNAP91;HSP90AA1;TFR2
prerank,regulation of T cell cytokine production (GO:0002724),0.43513003721831944,0.9835240144015726,0.48428571428571426,0.8981390014566127,1.0,2/15,2.90%,B2M;CD55
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4005594559852565,0.9832616596069833,0.5013157894736842,0.898274864578966,1.0,11/21,31.11%,SKP1;MAD2L2;BTRC;RPL11;RAB1A;RPL5;PTEN;MAD2L1;FBXO5;UBE2S;FZR1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.36332577146170786,-0.9832499258919036,0.43973941368078173,0.996451776674286,1.0,4/12,18.27%,NABP1;NABP2;BUB1;PLK2
prerank,mitochondrion organization (GO:0007005),0.3112548917891963,0.9831793805411061,0.5566905005107252,0.8979568971114348,1.0,66/165,28.20%,IFIT2;MTFR2;PNPT1;FIS1;FBXO7;CHCHD10;POLG2;TRAK1;TFB2M;GDAP1;ATAD3A;TOMM5;TIMM50;SLIRP;TWNK;SAMM50;DNM2;DNAJA3;LONP1;PPARGC1A;TSPO;NDUFS1;PITRM1;AFG1L;VPS13D;AIP;MEF2A;RAB32;MIGA2;TOMM40;MTFP1;CHCHD2;BAX;RHOT2;GABPB1;COX7A2;VPS13C;BCAP31;ADCK1;HIGD2A;MTX1;MYH14;AKT3;ATP5F1B;SSBP1;PRDX3;PTCD2;OPA1;RAB29;DNM3;TFAM;BCS1L;CAV2;SLC25A33;COX7A2L;STOML2;HIGD1A;BNIP3L;CYCS;DNM1;BCL2L1;ESRRA;WASF1;PYROXD2;HSD17B10;BID
prerank,regulation of B cell proliferation (GO:0030888),-0.25532995473652625,-0.9831593896113692,0.48,0.9940988217815279,1.0,8/44,8.81%,GPR183;CD38;CD81;NCKAP1L;TNFRSF13B;SASH3;EPHB2;TFRC
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3636684964761052,0.9830623516324536,0.5054678007290401,0.8977155693568811,1.0,11/35,18.94%,DHX36;CTNNB1;RTEL1;CCT4;HNRNPA2B1;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.35524769656659716,0.9827746396184497,0.5162064825930373,0.8979193220503646,1.0,12/42,18.75%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;YARS2;EEF1E1;TARS2;PPA1
prerank,microtubule depolymerization (GO:0007019),0.41460366422939426,0.9827175729229615,0.5223880597014925,0.8975342923140991,1.0,6/17,18.42%,KIF2C;STMN4;STMN3;KIF2A;STMN2;KIF19
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3578938556861699,0.982687755510341,0.4916267942583732,0.8970741884666565,1.0,15/39,27.61%,FXYD4;UTRN;FXYD6;SPHK2;AHCYL1;FXYD5;SCN1B;STK39;FXYD7;YWHAE;ANK2;WNK3;CHRM3;SCN4B;CACNA1D
prerank,DNA repair (GO:0006281),0.3069710891485322,0.982620095865027,0.5501002004008017,0.896702004342959,1.0,59/284,16.70%,PARP9;TENT4A;MSH2;ASCC3;DTX3L;EXO5;TIMELESS;CHEK2;POLE2;PSME4;POLD4;APLF;MAD2L2;CHEK1;UBE2B;NOP53;RNASEH2A;CHD1L;CDKN2D;POLB;RFC4;TNKS1BP1;WDR33;HERC2;UBXN1;BRIP1;BACH1;ALKBH1;RAD51C;RPAIN;FEN1;ERCC4;XRCC3;MPG;ACTR8;BARD1;POLK;WDHD1;MNAT1;MEN1;VCPIP1;CIB1;NPM1;POLQ;PRKDC;ZRANB3;APBB1;USP45;MLH3;ASCC2;ALKBH2;DCLRE1A;NSMCE1;RECQL5;ERCC6L2;TDG;SPRTN;UPF1;NEIL2
prerank,positive regulation of synapse assembly (GO:0051965),0.37913730613585117,0.9826140607113371,0.4951219512195122,0.8961787842792187,1.0,7/27,16.25%,BDNF;CLSTN1;SEMA4D;AGRN;IL1RAP;CLSTN3;NLGN3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.42478381859403463,0.9824849892335079,0.48783977110157367,0.8959583653486772,1.0,1/14,1.54%,WNT5A
prerank,interstrand cross-link repair (GO:0036297),-0.24448431622085937,-0.9823410726104095,0.5043478260869565,0.9942141967168329,1.0,19/53,20.12%,RPA1;FANCC;FAAP20;SLX4;FANCM;DCLRE1B;UBB;FAAP100;UBC;FANCD2;UBA52;NEIL3;FANCG;RPS27A;ERCC1;RPA3;XPA;RAD51AP1;CENPX
prerank,reticulophagy (GO:0061709),-0.3810060881167063,-0.9822900977585629,0.43973941368078173,0.9916945778226257,1.0,5/12,8.88%,UBA5;ULK2;ATG2B;UFM1;ATG2A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4129267334830132,0.98225941745732,0.502724795640327,0.8959903704380846,1.0,6/17,17.35%,HASPIN;CTCF;RB1;MIS12;CHAMP1;ZWILCH
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.44961316832321097,0.9822194150341685,0.498567335243553,0.8955610041435842,1.0,6/12,19.23%,KIF2C;CDT1;MIS12;CHAMP1;RMDN1;NDC80
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3905607813455431,-0.9821449464160874,0.47058823529411764,0.9894647076771064,1.0,8/10,36.49%,MARK4;GSK3B;APC;CEP72;CEP250;NUP62;PARD6A;NSFL1C
prerank,mismatch repair (GO:0006298),0.3827752147505185,0.9818554521181428,0.4961439588688946,0.8959671514761086,1.0,4/27,6.39%,MSH2;POLD4;RNASEH2A;MCM9
prerank,substrate-dependent cell migration (GO:0006929),0.43191488416993656,0.9817877147100803,0.5027472527472527,0.8955910187039867,1.0,4/14,17.53%,ITGA2;NRP1;OPHN1;PTPRC
prerank,organophosphate ester transport (GO:0015748),0.39071851263773877,0.9814893829959339,0.49625,0.8958226431763195,1.0,10/24,23.30%,SLC25A19;OSBPL8;PITPNM1;NPC2;MTTP;LDLR;OSBPL2;PCTP;TNFAIP8L3;PITPNA
prerank,regulation of neuron migration (GO:2001222),0.38593110009932036,0.9813782408597134,0.5126582278481012,0.8955724533658369,1.0,8/26,16.95%,PLXNB2;CAMK2B;CX3CL1;RAPGEF2;COL3A1;SRGAP2;IGSF10;MDK
prerank,intracellular protein transport (GO:0006886),0.30660152217204356,0.9812654854701812,0.5461847389558233,0.8953308359072327,1.0,76/304,19.92%,ARF3;TBC1D1;RANBP6;STAT3;MYO1C;RAB21;LAMP2;SRPRA;NUP153;KPNB1;SEC16A;CSE1L;PRICKLE1;AP2A1;TRAK1;STX7;HERC2;ARF5;GGA3;NXT1;TMED5;VPS33A;TBC1D8;UNC93B1;RPAIN;RAB22A;RAB43;RAB5C;STX8;PPP1R10;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;FUT10;VIPAS39;RAB14;ARL1;SORL1;RAB24;SCFD1;IPO8;SMURF1;VPS28;RIC1;ARL5C;TNPO2;NAPA;NAPB;MYO6;STX4;FAM91A1;RANBP3L;NUP155;ARF4;VPS26A;RPL11;RAB32;TBCK;SNX1;RANBP17;TBC1D2;TMED1;NUP88;CDC37;TMED3;SLU7;COPB2;RAB5B;NUP133;RAB1A;SGSM1;TBC1D4;SGSM3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3301797322991492,-0.9810032843751413,0.4602076124567474,0.9906209918736523,1.0,7/16,30.03%,IGFBP5;IGFBP4;ZFAND2B;IGFBP6;IGFBP3;BMP5;BMP2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31043670314111776,0.9807994414149929,0.552738336713996,0.8959734536862267,1.0,42/199,21.70%,WNT11;LOXL2;IL15;NR1H2;SPRY2;SFRP2;MAD2L2;PTGER4;CRHBP;EVL;SOX9;SRF;N4BP1;NFIB;PPP1R11;BMPR2;LRPAP1;IL17D;ZNF423;DUSP10;ACOT13;RB1;FCGR2B;ALDH1A1;PTCH1;NPTN;BBS2;MCC;RBPJ;MDK;SPRED3;CORO1C;SPRED1;ASB1;PCTP;SFMBT1;IFNGR1;STK11;USF3;ADIPOR1;PGAM5;RHEB
prerank,detection of calcium ion (GO:0005513),0.43376035996315915,0.9806494027905122,0.4955357142857143,0.8958423133641007,1.0,1/13,0.74%,KCNMB3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3481513015187075,0.9804015851426943,0.5129716981132075,0.8959397271314817,1.0,11/46,16.79%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;HK1;TSPO;PITRM1;AIP;TOMM40
prerank,regulation of interleukin-17 production (GO:0032660),0.37387875615300403,0.9802906305447461,0.5096385542168674,0.8956778182096848,1.0,2/31,0.94%,IL15;NOD2
prerank,negative regulation of bone remodeling (GO:0046851),0.4617679051066303,0.9801684818501397,0.512372634643377,0.8954887241424194,1.0,1/11,0.60%,CALCA
prerank,endocardial cushion morphogenesis (GO:0003203),0.40614609137470137,0.9800128218509853,0.49859943977591037,0.8953475726692484,1.0,5/18,23.31%,ACVR1;SOX9;BMPR1A;ACVRL1;NOTCH1
prerank,protein localization to centrosome (GO:0071539),0.4134322115371564,0.9797967603311831,0.5188679245283019,0.8954055990559119,1.0,9/17,27.47%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;BBS4;CEP83;CEP192;CCDC14
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.39589520431729497,0.9796023061395887,0.496757457846952,0.8953776440134349,1.0,5/20,18.34%,ATP1B3;SLC8A1;TFAP2B;KCNJ2;LACC1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.39529561796862855,0.9793421691101,0.521505376344086,0.8955138021874275,1.0,5/23,12.23%,NFKB1;ENTPD5;APP;INSR;PSEN1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.37980451589039554,-0.979329311663169,0.4608150470219436,0.993706904102709,1.0,3/11,6.15%,SYK;PRKCQ;ANK3
prerank,positive regulation of gene expression (GO:0010628),0.30534697749788864,0.9788773085912501,0.591,0.8961194183951424,1.0,68/442,16.80%,EIF2AK2;HSPA1B;WNT11;MOV10;IL15;AGT;TENT4A;WNT5A;MYBBP1A;SPRY2;PLXNB2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;MYO1C;SLC38A2;YTHDF1;DDX5;PTGER4;DHX36;SOX9;ZCCHC4;MT3;ITGB8;CSF1;CTSH;POU3F1;SCX;DNMT1;APP;POLR2K;MAPK14;PRKAG1;SPHK2;NPM1;PPM1F;CCDC88B;ZC3H12A;FAM98B;CTCF;FGF9;EIF6;MITF;MAP2K2;GSN;STAP1;PSEN1;PRKDC;EPHX2;PPARGC1A;UPF3A;TAF1B;LIMS1;PIK3CB;ACTB;TFR2;MYD88;RBM3;HGS;TLR2;SLC24A3;RPL11;MTOR;RBPJ;METTL14;LGALS9
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35115215918414966,0.9786781741700632,0.5115740740740741,0.8960728843114589,1.0,10/44,14.01%,WNT11;CD47;EVL;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;NRP1;RAC1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4612108546302278,0.9783148816553173,0.5046728971962616,0.8964755119532968,1.0,3/10,14.82%,FEM1B;ETAA1;DDX39B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.45551187907065366,0.9781576762222631,0.5236686390532544,0.8963613505532451,1.0,3/11,12.99%,FBXO7;NONO;RACK1
prerank,protein catabolic process (GO:0030163),0.3363537765722828,0.9780873225554313,0.49887640449438203,0.8960239115126908,1.0,16/59,18.99%,CHEK2;RNF5;LAMP2;SIAH1;RAB12;LRSAM1;UCHL3;NGLY1;HSPA8;APOE;HSP90AA1;ATE1;MTOR;STT3B;SOCS6;DDI2
prerank,response to nitric oxide (GO:0071731),-0.3627029178011405,-0.9778142093957972,0.48264984227129337,0.9961008066770995,1.0,4/13,14.15%,KCNC2;EGLN1;MTR;FOXO1
prerank,cardiac muscle cell contraction (GO:0086003),0.4001711581111732,0.9775884395321169,0.4934210526315789,0.8967587311816039,1.0,4/19,16.85%,CAMK2D;GSN;SCN1B;KCNJ2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.32025062445794233,-0.977400497630607,0.4357976653696498,0.9948218805597716,1.0,5/18,11.91%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,histone deacetylation (GO:0016575),0.3497623034772529,0.9769196038562831,0.5202780996523755,0.8979641770208422,1.0,15/43,25.39%,PER2;RBM14;MTA3;MTA2;SIRT6;MIER1;HDAC8;RCOR3;HDAC1;PER1;HDAC2;HDAC4;HDAC6;SMARCAD1;SIRT2
prerank,ERAD pathway (GO:0036503),0.328202539313574,0.9769194995641659,0.5236051502145923,0.8974396652351991,1.0,18/83,15.45%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;POMT2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;TMEM67;ERLIN2;RNF103
prerank,cell-cell junction maintenance (GO:0045217),-0.37911721897998596,-0.976882857774036,0.4835820895522388,0.9938433838144637,1.0,7/11,41.85%,NLGN2;F2R;TJP1;PARD6A;INAVA;PRTN3;CD177
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.381301041521105,-0.9765559486858698,0.4823529411764706,0.9922686082038896,1.0,3/10,15.02%,CEACAM1;CD9;PRKG1
prerank,hexose biosynthetic process (GO:0019319),0.3539796298503246,0.9765103620795279,0.4982497082847141,0.8978991709432242,1.0,6/42,8.04%,SORD;PER2;TPI1;SLC25A1;PGM1;SLC25A10
prerank,leukocyte tethering or rolling (GO:0050901),-0.3249548590379878,-0.9761351028187774,0.48698884758364314,0.9910179174657864,1.0,5/17,11.91%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.33264172284821003,0.9758987931645504,0.5294759825327511,0.8989393030936809,1.0,9/73,9.16%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;APP
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.27750746491407874,-0.9758131374099529,0.48066298342541436,0.9895429208757325,1.0,5/33,8.45%,CASP8;FES;TRAF6;ID2;RIPK1
prerank,protein phosphorylation (GO:0006468),0.3046191356047199,0.9755783642221528,0.594,0.8991934674348718,1.0,104/478,19.18%,EIF2AK2;WNT11;TAOK3;FLT1;DAPK3;GLYCTK;SGK2;SGK3;RSKR;CAMK2D;TP53RK;KDR;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;HASPIN;CDC25B;STK38L;PKN2;PNCK;USP15;HCK;CHEK1;ILF3;IKBKE;PEAK1;MORC3;CDK12;EPHA4;MKNK1;FGFR2;PAK3;CAB39;NRBP2;RET;CSNK2B;CSNK2A2;GMFB;HTATIP2;FAM20B;SMAD2;VRK3;LTK;LYN;CLK3;APP;INSR;PIK3R4;SRPK1;MAST3;MAPK14;BMPR2;PRKAG1;CDK19;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;DYRK2;NEK6;PRKDC;PRKCE;CLK2;FYN;JAK2;PRKCH;MINK1;FAM20C;MASTL;BMPR1A;STK25;NRBP1;TLR2;TAOK2;OXSR1;FGFR3;MTOR;TBCK;IRAK1;STK39;CSK;BCR;TLR3;SNRK;BIRC6;PRKG2;ACVR2A;FNIP2;COPS8;CTBP1;MARK1;BRSK1;NEK7;STK24;STK3;CAMKK2;STK16
prerank,negative regulation of heart contraction (GO:0045822),-0.36816041992345994,-0.975527385717688,0.4542857142857143,0.9879055896377253,1.0,5/11,22.05%,SPTBN4;PIK3CG;GRK2;FKBP1B;SRI
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.315686378887623,-0.9753538869456165,0.46545454545454545,0.9858461736619237,1.0,4/18,8.45%,TGFB1;EGFR;ESR1;RIPK1
prerank,rRNA 3'-end processing (GO:0031125),-0.37718647873682065,-0.975214396268901,0.46200607902735563,0.9837272746983767,1.0,4/10,13.22%,EXOSC7;EXOSC10;ERI1;EXOSC3
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.28268256242797335,-0.9749828079267243,0.511520737327189,0.9819232775214394,1.0,11/30,22.07%,TECR;HACD1;ELOVL5;SLC27A4;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;SLC27A2;ELOVL6
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4269761385914688,0.9745133403952461,0.4958904109589041,0.9007929153947735,1.0,4/15,18.35%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4269761385914688,0.9745133403952461,0.4958904109589041,0.9007929153947735,1.0,4/15,18.35%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,carnitine metabolic process (GO:0009437),-0.3739207274772143,-0.9738345228768605,0.4793650793650794,0.9830164062426384,1.0,6/12,18.01%,ACADM;TMLHE;CROT;CPT2;CPT1C;CRAT
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.40149777545637677,0.9737659917660348,0.5095298602287166,0.9021579279302273,1.0,11/22,26.13%,RNF5;AMFR;MAN1A2;RNF185;RNF103;MAN1C1;TRIM13;EDEM2;EDEM3;DERL2;EDEM1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4117087269676647,0.9737175984660329,0.5046480743691899,0.9017578679687471,1.0,9/18,26.80%,GRIK3;GRIA2;NAPA;NAPB;GRID1;GRIK4;GRIK2;GRIK5;CDH8
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3426508718898948,0.9734137530032007,0.5311438278595696,0.9020189768571509,1.0,21/53,28.20%,EYA4;TMEM161A;DDX5;DHX9;NSMCE1;EYA2;EEF1E1;SPRED3;BABAM2;SPRED1;SMCHD1;PRKCD;FBH1;NACC2;TIGAR;TRIM28;EYA3;EYA1;ATR;UBE2N;BABAM1
prerank,neuron projection development (GO:0031175),0.30958833276770203,0.9725645110771814,0.5474006116207951,0.9036068270391805,1.0,46/168,20.59%,BLOC1S4;TAOK3;BDNF;CNTNAP1;PPP1R9A;GAS7;EPHA4;PAK3;TBC1D23;MYOC;SAMD14;MAPK8IP3;STMN4;RAPGEF2;EPB41L3;LYN;GDNF;HMGB1;APP;TNIK;STMN3;DNM2;ADGRV1;ANKRD27;SRGAP2;APOE;RB1;CTNND2;MINK1;MAP4;DBNL;LRP12;TAOK2;PRMT1;RAB11A;OPHN1;STMN2;NYAP2;DICER1;CAMSAP2;DTNBP1;SVBP;NCKAP1;PLP1;DOCK10;LGI1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4476277810321099,0.9722550010667653,0.5207100591715976,0.9038485183509675,1.0,3/11,19.03%,SOCS5;ZC3H12A;RC3H2
prerank,positive regulation of transporter activity (GO:0032411),0.4326188845772443,0.9721842021239128,0.5130057803468208,0.9035199447994031,1.0,2/13,5.65%,SGK2;KMT2A
prerank,protein import into peroxisome matrix (GO:0016558),0.43793334783015914,0.97214096952602,0.5146831530139103,0.903123161468069,1.0,4/12,17.09%,PEX7;PEX2;PEX5;PEX13
prerank,ameboidal-type cell migration (GO:0001667),-0.24008655397033776,-0.9720648624047069,0.4727272727272727,0.9862581686622096,1.0,15/51,16.13%,PDXDC1;CENPV;SEMA4C;SEMA4G;SEMA4A;SEMA6A;ANXA6;PDLIM1;SEMA4B;SEMA3E;SEMA5B;AKT1;SOX10;AMOTL1;AMOT
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3876094633379732,0.9718389257184894,0.5134443021766966,0.9033397323136005,1.0,11/23,23.70%,KIF7;BTRC;ENPP1;RACK1;PTCH1;TULP3;MGRN1;GLI3;HERC4;KCTD21;VCP
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3481587005353,0.9717259170546071,0.5284552845528455,0.9030892452026031,1.0,5/43,11.25%,ACVR1;CCDC40;NPHP3;SRF;SETDB2
prerank,embryonic digestive tract development (GO:0048566),-0.31466024563527617,-0.9716574093102324,0.5135135135135135,0.9851134882486972,1.0,4/18,8.68%,NIPBL;SALL1;ID2;TGFB2
prerank,DNA metabolic process (GO:0006259),0.3039562509111375,0.9713781825976682,0.5758793969849246,0.9034378863350676,1.0,47/270,13.67%,SP100;SAMHD1;MSH2;MCM2;LRWD1;TIMELESS;POLE2;PSME4;POLD4;MCM7;CHEK1;UBE2B;NOP53;RNASEH2A;MCM4;CHD1L;POLB;RFC4;RFC1;CDT1;TCF7L2;BACH1;RTEL1;ALKBH1;RAD51C;RPAIN;FEN1;ERCC4;XRCC3;MPG;HMGB1;BARD1;POLK;DNMT1;WDHD1;MNAT1;MEN1;NPM1;LONP1;POLQ;HMGB3;PRKDC;ORC3;ZRANB3;DNASE2;USP45;STN1
prerank,mitochondrion localization (GO:0051646),-0.3199341463269108,-0.9710510507796548,0.4939759036144578,0.9845323728182634,1.0,8/19,24.75%,MFN1;TRAK2;BRAT1;ATCAY;MTM1;MUL1;MSTO1;NECTIN2
prerank,amyloid fibril formation (GO:1990000),0.34089913999696647,0.9708318594854486,0.5253093363329584,0.9042744281489595,1.0,10/51,15.36%,CALCA;UBE2L6;B2M;SIAH1;GGA3;APP;SORL1;GSN;APH1A;APH1B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3122940995376818,0.9701720595594904,0.5483539094650206,0.9053696623482753,1.0,38/129,23.89%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;PSMA4;PSMD7;PSMD9;PSMD8;PIN1;PSMF1;DDX3X;PSMB6;USP8;PSMD12;PSMC2;SMURF2;PSMD4;GPRC5B;XIAP;PSMA2;VCP;AXIN1;CAPRIN2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.35377153029802966,-0.9700573298452078,0.47368421052631576,0.9849384916439072,1.0,4/13,16.27%,EPHB2;SHANK3;CHRNA7;SHISA7
prerank,protein import into nucleus (GO:0006606),0.3302232796674114,0.9698363796273517,0.5290889132821076,0.9056787286268808,1.0,15/66,17.56%,RGPD1;RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;NXT1;RPAIN;PPP1R10;IPO8;TNPO2;NUP155;RANBP17;NUP88
prerank,cellular protein localization (GO:0034613),0.3027387036466094,0.9697379084510273,0.572289156626506,0.9054050355917135,1.0,71/285,19.92%,WNT11;WNT5A;ARF3;TBC1D1;RAB21;CNTNAP1;RTP4;COG3;TM9SF1;RRAGC;CTNNB1;AP2A1;STX7;HERC2;ARF5;GGA3;TMED5;VPS33A;TBC1D8;UNC93B1;RAB22A;CNTLN;RAB43;EPB41L3;RAB5C;STX8;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;VIPAS39;RAB14;ARL1;RAB24;SCFD1;SMURF1;LAMTOR3;RIC1;ARL5C;CORO1B;NAPA;SEPTIN9;NAPB;MYO6;STX4;FAM91A1;HGS;BBS2;ARF4;VPS26A;RAB32;TBCK;JAM3;SNX1;PTPRU;SH3PXD2B;TBC1D2;TMED1;TMED3;SLU7;COPB2;ARMCX3;RAB5B;PIGK;RAP2A;RAB1A;SGSM1;TBC1D4;SGSM3
prerank,bicarbonate transport (GO:0015701),0.38569980820368077,0.9696850149081355,0.5092348284960422,0.9050182540985114,1.0,2/25,1.70%,CA4;CYB5R2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3244309806232566,0.9696546501826511,0.5396145610278372,0.9045781407488335,1.0,24/80,23.77%,TRIB3;BIRC2;ARRDC4;FBXW7;PRICKLE1;UBE3A;DCUN1D4;RBX1;UBQLN1;PAXIP1;UBE2L3;BIRC3;MYCBP2;SPRTN;PIN1;RIPK2;HSPBP1;HUWE1;DCUN1D5;STUB1;CUL3;SENP2;XIAP;AXIN1
prerank,negative regulation of metabolic process (GO:0009892),0.3415749085738573,0.9694945462135239,0.5290178571428571,0.9044529273365511,1.0,15/54,24.07%,IL15;NR1H2;FIS1;ZNF423;ACOT13;RB1;ALDH1A1;RBPJ;PCTP;STK11;CCDC3;PGAM5;RHEB;NOTCH1;ACOT11
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3879064765346056,0.9687512693247697,0.5179282868525896,0.9058324904773434,1.0,10/22,29.39%,DHX33;UBTF;DDX11;WDR43;MTOR;UTP15;PIH1D1;NCL;SMARCB1;ATF4
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4491594627588267,0.9684561527357017,0.5269286754002911,0.9060565190708297,1.0,2/11,6.69%,ITPKC;PPIP5K1
prerank,cyclooxygenase pathway (GO:0019371),-0.3926355411102705,-0.9684504414105316,0.5044776119402985,0.9876893802426343,1.0,6/10,26.58%,PTGDS;PTGS1;PTGES;CBR1;HPGDS;PTGIS
prerank,cellular response to unfolded protein (GO:0034620),0.3821740761554992,0.9677770887058039,0.5148387096774194,0.9071837603614543,1.0,2/26,1.78%,HSPA1B;DAXX
prerank,carbohydrate homeostasis (GO:0033500),0.33358973413625403,0.967703192811331,0.528835690968444,0.9068474546343795,1.0,15/67,21.82%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;RPS6;BAD;INPP5K;SELENOT;APPL2;STK11;ADIPOR1;CRTC2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.4575383228479328,0.967601919100801,0.5161290322580645,0.9065697384907478,1.0,2/10,6.40%,CCL5;PODXL
prerank,mitochondrial gene expression (GO:0140053),0.349426879011418,0.9675546711167564,0.5205158264947245,0.9061708194474616,1.0,11/42,19.11%,IARS2;MRPL12;TFB2M;MRPL16;MRPS28;TWNK;MRPS2;NOA1;MRPL57;FASTKD2;MRPS11
prerank,negative regulation of protein binding (GO:0032091),0.33229255070334157,0.9675483929929838,0.5518763796909493,0.9056727792834941,1.0,21/71,24.15%,IFIT1;IFIT2;B2M;SLPI;DACT1;ARRB2;LRPAP1;SORL1;DDX11;RACK1;DAB2;ACTB;BAX;ITGA4;PIN1;PTPRF;USP33;PRKCD;DNAJB2;ADAM15;TLE5
prerank,regulation of cell development (GO:0060284),0.3564126008795324,0.9674928853448995,0.525934861278649,0.9052903655131318,1.0,5/36,8.46%,PER2;BHLHE40;CX3CL1;CTNNB1;YTHDF2
prerank,neutrophil degranulation (GO:0043312),0.30290560537174227,0.9672856905765976,0.6036036036036037,0.9052671549161598,1.0,111/425,22.02%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;KPNB1;HSP90AB1;FGL2;NAPRT;CYFIP1;DEGS1;SLPI;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;UNC13D;PPIA;PGM1;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;HMGB1;NEU1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;TUBB4B;LAMTOR3;DYNLL1;CMTM6;KCMF1;CAPN1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;NPC2;DBNL;SYNGR1;NHLRC3;PTGES2;CD300A;TLR2;UBR4;HMOX2;PGRMC1;TCIRG1;IST1;LAMP1;PTPRC;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;RAB5B;CD33;TYROBP;SIRPA;DDX3X;PLAUR;DDOST;STXBP3;PSMD12;PRKCD;PSMC2;TMC6;ARSA;ALDOC;MGST1;HUWE1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.40032212733198547,0.9671739833832085,0.5146666666666667,0.9050141256417387,1.0,3/19,6.89%,MYO1C;RUNX1;SNAI2
prerank,embryonic limb morphogenesis (GO:0030326),-0.2625201549756456,-0.9669607719974381,0.5207100591715976,0.9901124848206923,1.0,6/34,8.68%,MAP3K20;FBXW4;LRP6;NIPBL;SALL1;TGFB2
prerank,mitotic DNA replication (GO:1902969),0.460002804772483,0.9669436328586508,0.5305810397553516,0.9050743711230655,1.0,2/10,5.07%,MCM2;MCM4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3691203976512669,0.9668848572321876,0.5296296296296297,0.9047132646008563,1.0,10/30,20.21%,XRN1;DCP2;ERCC4;MEN1;BMPR2;HNRNPA1;STN1;DACH1;TERF2;ACVRL1
prerank,protein-containing complex subunit organization (GO:0043933),0.31938039976571214,0.9668030701147823,0.5647181628392485,0.9044105077564936,1.0,19/109,14.36%,PML;GPAA1;TEAD2;CD40;LAMC1;MDN1;CHCHD10;TSPAN4;TAPBP;SOX9;KMT2A;SKAP2;DET1;MNAT1;SNX9;MITF;PPARGC1A;VAMP2;IL1RAP
prerank,neural tube development (GO:0021915),0.4173728622779862,0.9664196497558764,0.5134751773049645,0.9048516652541742,1.0,4/15,13.61%,DACT1;ALDH1A2;PROX1;PTCH1
prerank,regulation of cell adhesion (GO:0030155),0.3126296839219272,0.9663311311579942,0.5661538461538461,0.9045480295430658,1.0,22/129,17.19%,PLXNA3;HYAL1;CXCR4;PLXNB2;SEMA4D;CDH13;ADAM8;CCL5;PLXNB3;EPHA4;PODXL;RET;YTHDF2;LYN;DUSP26;PTPN11;STX4;MINK1;DSCAM;IL18;MDK;CBLL1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.31203804417604253,-0.9661966025666912,0.502092050209205,0.9899950379430904,1.0,4/19,16.74%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3064745530725578,0.9661064792828048,0.5793172690763052,0.9046072239488033,1.0,62/241,18.25%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;HNRNPL;HSPA8;RBM17;RSRC1;RNPS1;SNW1;WDR83;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;SNRPD2;SNRPD1;SART1;PAPOLA;BUD31;GEMIN7;DBR1;EFTUD2;PCF11;RBM15;DDX39B;SNRPG;PRPF40B;NCBP1;DHX16;SF3B4;SRSF7;SRSF4;HNRNPA3;METTL14;CWF19L1;DDX46;CWC22;DDX23;SNRPB2;SNRNP48;SLU7;LSM5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.39452834867824604,0.9658933361042571,0.52,0.9046245716673118,1.0,7/20,18.57%,ZFP36;HOXA9;CIB1;ZFP36L1;LDB1;PRMT1;HOXA5
prerank,sulfate transport (GO:0008272),0.413620990877574,0.9656938029651785,0.5288184438040345,0.9046052922587753,1.0,6/14,23.27%,SLC26A1;SLC25A10;SLC26A2;SLC13A4;SLC25A30;SLC26A7
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2923366049193543,-0.9653504978747689,0.4801762114537445,0.990182617509109,1.0,11/24,17.31%,MAP2K6;CASP8;TAB1;TRAF6;IKBKG;ITCH;UBB;AAMP;UBC;UBA52;RPS27A
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.40574401173494273,0.9649222382209938,0.5217391304347826,0.9059934694999724,1.0,5/18,21.82%,LPAR5;CRTC1;CRTC3;LRP8;CRTC2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.33622666341976704,0.9639744382002685,0.5288135593220339,0.9078382763225962,1.0,13/56,20.21%,GDF9;ACVR1;PMEPA1;CSNK2B;BMPER;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;SNX25;PIN1;ACVRL1
prerank,positive regulation of B cell activation (GO:0050871),0.3459163580699251,0.9637060799591323,0.5324074074074074,0.9079907862482566,1.0,13/50,17.53%,NOD2;CD40;MMP14;MAD2L2;NFATC2;XBP1;SHLD1;PAXIP1;IRS2;TNIP2;CHRNB2;CD27;PTPRC
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2872802293664676,-0.9635362591857471,0.49740932642487046,0.9933323491333601,1.0,10/27,22.33%,CMPK1;CTPS1;DTYMK;TYMS;TXNRD1;RRM2B;NME1;DUT;RRM1;GUK1
prerank,carbohydrate transport (GO:0008643),0.4499630167395547,0.9631011534960913,0.5180897250361794,0.9089934453511825,1.0,1/11,3.32%,AQP11
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.272727472476621,-0.9630190497062209,0.4845360824742268,0.9924680824204787,1.0,12/27,27.00%,TAB1;IRAK3;TRAF6;UBB;UBC;UBA52;RPS27A;CD14;BTK;TLR4;HSPD1;TLR5
prerank,transcription by RNA polymerase I (GO:0006360),-0.2718507688201482,-0.9629955628636938,0.5308056872037915,0.9900095494426095,1.0,14/34,18.18%,POLR1A;MAPK3;ERCC3;TBP;TTF1;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.34099749129306345,-0.9629828478589537,0.49363057324840764,0.9875308192520946,1.0,9/15,29.04%,DYRK1A;EGFR;MAPK3;IGF1R;TXK;ABL1;DDR1;ITK;PTK2B
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.45548495019044993,0.9628902516867146,0.530791788856305,0.9089974005301578,1.0,2/10,10.09%,XYLT2;CSGALNACT2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.4260031232542244,0.9628572833371162,0.5362116991643454,0.9085458914462192,1.0,5/14,17.86%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34
prerank,positive regulation of cholesterol transport (GO:0032376),-0.28867863869167026,-0.9626918034803128,0.5065502183406113,0.9859914021961513,1.0,12/27,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;PLTP;ABCA3;ABCA13;NR1H3;ABCA7;CAV1
prerank,translational termination (GO:0006415),0.31328521972192724,0.9622358121374769,0.5537974683544303,0.9095300032372519,1.0,24/95,19.26%,MRPL36;ERAL1;MRPS30;GSPT1;MRPL12;MRPL16;MRPS35;MRPS28;ABCE1;MRPL42;MRPL4;MRPS22;MRPS23;MRPS2;AURKAIP1;MRPL24;ETF1;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,regulation of ATP metabolic process (GO:1903578),0.33998025661827475,0.9616940212760619,0.5429864253393665,0.9103239594117197,1.0,15/54,20.35%,NUP37;FIS1;SLC2A6;NUP153;RAE1;ABCD1;PRKAG1;SPHK2;EIF6;AK4;NUP155;NUP88;COX7A2;NUP133;NUP43
prerank,neutrophil mediated immunity (GO:0002446),0.3010719862673497,0.9616869515529297,0.6146146146146146,0.909824095587295,1.0,112/432,22.02%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;KPNB1;HSP90AB1;FGL2;NAPRT;CYFIP1;DEGS1;SLPI;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;UNC13D;PPIA;PGM1;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;HMGB1;NEU1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;IRAK4;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;TUBB4B;LAMTOR3;DYNLL1;CMTM6;KCMF1;CAPN1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;NPC2;DBNL;SYNGR1;NHLRC3;PTGES2;CD300A;TLR2;UBR4;HMOX2;PGRMC1;TCIRG1;IST1;LAMP1;PTPRC;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;RAB5B;CD33;TYROBP;SIRPA;DDX3X;PLAUR;DDOST;STXBP3;PSMD12;PRKCD;PSMC2;TMC6;ARSA;ALDOC;MGST1;HUWE1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.34784223075554016,-0.9616127951309485,0.4882943143812709,0.9871256825721075,1.0,4/13,14.70%,UBAC2;UBE2J1;UBE2G2;YOD1
prerank,regulation of focal adhesion assembly (GO:0051893),0.33534946336955895,0.9615952087699248,0.5256556442417332,0.9095375090952547,1.0,11/54,14.01%,DAPK3;KDR;THY1;PEAK1;DUSP3;MYOC;PPM1F;LDB1;LIMS1;NRP1;RAC1
prerank,regulation of DNA repair (GO:0006282),0.34687278228790097,0.9615026687847366,0.5328638497652582,0.9092472687714374,1.0,3/44,1.15%,PML;EYA4;TMEM161A
prerank,positive chemotaxis (GO:0050918),0.4081607852254462,0.9611761648769999,0.5164690382081687,0.9095430669155331,1.0,4/17,13.33%,PLXNB3;CX3CL1;MET;NRP1
prerank,heterochromatin organization (GO:0070828),0.42127267047084027,0.960714165639877,0.5269886363636364,0.9101513747179083,1.0,5/14,21.63%,LOXL2;SETDB2;BAHD1;SETD7;SMCHD1
prerank,protein glycosylation (GO:0006486),0.3106445637364984,0.960666281570411,0.5702564102564103,0.9097614077631149,1.0,31/125,18.83%,TMEM258;AQP11;COG3;POMT1;TRAK1;MPI;POMT2;GALNT7;B4GALT1;GCNT4;GFPT1;ENTPD5;B4GALT5;ST3GAL1;DAD1;FUT10;GALNT18;MGAT4C;B3GALNT1;NPC1;ALG11;RPN1;TET2;GALNT1;MGAT5;ST8SIA1;MAGT1;MAN1C1;FUT9;STT3B;SERP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4340606941672768,0.9605919680647,0.5204081632653061,0.9094348340527635,1.0,3/12,14.65%,CYP26B1;SNW1;EZH2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39136896539049515,0.9604108316562452,0.538163001293661,0.9093699305894559,1.0,4/20,10.07%,CCND2;HSP90AB1;CCND1;PROX1
prerank,hepaticobiliary system development (GO:0061008),0.3882281665344078,0.9603251292834148,0.5026666666666667,0.9090552772489902,1.0,5/20,11.51%,GFER;ARID5B;MET;PROX1;XBP1
prerank,aminoglycan catabolic process (GO:0006026),0.3722680987032759,0.9602471292143422,0.530209617755857,0.9087319206875607,1.0,6/28,13.20%,SDC3;HYAL4;SDC4;AGRN;HPSE;HPSE2
prerank,snRNA transcription (GO:0009301),0.32308910646616634,0.9601874801940949,0.5447513812154696,0.9083829000610475,1.0,17/70,17.70%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;SNAPC5;ICE2;ELL2;GTF2E2;USPL1;NCBP1;CCNK;POU2F2
prerank,negative regulation of potassium ion transport (GO:0043267),0.42196764943442744,0.9595503281810104,0.5327635327635327,0.9093463112462236,1.0,3/13,16.66%,ACTN2;CAB39;STK39
prerank,synaptic membrane adhesion (GO:0099560),-0.3436691038334694,-0.9594974014774119,0.5056179775280899,0.9912125783533415,1.0,7/14,30.05%,LRFN5;SLITRK1;GPC4;SLITRK3;SLITRK2;PTPRD;NTNG1
prerank,regulation of lamellipodium organization (GO:1902743),0.4139592332299208,0.9591036017860383,0.5159944367176634,0.9099231593156211,1.0,4/14,14.01%,CARMIL1;PDPN;CAPZB;RAC1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3501967594579394,-0.9589931238994114,0.48672566371681414,0.9903193865372559,1.0,9/13,29.22%,GLRX3;CIAO1;MMS19;CIAO2A;BOLA2;ISCA1;GLRX5;CIAO2B;CISD3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.28184200592608155,-0.9589449542499673,0.5025906735751295,0.988014694336607,1.0,10/29,17.51%,ITGAV;MMD2;FGF10;RASGRF1;SRC;SHOC2;CRKL;RASGRP4;RASGEF1A;LRRC59
prerank,response to interleukin-6 (GO:0070741),-0.38754781637919133,-0.9586206613886412,0.5028571428571429,0.9865996308631353,1.0,2/10,3.15%,ST3GAL6;SELPLG
prerank,positive regulation of DNA recombination (GO:0045911),0.3690605999738871,0.9585559942842757,0.5286783042394015,0.910791408275924,1.0,7/27,15.84%,TIMELESS;ACTR2;MAD2L2;ARID2;SHLD1;PAXIP1;ZCWPW1
prerank,regulation of autophagy (GO:0010506),0.30229371779147785,0.9579448586899498,0.6008064516129032,0.9117495759435127,1.0,56/216,21.74%,IRGM;TRIM14;DAPK3;TRIB3;ATP6V0D1;STAT3;TRIM21;UBQLN2;ITPR1;OSBPL7;FBXW7;RRAGC;SH3GLB1;MT3;IL10RA;CSNK2A2;CISD2;MET;LEPR;HMGB1;PRKAG1;UBQLN1;FOXK1;ZC3H12A;CAPNS1;SVIP;LAMTOR3;CAPN1;PIK3CB;BAD;RUBCN;EIF4G3;RB1CC1;TMEM59;BMF;VPS26A;MTOR;SREBF1;KAT8;WDR41;ATP6V1B2;ATP6V1G1;ZKSCAN3;NPRL2;ATP6V1G2;TAB3;ERN1;LAMTOR4;TLK2;STK11;MCL1;OPTN;VPS35;USP33;RHEB;ABL2
prerank,negative regulation of myotube differentiation (GO:0010832),0.43536964831496866,0.9577985798746947,0.5353535353535354,0.911596201216344,1.0,5/12,23.57%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.28060988940415116,-0.9575553295929095,0.505,0.9874740113678242,1.0,13/24,28.97%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2751777648498743,-0.9572561914056974,0.5265700483091788,0.9860353147553075,1.0,13/30,22.02%,CASP8;TRAF2;HMOX1;TMBIM1;RIPK1;GSK3B;TRADD;BRCA1;ARHGEF2;FAIM2;FAS;TNFAIP3;GPX1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.36706647373167306,0.9572308688708491,0.5325814536340853,0.9124203111362448,1.0,8/30,12.73%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,response to hexose (GO:0009746),0.37280702797123616,0.9570396481795628,0.5181818181818182,0.9123693114669129,1.0,7/25,18.98%,TCF7L2;EIF2B2;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3
prerank,DNA packaging (GO:0006323),0.408006082793982,0.9566647658560749,0.5263870094722598,0.9127391604416941,1.0,3/16,10.26%,PRM1;BANF1;CHAF1B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3584794095716268,-0.9565759103916565,0.4626334519572954,0.9857233337043908,1.0,3/13,13.25%,ENO1;PINK1;TREM2
prerank,neutrophil activation involved in immune response (GO:0002283),0.29938125736515725,0.95590042180649,0.6376376376376376,0.9141231051631149,1.0,111/428,22.02%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;KPNB1;HSP90AB1;FGL2;NAPRT;CYFIP1;DEGS1;SLPI;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;UNC13D;PPIA;PGM1;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;HMGB1;NEU1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;TUBB4B;LAMTOR3;DYNLL1;CMTM6;KCMF1;CAPN1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;NPC2;DBNL;SYNGR1;NHLRC3;PTGES2;CD300A;TLR2;UBR4;HMOX2;PGRMC1;TCIRG1;IST1;LAMP1;PTPRC;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;RAB5B;CD33;TYROBP;SIRPA;DDX3X;PLAUR;DDOST;STXBP3;PSMD12;PRKCD;PSMC2;TMC6;ARSA;ALDOC;MGST1;HUWE1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.34790778097120767,0.9556223657111588,0.5545350172215844,0.9142602943587468,1.0,9/41,20.02%,SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,protein localization to chromatin (GO:0071168),0.39326655822433676,0.9555657535374479,0.5156037991858887,0.9138816454793717,1.0,3/18,6.39%,MSH2;LRWD1;MCM9
prerank,mitochondrial translational elongation (GO:0070125),0.31343844969767104,0.955300200808111,0.5652173913043478,0.9139873417159678,1.0,22/88,19.26%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS22;MRPS23;MRPS2;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.323808847843618,0.9551393179033797,0.5627009646302251,0.9138530609484842,1.0,22/75,19.83%,SLITRK6;ATL1;FGFR2;PAK3;BTBD3;APP;RB1;APBB1;ACTB;MINK1;TBCD;TAOK2;MEF2A;BAIAP2;DSCAML1;LLGL1;OPHN1;DCDC2;ABITRAM;BRSK1;MAP1B;CCK
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.35743948677539056,0.9547835823884182,0.5341317365269461,0.9141978174928542,1.0,9/36,14.65%,PCGF6;CHEK1;TFDP1;RING1;MAX;TFDP2;RYBP;UXT;EZH2
prerank,regulation of cellular metabolic process (GO:0031323),0.349782024674296,0.9547302670338055,0.548460661345496,0.9138183683312416,1.0,8/45,15.83%,BCO2;ABCG1;KIF16B;MKLN1;EIF6;PANK2;NPC2;ARF4
prerank,T cell activation (GO:0042110),0.3232484441760583,0.9546187320472708,0.5639344262295082,0.913597485641684,1.0,17/69,23.17%,TREML2;ICOSLG;PIK3CD;CHD7;CD276;NCK1;LEPR;NCK2;LMBR1L;NHEJ1;MDK;PTPRC;LCK;DDOST;RHOH;MSN;RAB29
prerank,sodium ion transmembrane transport (GO:0035725),-0.21948714455966745,-0.9543632765389715,0.5714285714285714,0.9902867736904266,1.0,13/84,13.67%,SLC9A9;ATP1B1;SLC12A2;ATP1B2;NALCN;SLC6A15;SLC8A3;SLC6A8;SCN3A;SLC4A8;TRPM4;SCN3B;PKD2L1
prerank,negative regulation of receptor binding (GO:1900121),0.45130411549592486,0.9543512151351824,0.5271084337349398,0.9137181780006487,1.0,1/10,2.21%,B2M
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3711693776276713,0.9542306125399622,0.542566709021601,0.9134914364935149,1.0,9/25,23.31%,SMAD2;BMPR2;ZNF423;BMPR1A;RBPJ;ACVR2A;NUMA1;ACVRL1;NOTCH1
prerank,T-helper cell differentiation (GO:0042093),0.42625154412820665,0.9541194162643392,0.5302593659942363,0.9132296779904899,1.0,3/14,9.03%,PTGER4;TMEM98;HMGB1
prerank,positive regulation of developmental process (GO:0051094),0.3041219195887154,0.9539382356421341,0.6024464831804281,0.9131657273120313,1.0,32/164,16.95%,WNT5A;KDR;ESRRB;FIS1;CAMK2B;AGO2;ACVR1;MAD2L2;HSP90AB1;SYDE1;SOX9;ARHGEF7;SRF;GDNF;B4GALT5;SCX;INSR;BMPR2;PHLDB1;XBP1;SORL1;PSEN1;SHLD1;APOE;PAXIP1;CORO1B;RREB1;BMPR1A;SOX5;LRP8;ANAPC2;MDK
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3373798836147971,-0.9537868743064025,0.47157190635451507,0.9896726794805599,1.0,3/14,10.33%,TRAF2;TRAF6;ZFP91
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.36186314877458,0.953573151548788,0.5649509803921569,0.9135151129259844,1.0,8/32,18.84%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1
prerank,sphingosine biosynthetic process (GO:0046512),0.44512111196976656,0.9534797995981351,0.5261627906976745,0.9127106446068874,1.0,4/11,18.47%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.44512111196976656,0.9534797995981351,0.5261627906976745,0.9127106446068874,1.0,4/11,18.47%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,negative regulation of transposition (GO:0010529),0.40614261033394383,0.9531756312638783,0.5275813295615276,0.9129525086790152,1.0,1/16,0.61%,MOV10
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3798977629161737,0.9529593879630635,0.538163001293661,0.912943572043094,1.0,2/22,9.56%,LRP2;ALDH1A2
prerank,axonal transport (GO:0098930),0.356613035269977,0.952406783564031,0.5577395577395577,0.9137895470623353,1.0,6/36,12.16%,BLOC1S4;RAB21;DYNC1H1;KIF3B;AP3M2;AP3S2
prerank,regulation of transport (GO:0051049),0.3553491261759173,0.9522503731192651,0.558645707376058,0.9136541924480505,1.0,10/36,16.29%,GAPVD1;LEPR;RSC1A1;SCFD1;VAMP2;NRP1;MYO6;ACTB;CLDN10;RAB11A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3614458556709967,0.9521108401081547,0.5403128760529483,0.9134744246432682,1.0,7/31,16.75%,PRMT2;RBL1;CDKN2D;DACT1;RB1;DLG1;BRD7
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4291432204035719,0.951999826665461,0.5071633237822349,0.9132547715610251,1.0,2/12,10.42%,SKP1;BTRC
prerank,neuron differentiation (GO:0030182),0.3040342283499764,0.9517050931799599,0.6163265306122448,0.9134270871899287,1.0,25/165,19.54%,WNT11;PITX2;LHX2;LMX1A;WNT5A;RUNX1;CTNNB1;NGRN;WNT7B;NRBP2;SRF;DTNB;MET;XBP1;DDIT4;LDB1;SMARCA1;ADNP2;IER2;OPHN1;HS6ST1;ITM2C;FUT9;BRSK1;PIN1
prerank,chromatin assembly or disassembly (GO:0006333),0.4438646090582551,0.9516142723881238,0.5419734904270986,0.9131354087638183,1.0,3/11,13.36%,MTA2;CHAF1B;HDAC8
prerank,positive regulation of protein catabolic process (GO:0045732),0.31515591653769864,0.9515666889853177,0.5555555555555556,0.9127440080799444,1.0,26/84,23.77%,WNT5A;SNX33;ADAM8;EGLN2;RILP;AREL1;VPS11;DACT1;BARD1;PLK3;SNX9;SORL1;SMURF1;APOE;VPS28;HSP90AA1;TIPARP;SH3D19;WWP1;VPS35;HUWE1;SMURF2;IDE;MSN;VCP;AXIN1
prerank,cellular respiration (GO:0045333),0.34756696952501603,0.9515302452891133,0.5448028673835126,0.9123235997190058,1.0,18/41,29.73%,MTFR2;NDUFA5;COQ10B;SDHAF4;PPARGC1A;NDUFS1;UQCR10;NDUFS4;NDUFS8;NDUFS7;SDHB;UQCRFS1;LYRM7;CYCS;SDHA;SDHC;SIRT3;ETFDH
prerank,sodium ion import across plasma membrane (GO:0098719),-0.32124731142667995,-0.9515138569935099,0.5019157088122606,0.9942600456164999,1.0,3/17,9.90%,SLC9A9;SLC12A2;TRPM4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3414156857312401,0.9514937958432432,0.5364161849710982,0.9118897773301197,1.0,14/47,18.90%,CARMIL1;ARHGEF7;MYOC;PDPN;KANK1;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CORO1C;TESK1
prerank,regulation of cellular localization (GO:0060341),0.34269973000547527,0.95133635542904,0.5546511627906977,0.9117527448939777,1.0,12/46,19.01%,CAMK2D;DYNC1H1;ADCY5;HSP90AB1;UNC13D;LYN;PPM1F;GSN;HSP90AA1;GOSR1;BRSK1;NUMA1
prerank,protein secretion (GO:0009306),0.33208655331473363,0.9507364906783353,0.57307249712313,0.9126834300155009,1.0,7/56,10.93%,GAL;ABCA1;RAB8B;RAB12;NAGPA;SNX19;TMEM167A
prerank,regulation of bone mineralization (GO:0030500),0.3365221075138494,0.9506574214841669,0.5767918088737202,0.9123648629433239,1.0,10/55,15.05%,ISG15;ACVR1;SLC8A1;NBR1;ANKH;BMPR2;ADGRV1;ENPP1;NELL1;BMPR1A
prerank,positive regulation of histone modification (GO:0031058),-0.2666742031147801,-0.9506341201994055,0.5555555555555556,0.994699216608933,1.0,10/33,15.41%,ARRB1;NIPBL;SAP30BP;GLYR1;MAPK3;ZBTB7B;BRCA1;RPS6KA4;KDM1A;ING2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.2196379560616183,-0.9500839543800446,0.639344262295082,0.9938751187993619,1.0,40/87,27.63%,COX16;NDUFAF5;PET100;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;AIFM1;NDUFC1;UQCC2;NDUFB7;TTC19;TIMMDC1;NDUFAF1;UQCC1;CHCHD4;NDUFA8;NDUFA3;SCO1;NDUFB8;NDUFA2;SURF1;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;UQCC3;COA3;NDUFS6;NDUFA11;NDUFA1;COX18;NDUFAF8;NDUFA6;SDHAF1;NDUFAF4;NDUFA13
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3145663085206527,0.9496598015423132,0.5920502092050209,0.9141428574939661,1.0,20/108,14.15%,GRB10;SFRP2;RUNX1;CTNNB1;FGFR2;ITGA3;HMGXB4;MDFIC;FRZB;DACT1;KANK1;APP;BTRC;APCDD1;MDFI;PSEN1;RACK1;CXXC4;ZRANB1;CTNND2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.30177387125448285,-0.9495854343774867,0.4981132075471698,0.9931590716531934,1.0,4/21,11.95%,LRP6;GSK3B;DVL3;APC
prerank,regulation of acrosome reaction (GO:0060046),0.4487732185051171,0.9495731080995237,0.5385756676557863,0.913829926381468,1.0,2/10,21.17%,SPINK13;GLRA1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.36007166960135084,0.9495468953663156,0.5477941176470589,0.9133839823589416,1.0,4/33,3.72%,PRMT2;DDRGK1;DDX5;RUNX1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.30554621461738096,0.9495067998786789,0.6041025641025641,0.9129822214498213,1.0,48/148,24.47%,PML;TAF4B;TP53RK;DAXX;PAK1IP1;CHEK2;CHEK1;NOP53;RFC4;PPP2R5C;BRIP1;CSNK2B;RRS1;CSNK2A2;MTA2;TAF2;BARD1;PLK3;MAPK14;PRKAG1;SSRP1;TAF3;DYRK2;NOP2;BRPF1;RMI1;TAF15;RPL11;MTOR;BRD7;HDAC1;RFFL;PIN1;SMYD2;ATRIP;STK11;JMY;RPL5;PRDM1;ING5;HDAC2;KAT6A;RAD9A;PDPK1;KAT5;TAF7;TAF4;PRKAB2
prerank,response to steroid hormone (GO:0048545),0.3568392759546255,0.9490530250382632,0.5489467162329615,0.913596295091622,1.0,5/31,12.73%,CATSPER4;ABHD2;UBE3A;NR3C1;UBE2L3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.320729471735806,0.9489947744346342,0.5600436681222707,0.9132257967163155,1.0,15/71,18.99%,ISG15;CHMP4B;CTSS;UBE2W;CTSC;RSPRY1;CTSH;NGLY1;LONP1;ZRANB1;ADAMTS12;ATE1;HM13;SOCS6;DDI2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3232288967153897,-0.9489760548616054,0.5220338983050847,0.9928350714063121,1.0,4/16,9.10%,ARHGAP44;AUTS2;RASGRF1;PIK3CG
prerank,membrane lipid metabolic process (GO:0006643),0.3872933985060228,0.9486216935918166,0.5552665799739922,0.9136154447136815,1.0,4/22,10.01%,ST6GALNAC4;B4GALT4;CERKL;SPHK2
prerank,positive regulation of macroautophagy (GO:0016239),0.33737106384794213,0.9485540468083887,0.5529953917050692,0.9132889384972823,1.0,6/48,6.32%,IRGM;KDR;FYCO1;LARP1;LRSAM1;SH3GLB1
prerank,regulation of synapse maturation (GO:0090128),-0.3777300573009358,-0.9484790956370162,0.5492537313432836,0.9920094610645255,1.0,4/10,9.11%,ADGRL1;YWHAZ;NRXN1;DAB2IP
prerank,positive regulation of isotype switching (GO:0045830),0.4085189048346266,0.9482982458706894,0.5458452722063037,0.9134178018675261,1.0,4/15,12.62%,CD40;MAD2L2;SHLD1;PAXIP1
prerank,mitochondrial transport (GO:0006839),0.3301430120157212,0.9481878634206912,0.5671296296296297,0.913177203300033,1.0,14/53,19.69%,FIS1;FBXO7;GDAP1;SLC25A16;TOMM5;STARD3;TSPO;BAD;PITRM1;AIP;HSP90AA1;TOMM40;FLVCR1;BCAP31
prerank,regulation of Notch signaling pathway (GO:0008593),0.31800988506931327,0.9478775073852996,0.5754923413566739,0.9134398602391145,1.0,13/76,11.01%,NOD2;DLK2;STAT3;TM2D3;MMP14;YJEFN3;FBXW7;ENHO;YTHDF2;EGFL7;MAML2;SNW1;NOTCH4
prerank,ephrin receptor signaling pathway (GO:0048013),0.3149247692441071,0.9473413602198875,0.5765957446808511,0.9142220123131043,1.0,22/82,15.54%,ACTR2;AP2A1;EPHA4;ARHGEF7;PAK3;ACTR3;EPHA6;LYN;NCK2;GIT1;AP2S1;ARPC5;PSEN1;PTPN11;CHN1;SIPA1L1;ACTB;RAC1;FYN;APH1A;APH1B;CRK
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.28273283756212697,-0.9466344387863597,0.48130841121495327,0.9954029100182618,1.0,4/26,3.80%,PAK1;FES;DRG1;CLIP1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2848888405928208,-0.946489478401541,0.5426008968609866,0.9934537843234322,1.0,10/23,34.74%,GABPA;MAPK3;SNCA;GNG2;ABL1;ATP2B4;PRKN;MAPK1;RYR2;KCNQ1
prerank,TOR signaling (GO:0031929),0.3653011802374473,0.9463831307165138,0.5483460559796438,0.9160076321020932,1.0,10/26,25.83%,LARP1;RHEBL1;EIF4EBP2;CCDC88A;RPS6;MTOR;NPRL3;TIPRL;FNIP1;RPS6KB2
prerank,glucose homeostasis (GO:0042593),0.3178431252796745,0.9459520453349125,0.5765957446808511,0.9165488102259054,1.0,14/83,15.35%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;HK1;FOXK1;PPARGC1A;RPS6;BAD;INPP5K;SELENOT
prerank,ribosome biogenesis (GO:0042254),0.2999546704259614,0.9457245018277293,0.6381048387096774,0.9165803610557526,1.0,59/187,23.38%,PWP2;LTV1;MRPL36;XRN2;PAK1IP1;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;LSG1;RRS1;ABCE1;NOLC1;NPM1;EIF6;DDX54;RPS6;NOP16;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;PELP1;RRP1B;RRP1;WDR12;RPL24;UTP3;RPL37A;RPL3;TSC1;ESF1;MRPL22;EMG1;RPL29;URB2;RPL5;RRP9;EXOSC4;UTP15;RPL6;LTO1;NOL6;UTP14A;RRP36
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3229932557730113,-0.9456478757320202,0.5224913494809689,0.9937751524398333,1.0,7/17,15.68%,DOCK4;DOCK7;ADAMTS1;IGFBP5;DOCK5;S100A11;VTN
prerank,polyamine metabolic process (GO:0006595),0.42382938279142146,0.9456178181288463,0.5413105413105413,0.916326183620948,1.0,3/13,7.70%,SAT1;SMOX;SMS
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3803606051017625,0.9454725336210533,0.5573122529644269,0.9161535529954015,1.0,4/23,18.73%,CNGB1;CAMKMT;METAP2;FNTA
prerank,proton transmembrane transport (GO:1902600),0.3503948061702703,0.9453787426612728,0.5588942307692307,0.9158883627061115,1.0,5/36,14.89%,ATP6V0D1;UCP3;SLC46A1;DMAC2L;ATP5PO
prerank,mucosal immune response (GO:0002385),-0.3273228839164855,-0.9452091342395524,0.5070921985815603,0.9927668513534493,1.0,5/15,35.90%,RPL39;DEFA6;OTUD7B;IFNLR1;LTF
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.335307938233594,0.9450815003249978,0.5707762557077626,0.9160847585771189,1.0,12/49,17.00%,CLU;PTGER4;PMEPA1;NOP53;DACT1;HMGB1;RIOK3;ANKRD27;SORL1;SVIP;JAM3;PEX5
prerank,positive regulation of programmed cell death (GO:0043068),0.29557589334050116,0.9449195654525451,0.6556224899598394,0.9159498215237898,1.0,41/272,13.46%,ZBP1;TNFSF10;IFIT2;DAPK3;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;FRZB;HTATIP2;ABR;HMGB1;BARD1;VAV1;SPHK2;PRR7;DIABLO;DNM2;PHLDA1;RNPS1;RNF122;RYBP;ARHGEF11;SOS1;PSEN1;RPS6;RACK1;BAD;AKAP13;APBB1;TIAM2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3203522903274232,0.9448636878539075,0.5846994535519126,0.9155766916259597,1.0,12/67,16.07%,IL15;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR;FYN;JAK2;PIBF1;FGFR3
prerank,regulation of cell differentiation (GO:0045595),0.3029283103198527,0.9448435364965917,0.6127049180327869,0.9151289470112569,1.0,21/148,11.45%,EIF2AK2;BDNF;BIRC2;DDX5;RUNX1;HSP90AB1;FGFR2;BCL6;TFAP2B;SNAI2;CSF1;SRF;MEGF10;CDK5RAP2;LTK;GDNF;TAF8;NOTCH4;ZFP36L1;PHLDB1;SIK1
prerank,protein O-linked mannosylation (GO:0035269),0.39772195396584636,0.9448347080560147,0.5459533607681756,0.9146494001494301,1.0,5/18,16.23%,TMTC1;POMT1;POMT2;CRPPA;TMTC4
prerank,response to histamine (GO:0034776),-0.38384981259561607,-0.9443710029950402,0.5096952908587258,0.9929479818062241,1.0,4/10,24.85%,GABRB1;HRH1;GABRB3;DRD2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3120590558125968,-0.943063733065902,0.5098814229249012,0.9947134198032407,1.0,4/17,16.74%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,branched-chain amino acid catabolic process (GO:0009083),0.388433746942099,0.9429014574553034,0.567741935483871,0.9181443092869671,1.0,8/20,23.64%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.388433746942099,0.9429014574553034,0.567741935483871,0.9181443092869671,1.0,8/20,23.64%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.42708610657872065,0.9426557403593314,0.547925608011445,0.918209771497925,1.0,4/12,14.57%,TRIB3;ACADL;ERLIN2;PIBF1
prerank,ncRNA processing (GO:0034470),0.297382821267107,0.942249514693438,0.6398390342052314,0.918654713975264,1.0,63/200,23.71%,PWP2;XRN2;ADAR;TRPT1;AGO2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;TARBP2;MDN1;SRRT;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;AARS1;HNRNPA2B1;SMAD2;NOLC1;DDX54;RPS6;ADAT1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;TUT7;DHX37;DDX47;DICER1;RPL10A;PRKRA;RPP30;PELP1;RRP1B;RRP1;WDR12;RPL24;UTP3;RPL37A;RPL3;ESF1;EMG1;RPL29;RPL5;RRP9;PUS10;EXOSC4;UTP15;RPL6;NOL6;AGO4;RPP21;UTP14A;RRP36;INTS1
prerank,regulation of DNA recombination (GO:0000018),0.35783851590174387,0.9420860774416587,0.5554187192118226,0.9185047738055816,1.0,7/32,15.84%,MSH2;CHEK1;RTEL1;SIRT6;PPP4R2;ZRANB3;ZCWPW1
prerank,protein kinase B signaling (GO:0043491),0.3784511672003331,0.9420214226644974,0.5542328042328042,0.9181498802866089,1.0,5/23,11.03%,KDR;CCL5;MT3;PLK3;ZFP36L1
prerank,ERBB signaling pathway (GO:0038127),0.3249939465824438,0.941955872983904,0.5914221218961625,0.9178030061059663,1.0,14/64,17.71%,CPNE3;GAREM1;CUL5;TGFA;PTPN18;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11;HSP90AA1;CDC37;PLCE1
prerank,chromatin disassembly (GO:0031498),0.41257947300726394,0.9419298104199597,0.5450643776824035,0.9168685716191411,1.0,6/14,19.06%,ARID1A;SMARCC2;SMARCE1;ARID2;SMARCD2;SET
prerank,nucleosome disassembly (GO:0006337),0.41257947300726394,0.9419298104199597,0.5450643776824035,0.9168685716191411,1.0,6/14,19.06%,ARID1A;SMARCC2;SMARCE1;ARID2;SMARCD2;SET
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.34599721565435193,0.9418194144991424,0.5633136094674556,0.9166269271501565,1.0,7/39,13.33%,KDR;SFRP2;CTNNB1;MET;GDNF;NOTCH4;NRP1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2984693779776193,0.9417601648642706,0.6187563710499491,0.9162566070832341,1.0,51/166,24.90%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;UBTF;TFB2M;TBPL1;TAF2;TAF8;RORA;MAML2;POLR2K;MNAT1;NR2C1;SNW1;NOTCH4;TAF3;NR3C1;PPARGC1A;GTF2E2;TAF1B;NRBP1;TAF15;PPARD;MED27;RBPJ;CAVIN1;POLR1G;HDAC1;TAF1C;BRF1;MED7;NR1D2;CDK9;GTF3C1;NOTCH1;NR2C2AP;BRF2;NCOR2;TAF7;KAT2B;POLR2C;POLR1F;TAF4;TFAM;CCN2;RARB;TAF11
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.30992371005234376,0.9416490261012245,0.597872340425532,0.9159872820543838,1.0,30/101,23.50%,AGT;NR1H2;ASPH;PLXNB2;YTHDF1;ZCCHC4;VPS11;CSF1;DACT1;BTRC;NPM1;EIF6;PRKDC;UPF3A;BAD;AURKAIP1;HSP90AA1;RBM3;MTOR;METTL14;IST1;DDX3X;RPL5;VPS35;PYM1;STUB1;HDAC2;MSN;CLN6;EIF3C
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3206490298560974,0.9414828742685313,0.5647840531561462,0.9158611770109188,1.0,11/59,16.20%,PLXNB2;CDH13;NECTIN4;PLXNB3;NECTIN3;SDK1;CD84;NPTN;HMCN1;DSCAM;DSCAML1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.33020062292592217,-0.9413725109643803,0.5018181818181818,0.9976493720572077,1.0,3/15,5.54%,SYK;HSPH1;PNP
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.38894834469014095,0.9413504062437111,0.5456953642384106,0.9156526487349953,1.0,5/20,22.01%,SPRY2;SMOC2;NPTN;DSTYK;FGF2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4307540505188093,0.9413356107213604,0.5323308270676692,0.9151957150331018,1.0,2/11,4.27%,ACVR1;USP15
prerank,positive regulation of phosphorylation (GO:0042327),0.2963068958148271,0.9409518049285287,0.6409227683049148,0.9155970781703093,1.0,38/240,14.73%,AXL;IRGM;FLT1;KDR;DAXX;SEMA4D;CD40;CCL5;CCND2;SOX9;CCND1;EPHA4;MYDGF;FGFR2;MT3;RET;EPHA6;PPIA;LTK;ENTPD5;LYN;MET;LEPR;APP;ROR2;INSR;TNIK;CIB1;VEGFD;FGF9;PSEN1;RACK1;NRP1;DAB2;RAC1;RB1CC1;HSP90AA1;NPTN
prerank,exit from mitosis (GO:0010458),0.4336971665495448,0.9407379996815706,0.5432835820895522,0.9156064838791372,1.0,1/12,0.58%,CHMP4B
prerank,negative regulation of receptor internalization (GO:0002091),0.4322718063832782,0.9406450835461564,0.5462822458270106,0.9153329645931266,1.0,3/12,10.05%,UBQLN2;WDR54;LRPAP1
prerank,histone mRNA metabolic process (GO:0008334),0.36952032214499225,0.9404732736521899,0.5541561712846348,0.9152715415794714,1.0,10/27,23.45%,NCBP2;XRN1;DCP2;SNRPG;NCBP1;TUT7;UPF1;MTPAP;EXOSC4;SNRPD3
prerank,acute-phase response (GO:0006953),-0.35176973060027883,-0.9404242901719991,0.5217391304347826,0.9981482237986848,1.0,2/12,13.70%,PLSCR1;CEBPB
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.44514228944370693,0.940187601435023,0.555045871559633,0.9154408199722702,1.0,4/10,17.53%,ARRB2;FCGR2B;LGALS9;PTPRC
prerank,response to ionizing radiation (GO:0010212),-0.22174835775291615,-0.9401514657280443,0.6136363636363636,0.9966278794606401,1.0,26/70,20.91%,INO80;BRAT1;USP28;NABP1;XRCC4;RHNO1;SPIDR;SIRT1;EEF1D;DCUN1D3;MRNIP;BRCA1;INIP;NABP2;HUS1;FANCD2;TP53;CDKN1A;RAD1;ANXA1;NET1;ECT2;MYC;RAD51AP1;ABRAXAS1;SMPD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.22963510430009382,-0.9401501734961505,0.6063829787234043,0.9942709030656188,1.0,19/61,21.29%,LPAR1;ARRB1;AUTS2;MMD2;FGF10;RASGRF1;PIK3CG;SHOC2;CRKL;PRAG1;RASGRP4;RASGEF1A;ARHGEF3;MAP4K4;F11R;LRRC59;NET1;F2R;RASGRP1
prerank,protein modification process (GO:0036211),0.32089413142700157,0.94003013254853,0.591304347826087,0.9153539731426189,1.0,23/76,24.06%,LIPT1;LOXL2;UBE2L6;USP25;UBE2M;NAGPA;SEPHS1;ST3GAL1;PRKDC;PPP4R2;GGCX;UBE2L3;RPN1;MSRA;SERP1;UBL5;ERO1A;YES1;ABL2;MMP15;FBXW2;PLAT;LOX
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.35307309687192184,0.9399821434284273,0.55,0.9149686915720181,1.0,11/34,18.90%,CARMIL1;ARHGEF7;MYOC;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;TESK1
prerank,positive regulation of organelle assembly (GO:1902117),0.33877237196687077,0.9394862246102288,0.5824682814302191,0.9156016262120588,1.0,7/44,10.22%,SDC4;DYNC1H1;KCTD17;LRSAM1;SH3GLB1;CCDC88A;G3BP2
prerank,magnesium ion transport (GO:0015693),-0.3524605955041825,-0.9392082303317227,0.5301204819277109,0.9947296494324652,1.0,5/12,21.89%,TUSC3;NIPAL3;MMGT1;CNNM4;NIPAL2
prerank,mesenchymal cell development (GO:0014031),0.3893852065343453,0.938746071991928,0.5380359612724758,0.9168227284592066,1.0,3/18,8.36%,TCOF1;SNAI2;NOLC1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3661331868468621,0.9385476622909219,0.5561160151324086,0.916800116832805,1.0,6/26,14.43%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3024348853554247,0.938242983005263,0.6195876288659794,0.917010657297675,1.0,37/151,21.85%,NMRAL1;SLC27A1;SGPP2;MOCS3;CERS6;DEGS1;CSNK2B;CSNK2A2;LPIN2;CEPT1;B4GALT5;NFS1;LPCAT2;VAPB;SPHK2;TNIP1;GCH1;MOCOS;HACD3;APOE;ABHD3;PAM;ACER3;CHPT1;SGPL1;SPTLC2;CERS2;PCYT1A;PCTP;ELOVL4;SLC44A1;SLC25A15;CHKA;SPTSSA;PLPP2;PCYT1B;MGST1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4465915995102796,0.9381443352157399,0.5473372781065089,0.9167431007431079,1.0,2/10,9.68%,IFI35;WDFY1
prerank,negative regulation of autophagy (GO:0010507),0.3283630123742947,0.9380011242576689,0.5632698768197089,0.9165938877037042,1.0,21/54,25.74%,STAT3;MT3;NRBP2;IL10RA;MET;LEPR;FOXK1;RUBCN;EIF4G3;BMF;MTOR;ZKSCAN3;TSC1;TAB3;TLK2;MCL1;RRAGA;EIF4E;PIK3CA;SIRT2;SNRNP70
prerank,neuron apoptotic process (GO:0051402),0.38139552417460276,0.9379803114573532,0.5499334221038615,0.9161576668910139,1.0,4/19,12.30%,SIAH1;APP;DIABLO;SCN2A
prerank,regulation of acute inflammatory response (GO:0002673),0.3921572586948422,0.937777589394896,0.578042328042328,0.9161597053272668,1.0,1/18,3.68%,ADAM8
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4413625488422599,0.9371217283047691,0.5610859728506787,0.9171735546325074,1.0,5/11,23.86%,TMEM106A;XBP1;JAK2;HDAC2;TAF7
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.39138534887150833,0.9370638371719489,0.57991513437058,0.9167963572624127,1.0,7/19,19.54%,CLU;GGA3;PRNP;SORL1;APOE;FLOT2;PIN1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.27673713933430666,-0.936922922079733,0.5428571428571428,0.9996334975710945,1.0,8/27,12.03%,TGFB1;PPP1R16B;PTPA;MTMR9;SYMPK;NSMF;SRC;CAMTA1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.349694485475225,-0.9364090894336385,0.5501519756838906,0.9989525128537007,1.0,2/12,2.44%,STARD3NL;AKR1B1
prerank,smooth muscle tissue development (GO:0048745),0.4390293146020573,0.9360109293054415,0.56752655538695,0.9187512267541216,1.0,3/10,17.97%,PROX1;PTCH1;NF1
prerank,zymogen activation (GO:0031638),0.343158734333245,0.9359757885551763,0.5778045838359469,0.9183402733209949,1.0,6/39,13.15%,ASPH;PRSS12;MMP14;CTSH;KLK1;BAD
prerank,response to amino acid starvation (GO:1990928),0.317896337142135,0.935920048360369,0.6133909287257019,0.9179684275737771,1.0,20/72,22.25%,EIF2AK2;MIOS;ATP6V0D1;LARP1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2933305455825419,0.935909966858957,0.706,0.9175014373996009,1.0,69/348,22.02%,HSPA1B;WNT11;MOV10;DTX3L;RESF1;WNT5A;SPRY2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;SLC38A2;DHX36;SOX9;MT3;ITGB8;CSF1;MAGI2;CTSH;POU3F1;SCX;DNMT1;APP;INSR;MAPK14;PRKAG1;ARRB2;PPM1F;ZC3H12A;FAM98B;CTCF;SCYL2;SETDB2;FGF9;MITF;GSN;STAP1;PSEN1;EPHX2;PPARGC1A;LIMS1;PIK3CB;MYD88;HGS;TLR2;SLC24A3;RPL11;MTOR;RBPJ;LGALS9;TLR3;ATAD1;DTNBP1;HINFP;HOXA5;TERF2;TYROBP;POU3F3;IFNGR1;DDX3X;CD46;RPL5;F3;VPS35;CITED2;TASOR;FGF2;MAPK9
prerank,regulation of neuroblast proliferation (GO:1902692),0.4111923591848719,0.9357582511808925,0.5421853388658368,0.917346099667937,1.0,2/15,5.48%,CX3CL1;CTNNB1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.3709547473996928,-0.9354904381752883,0.5485714285714286,0.9992619887252958,1.0,4/11,15.29%,TGFB1;EGFR;RIPK1;TP53
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3197931973338481,0.9354246908972653,0.5938189845474614,0.9176279170711551,1.0,20/65,22.73%,PSMB10;SKP1;PSME2;PSMA5;PSME4;CHEK1;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.31520977618901447,-0.9353819449297004,0.5524193548387096,0.9972586315039746,1.0,9/17,46.81%,SCN3B;KCNH2;RYR2;KCNQ1;SNTA1;KCNE3;KCNE4;KCNJ8;KCNE2
prerank,artery development (GO:0060840),0.3757917452669546,0.9351741038737446,0.561314791403287,0.9177406258310014,1.0,5/23,20.21%,BMPR2;NRP1;HECTD1;NF1;ACVRL1
prerank,response to estradiol (GO:0032355),0.3516716806603827,0.9350757962788347,0.5592185592185592,0.9174889996103819,1.0,11/31,23.60%,STAT3;CRHBP;CTNNB1;GGT7;LCOR;SOCS2;CCDC62;STRN3;NRIP1;RUVBL2;KAT5
prerank,camera-type eye morphogenesis (GO:0048593),-0.3721416102965375,-0.9347245421198781,0.5085714285714286,0.996949509869828,1.0,2/10,10.46%,LRP6;TENM3
prerank,positive regulation of neurogenesis (GO:0050769),0.3208849732452055,0.9345238820396817,0.5865490628445424,0.9182488682064022,1.0,13/68,14.73%,PLXNA3;PLXNB2;LRP2;PLXNB3;CX3CL1;CTNNB1;CUL7;FBXW8;SNW1;CUX1;NUMBL;TIAM2;NPTN
prerank,protein insertion into membrane (GO:0051205),-0.2688299100975051,-0.9344558672396339,0.56,0.9955990412695067,1.0,9/32,13.90%,TRAM1;CCDC47;EGFR;CYB5A;HMOX1;REEP1;UBE2J2;SEC61G;SEC61B
prerank,regulation of synapse organization (GO:0050807),-0.2785531496136797,-0.9342967249863134,0.5772727272727273,0.9937358258122377,1.0,14/26,25.35%,PDLIM5;IL1RAPL1;GRIPAP1;CTNNA2;YWHAZ;ABHD17B;ABHD17C;CLN3;NEDD4;ABL1;MEF2C;KLK8;SLITRK2;MDGA1
prerank,necroptotic process (GO:0070266),0.40525399659807443,0.9342470971477292,0.5692090395480226,0.9184049379980112,1.0,6/16,21.50%,MLKL;CYLD;ITPK1;TRPM7;TLR3;PGAM5
prerank,gluconeogenesis (GO:0006094),0.3419086015713116,0.9340600817811825,0.5648584905660378,0.918359239674329,1.0,11/39,22.26%,PER2;TPI1;SLC25A1;PGM1;SLC25A10;PPARGC1A;SLC25A12;ALDOC;CRTC2;GOT1;MDH1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4363455174892556,0.9339480382360631,0.5384615384615384,0.9181233198697909,1.0,7/11,27.78%,DIABLO;STK25;STK24;PRKCD;ARL6IP5;MAP3K5;PDCD10
prerank,protein maturation (GO:0051604),0.3109908109327648,0.9338580384976637,0.6109936575052854,0.9178513272009223,1.0,19/95,16.62%,LIPT1;CTSS;ADAMTS3;MMP14;NAA50;LONP2;NFU1;AEBP1;PCSK7;SORL1;NAA35;PSEN1;PITRM1;PTCH1;APH1A;GCSH;APH1B;LMF2;METAP2
prerank,negative regulation of lyase activity (GO:0051350),-0.3267047260204168,-0.9331184796811056,0.5384615384615384,0.9948869362210632,1.0,4/16,12.61%,GRM3;EDNRB;PALM;CCR2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.39432949796657446,0.9327828554747644,0.5516304347826086,0.919738705578088,1.0,3/17,13.33%,KDR;SRF;NRP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.2903922378297554,0.9327357781267965,0.708,0.9193546172611451,1.0,109/420,21.34%,PML;TAF4B;TAOK3;TP53RK;WNT5A;DAXX;BIRC2;PAK1IP1;CHEK2;TAGAP;RHOF;SLC15A2;CHEK1;NOP53;RFC4;SYDE1;RRAGC;PPP2R5C;RHOJ;TRAF4;ARHGEF7;PAK3;TMBIM4;ARHGAP4;BRIP1;WDR54;PIP5K1A;CSNK2B;RRS1;CYLD;CSNK2A2;MTA2;MYOC;ABR;PRKAR2B;ENTPD5;LYN;TAF2;BARD1;SYDE2;PLK3;MAPK14;VAV1;PRKAG1;TRAF3;SSRP1;SPHK2;TNIK;AKAP12;ARHGAP25;STARD8;TRAF5;TAF3;ARHGEF11;SRGAP3;SRGAP2;DYRK2;SOS1;DDIT4;ARHGAP21;ARHGAP10;NOP2;BRPF1;CHN1;ARHGAP11A;PIP5K1C;AKAP13;TIAM2;ARHGAP39;TELO2;BIRC3;ARHGAP30;RAC1;DLG1;MINK1;PRDM11;RMI1;CRK;TAF15;MOB3B;TAOK2;RPL11;MTOR;OPHN1;TBCK;BRD7;PRKAR2A;OCRL;BCR;RHOT2;ARHGAP29;HDAC1;SPRED1;RFFL;ARAP1;STK3;ARHGAP24;DIPK2A;PIN1;SMYD2;ARHGAP18;ATRIP;ARHGAP31;STK11;JMY;ZFAND6;RPL5;OPTN;RHOH
prerank,activation of protein kinase activity (GO:0032147),0.3026978277179231,0.9316115369768623,0.6026970954356846,0.9213959854447317,1.0,30/106,23.77%,CALCA;TAOK3;WNT5A;ADCY5;OSBPL8;PAK3;MT3;PPIA;CCDC88A;PRKAR2B;INSR;TNIK;JAK2;PIBF1;MINK1;TAOK2;IL18;MTOR;IRAK1;PRKAR2A;TLR3;COPS8;STK3;STK11;PRKCD;ADCY7;PAK5;PDPK1;ANG;AXIN1
prerank,positive regulation of embryonic development (GO:0040019),-0.30446593229873686,-0.9307334031502653,0.5643153526970954,0.9999797339304429,1.0,3/19,5.06%,CFL1;NIBAN2;RBM19
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.25821608495941967,-0.930587555126354,0.5879120879120879,0.9980734943302044,1.0,8/33,16.39%,EPN1;PPP1R16B;PKM;E2F2;SEMA6A;CEACAM1;S100A1;KLF4
prerank,regulation of signal transduction (GO:0009966),0.2952944043190123,0.9299330654542703,0.6598984771573604,0.9247054293189315,1.0,41/190,18.35%,SP100;CLU;ACVR1;CD55;KIF26A;RUNX1;GNG4;UBTF;YJEFN3;CX3CL1;FGFR2;ITGA3;AMFR;DOK5;MDFIC;PPIA;NCK1;SOCS5;GDNF;APP;NCK2;RORA;PRNP;GIT1;SNW1;GAS1;SOCS2;RGS16;SHARPIN;PTCH1;FYN;CRK;LLGL1;IRAK1;CSK;ELF1;TULP3;PLCE1;DCDC2;FRRS1L;DTNBP1
prerank,cellular response to starvation (GO:0009267),0.3015938108843381,0.9298474337779871,0.6280487804878049,0.9244008257126051,1.0,37/147,22.25%,EIF2AK2;MYBBP1A;MIOS;ATP6V0D1;LAMP2;RRAGC;KPTN;SH3GLB1;PIK3R4;BMPR2;HSPA8;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;KLF10;HNRNPA1;MAP1LC3B;LAMTOR3;EIF2S1;MTOR;TCIRG1;SREBF1;ATP6V1B2;ATP6V1G1;BRSK1;NPRL2;STK24;BECN1;NPRL3;ATP6V1G2;LAMTOR4;USP33;RHEB;WDR59;RRAGA
prerank,response to acidic pH (GO:0010447),0.41827820645003067,0.9298074480054849,0.5515759312320917,0.9240124141255771,1.0,2/13,8.11%,CTSS;RAB11B
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3201590814253767,0.9291638999362725,0.6064659977703456,0.9249767256850109,1.0,21/61,23.74%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PANK2;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;PSMA2;NCOR2
prerank,myeloid leukocyte differentiation (GO:0002573),0.3187157980996387,0.9291345752085164,0.5888767720828789,0.9245517186970391,1.0,7/65,6.90%,PML;IL15;PIK3CD;BATF3;RUNX1;SNX10;CSF1
prerank,base-excision repair (GO:0006284),-0.23825720374762005,-0.928717613883476,0.5625,1.0,1.0,20/48,21.07%,APEX2;RPA1;RFC2;PARP1;PARG;DNA2;PNKP;RFC3;LIG1;HMGA2;OGG1;NEIL1;NEIL3;RPA3;XPA;RFC5;USP47;POLD1;POLE;POLL
prerank,post-translational protein modification (GO:0043687),0.29118049290331316,0.9285282894031427,0.698,0.9254392293297902,1.0,89/332,23.29%,PSMB10;SKP1;FBXL16;PSME2;PNPLA2;DCAF17;KLHL20;PSMA5;CUL5;RCN1;FBXO7;PSME4;RBBP5;SERPINC1;LAMC1;LAMB2;FEM1B;FBXW7;TNC;PSMA3;CUL7;UBE2M;CSF1;KLHL13;FBN1;SPSB1;FBXW8;CAND1;RAB11B;PSMB9;UCHL3;SOCS5;MXRA8;RBX1;APP;LRRC41;MEN1;COPS7B;WDR5;WSB2;ELOC;BTRC;ASB7;PSMD2;PDIA6;ASB10;PSME3;APOE;FBXL14;KLHL9;SOCS2;KTN1;FBXL19;DCAF4;PSMA4;FAM20C;RAB11A;LMO7;SPARCL1;FBXL5;ASB3;COPS8;PSMD7;STT3B;ASB1;SOCS6;PSMD9;PSMD8;FBXO30;RAB1A;PSMF1;APLP2;PSMB6;SUMF1;PSMD12;PSMC2;ASB13;NUB1;SENP8;DCAF5;COPS7A;HSP90B1;RAB2A;PTP4A2;FBXW2;PSMD4;CUL3;FEM1C;FEM1A
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.31270825995876633,0.9285005672734834,0.5905077262693157,0.9250069889131429,1.0,13/69,12.56%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;SNAPC5;ICE2;ELL2;GTF2E2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.36308145355544913,0.9284134257811553,0.5754475703324808,0.9247042561669211,1.0,7/26,13.27%,FMOD;B4GALT1;B4GALT4;B4GALT5;ST3GAL1;B4GALT2;CHST2
prerank,melanosome organization (GO:0032438),0.36371913658791105,0.9282743784062336,0.57625,0.9245350716000663,1.0,8/26,26.58%,BLOC1S4;LYST;RAB32;DTNBP1;TRAPPC6A;RAB29;AP3B1;SHROOM2
prerank,gastrulation (GO:0007369),0.39673304809337817,0.928193671549362,0.5522598870056498,0.924233970211059,1.0,2/15,7.94%,NPHP3;SMAD2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3207935192710216,-0.9281429383247991,0.5555555555555556,1.0,1.0,10/16,31.80%,AKIRIN1;HIF1AN;BTG1;RIPOR2;BOC;MEF2C;LRRC8A;IGFBP3;XKR8;PLCB1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.41167724246455706,0.9280633768232738,0.5589459084604715,0.9240572601271616,1.0,4/14,16.95%,CCL5;CSF1;CXCL17;MDK
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2603438286573342,-0.9278852346558465,0.5526315789473685,0.9994166598610462,1.0,10/30,19.96%,ALG5;DPM1;UBE2J1;TUSC3;UGGT2;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,detection of mechanical stimulus (GO:0050982),-0.307908355710012,-0.927741361438538,0.5661157024793388,0.9975722841502959,1.0,6/19,26.26%,CDH2;PKD2L1;PKD1L2;PKD2L2;JUP;PKD1L3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3263736209972391,-0.9276405653998663,0.5264900662251656,0.9956389499350831,1.0,3/15,10.02%,SMARCA4;CCNT1;CTDP1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2975831195571851,0.9272427425947687,0.6479017400204709,0.925384720086268,1.0,25/138,16.74%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;TAF2;TAF8;RORA;MAML2;POLR2K;MNAT1;NR2C1;SNW1;NOTCH4;TAF3;NR3C1;PPARGC1A;GTF2E2;NRBP1;TAF15;PPARD;MED27;RBPJ
prerank,response to UV (GO:0009411),0.30757944138739873,0.9270946599725243,0.6081932773109243,0.9251959359588116,1.0,20/95,16.03%,MSH2;TMEM161A;UVSSA;UBE2B;DHX36;CDKN2D;CCND1;USF1;FEN1;N4BP1;ERCC4;POLK;MEN1;NPM1;ZRANB3;MAP3K4;EIF2S1;UBE4B;BMF;SPRTN
prerank,triglyceride homeostasis (GO:0070328),0.36307651546684644,0.9268802084705497,0.574468085106383,0.9251629904268827,1.0,6/26,16.08%,LIPC;RORA;XBP1;APOE;APOC4;IL18
prerank,vacuolar acidification (GO:0007035),-0.29068315009390666,-0.9263546707940058,0.5450643776824035,0.9972618381944559,1.0,9/21,20.69%,ATP6V0A1;ATP6V1H;DMXL1;DMXL2;CLN5;CCDC115;CLN3;ATP6V0E2;TMEM199
prerank,glucose metabolic process (GO:0006006),0.32165144125110157,0.9254310308050819,0.6050884955752213,0.9278745490081479,1.0,11/58,15.96%,SORD;PER2;TPI1;SLC25A1;TFAP2B;PGM1;SLC25A10;PPARGC1A;IRS2;SLC25A12;PPARD
prerank,nervous system development (GO:0007399),0.2880271994211398,0.9253328084620759,0.73,0.9276085988930296,1.0,76/429,18.32%,IGF2BP1;AXL;PCDHA3;SLITRK6;PMP22;PCDHB13;CXCR4;BDNF;NRSN2;IGF2BP3;STAT3;MSI1;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SIAH1;EVL;TMEM223;CHERP;TRAK1;RAPGEFL1;GMFB;CDK5RAP2;DACT1;BTBD3;MET;EIF2B2;GDNF;POU3F1;JRKL;BTBD2;SCD5;ALDH1A2;GFRA2;PROX1;DHX30;STMN3;FUT10;ADGRV1;RBFOX1;NAB1;PCDHB16;PPP2R5D;GSN;SDK1;HPCAL4;LDB2;LDB1;SCN2A;ATXN1;MOBP;FGF13;NELL1;MYLIP;NUMBL;DNER;RBM45;DAGLA;RBFOX3;DBNL;RNF103;NHEJ1;DSCAM;DSCAML1;NLGN3;OPHN1;PCDHA4;MDK;MPZ;FEZ2;NF1;SCN8A;DPYSL5;WWP1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3023960879739626,0.9250581866851846,0.6215932914046122,0.9277388111670153,1.0,22/110,16.08%,AGT;NR1H2;WNT5A;CLU;EGLN2;RILP;AREL1;CSF1;DACT1;BARD1;APP;IL17D;SORL1;LDB1;PSEN1;SMURF1;APOE;VPS28;TFR2;PRMT1;TIPARP;IL18
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3632427051804762,-0.924987425226172,0.5459940652818991,0.9990824968586867,1.0,3/10,10.41%,PDCD4;PTPN22;MAPK8IP1
prerank,heart process (GO:0003015),0.4047233116479979,0.9248884286087857,0.5668523676880223,0.9276227130027653,1.0,1/14,1.20%,PPCS
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3372027644007529,0.9248794550945847,0.597877358490566,0.9271566796428726,1.0,5/39,6.07%,SPRY2;TGFA;PTPN18;DUSP3;ARHGEF7
prerank,cellular response to reactive oxygen species (GO:0034614),-0.22386939265200417,-0.924689190787524,0.6464646464646465,0.9976492271173051,1.0,20/59,25.42%,PTPRK;IMPACT;MPV17;PXN;EGFR;MAPK3;TPM1;SIRT1;RIPK1;AKT1;MAPK7;ANXA1;NET1;ECT2;ABL1;ROMO1;TNFAIP3;PDGFRA;RPS3;PPIF
prerank,mitotic chromosome condensation (GO:0007076),0.3636433537636896,0.9243354297522838,0.5950840879689522,0.9278716293163592,1.0,5/26,12.70%,TENT4A;CSNK2B;CSNK2A2;NCAPG2;RB1
prerank,7-methylguanosine RNA capping (GO:0009452),0.34424134828994296,0.9242849026297723,0.5512978986402967,0.9269977045850494,1.0,5/31,9.63%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.34424134828994296,0.9242849026297723,0.5512978986402967,0.9269977045850494,1.0,5/31,9.63%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3718709651130794,0.9239189146632263,0.5541069100391134,0.9273169771484023,1.0,3/21,5.04%,DAPK3;PEAK1;DUSP3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.37856503505226724,0.9238051434284491,0.5875331564986738,0.9270656031288949,1.0,5/21,16.95%,CCL5;CSF1;STAP1;CXCL17;MDK
prerank,regulation of intracellular transport (GO:0032386),0.3401727937083352,0.9237929966125499,0.5827250608272506,0.926605541572535,1.0,11/38,19.01%,DYNC1H1;RAB11B;MLC1;DNAJC30;GAS1;SCFD1;RINT1;DYNLT2B;LAMP1;ATPSCKMT;NUMA1
prerank,mRNA processing (GO:0006397),0.29100750938336234,0.923721881048684,0.7017017017017017,0.9262774755514921,1.0,92/287,24.16%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;PRPF18;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;RNMT;POLR2K;RNPC3;HNRNPL;MNAT1;HSPA8;RBM17;RSRC1;RNPS1;SNW1;WDR83;RALY;HNRNPH3;HNRNPA1;PPARGC1A;USP39;RBM41;ZC3H11A;SNRPD2;SNRPD1;SART1;PAPOLA;BUD31;CHTOP;GEMIN7;DBR1;EFTUD2;PCF11;AURKAIP1;RBM15;DDX39B;SNRPG;PRPF40B;NCBP1;DHX16;GEMIN2;SF3B4;SRSF7;SRSF4;HNRNPA3;METTL14;CWF19L1;DDX46;CWC22;DDX23;SNRPB2;SNRNP48;SLU7;LSM5;TBRG4;HNRNPF;UBL5;ERN1;THOC7;SRSF5;SF3A2;PPIH;BUD13;TCERG1;SRSF10;WBP4;SART3;SRSF2;HNRNPUL1;SNRPD3;TRA2B;LSM4;MAGOH;RPRD2;POLR2C;SON
prerank,regulation of cytokinesis (GO:0032465),0.30823475587924176,0.923714923709874,0.6123535676251332,0.9258098978581457,1.0,19/78,19.54%,CDC25B;PKN2;PRPF40A;PDXP;SH3GLB1;KLHL13;ZFYVE26;PIK3R4;PLK3;GIT1;KLHL9;PRKCE;AHCTF1;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1
prerank,glycerolipid catabolic process (GO:0046503),0.38182690947286196,0.923137656301906,0.571041948579161,0.9266418426390626,1.0,5/19,19.75%,ABHD2;LYPLA2;PNPLA6;ENPP6;PLA2G4E
prerank,epithelial cell development (GO:0002064),0.38094672724227774,0.923131083548646,0.5834445927903872,0.926167736201991,1.0,3/20,9.16%,RILPL1;WNT7B;BFSP1
prerank,regulation of actin filament polymerization (GO:0030833),0.31642732877876134,0.9230762877214983,0.6148867313915858,0.9258169642734336,1.0,23/69,25.94%,HCK;EVL;CARMIL1;PAK3;NCK1;KANK1;SSH3;NCK2;SNX9;PRKCE;DBNL;BAIAP2;BAIAP2L1;ABITRAM;GBA2;ARHGAP18;NCKAP1;PRKCD;TWF1;CDC42EP3;TENM1;PFN2;WASHC5
prerank,presynapse assembly (GO:0099054),0.3955275821462569,0.9229777228557882,0.5661157024793388,0.9255630994827836,1.0,7/16,26.55%,WNT5A;LRRTM3;BSN;NLGN3;PCLO;LRP4;PTEN
prerank,negative regulation of interleukin-2 production (GO:0032703),0.39408109747475617,0.9228825235226065,0.595108695652174,0.9253058295907078,1.0,4/18,17.53%,ZFP36;PRNP;HAVCR2;PTPRC
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3262978375717443,0.9228620560333175,0.5928074245939675,0.9248680059574628,1.0,10/42,15.58%,ARID1B;ARID1A;MBD2;SMARCC2;SMARCE1;MTA2;ACTR8;ACTB;SMARCA1;SMARCD2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3001329304512302,0.9224974390769665,0.6457260556127703,0.9251745073834594,1.0,21/117,18.66%,AGXT;AOAH;BCO2;ALKBH7;PER2;GRHPR;PTGR1;DLD;CYP26B1;ALDH1A2;GNPAT;ECHDC3;PDHX;LDHB;NPC1;PANK2;PPARD;MCCC1;AASDH;SGPL1;GBA2
prerank,catecholamine biosynthetic process (GO:0042423),0.4226048595507301,0.9224223194302318,0.5542347696879644,0.9248759576391589,1.0,2/11,10.29%,DDC;GCH1
prerank,RNA destabilization (GO:0050779),-0.30616294688983303,-0.9223094663635573,0.5408560311284046,1.0,1.0,6/18,12.98%,ROCK1;METTL16;GIGYF2;RIDA;METTL3;ZC3H18
prerank,histone H3-K9 demethylation (GO:0033169),0.42584779042337334,0.922207722167212,0.5770348837209303,0.9248859452374871,1.0,4/11,16.02%,KDM4D;HR;KDM3B;KDM7A
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.44707440285664124,0.9216180288461296,0.5819548872180451,0.925720740725832,1.0,2/10,2.90%,SOCS1;CD55
prerank,positive regulation of organelle organization (GO:0010638),0.3478930791678834,0.9214088456226638,0.5924112607099143,0.9256978662801033,1.0,4/32,8.07%,IRGM;SYNJ1;FYCO1;KATNBL1
prerank,positive regulation of signal transduction (GO:0009967),0.2908008487908124,0.9213871621456241,0.6897590361445783,0.9252627753275519,1.0,45/238,17.93%,AXL;NOD2;TUBD1;IRS1;BDNF;ADAMTS3;SASH1;STAT3;MYO1C;TM2D3;GRB10;KIF7;LY86;FGFR2;MT3;TRIM39;TPD52L1;ENHO;UCHL5;DACT1;SMOC2;KANK1;MAML2;PHIP;PDCL;SNW1;NOTCH4;XBP1;SORL1;PTPN11;LIMS1;NRP1;ZRANB1;JAK2;NPTN;TLR2;GKAP1;NLGN3;MGAT5;RBPJ;BAX;PTPRC;EPN2;CRADD;DCDC2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3607163778555258,0.9213452427942629,0.5878552971576227,0.9248761813664953,1.0,9/26,22.85%,KMT2A;SETD3;EEF2KMT;SETD5;TET2;ATPSCKMT;SMYD5;KMT5C;KMT2D
prerank,regulation of aerobic respiration (GO:1903715),0.39367933647456815,0.9204805586592021,0.5726375176304654,0.9263293079277956,1.0,8/15,26.08%,NOP53;ABCD1;AK4;COX7A2;IDE;VCP;SLC25A33;COX7A2L
prerank,mitotic spindle assembly (GO:0090307),0.3323764785935779,0.9202484289317843,0.5686046511627907,0.9263557228375141,1.0,11/42,16.29%,CHEK2;KPNB1;WRAP73;KIF3B;STAG1;TOGARAM2;ARHGEF10;CCDC61;PIBF1;KIF2A;RAB11A
prerank,adenine nucleotide transport (GO:0051503),-0.31049707416729855,-0.9201965392764802,0.541501976284585,1.0,1.0,6/17,21.19%,SLC25A4;SLC17A9;SLC35B2;SLC25A5;SLC25A42;LRRC8A
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.31532874761405855,0.9195607150175643,0.6245883644346871,0.9274030060474764,1.0,17/70,18.80%,ACTN1;LAMC1;LAMB2;PARVB;PEAK1;RILPL1;YTHDF2;PROX1;SRGAP2;ANTXR1;RB1;NRP1;RAC1;TBCD;OPHN1;ITGA4;SIPA1L3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3203497953448407,-0.9193926402172083,0.5714285714285714,1.0,1.0,6/15,30.03%,LRP6;EDA;ROGDI;FOXC1;GLI2;BMP2
prerank,synapse organization (GO:0050808),0.30061424922982294,0.9190854207837409,0.666323377960865,0.9279416232197736,1.0,23/125,16.25%,SLITRK6;PCDHB13;ELFN1;BDNF;CHCHD10;CX3CL1;CYFIP1;PAK3;WNT7B;DOK7;APP;AGRN;PCDHB16;SDK1;PSEN1;ARHGAP39;PPFIA4;CTNND2;DNER;DBNL;DSCAM;C1QB;NLGN3
prerank,negative regulation of neuron projection development (GO:0010977),0.3208272326365946,0.9186032545646247,0.6204954954954955,0.9284859307618707,1.0,20/56,25.20%,THY1;RUFY3;EPHA4;MT3;PAQR3;KANK1;CIB1;MAG;APOE;TRPV4;MYLIP;PTPN9;STMN2;ITM2C;RTN4RL1;HDAC2;RAB29;LINGO1;PTPRS;LRP4
prerank,regulation of G0 to G1 transition (GO:0070316),0.33906829046971937,0.9185870237504287,0.5988235294117648,0.9280405619196842,1.0,9/38,14.65%,PCGF6;CHEK1;TFDP1;RING1;MAX;TFDP2;RYBP;UXT;EZH2
prerank,stem cell development (GO:0048864),0.39507916969785806,0.9183767131129243,0.5672937771345875,0.928009305486419,1.0,3/16,8.36%,TCOF1;SNAI2;NOLC1
prerank,macrophage chemotaxis (GO:0048246),0.44113297642931154,0.9183036876540118,0.589041095890411,0.9276904969611671,1.0,3/10,12.43%,CCL5;TAFA4;CXCL17
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2953310669714644,-0.9181031355615983,0.5533596837944664,1.0,1.0,2/20,2.44%,STARD3NL;AKR1B1
prerank,histone mRNA catabolic process (GO:0071044),0.40012440777853786,0.917923172076485,0.5883190883190883,0.9280674776051095,1.0,6/15,21.95%,XRN1;DCP2;TUT7;UPF1;MTPAP;EXOSC4
prerank,lipid transport (GO:0006869),0.3019468243052859,0.9177270656281347,0.6315228966986155,0.9279978124458729,1.0,25/97,22.55%,ABCC2;ABCA1;ABCG1;SLC27A1;SLCO1C1;ATP8A1;OSBPL8;NCOA1;PITPNM1;SLCO1B1;ABCD1;APOE;PLEKHA3;NPC2;PPARD;OSBP;MTTP;LDLR;OSBPL2;PCTP;GLTP;CHKA;TNFAIP8L3;ABCA5;CERT1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.42632375385719534,0.9174412878120219,0.562962962962963,0.9276744652673221,1.0,3/10,13.34%,AP2A1;AP2S1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.42632375385719534,0.9174412878120219,0.562962962962963,0.9276744652673221,1.0,3/10,13.34%,AP2A1;AP2S1;MYLIP
prerank,phospholipid dephosphorylation (GO:0046839),-0.24909976868571576,-0.9173723143457835,0.625,1.0,1.0,11/37,16.37%,INPP5F;PLPP4;MTMR4;MTMR1;INPP5B;MTMR9;SYNJ2;MTMR10;PLPPR4;PLPP3;MTM1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.394556168468327,0.9173534141094036,0.579750346740638,0.927374809575858,1.0,1/16,0.65%,AGT
prerank,positive regulation of growth (GO:0045927),0.3135091884941434,0.917330517382149,0.6120218579234973,0.9269489669690486,1.0,12/64,15.53%,HYAL1;CXCL16;MMP14;SFRP2;FXN;DDX49;INSR;CIB1;PPM1F;EXOSC9;NCBP1;ADNP2
prerank,DNA biosynthetic process (GO:0071897),0.3959859035461182,0.9172944171557765,0.5836680053547524,0.9265484365176545,1.0,3/16,7.79%,POLD4;CDKN2D;PPIA
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2634991481930778,-0.9172572162021024,0.5792349726775956,1.0,1.0,9/30,14.89%,SMARCA4;AR;KDM4C;ZBTB7A;RNF14;SIRT1;FOXP1;SAFB2;KDM1A
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3833112094830797,0.9172003578671014,0.6021650879566982,0.9262560420673607,1.0,7/18,23.37%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3;LIG3
prerank,telomere organization (GO:0032200),0.3319950177063291,0.916976180772386,0.6133960047003525,0.9262491620447798,1.0,6/43,13.67%,SP100;POLD4;RTEL1;ERCC4;PRKDC;STN1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3347942540884359,0.9168097800255857,0.5933806146572104,0.9261357130546162,1.0,8/40,15.02%,TIMELESS;TIPIN;ETAA1;MCM9;RTEL1;ZRANB3;DDX11;GEN1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.41778401631748885,0.9165008743286006,0.5708029197080292,0.9263414272859448,1.0,5/13,16.15%,IRS1;ECHDC3;SORL1;PTPN11;GKAP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3070132984653979,0.9162990810219719,0.6330472103004292,0.9263236605277423,1.0,11/72,9.77%,POLR2G;UVSSA;POLD4;RFC4;RFC1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,establishment of protein localization to membrane (GO:0090150),0.31211948864640915,0.916271505958195,0.6015037593984962,0.9258947307005354,1.0,13/66,16.29%,GOLGA7;MYO1C;AQP11;RTP4;ZDHHC21;ZDHHC20;RAB11B;VPS37A;NACA;NECTIN3;NPC1;TAOK2;RAB11A
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.30406950336155064,0.916193325722546,0.625531914893617,0.9255896369634712,1.0,13/86,14.38%,IL15;AGT;SEMA4D;ACVR1;SFRP2;CNOT7;CSPG4;APP;PRNP;PTPN11;NRP1;FYN;JAK2
prerank,epithelial tube morphogenesis (GO:0060562),0.3460082518789058,0.9161127024411848,0.5947955390334573,0.9252760849638946,1.0,5/32,8.69%,ACVR1;CTNNB1;PODXL;CSNK2B;MET
prerank,neutral amino acid transport (GO:0015804),0.3559709095040023,0.9158395469434362,0.5804816223067174,0.9253960957604052,1.0,6/28,16.77%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;CTNS;SLC36A4
prerank,regulation of glucose metabolic process (GO:0010906),0.34211671978369723,0.9153754617648381,0.581032412965186,0.9259572482210056,1.0,7/34,14.43%,IRS1;RUBCNL;SLC45A3;RORA;FOXK1;BCKDK;IRS2
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2107166144383305,-0.9153276831674022,0.7654320987654321,1.0,1.0,11/75,10.81%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;ATP1B2;KCNJ10;SLC39A14;CACNA2D1;SLC8A3;TRPM4;SLC39A12
prerank,regulation of exit from mitosis (GO:0007096),0.3405930459612004,0.915168890841333,0.6064441887226697,0.9259170636006954,1.0,8/38,16.30%,CDC26;ANAPC5;ANAPC4;UBE2E1;CDC16;CDC27;ANAPC15;ANAPC2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3957716529221771,0.9149099436162499,0.5778401122019635,0.9259824884839856,1.0,5/15,22.93%,ATL1;REEP2;REEP3;ZFYVE27;RAB10
prerank,regulation of lipid metabolic process (GO:0019216),0.30311891682547215,0.9148445197442023,0.6378205128205128,0.925652040049859,1.0,23/88,24.55%,HELZ2;NCOA1;EDF1;RUBCNL;FDFT1;RORA;TGS1;GGPS1;IRS2;PANK2;NPC2;PPARD;SREBF1;IDI1;CERS2;NR1D2;ADIPOR1;CCDC3;TNFAIP8L3;HMGCS1;HMGCR;NCOR2;BBS4
prerank,extracellular matrix disassembly (GO:0022617),0.32105924819909926,0.9146814735265566,0.6098398169336384,0.9255354227111295,1.0,8/53,13.10%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3649934087819285,-0.9143373605102925,0.5805471124620061,1.0,1.0,4/10,13.25%,NCKAP1L;C3;RAB31;TREM2
prerank,hexose transmembrane transport (GO:0008645),0.37437719909020795,0.9141982391269093,0.5933926302414231,0.926133627158516,1.0,4/21,15.96%,SLC2A6;SLC45A3;SLC2A9;PPARD
prerank,cell chemotaxis (GO:0060326),0.3181563419834513,0.9134913761665076,0.6282194848824189,0.9271274430629913,1.0,11/60,13.63%,CXCR4;ELMO2;PLXNB3;CX3CL1;PIP5K1A;BCAR1;ACKR3;ARRB2;ABCC1;NRP1;CORO1B
prerank,sodium-independent organic anion transport (GO:0043252),0.43645585058774533,0.9132812751636534,0.5834609494640123,0.9271104099984302,1.0,2/10,6.37%,SLCO1C1;SLCO1B1
prerank,indolalkylamine catabolic process (GO:0046218),-0.35371212013330877,-0.9131632596168701,0.5950920245398773,1.0,1.0,4/10,39.83%,KMO;IL4I1;IDO2;KYAT1
prerank,cellular response to insulin stimulus (GO:0032869),0.29696849586314833,0.9131286576571843,0.6567622950819673,0.9269609413245299,1.0,27/124,18.34%,NAMPT;TRIB3;IRS1;ATP6V0D1;SLC27A1;RAB8B;ZNF106;GRB10;RAB12;USF1;BCAR1;LPIN2;INSR;PHIP;ZFP36L1;XBP1;SOS1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1;CPEB2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.36624543207663496,0.912635377981365,0.590728476821192,0.9275382051782607,1.0,6/25,14.01%,UBQLN2;WDR54;APP;LRPAP1;PSEN1;RAC1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.36269127045977956,-0.9125846418790442,0.5654761904761905,1.0,1.0,5/10,21.91%,JARID2;SIRT1;BRCA1;KDM1A;ATRX
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3040130385767161,-0.9118737726570684,0.5873015873015873,1.0,1.0,8/18,21.82%,TOMM20;DNAJC15;TIMM21;GRPEL1;PAM16;TIMM17A;GRPEL2;ROMO1
prerank,regulation of endocytic recycling (GO:2001135),0.42396362704629476,0.9116297491013245,0.592375366568915,0.9292406025609168,1.0,5/11,23.55%,ACTN2;RAB11B;SORL1;PLA2G4E;ARHGAP1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3352203837184523,-0.9114330574466366,0.5734265734265734,1.0,1.0,4/14,12.61%,SYK;CD81;PTPN22;CCR2
prerank,selective autophagy (GO:0061912),0.31888041379096405,0.9111109688027602,0.6094808126410836,0.9298781339312424,1.0,13/56,19.16%,AUP1;DDRGK1;DYNC1H1;DYNC1LI2;NBR1;UBQLN1;MAP1LC3B;DYNLL1;RB1CC1;PEX5;RETREG1;UBE2V1;BECN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.25435532029723107,-0.9110859981775544,0.6306818181818182,1.0,1.0,13/34,24.85%,GRIN2A;GABRG3;GRIN2B;GRIN1;GSK3B;GABRA2;AKT1;GABRA5;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3264933901472041,0.9109604570862511,0.6048109965635738,0.9297085995660109,1.0,13/46,24.07%,IL15;NR1H2;ZNF423;ACOT13;RB1;ALDH1A1;RBPJ;PCTP;STK11;PGAM5;RHEB;NOTCH1;ACOT11
prerank,prostanoid biosynthetic process (GO:0046457),-0.3189335232956538,-0.9108045134886532,0.5680272108843537,1.0,1.0,6/15,27.73%,PTGDS;PTGS1;MIF;PTGES;PTGIS;PRXL2B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.35307169027585117,0.9104830154419516,0.6019900497512438,0.930286864014913,1.0,5/27,14.33%,CAMK2D;AKAP9;CTNNA3;FGF13;DLG1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3043249149062528,0.9100377877001786,0.6192513368983957,0.9307908370445213,1.0,16/75,18.90%,AGT;SPRY2;SLC8A1;PAQR3;PRKAR2B;LYN;MEN1;SORL1;APOE;RB1;PIK3CB;INPP5K;CD300A;PRKAR2A;NF1;TESK1
prerank,"transcription, DNA-templated (GO:0006351)",0.28752213044069036,0.9100206385997669,0.7074898785425101,0.9303499751611942,1.0,44/207,16.91%,TAF4B;POLR2G;GMEB2;NFX1;DDX5;SNAPC2;RBMX;NCBP2;UBTF;MRPL12;RRAGC;CCNT2;TFB2M;NFKB1;TBPL1;GLIS3;RO60;TFDP1;GTF3C5;POLR3GL;RNMT;TAF2;SCX;POLR2K;IRF9;MNAT1;TWNK;ARRB2;SSRP1;ELOC;RNPS1;XBP1;TAF3;GTF2E2;TAF1B;RREB1;MLLT3;NCBP1;SOX5;TAF15;MEF2A;GTF3C3;CCNK;MED16
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.35976549466888874,0.9100101185738859,0.5883116883116883,0.9298983147896324,1.0,6/21,22.01%,DNMT1;LDLRAP1;FGF9;BMPR1A;ERN1;FGF2
prerank,RNA polyadenylation (GO:0043631),0.34900020373997126,0.9099868572082348,0.6090686274509803,0.9289984183401762,1.0,6/26,14.37%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,mRNA polyadenylation (GO:0006378),0.34900020373997126,0.9099868572082348,0.6090686274509803,0.9289984183401762,1.0,6/26,14.37%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,phagosome maturation (GO:0090382),-0.2501604396503751,-0.9094909136380563,0.6303030303030303,1.0,1.0,10/35,18.51%,ATP6V0A1;ATP6V1H;ATP6V1E1;CORO1A;ATP6V1C1;ATP6V1D;ATP6V1A;RAB31;MREG;ATP6V0E2
prerank,monocarboxylic acid transport (GO:0015718),0.3172045214386055,0.9093793241272148,0.6118721461187214,0.9298070473155572,1.0,8/51,14.70%,ABCC2;SLC27A1;SLCO1C1;NCOA1;SLCO1B1;SLC16A13;SLC16A14;SLC16A6
prerank,positive regulation of actin nucleation (GO:0051127),0.42378271201479034,0.9093342755860984,0.5894736842105263,0.9294285281165775,1.0,5/11,22.51%,CYFIP1;GSN;WHAMM;NCKAP1;BRK1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.39208335349433887,0.9092688843422436,0.6067415730337079,0.9290876232681955,1.0,8/16,25.49%,GSPT1;INSR;ETF1;UPF1;OGFOD1;GLE1;HDAC6;TNF
prerank,purine ribonucleotide metabolic process (GO:0009150),0.31021583291100546,0.9092321027813343,0.6275787187839305,0.92869609240813,1.0,18/68,24.07%,TPST1;ACOT9;ACBD6;SULT6B1;HPRT1;AK4;AK3;ACOT13;ENPP1;BAD;ACAT1;OXSM;AMPD3;BPNT1;PDE9A;ENTPD7;OPA1;ACOT11
prerank,ERBB2 signaling pathway (GO:0038128),0.3450682566656854,0.9092138285653458,0.5965130759651308,0.9282636926600629,1.0,11/31,25.72%,CPNE3;CUL5;PTPN18;MYOC;SOS1;HSP90AA1;CDC37;STUB1;ERBB3;PIK3CA;SHC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.22447885871712175,-0.9090829298535862,0.6868686868686869,1.0,1.0,27/56,27.63%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.22447885871712175,-0.9090829298535862,0.6868686868686869,1.0,1.0,27/56,27.63%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,cellular component disassembly (GO:0022411),0.3176172690518832,0.9085114455303706,0.6179138321995464,0.9292890916631785,1.0,8/53,13.10%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3305368806031359,-0.9084485259348493,0.5610687022900763,1.0,1.0,4/14,17.86%,RHOA;KLF4;MAP2K5;ITGB1BP1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33474029928316645,0.9080534129072731,0.6137184115523465,0.9298111140013153,1.0,7/37,9.10%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,T cell mediated immunity (GO:0002456),0.4001104801693762,0.9079995271664651,0.6166902404526167,0.9294591802454023,1.0,2/13,8.20%,CD55;CTSH
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3773290948992163,0.9077396962127379,0.6220159151193634,0.9295362143498493,1.0,4/19,16.89%,MAD2L2;PPM1F;NOTCH4;PTPRU
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3691214259812261,0.9074103363027971,0.5853976531942634,0.9297422473414179,1.0,8/21,16.96%,RUNX1;LYN;STAP1;FCGR2B;PRKCH;SLC39A10;CD300A;ELF1
prerank,regulation of establishment of cell polarity (GO:2000114),0.3769894715283121,0.907380477272314,0.5742574257425742,0.929339075809675,1.0,4/16,12.99%,RUFY3;KANK1;GSN;RACK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.42530129361010743,0.907016979881195,0.5877061469265368,0.9296181033010594,1.0,1/11,1.22%,CAMK2D
prerank,iron ion transmembrane transport (GO:0034755),0.42899240944469497,0.9069729640520193,0.5852895148669797,0.9292311324666286,1.0,4/10,21.51%,SLC11A2;ABCB7;ABCC5;SLC25A28
prerank,calcium ion transport (GO:0006816),0.300707619715916,0.9064373169757967,0.6666666666666666,0.9298973936423102,1.0,20/113,15.96%,TRPM5;TRPM2;CACNA2D4;TRPM6;SLC8A1;CCL5;ITPR1;CACNA1A;P2RX4;MCUR1;TRPM3;CRACR2A;PANX1;PSEN1;MCOLN2;TRPV4;FYN;CHRNB2;TRPM7;SLC24A3
prerank,alanine transport (GO:0032328),0.43246946014299564,0.9057276831252362,0.5921259842519685,0.9308711711424938,1.0,5/10,25.62%,SLC38A3;SLC36A4;SLC6A6;SLC6A17;SLC36A1
prerank,calcium import into the mitochondrion (GO:0036444),0.42257316181347404,0.9056691822123781,0.5927601809954751,0.9305211381266614,1.0,5/10,25.90%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3006973451865314,0.9056377816859841,0.6609071274298056,0.930113731568915,1.0,15/79,18.22%,AGT;SPRY2;LRP2;BAMBI;BMPER;BMPR2;SORL1;SKIL;SMURF1;ADAMTS12;BMPR1A;HGS;HTRA3;EPN2;ACVR2A
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3593714188749374,-0.9054349901183785,0.5753012048192772,1.0,1.0,4/10,9.10%,PPARG;RXRB;RXRA;RARA
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.42410801785277374,0.9051242763060752,0.5795107033639144,0.9307291069789345,1.0,3/10,13.00%,ST6GAL1;ST3GAL1;GNE
prerank,transcription by RNA polymerase II (GO:0006366),0.282945166499096,0.9051202933561793,0.7550200803212851,0.9302668670876275,1.0,61/305,16.96%,TAF4B;NR1H2;ESR2;POLR2G;GMEB2;ESRRB;RARG;NFX1;PHAX;TEAD2;DDX5;SNAPC2;RBMX;SRRT;NCBP2;CDK12;CCNT2;WDR33;NFKB1;TBPL1;GLIS3;TFDP1;RPAP2;RNMT;ELP2;TAF2;TAF8;RORA;MAML2;POLR2K;IRF9;MNAT1;NR2C1;ARRB2;SSRP1;ELOC;SNW1;NOTCH4;XBP1;TAF3;SNAPC5;ICE2;ELL2;NR3C1;PPARGC1A;GTF2E2;PAPOLA;PCF11;RREB1;SNRPG;MLLT3;NCBP1;NRBP1;SOX5;TAF15;PPARD;MED27;CCNK;RBPJ;MED16;ELOF1
prerank,maturation of 5.8S rRNA (GO:0000460),0.3834050005088972,0.9048279062138048,0.6005434782608695,0.9304315484666329,1.0,6/17,21.95%,NOL9;LAS1L;EIF6;PRKDC;WDR12;EXOSC4
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4009330685122389,0.9045257287882277,0.5941176470588235,0.930600106618778,1.0,6/13,23.31%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,aorta morphogenesis (GO:0035909),0.37774047224547724,0.9043455724672708,0.5986577181208054,0.9305068512031828,1.0,5/17,20.21%,TFAP2B;PROX1;BMPR1A;RBPJ;ACVRL1
prerank,response to light stimulus (GO:0009416),0.31588405380725737,0.9041454863394068,0.6286031042128604,0.930467203753541,1.0,9/55,16.03%,UVSSA;UBE2B;CDKN2D;USF1;ERCC4;MEN1;ZRANB3;UBE4B;SPRTN
prerank,cellular calcium ion homeostasis (GO:0006874),0.292765172756725,0.9041439923344321,0.6890243902439024,0.9300007089389352,1.0,19/133,16.04%,PML;CALCA;CCL7;CAMK2D;CD40;SLC8A1;CCL5;KCTD17;SLC30A1;CHERP;VAPB;CCL14;HTR2A;PSEN1;TRPV4;MICU2;NPTN;SLC24A3;HCRTR1
prerank,sulfation (GO:0051923),-0.3457108940319409,-0.9041352995498775,0.5660377358490566,1.0,1.0,4/11,22.99%,UST;SULT1A1;HS3ST5;SULT4A1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3330403309543699,-0.9037764620511765,0.5766666666666667,1.0,1.0,5/14,21.40%,NT5M;ERH;UMPS;NT5E;DHODH
prerank,negative regulation of viral entry into host cell (GO:0046597),0.409986245020762,0.9034920012292365,0.5916542473919523,0.9308812740332485,1.0,3/12,11.99%,LY6E;GSN;TRIM26
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3631051895151009,0.903393419802479,0.6080206985769728,0.9306267568965847,1.0,7/24,18.67%,CGAS;UBE2B;RAPGEF2;PRKAR2B;PRKAR2A;PDE3A;MGRN1
prerank,integrated stress response signaling (GO:0140467),-0.32915246087424654,-0.9032318886528836,0.5753424657534246,1.0,1.0,6/14,33.57%,IMPACT;HERPUD1;CCL2;EIF2AK3;QRICH1;EIF2AK4
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3019397398450255,-0.902642393053011,0.6015325670498084,1.0,1.0,8/18,27.73%,PTGDS;PTGS1;MIF;PTGES;CBR1;HPGDS;PTGIS;PRXL2B
prerank,kidney development (GO:0001822),0.3079350426755906,0.9025630241226431,0.6469298245614035,0.9318855086743124,1.0,8/65,10.70%,AGT;GREB1L;TFAP2B;NPHP3;CTSH;GDNF;PROX1;IFT27
prerank,sensory perception of pain (GO:0019233),-0.2853567350027568,-0.9024019467169329,0.6040816326530613,1.0,1.0,10/21,25.20%,OPRM1;CCR2;KCNA2;PTGES;SCN9A;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3863280222964731,0.9023179389209945,0.6047819971870605,0.9319454805973458,1.0,6/14,22.37%,RBMX;RNPS1;SRSF7;SRSF4;PCBP4;SRSF10
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.33930594415663107,-0.9020111353354147,0.5439739413680782,1.0,1.0,3/12,14.21%,APOD;SNCA;CBL
prerank,clathrin-dependent endocytosis (GO:0072583),0.35134563648252815,0.9014293969085985,0.5944931163954944,0.933356323872644,1.0,6/26,14.30%,SIGLEC1;AP2A1;FNBP1L;AP2S1;PIP5K1C;SNAP91
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3985693925901149,0.9013517183133847,0.5921237693389592,0.9330321540387082,1.0,6/14,26.94%,CX3CL1;CST7;PTPRC;LDLR;SYT11;GRN
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4039990395735268,0.9010622560920543,0.5878084179970973,0.933166380922293,1.0,5/12,18.30%,EPHA4;NFIB;CHRNB2;MYCBP2;PAFAH1B1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.346227121243418,0.9010458865744589,0.6185819070904646,0.932727040286294,1.0,13/29,29.44%,PWP2;RPS21;RRS1;KRI1;DHX37;UTP3;MRPS11;RRP36;NGDN;BMS1;NOL10;HELB;RPS19
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.2923656793073742,-0.9009418076180186,0.609375,1.0,1.0,2/19,1.85%,PPP3R1;PPP3CC
prerank,inorganic ion transmembrane transport (GO:0098660),-0.341135653964196,-0.9008221616099642,0.6,1.0,1.0,8/12,47.82%,TRPM4;PKD2L1;ABCC8;CACNA1H;P2RX3;RHAG;KCNJ8;ATP1B4
prerank,keratan sulfate catabolic process (GO:0042340),0.42566292415264717,0.9004563764132888,0.6128093158660844,0.9334997324097459,1.0,5/11,23.91%,FMOD;GLB1;OGN;GALNS;GNS
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.35657809494018317,0.9002706455826294,0.5997425997425997,0.93342968413972,1.0,10/25,24.86%,CTSS;ATP1B3;ACTN2;AKAP9;STK39;GLRX;COX17;ANK2;WNK3;CFTR
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.36524722290925343,0.9000661175254783,0.590728476821192,0.9333893131357195,1.0,6/20,16.47%,HCK;CCL5;LYN;PRKCE;IL18;IRAK1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39595034792974493,0.899499526421114,0.6150568181818182,0.9341033352618247,1.0,5/14,22.52%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,maintenance of blood-brain barrier (GO:0035633),-0.25561503403874875,-0.8994986385570445,0.6,1.0,1.0,18/30,35.27%,SLC12A2;DMD;LAMA2;JAM2;SLC1A1;F11R;GJB6;LSR;VCL;TJP1;PECAM1;ESAM;OCLN;TJP3;MFSD2A;CLDN1;CDH5;CLDN5
prerank,regulation of chromosome segregation (GO:0051983),-0.30296847092294343,-0.8994253192810898,0.6300813008130082,1.0,1.0,6/16,19.21%,CSNK2A1;RAD18;SMC6;MKI67;BUB1;IHO1
prerank,secretory granule organization (GO:0033363),0.42753168411532616,0.8992926301767634,0.5935085007727975,0.9340711899827664,1.0,3/10,18.35%,ABCA1;LYST;DTNBP1
prerank,energy reserve metabolic process (GO:0006112),0.37355799349415997,0.8990756410102881,0.5870712401055409,0.9340065077706704,1.0,4/19,16.59%,MT3;GFPT1;LEPR;PHKG2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2694099730592511,-0.898850977110179,0.6130653266331658,1.0,1.0,3/22,3.31%,PPM1E;DUSP6;PPM1G
prerank,transport along microtubule (GO:0010970),-0.32703028089774633,-0.8985441913953038,0.5780730897009967,1.0,1.0,7/13,26.42%,SPG11;CDC42;CLIP3;BAG3;DYNC1I2;COPG2;APBA1
prerank,Golgi ribbon formation (GO:0090161),-0.32387779534285005,-0.8984932024512331,0.5366666666666666,1.0,1.0,6/13,16.67%,TRIP11;GCC2;PRMT5;MYO18A;GOLPH3;GOLGA2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.32069336053557074,0.8975191003623936,0.6210153482880756,0.9366968588751974,1.0,5/44,12.35%,KCNMB3;ATP1B3;ACTN2;GABBR2;AKAP9
prerank,regulation of wound healing (GO:0061041),-0.2321868903626294,-0.8974001293194618,0.6688311688311688,1.0,1.0,12/42,23.94%,SRSF6;DMTN;EPHB2;VTN;HRAS;ANXA1;CD109;F2R;CAV1;HBEGF;TNFAIP3;ADRA2A
prerank,error-prone translesion synthesis (GO:0042276),0.36208461111643175,0.8972296945689324,0.6116129032258064,0.9368251478840595,1.0,5/21,9.10%,POLE2;MAD2L2;RFC4;RFC1;POLK
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2606703239031649,-0.8970826864062587,0.6428571428571429,1.0,1.0,10/31,18.69%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;GSK3B;PPP1R13B;TP53;E2F1;BAK1
prerank,histone deubiquitination (GO:0016578),0.37626015696073944,0.8967353004114845,0.5994513031550068,0.9374105942153342,1.0,4/18,17.70%,USP21;USP15;ATXN7;ENY2
prerank,negative regulation of cell communication (GO:0010648),0.3562261143418134,0.8965894521772609,0.5994865211810013,0.9372333608388554,1.0,3/21,8.73%,ACVR1;KIF26A;SOCS5
prerank,endodermal cell fate commitment (GO:0001711),-0.35497585780194735,-0.8963199072933908,0.5661538461538461,1.0,1.0,1/10,1.80%,CTR9
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3492068946225836,0.8961038679195594,0.615877080665813,0.9377425477915249,1.0,4/27,13.28%,CLTRN;SYT7;SYT3;VAMP2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.40822840380343745,0.8959559285673425,0.5824964131994261,0.9375893047124222,1.0,5/12,24.27%,APOC4;SOAT2;SOAT1;MTTP;ACSL3
prerank,cAMP biosynthetic process (GO:0006171),0.4128340048754144,0.8957049793137931,0.5861538461538461,0.9376489225917038,1.0,2/10,6.18%,ADCY5;ADCY10
prerank,regulation of keratinocyte proliferation (GO:0010837),0.36627386541151696,0.8956031260240621,0.62905317769131,0.9373965645422384,1.0,4/22,11.03%,ZFP36;FGFR2;SNAI2;ZFP36L1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.27866445059270556,-0.8954090493298998,0.6491228070175439,1.0,1.0,13/25,28.70%,GRIN1;ANK3;TMTC2;SNCA;FAM20A;WFS1;SELENON;CNNM4;CAV1;TMC8;CNNM2;ATP13A2;PRKN
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.28809787558342886,0.8953763109729549,0.6887755102040817,0.9373848880262082,1.0,51/145,26.19%,PSMB10;SKP1;PSME2;PSMA5;MECP2;PSME4;CDC25B;DYNC1H1;CCND1;PSMA3;ACTR1A;RAD51C;MAPRE1;CDK5RAP2;PSMB9;PRKAR2B;RBX1;NEDD1;CEP152;PSMD2;CEP131;CEP70;PSME3;AKAP9;TUBB4B;DYNLL1;PSMA4;HSP90AA1;RAB11A;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;HAUS3;YWHAG;PSMD4;PSMA2;YWHAE;TUBA4A;CEP192;DCTN1;HAUS6;PSMD1;PSMD11;CEP57
prerank,carboxylic acid transport (GO:0046942),0.31303463448279056,0.8949043741410831,0.6275862068965518,0.9378917358182192,1.0,10/55,16.77%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC25A10;SLC7A6;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3652678056858637,0.8948624569225161,0.6379310344827587,0.9375105681018596,1.0,2/20,3.73%,CAMK2D;SLC8A1
prerank,regulation of cell cycle (GO:0051726),0.28223034889081544,0.8946489107203958,0.7745490981963928,0.9374834120311086,1.0,70/271,24.33%,PML;DAPK3;MYBBP1A;PER2;PNPT1;ZBTB17;BIRC2;GADD45G;CDC26;TARDBP;STAT3;ASAH2;RNF40;TRIM21;CHEK1;NOP53;HSP90AB1;JUNB;CDKN2D;SOX9;SRA1;CCND1;FGFR2;TCF7L2;MAGI2;CYLD;CSNK2A2;BARD1;MEN1;LIN9;PROX1;CDK10;SIK1;NEK6;RB1;RACK1;APBB1;WHAMM;BIRC3;SOX2;MASTL;PRDM11;PHACTR4;RPS15A;PTPRC;ZBTB49;WDR12;GBF1;TBRG4;CTBP1;NEK7;TSC1;BEX2;ERN1;STK11;JMY;GADD45A;CDK9;CKS2;CITED2;CHMP1A;PIM3;NOTCH1;XIAP;IRF1;MAEA;KAT2B;TFAP4;SON;APBB2
prerank,mRNA splice site selection (GO:0006376),0.341347178854853,0.8945123547030508,0.6182926829268293,0.9373158957640846,1.0,1/30,0.16%,NOL3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2729020477645216,-0.8943573853610516,0.6346153846153846,1.0,1.0,13/27,24.01%,CHSY1;VCAN;CSGALNACT1;B3GAT1;CHST7;CHST15;CHST3;BGN;DCN;PXYLP1;BCAN;UGDH;CSPG5
prerank,metanephros development (GO:0001656),0.3521119207730429,0.8941055195799464,0.6292993630573248,0.9377103133138321,1.0,5/26,17.97%,WNT7B;CTSH;GDNF;PTCH1;NF1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3504894305080348,0.8940121501002147,0.6296758104738155,0.9374224961850107,1.0,5/24,9.10%,POLD4;POLB;RFC4;RFC1;POLK
prerank,cellular response to alcohol (GO:0097306),0.32154743264899605,0.8938507622018619,0.6378896882494005,0.9373069563640483,1.0,10/42,15.41%,PTGER4;LARP1;ADCY5;OSBPL7;CTNNB1;MLC1;SPHK2;GLRA2;PTCH1;GRAMD1C
prerank,regulation of gene silencing by RNA (GO:0060966),0.3176844986405629,0.8935404034521157,0.6444188722669736,0.9370141460744986,1.0,11/50,20.35%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3176844986405629,0.8935404034521157,0.6444188722669736,0.9370141460744986,1.0,11/50,20.35%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,hexose metabolic process (GO:0019318),0.32958727800529275,0.8932170722242839,0.6238095238095238,0.9372151535069181,1.0,8/39,15.96%,GALT;SORD;TFAP2B;PGM1;HK1;GALK2;IRS2;PPARD
prerank,chromosome condensation (GO:0030261),0.33189411150892845,0.8930726323537846,0.6470588235294118,0.9370657141034715,1.0,6/36,12.70%,TENT4A;CSNK2B;CSNK2A2;BANF1;NCAPG2;RB1
prerank,B cell differentiation (GO:0030183),-0.22997721522551706,-0.8925951148829488,0.6564885496183206,1.0,1.0,10/46,17.34%,NFAM1;KLF6;DCAF1;ZBTB7A;LYL1;PTPN2;DNAJB9;JAK3;SLC25A5;ADGRG3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.43142005037270836,0.8924125573057393,0.6235119047619048,0.9379314403358526,1.0,3/10,9.03%,SOCS1;RUNX1;HMGB1
prerank,regulation of telomere capping (GO:1904353),-0.27270822529185945,-0.8924086531285897,0.645933014354067,1.0,1.0,5/23,12.48%,PRKCQ;NBN;MAPK3;PNKP;NABP2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3465367384296017,0.8921579911248247,0.61557478368356,0.9379651705773339,1.0,1/29,0.40%,SYCP1
prerank,mitochondrial translational termination (GO:0070126),0.2934467030242033,0.891938259855564,0.6766275346851655,0.937974594536398,1.0,21/88,19.26%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;MRPL42;MRPL4;MRPS22;MRPS23;MRPS2;AURKAIP1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,fatty acid metabolic process (GO:0006631),0.2896218673097413,0.891613894560123,0.6927835051546392,0.9381776016068095,1.0,23/115,21.85%,MCAT;AOAH;ALKBH7;PER2;ACSL5;LIPC;LPIN2;PEX2;GNPAT;ECHDC3;XBP1;PPARGC1A;PPARD;AASDH;SGPL1;ACOX1;OXSM;GPX4;ELOVL4;PNPLA3;ADIPOR1;PNPLA8;PON3
prerank,digestive tract development (GO:0048565),-0.25492436222702664,-0.891355950992475,0.6369047619047619,1.0,1.0,6/32,12.01%,COBL;NIPBL;EDNRB;SALL1;TGFB2;CCDC39
prerank,negative regulation of B cell activation (GO:0050869),-0.28231448016505584,-0.8910131542853187,0.5909090909090909,1.0,1.0,4/21,7.75%,SAMSN1;TNFRSF13B;ID2;BANK1
prerank,membrane repolarization during action potential (GO:0086011),-0.3273668504510153,-0.8909188866300402,0.6013745704467354,1.0,1.0,8/13,40.07%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,BMP signaling pathway (GO:0030509),0.3101723075939376,0.8908733480574086,0.6602491506228766,0.9392647529885927,1.0,9/62,12.33%,GDF9;ACVR1;DDX5;USP15;SMAD2;SCX;BMPR2;RGMB;SMURF1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3364205730949649,0.8908062572004987,0.6297662976629766,0.9389426123845441,1.0,6/33,14.65%,PSME2;DDRGK1;FBXW7;TRIM39;PSME3;EZH2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2343158334291602,-0.8905256649140743,0.70625,1.0,1.0,14/40,21.85%,SYT2;SYT10;SNCA;RIMS1;SNAP47;STX1B;RIMS3;UNC13A;SYT8;BLOC1S6;RIMS2;SYT1;OTOF;STX1A
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.32476450474298457,0.8904089891820123,0.6305361305361306,0.9392718992827868,1.0,11/41,21.72%,DEGS1;PTGR1;FADS3;SCD5;ABCD1;FADS2;DAGLA;ACOX1;GPX4;DECR2;PNPLA8
prerank,sodium ion export across plasma membrane (GO:0036376),-0.32477411230193964,-0.8902130726620217,0.5794701986754967,1.0,1.0,2/13,3.63%,ATP1B1;ATP1B2
prerank,positive regulation of cell communication (GO:0010647),-0.25301172054871257,-0.8900562920689887,0.6103286384976526,0.9998475799290869,1.0,11/28,23.92%,DLG4;HOMER1;ANK3;RIMS1;RIMS3;RIMS2;CDKN2AIP;KCTD13;SYT1;NMU;CD80
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.34642769358684244,-0.8899634570740539,0.5701492537313433,0.9980491045033689,1.0,4/12,17.04%,GCLM;GSS;HAGH;GGCT
prerank,nucleotide biosynthetic process (GO:0009165),-0.3008651163657238,-0.8897775067633326,0.6133828996282528,0.9964490665093111,1.0,9/18,24.88%,NMNAT2;PNP;PRPSAP1;ME1;RRM2B;RRM1;PPAT;PRPS1;PRPS1L1
prerank,regulation of mast cell degranulation (GO:0043304),0.39009191350889383,0.8887727323197584,0.601418439716312,0.9421214936433943,1.0,6/14,16.80%,UNC13D;LYN;SPHK2;CD84;CD300A;LGALS9
prerank,artery morphogenesis (GO:0048844),0.3417331708635153,0.8884222535809806,0.6253071253071253,0.9423723345556889,1.0,6/30,17.97%,LRP2;TFAP2B;BMPR2;NRP1;BMPR1A;NF1
prerank,response to insulin (GO:0032868),0.29936103266080205,0.8883875844559191,0.6740976645435244,0.94198166675419,1.0,16/80,15.07%,TRIB3;IRS1;SLC27A1;RAB8B;RAB12;USF1;LPIN2;INSR;ZFP36L1;EIF6;XBP1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2854366477863286,-0.8880505546477967,0.6199095022624435,0.9948981621830993,1.0,10/20,31.54%,MAD1L1;TEX14;APC;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2854366477863286,-0.8880505546477967,0.6199095022624435,0.9948981621830993,1.0,10/20,31.54%,MAD1L1;TEX14;APC;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2854366477863286,-0.8880505546477967,0.6199095022624435,0.9948981621830993,1.0,10/20,31.54%,MAD1L1;TEX14;APC;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.38266854871562483,0.8879445984938226,0.6299862448418156,0.9424637410482227,1.0,7/15,29.92%,DDRGK1;NPM1;EZH2;CUL3;KLHL18;CDC73;PAF1
prerank,cellular iron ion homeostasis (GO:0006879),0.3110098044937295,0.8878812632957069,0.6519774011299435,0.9421394978256232,1.0,13/55,19.97%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2
prerank,melanocyte differentiation (GO:0030318),0.4134129137570478,0.8878427036415516,0.6186186186186187,0.9417544503364712,1.0,3/11,12.91%,LRMDA;MITF;ENPP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3687230803930668,-0.8877199537462521,0.5855072463768116,0.993740917632684,1.0,4/10,15.29%,ESR1;THRA;PSMC4;TP53
prerank,metallo-sulfur cluster assembly (GO:0031163),0.35776302091892254,0.8875623229789353,0.6096605744125326,0.9418476879097786,1.0,6/22,17.86%,HSCB;FXN;NFU1;NFS1;CIAPIN1;ABCB7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36144277827650645,0.8872900750565804,0.6126005361930295,0.9419570845326746,1.0,6/20,18.22%,SPPL2A;NFKB1;PSEN1;APH1A;APH1B;HM13
prerank,neuron projection morphogenesis (GO:0048812),0.2883996318421041,0.8871276982829412,0.7181069958847737,0.9418138735092524,1.0,36/137,19.83%,SLITRK6;TAOK3;BDNF;ATL1;LRP2;CNTNAP1;CTNNB1;GAS7;FGFR2;PAK3;EPB41L3;BTBD3;APP;TNIK;DNM2;ANKRD27;SRGAP2;APBB1;ACTB;CTNND2;MINK1;DBNL;TAOK2;MEF2A;BAIAP2;DSCAML1;LLGL1;NYAP2;DICER1;DCDC2;DTNBP1;ABITRAM;BRSK1;MAP1B;NCKAP1;CCK
prerank,positive regulation of hormone secretion (GO:0046887),-0.30110974255557477,-0.8870094011764523,0.61003861003861,0.9936668045492645,1.0,10/17,40.26%,SNX4;PLA2G3;VAMP7;C1QTNF3;GRP;HCAR2;SPP1;VAMP8;RASL10B;NMB
prerank,fat cell differentiation (GO:0045444),-0.21618427121899056,-0.8868523278754366,0.7288135593220338,0.9920187696998354,1.0,16/57,16.39%,OSBPL11;PPARG;MAFB;BBS9;ZBTB7A;PSMB8;SIRT1;TMEM120A;AKT2;CEBPA;HMGA2;CLIP3;FOXO1;WNT5B;SMAD6;KLF4
prerank,positive regulation of phosphatase activity (GO:0010922),0.36156814491465605,0.8867805913577959,0.6339165545087483,0.9420687999137917,1.0,5/21,16.20%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.36530553527557363,0.8867108558235208,0.6132450331125828,0.9417363623910076,1.0,7/19,24.46%,DHX36;ZNF76;ICE2;MTOR;BRF2;CHD8;TENM1
prerank,cellular response to amino acid starvation (GO:0034198),0.3009359082796066,0.8865986812318231,0.692972972972973,0.9415153251796657,1.0,19/71,22.25%,EIF2AK2;MIOS;ATP6V0D1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,nucleus organization (GO:0006997),0.31780157081563254,0.8865590773329243,0.6449026345933563,0.9411402559446035,1.0,11/47,19.73%,CHMP4A;CHMP4B;CHMP1B;ATXN7;SUN2;CHMP3;REEP3;NUP155;CHMP5;NUMA1;NUP133
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3230371243688048,0.8864061458014357,0.6453143534994069,0.9409801200638491,1.0,7/39,9.10%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,lipoprotein catabolic process (GO:0042159),-0.3452111050413662,-0.8861649990629432,0.5789473684210527,0.9918462372925314,1.0,4/11,10.83%,LYPLA1;LYPLAL1;ABHD17B;ABHD17C
prerank,organelle disassembly (GO:1903008),-0.24853222744694478,-0.8860729379297381,0.654639175257732,0.9900805285168564,1.0,9/33,11.64%,UBA5;VRK1;EIF2D;KIF9;ULK2;ATG2B;UFM1;ATG2A;ZFAND1
prerank,cellular response to metal ion (GO:0071248),0.2878782443271036,0.8859179663035921,0.7061266874350987,0.9415032745597832,1.0,16/123,11.08%,CAMK2D;CLIC4;RASA4;WNT5A;DAXX;CPNE3;TRPM2;B2M;CRHBP;MT3;SYT7;SYT3;P2RX4;PRNP;ADGRV1;GLRA2
prerank,positive regulation of cell growth (GO:0030307),0.2928958425440315,0.8858211141144624,0.6874340021119324,0.9412352040956125,1.0,17/96,15.53%,HYAL1;BDNF;SEMA4D;CXCL16;MMP14;SFRP2;FXN;RUFY3;DDX49;SYT3;CIB1;SMURF1;RASAL1;EXOSC9;DBNL;NCBP1;ADNP2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.36980508343662843,0.8857882768044477,0.6170798898071626,0.9408409045538336,1.0,2/18,6.21%,CAMK2D;CAB39
prerank,glycolipid metabolic process (GO:0006664),0.3190372246598037,0.8857221252659973,0.6547756041426928,0.9405077552122648,1.0,14/47,22.77%,PIGW;ST6GALNAC4;GBGT1;ST6GALNAC6;NEU1;SCCPDH;B3GALNT1;GLB1;GBA2;PGAP3;GLTP;SUMF1;ARSA;ESYT2
prerank,cell cycle G1/S phase transition (GO:0044843),0.30625535735687104,0.885457248623516,0.6692056583242655,0.9406044838523618,1.0,11/61,15.03%,ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;PLK3;MNAT1;MAX;RB1;USP37
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.42595404254018043,0.8851356415480892,0.6246246246246246,0.9407809159595059,1.0,3/10,11.83%,NBR1;LYN;MAP2K2
prerank,positive regulation of developmental growth (GO:0048639),0.31421159894130735,0.884808750606932,0.6572398190045249,0.9409777271712523,1.0,9/49,15.09%,BDNF;SEMA4D;RUFY3;SYT3;INSR;AGRN;SMURF1;RASAL1;DBNL
prerank,negative regulation of neuron differentiation (GO:0045665),0.3570134934341409,0.8846561177899817,0.6450331125827815,0.9408124268736991,1.0,2/22,5.43%,B2M;SOX9
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.22858155818265186,-0.884420752558414,0.7375886524822695,0.9924732217727521,1.0,17/46,23.39%,TGFB1;ANP32B;EFCAB7;GSK3B;PIK3R2;CAMK1;RAPGEF3;TP53;ZIC1;UBR5;ECT2;DMAP1;BAG3;NEDD4;TPR;RBM22;IL1B
prerank,ceramide catabolic process (GO:0046514),0.3890333242289099,0.8839789757014186,0.6149584487534626,0.9416968309763718,1.0,3/14,15.71%,ASAH2;NEU1;ACER3
prerank,ESCRT complex disassembly (GO:1904896),0.4169518759934378,0.8836227164431666,0.6210045662100456,0.941456360405246,1.0,4/10,22.00%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,ESCRT III complex disassembly (GO:1904903),0.4169518759934378,0.8836227164431666,0.6210045662100456,0.941456360405246,1.0,4/10,22.00%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,sister chromatid segregation (GO:0000819),-0.2499582707681959,-0.8835229092194319,0.6228571428571429,0.9927987681613476,1.0,12/31,23.12%,TOP2B;SMC1A;INO80;KIF18A;TOP2A;CENPK;KNSTRN;NUSAP1;NSL1;CDCA8;DSN1;KIFC1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35260438935287913,0.8833083334912861,0.6343669250645995,0.9416504107780002,1.0,7/22,21.76%,DHX36;SRF;MED12;PAXIP1;MED16;MED24;PSMC2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3691702021053679,0.8832421724416366,0.6175298804780877,0.9413339395539698,1.0,3/19,10.62%,CX3CL1;GIT1;ZC3H12A
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.25773221795593365,-0.8829277881423461,0.7035175879396985,0.9923954689544255,1.0,6/29,8.29%,PATL1;EXOSC7;DIS3;DDX6;DCP1A;EXOSC5
prerank,regulation of isotype switching (GO:0045191),0.38888163373313483,0.882715784762635,0.6173913043478261,0.9418760443878352,1.0,5/14,22.52%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,neuron remodeling (GO:0016322),0.41847698788768184,0.8826084973915883,0.6233382570162481,0.9416333709543321,1.0,2/10,9.16%,CX3CL1;APP
prerank,protein localization to cilium (GO:0061512),0.3372804238608577,0.8825560995538008,0.6402439024390244,0.9412710876409786,1.0,12/32,25.61%,SNX10;TUB;WDR35;ZNF423;ODAD4;WDR19;TULP3;RABEP1;RAB29;IFT140;BBS4;INVS
prerank,regulation of cation transmembrane transport (GO:1904062),-0.25023031658146644,-0.8822953127113694,0.66,0.9920076698296629,1.0,3/29,5.78%,KCNIP3;SLMAP;HOMER1
prerank,muscle cell migration (GO:0014812),-0.3539752429819616,-0.8821230464671105,0.6101694915254238,0.9904691280633889,1.0,5/10,23.12%,ROCK1;AAMP;ITGB1BP1;ITGB3;DDR1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2948499397952628,0.8820220784127247,0.6759656652360515,0.941929785662258,1.0,9/88,6.83%,HAS3;HYAL1;CLU;BCL2L11;SDC4;CX3CL1;CDT1;SH3GLB1;SLF2
prerank,positive regulation of intracellular transport (GO:0032388),0.32830629375599835,0.8819983222799367,0.6394230769230769,0.9415151461562667,1.0,17/38,28.70%,ACTN2;RUFY3;DYNC1H1;PLK3;MLC1;CEP131;SORL1;VAMP2;NUMA1;PLA2G4E;STK11;RAB29;TENM1;TBC1D20;STX18;PDCD10;ICE1
prerank,replication fork processing (GO:0031297),0.32547301423849,0.8818251000048493,0.6506602641056423,0.9413952227660248,1.0,6/38,15.02%,SAMHD1;ETAA1;RTEL1;ZRANB3;DDX11;GEN1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.25033916379821886,-0.8816756437314673,0.6358695652173914,0.9896520051445161,1.0,8/31,11.72%,PDLIM5;CFL1;ARHGAP44;SRCIN1;PPFIA2;TANC2;SHANK3;ZDHHC15
prerank,actin filament organization (GO:0007015),0.2857124638044711,0.8815852617902821,0.7341513292433538,0.9414052398666708,1.0,28/151,16.39%,ACTN1;MYO1C;ELMO2;RHOF;MAD2L2;RUFY3;PPP1R9A;EVL;CARMIL1;SAMD14;BCAR1;PROX1;ARHGAP25;CORO7;GSN;FAT1;TMOD3;TRPV4;WHAMM;CORO1B;MYO6;RAC1;DLG1;GAS2L3;SH3BP1;AIF1;BAIAP2;BAIAP2L1
prerank,Golgi to plasma membrane transport (GO:0006893),0.3127245882636023,0.8811535443979243,0.6468571428571429,0.9418142506580781,1.0,18/47,24.97%,BLZF1;GOLGA7;GGA3;AMN;EXOC6;ARFGEF2;VAMP2;VAMP4;BBS2;PREPL;LLGL1;VAMP5;GOLPH3L;OPTN;RABEP1;RAB10;EXOC2;COMMD1
prerank,regulation of MAPK cascade (GO:0043408),0.2828670440406428,0.8810446198578195,0.7355035605289929,0.9415729163584824,1.0,21/157,10.14%,TAOK3;FLT1;KDR;GPR37L1;DHX33;DUSP3;CX3CL1;MYDGF;FGFR2;PAK3;WDR54;GPR37;NBR1;RET;TMEM106A;MYOC;LYN;HMGB1;ROR2;INSR;TNIK
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3144029994420068,0.8809971649752548,0.6611570247933884,0.9412012094390643,1.0,8/45,12.23%,GAREM1;TGFA;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11
prerank,protein prenylation (GO:0018342),-0.34230888823321665,-0.8809808717491463,0.56973293768546,0.9895736904719445,1.0,6/10,21.88%,CHML;RABGGTA;PGGT1B;CHM;FNTB;RCE1
prerank,cellular response to osmotic stress (GO:0071470),0.35784414061853215,0.8809376659141203,0.6246719160104987,0.9408599505554873,1.0,8/21,21.35%,CAB39;ZFP36L1;SCN2A;TRPV4;OXSR1;STK39;DDX3X;RCSD1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.25161187609593283,-0.8807172849714467,0.6871794871794872,0.9883561589915179,1.0,5/30,7.68%,TGFB1;TGFBR3;TWSG1;TRIM33;PCSK6
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2709653676276095,-0.8805282060141819,0.6341463414634146,0.9848730413715131,1.0,7/20,30.03%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.2709653676276095,-0.8805282060141819,0.6341463414634146,0.9848730413715131,1.0,7/20,30.03%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,serine family amino acid catabolic process (GO:0009071),0.4153203813697567,0.8803766657517514,0.6092307692307692,0.9415075659505107,1.0,3/10,15.07%,DLD;SHMT1;GCSH
prerank,phospholipid biosynthetic process (GO:0008654),0.3311046998576837,0.8801737369805782,0.6363636363636364,0.941464654108808,1.0,7/36,12.69%,CPNE3;PCYT2;AGPAT5;PIP5K1A;GNPAT;SPHK2;DHDDS
prerank,protein N-linked glycosylation (GO:0006487),0.3023071307304054,0.8799259720406032,0.6564885496183206,0.9414939871999854,1.0,22/66,25.22%,TMEM258;ST6GAL1;B4GALT1;GFPT1;ENTPD5;ST3GAL1;DAD1;MGAT4C;ALG13;ALG11;RPN1;MGAT5;MAGT1;MAN1C1;STT3B;KRTCAP2;DDOST;DPAGT1;DOLPP1;TMEM165;PMM2;MGAT5B
prerank,positive regulation of cellular component organization (GO:0051130),0.28599361883253116,0.8798883425911537,0.6902748414376322,0.9411101391861331,1.0,23/107,18.29%,ATP10A;HAS3;HYAL1;CLU;CAMK2B;BCL2L11;RUNX1;CDT1;SH3GLB1;SLF2;INSR;APOE;RB1;RACK1;DAB2;PLEKHM2;TFR2;BMF;ANAPC2;BAX;CBLL1;ABCB7;FNIP2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.3263914853813952,-0.8798797228177807,0.6204620462046204,0.9845973867819684,1.0,2/13,5.24%,SYK;FGR
prerank,positive regulation of protein sumoylation (GO:0033235),0.4124774924279552,0.8798470556094583,0.6411042944785276,0.9407494156137789,1.0,6/10,29.65%,UBA2;PIAS1;HDAC4;PIAS4;GNL3;RWDD3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2814549713025596,0.879831946248265,0.7492416582406471,0.9403280709095198,1.0,64/184,26.19%,PSMB10;SKP1;PSME2;PSMA5;CDC26;PSME4;ANAPC5;DYNC1H1;PSMA3;ACTR1A;MAPRE1;CDK5RAP2;PSMB9;ANAPC4;PRKAR2B;UBE2E1;BTRC;NEDD1;ZFP36L1;CEP152;PSMD2;CEP131;CDC16;CDC27;CEP70;NEK6;PSME3;AKAP9;TUBB4B;DYNLL1;ANAPC15;PSMA4;HSP90AA1;ANAPC2;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD9;PSMD8;PSMF1;APPL2;PSMB6;PSMD12;PSMC2;HAUS3;YWHAG;PSMD4;CUL3;ZFP36L2;PSMA2;TFAP4;PTPN6;KLHL18;YWHAE;TUBA4A;CEP192;DCTN1;SIRT2;HAUS6;PSMD1;PSMD11;ANAPC10;CEP57
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.35639874568203594,-0.8797996146022382,0.5861111111111111,0.9828876570531808,1.0,2/10,6.93%,IMPACT;MVP
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2827651409426571,-0.8795688900813956,0.6626984126984127,0.981533473901264,1.0,5/18,17.13%,GSK3B;RIMS1;SLC4A8;RIMS3;RIMS2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3469782113898815,-0.8794484858995849,0.6034985422740525,0.9799025846926462,1.0,5/11,27.63%,TIMM13;TIMM8B;TIMM9;ROMO1;NDUFA13
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.32316927110048244,-0.8793792920205001,0.6099290780141844,0.9781849040948642,1.0,6/14,23.13%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3779918752372459,0.879266349532479,0.6221910112359551,0.9409861589514749,1.0,6/15,21.58%,ZC3H12C;ZC3H12A;NUDT16;DICER1;RPP30;RNASEH1
prerank,lipoprotein localization (GO:0044872),-0.3318672265225363,-0.8791801391416998,0.6147308781869688,0.97677422158346,1.0,1/11,1.74%,PPARG
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.26405449789122115,-0.878905776386195,0.6739130434782609,0.9756030005361956,1.0,12/24,28.44%,PAK2;RHPN2;CLASP2;WAS;F11R;WASF2;CLASP1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28
prerank,positive regulation of cyclase activity (GO:0031281),-0.3134069732152063,-0.8786928657416324,0.6466876971608833,0.9742009004142864,1.0,2/14,5.66%,STIM1;MAPK3
prerank,modulation by host of symbiont process (GO:0051851),-0.25537788369889775,-0.878665264209416,0.6935483870967742,0.9723708820682135,1.0,9/31,12.93%,SMARCA4;CCNT1;SAP30BP;REST;NAPEPLD;CX3CR1;CTDP1;CCL3;HMGA2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3190313986572322,-0.8785873699494386,0.6118421052631579,0.9707190438589364,1.0,7/13,29.83%,NAPEPLD;ZBTB7B;VSTM2A;SOX13;FNDC5;TFE3;METRNL
prerank,regulation of actomyosin structure organization (GO:0110020),0.39136712640016225,0.8782184589598236,0.6145251396648045,0.9426176993231663,1.0,5/13,19.12%,PTGER4;AKAP13;RAC1;ASAP3;TSC1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.26144482713326134,-0.8782049834816285,0.6941747572815534,0.9698084226366587,1.0,9/25,17.59%,AR;NCKAP1L;EGFR;SNCA;SRC;MIF;KCTD20;FZD7;GLMN
prerank,cellular response to decreased oxygen levels (GO:0036294),0.29897982313763993,0.8781867897197986,0.656319290465632,0.9422236048132868,1.0,12/65,13.15%,ADAM8;EGLN2;NOP53;HYOU1;MT3;RORA;UBQLN1;ZFP36L1;AK4;SCN2A;NPEPPS;BAD
prerank,membrane fusion (GO:0061025),0.3304971579476271,0.8781505273084694,0.641439205955335,0.9418371344341638,1.0,17/33,30.13%,UBXN2B;DNM2;VAMP2;VTI1B;NAPA;SNAP23;HUWE1;RABEP1;OPA1;DNM3;GCA;CHP1;RABIF;DNM1;NAPG;HACE1;SNAP29
prerank,protein localization to vacuole (GO:0072665),0.3916736179133632,0.8779868569590699,0.6444759206798867,0.9416817762532024,1.0,6/13,26.95%,KPTN;SH3GLB1;LAMTOR4;SZT2;GLMP;LMBRD1
prerank,glutathione biosynthetic process (GO:0006750),-0.3464383799732018,-0.8775834618451452,0.5988538681948424,0.9694891929189396,1.0,4/11,17.04%,GCLM;GSS;HAGH;GGCT
prerank,histone H4 deacetylation (GO:0070933),0.41573218381490995,0.8774038001538903,0.6414814814814814,0.9424046940000648,1.0,6/10,25.39%,HDAC8;HDAC1;HDAC2;HDAC4;SMARCAD1;SIRT2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4011330996553125,0.8772171810577578,0.6244604316546762,0.9423254084772792,1.0,2/12,6.00%,TIPIN;CDT1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.27315847154917794,-0.8771624902050131,0.6666666666666666,0.9686914785072812,1.0,8/22,27.05%,DMD;AHNAK;CACNB1;CBARP;SRI;NOS1AP;DRD2;CRHR1
prerank,regulation of catecholamine secretion (GO:0050433),-0.2521112867018057,-0.8768564306869115,0.6540284360189573,0.9675820882609791,1.0,15/29,29.27%,SYT2;SYT10;SNCA;GRK2;KCNA2;SYT8;SYT1;CHRNA4;STX1A;CHGA;SYT13;DRD2;SYT5;PRKN;SYT17
prerank,ketone body metabolic process (GO:1902224),0.4142587554990512,0.8767171366108342,0.6066565809379728,0.9428675266694309,1.0,3/10,16.64%,HMGCL;OXCT1;ACAT1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.29098017222197775,-0.876676605875423,0.6584507042253521,0.9662161254394721,1.0,3/17,6.53%,ADCY9;ADCY3;PRKACB
prerank,glucose import (GO:0046323),0.39872794464407385,0.8765084648219813,0.6378066378066378,0.9428189294973771,1.0,1/13,2.35%,SLC27A1
prerank,negative regulation of histone methylation (GO:0031061),0.4148960177810924,0.8764982445105951,0.6273932253313697,0.9423865760453969,1.0,3/10,9.82%,AASS;DNMT1;WDR5
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.27662130669931007,-0.87649139880617,0.6637168141592921,0.9648230922715448,1.0,8/22,24.21%,APC;NR2F2;CEBPA;INCA1;CDKN1A;HEXIM1;CDKN1B;CDK5RAP1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4166225335994451,0.8763165074938715,0.6351351351351351,0.942277127868618,1.0,3/10,10.66%,CCT4;CCT7;CCT3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3758276500284958,0.876215220828336,0.6356164383561644,0.9420321153659215,1.0,3/17,7.44%,ITGA3;TFAP2B;DOK5
prerank,leukotriene biosynthetic process (GO:0019370),-0.31161094253965077,-0.8761400502026185,0.6464646464646465,0.9638507409960442,1.0,2/14,4.64%,LTC4S;ALOX5AP
prerank,blood vessel morphogenesis (GO:0048514),0.30668743105458524,0.875298782311626,0.6681664791901012,0.9433785247731945,1.0,10/54,17.97%,FLT1;KDR;CUL7;ITGB8;EGFL7;PROX1;NRP1;AGGF1;RBPJ;NF1
prerank,steroid biosynthetic process (GO:0006694),0.2970168634090939,0.8752673835454495,0.6845039018952063,0.9429885476933352,1.0,13/56,20.74%,OSBPL7;CH25H;HSD11B1;FDFT1;OSBPL3;DHRS11;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1;SRD5A1
prerank,cardiac muscle contraction (GO:0060048),0.3281631570047892,0.8747701055515434,0.6606060606060606,0.9434598308369953,1.0,6/34,17.47%,CAMK2D;SLC8A1;TNNC1;GSN;SCN1B;TNNI2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3065556048099882,-0.8745764818922143,0.6284722222222222,0.9658995076396347,1.0,7/16,25.77%,SNCAIP;FLOT1;RIMS1;MCTP2;CAMK2A;MEF2C;KCNMB4
prerank,chloride transmembrane transport (GO:1902476),-0.2208040169887165,-0.8743883370171059,0.743801652892562,0.9645433783250715,1.0,14/48,21.82%,SLC12A6;GABRG3;SLC12A2;GABRB1;GLRB;GABRA2;SLC4A8;GLRA3;GABRB3;SLC1A1;SLC12A9;GABRA5;LRRC8A;ANO6
prerank,cell junction organization (GO:0034330),0.29984175321343476,0.8742246995162484,0.6897297297297297,0.9440607898026957,1.0,16/71,16.33%,ELFN1;RAB8B;PAK3;WNT7B;APP;AGRN;SDK1;PSEN1;TJP2;LIMS1;PPFIA4;ACTB;CTNND2;SH3BP1;NLGN3;OPHN1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3587178239944341,0.8741077060356458,0.6430446194225722,0.9438414268099894,1.0,7/21,21.14%,XDH;HPRT1;NUDT16;ACAT1;NUDT4;AMPD3;PDE9A
prerank,L-amino acid transport (GO:0015807),0.33981207296425203,0.8739696922053402,0.6489226869455006,0.9436462596048937,1.0,9/28,23.55%,SLC25A22;SLC38A2;SLC38A3;CTNS;SLC25A12;SLC36A4;SFXN1;SLC1A3;ARL6IP5
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.27768141531517093,0.8739412453645072,0.7530120481927711,0.9432527720088563,1.0,48/214,22.01%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;DUSP3;CX3CL1;FBXW7;FGFR2;MT3;DUSP29;CNKSR3;RAPGEF2;ACKR3;LYN;HMGB1;APP;ROR2;BMPER;ARRB2;TNIP1;CIB1;DUSP26;CCL14;HTR2A;PTPN11;APOE;DUSP10;NRP1;DLG1;MTURN;FGFR3;LGALS9;SPRED3;PTPRC;DSTYK;SPRED1;MFHAS1;RANBP9;PIN1;SIRPA;CCL4;TNFAIP8L3;ROR1;GCNT2;FGF2
prerank,actin filament network formation (GO:0051639),0.40396185611019014,0.8737353990487939,0.6385542168674698,0.9431913063219355,1.0,2/11,6.03%,ACTN1;CARMIL1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.36623631423192826,0.8736243139921002,0.6401062416998672,0.9429598446424756,1.0,5/19,16.95%,CCL5;CSF1;CXCL17;JAM3;MDK
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3468543853797128,-0.8730380540442447,0.6064139941690962,0.966158737637285,1.0,2/10,7.79%,ESCO1;SIRT1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.28976319522284194,0.8727386152207387,0.7164339419978518,0.9442305953734429,1.0,19/86,21.59%,GDF9;ACVR1;HSP90AB1;CSNK2B;SMAD2;MEN1;BMPR2;SNW1;ZNF423;DAB2;JAK2;BMPR1A;RBPJ;ACVR2A;RBPMS;NUMA1;ACVRL1;STK11;CITED2
prerank,negative regulation of locomotion (GO:0040013),-0.3305097209755018,-0.8726025356923472,0.6349693251533742,0.9655168531276682,1.0,5/12,15.96%,FRMD5;SPOCK3;PTPN2;WAS;CCDC125
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.41150968055701476,0.8723623915887052,0.619482496194825,0.9445147568596618,1.0,3/10,15.59%,ACADL;ACADS;GCDH
prerank,excitatory postsynaptic potential (GO:0060079),-0.2872154666573763,-0.8721655259219239,0.6403162055335968,0.9648323127087318,1.0,9/19,27.26%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;MAPK8IP2;DRD2;GRID2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.28841105136266565,0.8717858616497667,0.7103004291845494,0.9451951921909746,1.0,22/84,17.60%,DDX5;RBMX;HNRNPK;SRPK1;HNRNPL;RNPS1;SNW1;RBFOX1;HNRNPA1;CELF6;RBM15;MBNL2;DAZAP1;RBFOX3;RBM3;RBM39;NCBP1;SF3B4;SRSF7;SRSF4;PCBP4;CWC22
prerank,tryptophan metabolic process (GO:0006568),-0.3254601159473001,-0.8708506798868717,0.6477987421383647,0.9662804577972959,1.0,4/11,39.83%,KMO;IL4I1;IDO2;KYAT1
prerank,integrin-mediated signaling pathway (GO:0007229),0.2946351487882213,0.8703571162064995,0.6794310722100656,0.9475756272767727,1.0,10/73,13.78%,ISG15;ITGA2;THY1;CD47;HCK;ITGB8;BCAR1;COL3A1;NRP1;DAB2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.41755384568933107,0.8700436870425365,0.6305637982195845,0.9477316253653562,1.0,3/10,21.28%,RAPGEF2;CTNS;MFSD12
prerank,Golgi localization (GO:0051645),0.40798766437302236,0.8695509881466076,0.6331877729257642,0.9482275669002351,1.0,5/11,19.07%,TBCCD1;ARHGAP21;HOOK3;STK25;UVRAG
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3280484071745557,-0.8692506619859838,0.6182432432432432,0.968424968645551,1.0,5/13,11.92%,CASP8;GRIN2A;TBC1D10A;NLRC4;CYFIP2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3387589894144607,0.8681336598283718,0.6382165605095541,0.9504408288819681,1.0,5/24,14.25%,FIS1;MYO1C;PRNP;CIB1;FYN
prerank,DNA methylation (GO:0006306),-0.2711910237081101,-0.8679335921272595,0.6651162790697674,0.9698721016365089,1.0,13/23,30.25%,EHMT1;KMT2E;N6AMT1;METTL4;TEX15;BEND3;DMAP1;ATRX;PPM1D;BAZ2A;PICK1;ZFP57;FOS
prerank,negative regulation of protein depolymerization (GO:1901880),0.3378995124899252,0.8679172486949778,0.6499356499356499,0.9503948146370899,1.0,7/24,17.49%,SPEF1;CIB1;ATXN7;FGF13;PLEKHH2;STMN2;CAMSAP2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3531523443462848,0.8678960449618386,0.6503957783641161,0.9499858658530105,1.0,3/21,9.50%,SLC18A2;MT3;ABCD1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.3300424681282169,0.8677617595447493,0.6599749058971142,0.949796610513952,1.0,10/32,19.65%,SEMA4D;CUL7;FBXW8;RAPGEF2;TNIK;CUX1;CHRNB2;CAPRIN1;SS18L1;RAP2A
prerank,negative regulation of chemotaxis (GO:0050922),-0.24172582299784356,-0.8672092517585812,0.7457627118644068,0.9697345526189137,1.0,16/31,28.97%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;PTPN2;SEMA4B;SEMA3E;SEMA5B;ANGPT2;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,diacylglycerol metabolic process (GO:0046339),0.3426098758486619,0.8670711418911304,0.6478149100257069,0.950694005018104,1.0,7/23,18.23%,PNPLA2;DGKB;DGKK;DAGLA;DGKA;PLCE1;DGKI
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3328463029116235,0.8669685297280272,0.6604938271604939,0.9504293383409369,1.0,5/28,9.11%,DLK2;MMP14;FBXW7;YTHDF2;EGFL7
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3973425364163245,0.8662389885542834,0.655367231638418,0.9513631890905099,1.0,2/13,2.75%,ABCA1;CDH13
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.29882070598069566,0.8660725910566055,0.6950276243093922,0.9512312162215393,1.0,8/66,12.23%,PARP9;DTX3L;MEPCE;CCT4;CCT7;ZC3H12A;CCT3;PSEN1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.3929614795119947,0.8658555538634651,0.6332842415316642,0.9511921139817271,1.0,2/11,14.31%,PXDNL;PRDX2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35135099354921573,0.8654964326852872,0.6409921671018277,0.9509448615837467,1.0,3/22,5.19%,GOLGA7;ZDHHC21;ZDHHC20
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35135099354921573,0.8654964326852872,0.6409921671018277,0.9509448615837467,1.0,3/22,5.19%,GOLGA7;ZDHHC21;ZDHHC20
prerank,metal ion export (GO:0070839),-0.25791507229575256,-0.8652378232957013,0.6506024096385542,0.9727203009691952,1.0,14/31,37.89%,ATP1B1;ATP1B2;KCND3;KCNT2;KCNK5;ATP2B4;KCNH2;ATP1A1;ATP1A3;FXYD2;KCNQ1;KCNIP2;ATP1A2;KCNE3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.38034340734459654,0.8646483728092478,0.6532951289398281,0.9521317733450897,1.0,7/13,30.17%,ZDHHC21;IRAK1;MDK;FUT9;TNF;NFAT5;RELA
prerank,positive regulation of protein polymerization (GO:0032273),0.3002668208239687,0.8645940400123365,0.6877729257641921,0.9517771071681346,1.0,16/65,16.39%,HCK;EVL;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;NCK2;SNX9;TPPP3;AKAP9;PRKCE;RAC1;HSP90AA1;BAIAP2;BAIAP2L1
prerank,positive regulation of lipid storage (GO:0010884),-0.28032080131185705,-0.8645249551147288,0.6622222222222223,0.9725500704777985,1.0,6/21,14.47%,OSBPL11;SCARB1;C3;EHD1;VSTM2A;LPL
prerank,regulation of secretion by cell (GO:1903530),0.29915062961414535,0.8644772367985124,0.6727898966704937,0.9515580068510529,1.0,11/54,16.42%,RAB8B;RAB21;RAB12;CPLX1;P3H1;RHBDF2;RIC1;VAMP2;STX4;LLGL1;STXBP5L
prerank,alpha-amino acid metabolic process (GO:1901605),0.3084550800715788,0.8644245254626396,0.6751740139211136,0.9512044221811184,1.0,11/45,23.05%,MTHFR;THAP4;SLC25A12;GLUD1;FOLH1;MTHFD1;GADL1;MMUT;GPT2;GOT1;RIMKLA
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.19395851498945976,-0.8643986417497705,0.82,0.9710455554757115,1.0,25/98,18.25%,CASP8;SORBS1;PPP3R1;CD81;PPP3CC;EGFR;EFCAB7;ANK3;YWHAQ;TCAF1;YWHAZ;EPHB2;MTCL1;CEMIP;AKT2;PRKCI;AKT1;TREM2;CLIP3;PPP1R13B;TP53;E2F1;HRAS;ITGB1BP1;ZDHHC5
prerank,cellular response to interleukin-12 (GO:0071349),0.30955722517160755,0.8643878312089907,0.6790697674418604,0.950816566938248,1.0,16/48,25.31%,PSME2;SOD2;CD47;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP;HNRNPF;SIRPA;TALDO1;MSN;PITPNA;JAK1;ANXA2
prerank,receptor metabolic process (GO:0043112),0.30131954273832257,0.8641169281740977,0.6826815642458101,0.9508943679310229,1.0,15/53,19.16%,MVB12A;SH3GLB1;RAB11B;ACKR3;LDLRAP1;KIF16B;PIK3R4;ARRB2;DNM2;SMURF1;ARFGEF2;SNX1;UVRAG;SNX25;BECN1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28497788784661354,0.8637149922428264,0.7315789473684211,0.9512069981484667,1.0,24/108,21.31%,TNFSF10;CASP4;XDH;NOD1;FIS1;CFLAR;HMGB1;PRR7;PPM1F;DIABLO;GSN;RACK1;BAD;ST18;JAK2;UACA;LGALS9;BAX;CRADD;BCAP31;DDX3X;LCK;MTCH1;F3
prerank,ear morphogenesis (GO:0042471),0.3565880052737719,0.8636606469320525,0.6473684210526316,0.9508547207401614,1.0,3/20,13.86%,CHD7;FGFR2;MYO6
prerank,negative regulation of ossification (GO:0030279),-0.26954005603763026,-0.8633216966739391,0.6482412060301508,0.971811785951512,1.0,7/23,16.59%,CHSY1;SRGN;TRPM4;CCL3;CCR1;SMAD6;ECM1
prerank,positive regulation of cilium assembly (GO:0045724),0.35515247101287273,0.8632219282789387,0.6541554959785523,0.9512238521120696,1.0,7/18,24.55%,KCTD17;WRAP73;CCDC88A;SEPTIN9;CEP135;ENTR1;BBS4
prerank,positive regulation of bone resorption (GO:0045780),0.4022604331668953,0.8629846020815728,0.6623188405797101,0.9512299025443766,1.0,2/11,10.11%,ADAM8;DEF8
prerank,regulation of Rho protein signal transduction (GO:0035023),0.2920855884242267,0.862832715730172,0.7051835853131749,0.9510728655267952,1.0,15/72,17.17%,ABCA1;TNFAIP1;ITGA3;MYOC;MET;KANK1;STARD8;COL3A1;APOE;GPR35;AKAP13;NRP1;RAC1;OPHN1;BCR
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.29008390698279124,0.8627044792659228,0.723952738990333,0.9508507746463546,1.0,12/80,14.68%,TNFSF10;NOD1;FIS1;CDKN2D;IGBP1;MT3;HMGB1;DNAJB6;PPM1F;BAD;UACA;SOX2
prerank,heart morphogenesis (GO:0003007),0.3051905426699064,0.8626791342481456,0.6831797235023042,0.9504503806310419,1.0,7/50,20.21%,ACVR1;CHD7;SOX9;INSR;BMPR1A;FLRT2;ACVRL1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4004469206265976,0.8625287039766902,0.6593245227606461,0.950274107326379,1.0,2/11,13.52%,SIK1;CLK2
prerank,response to X-ray (GO:0010165),0.3802854518105607,0.8624203942674434,0.638205499276411,0.9500324183456158,1.0,1/14,0.99%,MSH2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.309759885131339,-0.8620781773868152,0.6402640264026402,0.9729316629311295,1.0,3/13,16.67%,ABCA2;ALG10B;GOLGA2
prerank,rRNA processing (GO:0006364),0.27446753042727473,0.8609849966207048,0.7836198179979778,0.9523224437132638,1.0,61/172,26.33%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;RSL1D1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;NOLC1;RIOK3;EIF6;NOP2;PRKDC;DDX54;RPS6;SART1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;PELP1;RRP1B;RRP1;WDR12;RPL24;UTP3;RPL37A;RPL3;ESF1;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6;NOL6;UTP14A;RRP36;NHP2;RPL27;IMP4;RPS24;RPL12;PIH1D1;NVL;BMS1;C1D
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.31272273213781177,0.8608278724418518,0.6772673733804476,0.9521615650574148,1.0,11/41,20.35%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;LACC1;NUP133;NUP43
prerank,negative regulation of phosphorylation (GO:0042326),0.2853335817358693,0.8607837856611501,0.7215053763440861,0.9518038990503133,1.0,17/85,15.07%,XDH;TARDBP;ANKLE2;CDKN2D;PPIA;PAQR3;LYN;PRNP;MEN1;GIT1;CIB1;ZC3H12A;STAP1;PRKDC;DYNLL1;IRS2;INPP5K
prerank,chromosome organization (GO:0051276),0.2851884641375328,0.8606878656640046,0.7376705141657922,0.9515468759288668,1.0,20/99,19.73%,MTHFR;GATAD1;MSH2;HMGN3;LRWD1;CDT1;TCF7L2;RAE1;RBX1;COPS7B;LDB1;HDAC8;EZH2;SOX2;NUP155;BAHD1;HDAC1;COPS8;NDC80;NUP133
prerank,negative regulation of developmental process (GO:0051093),0.29238949880470133,0.8601285052004072,0.7120879120879121,0.9521557160372082,1.0,8/69,11.07%,WNT11;LOXL2;THY1;SOX9;NFIB;KANK1;NOTCH4;IL17D
prerank,negative regulation of protein phosphorylation (GO:0001933),0.27534831492194917,0.8597105004018597,0.7633196721311475,0.9524962805201368,1.0,36/150,19.14%,XDH;TRIB3;SPRY2;TARDBP;SEMA4D;THY1;SFRP2;TARBP2;PMEPA1;PPIA;CNKSR3;PAQR3;NCK1;LYN;NCK2;PRNP;MEN1;CIB1;PPM1F;ZC3H12A;DDIT4;PRKDC;AKT1S1;RB1;ENPP1;RACK1;INPP5K;CALM3;SPRED3;PTPRC;NF1;CORO1C;DTNBP1;SPRED1;TESK1;SNX25
prerank,regulation of cellular protein localization (GO:1903827),0.3083695941001409,0.8597069070126264,0.6797235023041475,0.9520549521415914,1.0,11/45,19.54%,BDNF;SUMO3;HSP90AB1;CTNNB1;RAB11B;VCPIP1;PPM1F;HSP90AA1;CCDC66;GBF1;PIN1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3013027330239346,-0.8592551823678094,0.6586345381526104,0.9779044352318438,1.0,3/15,6.08%,GRM3;HOMER1;HOMER3
prerank,activation of GTPase activity (GO:0090630),0.285998639470183,0.859145962016897,0.7368421052631579,0.9526509462209904,1.0,26/89,19.92%,TBC1D1;SYDE1;PIP5K1A;TBC1D8;ABR;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;ARHGAP25;ARHGEF10;SIPA1L1;TIAM2;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;CORO1C;SIPA1L3;TSC1;ARHGAP24;ARHGAP42;SGSM1;TBC1D4;SGSM3
prerank,gene expression (GO:0010467),0.26908668208036285,0.8588788128611987,0.855,0.9526957527436485,1.0,88/348,21.29%,APOBEC1;NUP37;POLR2G;MRPL36;XRN2;ADAR;IGF2BP3;AGO2;RPL36;MAGOHB;HARS2;SMG7;HNRNPH1;NUP153;NCBP2;GSPT1;NOL9;RPL22;RRAGC;HNRNPK;EIF4EBP2;RPS21;WDR33;RBMS2;DDX20;NXT1;HNRNPA2B1;RAE1;SCX;POLR2K;HNRNPL;TNIP1;RNPS1;MRPL42;SORL1;SMG5;ABCF1;HNRNPH3;UPF2;DDX54;ATXN1;ZC3H11A;TAF1B;RPS6;CHTOP;DUSP11;RPS11;DDX39B;NUP155;RPL30;RBM3;RBM39;MRPL24;NCBP1;DDX19B;MEF2A;RPL32;SRSF7;RPL23A;LMF2;RPL11;SRSF4;UPF1;YARS2;RPL10A;RPS15A;MRPL13;NUP88;HBS1L;SLU7;SRBD1;RBPMS;RSL24D1;RPL24;RPL37A;FASTKD2;RPL3;MRPS11;HNRNPF;NUP133;RRBP1;GLE1;NUP43;THOC7;RPL29;SRSF5;RPL5;FARSB
prerank,regulation of urine volume (GO:0035809),0.4066614425725283,0.8587977811420481,0.6419019316493314,0.9524127367720532,1.0,2/10,15.07%,TFAP2B;INPP5K
prerank,ion homeostasis (GO:0050801),0.32485116481100124,0.8585931208446786,0.6617466174661747,0.9523585737952813,1.0,2/30,5.11%,CAMK2D;SLC12A5
prerank,apoptotic process (GO:0006915),0.26991290788552125,0.8585566184072583,0.7993951612903226,0.9519741729829956,1.0,33/203,16.20%,CASP4;CASP7;IFIT2;DAPK3;CXCR4;MCM2;BCL2L11;FEM1B;CASP6;MRPS30;SIAH1;CHEK1;TNFAIP1;RRAGC;CFLAR;PPIA;APP;PLK3;CIB1;DIABLO;AHCYL1;DDIT4;SCN2A;PRKCE;NDUFS1;BAD;JAK2;MYD88;TLR2;TAOK2;BMF;PPARD;MTOR
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3839868094746829,0.858317584446151,0.644640234948605,0.9519826349849178,1.0,3/13,12.01%,SOCS1;RUNX1;NKAP
prerank,regulation of cellular catabolic process (GO:0031329),0.2964150168093734,0.85805308323694,0.7024608501118568,0.9520398360544775,1.0,8/62,9.50%,DAPK3;TRIB3;LONP2;ITPR1;OSBPL7;RRAGC;CISD2;ABCD1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3213399004206383,0.8577907471778502,0.6563245823389021,0.9520754325543666,1.0,8/30,19.61%,PIGW;GPAA1;PIGV;PGAP2;PIGQ;PIGB;PGAP3;PIGK
prerank,regulation of glycolytic process (GO:0006110),0.29236455694094504,0.8576975224762664,0.712707182320442,0.9518084850087487,1.0,23/68,27.02%,NUP37;SLC2A6;NUP153;RAE1;ENTPD5;APP;INSR;PRKAG1;GIT1;EIF6;PSEN1;NUP155;NUP88;NUP133;NUP43;ZBTB20;TIGAR;HDAC4;NUP205;SEH1L;SLC4A4;NUP188;EP300
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3365319913876282,0.8576635138925547,0.6579634464751958,0.9514308556110768,1.0,5/23,16.12%,MMP14;MAPK14;PROX1;ATP11A;SMYD1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2921204135002445,0.857308383946296,0.721081081081081,0.951636046703457,1.0,4/73,1.44%,TNFSF10;CASP4;XDH;NOD1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3695858771974894,0.8565458739904005,0.6614285714285715,0.9526491064186885,1.0,2/15,10.85%,TMC1;ADGRV1
prerank,nucleic acid-templated transcription (GO:0097659),-0.22173232120636824,-0.8563312389614368,0.7615894039735099,0.9832268151978006,1.0,19/42,25.49%,THRB;DRG1;EPC1;BCL3;PTMA;MMS19;POLR2F;POLR2J;CREBL2;NFKBIB;E2F1;HOXD3;POLR2A;THAP1;PPP5C;NR4A2;PAX8;POLR2L;BAZ2A
prerank,atrioventricular valve morphogenesis (GO:0003181),0.353905715008875,0.8562550674138798,0.6508795669824087,0.9527488382097603,1.0,4/19,15.05%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,phosphatidylcholine catabolic process (GO:0034638),0.400363147627571,0.856040109353775,0.6409495548961425,0.9526802881179508,1.0,4/10,26.58%,LIPC;PLA2G6;PNPLA8;PLA2G4A
prerank,endoplasmic reticulum organization (GO:0007029),0.2911963501169559,0.8556569874262375,0.7041484716157205,0.952978843213793,1.0,12/72,13.55%,TOR1AIP2;ATL1;REEP2;SEC16A;DOP1B;APP;VAPB;TRAM2;PRNP;VCPIP1;VAMP2;REEP3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3795274796067534,0.8551605645063964,0.6564673157162726,0.9534381510728898,1.0,2/15,2.65%,AUP1;TMEM129
prerank,glycoprotein biosynthetic process (GO:0009101),0.28676709964768415,0.8550912386985331,0.7167381974248928,0.9531221102126816,1.0,20/79,22.14%,CANT1;COG3;MPI;TMEM106A;FAM20B;B4GALT5;BMPR2;CSGALNACT2;TNIP1;DAD1;FUT10;B3GALNT1;NPC1;ST8SIA1;FUT9;SERP1;DDOST;XYLT1;GCNT2;CHST11
prerank,negative regulation of developmental growth (GO:0048640),0.3217562917743822,0.854445934768295,0.6708229426433915,0.9538602506840609,1.0,7/30,16.07%,MT3;MAG;DUSP10;FGF13;PTCH1;BBS2;FGFR3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.34130089143198794,0.854045814936034,0.656084656084656,0.9541274046917252,1.0,3/23,14.25%,CAMK2D;PRNP;FYN
prerank,cell-cell junction organization (GO:0045216),-0.19806460457125666,-0.8535300701257272,0.8024691358024691,0.9881492464993777,1.0,10/79,8.68%,TGFB1;CDH10;CDH2;CTNNA1;CADM3;NECTIN1;ARVCF;SDK2;NLGN2;TGFB2
prerank,peptide metabolic process (GO:0006518),0.28824329271819177,0.8534882321857677,0.7285559174809989,0.9547171708120082,1.0,12/75,14.26%,ETHE1;ERAP1;ABCB9;CPQ;NLN;AEBP1;GSR;SPCS1;PSEN1;NPEPPS;SPPL3;CTNS
prerank,early endosome to Golgi transport (GO:0034498),-0.32437782469561277,-0.8531723708591658,0.6575757575757576,0.9871294604015377,1.0,3/11,10.93%,SNX8;SURF4;TRAPPC10
prerank,Fc receptor signaling pathway (GO:0038093),0.27684961111277495,0.8531227683582179,0.7531380753138075,0.9549347828102659,1.0,37/110,25.95%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD9;PSMD8;TAB3;PSMF1;PSMB6;PSMD12;PSMC2;MAPK9;PSMD4;PDPK1;PSMA2;MAP2K4;PIK3CA;GAB2;SHC1;PSMD1;PSMD11
prerank,purine nucleotide metabolic process (GO:0006163),-0.25436941862745815,-0.8531099666227687,0.7447698744769874,0.9854838790291368,1.0,11/24,24.88%,FHIT;GDA;PNP;PRPSAP1;ITPA;NT5E;GPX1;GUK1;PPAT;PRPS1;PRPS1L1
prerank,regulation of protein metabolic process (GO:0051246),0.30812321770870826,0.8531008910468441,0.6754890678941312,0.9545322060615509,1.0,11/44,21.46%,CHEK2;HSP90AB1;TMEM9;APP;TRAF3;APOE;HGS;LDLR;SPOP;PLAUR;VPS35
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.278927392481158,0.8524237248290387,0.7386722866174921,0.9553135719273066,1.0,30/105,24.10%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD9;PSMD8;TAB3;TYROBP;PSMF1;PSMB6;PSMD12;PRKCD;PSMC2;PSMD4;PDPK1;PSMA2;RAF1
prerank,ATP transport (GO:0015867),-0.3450330359602303,-0.8519941334534163,0.6422018348623854,0.9861113443516945,1.0,4/10,19.05%,SLC25A4;SLC17A9;SLC25A5;SLC25A42
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.27195245530330847,-0.851866505148409,0.6919831223628692,0.9846177317088537,1.0,7/22,16.55%,CDK13;CCNT1;THOC5;BRD4;HMGN1;THOC1;ELL
prerank,cardiac cell development (GO:0055006),0.3884784541517151,0.8518349838153875,0.6507462686567164,0.9559361046621123,1.0,1/11,3.73%,SLC8A1
prerank,cellular response to organonitrogen compound (GO:0071417),0.28144763092364233,0.851810387749224,0.7360672975814931,0.9555447790358804,1.0,25/99,22.26%,TRPM2;LARP1;CRHBP;RRAGC;SOX9;CTNNB1;PDXP;RAPGEF2;P2RX4;ZFP36L1;GLRA2;XBP1;AKAP9;LAMTOR3;RAPGEF1;ACTB;INPP5K;MTOR;PDE3A;LAMTOR4;GLRA1;HCN2;GABRB2;RRAGA;HSP90B1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.30222193981422085,0.8515339913179377,0.7042577675489068,0.9556016831826651,1.0,5/50,9.90%,NOL3;CDKN2D;IGBP1;MT3;DNAJB6
prerank,potassium ion homeostasis (GO:0055075),0.34393653402011,0.8512747454269745,0.6751269035532995,0.95562788571202,1.0,4/23,8.79%,ATP1B3;SLC12A5;TFAP2B;SLC12A8
prerank,negative regulation of cell adhesion (GO:0007162),0.28910961677982927,0.8512037018773165,0.7019650655021834,0.9553156899621545,1.0,8/72,6.89%,PLXNA3;PLXNB2;SEMA4D;CDH13;PLXNB3;CX3CL1;PODXL;SNAI2
prerank,regulation of protein dephosphorylation (GO:0035304),0.3109816329356434,0.8511909407700188,0.6852731591448931,0.9549012509988387,1.0,16/37,24.80%,ARPP19;ANKLE2;PPIA;PPP6R3;SPPL3;CALM3;PPP1R7;MFHAS1;TSC1;PIN1;PPP2R5A;PRKCD;HSP90B1;ENSA;CALM2;TIPRL
prerank,cellular response to lectin (GO:1990858),0.2789425902430714,0.8511568203024886,0.7378435517970402,0.9540809395114143,1.0,30/104,24.10%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD9;PSMD8;TAB3;TYROBP;PSMF1;PSMB6;PSMD12;PRKCD;PSMC2;PSMD4;PDPK1;PSMA2;RAF1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2789425902430714,0.8511568203024886,0.7378435517970402,0.9540809395114143,1.0,30/104,24.10%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD9;PSMD8;TAB3;TYROBP;PSMF1;PSMB6;PSMD12;PRKCD;PSMC2;PSMD4;PDPK1;PSMA2;RAF1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.27893410590330125,0.8511432736070297,0.7377220480668757,0.9536625498717173,1.0,18/102,15.07%,TRIB3;IRS1;RAB8B;CRHBP;ADCY5;RAB12;NFKB1;USF1;LPIN2;PRKAR2B;INSR;ZFP36L1;XBP1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.26972846592512434,-0.8506972684021011,0.7028301886792453,0.9854810885289964,1.0,10/21,31.54%,MAD1L1;TEX14;APC;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.34330293642625426,0.8506228021448665,0.656498673740053,0.9541475712663425,1.0,3/21,7.49%,ADCY5;ADCY10;NPPC
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.35240765623338527,0.8504431997588993,0.6752717391304348,0.9536116942905895,1.0,4/20,12.23%,ENTPD5;APP;INSR;PSEN1
prerank,positive regulation of glycolytic process (GO:0045821),0.35240765623338527,0.8504431997588993,0.6752717391304348,0.9536116942905895,1.0,4/20,12.23%,ENTPD5;APP;INSR;PSEN1
prerank,neuronal action potential (GO:0019228),0.33735551329833796,0.849910646596147,0.6714471968709257,0.9541150280693176,1.0,1/22,0.74%,KCNMB3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.27602094743007555,0.8498609905020893,0.7463312368972747,0.9537646117023173,1.0,37/109,25.95%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD9;PSMD8;TAB3;PSMF1;PSMB6;PSMD12;PSMC2;MAPK9;PSMD4;PDPK1;PSMA2;MAP2K4;PIK3CA;GAB2;SHC1;PSMD1;PSMD11
prerank,C4-dicarboxylate transport (GO:0015740),0.37373143761224303,0.849497767640387,0.6841359773371105,0.9539901977277179,1.0,3/14,14.86%,SLC25A22;SLC25A10;SLC25A12
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3265557423374497,-0.8487691840862592,0.6254180602006689,0.9880435345125149,1.0,5/11,31.49%,KIFC3;VCL;JUP;CCN3;CAMSAP3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3698588635588289,0.848272286687417,0.6587078651685393,0.955831907269834,1.0,2/15,4.89%,CHEK2;TIPIN
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.35683197017564205,0.84826482892576,0.6577540106951871,0.955406867303823,1.0,7/18,22.74%,VPS11;CTSC;DACT1;APOE;HSP90AA1;VPS35;MSN
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3579911578005478,0.8480859628631225,0.6666666666666666,0.9553019576518956,1.0,3/17,10.07%,CCND2;CCND1;PROX1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2771085830461303,0.8479109600702055,0.7556701030927835,0.9551823870720951,1.0,27/110,19.08%,HELZ2;RPL36;MAGOHB;SMG7;NCBP2;GSPT1;RPL22;RPS21;RNPS1;SMG5;UPF2;UPF3A;RPS6;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;UPF1;PPP2R2A;RPL10A;RPS15A;RPL24;RPL37A;RPL3
prerank,positive regulation of RNA splicing (GO:0033120),0.3251835642786092,0.8478815874398268,0.67625,0.9548015625779525,1.0,7/29,15.80%,SLC38A2;RBMX;SNW1;DAZAP1;RBM3;NCBP1;SF3B4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.31639106255719535,0.8471813672669252,0.6929510155316607,0.9556167276409967,1.0,8/38,12.73%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.38607798987230085,0.8468785243019422,0.6695652173913044,0.9557223791681485,1.0,3/12,14.55%,GALT;GFPT1;SLC35A3
prerank,translational elongation (GO:0006414),0.2754508468700507,0.84673441884732,0.7292759706190975,0.9555264213720027,1.0,23/101,19.26%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;RACK1;MRPS22;MRPS23;MRPS2;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,regulation of protein polymerization (GO:0032271),-0.2343304953092998,-0.8467342506202097,0.7341040462427746,0.9909048864791691,1.0,7/35,11.62%,FCHSD2;PRUNE1;TPPP;COTL1;TTBK1;ARL2;PLEKHG2
prerank,aerobic respiration (GO:0009060),0.3484793959643477,0.8464005845022404,0.6781609195402298,0.9557065556044135,1.0,5/20,21.21%,MTFR2;UQCR10;NDUFS8;NDUFS7;SDHB
prerank,cellular response to cAMP (GO:0071320),0.32577243242422443,0.8460364113597701,0.702801461632156,0.9559265359354361,1.0,6/30,15.07%,CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K
prerank,phasic smooth muscle contraction (GO:0014821),0.4029206647515905,0.8458957275606817,0.6551204819277109,0.9557574162103213,1.0,2/10,8.82%,PTGER3;GDNF
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.34579433555336747,0.8455463557287409,0.6832694763729247,0.9559679819008116,1.0,3/23,5.15%,AUP1;TMEM129;SEC16A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3879756527267661,0.8455155628470556,0.6617210682492581,0.9555858972662892,1.0,3/11,14.01%,BCAR1;NRP1;RAC1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.28132619280708654,-0.8452324647931961,0.6941176470588235,0.9925321857425774,1.0,3/20,7.14%,TGFB1;NIBAN2;TRAF6
prerank,atrial septum development (GO:0003283),0.3766552221217083,0.8449427554784712,0.6849507735583685,0.9561695634644388,1.0,2/13,9.69%,NPHP3;BMPR2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.23927577211845702,-0.8446797395036044,0.7759562841530054,0.9920342077650977,1.0,12/29,28.70%,SSH2;CORO1A;FKBP4;SHANK3;SMAD4;SSH1;CLASP1;SHANK1;KANK3;TJP1;KANK4;PRKN
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3176606493431029,0.8444953909542526,0.6866746698679472,0.9565636495193185,1.0,8/35,16.95%,DAPK3;TRPM2;HCK;STAP1;NRP1;BAIAP2;BAIAP2L1;MDK
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3815379993806157,0.8444869346165781,0.6666666666666666,0.9561400807506995,1.0,6/13,30.06%,ALG13;ALG11;DPAGT1;ALG12;ALG9;ALG14
prerank,cilium assembly (GO:0060271),0.266316717060674,0.8442437068417504,0.845691382765531,0.9561473642096717,1.0,60/296,18.46%,CNGB1;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;KIF3C;ACTR2;CEP162;DYNC1H1;CCDC40;RILP;SNX10;RILPL1;TTC39C;ACTR3;ACTR1A;NPHP3;KIF3B;TMEM80;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;SPATA6;CFAP54;FNBP1L;WDR35;IFT27;NEDD1;CEP152;CEP131;TMEM138;EXOC6;CEP70;GSN;DYNC2LI1;AKAP9;DYNLT2B;TUBB4B;DYNLL1;E2F4;DZIP1;TMEM67;PIBF1;HSP90AA1;CFAP20;CCDC66;BBS2;ARF4;RAB11A;CEP89;DYNC2H1;WDR19;OCRL;DCDC2;DCTN3;GBF1;PAFAH1B1;IFT46
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3014952852277839,0.8442330628647096,0.6971098265895954,0.9557234566993396,1.0,6/46,9.85%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,regulation of lamellipodium assembly (GO:0010591),0.3108788265658619,0.8433577678632261,0.6833333333333333,0.9568631241894665,1.0,14/34,28.71%,ACTR2;PLXNB3;CYFIP1;ACTR3;CAPZB;RAC1;PLCE1;NCKAP1;BRK1;TWF1;PIK3CA;FER;SLIT2;PIK3R1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.39359131451075624,0.8433402764252004,0.665158371040724,0.9564626248357634,1.0,3/10,14.38%,STAT3;LYN;JAK2
prerank,embryonic digit morphogenesis (GO:0042733),-0.27284898860786944,-0.8431012758615314,0.7061224489795919,0.9937437108452865,1.0,3/18,14.09%,MAP3K20;SALL1;INTU
prerank,regulation of stress fiber assembly (GO:0051492),0.2827472517291259,0.843094526495059,0.7132116004296455,0.9564509864578067,1.0,14/74,15.07%,WNT11;CD47;PTGER4;EVL;CARMIL1;MYOC;CCDC88A;MET;PPM1F;ARHGEF10;NRP1;RAC1;ASAP3;INPP5K
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.38800910684123385,0.8425793984845812,0.6732673267326733,0.9569283008055459,1.0,4/11,24.16%,LYN;ACOD1;MFHAS1;CYBA
prerank,positive regulation of potassium ion transport (GO:0043268),0.30809901250731264,0.8425163625461234,0.6830143540669856,0.9566046679106555,1.0,5/38,16.85%,KCNMB3;ACTN2;GABBR2;DLG1;KCNJ2
prerank,retrograde axonal transport (GO:0008090),-0.2957508460534769,-0.8424265179304093,0.6541095890410958,0.9935297761546021,1.0,3/16,9.09%,DST;MAP1A;FBXW11
prerank,regulation of BMP signaling pathway (GO:0030510),0.28283445116615463,0.8423849055075397,0.7425742574257426,0.956400598179381,1.0,20/73,23.39%,LRP2;ITGA3;TFAP2B;SMAD2;BAMBI;BMPER;BMPR2;SORL1;SKIL;ZNF423;SMURF1;BMPR1A;HTRA3;RBPJ;ACVR2A;NUMA1;ACVRL1;SMURF2;NOTCH1;XIAP
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3450000095237771,0.8423099325418131,0.6622162883845126,0.9561049062587913,1.0,4/21,15.74%,SPRY2;ARHGAP25;LZTR1;SH3BP1
prerank,synaptic vesicle transport (GO:0048489),0.37995637559321005,0.8422534615619997,0.658465991316932,0.9557592633497317,1.0,2/11,10.72%,SYNJ1;DNM2
prerank,striated muscle cell development (GO:0055002),-0.3037092046288011,-0.8416766440965031,0.673469387755102,0.9934495914232716,1.0,10/14,47.83%,CAPN3;PGM5;TMOD1;KLHL41;SDC1;LMOD3;TMOD2;LMOD1;MYH6;TMOD4
prerank,response to metal ion (GO:0010038),0.28787162604664784,0.8414933099041324,0.7400442477876106,0.9566643103856979,1.0,10/67,15.26%,LOXL2;FXN;SLC30A5;MT3;SLC11A2;AHCYL1;TFR2;SLC25A12;PAM;CALM3
prerank,triglyceride metabolic process (GO:0006641),-0.2128972855173606,-0.8413209671028705,0.7769784172661871,0.9924674616971892,1.0,13/48,22.79%,PLAAT3;MOGAT3;LIPH;DGAT1;SIRT1;SEL1L;GPAM;LPL;GK5;FABP4;CAV1;GPAT4;GPAT3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.30793499421595,0.8411759656642183,0.7009569377990431,0.9567976677691684,1.0,6/35,8.68%,POLD4;POLB;RFC4;RFC1;FEN1;MPG
prerank,negative regulation of axonogenesis (GO:0050771),0.3276815046888113,0.8408253252114694,0.6833333333333333,0.9569714812279553,1.0,5/27,13.09%,THY1;RUFY3;MT3;MAG;FGF13
prerank,cellular response to estrogen stimulus (GO:0071391),0.3759604535184389,0.8405538861464652,0.6838340486409156,0.9570120667335711,1.0,2/14,5.46%,CRHBP;SRA1
prerank,potassium ion transmembrane transport (GO:0071805),-0.17965461015538986,-0.8404242688777727,0.7692307692307693,0.9927099781068148,1.0,52/135,36.51%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;KCNC2;KCNH1;ATP1B2;KCNJ10;NALCN;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNK12;PKD2L1;KCNA2;KCNC3;KCNG2;SLC12A9;KCNC1;SLC9A8;KCNT2;KCNAB1;KCNJ6;KCNK9;KCNJ13;KCNB2;HCN3;KCNH5;KCNK5;ABCC8;KCNC4;KCNH2;SLC12A1;KCNQ4;ATP1A1;ATP1A3;FXYD2;KCNJ12;HCN4;LRRC55;KCNJ16;KCNK4;KCNH4;KCNN1;KCNK13;KCNQ1;KCNIP2;KCNK7;KCNG1;SLC9A4
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.23229207362810111,-0.8399926291352872,0.7792207792207793,0.9919221680800788,1.0,8/37,11.84%,DLG4;ITGAV;PINK1;EDNRB;ANKRD13A;ABCA2;SIRT5;BRCA1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22716194029960163,-0.8397990850505583,0.7887323943661971,0.9905502462093828,1.0,8/42,9.42%,ST3GAL5;GM2A;CTSA;ASAH1;SMPD3;ABCA2;ST8SIA5;GALC
prerank,cellular response to oxygen levels (GO:0071453),0.402338314454813,0.8397739952834793,0.6536144578313253,0.9579303861672732,1.0,1/10,2.09%,ATP6V0D1
prerank,actin cytoskeleton reorganization (GO:0031532),0.28985813506376223,0.8394186752428846,0.7527593818984547,0.9580984397264112,1.0,14/63,14.59%,S1PR2;PARVB;SYDE1;PIP5K1A;BCAR1;MKLN1;TNIK;GSN;ANTXR1;TRPV4;SIPA1L1;NRP1;WHAMM;MINK1
prerank,mitotic nuclear division (GO:0140014),0.28690248951308006,0.8392407965390881,0.7301075268817204,0.9579882758561803,1.0,14/71,16.29%,CHMP4B;CHEK2;KPNB1;WRAP73;KIF3B;STAG1;TOGARAM2;NCAPG2;ARHGEF10;CCDC61;PIBF1;MIS12;KIF2A;RAB11A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2678277077640238,0.8392217910148421,0.797752808988764,0.9575916304930497,1.0,41/152,23.89%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;ZRANB1;PSMA4;TLR2;PSMD7;PSMD9;PSMD8;PIN1;PSMF1;SPIN1;DDX3X;PSMB6;USP8;PSMD12;PSMC2;SMURF2;PSMD4;GPRC5B;XIAP;PSMA2;VCP;AXIN1;CAPRIN2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2430609118611574,-0.8388914813435367,0.7688679245283019,0.9908216108631226,1.0,6/28,9.52%,PRUNE1;MAP1A;FKBP4;SKA2;CLASP2;ARL2
prerank,positive regulation of chromatin organization (GO:1905269),0.3742392668264538,0.8388797863786082,0.6546463245492372,0.9577764323452926,1.0,3/12,18.77%,DAXX;MIER1;TERF2
prerank,positive regulation of sodium ion transport (GO:0010765),0.37840913462944165,0.8386352460211792,0.6909620991253644,0.9578024535179209,1.0,5/12,27.01%,CNKSR3;AHCYL1;SCN1B;WNK3;SCN4B
prerank,cellular metal ion homeostasis (GO:0006875),0.2757246621639216,0.8382733190944806,0.7505175983436853,0.9580010747098543,1.0,15/102,16.85%,CCL7;CD40;ATP1B3;SLC8A1;CCL5;SLC30A1;CHERP;MT3;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3;KCNJ2
prerank,protein hydroxylation (GO:0018126),-0.29903028715755486,-0.8381276857114742,0.6528301886792452,0.9908395787007579,1.0,5/15,8.02%,P3H2;P3H3;PLOD1;PLOD2;HIF1AN
prerank,microtubule anchoring at centrosome (GO:0034454),-0.33032600740559115,-0.838086249874549,0.6758409785932722,0.9891486820260132,1.0,3/10,5.28%,NINL;KIF3A;PCM1
prerank,regulation of protein targeting to membrane (GO:0090313),0.31790190214973885,0.8380521396392132,0.6720098643649816,0.9579584064247587,1.0,6/28,15.07%,FIS1;MYO1C;PRNP;CIB1;FYN;INPP5K
prerank,regulation of gastrulation (GO:0010470),0.3729024528965437,0.8380427567528841,0.6590584878744651,0.9575404335921539,1.0,3/14,12.99%,SCX;PHLDB1;RACK1
prerank,lipid phosphorylation (GO:0046834),-0.33238405543248595,-0.8380080882309436,0.6656891495601173,0.9875417608693156,1.0,4/10,12.24%,DGKH;DGKZ;DGKD;DGKE
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3637492761462397,0.8379891578675819,0.6717032967032966,0.9571990533477903,1.0,1/14,1.59%,SPRY2
prerank,blood vessel endothelial cell migration (GO:0043534),0.3369724424525102,0.8378656336714461,0.6751918158567775,0.9569890292238494,1.0,5/22,22.01%,KDR;SRF;NRP1;MYH9;FGF2
prerank,regulation of interleukin-2 production (GO:0032663),-0.2238384365436934,-0.8377403989480798,0.8333333333333334,0.9864710071931243,1.0,20/43,28.43%,CARD11;TRAF2;PNP;HOMER3;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;TNFAIP3;IL1B;CD80;IL1A;RPS3;VSIG4;HDAC7;CD34;PDE4D
prerank,regulation of DNA replication (GO:0006275),-0.21538397645558513,-0.8376330298043566,0.8362068965517241,0.9849416385126153,1.0,12/49,17.49%,WAPL;FAF1;EGFR;PPP2R1A;ESCO1;SMC3;CDAN1;DNA2;RAD17;S100A11;TERF1;TSPYL2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.38414700080176645,0.8374200748606305,0.6671490593342981,0.9573833711433147,1.0,3/12,10.66%,CCT4;CCT7;CCT3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.3559225230686104,0.8367517598013863,0.6770538243626062,0.9581366175958205,1.0,6/16,23.31%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,protein localization to plasma membrane (GO:0072659),0.26832571463053884,0.8359165417753023,0.7847579814624099,0.9591396014641511,1.0,40/129,25.84%,PIGW;RAB8B;ATP1B3;ACTN2;RAB12;SEC16A;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;EPB41L3;CCDC88A;TNIK;EFR3A;NECTIN3;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;FLOT2;ASB3;RAP2A;GORASP2;ZDHHC3;ZFYVE27;RAB10;ZDHHC22;C2CD5;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2693608394491046,0.8357450892500825,0.7769709543568465,0.9590060276026819,1.0,25/124,16.67%,BLOC1S4;PPP1R9A;CYFIP1;CARMIL1;TBC1D23;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;HMGB1;APP;STMN3;PLEKHA1;APOE;RB1;CORO1B;RAC1;MAP4;LRP12;PRMT1;RAB11A;OPHN1;STMN2
prerank,positive regulation of nuclear division (GO:0051785),0.3327187565295202,0.835527350625367,0.7006369426751592,0.9589490344883772,1.0,3/25,10.17%,TGFA;INSR;PHIP
prerank,negative regulation of RNA splicing (GO:0033119),-0.2743240702894288,-0.8355240691941834,0.7198443579766537,0.9880126021421981,1.0,8/19,21.03%,TMBIM6;RPS26;SRSF6;SFSWAP;C1QBP;PTBP3;PTBP1;U2AF2
prerank,positive regulation of ion transport (GO:0043270),0.29570993625231484,0.8352840160920464,0.7077100115074798,0.9589386717492325,1.0,10/48,16.23%,ACTN2;CCL5;CNKSR3;GDNF;P2RX4;CRACR2A;AHCYL1;DLG1;CHRNB2;SCN1B
prerank,response to nutrient levels (GO:0031667),0.3484154876557509,0.8351519739957551,0.6864064602960969,0.9587316902183785,1.0,7/17,33.70%,MTOR;CD68;KCNB1;RPS6KB1;ATF4;EIF4G1;PRKAA1
prerank,negative regulation of transmembrane transport (GO:0034763),0.3950111177491966,0.8346410089396247,0.674591381872214,0.9591935814031798,1.0,3/10,15.07%,RSC1A1;IRS2;INPP5K
prerank,transition metal ion homeostasis (GO:0055076),0.3262289645814804,0.8344080474818236,0.6900369003690037,0.959165509627227,1.0,9/28,24.97%,B2M;MT3;TFR2;HMOX2;FBXL5;ABCB7;XIAP;CP;COMMD1
prerank,renal water homeostasis (GO:0003091),0.332108157358334,0.8343183482310041,0.6807387862796834,0.9588833205064816,1.0,6/23,16.81%,ADCY5;TFAP2B;AQP4;PRKAR2B;RAB11A;PRKAR2A
prerank,cilium-dependent cell motility (GO:0060285),-0.2607944393712545,-0.8341297204930546,0.7031963470319634,0.9894194751951051,1.0,16/22,41.82%,CCDC39;CFAP44;DNAH8;EFHC1;DNAH2;DNAI3;RSPH9;RFX3;DNAH3;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,regulation of centriole replication (GO:0046599),0.35315703651641334,0.8341056142055222,0.6846473029045643,0.9588454872013719,1.0,4/17,14.29%,RBM14;CDK5RAP2;NPM1;CEP295
prerank,negative regulation of stem cell differentiation (GO:2000737),0.377201969976441,0.8340089110715395,0.6711509715994021,0.9585754221415269,1.0,2/12,8.46%,ESRRB;YTHDF2
prerank,smooth muscle cell differentiation (GO:0051145),-0.31038651143608,-0.8334579170783721,0.6873065015479877,0.989197427719907,1.0,8/12,37.69%,EDNRB;MRTFB;TMEM204;MEF2C;BMP4;HEY1;HEY2;APLNR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.23366605500363746,-0.8328318841643841,0.7688172043010753,0.988865756765836,1.0,8/31,16.10%,LRRC7;DLG3;CDC42;MTCL1;PRKCI;RHOA;SCRIB;PDZD11
prerank,cellular response to ketone (GO:1901655),0.31236365030408986,0.8327496723476825,0.699642431466031,0.9602949746717707,1.0,15/35,28.80%,PTGER4;LARP1;ADCY5;SPHK2;NR3C1;ACOD1;DCPS;MSN;ADAM15;NDOR1;CFTR;NCOA4;ADCY6;KLF9;GNB1
prerank,insulin receptor signaling pathway (GO:0008286),0.28453981974195947,0.8321586457388837,0.7544642857142857,0.9608207038464509,1.0,14/69,17.83%,NAMPT;IRS1;ATP6V0D1;ZNF106;GRB10;BCAR1;INSR;PHIP;SOS1;IRS2;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28827258015748974,0.8319976736744413,0.7409502262443439,0.9606847828311215,1.0,23/58,28.20%,POLM;POLB;HERC2;ERCC4;HMGB1;BARD1;POLQ;PRKDC;PAXIP1;NSMCE2;DCLRE1A;NHEJ1;BABAM2;UVRAG;DCLRE1C;SUMO1;LIG3;KAT5;NSD2;PIAS4;PRPF19;UBE2N;BABAM1
prerank,regulation of insulin secretion (GO:0050796),0.2752114829799588,0.8318757955604108,0.7758081334723671,0.9604738020160424,1.0,10/101,8.39%,PER2;IRS1;ADCY5;CCL5;ITPR1;TCF7L2;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.29909448799662985,0.831513132474001,0.7204678362573099,0.9606761005715909,1.0,9/45,20.21%,GDF9;ACVR1;CSNK2B;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;ACVRL1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.2515485925919057,-0.8313862179307706,0.7242990654205608,0.9902007022923012,1.0,11/25,27.26%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2;GRID2
prerank,positive regulation of cytokinesis (GO:0032467),-0.24047558432994237,-0.831258832395407,0.7696629213483146,0.9887175956628157,1.0,9/32,18.58%,CENPV;CDC42;CIT;KIF20B;RACGAP1;RHOA;KIF23;CSPP1;ECT2
prerank,innate immune response in mucosa (GO:0002227),-0.3348998553930964,-0.8310873914621618,0.668769716088328,0.9873756770877488,1.0,2/10,15.74%,RPL39;DEFA6
prerank,histone H4-K16 acetylation (GO:0043984),0.34761363868708545,0.8307758940002301,0.6868421052631579,0.9615088189364716,1.0,5/19,19.75%,JADE3;KMT2A;WDR5;KAT8;KAT7
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.25365543722417205,-0.8307086356006688,0.7584541062801933,0.9864770002199116,1.0,12/25,27.12%,CDK13;EAF2;LARP7;NELFB;BRD4;EAF1;ELL;NELFE;HEXIM1;NELFA;SUPT4H1;RNF168
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2443713901171798,-0.8306296768816845,0.7685185185185185,0.9849213489370445,1.0,12/30,20.62%,POLR1A;ERCC3;TBP;TTF1;ERCC2;TAF1D;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3;GTF2H4
prerank,Golgi to lysosome transport (GO:0090160),0.38667230755974363,0.8305027428845019,0.6621823617339312,0.9615445746842093,1.0,4/11,25.16%,ANKFY1;LAMP1;RBSN;CCDC91
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3435271783428007,0.8302555610830058,0.685823754789272,0.9615200809580867,1.0,4/20,18.54%,ZDHHC21;RAPGEF2;AKAP13;LMBRD2
prerank,rRNA metabolic process (GO:0016072),0.26603190529455456,0.8301339796897855,0.8163265306122449,0.961306503483675,1.0,48/160,23.38%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;XRN1;LAS1L;NOLC1;DDX54;RPS6;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;PELP1;RRP1B;RRP1;WDR12;RPL24;UTP3;RPL37A;RPL3;ESF1;TRIR;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6;NOL6;UTP14A;RRP36
prerank,anion transport (GO:0006820),0.3067859059465412,0.8293539087123585,0.715698393077874,0.9622416106642071,1.0,10/33,27.40%,SLC19A1;SLCO1B1;TSPO;SLC13A4;SLC4A2;ABCG2;VDAC2;SLC26A7;SLC17A5;LRRC8B
prerank,T cell differentiation (GO:0030217),0.301145223915284,0.8292235729839321,0.7365911799761621,0.962042262316896,1.0,11/40,23.59%,PIK3CD;CHD7;LEPR;ZFP36L1;LMBR1L;NHEJ1;PTPRC;LCK;RHOH;GLI3;ZFP36L2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.27006771773086524,-0.8288292313542462,0.7372262773722628,0.9871497987248202,1.0,6/18,22.73%,LTBP1;ITGAV;TGFB2;SMAD4;HIF1A;CD200
prerank,protein localization to lysosome (GO:0061462),0.3218772359332688,0.8287930046212125,0.6923076923076923,0.9623580611295603,1.0,11/28,26.95%,KPTN;GGA3;NAGPA;SORL1;HGS;LAMTOR4;M6PR;SZT2;GLMP;NCOA4;LMBRD1
prerank,histone H4-K8 acetylation (GO:0043982),0.3629970699995411,0.8286620227099879,0.691156462585034,0.9617079192943514,1.0,5/15,24.05%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),0.3629970699995411,0.8286620227099879,0.691156462585034,0.9617079192943514,1.0,5/15,24.05%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3732741755760979,0.8284882830085983,0.6963276836158192,0.9615597874265899,1.0,4/12,19.60%,KPNB1;CLCN2;SREBF1;SEC14L2
prerank,steroid catabolic process (GO:0006706),0.3937180483794667,0.8283956127622666,0.6702619414483821,0.9612931269662318,1.0,1/10,8.34%,HSD11B1
prerank,RNA 3'-end processing (GO:0031123),0.2817810151927949,0.8278771007085056,0.7595628415300546,0.9617849005815012,1.0,22/69,23.86%,TENT4A;PNPT1;MAGOHB;NCBP2;WDR33;RNPS1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;TUT7;SRSF4;SLU7;THOC7;SRSF5;MTPAP;SRSF2;MAGOH;RPRD2
prerank,spliceosomal snRNP assembly (GO:0000387),0.3074770599910947,0.8277369566386493,0.7332549941245593,0.9615926423704971,1.0,14/38,23.52%,DDX20;TGS1;SNRPD2;SNRPD1;SART1;GEMIN7;CLNS1A;SNRPG;GEMIN2;SNUPN;SRSF10;SART3;SNRPD3;LSM4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.33955852706554873,0.8277054321669524,0.6970509383378016,0.9612172128372659,1.0,8/21,25.90%,FIS1;MCUR1;MICU2;BCAP31;TGM2;SMDT1;MICU3;SLC25A23
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3805654008529779,0.8274173598814794,0.6917613636363636,0.9612940133335101,1.0,3/11,19.98%,STAP1;STX4;TYROBP
prerank,response to glucagon (GO:0033762),-0.2640442662940893,-0.8270813378948749,0.7547169811320755,0.9892977641224202,1.0,5/19,16.20%,ADCY9;ADCY3;PRKACB;CRY1;CREB1
prerank,adherens junction organization (GO:0034332),0.29357601320749627,0.8268483923506591,0.7298850574712644,0.9618215454459164,1.0,11/48,18.13%,CDH13;NECTIN4;CTNNB1;CDH9;NECTIN3;PIP5K1C;ACTB;TBCD;JAM3;CSK;CADM2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.35829798685363823,0.8267927678327595,0.7018284106891702,0.9614898340756669,1.0,4/14,15.36%,ABCG1;PSEN1;APH1A;APH1B
prerank,secretion (GO:0046903),-0.300706480027969,-0.8263960792402595,0.6711409395973155,0.9890742260151787,1.0,10/14,49.35%,RIMS1;PRKCI;GUCA1B;NPR1;FBLN5;DRD3;VIP;ABCB11;SLC22A2;SLC22A6
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2707769216694058,-0.8259204779269712,0.6974789915966386,0.9882528630454402,1.0,6/18,13.25%,CCT8;CCT5;CORO2B;CEP120;WRAP53;TREM2
prerank,brain morphogenesis (GO:0048854),0.37270282082299283,0.825628144440521,0.6721311475409836,0.963073839358431,1.0,5/12,26.55%,VPS51;BBS2;PAFAH1B1;BBS4;PTEN
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3573923995924138,0.8252948806519622,0.7056396148555708,0.96323623581011,1.0,7/17,25.55%,AUP1;TMEM129;FAF2;HM13;HSP90B1;VCP;DERL2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.2826348829681786,-0.8251981235512427,0.7191489361702128,0.9880852997803818,1.0,10/17,37.60%,ATP1B1;ATP1B2;FKBP1B;GJC1;GJD3;ATP1A1;ATP1A3;RYR2;ATP1A2;CACNA1C
prerank,chondrocyte differentiation (GO:0002062),0.31083685294968827,0.82445040124215,0.7021276595744681,0.9642302474107542,1.0,9/32,18.89%,RUNX1;SOX9;SNX19;NFIB;SCX;BMPR2;SOX5;FGFR3;CREB3L2
prerank,DNA strand elongation (GO:0022616),0.34715797613335025,0.8244015228143399,0.6980874316939891,0.9638931511486734,1.0,6/18,20.48%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3
prerank,mitotic cytokinesis (GO:0000281),0.29195926030185093,0.8241729577803103,0.735981308411215,0.9638682656616875,1.0,5/47,10.38%,CHMP4B;SNX33;CUL7;EFHC2;SNX9
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34134755924925236,0.8235010975724739,0.714663143989432,0.9645956644937903,1.0,11/20,31.72%,MT3;XBP1;CARF;RBPJ;NOTCH1;SMAD1;EP300;CHD6;ATF4;RELA;SESN2
prerank,histone lysine demethylation (GO:0070076),0.3229484189579431,0.8234496736416252,0.7155727155727156,0.9642530676721254,1.0,6/25,16.02%,KDM4D;HR;KDM3B;RIOX2;KDM8;KDM7A
prerank,negative regulation of signaling (GO:0023057),0.32046074703701877,0.8232610420856983,0.7159090909090909,0.964160861488626,1.0,3/25,8.73%,ACVR1;KIF26A;SOCS5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2874544960585108,0.8231269942184855,0.7550335570469798,0.9639815571324593,1.0,16/57,23.38%,LTV1;MRPL36;PAK1IP1;RRS1;TGS1;NPM1;RPS6;NOP16;RPL11;DHX37;WDR12;EMG1;URB2;RPL5;LTO1;RRP36
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.36551444541150024,0.8226762906848816,0.695898161244696,0.964292359650745,1.0,1/13,3.68%,ADAM8
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.32424579864871866,0.8221154262428139,0.704225352112676,0.9648259760888839,1.0,8/24,24.76%,ACTR2;CYFIP1;ACTR3;RAC1;PLCE1;NCKAP1;BRK1;PIK3CA
prerank,triglyceride biosynthetic process (GO:0019432),-0.2752020763295681,-0.8220775128530303,0.7224489795918367,0.9930773347638837,1.0,7/18,26.08%,MOGAT3;DGAT1;GPAM;PCK2;GPAT4;GPAT3;DGAT2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3624543974632605,0.8219311439239851,0.6974431818181818,0.9647123576238941,1.0,4/14,14.38%,STAT3;LYN;SOCS2;JAK2
prerank,modulation by host of viral genome replication (GO:0044827),0.3685748070902327,0.8217390488994941,0.6902017291066282,0.9646023919018473,1.0,4/13,25.66%,ZC3H12A;CCNK;TBC1D20;PPIB
prerank,regulation of mononuclear cell migration (GO:0071675),0.3330387723739535,0.821523143944756,0.7091836734693877,0.9645630895473045,1.0,6/23,16.95%,CCL5;CSF1;LYN;CXCL17;AIF1;MDK
prerank,keratan sulfate metabolic process (GO:0042339),0.31460431244726705,0.8214061942630156,0.7292954264524104,0.9643193156369215,1.0,11/31,23.91%,FMOD;B4GALT1;B4GALT4;B4GALT5;ST3GAL1;B4GALT2;CHST2;GLB1;OGN;GALNS;GNS
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2795166218175916,0.820953668318428,0.7660044150110376,0.9646628433602396,1.0,14/69,17.97%,IRS1;PLCB4;PIK3CD;LTK;PLCB3;PI4KB;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;IRS2;NYAP2;PLCE1;NF1
prerank,membrane lipid biosynthetic process (GO:0046467),0.2845081784058709,0.8208644005751944,0.7632468996617813,0.9643651678508449,1.0,16/58,22.55%,SGPP2;GBGT1;CERS6;DEGS1;VAPB;SCCPDH;SPHK2;HACD3;ACER3;SGPL1;SPTLC2;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,protein localization to kinetochore (GO:0034501),-0.2943036549699337,-0.8205556083969952,0.6844106463878327,0.9944739751729731,1.0,8/14,31.54%,RCC2;MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,defense response to tumor cell (GO:0002357),-0.3215372056282074,-0.8203587583928131,0.6548672566371682,0.99317612805403,1.0,4/10,16.39%,DAPK1;RBMS3;ABI3;KLF4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2840547997093551,0.8201094825208405,0.7334851936218679,0.9652448764126637,1.0,11/51,18.22%,LRP2;FBN1;BAMBI;BMPER;BMPR2;SORL1;SKIL;SMURF1;BMPR1A;HTRA3;ACVR2A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2740548387673187,0.8198948310949956,0.77491961414791,0.9651774786633363,1.0,30/86,27.02%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;CHEK1;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;PSMD7;PSMD9;PSMD8;PSMF1;PSMB6;PSMD12;PSMC2;PSMD4;LIMD1;PSMA2;CUL2;EPAS1;PSMD1;PSMD11;HIGD1A;EP300
prerank,neural crest cell migration (GO:0001755),0.309185793131591,0.819793936265478,0.7336504161712247,0.9649193647968473,1.0,7/36,18.17%,PITX2;SEMA4D;GDNF;NRP1;PHACTR4;SEMA3D;CORO1C
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.28956670846512783,0.8195999204569265,0.7631578947368421,0.9648300482981959,1.0,14/52,19.03%,ZFP36;CNOT4;CNOT7;TNKS1BP1;DCP2;EXOSC9;PATL2;NT5C3B;TUT7;HBS1L;DCPS;LSM5;PAN3;RC3H2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.2904108215352219,0.8195625861719218,0.7419354838709677,0.9644683881690113,1.0,5/47,10.62%,AGT;XDH;DHRS4;MAPK14;ZC3H12A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.28478322341727447,0.81952748174553,0.7685393258426966,0.9641101414490306,1.0,14/60,18.94%,HSP90AB1;POLG2;RFC4;CTNNB1;CCT4;CCT7;SMOC2;CCT3;HNRNPA1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,cellular response to ATP (GO:0071318),0.36556391405343747,0.8194410734642378,0.6888567293777135,0.963830418849235,1.0,2/14,9.00%,PDXP;P2RX4
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.29908881541051796,-0.8194120538235794,0.7018633540372671,0.99344417576602,1.0,5/11,27.41%,GLRX3;FOXO1;SMAD4;MLIP;ATP2B4
prerank,response to glucose (GO:0009749),0.29289582387296664,0.8192363156645923,0.7329479768786127,0.9637510145793902,1.0,12/46,23.47%,TCF7L2;EIF2B2;XBP1;RACK1;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3;ERN1;ZBTB20;TRA2B
prerank,synaptic vesicle localization (GO:0097479),0.36002917227702935,0.8189879314756257,0.6928471248246845,0.9637259804608225,1.0,2/13,10.72%,SYNJ1;DNM2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2748583032642578,0.8189170647452773,0.758957654723127,0.9634300282530542,1.0,17/72,18.15%,CLU;PFDN5;MAPRE1;KANK1;SSH3;HSPA8;SPEF1;CIB1;ATXN7;APOE;PFDN4;FGF13;PLEKHH2;TBCD;STMN2;CAMSAP2;LDLR
prerank,neuron maturation (GO:0042551),0.34344054912097216,0.8187169167896153,0.7156208277703605,0.9633332620043095,1.0,3/18,9.16%,CX3CL1;B4GALT5;APP
prerank,neurotransmitter uptake (GO:0001504),0.37404289733045365,0.8186372886180698,0.6956521739130435,0.9630421518017056,1.0,1/12,3.44%,SLC38A1
prerank,nucleotide-excision repair (GO:0006289),0.26842644819892575,0.8184931109166667,0.7791798107255521,0.9628447235795669,1.0,14/101,9.77%,POLR2G;UVSSA;POLD4;CHD1L;POLB;RFC4;RFC1;BRIP1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,positive regulation of macrophage activation (GO:0043032),0.3461060734921638,0.8184911605679008,0.6997282608695652,0.9624232571085195,1.0,3/17,14.78%,WNT5A;STAP1;TNIP2
prerank,snRNA metabolic process (GO:0016073),-0.28174212330156784,-0.8184237430549199,0.7103448275862069,0.9936856918065186,1.0,6/17,22.38%,RBM7;INTS10;INTS12;INTS2;TUT1;INTS6
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.23585066375831157,-0.8183428668563102,0.7790697674418605,0.9921606914438778,1.0,9/33,20.80%,TGFB1;SMARCA4;PPARG;TGFB2;EGR1;TP53;KLF4;TEAD1;HIF1A
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3215822457055054,-0.817672835368771,0.7178683385579937,0.9918199978130458,1.0,4/11,23.51%,CEACAM1;AHR;IL4I1;KLRD1
prerank,metal ion transport (GO:0030001),0.27446002929530666,0.8176309500314135,0.761854583772392,0.9634538339865376,1.0,17/86,17.69%,TRPM2;LRP2;SLC8A1;CCL5;ITPR1;SLC30A1;SLC30A5;MT3;CACNA1A;PANX1;PSEN1;TRPV4;FYN;CHRNB2;TRPM7;NIPA2;MAGT1
prerank,regulation of axon regeneration (GO:0048679),0.36750176069086704,0.8172465393288448,0.6818181818181818,0.963627055857615,1.0,6/12,26.94%,EPHA4;CERS2;STK24;RTN4RL1;PTPRS;GRN
prerank,cellular response to nutrient levels (GO:0031669),0.2859681328748929,0.8169541901220391,0.7618522601984564,0.9636531941657914,1.0,19/62,26.23%,LAMP2;RRAGC;BMPR2;HSPA8;XBP1;KLF10;MAP1LC3B;MTOR;SREBF1;STK24;TSC1;CD68;USP33;RRAGA;ZFYVE1;FNIP1;WRN;KCNB1;EHMT2
prerank,central nervous system development (GO:0007417),0.2566415096846236,0.8169073351322095,0.876629889669007,0.9633015886961441,1.0,47/250,18.71%,CXCR4;PLXNB2;GRIN2D;STAT3;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SYNJ1;PHGDH;CIC;SOX9;PITPNM1;UBE3A;TBC1D23;MEIS3;CDK5RAP2;EIF2B2;NFIB;JRKL;BPTF;PROX1;DHX30;DNAJC30;SCYL2;GSN;DDIT4;HPCAL4;PTPN11;ATXN1;PTCH1;SMARCA1;DNER;CTNS;POU6F1;RNF103;NHEJ1;DSCAML1;NDUFS4;DHX37;NF1;VIT;WWP1;GBA2;EIF2B5;UTP3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.34708019366870235,0.8169057612415738,0.7025920873124147,0.9628821647004032,1.0,4/17,16.74%,ABHD2;NR3C1;UBE2L3;ACOD1
prerank,regulation of protein catabolic process (GO:0042176),0.26648344282747,0.8168684077297347,0.7939011566771819,0.9625268121836441,1.0,33/99,26.43%,WNT5A;AZIN2;CHEK2;MAD2L2;EGLN2;RILP;AREL1;TMEM9;AGAP2;DACT1;BARD1;AZIN1;SORL1;SMURF1;VPS28;HGS;TIPARP;WWP1;WDR91;PIN1;HUWE1;SMURF2;IDE;HMGCR;VCP;AXIN1;SNX12;FLNA;SIRT2;TNF;SEC22B;SNF8;FMN2
prerank,regulation of protein neddylation (GO:2000434),0.3858244324511311,0.816738284873216,0.7008928571428571,0.9622986835804166,1.0,6/10,28.85%,DCUN1D4;RPL11;RPL5;DCUN1D5;EPAS1;DCUN1D1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3192450844346204,0.8166846498091853,0.7354085603112841,0.9619605780871558,1.0,8/25,19.75%,HTATSF1;CCNT2;SETD5;LDB1;WDR43;DDX39B;CCNK;KAT7
prerank,negative regulation of lymphocyte activation (GO:0051250),0.32940151244907434,0.8165909326130706,0.7225891677675033,0.9617030615496948,1.0,6/21,19.77%,DUSP3;LST1;FCGR2B;PIBF1;PAG1;TNFAIP8L2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.25297392659915063,-0.8162442883743313,0.7431192660550459,0.993070261140646,1.0,3/23,6.86%,TGFB1;TGFBR3;TRIM33
prerank,spindle assembly (GO:0051225),0.27816945848537405,0.8160688226687255,0.7835497835497836,0.9621509860694022,1.0,25/67,26.60%,CHEK2;GOLGA8B;KPNB1;WRAP73;KIF3B;MAPRE1;STAG1;TOGARAM2;NEK6;ARHGEF10;CCDC61;PIBF1;KIF2A;RAB11A;NEK7;NUMA1;STARD9;HAUS3;MAPRE3;FLNA;CEP192;HAUS6;MAPRE2;ABRAXAS2;TUBGCP5
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.36829573721439846,0.8160325259777612,0.6961483594864479,0.961375742945811,1.0,3/12,14.03%,CHERP;CIB1;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.36829573721439846,0.8160325259777612,0.6961483594864479,0.961375742945811,1.0,3/12,14.03%,CHERP;CIB1;SPPL3
prerank,protein-DNA complex disassembly (GO:0032986),0.3460537926041417,0.8159386827703426,0.7006802721088435,0.9611123623432237,1.0,4/16,8.42%,ARID1A;SMARCC2;SMARCE1;ARID2
prerank,positive regulation of viral transcription (GO:0050434),0.31634957985422096,0.8158845907605338,0.7201540436456996,0.9607892331908467,1.0,4/25,9.35%,POLR2G;DHX9;MDFIC;POLR2K
prerank,cellular response to organic cyclic compound (GO:0071407),0.26273903297575324,0.8158160622259828,0.8345323741007195,0.9604751384349932,1.0,25/141,16.94%,CASP7;TRPM2;CASP6;LARP1;CRHBP;ADCY5;CCL5;CTNNB1;PDXP;RAPGEF2;P2RX4;RORA;RIOK3;ZC3H12A;ZFP36L1;NR3C1;AKAP9;LCOR;UBE2L3;RAPGEF1;ACTB;INPP5K;TIPARP;IL18;PDE3A
prerank,nucleotide metabolic process (GO:0009117),0.322051206470861,0.8157260875289681,0.7129629629629629,0.9602260557967902,1.0,6/23,15.46%,ENPP3;DCK;NUDT5;AK4;CMPK2;RNASEH2B
prerank,cellular biogenic amine metabolic process (GO:0006576),0.37048574111992283,0.8156052654139222,0.6976744186046512,0.9600117314826376,1.0,2/12,7.70%,DDC;SMS
prerank,embryonic axis specification (GO:0000578),0.35381754131929494,0.8152710201655092,0.7063711911357341,0.9601424161774715,1.0,5/15,22.93%,SMAD2;CXXC4;PTCH1;TASOR;RIPPLY2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3203825432596168,0.8152055454329139,0.7275031685678074,0.9598422564524096,1.0,7/27,20.63%,THY1;CD47;CCDC88B;IRAK1;MDK;SIRPA;LCK
prerank,glycoprotein catabolic process (GO:0006516),-0.27660074740828017,-0.8143545244359452,0.72,0.9951182643203492,1.0,3/17,5.70%,OGA;CTSL;MANBA
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2534341779224525,-0.814278861124023,0.7772511848341233,0.9935843018845485,1.0,5/21,8.56%,PPP1R8;CRY2;PPP1R16B;PTPA;GSK3B
prerank,neural crest cell differentiation (GO:0014033),0.3351092358957263,0.8142711319534115,0.7180555555555556,0.960969350064981,1.0,3/18,8.36%,TCOF1;SNAI2;NOLC1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.26788753768887913,0.8142331276813707,0.8104712041884817,0.9606145334147145,1.0,12/107,9.86%,CASP4;TRIB3;DDRGK1;BCL2L11;RNF5;ERP44;ITPR1;HYOU1;SEC16A;ATF6B;NCK1;UBQLN1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.2974948772296945,0.8141656528276077,0.7293413173652694,0.9603023444551344,1.0,2/39,2.63%,KDR;CD40
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.21390353752949354,-0.8140753358965789,0.8688524590163934,0.9922820008727743,1.0,13/44,22.02%,CSNK2A1;SH3RF1;RPS6KA3;SIAH2;SNCA;SRC;AKT1;KLF4;MAP2K5;CAST;USP47;RPS6KA1;GPX1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2964254693605786,-0.8139196776255296,0.7115384615384616,0.9909099041216579,1.0,6/13,33.74%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,maturation of SSU-rRNA (GO:0030490),0.3079721360744091,0.8137695859701229,0.7300613496932515,0.9605228881313836,1.0,14/34,29.88%,PWP2;NOB1;RIOK3;DHX37;UTP3;MRPS11;RRP36;NGDN;BMS1;NOL10;HELB;DDX52;RPS19;TSR3
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3351188691043303,0.8136975065797705,0.7242268041237113,0.9602149336879333,1.0,3/21,11.03%,ZFP36;RUNX1;ZFP36L1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3811282255773706,0.8136897025618878,0.7081481481481482,0.9598087773092228,1.0,3/11,10.66%,CCT4;CCT7;CCT3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.32499721399358794,0.813663623435274,0.7218710493046776,0.9594378153467181,1.0,3/23,8.79%,SLC12A5;TFAP2B;SLC12A8
prerank,synaptic vesicle recycling (GO:0036465),0.31051405881654204,0.8130908152021171,0.7426108374384236,0.9599443619765476,1.0,8/31,17.48%,SYNJ1;SYT7;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,autophagosome assembly (GO:0000045),0.2859303080837095,0.8123520016244631,0.7563218390804598,0.9607211252626712,1.0,8/52,14.48%,IRGM;UBQLN2;RAB43;UBQLN1;UBXN2B;SMURF1;MAP1LC3B;RB1CC1
prerank,mitotic spindle organization (GO:0007052),0.2634908536750139,0.8118564022656034,0.8459958932238193,0.9611196774164179,1.0,27/153,14.87%,NUP37;CHEK2;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;WRAP73;DYNC1LI2;KIF3B;EFHC2;MAPRE1;STAG1;NEK9;TOGARAM2;CENPN;SUN2;NEK6;ARHGEF10;DYNLL1;CCDC61;AHCTF1;PIBF1;MAP4;MIS12;KIF2A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.28774675130463984,0.8117730994293435,0.7603211009174312,0.9608400904213503,1.0,13/51,18.94%,XRN1;CTNNB1;DCP2;CCT4;CCT7;CCT3;SMG5;HNRNPA1;STN1;MAP3K4;HMBOX1;TERF2;NEK7
prerank,transepithelial transport (GO:0070633),0.35824696429329583,0.811692901161399,0.7273991655076495,0.9605611804858998,1.0,4/15,22.19%,ABCC2;ABCC1;ABCG2;SLC1A3
prerank,regulation of microtubule depolymerization (GO:0031114),0.31235210486974435,0.8116492156162181,0.7049808429118773,0.9602169202562942,1.0,8/25,19.08%,SPEF1;CIB1;ATXN7;TRPV4;FGF13;STMN2;CAMSAP2;MAP1B
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.29625760046733324,0.8115800163644011,0.7414403778040142,0.9599046546891612,1.0,10/41,20.35%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;NUP133;NUP43
prerank,purine-containing compound catabolic process (GO:0072523),0.36640040643980654,0.8110580443443064,0.7037037037037037,0.9603191897265362,1.0,1/13,1.40%,XDH
prerank,long-chain fatty acid import into cell (GO:0044539),0.3838522654267747,0.8108424736731809,0.7274096385542169,0.9602500897586217,1.0,1/10,2.35%,SLC27A1
prerank,cellular response to sterol (GO:0036315),0.3611521618939231,0.8106418819077581,0.6913767019667171,0.9601632706453083,1.0,5/13,15.41%,OSBPL7;RORA;MLC1;PTCH1;GRAMD1C
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.31123391166922093,0.8102510201802124,0.748780487804878,0.9603925082439345,1.0,11/29,27.60%,RBBP5;CTNNB1;TCF7L2;MEN1;PYGO1;HDAC1;KMT2D;KAT5;RUVBL1;EP300;CDC73
prerank,regulation of sequestering of triglyceride (GO:0010889),0.35388092205567734,0.8101602822177307,0.6963562753036437,0.9601254673482127,1.0,2/15,4.76%,PNPLA2;OSBPL8
prerank,ATP synthesis coupled proton transport (GO:0015986),0.34066967067180987,0.8100609877033244,0.7202702702702702,0.9598768462244143,1.0,6/17,26.46%,ATP5MC1;DMAC2L;ATP5PO;ATP5F1B;VPS9D1;STOML2
prerank,negative regulation of protein polymerization (GO:0032272),-0.2349943714497175,-0.8098635247041912,0.8017241379310345,0.9975687695582621,1.0,4/27,7.46%,SSH2;DYRK1A;TUBB4A;SNCA
prerank,regulation of cytoplasmic translation (GO:2000765),0.35963931671443916,0.8098435036054275,0.7048022598870056,0.9598262676879391,1.0,2/14,7.30%,DHX36;DHX9
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3207547089024073,0.8096960927042277,0.7484116899618806,0.959230017731514,1.0,4/24,10.58%,TPI1;PFKM;HK1;FOXK1
prerank,canonical glycolysis (GO:0061621),0.3207547089024073,0.8096960927042277,0.7484116899618806,0.959230017731514,1.0,4/24,10.58%,TPI1;PFKM;HK1;FOXK1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.28584571457708174,0.8090088156906153,0.7584204413472706,0.9599315939773557,1.0,10/44,20.69%,PER2;OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1
prerank,cAMP metabolic process (GO:0046058),0.3572860086097963,0.8085289024922593,0.6940836940836941,0.9602967947787691,1.0,2/13,6.18%,ADCY5;ADCY10
prerank,glycolipid biosynthetic process (GO:0009247),0.2963205654970296,0.8084418541363675,0.7567567567567568,0.9600223938035164,1.0,9/38,19.29%,PIGW;GBGT1;PIGV;SCCPDH;PGAP2;ST8SIA1;PIGQ;PIGB;PGAP3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25893513966833026,-0.808436880776676,0.7860082304526749,0.9987209197183226,1.0,7/20,24.21%,APC;NR2F2;CEBPA;INCA1;HEXIM1;CDKN1B;CDK5RAP1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.25729298447625004,-0.8079480103561012,0.7488789237668162,0.997969248945343,1.0,5/19,12.90%,CDC42;MYO18A;CYTH1;GOLPH3;RHOA
prerank,muscle cell development (GO:0055001),-0.23883518752845023,-0.8078345620465194,0.805,0.9964979593504134,1.0,14/30,34.80%,DMD;BIN1;MYOF;NEBL;KDM1A;CXADR;NEB;EFEMP2;SGCZ;RAMP2;SDC1;MYH11;HEY2;HES1
prerank,regulation of NMDA receptor activity (GO:2000310),0.3046505334378881,0.807787914453101,0.7285180572851806,0.9606864536143349,1.0,8/32,16.11%,CAMK2B;ACTN2;CRHBP;GRIA2;APP;CAPN1;DLG1;GRIA4
prerank,ceramide biosynthetic process (GO:0046513),0.29780650988427776,0.8073541492243519,0.7582938388625592,0.9609528891498077,1.0,5/40,7.46%,ST6GALNAC4;ASAH2;CERS6;DEGS1;ST6GALNAC6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.22904317138422042,-0.8066722040478608,0.75625,0.9970188181393341,1.0,9/32,18.47%,MAP3K3;PIK3C2A;HMOX1;RHOA;JCAD;KLF4;MAP2K5;ITGB1BP1;ANXA1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3715750836157408,0.8064655412767636,0.7049418604651163,0.9620102697009802,1.0,4/12,16.15%,IRS1;SORL1;PTPN11;GKAP1
prerank,lysosome localization (GO:0032418),0.29498658618551243,0.8064211098656454,0.7566909975669099,0.9616635921219006,1.0,11/37,25.56%,PIK3CD;VPS33A;DEF8;PLEKHM2;SPAG9;KLC2;MYH9;S100A13;HDAC6;KXD1;RAB3A
prerank,regulation of phospholipase activity (GO:0010517),0.38477161793615383,0.8064196607654549,0.6976401179941003,0.9612508354160302,1.0,4/10,26.33%,FGFR2;FGFR3;PDPK1;LRP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.26633112846341367,0.8063871901662698,0.8143459915611815,0.9608888414768629,1.0,38/103,26.77%,USP50;RHEBL1;RRAGC;RAPGEF6;RAPGEF2;CCDC88A;ABR;DNMT1;MAPK14;G3BP2;HACD3;RIN2;SOS1;RB1;TIAM2;ARHGAP30;RAC1;RREB1;BCR;RUNDC3A;PLCE1;NF1;ARHGAP18;ARHGAP31;G3BP1;RIT1;USP8;RHEB;FGF2;ARHGAP1;RGL2;TRIM28;CDKN2A;SHC1;CHP1;PLD2;RERG;TIAM1
prerank,sphingolipid catabolic process (GO:0030149),-0.2849544898321023,-0.8062565118069891,0.7282229965156795,0.9961435570030425,1.0,7/15,25.13%,PDXDC1;SMPDL3A;ASAH1;ACER2;SMPD1;SMPD2;PPT1
prerank,odontogenesis (GO:0042476),0.2999105604328038,0.8062296793352344,0.7350427350427351,0.9607067402389493,1.0,2/35,6.02%,PITX2;FGFR2
prerank,cellular response to estradiol stimulus (GO:0071392),0.3327848698089783,0.8061845145246274,0.7262872628726287,0.9603706885191845,1.0,6/18,23.60%,CRHBP;LCOR;CCDC62;NRIP1;RUVBL2;KAT5
prerank,peptide cross-linking (GO:0018149),-0.24484055685833173,-0.805683120657819,0.7679324894514767,0.9955713146748573,1.0,17/25,49.34%,F13A1;NDNF;ANXA1;ABCA7;CD247;FCGR3A;TGM4;DSP;EVPL;TGM1;KRT10;TGM5;TGM6;EPB42;TGM7;CD3G;SPRR1A
prerank,glycerophospholipid metabolic process (GO:0006650),0.2717009587823274,0.8055866873981508,0.7806731813246471,0.960910117839915,1.0,16/75,20.32%,PIGW;CPNE3;SYNJ1;PDXP;PIP5K1A;PIGV;PLCB3;PNPLA6;ABHD3;ENPP6;PAFAH1B1;PIGQ;PIGB;PLA2G4E;PNPLA3;PLA2G6
prerank,regulation of rRNA processing (GO:2000232),0.3439987245158293,0.8054890101433813,0.7156862745098039,0.9606667380967471,1.0,7/16,23.88%,YTHDF2;DIMT1;WDR43;NUDT16;BUD23;UTP15;KAT2B
prerank,negative regulation of synaptic transmission (GO:0050805),0.3220420929217934,0.8053319329167385,0.7196870925684485,0.9604983719074899,1.0,2/23,5.29%,GRIK3;SLC30A1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2676637481530071,-0.8052269400317614,0.7385159010600707,0.9948145914775488,1.0,8/17,23.05%,TGFB1;BIN1;ID2;TNFRSF1B;IL34;PTPRZ1;EGR2;CLCF1
prerank,amino acid transport (GO:0006865),0.28839302808817574,0.8047907207160001,0.7647058823529411,0.9609429421146143,1.0,9/49,16.88%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6;SLC25A47;SLC36A4;SLC25A45
prerank,purine nucleotide catabolic process (GO:0006195),0.3619466191165995,0.8045890785343874,0.7084548104956269,0.9608540674570303,1.0,1/13,1.40%,XDH
prerank,iron-sulfur cluster assembly (GO:0016226),0.31662414344960904,0.8044336434531368,0.7163029525032092,0.9606995769253484,1.0,4/24,8.89%,HSCB;FXN;NFU1;NFS1
prerank,regulation of proteolysis (GO:0030162),0.2851307005796023,0.8043854755005789,0.757327080890973,0.9603598147751761,1.0,14/48,23.84%,TM4SF20;ASPH;TRAF3;BTRC;BAD;AURKAIP1;IST1;SPOP;PLAUR;STUB1;HDAC2;CLN6;PLAT;HDAC6
prerank,neuromuscular process (GO:0050905),-0.27090251695635825,-0.804048180773633,0.762589928057554,0.9953862868904613,1.0,4/16,15.94%,UBA5;AGTPBP1;NRXN1;CLN3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2767495872638294,0.8039625877682285,0.7793633369923162,0.9605990538261211,1.0,15/67,18.40%,TRPM2;TBC1D1;GAP43;RABEP2;PODXL;TBC1D8;CYLD;P2RX4;CAPZB;DYNC2LI1;DYNLT2B;RAC1;TBC1D2;DCDC2;ABITRAM
prerank,cellular response to leucine (GO:0071233),-0.33036027568524906,-0.8037399792481613,0.6915887850467289,0.9927102740275664,1.0,2/10,7.58%,RRAGD;LARS1
prerank,response to leucine (GO:0043201),-0.33036027568524906,-0.8037399792481613,0.6915887850467289,0.9927102740275664,1.0,2/10,7.58%,RRAGD;LARS1
prerank,neuropeptide signaling pathway (GO:0007218),0.28211070401188243,0.8034004738460178,0.777027027027027,0.961088941114805,1.0,6/58,11.56%,GAL;GPR37;RAPGEF2;GLRA2;GALR1;SORL1
prerank,negative regulation of coagulation (GO:0050819),-0.2924951902812557,-0.8033312638431027,0.7233333333333334,0.9918873168234548,1.0,8/14,39.90%,VTN;HS3ST5;THBD;CD34;PROCR;APOH;ADTRP;TFPI
prerank,androgen metabolic process (GO:0008209),0.3324478594181828,0.8031838820976787,0.7211796246648794,0.9610104810791064,1.0,1/18,3.59%,HSD17B7
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3333445252318066,0.8026824161216352,0.7104194857916103,0.9614080870270565,1.0,6/18,21.93%,ZC3H11A;DDX19B;ENY2;DDX19A;NUP133;MCM3AP
prerank,regulation of protein kinase activity (GO:0045859),0.26216435075343425,0.8024107693751492,0.8106139438085328,0.9613989355823831,1.0,25/106,19.14%,TRIB3;DAXX;LCP2;THY1;TARBP2;CACUL1;TRAF4;MAP2K3;CSF1;AGAP2;PPIA;RAPGEF2;PRKAG1;SNX9;PPM1F;AKT1S1;RB1;INPP5K;PTPRC;PLCE1;NF1;DTNBP1;SPRED1;UVRAG;CAMKK2
prerank,N-glycan processing (GO:0006491),0.33527495057657,0.8021541930482411,0.726158038147139,0.9613996376998976,1.0,5/18,17.78%,GNPTAB;MAN1A2;GANC;ST8SIA1;MAN1C1
prerank,regulation of Golgi organization (GO:1903358),-0.26687738467152766,-0.8021213180170097,0.7984790874524715,0.9926053175383905,1.0,4/17,9.82%,ARMH3;MAPK3;RAB33B;USP6NL
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3107841959412535,0.8020389198004422,0.7528373266078184,0.9611731280165353,1.0,8/27,22.01%,SMOC2;BMPR2;SMG5;HMBOX1;DACH1;TERF2;ACVRL1;FGF2
prerank,protein acylation (GO:0043543),0.2978820160686599,0.8020201833066715,0.7511848341232228,0.9607851371489681,1.0,16/38,27.26%,ZDHHC21;ZDHHC20;HHAT;NAT9;ZDHHC13;ZDHHC8;ZDHHC3;ING5;ZDHHC18;ZDHHC22;KAT6A;KAT2B;ZDHHC17;ZDHHC16;EP300;ZDHHC7
prerank,amide biosynthetic process (GO:0043604),0.28871090410284755,0.8017598871402462,0.757094211123723,0.960784817643454,1.0,4/47,5.77%,NMRAL1;ASAH2;CERS6;DEGS1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3330926617307698,0.8015709929775735,0.733957219251337,0.9606503118847197,1.0,5/19,18.77%,XRN1;DCP2;HNRNPA1;STN1;TERF2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.19632869767709304,-0.8014593202561086,0.8264462809917356,0.9921988435344239,1.0,5/57,3.95%,ADCY9;GNAL;LPAR1;ADCY3;OPRM1
prerank,neuron development (GO:0048666),0.2565668443369781,0.8013437567644909,0.8482051282051282,0.9605940917080729,1.0,34/141,22.59%,BLOC1S4;RUNX1;PPP1R9A;TBC1D23;SRF;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;B4GALT5;HMGB1;APP;STMN3;XBP1;APOE;RB1;MAP4;LRP12;TBCD;PRMT1;RAB11A;OPHN1;STMN2;HS6ST1;DTNBP1;GBA2;PLP1;LGI1;TENM4;UNC5A;CDK16;ZFYVE27
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.28628517290108146,-0.8009852412392374,0.7423312883435583,0.9914762373820436,1.0,3/13,10.06%,TGFB1;BMP6;NUP93
prerank,cell projection assembly (GO:0030031),0.32388024673245214,0.8006867007605855,0.7278562259306803,0.9612014486284131,1.0,8/22,23.67%,PARVB;CYFIP1;RHOJ;GSN;RAC1;NCKAP1;RHOH;PARVG
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.25819173344665397,0.8006553535718675,0.8447395301327886,0.9608467086853402,1.0,36/140,20.41%,TAGAP;RHOF;SYDE1;RHOJ;ARHGEF7;ARHGAP4;ABR;SYDE2;VAV1;ARHGAP25;STARD8;ARHGEF11;SRGAP3;SRGAP2;SOS1;ARHGAP21;ARHGAP10;CHN1;ARHGAP11A;AKAP13;TIAM2;ARHGAP39;ARHGAP30;RAC1;SH3BP1;OPHN1;OCRL;BCR;PLCE1;RHOT2;ARHGAP29;ARAP1;ARHGAP24;ARHGAP18;TGM2;ARHGAP31
prerank,inner dynein arm assembly (GO:0036159),0.37446184448694364,0.8000769501365722,0.7165932452276065,0.9613506260258149,1.0,2/10,14.23%,CCDC40;CFAP73
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33602541442771083,0.7999449378722558,0.7242302543507363,0.9611628611328585,1.0,6/18,22.85%,KMT2A;SETD3;ASH1L;SMYD2;SETD7;KMT2D
prerank,DNA catabolic process (GO:0006308),0.36982355834427943,0.7999128971153254,0.7265973254086181,0.9608111477998429,1.0,1/11,2.24%,XRN2
prerank,P-body assembly (GO:0033962),-0.2930480915293854,-0.799337957656082,0.7605177993527508,0.993079810950173,1.0,2/12,4.04%,PATL1;DDX6
prerank,RNA biosynthetic process (GO:0032774),-0.22416420514093438,-0.7992804807412315,0.8429319371727748,0.991512135919078,1.0,6/31,15.02%,TAF12;TBP;TTF1;PRMT5;TAF5;TAF10
prerank,DNA conformation change (GO:0071103),0.33721070940124775,0.7991432217399349,0.6895161290322581,0.961579881461345,1.0,4/17,14.77%,PRM1;HMGB1;HMGB3;TOP1MT
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3192696987397906,0.7990876026274444,0.7341772151898734,0.9612546951944195,1.0,2/24,4.59%,SLC27A1;PLA2G12A
prerank,ceramide transport (GO:0035627),-0.30042687506991206,-0.7989176258582373,0.7142857142857143,0.9905454416943962,1.0,4/12,20.42%,PLEKHA8;ABCA2;PLTP;ABCA13
prerank,phosphatidic acid metabolic process (GO:0046473),0.28472433997747615,0.7986249265408841,0.7720504009163803,0.9615819756301718,1.0,6/48,9.85%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3152380021364502,-0.798456233060752,0.7147435897435898,0.9897878337241375,1.0,6/11,36.02%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.37701171323915716,0.7982536044394499,0.7310549777117384,0.961760467804473,1.0,2/10,10.77%,KLF15;SETD5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.31334767302353606,0.797778400264961,0.7467191601049868,0.9620855543372422,1.0,2/25,3.86%,PER2;MAD2L2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3080063785010965,0.7974084272537842,0.7655677655677655,0.962294718805761,1.0,3/31,8.78%,CLTRN;SYT7;SYT3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3106860860530736,0.7967626284505327,0.7597977243994943,0.9629371952621762,1.0,6/26,19.12%,PTGER4;CX3CL1;SYNPO;RAC1;ASAP3;TSC1
prerank,L-glutamate transmembrane transport (GO:0015813),0.3847448868388424,0.7962265996043285,0.7549770290964778,0.963379466575885,1.0,1/10,0.81%,SLC25A22
prerank,negative regulation of cell aging (GO:0090344),-0.2717117006917368,-0.7961469935243067,0.75,0.9925174908022448,1.0,4/16,14.72%,MAP3K3;SIRT1;HMGA2;MIF
prerank,glycogen metabolic process (GO:0005977),0.30668579198322876,0.7960872153415717,0.7593052109181141,0.9631814465120389,1.0,3/27,7.83%,PER2;PGM2L1;PGM1
prerank,mitochondrion distribution (GO:0048311),-0.30682799360383073,-0.7958512766483429,0.7411003236245954,0.9915343625598634,1.0,5/12,21.17%,TRAK2;ATCAY;ARMC1;MTM1;MSTO1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3762660145148643,0.7954207966225058,0.7259684361549498,0.9638265510804003,1.0,1/10,4.40%,THAP4
prerank,cilium organization (GO:0044782),0.2534367895013435,0.7950283601270279,0.8850806451612904,0.9640256260255041,1.0,40/209,18.46%,CNGB1;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;ACTR2;CEP162;RILP;SNX10;RILPL1;TTC39C;ACTR3;NPHP3;KIF3B;MKS1;CFAP54;FNBP1L;WDR35;CEP131;TMEM138;EXOC6;GSN;DYNLT2B;DYNLL1;DZIP1;TMEM67;PIBF1;CFAP20;CCDC66;BBS2;ARF4;RAB11A;CEP89;DYNC2H1;WDR19;OCRL;DCDC2;GBF1;IFT46
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.33707308018085724,0.7948053170746652,0.7271487039563438,0.9639798323478003,1.0,3/16,14.89%,ATP5MC1;DMAC2L;ATP5PO
prerank,vesicle transport along microtubule (GO:0047496),0.31911554211780013,0.7947738535295986,0.7559055118110236,0.9636258941517167,1.0,4/23,6.86%,FYCO1;DYNC1H1;TRAK1;KIF3B
prerank,purine ribonucleotide transport (GO:0015868),-0.27216370576426857,-0.7947379816995433,0.7592592592592593,0.9920553470519025,1.0,5/16,21.19%,SLC25A4;SLC17A9;SLC35B2;SLC25A42;LRRC8A
prerank,intestinal absorption (GO:0050892),0.3590347286609023,0.7947079937498847,0.7396870554765291,0.9633180182934563,1.0,2/13,12.34%,SLC46A1;TJP2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3563955661940606,0.7941992787705563,0.727403156384505,0.9636995227895995,1.0,1/13,6.02%,STX7
prerank,activation of adenylate cyclase activity (GO:0007190),0.2920179181617868,0.7941309616074567,0.7527272727272727,0.9634066940437649,1.0,3/35,7.01%,RXFP2;ADCY5;TMIGD3
prerank,positive regulation of wound healing (GO:0090303),0.30044503522186716,0.7940556766182203,0.7729988052568698,0.9631251156865052,1.0,7/36,16.20%,SMOC2;KANK1;HPSE;XBP1;PRKCE;RREB1;MTOR
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.24905947639317247,-0.7939654539796297,0.7827868852459017,0.9919431089627151,1.0,3/22,13.69%,ATP1B1;HTT;GSTO1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3326271765390531,0.7937609209142812,0.7362045760430687,0.9631733047040134,1.0,6/17,23.32%,RNF40;NCBP2;NCBP1;ZC3H3;CDK9;ZC3H14
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3110402633869949,0.7936741684800959,0.7659033078880407,0.9628929081176513,1.0,6/27,15.68%,SKP1;MAP3K8;NFKB1;BTRC;TNIP2;TAOK2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3202878763524596,0.7929474991350993,0.7168831168831169,0.9635797928078222,1.0,3/23,10.62%,CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.31772517010310153,0.7928261446606364,0.7367724867724867,0.9633666357903675,1.0,6/21,17.49%,SPEF1;CIB1;ATXN7;FGF13;STMN2;CAMSAP2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3795033165197102,0.7927143504274742,0.7218259629101283,0.9631346547809765,1.0,4/10,19.73%,RTEL1;DCLRE1A;TERF2;DCLRE1C
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.28597817030242695,0.792628433569357,0.768957345971564,0.9628720540586506,1.0,18/43,31.21%,ACVR1;ZHX3;WNT7B;BMPR2;NELL1;BMPR1A;ACVR2A;DDR2;FERMT2;IL6R;ATRAID;FBXO5;IL6ST;LRP5;WWTR1;PRKD1;CCN1;IGF1
prerank,regulation of histone deacetylation (GO:0031063),0.3526772649348714,0.7925937407961944,0.7374301675977654,0.9625257069066819,1.0,2/13,10.01%,CAMK2D;SPHK2
prerank,cellular response to oxidative stress (GO:0034599),0.25896570276914277,0.792455028620971,0.8333333333333334,0.9623348626475567,1.0,20/118,17.01%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;EIF2S1;STX4;PRDX2;ERCC6L2;ADNP2;MSRA;AIF1;CHCHD2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3589327642144138,0.7921861211756029,0.7411095305832148,0.962322091019433,1.0,4/12,25.49%,THY1;LCK;GCNT2;TNF
prerank,myeloid cell differentiation (GO:0030099),-0.20385559935497105,-0.7916905555392364,0.8933333333333333,0.9943888362936876,1.0,10/47,15.30%,RPS14;UBA5;CASP3;KMT2E;PTPN2;ZBTB16;CEBPA;JAK3;RASGRP4;SLC25A5
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3681758904941673,0.791588355515405,0.7383458646616541,0.9623913585510242,1.0,3/11,16.87%,SYNJ1;INPP5K;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3681758904941673,0.791588355515405,0.7383458646616541,0.9623913585510242,1.0,3/11,16.87%,SYNJ1;INPP5K;OCRL
prerank,phosphate ion transport (GO:0006817),0.33802767908858083,0.791469881411623,0.7311977715877437,0.9621705750861647,1.0,5/16,23.00%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,protein export from nucleus (GO:0006611),-0.23714814380784796,-0.7914314054045826,0.8,0.9932472563863706,1.0,10/27,24.10%,TGFB1;STYX;STRADB;XPO5;CCHCR1;TPR;EGR2;RANBP3;XPO1;XPO7
prerank,endothelial cell development (GO:0001885),0.3154305412607797,0.7909312069960509,0.737171464330413,0.9625859332329301,1.0,5/25,17.76%,COL22A1;RAPGEF2;MET;RAPGEF1;COL15A1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.28715030530538066,-0.7906837633004064,0.7839506172839507,0.9929494578436291,1.0,4/14,11.05%,CMPK1;NMNAT2;PNP;ME1
prerank,cellular protein metabolic process (GO:0044267),0.24677378793464846,0.7906334705356541,0.948,0.9626424997630156,1.0,88/396,22.35%,LIPT1;LOXL2;UBE2L6;PNPLA2;MRPL36;IGF2BP3;AGO2;CHEK2;RCN1;USP25;RPL36;SERPINC1;HARS2;LAMC1;LAMB2;RNF5;GSPT1;RAB12;RPL22;TNC;EIF4EBP2;RPS21;UBE2M;CSF1;NAGPA;FBN1;SEPHS1;CTSH;MXRA8;APP;PAPPA;MEN1;ST3GAL1;SPCS1;TNIP1;MRPL42;PDIA6;ABCF1;PSEN1;PRKDC;APOE;PPP4R2;GGCX;KTN1;UBE2L3;RPS6;NAPSA;SPPL3;RPN1;APH1A;FAM20C;RPS11;RPL30;MRPL24;APH1B;RPL32;MSRA;RPL23A;RPL11;YARS2;RPL10A;SPARCL1;RPS15A;CSF2RA;MRPL13;HBS1L;SRBD1;HM13;RSL24D1;RPL24;RPL37A;SERP1;RPL3;MRPS11;UBL5;ERO1A;RRBP1;APLP2;YES1;RPL29;RPL5;MSRB1;FARSB;ABL2;RPL6;HSP90B1;MMP15;IDE
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2847912630506047,0.790612448559297,0.7677946324387398,0.9622696566183452,1.0,5/43,8.73%,SPRY2;TGFA;DUSP3;ARHGEF7;SOCS5
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2531832753921609,0.7906003451237158,0.8880976602238047,0.9618798917208794,1.0,45/198,21.82%,PLCB4;PIK3CD;ITPKC;STAT3;SYNJ1;ENPP3;PGM2L1;DUSP3;PFKM;PDXP;PPIP5K1;NUDT5;GFPT1;ITPK1;NADK;PLCB3;HK1;CERKL;SPHK2;DUSP28;BCKDK;EPHX2;DUSP10;ENPP1;PIK3CB;DUSP16;INPP4B;PANK2;INPP5K;MTOR;OCRL;NUDT4;PTPRC;PLCE1;DUSP8;PPA1;MINPP1;PTPRB;GPX4;PLA2G4E;PI4KA;LHPP;TNFAIP8L3;PLPP2;ALDOC
prerank,negative regulation of inflammatory response (GO:0050728),0.2495211109174556,0.7899967199643502,0.8815261044176707,0.962386274021469,1.0,33/182,21.67%,CALCA;AOAH;RXFP2;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;RORA;MAPK14;GIT1;RHBDF2;APOE;CXCL17;RB1;SHARPIN;FYN;PPARD;ACOD1;PRKAR2A;MDK;MYH9;MFHAS1;ADCYAP1R1;TNFAIP8L2;SIRPA;YES1;GPR176;VPS35;GIPR;PRKCD
prerank,regulation of phospholipase C activity (GO:1900274),0.3412487704192096,0.7899788330828079,0.7464589235127479,0.9620144270547794,1.0,1/15,1.08%,FLT1
prerank,cellular response to hexose stimulus (GO:0071331),-0.23365223773122284,-0.7899474800730883,0.8232558139534883,0.9926929497181338,1.0,7/23,21.16%,SLC39A14;SLC2A5;PCK2;IGF1R;PDK3;SLC26A6;SOX4
prerank,muscle filament sliding (GO:0030049),0.29173901012077486,0.7891336070320483,0.7670250896057348,0.9625209670642805,1.0,6/38,20.20%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,actin-myosin filament sliding (GO:0033275),0.29173901012077486,0.7891336070320483,0.7670250896057348,0.9625209670642805,1.0,6/38,20.20%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,protein palmitoylation (GO:0018345),0.3032659367991484,0.7889935827543889,0.7524630541871922,0.9623290659143129,1.0,12/30,27.26%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3297751992800193,0.7888476332274484,0.7378378378378379,0.9621478078352519,1.0,5/18,23.57%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,ribosomal small subunit assembly (GO:0000028),0.33797868560207756,0.788495599220543,0.745125348189415,0.9622634411659426,1.0,2/16,4.07%,PWP2;ERAL1
prerank,regulation of nervous system process (GO:0031644),-0.25641232235327205,-0.7884136442857937,0.8237704918032787,0.9938720163906516,1.0,4/18,15.19%,DLGAP1;SLC8A3;CHRNA7;NPTX1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.31612977792986974,0.7880440361077646,0.7493403693931399,0.9625821679725408,1.0,6/22,18.90%,ANKLE2;CDKN2D;STAP1;DYNLL1;INPP5K;TESK1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3194092206811655,0.7878951320139523,0.7516778523489933,0.9623964248503646,1.0,4/20,15.05%,CCL5;SORL1;NRP1;BMPR1A
prerank,epidermis development (GO:0008544),0.2761912789291282,0.7872948199224459,0.7721661054994389,0.9629366871918975,1.0,2/56,6.02%,EDAR;FGFR2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3130313286114176,-0.7869410639288972,0.7339181286549707,0.994937940892599,1.0,3/10,16.06%,PDE3B;NEXMIF;ACER2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.2632738647964737,0.7868367055311303,0.8324439701173959,0.9632392519653217,1.0,23/91,20.94%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC30A1;SLC30A5;MT3;SLC11A2;CAND1;APP;PRNP;COX19;TFR2;SLC39A10;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2;SLC31A1;LCK;SLC31A2
prerank,organonitrogen compound catabolic process (GO:1901565),0.2716013427271227,0.7863476847238984,0.8002244668911336,0.9635762788780803,1.0,17/57,23.32%,SIAH1;ERAP1;LRSAM1;CPQ;LIPC;UCHL3;BCKDK;NPEPPS;MTOR;GADL1;SGPL1;PLA2G6;PNPLA8;IDE;TRHDE;TXN2;CLN6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3289958834046718,0.7863033554932305,0.7472826086956522,0.9632436867011541,1.0,4/18,10.66%,DCP2;CCT4;CCT7;CCT3
prerank,protein localization to membrane (GO:0072657),0.24801945975430598,0.7856527130394783,0.8792756539235412,0.963838693206155,1.0,60/187,26.53%,PIGW;RAB8B;ATP1B3;THY1;ACTN2;RAB12;SEC16A;TM9SF1;ANK1;SH3GLB1;PIP5K1A;MAGI2;RAPGEF6;RAPGEF2;RAB11B;EPB41L3;AGRN;TNIK;EFR3A;SMURF1;ARL5C;FGF13;PTCH1;NPC1;DLG1;NUP155;INPP5K;HGS;RAB11A;RAB32;FLOT2;WDR19;SH3PXD2B;ITGA4;RAP2A;LRRC4;TM9SF4;ZDHHC3;SAV1;ZFYVE27;RABEP1;RAB10;ZDHHC22;C2CD5;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;FERMT2;TM9SF2;ARL5A;LIN7C;RAB3D
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2685404548535752,0.7855741122455303,0.7875,0.9635568138070164,1.0,13/62,16.96%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2901019894384019,0.7854727024736236,0.7644970414201183,0.9632943767125381,1.0,10/37,18.46%,KIF3C;KIF3B;WDR35;IFT27;CEP131;DYNC2LI1;DYNLL1;DYNC2H1;WDR19;IFT46
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3603262833152705,0.7854100322370344,0.744776119402985,0.9629912551434642,1.0,5/12,19.30%,PRNP;TMED10;APOE;FLOT2;RANBP9
prerank,translation (GO:0006412),0.2473661750029963,0.7851631810305756,0.8862034239677744,0.9629495560547356,1.0,47/208,19.11%,VARS1;MRPL36;IGF2BP3;AGO2;RARS1;RPL36;HARS2;IARS2;GSPT1;RPL22;EIF4EBP2;RPS21;MRPL16;AARS1;MRPS28;TUFM;ABCE1;TNIP1;MRPL42;ABCF1;IARS1;RPS6;NARS1;MRPS2;NOA1;RPS11;RPL30;MRPL24;ETF1;RPL32;RPL23A;RPL11;YARS2;EEF1E1;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;MRPL57;RPL37A;PPA1;FASTKD2;RPL3;MRPS11
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.32292420506069675,-0.7849297147229115,0.7604790419161677,0.9968623271995709,1.0,2/10,10.94%,IFT88;WHRN
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3509575596304607,0.7844201383916909,0.7289073305670816,0.9636577134051246,1.0,2/12,6.87%,TMEM9;VPS33A
prerank,peptidyl-proline modification (GO:0018208),-0.23641780900986292,-0.7844000345254645,0.8458333333333333,0.9962149634219989,1.0,4/25,6.77%,P3H2;PPIL3;FKBP4;PPIL2
prerank,acidic amino acid transport (GO:0015800),0.33545907987893886,0.7841196239681492,0.7399165507649513,0.9637024781438261,1.0,1/17,0.81%,SLC25A22
prerank,cell junction assembly (GO:0034329),0.2596104522994404,0.7838266036631788,0.8422712933753943,0.9637530392348503,1.0,16/100,16.33%,SLITRK6;PCDHB13;BDNF;CDH9;PCDHB16;SDK1;TRPV4;LIMS1;ACTB;CTNND2;DNER;DBNL;SH3BP1;DSCAM;NLGN3;OPHN1
prerank,heart looping (GO:0001947),0.2849335843144213,0.7836730017240466,0.785377358490566,0.9635869725722389,1.0,4/39,11.25%,CCDC40;NPHP3;SRF;SETDB2
prerank,negative regulation of protein kinase activity (GO:0006469),0.25928345708832456,0.7835209575530626,0.8295819935691319,0.9633869041827555,1.0,22/88,19.29%,TRIB3;ADAR;THY1;SLC8A1;TARBP2;DUSP3;PPIA;DUSP26;NPM1;PPM1F;SORL1;AKT1S1;DUSP10;RB1;INPP5K;PTPRC;NF1;CORO1C;DTNBP1;SPRED1;TESK1;PTPRB
prerank,organophosphate catabolic process (GO:0046434),0.36671370557847566,0.7834269938957329,0.727540500736377,0.9631258256978563,1.0,1/11,5.68%,PDXP
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2964466398898619,-0.7830960292874488,0.7360248447204969,0.9969231792730439,1.0,6/12,33.74%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.24476485637951415,0.7826460422507754,0.919,0.9638853931140599,1.0,66/306,20.39%,EXT1;POLR2G;MCM2;MRPL36;TIMELESS;IGF2BP3;AGO2;POLE2;RPL36;HARS2;MCM7;CHEK1;TIPIN;RNASEH2A;GSPT1;MCM4;RFC4;RPL22;RRAGC;EIF4EBP2;RPS21;MCM9;BRIP1;FEN1;TUFM;B4GALT5;BARD1;SCX;POLR2K;PTMS;TNIP1;RNPS1;MRPL42;ABCF1;APOE;ORC3;TAF1B;RPS6;RPS11;TOP1MT;RPL30;RMI1;MRPL24;RECQL5;MEF2A;RPL32;RPL23A;RPL11;UPF1;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;FUT9;RSL24D1;RPL24;RPL37A;SET;RPL3;MRPS11;KAT7;RRBP1;ORC1;ATRIP
prerank,T cell proliferation (GO:0042098),0.3457850113793637,0.7824196276171774,0.743988684582744,0.9638255811866644,1.0,1/13,1.44%,DOCK8
prerank,ganglioside metabolic process (GO:0001573),0.32520821429973995,0.7823753104265796,0.7259358288770054,0.9634964794660282,1.0,3/20,9.11%,ST6GALNAC4;ST6GALNAC6;NEU1
prerank,histone methylation (GO:0016571),0.3070152119340619,0.7821807217474699,0.7534591194968554,0.9633953308839216,1.0,7/26,19.56%,PRMT2;NTMT1;NSD3;EZH2;PRMT1;SMYD1;SMYD2
prerank,microtubule bundle formation (GO:0001578),-0.20510201077942436,-0.7818080224888376,0.8904109589041096,0.9976658520275626,1.0,7/42,9.35%,TTLL3;CLIP1;TPPP;NCKAP5L;MARK4;AAAS;MTCL1
prerank,glycine metabolic process (GO:0006544),0.35514098796911925,0.781444848883798,0.7517831669044223,0.9640671445180792,1.0,3/12,15.07%,DLD;SHMT1;GCSH
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.30655804765942907,0.7812460993718688,0.7601977750309024,0.963969164385022,1.0,2/27,3.44%,SLC25A22;SLC38A1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.28109603833501895,0.7811695351891492,0.7852112676056338,0.963698642536774,1.0,9/43,20.19%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1;ORC1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.366131396035205,0.7805833377924142,0.7399103139013453,0.9641554663101394,1.0,2/10,14.89%,ATP5MC1;ATP5PO
prerank,inositol phosphate catabolic process (GO:0071545),0.3583937494869015,0.7805149371760636,0.7588757396449705,0.9638560681514671,1.0,3/12,16.87%,SYNJ1;INPP5K;OCRL
prerank,regulation of protein kinase A signaling (GO:0010738),0.31839708536268435,0.780368510264124,0.7680965147453083,0.9636601141791045,1.0,4/20,16.81%,PRKAR2B;AKAP12;ADGRV1;PRKAR2A
prerank,outer dynein arm assembly (GO:0036158),0.3406736458885839,0.7801518702529687,0.7195467422096318,0.9635786614643954,1.0,3/14,16.38%,ODAD2;ODAD4;DNAL1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3305075753771052,0.7795376384877576,0.7404371584699454,0.9640861283147548,1.0,2/16,6.89%,PIGW;PIGV
prerank,acetyl-CoA metabolic process (GO:0006084),0.33313531946784775,0.7792017489284944,0.7634560906515581,0.9641813152010779,1.0,1/15,1.20%,PPCS
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.30952604209390866,-0.7789157601738876,0.7694704049844237,1.0,1.0,1/10,0.09%,DLGAP1
prerank,negative regulation of platelet activation (GO:0010544),-0.2604013271850696,-0.7788332829399127,0.7670250896057348,0.9996360247615618,1.0,5/16,24.03%,CEACAM1;CD9;PRKG1;PDGFRA;THBD
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3152166561417158,0.7788170110754251,0.7400530503978779,0.96434924515589,1.0,3/20,17.43%,CD40;GSN;ITGA4
prerank,apoptotic nuclear changes (GO:0030262),0.30336396485182415,0.7786815389405715,0.7444589308996089,0.9641534920060028,1.0,6/24,21.04%,KPNB1;HMGB1;DFFA;DNASE2;DICER1;BLCAP
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2629720556808916,0.7785180470383072,0.8234660925726588,0.9639975885067009,1.0,18/78,17.44%,MMP14;STX7;ITGA3;STX8;LDLRAP1;RSC1A1;CIB1;PRKCE;VTI1B;DAB2;ACTB;STX4;DLG1;PRKCH;TMEM59;PTPN9;STAC3;ZDHHC8
prerank,cellular response to light stimulus (GO:0071482),0.2683822456874353,0.777989302749061,0.8022346368715084,0.9644129218030973,1.0,7/66,10.56%,CNGB1;TMEM161A;DHX36;N4BP1;ERCC4;POLK;NPM1
prerank,positive regulation of telomere capping (GO:1904355),-0.2612806239667449,-0.7777762395756374,0.7651821862348178,0.9998414373388842,1.0,4/17,12.48%,PRKCQ;MAPK3;PNKP;NABP2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2908364226102669,0.7775244911117476,0.7628128724672228,0.9646639210167243,1.0,13/34,26.56%,PTPN18;DUSP3;PTPN11;DUSP10;DUSP16;PTPN9;DUSP8;PTPRB;PTPRF;PTPN6;PTPRS;PTPN1;DUSP7
prerank,prostaglandin metabolic process (GO:0006693),-0.22915015356761384,-0.7771795555991858,0.8584474885844748,0.9992669399447742,1.0,9/26,27.73%,HPGD;PTGDS;PTGS1;MIF;PTGES;GSTM1;HPGDS;PTGIS;PRXL2B
prerank,limb development (GO:0060173),0.29724424121666093,0.7768127594875485,0.7782002534854245,0.9653156461673614,1.0,2/28,3.27%,COMP;CHD7
prerank,regulation of myoblast fusion (GO:1901739),0.3657432258879475,0.7768081196145623,0.7474150664697193,0.9649263244472486,1.0,3/11,19.36%,CFLAR;MAPK14;CD53
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.2568136627215108,-0.7766995970649686,0.7925311203319502,0.9984756118513556,1.0,4/18,12.83%,GPR137B;MAFB;CCL3;TMEM178A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2836257850247951,0.7766536907452288,0.7918660287081339,0.9647423691373095,1.0,10/38,19.72%,NDUFA5;NDUFB9;NDUFB11;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,phosphatidylserine metabolic process (GO:0006658),0.2928406455431209,0.7762859469703891,0.7830882352941176,0.9648604400688756,1.0,3/32,4.76%,SLC27A1;PLA2G12A;OSBPL8
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3070556138472365,0.7761896593618962,0.780891719745223,0.964604935585888,1.0,4/25,10.58%,TPI1;PFKM;HK1;FOXK1
prerank,stabilization of membrane potential (GO:0030322),0.33064686410321653,0.7756677416245068,0.7622282608695652,0.9649417688221856,1.0,2/16,11.84%,CHCHD10;KCNK3
prerank,signal peptide processing (GO:0006465),-0.299558535004182,-0.7750050097399109,0.7286585365853658,0.9998715639846061,1.0,3/11,13.27%,SEC11C;SPCS3;CLN5
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.24993980956543332,-0.7749720214111928,0.752,0.9983394324726432,1.0,4/19,9.91%,PNP;ADK;APRT;TYMS
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3071863652790273,-0.7747909148357227,0.7205479452054795,0.9970707973127961,1.0,6/10,35.95%,BLMH;ADO;TST;MPST;CBS;CTH
prerank,regulation of synapse assembly (GO:0051963),0.2770834266378132,0.7746737275933064,0.7990867579908676,0.9659793599342866,1.0,10/46,16.25%,BDNF;CLSTN1;APP;SETD5;SLIT1;IL1RAP;CLSTN3;CHRNB2;TLR2;NLGN3
prerank,positive regulation of catabolic process (GO:0009896),0.2620445036559102,0.7737052817654345,0.8044198895027624,0.9670173336241342,1.0,26/65,29.53%,WNT5A;EGLN2;RILP;AREL1;DACT1;BARD1;SORL1;SMURF1;VPS28;TIPARP;WWP1;HUWE1;SMURF2;IDE;VCP;AXIN1;TNF;SEC22B;SNF8;VSIR;HECW2;DDB1;TRIM32;HACE1;RAB7A;TNFSF12
prerank,inositol lipid-mediated signaling (GO:0048017),0.2725813774255267,0.7734397149528396,0.8213879408418657,0.9669807194938236,1.0,8/50,14.43%,IRS1;PLCB4;PIK3CD;ADAP2;PLCB3;PI4KB;PIK3CB;IRS2
prerank,muscle tissue morphogenesis (GO:0060415),-0.2704140846540066,-0.7733854867210322,0.7931034482758621,0.9978388391084716,1.0,7/16,35.03%,TGFBR3;ZFPM1;EFEMP2;BMP2;BMP4;HEY2;MYLK
prerank,positive regulation of cell cycle process (GO:0090068),0.2542950125520042,0.7732340545854998,0.8468848996832101,0.9668717322693453,1.0,15/91,15.63%,TGFA;CDC25B;PKN2;DYNC1H1;FEN1;XRCC3;INSR;UBXN2B;PHIP;DDX11;PRKCE;RANBP1;CEP295;GEN1;NUDT16
prerank,protein localization to cell periphery (GO:1990778),0.24798552489128517,0.7723925998006752,0.8766700924974307,0.9676658577010685,1.0,41/133,26.53%,PIGW;RAB8B;ATP1B3;ACTN2;RAB12;SEC16A;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;EPB41L3;TNIK;EFR3A;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;FLOT2;WDR19;RAP2A;ZDHHC3;ZFYVE27;RABEP1;RAB10;ZDHHC22;C2CD5;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;LIN7C;RAB3D
prerank,acylglycerol biosynthetic process (GO:0046463),0.3082767955278135,0.7723612236835712,0.759379042690815,0.9673088192738762,1.0,7/23,23.93%,PNPLA2;LPIN2;LPGAT1;PLCE1;PNPLA3;ANG;AWAT2
prerank,glycoprotein metabolic process (GO:0009100),0.2720531759698177,0.7722870866606526,0.8205417607223476,0.9670326052305465,1.0,8/53,10.73%,ERP44;ST6GALNAC6;MAN1A2;NGLY1;B4GALT5;GANC;TNIP1;HPSE
prerank,ethanol metabolic process (GO:0006067),-0.29794220096461144,-0.7718672942635538,0.7722772277227723,0.9988418157597969,1.0,3/12,18.59%,ALDH2;ACSS1;SULT1A1
prerank,cortical cytoskeleton organization (GO:0030865),0.2807204895068571,0.7717461667601865,0.7909930715935335,0.9674400343175017,1.0,11/41,21.34%,FMNL2;RHOF;EPB41L3;TRPV4;RAC1;DLG1;LLGL1;FMNL3;NCKAP1;RND2;RHOH
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3269865523423384,0.7716654566188264,0.7686980609418282,0.9671607085204438,1.0,7/16,26.08%,ABCD1;AK4;COX7A2;VCP;PDE12;SLC25A33;COX7A2L
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3373639943562505,0.7712094426401314,0.7674094707520891,0.967417555752533,1.0,3/16,15.95%,NAA50;NAA35;NAA25
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2634358793021,0.7711493206660129,0.8217934165720772,0.9671093434309586,1.0,13/64,16.96%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,negative regulation of GTPase activity (GO:0034260),0.31051971811873014,0.7710734809784833,0.7578534031413613,0.9668239352527594,1.0,5/22,18.34%,RASA4;PLXNB3;LRCH1;RRP1B;CPEB2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.31966163170851886,0.7706414044363763,0.7439678284182306,0.9670576525070647,1.0,3/18,15.07%,TRIB3;RSC1A1;INPP5K
prerank,cobalamin metabolic process (GO:0009235),0.3308452564251711,0.7703711879362485,0.7594594594594595,0.9670875579047139,1.0,7/17,28.06%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.34392468572741836,0.7698433372193857,0.7415254237288136,0.9674569411191386,1.0,6/13,30.78%,DDX20;SRSF10;SART3;PRPF19;AAR2;USP4
prerank,protein K63-linked deubiquitination (GO:0070536),0.29221361289754055,0.7693556718164662,0.7957124842370744,0.9677678927218248,1.0,13/31,29.09%,USP50;USP25;CYLD;OTUD1;ZRANB1;BABAM2;USP8;USP33;OTUD5;ABRAXAS2;STAMBPL1;BABAM1;ATXN3
prerank,covalent chromatin modification (GO:0016569),0.34294216508618747,0.7693500210132417,0.7482319660537482,0.9673796804884853,1.0,7/14,26.82%,MBD2;MT3;SETD5;HDAC1;HLCS;HELLS;UFL1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.27831876290315793,-0.7692579288503085,0.7446043165467626,1.0,1.0,6/14,23.92%,PRKCZ;RARA;NFKBID;CD86;ANXA1;CD80
prerank,protein deacetylation (GO:0006476),0.27698551002204397,0.7691744926713908,0.8144690781796966,0.9672552010053,1.0,12/41,25.39%,RBM14;MTA3;MTA2;SIRT6;MIER1;RCOR3;HDAC1;HDAC2;HDAC4;HDAC6;FLNA;SIRT2
prerank,smoothened signaling pathway (GO:0007224),-0.21475638609216538,-0.7684690488362219,0.8807339449541285,1.0,1.0,15/32,26.51%,PKD2L1;ULK3;TTBK2;HIPK1;TCTN2;GPC2;DISP3;HIPK2;EVC2;TCTN3;TMEM231;TMEM17;STIL;GLI2;MAP3K10
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2874373228328034,0.7684577633064431,0.7923832923832924,0.9679056202394526,1.0,6/31,16.74%,LRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,second-messenger-mediated signaling (GO:0019932),0.25634181025028857,0.7683308264496911,0.8501594048884166,0.9676943839928265,1.0,7/82,9.00%,AGT;CXCR4;RCAN1;PPP1R9A;SAMD14;ACKR3;P2RX4
prerank,synaptic vesicle endocytosis (GO:0048488),0.28790182992084046,0.7676644136923712,0.7768395657418576,0.9682460465460757,1.0,12/33,23.92%,SYNJ1;DNM2;PIP5K1C;VAMP2;STON1;SNAP91;NLGN3;OPHN1;STON2;ITSN2;DNM3;PACSIN1
prerank,purine-containing compound salvage (GO:0043101),0.3501124323691029,0.7672197973677454,0.7478134110787172,0.9684844526005921,1.0,3/12,18.93%,DCK;HPRT1;AMPD3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.22451003135780212,-0.7671329666214564,0.8282208588957055,1.0,1.0,15/30,36.61%,LPAR1;ARRB1;PRAG1;ARHGEF3;F11R;NET1;F2R;ROBO1;LPAR6;GPR18;F2RL2;GPR65;RTN4R;GPR174;LPAR4
prerank,actin filament-based transport (GO:0099515),0.3107133458199447,0.766533277651929,0.76953125,0.9690426914736158,1.0,4/21,13.86%,MYO1C;FNBP1L;SUN2;MYO6
prerank,actomyosin structure organization (GO:0031032),0.2569484335262599,0.7664128556337222,0.8313384113166485,0.9688060383269811,1.0,8/75,12.83%,MYOZ2;CSRP1;ACTN2;TNFAIP1;FRMD6;EPB41L3;TMOD3;EPB41L5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3066325705856558,0.7662746924611724,0.7730138713745272,0.9686017991891944,1.0,4/22,12.60%,UBAP1;MVB12A;VPS37A;VPS28
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3488591532206113,0.7661875170342445,0.7510853835021708,0.9683316789079726,1.0,5/11,28.00%,ZC3H12A;DFFA;SIRT2;BCL2L1;FZD3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.29704274432455013,0.7661136018311362,0.8043202033036849,0.9680312132949341,1.0,3/26,10.01%,SLC18A2;ABCD1;SPHK2
prerank,presynaptic endocytosis (GO:0140238),0.3052198780556994,0.7660546958131631,0.7831632653061225,0.9677216224969494,1.0,7/24,17.48%,SYNJ1;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3462750705540583,0.7659819457762747,0.7492447129909365,0.9674147265118522,1.0,4/12,16.67%,ARHGEF7;MAPRE1;TBCD;STMN2
prerank,determination of heart left/right asymmetry (GO:0061371),0.2756121020814228,0.7658870563935339,0.8035087719298246,0.9671565172549773,1.0,4/42,11.25%,CCDC40;NPHP3;SRF;SETDB2
prerank,positive regulation of lyase activity (GO:0051349),-0.27407299852387396,-0.7658267481503712,0.7935483870967742,1.0,1.0,2/14,6.57%,STIM1;ISCU
prerank,positive regulation of histone acetylation (GO:0035066),0.30424077525339926,0.7657047173564859,0.7681347150259067,0.9670075593375014,1.0,8/23,22.40%,TADA2A;TADA2B;SPHK2;PPARGC1A;PAXIP1;BRD7;KAT7;RUVBL2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.31038428229767634,0.7656576463626285,0.779467680608365,0.9666818048815254,1.0,2/23,2.84%,TAOK3;SASH1
prerank,iron ion transport (GO:0006826),0.2726442404101208,0.7655222752374371,0.8236658932714617,0.9664868146406128,1.0,11/47,19.41%,ATP6V0D1;SLC11A2;RAB11B;TTYH1;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ABCB7;ATP6V1G2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.30452321721148823,0.7653204588601425,0.788586251621271,0.9663813854652104,1.0,5/24,13.67%,XRN1;DCP2;ERCC4;HNRNPA1;STN1
prerank,icosanoid secretion (GO:0032309),-0.28323447725570533,-0.7649691909434044,0.7913907284768212,1.0,1.0,7/12,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,catecholamine metabolic process (GO:0006584),0.3378138663048254,0.7647615478633246,0.7566807313642757,0.9667817759449547,1.0,3/14,20.78%,DDC;COMT;RNF180
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.27467783444484867,0.7644991710953923,0.7983682983682984,0.9667494012608998,1.0,8/46,14.42%,PSME2;SOD2;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.25023466043752207,0.7643798370593483,0.8756476683937824,0.9665360289188117,1.0,20/125,14.87%,NUP37;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;DYNC1LI2;KIF3B;EFHC2;MAPRE1;NEK9;CENPN;SUN2;NEK6;DYNLL1;AHCTF1;MAP4;MIS12;KIF2A
prerank,positive regulation of protein modification process (GO:0031401),0.24215445947513317,0.76433331194979,0.9144008056394763,0.9662100395157486,1.0,30/203,15.26%,IRGM;KDR;DAXX;SEMA4D;CD40;ANKLE2;CCND2;SOX9;CCND1;MYDGF;MT3;PPIA;LYN;LEPR;APP;INSR;TNIK;CIB1;VEGFD;FGF9;SVIP;RACK1;DAB2;RAC1;SPPL3;CEP295;RB1CC1;HSP90AA1;NPTN;CALM3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3200339108755717,0.7638478034847673,0.7797062750333779,0.9665076514286743,1.0,3/19,7.36%,FBXO7;FBXW7;CSNK2A2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3099109600282576,0.7633336535898361,0.775,0.9668605610632213,1.0,2/21,4.76%,PLA2G12A;OSBPL8
prerank,positive regulation of signaling receptor activity (GO:2000273),0.28547590423087,0.7632849648243675,0.8156956004756243,0.9665364567948169,1.0,7/36,18.30%,TGFA;FBXW7;NRP1;BUD31;JAK2;NLGN3;HDAC1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3389502131080403,0.7632094300578779,0.7619718309859155,0.9662555511966323,1.0,2/13,8.41%,HYAL1;CSPG4
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.32364536343090805,0.7628416873171102,0.7665369649805448,0.966387869763132,1.0,7/18,25.55%,RNF5;AMFR;RNF185;RNF103;TRIM13;EDEM2;DERL2
prerank,cellular response to interleukin-4 (GO:0071353),-0.3106488430120024,-0.7628240162421878,0.7549019607843137,1.0,1.0,6/10,33.91%,JAK3;SHPK;LEF1;STAT6;TCF7;GATA3
prerank,chemical synaptic transmission (GO:0007268),0.23893472388269235,0.7628029314342942,0.949,0.9660465407300637,1.0,46/284,19.26%,CHRNA9;PDE7B;PMP22;PCDHB13;GRIN2D;GRIK3;SLC18A2;CRHBP;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;CACNA1A;PRKAR2B;MYCBPAP;HSPA8;GLRA2;PCDHB16;RAPSN;GABBR2;KCNK3;HTR2A;AKAP9;APOE;HTR1F;VAMP2;NAPA;NAPB;BSN;DLG1;MINK1;CHRNB2;GRID1;HCRTR1;GRIA4;NLGN3;STAC3;PRKAR2A;MPZ;SLC32A1;GAD1;PAFAH1B1;BRSK1;CAMKK2;GABRG1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3032068139708676,0.7626458557558847,0.7673830594184576,0.9658798579395543,1.0,6/22,17.87%,NOL9;RPS21;RRS1;KRI1;EXOSC9;WDR12
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.291584550939024,0.7626303783912267,0.7947434292866082,0.9655163624991562,1.0,9/31,18.25%,POLR2G;CNOT7;DCP2;DIS3L2;EXOSC9;NT5C3B;HBS1L;DCPS;LSM5
prerank,neuron projection extension (GO:1990138),0.28489890915160937,0.7621129094179553,0.7963414634146342,0.965855335377119,1.0,8/32,19.08%,NRP2;HSP90AB1;CYFIP1;CTNNB1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.32931256934912456,0.7618055822415488,0.773841961852861,0.9658853155867076,1.0,3/16,24.51%,CLDN10;CLDN11;CLDN12
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.2807029156674859,0.7617108200921785,0.8177278401997503,0.9656252570781004,1.0,7/36,14.62%,DHFR;ZDHHC21;GCH1;DNM2;APOE;PIK3CB;HSP90AA1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.23761583443554957,-0.7615893204433081,0.8347826086956521,1.0,1.0,8/23,20.62%,ZFYVE19;NABP1;NABP2;BUB1;PLK2;CDK5RAP3;SETMAR;VPS4A
prerank,cellular amino acid catabolic process (GO:0009063),0.25361483342379937,0.7615633402234437,0.8407172995780591,0.9654510046614312,1.0,16/87,18.12%,HYKK;AUH;HMGCL;ALDH7A1;DLD;AASS;BCKDK;SHMT1;GCSH;GCDH;PIPOX;GLUD1;ACAT1;HIBADH;MCCC1;GAD1
prerank,regulation of cilium assembly (GO:1902017),0.2634111818662165,0.7613259432945311,0.827433628318584,0.9653890919105398,1.0,21/62,25.54%,TBC1D1;KCTD17;RABEP2;TBC1D8;CYLD;CCDC88A;CDK10;ODF2L;DYNC2LI1;DYNLT2B;TBC1D2;DCDC2;TESK1;SGSM3;ENTR1;IFT140;BBS4;TBC1D2B;EVI5L;TBC1D20;TBC1D17
prerank,calcium ion homeostasis (GO:0055074),0.25142562667839746,0.7610403971490938,0.8569937369519833,0.9654018639585752,1.0,13/95,15.96%,CCL7;CD40;SLC8A1;CCL5;SLC30A1;CHERP;TFAP2B;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3
prerank,regulation of hemopoiesis (GO:1903706),0.35663989179291755,0.7610098074184847,0.7754800590841949,0.9650516828951042,1.0,2/10,11.07%,RUNX1;IL17D
prerank,lymphocyte proliferation (GO:0046651),0.30894914118258154,0.7607284927255565,0.80859375,0.9650452312269527,1.0,4/22,17.53%,CD40;ELF4;LMBR1L;PTPRC
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.20647167557962187,-0.7606463234393616,0.89171974522293,1.0,1.0,12/34,21.99%,TICAM2;IRAK3;DAB2IP;TREM2;CACTIN;OTUD4;SMPDL3B;TYRO3;CD14;LRRC14;NLRP2B;TNFAIP3
prerank,pulmonary valve development (GO:0003177),-0.25128748187360017,-0.760252956009591,0.8068181818181818,1.0,1.0,8/18,33.49%,JAG1;TGFB2;TNFRSF1B;SMAD6;ROBO1;BMP4;HEY1;HEY2
prerank,mRNA modification (GO:0016556),0.30519071466051095,0.7602171837440608,0.7915567282321899,0.9653426056626538,1.0,7/22,19.19%,TRMT61B;TRMT10C;ZC3H13;PUS7;METTL14;CBLL1;WTAP
prerank,positive regulation of secretion (GO:0051047),0.35655079216212915,0.7601431654559552,0.75,0.9650609410817922,1.0,2/11,24.27%,XBP1;ACSL3
prerank,fatty acid transmembrane transport (GO:1902001),0.3176778132154823,0.7595921203716116,0.7896138482023968,0.9654365814922514,1.0,2/19,9.50%,SLC27A1;ABCD1
prerank,positive regulation of nervous system development (GO:0051962),0.27515339732968264,0.7585639033003188,0.8278301886792453,0.9664888579620472,1.0,8/42,16.25%,BDNF;CLSTN1;LRP2;SNW1;NUMBL;IL1RAP;CLSTN3;NLGN3
prerank,positive regulation of vascular permeability (GO:0043117),-0.2822803680947671,-0.7584034181863493,0.796969696969697,1.0,1.0,7/12,31.95%,TGFB1;BMP6;PDE2A;FGFBP3;TJP1;OCLN;TJP3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.31155323869295637,0.7583351501026344,0.7707182320441989,0.9663868998580952,1.0,4/18,16.21%,RUFY3;KANK1;RACK1;LLGL1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3014029101121566,0.7580461964989946,0.7915006640106241,0.9663807321963721,1.0,5/23,16.76%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.32478487598973477,0.7575883424414581,0.7697547683923706,0.9666266082632737,1.0,6/16,22.68%,NCBP2;SART1;DDX23;DCPS;PRPF39;WBP4
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3044826469266664,0.7570961917237125,0.7764390896921017,0.9669172903856578,1.0,9/22,24.76%,AEBP1;HSPA8;APOE;AKAP13;CAMSAP2;GBA2;MAP1B;MAPRE3;PIK3CA
prerank,phagolysosome assembly (GO:0001845),0.3423115412233376,0.756634514997809,0.7719546742209632,0.9671555245411033,1.0,2/12,11.03%,SYT7;RAB14
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.269305197157287,-0.7560472944253377,0.8157894736842105,1.0,1.0,9/15,35.35%,ETV4;FOXC1;NME2;NCOA3;BMP4;SFRP4;SFN;TRIM16;SULT2B1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.31708424921648515,0.754811481908664,0.8005502063273727,0.9692544859250651,1.0,3/18,10.51%,KDR;RHOJ;CIB1
prerank,regulation of plasminogen activation (GO:0010755),0.34997873098134674,0.7547874597167392,0.7517337031900139,0.9689016355273483,1.0,1/12,3.72%,RUNX1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.32349973841045093,0.7547749810467685,0.7942779291553134,0.9685318172772974,1.0,4/16,13.88%,TUBB4B;VAMP2;PLEKHM2;LYST
prerank,negative regulation by host of viral process (GO:0044793),0.36343912984329146,0.7546266690330199,0.7932098765432098,0.9683515720029188,1.0,2/10,16.49%,ZC3H12A;CCNK
prerank,acylglycerol metabolic process (GO:0006639),0.2769507219638396,0.754589306373256,0.8062575210589651,0.9680171435998134,1.0,9/37,20.03%,PNPLA2;ABHD2;DGKB;DGKK;LYPLA2;APOE;DGKA;DGKI;PNPLA3
prerank,protein localization to chromosome (GO:0034502),0.2786018817604031,0.7545541880567658,0.8156288156288156,0.9676845853921311,1.0,6/34,12.70%,MSH2;HASPIN;MCM9;SLF2;CTCF;RB1
prerank,pharyngeal system development (GO:0060037),0.3259418558816793,0.75440059239795,0.7729885057471264,0.9675052953908121,1.0,3/15,15.05%,BMPR2;PTCH1;BMPR1A
prerank,leukotriene metabolic process (GO:0006691),0.31286641083911965,0.7543019966997555,0.7882037533512064,0.967246875438891,1.0,3/19,11.15%,PTGR1;DPEP2;ABCC1
prerank,positive regulation of myelination (GO:0031643),-0.2953040939036848,-0.754260406579842,0.7785016286644951,1.0,1.0,5/11,21.84%,TPPP;RNF10;TNFRSF1B;EGR2;NCMAP
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.24304209457886533,-0.7541451120470443,0.8292682926829268,1.0,1.0,6/20,14.31%,ARRB1;DIP2B;GLYR1;MAPK3;BRCA1;RPS6KA4
prerank,inorganic cation transmembrane transport (GO:0098662),0.2386719789818014,0.7539432100786523,0.9519519519519519,0.9673372446797767,1.0,26/268,12.88%,TRPM5;TRPM2;ATP6V0D1;CACNA2D4;UCP3;TRPM6;ATP1B3;KCNH8;SLC8A1;SLC46A1;SLC30A1;SLC30A5;ASIC4;SLC11A2;KCNS3;CACNA1A;P2RX4;KCNA4;CCDC51;TRPM3;DMAC2L;SLC30A6;KCNK3;SCN2A;MCOLN2;TRPV4
prerank,regulation of embryonic development (GO:0045995),0.27995198748539085,0.753883474345631,0.8128019323671497,0.9670310921259455,1.0,6/34,11.31%,DHX36;NPHP3;B4GALT5;INSR;RAB14;PHLDB1
prerank,mammary gland development (GO:0030879),0.3010611418679765,0.7528458268271347,0.7758389261744967,0.9680300264707944,1.0,3/21,14.38%,WNT7B;NOTCH4;JAK2
prerank,regulation of protein autophosphorylation (GO:0031952),0.27683573315168375,0.7528283679570529,0.7961399276236429,0.9676630827120745,1.0,11/36,20.49%,PPP2R5C;TNKS1BP1;MOB1B;PPP2R5D;ENPP1;CALM3;TAOK2;TESK1;RAP2A;PPP2R5A;DDX3X
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.24772037677776487,0.7526500767059209,0.8524762908324552,0.9675165955046581,1.0,8/90,8.91%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2720094987846653,0.7524412614736387,0.826945412311266,0.9674213498423622,1.0,12/45,23.59%,BRINP3;CHEK1;CTNNB1;BCL6;ZFP36L1;GAS1;AURKAIP1;ZWILCH;WEE1;TOM1L2;ZWINT;ZFP36L2
prerank,cell-cell junction assembly (GO:0007043),0.25974422325930324,0.7521914023057289,0.8387096774193549,0.9673513330234867,1.0,12/63,17.41%,CNTNAP1;PKN2;CTNNB1;CDH9;EPB41L3;TRPV4;PIP5K1C;ACTB;CTNND2;TBCD;JAM3;CLDN11
prerank,prostanoid metabolic process (GO:0006692),-0.2805989761667766,-0.7518190361812748,0.8088737201365188,1.0,1.0,4/13,18.35%,HPGD;PTGS1;PTGES;GSTM1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.30445259763320065,0.7517477015938097,0.7994891443167306,0.9675858808322344,1.0,6/22,20.41%,IFI35;LYN;WDFY1;ACOD1;MFHAS1;APPL2
prerank,protein lipidation (GO:0006497),0.26349591011890666,0.7516817820847096,0.845464725643897,0.9672956419727573,1.0,22/59,27.95%,PIGW;ZDHHC21;ZDHHC20;PIGV;HHAT;PGAP2;ZDHHC13;ZDHHC8;PIGQ;PIGB;PGAP3;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;PGAP4;ZDHHC16;PIGN;ZDHHC7;WDR45B;ATG12;PIGF
prerank,Golgi inheritance (GO:0048313),0.35366604937500973,0.7514727259866588,0.7734724292101341,0.9671986419566008,1.0,4/11,18.20%,PLK3;VCPIP1;STK25;GBF1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.35345239656987276,0.7514286360541801,0.7727930535455861,0.9668717165602643,1.0,2/11,4.10%,P4HA1;EGLN2
prerank,heart development (GO:0007507),-0.15748153734793705,-0.7509512685593372,1.0,1.0,1.0,17/150,10.39%,PDLIM5;TGFB1;CASP8;SGCD;NTRK3;TGFBR3;NIPBL;ZFPM2;SALL1;CACYBP;ID2;TSC2;LDB3;TGFB2;SMYD4;PDLIM1;KDM6B
prerank,phagosome-lysosome fusion (GO:0090385),0.35782241931383424,0.7509208849158621,0.7916666666666666,0.967164257111072,1.0,4/10,29.52%,SYT7;RAB7B;RAB20;RAB7A
prerank,positive regulation of exocytosis (GO:0045921),0.278367824417719,0.7505897180599459,0.8143564356435643,0.9672100167567342,1.0,13/35,27.96%,SDC4;UNC13D;CADPS2;RAB2B;HGS;CADPS;TSG101;CFTR;RAB3A;SNF8;RAB3D;SDCBP;PDCD6IP
prerank,mRNA methylation (GO:0080009),0.32505855793898575,0.7505563971410941,0.7765205091937766,0.9668727266457565,1.0,6/15,19.19%,TRMT61B;TRMT10C;ZC3H13;METTL14;CBLL1;WTAP
prerank,regulation of actin filament-based movement (GO:1903115),0.3490368756860871,0.7502780940815059,0.7803030303030303,0.966867225697056,1.0,3/10,24.71%,PDPN;PDE4B;ANK2
prerank,arachidonic acid metabolic process (GO:0019369),-0.2092129761287844,-0.7502153241151848,0.8793103448275862,1.0,1.0,14/35,30.32%,PTGDS;PTGS1;MGLL;CYP2A6;FAAH;PTGES;CBR1;GPX1;HPGDS;EPHX1;PTGIS;PLA2G4C;CYP1A1;ALOXE3
prerank,regulation of lipid catabolic process (GO:0050994),-0.24753249226051993,-0.7500089159311666,0.819327731092437,1.0,1.0,2/19,3.13%,PDE3B;ALK
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.33394153059903164,0.749216244063624,0.78,0.9679139807682534,1.0,6/13,26.13%,SEC16A;SORL1;BCAP31;TM9SF4;EDEM2;EDEM1
prerank,cellular glucose homeostasis (GO:0001678),-0.19173273432596544,-0.7491445755183088,0.9154929577464789,1.0,1.0,11/41,21.19%,FOXK2;SLC39A14;SIRT1;PIK3R2;FOXO1;PCK2;IGF1R;PDK3;HIF1A;SOX4;LRRC8A
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.32037969983972314,0.749090741784332,0.7744154057771664,0.9677080435608157,1.0,5/17,16.39%,HCK;STAP1;NRP1;BAIAP2;BAIAP2L1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.28108333919932593,-0.7489689266590991,0.8338762214983714,1.0,1.0,2/11,5.81%,REST;PINK1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.266305278079391,-0.7488217232318285,0.8226415094339623,1.0,1.0,2/15,10.36%,ATP1B1;KCND3
prerank,establishment of vesicle localization (GO:0051650),0.3079393336896691,0.7486986240752936,0.7810413885180241,0.9678469118556996,1.0,7/18,27.30%,SYNJ1;DNM2;RAB11A;TESK1;CCDC186;SYT11;CDK5
prerank,neuron migration (GO:0001764),0.26572079417719363,0.7486380820065152,0.831603229527105,0.9675370579416093,1.0,14/48,19.83%,TUBB2B;RAPGEF2;DDIT4;FGF13;NRP1;RAC1;DNER;LRP12;PEX13;DCDC2;PAFAH1B1;MARK1;MAP1B;CCK
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3151952107875457,0.748567478341025,0.7994389901823282,0.9672453234705342,1.0,2/17,4.40%,S1PR2;ZDHHC21
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3318415105116503,0.7483925516802715,0.7942446043165468,0.9670884162613138,1.0,1/14,2.63%,CD40
prerank,regulation of peptidase activity (GO:0052547),0.3054843405686092,0.7483449076204476,0.8024861878453039,0.9667669275619758,1.0,5/19,18.45%,PSMA3;CTSH;CST7;HDAC1;SVBP
prerank,negative regulation of cholesterol transport (GO:0032375),0.35668460645651834,0.7480796051475135,0.7733333333333333,0.9667309381509632,1.0,1/10,6.30%,NFKB1
prerank,membrane repolarization (GO:0086009),-0.2686609893868389,-0.747983896275791,0.8148148148148148,1.0,1.0,3/15,10.36%,ATP1B1;ATP1B2;KCND3
prerank,mitochondrial fusion (GO:0008053),0.30970627516015814,0.7478432491512655,0.7935656836461126,0.966647389151673,1.0,4/18,17.15%,FIS1;GDAP1;MIGA2;BAX
prerank,positive regulation of phospholipase C activity (GO:0010863),0.27116398686996707,0.747803590341498,0.8301886792452831,0.9663145641108033,1.0,3/40,5.57%,FLT1;BDNF;GNA15
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3492724292081085,0.7470064541094154,0.7743362831858407,0.9670122617727441,1.0,4/11,19.77%,RAPGEF6;RAPGEF2;TJP2;RAB1A
prerank,regulation of cell size (GO:0008361),0.29538741067306745,0.7468499809633191,0.7750325097529259,0.9668332412640034,1.0,7/23,22.74%,RARG;VAV1;AKT1S1;RAC1;MTOR;LAMTOR4;MSN
prerank,negative regulation of insulin secretion (GO:0046676),0.3194842222726667,0.7467001295292717,0.7553191489361702,0.9666389205367868,1.0,5/17,25.50%,IRS1;MIDN;PSMD9;PIM3;KCNB1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.33027526615202274,0.746683881368094,0.7761627906976745,0.966275357682067,1.0,2/12,7.86%,PHGDH;SEPHS1
prerank,axonemal dynein complex assembly (GO:0070286),0.2884731722858297,0.7465607513770046,0.7997512437810945,0.9660620248649134,1.0,5/27,16.38%,ODAD2;CCDC40;ODAD4;CFAP73;DNAL1
prerank,phosphate ion transmembrane transport (GO:0035435),0.33808541630525446,0.7463423147870085,0.7847730600292826,0.965958406106734,1.0,5/12,23.00%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.2940645585195973,-0.7463312832320866,0.7761627906976745,1.0,1.0,4/10,21.51%,IMPACT;HIF1AN;BAG3;DNAJB1
prerank,digestive tract morphogenesis (GO:0048546),-0.26854136600956957,-0.7454012307233173,0.8113879003558719,1.0,1.0,2/14,7.16%,NIPBL;ID2
prerank,regulation of RNA splicing (GO:0043484),0.25533998486050313,0.7438819506205208,0.8565169769989047,0.9687276288274905,1.0,27/69,29.36%,FASTK;SLC38A2;HNRNPH1;HNRNPK;CLK3;SRPK1;HNRNPL;HNRNPH3;CLK2;MBNL2;RBM39;RRP1B;CWC22;HNRNPF;ERN1;SRSF10;TRA2B;SON;ZNF326;FUS;SNRNP70;SRPK2;KHDRBS2;SETX;PIK3R1;KHDRBS1;QKI
prerank,actin filament polymerization (GO:0030041),0.28674809024827536,0.7433375193533702,0.8272727272727273,0.9690221521730509,1.0,12/29,27.45%,GAS7;CORO7;GSN;RAC1;JAK2;AIF1;TTC17;MSRB1;ANG;DIAPH1;WASHC5;WASF1
prerank,autophagosome organization (GO:1905037),0.26175145200866146,0.7431829037103085,0.8274285714285714,0.9688207131487042,1.0,7/50,14.48%,IRGM;UBQLN2;RAB43;UBQLN1;UBXN2B;MAP1LC3B;RB1CC1
prerank,regulation of dephosphorylation (GO:0035303),0.32089224213922257,0.7431141409292695,0.8,0.9685345404357901,1.0,4/15,15.07%,SMG7;IGBP1;SMG5;INPP5K
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.2073498340721771,-0.743066846572848,0.8932584269662921,1.0,1.0,14/30,40.07%,CACNA2D1;SCN3B;GJC1;SCN2B;KCNH2;CACNA1G;ATP1A1;RYR2;KCNQ1;SNTA1;CACNA1C;KCNE3;FGF12;KCNE4
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.20752875730998477,-0.7423249397439974,0.8862275449101796,1.0,1.0,7/32,16.20%,SORBS1;ASAH1;C3;AKT1;CEACAM1;CREBL2;CREB1
prerank,GPI anchor metabolic process (GO:0006505),0.28555110776496495,0.7422089852602918,0.7975155279503106,0.9692858463067195,1.0,6/26,19.29%,PIGW;PIGV;PGAP2;PIGQ;PIGB;PGAP3
prerank,tetrapyrrole metabolic process (GO:0033013),0.3177717793339675,0.7421236922334257,0.7877551020408163,0.9690099737807821,1.0,7/18,28.06%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,cristae formation (GO:0042407),0.29015702849070274,0.7417667024251392,0.806861499364676,0.9691018827182932,1.0,5/27,14.89%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO
prerank,positive regulation of coagulation (GO:0050820),-0.2917082872697131,-0.7417482485729027,0.7935483870967742,1.0,1.0,4/10,28.29%,DMTN;ENPP4;F2R;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),-0.2917082872697131,-0.7417482485729027,0.7935483870967742,1.0,1.0,4/10,28.29%,DMTN;ENPP4;F2R;ST3GAL4
prerank,cellular response to increased oxygen levels (GO:0036295),0.3422503899994979,0.7415854706221754,0.7744807121661721,0.9689492984930953,1.0,1/11,2.09%,ATP6V0D1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.29569258775715346,0.7413068559215856,0.7911227154046997,0.9689178144223827,1.0,1/24,1.73%,KDR
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.2369557249886548,-0.7407242726720215,0.8697183098591549,1.0,1.0,5/20,16.43%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,plasma membrane repair (GO:0001778),-0.2789247964585393,-0.7405141070462934,0.8260869565217391,1.0,1.0,3/13,9.71%,AHNAK2;MYOF;ANXA6
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2254677109440435,-0.7405103050911065,0.8529411764705882,1.0,1.0,6/22,23.67%,SLC16A2;ID2;KDM1A;PTPRZ1;DISP3;SHCBP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.28609593917159176,0.7398623515840337,0.8417085427135679,0.9704194810443734,1.0,11/27,27.27%,FBXO7;EFHC2;CCDC88A;PSEN1;FCGR2B;MARK1;BRSK1;VPS35;NTNG2;PTEN;ULK4
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.22906163048556644,-0.739636321158838,0.8488372093023255,0.9998812161584792,1.0,3/21,10.06%,TGFB1;BMP6;NUP93
prerank,hydrogen peroxide metabolic process (GO:0042743),0.30378758959440516,0.7396235977512795,0.785809906291834,0.9703441301689681,1.0,5/19,24.16%,PXDNL;PRDX2;ACOX1;PRDX3;CYBA
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.24793963277653733,-0.7390394834799736,0.8695652173913043,0.9992139130481797,1.0,6/17,21.20%,CEACAM1;CEBPB;CD24;KLF7;MAFF;CAV1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2711562956115505,-0.7387032590868694,0.7929936305732485,0.9981915883041466,1.0,4/13,19.75%,NT5M;OGG1;NEIL1;DUT
prerank,negative regulation of TORC1 signaling (GO:1904262),0.33267791997316765,0.7380073505653063,0.7977207977207977,0.9720290526156806,1.0,4/13,27.04%,KPTN;STK11;SZT2;SESN1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2708172174164705,0.7379935200819244,0.8355184743742551,0.9716722033235895,1.0,5/39,11.69%,MAD2L2;PODXL;PPM1F;NOTCH4;FXYD5
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.28009767878122893,-0.7377247240206694,0.7842465753424658,0.9980180808614999,1.0,6/13,41.63%,SCN3B;GJC1;KCNQ1;CACNA1C;CACNB2;KCNJ5
prerank,tRNA processing (GO:0008033),0.2535571983806595,0.7375335738535644,0.8587075575027382,0.97188945716479,1.0,13/61,17.86%,TRMT9B;TRPT1;ADAT2;TRMT1;AARS1;TSEN2;FAM98B;WDR4;TRMT10C;ADAT1;RTCB;RPP30;TSEN34
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.287687778725711,0.7373167141446407,0.8341584158415841,0.9717829825700521,1.0,4/28,12.38%,YTHDF1;EPHA4;APP;APOE
prerank,regulation of cell motility (GO:2000145),0.2378446382467803,0.7372576418531939,0.8945191313340227,0.9714863841375279,1.0,27/121,22.56%,DAPK3;SGK3;PLXNA3;PLXNB2;SPATA13;PKN2;PLXNB3;OSGIN1;TBCCD1;FGF9;LDB2;LDB1;RAC1;MINK1;CFAP20;AMOTL2;KIF2A;CRK;CAVIN1;MEMO1;PIN1;ARHGAP18;DOCK10;CCDC25;ABL2;FGF2;ERBB3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.26170735366464637,-0.7367289595217836,0.8211920529801324,0.9978644562714603,1.0,6/14,24.33%,TPM1;IGFBP5;TRIB1;PRKG1;MEF2C;IGFBP3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.27339483858201175,-0.7363369890478298,0.8070175438596491,0.9969275711244182,1.0,5/12,23.92%,PAEP;CARD9;RASGRP1;IL1B;CD80
prerank,methylguanosine-cap decapping (GO:0110156),-0.2933530586775528,-0.7354560909174339,0.7988505747126436,0.996643881931119,1.0,2/10,6.28%,PATL1;DCP1A
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3180214428316075,0.7347964950039737,0.8016643550624133,0.9742973536377265,1.0,7/15,26.72%,CCT4;CCT7;CCT3;RUVBL2;NHP2;RUVBL1;TCP1
prerank,ventricular septum morphogenesis (GO:0060412),0.28283211513811896,0.7346853981911783,0.8228498074454429,0.9740710779085262,1.0,5/27,15.05%,ACVR1;BMPR2;PROX1;SLIT3;BMPR1A
prerank,cardiocyte differentiation (GO:0035051),-0.2956319256157617,-0.734660001016041,0.806060606060606,0.9961920140456993,1.0,4/10,19.27%,TGFB2;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,positive regulation of protein maturation (GO:1903319),0.33753012785284603,0.7341919738574381,0.8,0.9743466309781568,1.0,2/11,14.77%,ADAM8;TFR2
prerank,female gamete generation (GO:0007292),0.27965123368611633,0.7340119214849086,0.8357664233576643,0.97419310250391,1.0,6/29,22.85%,GDF9;MCM9;MARF1;MDK;MEI4;KMT2D
prerank,chloride transport (GO:0006821),0.2471117986868685,0.7337497337211387,0.8677595628415301,0.9741287284493975,1.0,18/74,23.27%,CLIC4;SLC26A1;SLC12A5;CLCN2;CLCN6;SLC12A8;TTYH1;GLRA2;ANO10;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;SLC1A3;CLIC1;GABRA3;SLC26A7
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2646079200094678,-0.7337073199108018,0.8381877022653722,0.9960287077866273,1.0,7/13,27.12%,LARP7;NELFB;NELFE;HEXIM1;NELFA;SUPT4H1;RNF168
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24793267297351151,0.7328741280592151,0.8730853391684902,0.9748544215324971,1.0,12/72,14.00%,XRN2;POLD4;CHD1L;RFC4;RFC1;FEN1;ERCC4;RBX1;POLK;ZC3H12A;ENPP1;RNASE1
prerank,aerobic electron transport chain (GO:0019646),0.25063768935351083,0.731715262631016,0.8758099352051836,0.9759428517841424,1.0,15/68,20.30%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.32170597242720267,0.7316670176627595,0.8085106382978723,0.9756243996150921,1.0,3/13,23.31%,SFRP2;RBPJ;NOTCH1
prerank,copper ion transport (GO:0006825),0.3426059521971651,0.7312978396889687,0.7792998477929984,0.9756985877906977,1.0,5/11,25.64%,SLC11A2;SLC31A1;SLC31A2;COX17;ATP7B
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2733147746859957,0.731134205493539,0.8373493975903614,0.9755276670088804,1.0,7/35,16.64%,SLC25A1;HMGCL;SCD5;GGT7;PAM;GCDH;ACAT1
prerank,hemidesmosome assembly (GO:0031581),0.33275480357588694,0.7306774906192388,0.8017751479289941,0.9757016171350344,1.0,1/11,3.78%,LAMC1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2709677862541403,0.7306168672953554,0.8473748473748474,0.9753982288560432,1.0,6/32,10.79%,TCOF1;CYFIP1;NOLC1;APP;TMED10;PUM3
prerank,V(D)J recombination (GO:0033151),-0.28308279655383883,-0.7304802075733035,0.8403614457831325,0.9987943447271896,1.0,3/11,12.62%,XRCC4;DCAF1;LIG1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.29626295658513024,-0.7304166071799837,0.8289855072463768,0.9973833232907245,1.0,4/10,23.94%,NIPSNAP2;CACNA2D1;SRI;NOS1AP
prerank,peptidyl-threonine modification (GO:0018210),0.24793071120522966,0.7304066067278173,0.8530701754385965,0.9753026967651036,1.0,12/66,16.66%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;GALNTL6;CDK10;DYRK2;PRKDC;GALNT1;OXSR1;STK39
prerank,cellular response to acid chemical (GO:0071229),0.28237662576214356,0.7300135947680585,0.8211586901763224,0.9753975804995101,1.0,8/27,22.25%,RRAGC;GLRA2;XBP1;LAMTOR3;MTOR;LAMTOR4;GLRA1;RRAGA
prerank,eye photoreceptor cell development (GO:0042462),0.314932715094025,0.7296356165361673,0.7900552486187845,0.9754853577909424,1.0,1/15,3.55%,THY1
prerank,glycine transport (GO:0015816),0.34415013808686923,0.7289874400449148,0.8116591928251121,0.9759331444916193,1.0,10/10,65.61%,SLC6A17;SLC36A1;SLC6A20;SLC6A9;SLC7A8;SLC6A5;SLC38A5;SLC36A3;SLC25A38;SLC36A2
prerank,vasoconstriction (GO:0042310),0.33645625526008666,0.7287052538609291,0.8051750380517504,0.9759070419095828,1.0,1/11,3.73%,SLC8A1
prerank,actin filament depolymerization (GO:0030042),-0.2819306071272184,-0.7286482513281712,0.8211143695014663,0.998163731108396,1.0,2/11,5.12%,CFL1;MICAL1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.22903148703595155,0.7283878288243554,0.9488977955911824,0.9759430071459044,1.0,30/224,16.99%,CHRNA9;PDE7B;PMP22;PCDHB13;SLC18A2;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;CACNA1A;PRKAR2B;MYCBPAP;GLRA2;PCDHB16;RAPSN;GABBR2;KCNK3;HTR2A;AKAP9;HTR1F;BSN;DLG1;MINK1;CHRNB2;HCRTR1;GRIA4;NLGN3;PRKAR2A;MPZ
prerank,positive regulation of phospholipid transport (GO:2001140),-0.30088102368931485,-0.7283277651798262,0.7920489296636085,0.9970874913066474,1.0,5/10,34.85%,DBI;ABCA3;ABCA7;ABCB4;TRIAP1
prerank,protein dephosphorylation (GO:0006470),0.23629127643447587,0.7279998759382164,0.9235537190082644,0.9760378470486386,1.0,45/135,26.67%,EYA4;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;RPAP2;NCK1;TIMM50;PTPN7;BTRC;DUSP26;PPM1F;PPP2R5D;PTPN11;PPP4R2;DUSP10;DUSP16;DUSP11;PTPN9;EYA2;PPP2R2A;PTPRU;PTPRC;DUSP8;PTPRB;PTPRF;PPTC7;PPP2R5A;STK11;LHPP;PPP2R3A;PTPRM;PPP1R12A;PTPN6;PTPRS;PPM1H;PDP1;PTPN1;EYA3;PPM1A;PTEN;DUSP7;EYA1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.31642991016637295,0.7279377431463425,0.8162393162393162,0.9757422911179269,1.0,2/16,7.46%,ST6GALNAC4;ST6GALNAC6
prerank,negative regulation of cellular senescence (GO:2000773),-0.26328146532910035,-0.727811968801135,0.8256578947368421,0.9963009951402568,1.0,3/13,12.93%,MAP3K3;SIRT1;HMGA2
prerank,regulation of muscle cell differentiation (GO:0051147),0.27386178378813236,0.7277973605115563,0.845,0.9755245314080272,1.0,7/31,15.72%,CTNNB1;FGFR2;SRF;MEGF10;MAPK14;SPAG9;MEF2A
prerank,negative regulation of catabolic process (GO:0009895),0.2569069248552735,0.7277762796068769,0.851894374282434,0.9751678435179876,1.0,18/47,27.39%,AZIN2;MAD2L2;RILP;AGAP2;GIT1;AZIN1;PIN1;HMGCR;TIGAR;HDAC4;SNX12;FLNA;BSCL2;SIRT2;TNF;FMN2;ZDHHC7;MAD2L1
prerank,positive regulation of metabolic process (GO:0009893),0.23743154602702204,0.7276352144521959,0.8917793964620188,0.9749703396832683,1.0,9/103,9.32%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR;INSR
prerank,carboxylic acid catabolic process (GO:0046395),-0.2770629270352185,-0.7270320826413897,0.8152866242038217,0.9958337708593594,1.0,6/12,29.44%,GNPDA1;NPL;IL4I1;ACOT8;GNPDA2;NAGK
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.256459279214015,0.7269941520403338,0.8589164785553047,0.975378391458274,1.0,11/52,13.15%,FBXW7;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;TFDP2;NPEPPS;UBE2L3;BAD
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.30543231455877407,0.7265647320563824,0.8159675236806495,0.9755405569087612,1.0,4/17,16.74%,ACVR1;SNAI2;BMPR1A;RBPJ
prerank,positive regulation of leukocyte activation (GO:0002696),0.30169022191558287,0.725633575849943,0.8234501347708895,0.9763300919551676,1.0,1/18,1.54%,WNT5A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.2298657577947629,-0.7256080977612399,0.9176470588235294,0.996173770593265,1.0,9/23,23.28%,SRCIN1;SH3BP5;MVP;SH3BP5L;CBL;ZFYVE28;DUSP22;CAV1;CHMP6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.2916441232055332,0.7255950738191106,0.8152454780361758,0.9759990602682854,1.0,4/24,14.51%,ZFP36;RUNX1;ZFP36L1;PRKCH
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2739217694462285,-0.7255875790392711,0.81,0.9947220438587174,1.0,2/13,9.11%,NIBAN2;DAB2IP
prerank,response to ATP (GO:0033198),0.30868408612453196,0.725586238909687,0.8142458100558659,0.9756325229641033,1.0,4/18,22.43%,PDXP;P2RX4;HSP90B1;ABCC9
prerank,ventricular septum development (GO:0003281),0.26449188186536626,0.7250523661923015,0.8484107579462102,0.9758953669075043,1.0,7/37,17.22%,ACVR1;BMPR2;PROX1;SLIT3;MATR3;BMPR1A;HECTD1
prerank,acute inflammatory response (GO:0002526),-0.225471804342774,-0.7239694468015175,0.8774509803921569,0.9952262951540172,1.0,10/23,48.53%,PLSCR1;CEBPB;ANO6;LBP;HPR;HP;SIGIRR;CRP;VNN1;CD6
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.3017713862816142,0.7235136009698058,0.8134228187919463,0.9774137713200904,1.0,5/18,31.34%,LYN;MDK;IL6R;SLIT2;MTUS1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3083696064523434,0.7232443617099904,0.8155737704918032,0.9773503509883783,1.0,9/17,33.47%,DHDDS;ALG13;DPAGT1;DOLPP1;ALG12;ALG9;ALG14;NUS1;MPDU1
prerank,transferrin transport (GO:0033572),0.26948759327467003,0.7230069302478466,0.8484848484848485,0.9772772767850538,1.0,8/33,19.41%,ATP6V0D1;RAB11B;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ATP6V1G2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.33242992762603607,0.7227102028535898,0.8106169296987088,0.9772737057216905,1.0,6/12,25.25%,CEP19;HOOK3;NIN;BICD2;BBS4;DCTN1
prerank,glucan catabolic process (GO:0009251),-0.2515372087005833,-0.7226607688172223,0.833976833976834,0.9954096066463847,1.0,2/15,4.66%,PYGB;PGM2
prerank,signal release from synapse (GO:0099643),0.26179070379054453,0.7225177583515507,0.8596698113207547,0.9771363397083377,1.0,17/43,27.74%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2567967294649022,0.7225107388588404,0.8544378698224852,0.9767703550082906,1.0,7/45,14.03%,PNPT1;SLC38A2;DDX5;NFKB1;DIMT1;MAP2K2;WDR43
prerank,cellular response to amino acid stimulus (GO:0071230),0.26991222127224485,0.7221957454333593,0.8313397129186603,0.9767627213983741,1.0,11/33,24.06%,RRAGC;GLRA2;XBP1;LAMTOR3;FYN;MTOR;LAMTOR4;GLRA1;RRAGA;UBR2;UBR1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2816057796075802,-0.7219392473210112,0.8206686930091185,0.9948626409966324,1.0,6/11,44.78%,ATG9A;PACS2;MFN2;ATG9B;TRAPPC8;ATG13
prerank,positive regulation of immunoglobulin production (GO:0002639),0.27433235775374265,0.721899942497228,0.8445532435740514,0.9767640031937195,1.0,8/31,22.52%,MAD2L2;XBP1;SHLD1;PAXIP1;STX4;PTPRC;HMCES;KMT5C
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2608943385423156,0.7218741890989042,0.834326579261025,0.9764202709348888,1.0,7/39,18.45%,ABCA1;RAB8B;RAB12;TMEM167A;MIA2;MTTP;SVBP
prerank,cardiac atrium morphogenesis (GO:0003209),0.30272380795510917,0.7213657493628718,0.7924528301886793,0.976646571963384,1.0,2/16,10.07%,BMPR2;PROX1
prerank,primary alcohol metabolic process (GO:0034308),-0.2164902199513767,-0.7212624616552372,0.8778280542986425,0.9942518300597276,1.0,2/25,5.14%,GPD2;NAPEPLD
prerank,heart contraction (GO:0060047),-0.19417153586493896,-0.7212177135589757,0.9710144927536232,0.9928542092473903,1.0,6/41,13.24%,SGCD;ATP1B1;DMD;TPM1;GRK2;SCN3B
prerank,negative regulation of protein modification process (GO:0031400),0.24399170455203573,0.7211244429797706,0.8962162162162162,0.9765608398859689,1.0,13/79,13.22%,XDH;TARDBP;ARPP19;P3H1;PPIA;PAQR3;LYN;PRNP;MEN1;CIB1;ZC3H12A;PRKDC;CDYL
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.23271041574179507,0.7210807754382302,0.9226804123711341,0.9762442712777225,1.0,12/116,14.25%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;RHBDF2;FCGR2B;FYN
prerank,estrogen metabolic process (GO:0008210),0.3097555926278044,0.7204099422202709,0.8141843971631205,0.9766408788016615,1.0,1/15,3.59%,HSD17B7
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.25814855835082084,0.7204005903541535,0.8517241379310345,0.9762738954844092,1.0,6/43,12.33%,STAT3;DDX5;SOX9;SRF;NFIB;NR3C1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34306377712352937,0.7200929153547284,0.8236173393124065,0.9762776802120088,1.0,2/10,15.26%,GPR35;CALM3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.1844123432961235,-0.7200850918109207,0.959731543624161,0.9929079506889993,1.0,11/40,22.29%,TGFB1;SORBS1;GRIN1;AKT1;CREBL2;CREB1;SUCO;MTPN;F2R;WNT4;RAB27A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2532314539352418,-0.7199639145712411,0.8621908127208481,0.9915989117492213,1.0,4/16,16.15%,DPYSL3;NT5M;CRMP1;NT5E
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2402891808083338,0.719679620946367,0.9031914893617021,0.9763691238667824,1.0,22/94,18.92%,B9D2;CEP162;DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;NEDD1;CEP152;CEP131;CEP70;AKAP9;TUBB4B;DYNLL1;TMEM67;HSP90AA1;RAB11A;CEP89;DCTN3;PAFAH1B1;CEP135
prerank,muscle contraction (GO:0006936),0.23374100409459092,0.7193716400866375,0.9177083333333333,0.9763493213630551,1.0,15/126,17.62%,ASPH;UTRN;MYL9;SLC8A1;ACTN2;UTS2;TNNC1;MYL1;ARHGEF11;TMOD3;MYH2;CHRNB2;SSPN;TNNI2;CLCN1
prerank,ovarian follicle development (GO:0001541),0.32111719962781893,0.7192397436270254,0.808972503617945,0.9761292633635361,1.0,4/13,27.63%,EIF2B2;EIF2B5;ANG;EIF2B4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.27588354016510275,-0.7188832343930947,0.8461538461538461,0.989976967688252,1.0,6/12,31.44%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.27588354016510275,-0.7188832343930947,0.8461538461538461,0.989976967688252,1.0,6/12,31.44%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,negative regulation of cell cycle process (GO:0010948),0.25281612341043913,0.7186788774910429,0.8773690078037905,0.9764112089722347,1.0,11/61,14.65%,PCGF6;CHEK1;TFDP1;PPP1R10;RING1;MAX;TFDP2;RYBP;UXT;AURKAIP1;EZH2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.31568081550143395,0.7184507772601958,0.7985401459854015,0.9763158392222663,1.0,4/14,19.77%,SEC24D;SEC23A;SEC24A;RAB1A
prerank,acyl-CoA metabolic process (GO:0006637),0.2684976713524032,0.7183419827942894,0.8499399759903962,0.9760652133832112,1.0,3/35,6.63%,ACOT9;MCEE;ACBD6
prerank,regulation of chromatin organization (GO:1902275),0.3158964748783975,0.7183391653632596,0.8179310344827586,0.9756957272889847,1.0,5/14,21.39%,SSRP1;SETD5;MLLT3;TLK2;CDK9
prerank,amyloid-beta metabolic process (GO:0050435),-0.24131389847511753,-0.7181519997589497,0.8896551724137931,0.9893656091576003,1.0,6/16,24.04%,DYRK1A;MGAT3;BACE1;ABCA7;PSEN2;NCSTN
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.23474992057964933,-0.7176219244154289,0.875,0.9885472756804177,1.0,3/20,8.68%,TGFBR3;PDCD4;TGFB2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2722690853201064,0.717470078613381,0.8658385093167702,0.9759866814710341,1.0,12/32,27.91%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,tRNA export from nucleus (GO:0006409),0.2722690853201064,0.717470078613381,0.8658385093167702,0.9759866814710341,1.0,12/32,27.91%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.24575493393297437,0.7173747761450038,0.8927410617551462,0.9757292550470561,1.0,15/69,20.30%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,action potential (GO:0001508),0.2558403673453929,0.7172636483993428,0.8767281105990783,0.9754862599074753,1.0,3/44,6.09%,KCNMB3;GNA15;GNA14
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3195788491938734,0.717227871949971,0.8161434977578476,0.9751607739814965,1.0,1/12,2.68%,CHEK2
prerank,regulation of hippo signaling (GO:0035330),-0.24127504770540456,-0.7170542324351793,0.843065693430657,0.9878161305647185,1.0,3/17,7.65%,SCHIP1;WTIP;CIT
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3187486363688073,0.7169845260226918,0.8254649499284692,0.9750861652281898,1.0,6/15,25.49%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,mitochondrion disassembly (GO:0061726),0.2699666044907863,0.7169376761708807,0.8595641646489104,0.97477299408619,1.0,7/34,20.12%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,nuclear envelope organization (GO:0006998),0.2933426311989557,0.7168910631855946,0.8222811671087533,0.9744577583943106,1.0,4/20,14.91%,TOR1AIP1;SUN2;REEP3;NUP155
prerank,regulation of cation channel activity (GO:2001257),0.2391724864869304,0.7166593277213317,0.908315565031983,0.974342421447431,1.0,14/89,14.59%,CAMK2D;CTSS;CAMK2B;ACTN2;CRHBP;CNIH3;GRIA2;NETO1;APP;FGF13;CAPN1;VAMP2;DLG1;MINK1
prerank,response to lipid (GO:0033993),0.23654223404503083,0.7165245280271648,0.9210799584631361,0.9741197063073791,1.0,16/105,16.80%,TMEM161A;ABCG1;RARG;STAT3;CDKN2D;SOX9;CTNNB1;SLPI;CTSH;GCH1;GGT7;SOCS2;JAK2;PPARD;IRAK1;LGALS9
prerank,cranial nerve development (GO:0021545),0.3320522697064612,0.7155519881791444,0.8088888888888889,0.9748858590116661,1.0,3/11,22.56%,CHD7;CHRNB2;ERBB3
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2954864346205517,0.714825387500352,0.8136729222520107,0.9753787459193874,1.0,3/19,15.18%,RAPSN;APOE;CHRNB2
prerank,anterior/posterior axis specification (GO:0009948),0.3062095812142901,0.7143206917144262,0.8044077134986226,0.9756067313888479,1.0,15/15,69.41%,TASOR;RIPPLY2;WLS;DDIT3;SKI;TBX3;MESP2;TBXT;CDX1;SIX2;WNT8A;SHH;HOXD8;LHX1;FZD5
prerank,peptidyl-lysine methylation (GO:0018022),0.2822303988222115,0.713958923908023,0.8413705583756346,0.9756456140530064,1.0,7/26,20.99%,METTL21A;SETD3;EEF2KMT;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,meiosis I (GO:0007127),0.28321023858009614,0.7136968278645028,0.8365758754863813,0.9755860165889537,1.0,3/23,19.31%,BCL2L11;ZCWPW1;PTTG1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2408817523603378,0.7134853796183896,0.9071729957805907,0.9754567715728779,1.0,22/87,22.88%,BST2;DAPK3;TRPM2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;MDK;TESK1;ARHGAP18;RND2;RHOH;PRKCD;ABL2;IQGAP2;TWF1
prerank,membrane depolarization during action potential (GO:0086010),0.2795940698640849,0.7133008354490463,0.8421733505821475,0.9753065722360478,1.0,6/26,21.77%,SLC8A1;SCN2A;SCN1B;KCNJ2;SCN8A;HCN2
prerank,visual system development (GO:0150063),-0.19360628188432055,-0.7122655499938125,0.9505494505494505,0.9919978970453608,1.0,14/37,29.62%,PBX2;C3;TGFB2;MEIS2;HIPK1;BMPR1B;HIPK2;SMG9;FOXC1;SALL2;FREM2;MAB21L2;RAB18;MEIS1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.25311344480270587,-0.7119888418926953,0.8504983388704319,0.9908582233185198,1.0,3/14,20.40%,PTPN2;TRAIP;NLRP2B
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.28525663189449935,-0.7112766925933981,0.8761061946902655,0.9902514354334726,1.0,2/10,8.96%,GABRG3;GABRA2
prerank,positive regulation of cell killing (GO:0031343),0.3119689658732156,0.711179295628657,0.8246376811594203,0.9774366196245724,1.0,1/13,1.54%,WNT5A
prerank,histone H4 acetylation (GO:0043967),0.2565483245964225,0.7107917830502818,0.8605990783410138,0.9774972966025312,1.0,19/47,29.06%,JADE3;KMT2A;EP400;WDR5;APBB1;KAT8;KAT7;PER1;RUVBL2;ING5;ACTL6A;JADE2;ZZZ3;RUVBL1;EP300;CHD5;BRD8;YEATS4;HCFC1
prerank,regulation of gluconeogenesis (GO:0006111),0.27697894733848516,0.7105419141324179,0.8498074454428755,0.9774302241464948,1.0,4/27,13.52%,ARPP19;SIK1;PPARGC1A;CLK2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22182632139997185,-0.7103726663524803,0.9295154185022027,0.9898807981510582,1.0,6/22,19.98%,RPL23;SPRED2;UBB;RPL37;CDK5RAP3;HEXIM1
prerank,glucose transmembrane transport (GO:1904659),0.29830305792408035,0.7091924328887493,0.8466666666666667,0.9786214015939709,1.0,3/18,15.96%,SLC2A6;SLC2A9;PPARD
prerank,positive regulation of mitochondrial translation (GO:0070131),0.3092888195662176,0.7091068060270632,0.8342696629213483,0.9783377096238166,1.0,4/14,18.81%,NGRN;RCC1L;TRMT10C;FASTKD2
prerank,membrane depolarization (GO:0051899),0.26634851590430714,0.7084897619157376,0.8595848595848596,0.9786782708659905,1.0,6/32,18.02%,CACNA1A;P2RX4;SCN2A;CHRNB2;SCN1B;SCN8A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2281428738011232,0.7083011929946947,0.934224049331963,0.9785413700202352,1.0,9/117,9.57%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14
prerank,membrane assembly (GO:0071709),0.2658007058699524,0.7078425904034474,0.8564476885644768,0.9786987999253974,1.0,6/34,16.51%,CHMP4B;TLCD2;UBXN2B;STX4;NLGN3;FLOT2
prerank,positive regulation of secretion by cell (GO:1903532),0.23984220020464136,0.7077700360550974,0.8914988814317674,0.9784128401559065,1.0,20/70,25.56%,ABCG1;ADAM8;UNC13D;PPIA;BAIAP3;P2RX4;CADPS2;TMED10;RAB2B;APBB1;DTNBP1;GOLPH3L;CD33;CADPS;FRMD4A;ANG;CD2AP;CFTR;KCNB1;RAB3A
prerank,aggrephagy (GO:0035973),0.27526403046095593,0.706561867013808,0.8630490956072352,0.9794079730155034,1.0,10/27,27.97%,DYNC1H1;DYNC1LI2;UBQLN1;DYNLL1;UBE2V1;HDAC6;WDFY3;CFTR;DYNC1LI1;UBE2N
prerank,UV protection (GO:0009650),-0.28494835176658095,-0.7065007669527115,0.8203592814371258,0.9928081138964086,1.0,7/10,38.37%,ERCC2;CAT;XPA;GPX1;SCARA3;ERCC5;MFAP4
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.2524693586747722,-0.7063668648768094,0.8793650793650793,0.9915498358662967,1.0,5/14,30.59%,CHAT;NOS1;MOXD1;ACHE;ALDH9A1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2731624473627611,0.7063666766490282,0.8539603960396039,0.9792622357357582,1.0,8/30,22.12%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.25674800578209916,0.7061670279360336,0.8705882352941177,0.979110512701934,1.0,13/40,27.59%,BCO2;ABCD1;RNF122;NDUFS1;BAD;BAX;PRDX3;ARL6IP5;VCP;SLC25A33;STOML2;BCL2L1;PRELID1
prerank,regulation of macroautophagy (GO:0016241),0.2312046772976878,0.7059538130216957,0.9228329809725159,0.9789775686855612,1.0,26/105,22.25%,KDR;ATP6V0D1;LARP1;UBQLN2;RRAGC;SH3GLB1;NRBP2;PRKAG1;UBQLN1;WAC;CAPNS1;LAMTOR3;CAPN1;RB1CC1;VPS26A;MTOR;ATP6V1B2;ATP6V1G1;TSC1;ATP6V1G2;ERN1;LAMTOR4;TRIM13;VPS35;RHEB;RRAGA
prerank,cellular response to drug (GO:0035690),0.27762814952840326,0.7058784529822055,0.8373570520965693,0.9786950922116555,1.0,3/25,10.57%,AIM2;CRHBP;PPM1F
prerank,positive regulation of intracellular protein transport (GO:0090316),0.22704722426675195,0.7044798601200981,0.9469387755102041,0.9799557914596959,1.0,25/144,14.25%,FIS1;MYO1C;RUFY3;SEC16A;FBXW7;TCF7L2;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;PRNP;PLK3;CIB1;ZC3H12A;CEP131;TFDP2;SORL1;PSEN1;NPEPPS;UBE2L3;BAD;VAMP2;FYN
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3345693626807188,0.7044231815920355,0.8131699846860643,0.9796450042204753,1.0,1/10,4.88%,HSP90AB1
prerank,neurotransmitter transport (GO:0006836),0.23932427989846636,0.7042933523538596,0.9077090119435396,0.9794146989744861,1.0,20/73,27.37%,SLC18A2;SLC38A2;SLC38A1;SYNJ1;CPLX1;HSPA8;VAMP2;PPFIA4;SLC32A1;GAD1;BRSK1;STXBP3;SLC1A3;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;GLS2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.22340772084557325,-0.7041319408210409,0.8843283582089553,0.9925864048508283,1.0,5/21,16.43%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,modulation of chemical synaptic transmission (GO:0050804),0.23011950841469964,0.7034130263610258,0.9325726141078838,0.980036907367189,1.0,38/107,27.74%,BDNF;CLSTN1;GRIK3;CPLX1;EIF4EBP2;BAIAP3;ABR;CACNA1A;APP;AKAP9;IQSEC2;CLSTN3;CHRNB2;GRID1;LRP8;NLGN3;OPHN1;BCR;DGKI;LRRC4;LGI1;MCTP1;BEGAIN;GRIK4;SYN1;GRM7;DLGAP4;GRM4;DLGAP3;GRIK2;GRIK5;CLSTN2;TNF;DLGAP2;PTEN;CDK5;ITGB1;CPLX2
prerank,oogenesis (GO:0048477),0.3030452276268073,0.7032629479729239,0.8163265306122449,0.9798263894676739,1.0,5/15,26.43%,MARF1;MDK;MEI4;KMT2D;FMN2
prerank,positive regulation of integrin activation (GO:0033625),-0.2701620967275239,-0.7031098156358021,0.8628158844765343,0.9923666028985885,1.0,3/11,29.14%,SRC;SKAP1;RAP1B
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2776501098678946,0.7030314618760052,0.8582474226804123,0.9797041635123227,1.0,5/23,13.62%,HOOK2;CCDC88A;HOOK1;CCDC88B;HOOK3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3374067679048209,0.7024562728105161,0.8375184638109305,0.9799708806984095,1.0,3/10,16.80%,SPHK2;IL18;LGALS9
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23448276158272088,-0.7024178902853798,0.915129151291513,0.9916862365402438,1.0,6/18,20.67%,NCKAP1L;METTL3;CCR2;IKZF3;IL4I1;ABL1
prerank,central nervous system neuron differentiation (GO:0021953),0.2630938264965853,0.7019588952786477,0.8671586715867159,0.9801675507163454,1.0,3/33,10.07%,LMX1A;CTNNB1;PROX1
prerank,defense response to fungus (GO:0050832),0.2958112272233278,0.7018825742492599,0.8510928961748634,0.9798893807782599,1.0,2/17,8.64%,RNASE7;FAM3A
prerank,positive regulation of protein transport (GO:0051222),0.24084757108620541,0.7016168367791061,0.9073660714285714,0.9798075224285474,1.0,11/67,13.28%,ABCG1;ADAM8;RUFY3;PPIA;PLK3;TMED10;CEP131;VPS28;RACK1;APBB1;VAMP2
prerank,heme biosynthetic process (GO:0006783),0.2815092597774249,0.7013078783712587,0.8500635324015248,0.9797719838011477,1.0,6/22,19.97%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2
prerank,fatty acid transport (GO:0015908),0.29628761739103415,0.7012709519848177,0.8504936530324401,0.9794370472701134,1.0,3/17,15.96%,SLC27A1;APOE;PPARD
prerank,endoderm formation (GO:0001706),0.25970259920002503,0.7012143145545844,0.8669064748201439,0.9791379782887231,1.0,3/35,7.33%,MMP14;COL4A2;COL8A1
prerank,response to prostaglandin E (GO:0034695),0.3305468895945439,0.701193774622929,0.7970588235294118,0.9787929300286441,1.0,1/10,4.13%,PTGER4
prerank,sulfur compound catabolic process (GO:0044273),0.257928323713042,0.7011587912020923,0.8632580261593341,0.978462907454436,1.0,12/38,23.91%,HYAL1;FMOD;CSPG4;GGT7;ACAT1;GADL1;GLB1;CHAC2;OGN;GALNS;TXN2;GNS
prerank,JNK cascade (GO:0007254),0.25751096794856476,0.7007243221870302,0.882903981264637,0.9785853773280042,1.0,3/40,4.13%,NOD2;NOD1;PTGER4
prerank,regulation of integrin activation (GO:0033623),0.3073482469544688,0.7005888930327779,0.85,0.9783634987181404,1.0,5/15,25.89%,PTGER4;JAM3;FARP2;PIEZO1;FERMT2
prerank,epiboly involved in wound healing (GO:0090505),0.2994349982898358,0.7005104023194522,0.8148148148148148,0.9780884669247296,1.0,2/16,9.06%,MRTFA;PDPN
prerank,regulation of fibrinolysis (GO:0051917),0.3179054419593017,0.7003759087569252,0.8430555555555556,0.9778612728811891,1.0,1/13,6.62%,USF1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.22818932728478336,-0.7002515426020353,0.8790035587188612,0.9927153341699336,1.0,5/18,19.04%,PTPN22;AKT1;JAK3;ASS1;IL4I1
prerank,regulation of potassium ion transport (GO:0043266),-0.19634467489521118,-0.6995926327392322,0.9453551912568307,0.9920250914041691,1.0,11/31,29.04%,KCNIP3;ANK3;FHL1;KCNAB1;ADRA2A;DRD2;NOS1;KIF5B;KCNIP4;KCNH2;PTK2B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.2619416669670939,0.6990609379384667,0.8524788391777509,0.9789526573486054,1.0,4/33,16.95%,KDR;TCF7L2;TNIP2;MDK
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.3212104448086829,0.6980926555387872,0.8374233128834356,0.979666997053997,1.0,3/11,15.19%,PLEKHA4;DAB2;MLLT3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.31927202956433276,0.6979486164219862,0.8250728862973761,0.9794624980770306,1.0,1/11,1.61%,IRS1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.26314248320664935,0.6972861791102349,0.8682266009852216,0.9798182865652858,1.0,6/33,12.23%,SFRP2;SNAI2;RET;LYN;CIB1;PTPN11
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.21553303369469268,-0.6964699880895138,0.9208333333333333,0.9938349849900424,1.0,2/23,2.34%,HPGD;LTC4S
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.23496011536844347,-0.6956468304313018,0.88671875,0.9932819785139684,1.0,6/20,17.04%,GCLM;GSS;PLOD2;PLSCR1;HAGH;GGCT
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.23953573317171084,0.6949647414851271,0.9060402684563759,0.9820331725013208,1.0,8/59,12.25%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;CDK10;DYRK2;PRKDC
prerank,positive regulation of cell development (GO:0010720),0.25985158270156783,0.6942855023847405,0.8651685393258427,0.9824261964236142,1.0,8/31,21.74%,LRP2;SNW1;BAD;NUMBL;PDE3A;TYROBP;TGM2;FAIM
prerank,regulation of cholesterol efflux (GO:0010874),0.2668736582515626,0.6942682812518769,0.8576874205844981,0.982078075639685,1.0,6/30,19.03%,NR1H2;YJEFN3;APOE;PTCH1;ZDHHC8;TTC39B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2545484105655585,0.6941704947788825,0.8941176470588236,0.9818221755629064,1.0,8/39,18.97%,TCF7L2;MYRIP;BAD;IRS2;TFR2;SELENOT;GLUD1;PSMD9
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.22690575815713432,0.6939629837179891,0.9188034188034188,0.9816836336915814,1.0,21/95,22.27%,SPRY2;PMEPA1;HSP90AB1;ITGA3;SMAD2;BAMBI;MEN1;DKK3;SNW1;SKIL;SMURF1;DAB2;HTRA3;SPRED3;SPRED1;SNX25;PIN1;STK11;CITED2;STUB1;SMURF2
prerank,regulation of mast cell activation (GO:0033003),0.32393371955165945,0.6939376172708785,0.8404255319148937,0.9813422099887762,1.0,3/10,18.74%,LYN;CD84;CD300LF
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2613766111602644,0.6936086742358943,0.8761061946902655,0.9813150069859269,1.0,6/31,17.00%,PEX7;TOMM40L;TIMM50;PEX2;TOMM40;PEX5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2592790058830074,0.693550282719039,0.8583638583638583,0.9810116095778183,1.0,8/32,18.94%,CTNNB1;CCT4;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2314158080076818,-0.6934555703846879,0.8803088803088803,0.9941634735155401,1.0,7/18,25.61%,COX16;PET100;TIMM21;SCO1;SURF1;COA3;COX18
prerank,negative regulation of cilium assembly (GO:1902018),0.3191350497336794,0.6931807120729241,0.8283261802575107,0.9810469958531984,1.0,4/12,18.90%,CDK10;ODF2L;MAP4;TESK1
prerank,cardiac conduction system development (GO:0003161),-0.2109369209723813,-0.6921955348579034,0.9264069264069265,0.9940069310840643,1.0,11/24,43.43%,SMAD4;GJB6;CACNA1G;BMP4;HCN4;HEY1;HEY2;MSC;GJA5;MSX1;SHOX2
prerank,regulation of calcium ion transport (GO:0051924),0.2420547682093493,0.6920128515948729,0.9012485811577753,0.9819295558429887,1.0,8/54,15.07%,CAMK2B;CCL5;GRAMD2A;CTNNB1;P2RX4;CRACR2A;CD84;INPP5K
prerank,membrane raft organization (GO:0031579),0.2999283435360157,0.691875160558486,0.8645980253878702,0.9816988162977058,1.0,3/15,16.51%,YJEFN3;NPC1;FLOT2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2436977410149085,0.6911182999579507,0.9111617312072893,0.9821385879437612,1.0,10/52,15.00%,DDX5;RBMX;HNRNPL;RNPS1;RBFOX1;HNRNPA1;CELF6;RBM15;MBNL2;RBFOX3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.22414783165757185,0.6908384506338114,0.9311440677966102,0.9820690793882716,1.0,19/104,19.54%,SPRY2;ACVR1;LRP2;PMEPA1;MAGI2;SMAD2;BAMBI;BMPER;BMPR2;SORL1;SKIL;SMURF1;BMPR1A;HTRA3;SPRED3;ACVR2A;SPRED1;SNX25;PIN1
prerank,cGMP metabolic process (GO:0046068),0.31961253887329205,0.6908122398285308,0.8384728340675477,0.9817229026175105,1.0,4/12,26.24%,NPPC;NPR2;PDE9A;GUCY1B1
prerank,regulation of exosomal secretion (GO:1903541),0.2901697717595484,0.690627879196696,0.8529801324503311,0.9815425047580453,1.0,8/19,29.52%,SDC4;CHMP3;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,positive regulation of protein secretion (GO:0050714),0.23157233371350144,0.6904047093285498,0.8998899889988999,0.9814102659618565,1.0,14/69,19.81%,ABCG1;ADAM8;TCF7L2;PPIA;TMED10;MYRIP;BAD;APBB1;IRS2;TLR2;GLUD1;GOLPH3L;PSMD9;CD33
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.20785562665382418,-0.6902332693052092,0.9285714285714286,0.9945659701805041,1.0,12/25,30.27%,ITGAV;PARVA;NINJ1;CD200R1;ITGB3;CXADR;ITGB7;CD200;ITGB2;JUP;CD2;DSG2
prerank,protein depolymerization (GO:0051261),0.2690328820916695,0.6902299168771989,0.8812903225806452,0.981224494431012,1.0,9/27,22.88%,KIF2C;STMN4;STMN3;GSN;KIF2A;STMN2;CFL2;DSTN;TWF1
prerank,receptor clustering (GO:0043113),0.26779327069669,0.6895499217989265,0.8835443037974684,0.9815768529474644,1.0,9/27,25.20%,THY1;MAGI2;AGRN;DNAJA3;DLG1;ITGA4;SAV1;FLNA;LRP4
prerank,regulation of immunoglobulin production (GO:0002637),-0.21779246374160321,-0.6890789429912029,0.9354838709677419,0.9943237183359688,1.0,7/23,23.05%,SASH3;EPHB2;DNAJB9;VAMP3;CD86;PHB2;CLCF1
prerank,regulation of dendritic spine development (GO:0060998),0.28753763696709156,0.6890406434742815,0.8482490272373541,0.981736317964598,1.0,3/19,12.38%,CAMK2B;PSEN1;APOE
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.2750940446301841,0.6890041862406974,0.862565445026178,0.9814019062260466,1.0,1/24,1.22%,CAMK2D
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.2469707872753621,0.6884355113378192,0.880648899188876,0.9816343422770318,1.0,8/46,14.01%,LAMC1;LAMB2;PARVB;PEAK1;SRGAP2;ANTXR1;NRP1;RAC1
prerank,neurotransmitter secretion (GO:0007269),0.24764557929584133,0.6875211570509819,0.9014084507042254,0.9822016447600164,1.0,17/44,27.74%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,mesoderm development (GO:0007498),0.2880559721416266,0.687199037031882,0.8592297476759628,0.9821843869406676,1.0,3/18,14.38%,HCK;IKZF1;JAK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.2969642119619991,0.6870582903435765,0.8615591397849462,0.9819804825732761,1.0,3/16,11.19%,RORA;FOXK1;BCKDK
prerank,axoneme assembly (GO:0035082),-0.19178429820086734,-0.6865981431626904,0.9326424870466321,0.9954005082739983,1.0,19/30,41.05%,DNAI4;TTLL3;CCDC39;DNAAF3;RSPH9;FOXJ1;DCX;CFAP74;JHY;DNAJB13;CFAP206;DRC1;GAS8;DNAAF2;RSPH1;RP1;DNAAF1;CCDC65;RSPH4A
prerank,regulation of catabolic process (GO:0009894),0.29088135095188694,0.686455454975974,0.8547945205479452,0.9822445135762395,1.0,2/18,6.61%,CHEK2;TMEM9
prerank,establishment of spindle orientation (GO:0051294),0.2662659519569779,0.6862268913492502,0.8676092544987146,0.9821098896628324,1.0,7/28,19.23%,CDK5RAP2;UBXN2B;MAP4;LLGL1;PAFAH1B1;NUMA1;NDC80
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.2896041115493205,0.685735312226663,0.8624833110814419,0.9822548552765883,1.0,7/17,27.61%,SLC8A1;SCN1B;KCNJ2;HCN2;ANK2;SCN4B;CACNA1D
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2616670134594952,0.6854727821103161,0.8803945745992602,0.9821729926750506,1.0,4/29,19.98%,STX7;STAP1;LAMP1;TYROBP
prerank,icosanoid metabolic process (GO:0006690),-0.18558309585235383,-0.6851785602889903,0.9507042253521126,0.9953886045654763,1.0,8/40,16.53%,HPGD;LTC4S;ALOX5AP;PTGS1;ABCC10;MGLL;GGT5;FAAH
prerank,organic cation transport (GO:0015695),0.27620119752107225,0.6851600483849569,0.8454545454545455,0.9821595178116883,1.0,5/20,28.72%,SLC25A19;SLC44A1;SLC25A26;SLC22A4;SLC5A7
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24243868614587244,-0.6846524409467134,0.9049295774647887,0.9945440800970089,1.0,6/15,18.30%,SPCS3;RAB3GAP2;SEC61G;SEC61A1;ZFAND2B;SRPRB
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2788569086087998,0.6846049606400518,0.8602442333785617,0.9823461048517075,1.0,1/19,1.37%,CLIC4
prerank,endodermal cell differentiation (GO:0035987),0.2553636857046776,0.6842497485322381,0.8721071863580999,0.9823467530732458,1.0,3/31,7.33%,MMP14;COL4A2;COL8A1
prerank,dephosphorylation (GO:0016311),0.22109751803428618,0.6833804807093805,0.958120531154239,0.9828788592486557,1.0,48/147,26.56%,SGPP2;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;TIMM50;PTPN7;BTRC;DUSP26;DUSP28;PPM1F;PPP2R5D;EPHX2;PPP4R2;DUSP10;DUSP16;DUSP11;INPP5K;PTPN9;PPP2R2A;PTPRU;PTPRC;DUSP8;PTPRB;PTPRF;PPP2R5A;STK11;LHPP;PLPP2;PPP2R3A;PTPRM;PLPPR2;PPP1R12A;FRA10AC1;PLPPR1;PTPN6;PTPRS;PPM1H;PLPP6;PDP1;PLPP1;PTPN1;NT5C;PPM1A;PTEN;DUSP7
prerank,T cell differentiation in thymus (GO:0033077),0.2991251586267163,0.6831443712272229,0.8523206751054853,0.9827566528065215,1.0,4/14,23.59%,ZFP36L1;PTPRC;GLI3;ZFP36L2
prerank,proteasome assembly (GO:0043248),0.31387007460417393,0.6825170446051374,0.8381240544629349,0.9830448534204307,1.0,7/11,29.27%,PSMG2;PSMD9;OTUD6B;ADRM1;PSMD4;PSMD11;PSMG1
prerank,melanosome transport (GO:0032402),-0.2312801776124478,-0.6820993759424717,0.9047619047619048,0.9941271250541893,1.0,7/18,24.41%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,pigment granule transport (GO:0051904),-0.2312801776124478,-0.6820993759424717,0.9047619047619048,0.9941271250541893,1.0,7/18,24.41%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,aortic valve development (GO:0003176),0.2564515778030059,0.682087952534855,0.890818858560794,0.9831242188396339,1.0,5/34,12.70%,SOX9;SNAI2;BMPR2;SLIT3;RB1
prerank,neuromuscular junction development (GO:0007528),0.2709974210611285,0.6816800907924712,0.8688311688311688,0.9831863949228187,1.0,3/24,10.94%,DOK7;AGRN;DNAJA3
prerank,Rap protein signal transduction (GO:0032486),0.3265357890057101,0.6813467340914147,0.8424153166421208,0.9831796566051123,1.0,4/10,19.92%,RAPGEF2;RAPGEF1;RAP2A;SGSM3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2640908465589023,0.6810397213210289,0.8861985472154964,0.983139804402639,1.0,10/28,25.49%,DAXX;DIABLO;DDX47;BAX;CRADD;DDX3X;ZDHHC3;DEDD;DELE1;TNF
prerank,natural killer cell mediated immunity (GO:0002228),0.2954753710407373,0.6803138105209153,0.8651994497936726,0.9835333434014901,1.0,3/15,13.88%,TUBB4B;PLEKHM2;LYST
prerank,dendritic spine organization (GO:0097061),0.2657519824331115,0.6802735199949779,0.8667529107373868,0.9832126456610492,1.0,6/26,14.25%,PAK3;ITGA3;INSR;PRNP;CTNND2;FYN
prerank,negative regulation of cell activation (GO:0050866),-0.2422525596170056,-0.6801175498095352,0.889937106918239,0.9945344318818592,1.0,5/14,26.06%,TREM2;CD200;PDGFRA;THBD;EMILIN1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.26463105200767423,-0.6800898074251385,0.9041533546325878,0.9931651436670025,1.0,2/12,7.16%,BIN1;ID2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.27787073943450014,0.6794933596927762,0.8830645161290323,0.9836114413227504,1.0,5/20,19.80%,FMNL2;DLG1;LLGL1;FMNL3;NCKAP1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2970675022333503,0.6794591238430039,0.85997171145686,0.9832790621889043,1.0,3/14,16.81%,RAPGEF2;PRKAR2B;PRKAR2A
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2357190347456708,0.6790523400796679,0.9278350515463918,0.9833272765526904,1.0,8/56,18.02%,CHMP4B;SNX33;CUL7;EFHC2;SNX9;SEPTIN9;IST1;DCTN3
prerank,epithelial cell differentiation (GO:0030855),0.2276602892498697,0.6788359443412767,0.9334741288278775,0.9831794113737989,1.0,18/88,25.69%,KDR;TDRD7;CASP6;FGFR2;EDF1;PROX1;HNRNPH3;E2F4;DAB2;ANXA4;HDAC1;CNN3;ALDOC;HDAC2;RAB10;ANXA7;ACADVL;PIH1D1
prerank,regulation of intracellular pH (GO:0051453),-0.18491239616411986,-0.6783762710846474,0.9578313253012049,0.9933659487198294,1.0,8/34,19.50%,SLC9A9;NOX1;SLC4A8;GPR89B;GPR89A;CLN3;SLC9A8;SLC26A6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.28843776627240036,0.6783658603789328,0.8563611491108071,0.9832918371936148,1.0,6/16,23.10%,ABCD1;ZC3H12A;CHID1;SIRPA;APPL2;ADCY7
prerank,regulation of cytoskeleton organization (GO:0051493),0.22298930919551424,0.67801185782366,0.9501039501039501,0.9832702414835064,1.0,18/108,16.20%,BST2;CLIC4;RHOF;SYDE1;PAK3;CYLD;KATNBL1;CCDC88A;SPEF1;STMN3;CDK10;PHLDB1;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR
prerank,melanosome localization (GO:0032400),0.27662409556778966,0.6778036774016484,0.8696236559139785,0.9830984542002378,1.0,7/21,26.58%,VPS33A;RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.28224723983743716,0.6776682348627783,0.8613037447988904,0.9828622842828172,1.0,3/18,12.70%,RUNX1;PDPN;RB1
prerank,substantia nigra development (GO:0021762),0.24825705411198157,0.6773169104527604,0.9175757575757576,0.9828542132981382,1.0,14/37,27.47%,SEC16A;FGF9;DYNLL1;ACTB;CALM3;GLUD1;PLP1;ZNF148;YWHAE;CALM2;SIRT2;CKB;BASP1;CCDC14
prerank,regulation of Ras protein signal transduction (GO:0046578),0.22589131677035193,0.677031263528508,0.9341126461211477,0.9827790929341185,1.0,16/85,17.71%,SPRY2;DENND1A;LYN;KANK1;VAV1;STARD8;RAPGEF1;AKAP13;JAK2;IRS2;LZTR1;SH3BP1;OPHN1;DENND4A;BCR;PLCE1
prerank,positive regulation of exosomal secretion (GO:1903543),0.2964730996742149,0.6766790418775741,0.8434903047091413,0.9827755026734445,1.0,7/15,29.52%,SDC4;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,negative regulation of hippo signaling (GO:0035331),0.3046004095978574,0.676466648327008,0.8681481481481481,0.9826116194112176,1.0,2/12,9.57%,MAP2K3;MAPK14
prerank,nuclear pore complex assembly (GO:0051292),0.3213329205088643,0.6758977420711267,0.8517397881996974,0.9828131075012291,1.0,2/10,13.72%,NUP153;AHCTF1
prerank,renal filtration (GO:0097205),0.31472844696368957,0.6758359529248591,0.8563049853372434,0.9825135690555734,1.0,2/10,10.36%,ITGA3;TBC1D8B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.28046257450611756,0.6754829952490613,0.863031914893617,0.9824853062773035,1.0,6/20,24.82%,SLC25A1;SCD5;GCDH;ACSL3;FAR2;CBR4
prerank,regulation of transposition (GO:0010528),-0.24569086810981294,-0.6747858104032861,0.890625,0.995213390256886,1.0,4/13,27.79%,SIRT7;TEX15;DDX4;PIWIL2
prerank,gas transport (GO:0015669),-0.27843782483368107,-0.6746841227885312,0.846875,0.993916672481263,1.0,2/10,19.29%,IPCEF1;MYC
prerank,glutathione metabolic process (GO:0006749),0.24871993141566046,0.6746449710431877,0.8995215311004785,0.982976794498593,1.0,7/38,20.73%,ETHE1;GSR;GGT7;CTNS;GCLC;CNDP2;CHAC2
prerank,positive regulation of rRNA processing (GO:2000234),0.3206728757992899,0.673359087000208,0.848159509202454,0.9838706919396545,1.0,4/10,22.05%,DIMT1;WDR43;BUD23;UTP15
prerank,oligosaccharide metabolic process (GO:0009311),0.24098190859040317,0.673171416153535,0.9104477611940298,0.983702334886225,1.0,7/46,18.31%,ST6GALNAC4;ST6GALNAC6;B4GALT1;NEU1;MAN2C1;ST8SIA1;FUT9
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.25865419673846346,0.6730282847125844,0.89171974522293,0.9834861003091553,1.0,3/29,10.07%,TNNC1;FGFR2;PROX1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2514583960695341,0.6730144519860475,0.9030303030303031,0.9831371465033396,1.0,8/34,24.71%,SLC8A1;P2RX4;ZC3H12A;CALM3;ASB3;PDE4B;CALM2;ANK2
prerank,histone H3-K36 demethylation (GO:0070544),0.3234068623876455,0.6713567499544161,0.8582554517133957,0.9844108155518955,1.0,3/10,16.02%,RIOX2;KDM8;KDM7A
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2764216146270894,0.6710245811691392,0.8777633289986996,0.984368280395983,1.0,3/21,11.51%,BCL2L11;NCK1;XBP1
prerank,regulation of actin nucleation (GO:0051125),0.30750836489751565,0.6705531121128445,0.8514115898959881,0.9844706754779552,1.0,3/12,13.63%,GSN;WHAMM;CORO1B
prerank,positive regulation of cell division (GO:0051781),0.24007160543413483,0.6704390053461738,0.9052132701421801,0.984218805248104,1.0,3/38,6.02%,CDC25B;PKN2;FGFR2
prerank,Ras protein signal transduction (GO:0007265),0.21673893729489785,0.670196699338221,0.9600409836065574,0.9840890700463945,1.0,51/137,29.02%,USP50;CDH13;KPNB1;CYFIP1;ARHGAP4;RAPGEF6;RAPGEF2;PDPN;DNMT1;MAPK14;G3BP2;ARHGEF11;HACD3;SOS1;RB1;RAPGEF1;RAC1;RREB1;DBNL;PHACTR4;AIF1;PLCE1;ARHGAP29;NF1;RAP2A;NCKAP1;SGSM3;CTNNAL1;G3BP1;RIT1;RHOH;USP8;FGF2;FARP2;BRK1;ARHGAP1;CDC42EP3;RGL2;TRIM28;CDKN2A;SHC1;RERG;TIAM1;WASF1;LIMK1;RIT2;JUN;GNB1;RALA;ARHGDIA;HACE1
prerank,skeletal system morphogenesis (GO:0048705),-0.17084791523500745,-0.6698769194134009,0.9818181818181818,0.9967722253730525,1.0,9/42,20.53%,DYNC2I1;LRP6;HHIP;RAB33B;HOXC4;HOXD3;HOXC9;FUZ;HOXB9
prerank,myotube cell development (GO:0014904),-0.2604192819482802,-0.6697762792007881,0.8775510204081632,0.995471428207877,1.0,10/10,73.98%,SELENON;ACTA1;LMOD3;KLHL40;RYR1;MYORG;SIX1;SKI;IGF1;CAV2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.2854157999456486,0.6694534152010403,0.8651226158038147,0.9844496283004561,1.0,5/17,24.47%,EIF6;PANK2;PPARD;ADIPOR1;PRKAB2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.25342269744360457,0.6692413257269799,0.8904458598726115,0.9842779336358044,1.0,9/32,24.29%,SLC30A1;CPLX1;BAIAP3;PREPL;DTNBP1;VPS18;MCTP1;SYN1;SYT11
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.23264383382535694,-0.6682742808950242,0.9210526315789473,0.9954279215161616,1.0,5/14,22.58%,GMPS;ADK;IMPDH2;RFK;PPAT
prerank,histone H2A acetylation (GO:0043968),0.287962693837681,0.6680706085519292,0.9,0.9850720563293368,1.0,8/16,31.03%,EP400;SPHK2;RUVBL2;ACTL6A;RUVBL1;BRD8;YEATS4;MORF4L1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.26324369977252166,0.6674013817778798,0.8915510718789408,0.9853707873103326,1.0,4/24,14.71%,TTLL8;TTLL7;GGCX;CFAP20
prerank,cGMP biosynthetic process (GO:0006182),0.3210345402076161,0.6673876442050988,0.8556390977443609,0.9850224224406848,1.0,3/10,26.24%,NPPC;NPR2;GUCY1B1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.21408322888031403,0.6671275046387836,0.9724489795918367,0.9849099560180988,1.0,19/153,12.92%,SGK2;SGK3;CAMK2D;STK38L;PKN2;PNCK;IKBKE;MORC3;MKNK1;CAB39;CSNK2A2;VRK3;MAST3;MAPK14;DYRK2;MAP2K2;NEK6;PRKDC;PRKCE
prerank,peptide biosynthetic process (GO:0043043),0.21319538250825779,0.6671019383668023,0.9605662285136501,0.9845737750782656,1.0,35/153,21.29%,MRPL36;IGF2BP3;AGO2;RPL36;HARS2;GSPT1;RPL22;EIF4EBP2;RPS21;TNIP1;MRPL42;ABCF1;GGT7;RPS6;RPS11;RPL30;MRPL24;RPL32;RPL23A;RPL11;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;RPL37A;RPL3;MRPS11;RRBP1;RPL29;RPL5;FARSB
prerank,mammary gland epithelium development (GO:0061180),-0.2374218672474044,-0.6670769291399383,0.9115646258503401,0.9950804933393125,1.0,5/14,21.47%,ID2;AKT2;AKT1;SCRIB;WNT4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2876731518655249,0.6669779711710664,0.8557951482479784,0.9843362898834126,1.0,5/16,17.49%,SPHK2;DNAJC30;AK4;PPARGC1A;ATPSCKMT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2565680111795866,0.6667511643123251,0.898034398034398,0.9838097162307259,1.0,5/29,18.87%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2565680111795866,0.6667511643123251,0.898034398034398,0.9838097162307259,1.0,5/29,18.87%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,protein localization to condensed chromosome (GO:1903083),-0.2519118199848007,-0.6662929682683856,0.8805460750853242,0.9943520970052352,1.0,7/12,31.54%,MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.2925665494726266,0.6662771893036724,0.8654970760233918,0.9838978845311551,1.0,14/14,70.77%,ECE1;CORIN;NOS3;EDN1;AGTR1;ACE2;AVPR1A;EDN2;EDN3;OXTR;ACE;AVPR2;RASL10B;ENPEP
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.30734938513499005,0.666187832298873,0.865021770682148,0.9836217457507433,1.0,2/10,19.03%,ZC3H12A;RC3H2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3064673522510127,0.6651405785570949,0.8584905660377359,0.9842577322403256,1.0,3/11,16.20%,NOP53;DDX11;MTOR
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.20893366080342005,-0.6650772040601514,0.9069767441860465,0.9939659593808612,1.0,3/23,9.79%,MBOAT1;PLAAT3;PLBD1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.1862358498865466,-0.664513885043075,0.9943820224719101,0.993027385902055,1.0,8/33,22.82%,GCLM;ALDH18A1;DDAH1;NIT2;OAT;PRODH;ALDH4A1;PYCR3
prerank,regulation of developmental growth (GO:0048638),0.2525643894124201,0.6644430705378894,0.9117276166456494,0.9845593338391507,1.0,5/29,16.07%,APP;INSR;DNM2;APOE;FGFR3
prerank,lung epithelium development (GO:0060428),0.3118906575162573,0.6641180271308211,0.8672566371681416,0.9844987039264507,1.0,1/10,6.47%,WNT7B
prerank,sensory perception of sound (GO:0007605),0.2218342444785917,0.6634897504642686,0.9408033826638478,0.9847073296762227,1.0,8/88,12.55%,TMC1;LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;ADGRV1;COL11A2
prerank,engulfment of apoptotic cell (GO:0043652),0.2860190405542926,0.6633241925984897,0.8709219858156029,0.9844800962441789,1.0,3/15,14.01%,XKR7;MEGF10;RAC1
prerank,hippo signaling (GO:0035329),0.25552369506953776,0.6631767117807922,0.8901515151515151,0.9842610809376173,1.0,7/26,21.42%,TEAD2;MOB1B;TJP2;AMOTL2;STK3;MOB1A;SAV1
prerank,regulation of ion transport (GO:0043269),0.2231449255870217,0.6626209556920878,0.9342672413793104,0.9844084641862818,1.0,13/76,18.35%,B2M;SYT7;RAB11B;SYT3;GDNF;P2RX4;SIK1;VAMP2;CA2;CLDN10;CHRNB2;KCNJ2;DTNBP1
prerank,kinetochore organization (GO:0051383),0.2957471291513456,0.6624679317004258,0.8678977272727273,0.9841856117564787,1.0,4/13,19.23%,CDT1;POGZ;MIS12;NDC80
prerank,cell projection organization (GO:0030030),0.2525129275810231,0.6623426015184485,0.8883435582822086,0.9839420824029689,1.0,5/30,14.01%,PARVB;CYFIP1;RHOJ;GSN;RAC1
prerank,regulation of cell-cell adhesion (GO:0022407),0.24097230197980068,0.6617703473900762,0.9185185185185185,0.9841117145588086,1.0,7/39,18.31%,ADAM8;CD47;PODXL;MEGF10;MINK1;FLOT2;FUT9
prerank,regulation of phosphatase activity (GO:0010921),-0.20939126537637023,-0.660665139198042,0.9395161290322581,0.994819524680276,1.0,5/24,14.04%,HTT;PTPA;MTMR9;URI1;ZCCHC9
prerank,DNA alkylation (GO:0006305),0.2766736441169553,0.6605507270710209,0.8973684210526316,0.9845291272621421,1.0,3/19,9.14%,GATAD2A;DNMT3A;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),0.2766736441169553,0.6605507270710209,0.8973684210526316,0.9845291272621421,1.0,3/19,9.14%,GATAD2A;DNMT3A;DNMT1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.22365105570866334,-0.6603829288583191,0.925,0.993658290924887,1.0,5/18,14.04%,PPP1R8;PPP1R16B;PTPA;URI1;ZCCHC9
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2579519243063211,-0.6598248659279586,0.8828828828828829,0.9927390221408283,1.0,1/10,0.47%,EHMT1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.29584165905948046,0.6590457717930936,0.8760806916426513,0.9855741703838036,1.0,5/13,27.93%,SOCS5;SOCS4;TSG101;CBLB;ZGPAT
prerank,regulation of multicellular organism growth (GO:0040014),0.28574663136951595,0.6589673774283621,0.8746594005449592,0.9852842313985871,1.0,5/15,25.66%,APP;PTCH1;BBS2;STAT5A;PPIB
prerank,positive regulation of DNA replication (GO:0045740),0.2796819406756555,0.6585114133006157,0.8803894297635605,0.9853312205903497,1.0,4/16,19.75%,CDT1;DHX9;STN1;KAT7
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2721069665288162,0.6577098612850549,0.8891928864569083,0.9856772086615448,1.0,1/18,1.39%,ALKBH7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.22132952327461197,-0.657688235028823,0.9375,0.9931357558082727,1.0,6/19,26.21%,TNFRSF1B;TREM2;CD200R1;CD200;IL1B;NUPR1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2424811150911902,-0.6576082113391953,0.89937106918239,0.9918360199807147,1.0,5/12,26.21%,TTBK1;CCL3;TREM2;IL1B;NUPR1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.22155105488289137,-0.6573119253568104,0.8992805755395683,0.9907056180683855,1.0,10/16,46.36%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.26289845802280193,0.6564490220033687,0.8980132450331125,0.9865245545695924,1.0,6/23,27.02%,GIT1;SIK1;CLK2;TIGAR;HDAC4;EP300
prerank,steroid hormone biosynthetic process (GO:0120178),0.24805189048840057,0.6561803478936296,0.9118387909319899,0.9864110658052124,1.0,3/29,13.00%,HSD17B7;STARD3;TSPO
prerank,cardiac ventricle morphogenesis (GO:0003208),0.236214204182688,0.6557338380103073,0.9209580838323354,0.9864466487607795,1.0,6/41,16.74%,SFRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,protein localization to cell-cell junction (GO:0150105),-0.2225691935868825,-0.6553924918984746,0.9450171821305842,0.9909176049655092,1.0,9/15,34.49%,PAK2;SCRIB;F11R;LSR;ARHGEF18;TJP1;TJP3;CDH5;MPP7
prerank,sodium ion transport (GO:0006814),0.21868157840951907,0.6552736859210165,0.9497863247863247,0.9865095166893076,1.0,4/85,6.08%,CATSPER4;ATP1B3;SLC8A1;ASIC4
prerank,actin crosslink formation (GO:0051764),0.29749272499491014,0.6550388127009081,0.8628005657708628,0.986360847878421,1.0,4/12,16.39%,GAS2L3;AIF1;BAIAP2;BAIAP2L1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2557431751680499,0.6546578123490445,0.8969465648854962,0.9863338229492219,1.0,4/26,15.26%,THADA;UBQLN1;GPR35;CALM3
prerank,pteridine-containing compound metabolic process (GO:0042558),0.29034699788655494,0.654608345993016,0.8732782369146006,0.9860176380519504,1.0,3/13,17.81%,GCH1;HSP90AA1;PRKG2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.2549828571325781,0.6545866655727361,0.9015748031496063,0.9856773203397982,1.0,4/24,17.57%,GRB10;MT3;HGS;EPN2
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.2644477558640732,-0.6537603793463104,0.879154078549849,0.9908308945162145,1.0,1/10,3.02%,NCKAP1L
prerank,regulation of cellular component size (GO:0032535),0.24913013924470961,0.653695376302295,0.9024691358024691,0.9861023833983572,1.0,8/30,24.11%,RARG;RAB22A;VAV1;RAC1;MTOR;LAMTOR4;MSN;RIN3
prerank,autophagy of mitochondrion (GO:0000422),0.2396301981881898,0.6535822297550703,0.9256198347107438,0.9858458527609004,1.0,7/38,20.12%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,regulation of mitochondrial translation (GO:0070129),0.26361342685864436,0.6524107505177874,0.8968253968253969,0.9865320653996914,1.0,6/21,20.47%,NGRN;RCC1L;ALKBH1;TRMT10C;FASTKD2;MTG2
prerank,regulation of protein sumoylation (GO:0033233),0.2746530669797143,0.6520182116783872,0.897364771151179,0.986515929853338,1.0,6/17,26.87%,CTNNB1;UBA2;PIAS1;HDAC4;PIAS4;GNL3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.30658179564739885,0.6507840741614177,0.8832116788321168,0.9872507649346558,1.0,1/10,6.59%,MT3
prerank,fibrinolysis (GO:0042730),0.29625211877707336,0.6507273097792311,0.894134477825465,0.9869441200408101,1.0,13/13,70.40%,PLAUR;PLAT;SERPINE1;FGG;CPB2;F2;GP1BA;KRT1;HRG;PLG;SERPINB2;SERPINF2;PLAU
prerank,regulation of establishment of protein localization (GO:0070201),0.2890445762115062,0.6504022310982297,0.8509142053445851,0.9868727232849108,1.0,4/13,18.92%,GAPVD1;SCFD1;CEP295;CEP135
prerank,regulation of TOR signaling (GO:0032006),0.22255707784204481,0.6489147602799642,0.9486607142857143,0.9878111175108751,1.0,21/67,26.51%,MIOS;RRAGC;DDIT4;AKT1S1;LAMTOR3;TELO2;TBCK;RFFL;NPRL2;TSC1;NPRL3;LAMTOR4;RHEB;WDR59;RRAGA;UBR2;UBR1;PIK3CA;FNIP1;PIH1D1;SEH1L
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2513446693351197,0.6488185123817445,0.9011553273427471,0.9875426580630349,1.0,6/27,19.56%,DDX5;SNAI2;EEF1E1;SPRED3;SPRED1;SMYD2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.24226487246047848,0.6487775795625352,0.9166666666666666,0.9872124392011224,1.0,12/33,28.35%,MECP2;CSNK2B;HMGB1;APOE;ACVRL1;GADD45A;FGF2;VASH1;NOTCH1;TNF;PDCD10;HDAC5
prerank,positive regulation of telomerase activity (GO:0051973),0.24538543143066577,0.6484544375171899,0.9214975845410628,0.9871392378338859,1.0,8/33,18.94%,HSP90AB1;CTNNB1;CCT4;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2161376872072534,-0.6480979020155283,0.9490196078431372,0.9937255947352427,1.0,5/18,27.64%,FCHSD2;DTNA;TSPOAP1;CHAT;FCHSD1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.30620919929997853,0.6478100060420104,0.8817518248175182,0.9873046734241806,1.0,4/10,22.74%,SH3BP1;OPHN1;RAP2A;MSN
prerank,tRNA 5'-end processing (GO:0099116),0.28100803916680595,0.6477804075701721,0.8720112517580872,0.9869676600991013,1.0,5/15,23.01%,TRMT10C;RPP30;RPP14;RPP25L;RPP21
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.2808770617233129,0.6476338678535412,0.8919667590027701,0.9867329115443793,1.0,2/16,9.08%,RUNX1;SCX
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.2574251600126372,0.6472659098051868,0.9191919191919192,0.9866961536566781,1.0,6/24,19.97%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.22408271639975869,-0.6467298523614564,0.9301470588235294,0.9933325835581844,1.0,5/15,24.85%,NLGN2;CLN3;ZDHHC12;CNTNAP4;DRD2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.28942422153207104,0.646439043325022,0.890295358649789,0.9870332310030987,1.0,4/14,20.34%,NCK1;PPM1F;PPP2R2A;PPTC7
prerank,mRNA 3'-end processing (GO:0031124),0.21709617110891954,0.6459930706812136,0.9475935828877006,0.9870505993394567,1.0,33/78,30.52%,MAGOHB;NCBP2;WDR33;APP;RNPS1;AHCYL1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;SRSF4;SLU7;THOC7;SRSF5;MTPAP;SRSF2;MAGOH;RPRD2;SCAF8;SARNP;CDC73;DDX39A;UPF3B;PABPC1;CPSF3;PAF1;PAPOLG;U2AF1;TENT2;SSU72
prerank,glutamate metabolic process (GO:0006536),-0.2118764498081468,-0.6448360542753706,0.9525691699604744,0.993275330580856,1.0,4/19,18.26%,GCLM;ALDH18A1;OAT;PRODH
prerank,retinol metabolic process (GO:0042572),0.2831865711080032,0.6434351969216758,0.8656509695290858,0.9888319705650386,1.0,1/14,7.89%,RDH11
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.25342303992839493,-0.642116862671391,0.9135446685878963,0.993727670551776,1.0,3/11,15.90%,CEBPB;TP53;ATF3
prerank,positive regulation of neutrophil migration (GO:1902624),0.26738084219720604,0.6414259125579587,0.9106438896189225,0.9901736505894454,1.0,3/18,16.95%,ADAM8;RAC1;MDK
prerank,cell junction maintenance (GO:0034331),0.28830928190472205,0.6409464278202799,0.8965014577259475,0.9902212755514318,1.0,1/14,4.39%,CHCHD10
prerank,regulation of pH (GO:0006885),0.3006716464754253,0.6406387910286928,0.8990825688073395,0.9901176632686085,1.0,11/11,69.95%,LACC1;SLC9A7;CLCN3;SLC9A1;ATP1A4;ATP6V1B1;SLC26A4;PDK4;ATP6AP1;ATP6V0A4;PDK2
prerank,ceramide metabolic process (GO:0006672),0.2299441635341143,0.6399862524260455,0.9504608294930875,0.9902980250615845,1.0,5/49,7.46%,ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.20651053719583182,0.6397084921660638,0.9675732217573222,0.9901800354687896,1.0,20/112,20.41%,WNT5A;GDF9;ACVR1;USP15;SOX9;SMAD2;BAMBI;ARRB2;ZFP36L1;COL3A1;SMURF1;NR3C1;LIMS1;BMPR1A;SOX5;PDE3A;FNTA;ACVRL1;WWOX;APPL2
prerank,sterol biosynthetic process (GO:0016126),0.2414542338965302,0.6395910928980639,0.9244604316546763,0.9899103700304195,1.0,9/33,25.17%,HSD17B7;CH25H;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6
prerank,regulation of dendrite extension (GO:1903859),-0.2134754712495596,-0.6390896362834381,0.9207547169811321,0.9943712451692601,1.0,6/18,20.13%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.2166220600848393,-0.6383258758378972,0.9416342412451362,0.9935063781930419,1.0,11/17,47.84%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A;IL12B
prerank,positive regulation of lipid transport (GO:0032370),-0.2404962469231532,-0.6373539006398137,0.910828025477707,0.9928116327074283,1.0,1/12,2.48%,DBI
prerank,eye photoreceptor cell differentiation (GO:0001754),0.2868039463195947,0.6369872916112267,0.874826147426982,0.991686589424364,1.0,1/12,2.89%,STAT3
prerank,purine nucleotide biosynthetic process (GO:0006164),0.29410724873592803,0.6369418107593448,0.8955223880597015,0.9913693878027328,1.0,3/12,17.59%,HPRT1;ADSL;MTHFD1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2249087125267698,0.6367042797719683,0.9400921658986175,0.9911892476572695,1.0,20/52,28.71%,ITGA3;CIB1;PRKCE;RACK1;STX4;DLG1;PRKCH;PTPN9;STAC3;ZDHHC8;PDPK1;ACSL3;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.24149426239919172,0.6354568216070147,0.9283154121863799,0.9918285033048876,1.0,6/33,17.04%,THY1;DUSP3;SH2D1A;PRNP;CD300A;UBASH3A
prerank,regulation of biomineral tissue development (GO:0070167),0.2507738896987947,0.6354175620316339,0.9407216494845361,0.9914997180387051,1.0,4/26,12.91%,SOX9;NBR1;ANKH;ENPP1
prerank,cardiac muscle cell action potential (GO:0086001),-0.18664583910155327,-0.6349215486255332,0.9836956521739131,0.9931026426954702,1.0,16/30,37.92%,ATP1B1;DMD;CACNA2D1;KCND3;SCN3B;SLC4A3;SCN2B;KCNH2;CACNA1G;ATP1A1;HCN4;KCNQ1;KCNIP2;ATP1A2;CACNA1C;FGF12
prerank,positive regulation of ATP metabolic process (GO:1903580),0.24158237133901622,0.634141916393233,0.9249692496924969,0.9921815673965608,1.0,5/32,12.39%,ENTPD5;APP;INSR;PSEN1;PPARGC1A
prerank,positive regulation of ruffle assembly (GO:1900029),-0.23537025190783448,-0.6341164368363693,0.9261744966442953,0.9922122008672185,1.0,6/13,33.63%,EPS8;HRAS;NDEL1;PLEKHM1;EPS8L1;CARMIL2
prerank,peptidyl-serine modification (GO:0018209),0.2024305038810178,0.6322643115930425,0.9867482161060143,0.9933343255503625,1.0,24/166,16.66%,SGK2;SGK3;CAMK2D;STK38L;PKN2;PNCK;IKBKE;MORC3;NTMT1;MKNK1;CAB39;CSNK2A2;VRK3;MAST3;MAPK14;DYRK2;NEK6;PRKDC;PRKCE;PRKCH;MASTL;GALNT1;MTOR;STK39
prerank,actin polymerization or depolymerization (GO:0008154),0.22172497875623104,0.6313269085203547,0.9402985074626866,0.9937321465494554,1.0,15/50,25.94%,EVL;GAS7;CORO7;GSN;RAC1;JAK2;AIF1;CFL2;TTC17;DSTN;MSRB1;TWF1;ANG;DIAPH1;WASHC5
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.28965089767560875,0.6309795475639637,0.8903703703703704,0.9936496393692074,1.0,3/11,17.89%,AGO2;SOAT1;ITM2C
prerank,positive regulation of collagen metabolic process (GO:0010714),0.26836620134001854,0.6308980505843788,0.9010840108401084,0.9933610192803627,1.0,2/17,9.08%,RUNX1;SCX
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.21104691110637697,0.6306345376639937,0.968682505399568,0.9932187418333132,1.0,21/80,24.76%,ACTR2;KCTD17;CYFIP1;ACTR3;CCDC88A;AGRN;DEF8;FNBP1L;NRP1;RAC1;MIEN1;PLCE1;ARAP1;NCKAP1;ENTR1;BRK1;DOCK11;CDC42EP3;TENM1;BBS4;PIK3CA
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2665235842220451,0.6304101001217116,0.912621359223301,0.9930449806871475,1.0,5/17,24.03%,FIS1;GIT1;TIGAR;HDAC4;PDE12
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.26531960665429,0.6274347262097156,0.9173333333333333,0.9949688826692773,1.0,3/17,19.75%,PLA2G12A;LPGAT1;PLA2G4E
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.1941672210794692,-0.6273990456409879,0.9695652173913043,0.9952062842001591,1.0,10/22,30.21%,NBN;RASSF2;RAP2C;NEK10;TOM1L1;MRE11;RAD50;PDGFC;GREM1;PDGFD
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.27082890647545277,0.6271826770692376,0.8983286908077994,0.9948017929229647,1.0,2/16,17.53%,STX7;PTPRC
prerank,regulation of striated muscle contraction (GO:0006942),-0.18539084659024058,-0.6267987861754458,0.9617224880382775,0.9942126113797504,1.0,13/27,37.08%,DMD;SLC8A3;GRK2;TNNI1;SRI;NOS1;HCN4;RNF207;RYR2;MYL2;MYBPC3;TNNT3;ATP1A2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24696831491219357,0.6263394932034414,0.9233766233766234,0.9950769052891921,1.0,6/25,18.93%,DCK;HPRT1;ADSL;SHMT1;MTHFD1;AMPD3
prerank,urogenital system development (GO:0001655),0.29409367710053,0.6260553084097621,0.9034090909090909,0.9949346269933275,1.0,1/11,5.43%,SOX9
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2364754048822975,-0.6259329954734336,0.9348534201954397,0.9933562655809888,1.0,6/12,27.12%,LARP7;NELFB;NELFE;HEXIM1;NELFA;RNF168
prerank,serine family amino acid metabolic process (GO:0009069),0.2694049423019512,0.625876759113795,0.9012693935119888,0.9947154189788211,1.0,4/16,17.59%,SEPSECS;SHMT1;GCLC;MTHFD1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20882864894656475,0.6251584300955978,0.9735729386892178,0.9949186356836877,1.0,8/85,12.55%,LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;P2RX4;ADGRV1;COL11A2
prerank,regulation of telomerase activity (GO:0051972),0.22594921715272714,0.6247932711749062,0.9447640966628308,0.99485676510969,1.0,10/45,18.94%,HSP90AB1;CTNNB1;CCT4;ERCC4;MEN1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,vesicle transport along actin filament (GO:0030050),0.2605073200190711,0.6247123180616215,0.9281842818428184,0.9945580076317555,1.0,3/19,13.86%,MYO1C;FNBP1L;MYO6
prerank,eye development (GO:0001654),0.22184755896566788,0.6243460945701754,0.9492502883506344,0.9944705502438201,1.0,3/54,8.04%,PITX2;FBN1;MEIS3
prerank,sphingolipid metabolic process (GO:0006665),0.2043381267200698,0.6238916429028685,0.9725738396624473,0.9944507504689308,1.0,26/108,22.77%,SGPP2;ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6;NEU1;VAPB;CERKL;SPHK2;HACD3;B3GALNT1;ACER3;GLB1;SGPL1;SPTLC2;CERS2;GBA2;ELOVL4;GLTP;SPTSSA;SUMF1;PLPP2;ARSA;CERT1;ESYT2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.25498159701479456,0.6236864084813996,0.9264516129032258,0.9942454125106562,1.0,5/22,25.49%,THY1;FLOT2;LCK;GCNT2;TNF
prerank,osteoclast differentiation (GO:0030316),0.25481658112972444,0.6234225802335827,0.9368556701030928,0.9940834653725683,1.0,3/22,9.57%,SNX10;CSF1;MAPK14
prerank,regulation of axon extension (GO:0030516),0.22803715465210064,0.6225168836824899,0.9345238095238095,0.9944092990485881,1.0,6/37,15.09%,RUFY3;MT3;DNM2;MAG;APOE;DBNL
prerank,positive regulation of dendrite extension (GO:1903861),-0.21348809794535997,-0.6224296946913076,0.9592592592592593,0.9940426910201128,1.0,6/17,20.13%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1
prerank,L-serine metabolic process (GO:0006563),0.28709935254049523,0.6217335866615332,0.9195046439628483,0.9946209738872601,1.0,2/10,13.86%,PHGDH;SHMT1
prerank,pore complex assembly (GO:0046931),0.2582054535684484,0.6211841557981954,0.9389416553595658,0.9946479240282896,1.0,4/19,19.18%,NUP153;BAD;AHCTF1;PLEKHA7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.24123973738597887,0.6192620205839956,0.9275730622617535,0.9956741254023593,1.0,1/27,1.22%,CAMK2D
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.20100205024065748,-0.6184501276493524,0.956989247311828,0.99498389900967,1.0,6/20,18.23%,PPIL3;FKBP4;PPIL2;NKTR;PPIL1;FKBP1B
prerank,regulation of interleukin-1 production (GO:0032652),0.26865619316161515,0.6183679603989414,0.9142857142857143,0.9959611127642743,1.0,2/15,10.27%,HMGB1;TMED10
prerank,regulation of actin filament-based process (GO:0032970),0.2106874602479742,0.6170064880792242,0.9660657476139979,0.9965670781816486,1.0,17/70,22.47%,BST2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;TESK1;ARHGAP18;RND2;RHOH;PRKCD;IQGAP2
prerank,protein polyglutamylation (GO:0018095),0.28483153893248203,0.6166757434798666,0.9189985272459499,0.9964250289862983,1.0,2/11,14.71%,TTLL7;CFAP20
prerank,negative regulation of interleukin-6 production (GO:0032715),0.24106064709556718,0.6162878418076451,0.9300254452926209,0.9963408135132914,1.0,3/27,10.62%,SLAMF1;CX3CL1;ZC3H12A
prerank,regulation of metal ion transport (GO:0010959),0.2660484125133716,0.6159867670285688,0.9090909090909091,0.9962017957317172,1.0,1/16,2.32%,CAMK2B
prerank,response to interleukin-4 (GO:0070670),-0.2514766117646788,-0.6152179727068942,0.9034267912772586,0.9953502742012093,1.0,5/10,33.91%,JAK3;SHPK;LEF1;TCF7;GATA3
prerank,positive regulation of axon extension (GO:0045773),0.24611981249456333,0.6152146408799848,0.9258312020460358,0.9964008359183048,1.0,4/22,15.85%,RUFY3;NRP1;DBNL;DSCAM
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2648753010059187,0.6149380235159241,0.9203778677462888,0.9962430278569312,1.0,2/17,14.84%,PLA2G12A;LPGAT1
prerank,cGMP-mediated signaling (GO:0019934),0.2736504527032451,0.614925028639829,0.917963224893918,0.9958992126885257,1.0,5/13,27.96%,APOE;PDE3A;PDE9A;GUCY1B1;HTR2B
prerank,activation of phospholipase C activity (GO:0007202),0.23335895665057996,0.6148697033630676,0.9420468557336621,0.995588014151154,1.0,3/29,11.96%,BDNF;GNA15;HTR2A
prerank,establishment of skin barrier (GO:0061436),0.2635532456612763,0.6141368658151992,0.9196185286103542,0.9953790029867484,1.0,1/15,8.69%,MET
prerank,regulation of water loss via skin (GO:0033561),0.2635532456612763,0.6141368658151992,0.9196185286103542,0.9953790029867484,1.0,1/15,8.69%,MET
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.23418041000199605,-0.6137573890079899,0.9504643962848297,0.9947569018182463,1.0,8/12,39.27%,BIN1;TRPM4;CAV1;JUP;DSG2;RYR2;CACNA1C;DSP
prerank,neural crest cell development (GO:0014032),0.22235242408824515,0.6130433841052337,0.9616724738675958,0.9957889974608196,1.0,5/44,8.82%,SEMA4D;TCOF1;SNAI2;NOLC1;GDNF
prerank,peptidyl-arginine modification (GO:0018195),0.26938096656170607,0.6130371655629024,0.9182561307901907,0.9954384926330797,1.0,3/15,20.23%,ART4;PRMT1;KRTCAP2
prerank,aortic valve morphogenesis (GO:0003180),0.2352685410042401,0.611322396654782,0.9540816326530612,0.9962664971513377,1.0,4/30,12.70%,SOX9;SNAI2;SLIT3;RB1
prerank,phospholipid catabolic process (GO:0009395),-0.19202957846616595,-0.6105074678117751,0.9525862068965517,0.9950616827631764,1.0,4/24,14.95%,SMPDL3A;PLBD1;ABHD12;GPCPD1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.24538299731779076,-0.6098838327454047,0.9130434782608695,0.9940444130116465,1.0,4/10,33.40%,HERPUD1;CCL2;EIF2AK3;QRICH1
prerank,response to hydrogen peroxide (GO:0042542),0.2206589412069414,0.6093790706818006,0.9622857142857143,0.9972011208293323,1.0,12/45,23.84%,TRPM2;FXN;PLEKHA1;FYN;ANKZF1;STK25;STK24;SIRPA;PRKCD;OSER1;PRDX3;HDAC6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.27197195300717547,0.6093373628336649,0.9120567375886525,0.9968788771312128,1.0,3/14,25.49%,CSF1;TYROBP;TNF
prerank,regulation of myelination (GO:0031641),0.24080782493613462,0.6087684973428581,0.9448621553884712,0.9969176267454237,1.0,3/25,8.86%,NKX6-2;TMEM98;CST7
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2288549125949635,-0.608597860305323,0.9193548387096774,0.9933574106288919,1.0,3/12,23.39%,CCR2;IL1R1;IL1B
prerank,polarized epithelial cell differentiation (GO:0030859),0.2713039780552041,0.6077717018335353,0.9172320217096337,0.9971992562107089,1.0,6/13,27.26%,SH3BP1;OPHN1;RAP2A;MSN;RAB10;ZDHHC7
prerank,negative regulation of TOR signaling (GO:0032007),0.22443758979248926,0.607444874678507,0.9590854392298436,0.9970556604487426,1.0,12/36,27.04%,KPTN;DDIT4;AKT1S1;NPRL2;TSC1;NPRL3;STK11;UBR2;UBR1;FNIP1;SZT2;SESN1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.24957154050725794,-0.6071288428918501,0.9096385542168675,0.9927606112651289,1.0,3/10,22.06%,ANK3;CAV1;KCNAB1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24387817097432385,0.6067988697434156,0.938382541720154,0.9971368294498841,1.0,9/22,29.91%,KANK1;SSH3;GSN;PRKCD;TWF1;PFN2;ARFGEF1;SLIT2;PFN1
prerank,"wound healing, spreading of cells (GO:0044319)",0.23711091091350525,0.6062872866652373,0.941101152368758,0.9971141507643536,1.0,9/24,31.51%,MRTFA;PDPN;ARHGAP24;ACVRL1;FLNA;PDCD10;CCN1;ARHGAP35;TOR1A
prerank,histone H3-K4 trimethylation (GO:0080182),0.27688285907479143,0.606086772843034,0.9187969924812031,0.9968896465770466,1.0,3/11,22.85%,KMT2A;TET2;KMT2D
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.2647412790983537,0.6044704167669313,0.9113372093023255,0.997587426353404,1.0,3/14,16.08%,IL17D;CD84;IL18
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.19294019210982905,0.6043148668778272,0.9919273461150353,0.9973307125310333,1.0,25/159,21.75%,PCDHB13;PLXNB2;CDH13;ACVR1;NECTIN4;PLXNB3;CDH9;NECTIN3;PCDHB16;MAG;SDK1;CD84;CLDN10;NPTN;HMCN1;DSCAM;DSCAML1;MPZ;CLDN11;LRRC4;PTPRF;FGFRL1;VCAM1;TENM4;KIRREL3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.21217558718227442,0.6036052911760539,0.9568181818181818,0.9974137635850627,1.0,19/52,28.71%,ITGA3;CIB1;PRKCE;STX4;DLG1;PRKCH;PTPN9;STAC3;ZDHHC8;NUMA1;PDPK1;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,tRNA transport (GO:0051031),0.2237351067901443,0.6035951239115946,0.9517490952955368,0.9970688901715653,1.0,12/35,27.91%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,transcription preinitiation complex assembly (GO:0070897),0.27366210625590104,0.603503052197525,0.9176646706586826,0.9967751616670295,1.0,2/12,12.87%,BDP1;TAF1B
prerank,manganese ion transport (GO:0006828),0.26862004354344987,0.6027403170407684,0.9296551724137931,0.9968865894617627,1.0,6/14,28.89%,SLC11A2;TRPC4;TRPC1;TMEM165;SLC11A1;TRPC7
prerank,glycogen catabolic process (GO:0005980),0.25663946064063625,0.6016324671388074,0.921832884097035,0.9972430832530255,1.0,3/15,16.59%,PGM2L1;RB1CC1;PHKG2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2606266210076132,0.6005429332548009,0.9218045112781955,0.9975894387422414,1.0,3/13,17.53%,JAK2;MGAT5;PTPRC
prerank,sphingolipid biosynthetic process (GO:0030148),0.20216544121012073,0.6004852369304825,0.9741379310344828,0.9972698198112999,1.0,16/71,22.55%,SGPP2;ASAH2;CERS6;DEGS1;VAPB;SPHK2;HACD3;ACER3;ST8SIA1;SGPL1;SPTLC2;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.22097239517191034,0.6004085069181742,0.9511059371362048,0.9969691276017161,1.0,5/38,16.85%,CAMK2D;AKAP9;CTNNA3;SCN1B;KCNJ2
prerank,negative regulation of hormone secretion (GO:0046888),-0.24113691136855106,-0.5989406373263971,0.9425675675675675,0.9953532420744747,1.0,2/10,23.39%,OSM;IL1B
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.242288871819617,-0.5985233615707165,0.9457831325301205,0.9942225833115648,1.0,1/10,3.18%,LRP6
prerank,glial cell differentiation (GO:0010001),0.2296464538806308,0.5983311910660799,0.949569495694957,0.9978968769018058,1.0,3/28,8.77%,STAT3;SOX9;NFIB
prerank,cellular response to hydrogen peroxide (GO:0070301),0.22659147804437577,0.5980237819304578,0.9480676328502415,0.9977294632852154,1.0,8/33,23.84%,TRPM2;FXN;PLEKHA1;ANKZF1;SIRPA;PRKCD;OSER1;HDAC6
prerank,negative regulation of wound healing (GO:0061045),-0.1818352609320823,-0.5975015335233721,0.9695431472081218,0.9933708180552792,1.0,6/28,24.03%,SLC12A2;CLASP2;VTN;CD109;CLASP1;THBD
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.27739085239053446,0.5972504160556484,0.9376854599406528,0.9978688326445767,1.0,1/10,6.00%,CDT1
prerank,regulation of cell communication (GO:0010646),0.2268567166445729,0.5967298243808555,0.9674306393244874,0.9978657486159878,1.0,2/35,3.73%,CAMK2D;SLC8A1
prerank,negative regulation of interferon-beta production (GO:0032688),0.2838983349262973,0.59662491639647,0.9146341463414634,0.9975741814220136,1.0,4/10,24.71%,RELB;REL;SIRPA;PTPRS
prerank,cardiolipin metabolic process (GO:0032048),0.2657737899109518,0.5953030127680341,0.9428571428571428,0.9979930394708325,1.0,4/13,21.72%,SLC27A1;HADHA;PLA2G6;PNPLA8
prerank,negative regulation of glycolytic process (GO:0045820),-0.24276976479658313,-0.5950609007736922,0.9228571428571428,0.991913829182379,1.0,1/10,2.11%,CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.24276976479658313,-0.5950609007736922,0.9228571428571428,0.991913829182379,1.0,1/10,2.11%,CBFA2T3
prerank,regulation of interleukin-13 production (GO:0032656),0.2675112893093872,0.5946641818907202,0.9289693593314763,0.998036730199878,1.0,3/13,16.80%,SPHK2;IL18;LGALS9
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2198520628020476,0.5946485766329256,0.9565217391304348,0.9976912221333799,1.0,5/37,11.31%,CYLD;MAPRE1;STMN4;STMN3;PHLDB1
prerank,clathrin coat assembly (GO:0048268),0.2552972882017652,0.5939882841420894,0.9347222222222222,0.9977184560488088,1.0,2/15,10.64%,NSG2;AP2S1
prerank,neuron projection fasciculation (GO:0106030),0.28489489863194295,0.5938181680325116,0.937592867756315,0.9974633176015634,1.0,1/10,5.76%,EPHA4
prerank,regulation of B cell differentiation (GO:0045577),0.25317012362255953,0.5937928585522,0.9274755927475593,0.9971313797138812,1.0,4/17,15.92%,MMP14;ZFP36L1;XBP1;CD27
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.1992414136419799,0.5936926932806469,0.9735169491525424,0.9968404342638669,1.0,14/82,14.62%,DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;NPM1;NEDD1;CEP152;CEP131;CEP70;AKAP9;TUBB4B;DYNLL1;HSP90AA1
prerank,axonal transport of mitochondrion (GO:0019896),0.27378429515692754,0.593218975713789,0.9308755760368663,0.9967755486031358,1.0,1/11,5.79%,TRAK1
prerank,regulation of macrophage activation (GO:0043030),0.22315046616901546,0.5929302790879201,0.9547123623011016,0.9966015069315317,1.0,4/30,14.78%,WNT5A;ZC3H12A;FCGR2B;TNIP2
prerank,positive regulation of calcium ion transport (GO:0051928),0.21837469155112732,0.5927146319752927,0.9675870348139256,0.9963830092692225,1.0,4/36,10.80%,CCL5;P2RX4;SPHK2;CRACR2A
prerank,spermatid development (GO:0007286),0.22152452303332024,0.5926029108991125,0.9587378640776699,0.9961029089842495,1.0,4/32,14.32%,NME5;CIB1;CDYL;ZMYND15
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.20336883300095482,0.5917424466091342,0.9747995418098511,0.9962814500054157,1.0,6/54,16.85%,KCNMB3;CAB39;GABBR2;DLG1;STK39;KCNJ2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.242199789446096,0.591453308672346,0.9565217391304348,0.9960945005300296,1.0,6/21,27.61%,AKAP9;SCN1B;FLNA;ANK2;SCN4B;CACNA1D
prerank,mitochondrial membrane organization (GO:0007006),0.22354890794894172,0.5892227892121479,0.9577639751552796,0.9970366941436589,1.0,5/32,13.15%,RCC1L;CHCHD6;TIMM50;SAMM50;BAD
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.24560936275461684,0.5890903014399763,0.9423592493297587,0.9967651664908347,1.0,2/18,9.57%,GNA15;AGRN
prerank,establishment of mitotic spindle localization (GO:0040001),0.22748953059120472,0.5875421150415832,0.9527458492975734,0.9972444595207179,1.0,6/28,19.23%,KPNB1;CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80
prerank,secondary alcohol biosynthetic process (GO:1902653),0.22538220693337752,0.5874308976643658,0.9613059250302297,0.9969597433708409,1.0,9/30,27.15%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,positive regulation of protein processing (GO:0010954),0.24020923420088788,0.5873924305413488,0.9552845528455285,0.9966332229505833,1.0,3/19,18.19%,ADAM8;GSN;MYH9
prerank,positive regulation of blood coagulation (GO:0030194),0.2520330524532733,0.5859959601683841,0.9353562005277045,0.9970550256208731,1.0,2/17,10.73%,USF1;HPSE
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.2497120263425606,0.585219973020244,0.9368998628257887,0.9971316487675359,1.0,8/16,31.08%,ATIC;ADSL;AMPD3;LHPP;PAICS;ADSS2;PFAS;AMPD2
prerank,intermediate filament organization (GO:0045109),0.24881631202748247,0.5843604776059298,0.930939226519337,0.9972396878414516,1.0,2/17,9.90%,BFSP1;DNAJB6
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.19784267011474227,0.5838721431335692,0.9870550161812298,0.9971435213477496,1.0,15/75,22.95%,CNGB1;GNG4;CCL5;CAMKMT;GIT1;RGS16;METAP2;TULP3;PLCE1;MGRN1;FNTA;ZDHHC3;USP33;NMT1;PDE6H
prerank,negative regulation of phosphatase activity (GO:0010923),0.2289788161861058,0.5829735097811077,0.9457070707070707,0.9972556739346052,1.0,4/25,14.99%,SEMA4D;PPP1R11;PPP1R26;MASTL
prerank,regulation of regulated secretory pathway (GO:1903305),0.21828159731207455,0.5827190299827109,0.9625,0.9970369665908075,1.0,12/34,26.80%,SYT7;UNC13D;SYT3;PREPL;DTNBP1;VPS18;SYN1;SYT12;SYT11;RAB3A;RAB3D;SYT4
prerank,smooth muscle contraction (GO:0006939),0.2510839395341614,0.582042206831022,0.9352941176470588,0.9970450247018993,1.0,2/14,15.18%,SLC8A1;CHRNB2
prerank,anterior/posterior pattern specification (GO:0009952),0.20187815693337752,0.5803811362823427,0.9715261958997722,0.9975941062849891,1.0,5/53,12.48%,BHLHE40;SMAD2;HOXA9;BMPR2;HOXB6
prerank,regulation of organelle organization (GO:0033043),0.19256003132993585,0.5799060656233566,0.9818956336528222,0.9975074049034616,1.0,8/80,12.35%,CLIC4;FIS1;SYDE1;CDT1;VPS11;SPEF1;STMN3;AKAP9
prerank,positive regulation of locomotion (GO:0040017),0.2212954834557277,0.5795026534596409,0.9539227895392279,0.9973544903511359,1.0,6/27,20.64%,PPM1F;STX4;CFAP20;AIF1;CAVIN1;CCDC25
prerank,protein deneddylation (GO:0000338),0.2717250930754741,0.5773755208010785,0.9475262368815592,0.9981159386572436,1.0,3/10,22.06%,COPS7B;COPS8;COPS7A
prerank,lipid modification (GO:0030258),0.21336398502760348,0.5768895932764989,0.9689366786140979,0.9980204321051442,1.0,11/37,25.40%,SGPP2;DGKB;DGKK;EPHX2;DGKA;DGKI;PLPP2;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.24519999154178732,0.5767887478464385,0.9464285714285714,0.9977221974514682,1.0,5/17,22.51%,CYFIP1;GMFB;CORO1B;NCKAP1;BRK1
prerank,axonal fasciculation (GO:0007413),0.2660799931162318,0.5763896441189138,0.9350282485875706,0.9975781289202852,1.0,1/12,5.76%,EPHA4
prerank,regulation of collagen biosynthetic process (GO:0032965),0.23675868497782648,0.574520675754295,0.952063914780293,0.9981350912236113,1.0,2/19,9.08%,RUNX1;SCX
prerank,placenta development (GO:0001890),0.2644805464963616,0.5737891109814374,0.9536903039073806,0.9981361291777461,1.0,1/12,6.30%,CUL7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.24720710598446127,0.5731403750906776,0.9598337950138505,0.9981020224269983,1.0,7/15,31.31%,BMPER;FGF2;PDPK1;JAK1;SMAD1;FGF1;JMJD8
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.20838988617697274,-0.5709119953138673,0.9537953795379538,1.0,1.0,4/13,25.17%,DDAH1;PRODH;ALDH4A1;NOS1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.22009371797140723,0.5708927063783876,0.9590062111801242,0.9988491867823069,1.0,5/29,15.10%,CAMK2B;NETO1;APP;APOE;SYNGR1
prerank,signal transduction by p53 class mediator (GO:0072331),0.22031935087398352,0.5706389823614834,0.9519595448798989,0.9986316084924977,1.0,2/30,3.56%,MYBBP1A;DDX5
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2731754836638189,0.5693268932755897,0.9350850077279753,0.9988817006626757,1.0,1/10,6.73%,NT5C3A
prerank,tricarboxylic acid metabolic process (GO:0072350),0.2573742031373144,0.5692989027898158,0.9516358463726885,0.9985485519344615,1.0,3/12,22.30%,IDH1;GLUD1;IDH3A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.19160665457730486,0.5689974492360673,0.9889746416758545,0.9983583979627381,1.0,15/65,23.51%,SPRY2;PMEPA1;FBN1;SMAD2;BAMBI;SKIL;SMURF1;HTRA3;SPRED3;SPRED1;SNX25;PIN1;STUB1;SMURF2;PDPK1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2050951524069601,0.5688175781771311,0.9855421686746988,0.998091983665608,1.0,5/37,15.05%,SOD2;DNMT1;LDLRAP1;FGF9;BMPR1A
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.26321338180993276,0.5678247328906378,0.9503649635036496,0.9982242437319299,1.0,2/12,11.88%,NEK9;NEK6
prerank,regulation of sodium ion transport (GO:0002028),0.2107891955042675,0.5675784696099749,0.9704069050554871,0.997996229984093,1.0,6/34,16.23%,CNKSR3;P2RX4;AHCYL1;SIK1;DLG1;SCN1B
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.2213180612936289,0.5671633616952976,0.947103274559194,0.9978429524796374,1.0,5/24,21.95%,DNMT3A;DNMT1;EZH2;SMYD5;TASOR
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.25161003968683654,0.5670101074466801,0.9588652482269504,0.9975680696150397,1.0,2/13,15.81%,UBA2;UBA1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.22193009942111247,-0.5668940181121357,0.9673590504451038,0.999267117446316,1.0,3/11,22.05%,GSTO1;FKBP1B;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.22193009942111247,-0.5668940181121357,0.9673590504451038,0.999267117446316,1.0,3/11,22.05%,GSTO1;FKBP1B;SRI
prerank,telomere capping (GO:0016233),0.24487768849704838,0.5666257329459792,0.9464524765729585,0.9973935548000359,1.0,5/16,19.73%,PRKDC;STN1;DCLRE1A;TERF2;DCLRE1C
prerank,leukocyte cell-cell adhesion (GO:0007159),0.2259196552042045,0.5655810215148602,0.9652956298200515,0.9975331045495366,1.0,3/24,10.21%,SEMA4D;CCL5;TNIP1
prerank,GTP metabolic process (GO:0046039),-0.1925839040379299,-0.564672748756534,0.9795918367346939,0.9987452101581705,1.0,7/15,31.46%,MFN1;RHOQ;IMPDH2;GTPBP1;GNAI3;IMPDH1;EFL1
prerank,spinal cord development (GO:0021510),0.25691053106952083,0.5642004595022666,0.9563253012048193,0.9978232403644364,1.0,2/12,18.18%,NF1;VIT
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.2485252175514388,0.5629350828102987,0.9489655172413793,0.9980456516660229,1.0,3/15,11.88%,CDC16;CDC27;NEK6
prerank,oligodendrocyte differentiation (GO:0048709),0.23181405414617057,0.5619254076282388,0.9501347708894878,0.998155408181506,1.0,4/19,18.98%,SOX9;EIF2B2;EIF2B5;EIF2B3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.23709633427731847,0.5609929224656003,0.9594240837696335,0.9982142213407839,1.0,2/17,13.24%,RAPGEF2;AKAP13
prerank,I-kappaB phosphorylation (GO:0007252),0.264214662908714,0.56034432563377,0.9571005917159763,0.9981484632879396,1.0,3/10,23.08%,TLR2;TLR3;TLR7
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.255899065148935,0.5603413620205406,0.9411764705882353,0.9978057656220133,1.0,3/12,18.36%,ABCD1;FADS2;ACOX1
prerank,peptidyl-methionine modification (GO:0018206),0.255315753133869,0.5597603361179961,0.9534883720930233,0.9977197987275379,1.0,2/12,16.62%,NAA25;METAP2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2491086242234396,0.5588011939591521,0.940406976744186,0.9978018335297203,1.0,3/13,18.96%,GFPT1;SLC35A3;UAP1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.26345603970024395,0.5568582615790407,0.9487179487179487,0.9982627609859068,1.0,1/10,4.53%,GAP43
prerank,inorganic anion transmembrane transport (GO:0098661),0.19041700779546308,0.5547449414713895,0.9944994499449945,0.9987876007389945,1.0,21/63,27.05%,SLC12A5;SLC25A10;SLC12A8;GLRA2;SLC26A2;SLC37A2;ANO5;CLCN1;SLC20A2;GABRG1;SLC37A1;SLC5A6;GLRA1;GABRB2;SLC1A3;SLC25A30;GABRA3;CFTR;ANO4;ANO3;GABRG2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.24040015438848972,0.5543814290649626,0.9578059071729957,0.9985830093149068,1.0,2/15,17.59%,FGFR2;MTHFD1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.24664116105953077,0.5508495190797609,0.9459459459459459,0.9996533010625079,1.0,4/13,26.76%,GLUD1;GAD1;GOT1;MTHFS
prerank,negative regulation of hemostasis (GO:1900047),-0.21440959873520335,-0.5505246425975472,0.9666666666666667,1.0,1.0,6/12,39.90%,VTN;THBD;CD34;APOH;ADTRP;TFPI
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.2562346445053026,0.5504809512056125,0.9523809523809523,0.9994595913933592,1.0,3/11,17.23%,UNC93B1;TNIP2;TLR3
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.21325605829394434,0.5492567167980459,0.9708491761723701,0.999570859821096,1.0,8/28,25.42%,PAK3;DBNL;SH3BP1;ABITRAM;GBA2;ARHGAP18;BRK1;PFN2
prerank,regulation of response to oxidative stress (GO:1902882),0.25147260028934104,0.549206612170969,0.9469914040114613,0.9992435571597746,1.0,2/11,12.10%,ABCD1;GGT7
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.256011518400308,0.5481209422100477,0.9409158050221565,0.9993282883918116,1.0,3/10,18.67%,UBE2B;PDE3A;MGRN1
prerank,cellular glucan metabolic process (GO:0006073),-0.213591873749206,-0.5476618182075023,0.9742765273311897,1.0,1.0,8/11,46.31%,GSK3B;PPP1R3C;GBE1;PRKAG2;PYGM;PHKB;PHKA1;G6PC1
prerank,female gonad development (GO:0008585),-0.18197936379082869,-0.5465622250842291,0.9841269841269841,1.0,1.0,5/19,23.27%,NR2F2;CEBPB;NUP107;INHBA;COL9A3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.22949976927978258,0.5454745812573076,0.9695712309820194,1.0,1.0,4/17,23.14%,VAMP2;KCNRG;KCNS1;SUMO1
prerank,heart trabecula morphogenesis (GO:0061384),-0.18380617676654226,-0.5450856751952363,0.9727626459143969,0.9994317465435791,1.0,13/18,46.78%,TGFBR3;TGFB2;S1PR1;TEK;BMP5;HEY1;BMP7;NOG;ADGRG6;DLL4;RBP4;ENG;NRG1
prerank,circulatory system development (GO:0072359),0.174425233631104,0.542471164625036,0.9968944099378882,1.0,1.0,26/118,24.88%,ACVR1;FBXW7;SOX9;SRF;FBN1;ADAP2;NOTCH4;COL3A1;PTPN11;AKAP13;POU6F1;MEF2A;PDLIM3;SH3PXD2B;MTHFD1;PLCE1;NF1;ACVRL1;BCOR;STK11;CITED2;ERBB3;NOTCH1;KAT2B;PIK3CA;ECE1
prerank,mitochondrion transport along microtubule (GO:0047497),0.24549533595554318,0.5419927802848938,0.9636913767019667,1.0,1.0,5/13,27.47%,UXT;RHOT2;OPA1;LRPPRC;MAP1S
prerank,response to molecule of bacterial origin (GO:0002237),0.1856399174856634,0.5412605110696181,0.9945175438596491,1.0,1.0,18/69,27.13%,C4B;SLPI;GCH1;GGT7;FCGR2B;JAK2;IRAK1;ACOD1;LGALS9;PRDX3;PELI1;IRF5;OTUD5;SIRT2;MAPKAPK2;NOCT;FER;LY96
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2152692700663632,0.540362453496491,0.9694656488549618,1.0,1.0,11/24,32.83%,MT3;ATF6B;RBPJ;NOTCH1;ATF6;CHD6;ATF4;KLF2;HSF1;SESN2;DDIT3
prerank,amino acid import (GO:0043090),0.22175767841740399,0.5401289652946987,0.9818652849740933,1.0,1.0,6/21,26.98%,SFXN2;SFXN1;SLC6A6;SLC1A3;SLC36A1;SLC22A4
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.21353018304665214,0.5390350061697469,0.9845758354755784,1.0,1.0,3/23,17.42%,ARRB2;LGALS9;LAMP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.18765675764750303,0.537926084590298,0.9921700223713646,1.0,1.0,1/53,0.65%,AGT
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.24816379127120353,0.5377921410820736,0.9642857142857143,0.9999814122167792,1.0,6/12,30.23%,ATIC;ADSL;LHPP;PAICS;ADSS2;PFAS
prerank,Notch signaling involved in heart development (GO:0061314),0.24832015256332435,0.5368752969833404,0.9563953488372093,0.9999326932326693,1.0,3/11,23.31%,SNAI2;RBPJ;NOTCH1
prerank,synaptic vesicle membrane organization (GO:0048499),0.2270733441846355,0.5351352697254003,0.9751381215469613,1.0,1.0,3/17,15.10%,STX4;SNAP23;SYNGR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.22480017853255183,0.5330372168143617,0.9693333333333334,1.0,1.0,4/17,18.77%,MPG;TDG;NEIL2;TERF2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2120315345992176,0.5327368444489908,0.9686684073107049,1.0,1.0,8/23,27.56%,CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80;DCTN1;MAD2L1;ITGB1
prerank,establishment of melanosome localization (GO:0032401),0.22365180199846948,0.5321000936700107,0.9738292011019284,1.0,1.0,6/19,26.58%,RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.23712229255312456,0.5297430897398456,0.9681620839363242,1.0,1.0,3/13,22.09%,IDH1;GPT2;GOT1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.17942000251280446,-0.5296415742317114,0.9964788732394366,1.0,1.0,7/16,30.21%,PIK3C2A;RGS14;ABL1;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,linoleic acid metabolic process (GO:0043651),0.2214408882973559,0.5290158153493236,0.9759679572763685,1.0,1.0,2/17,12.46%,ABCD1;FADS2
prerank,nucleoside catabolic process (GO:0009164),0.25184323063464253,0.528302905611154,0.9706336939721792,1.0,1.0,2/11,18.07%,NT5C3A;DERA
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2174156992346644,0.5244750378424317,0.9802371541501976,1.0,1.0,7/20,28.80%,AGRN;CHRNB2;LY6G6D;RGS10;CHRM3;CDK5R1;GNB1
prerank,T cell activation involved in immune response (GO:0002286),0.23898305084745783,0.5235675888625974,0.9609261939218524,1.0,1.0,12/12,76.12%,MDK;SLC11A1;LILRB1;IFNK;F2RL1;CD74;TNFSF18;ICAM1;EIF2AK4;ITGAL;FCER1G;LCP1
prerank,nuclear pore organization (GO:0006999),0.23005033895463664,0.5232208408065439,0.9719887955182073,1.0,1.0,5/14,26.51%,NUP153;AHCTF1;NUP133;NUP205;SEH1L
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.17538461538461536,-0.5230419073458197,0.9864864864864865,1.0,1.0,17/17,82.49%,HMGA2;KDM1A;PDCD2;CCNE1;N4BP2L2;TERT;THPO;CITED1;SOX11;EPCAM;NANOG;GJA1;LTBP3;HNRNPU;FERMT2;KAT7;PTPRC
prerank,negative regulation of signaling receptor activity (GO:2000272),0.20617541826682603,0.5229072343458232,0.9808673469387755,1.0,1.0,7/25,27.93%,CRHBP;SOCS5;SOCS4;TSG101;TNF;CBLB;ZGPAT
prerank,establishment of endothelial barrier (GO:0061028),0.2042986917500927,0.5215519671821931,0.9828009828009828,1.0,1.0,4/29,13.18%,RAPGEF6;RAPGEF2;TJP2;RAPGEF1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.21274246245113237,-0.5215073698568297,0.9701492537313433,1.0,1.0,3/10,20.10%,FGF10;MAP4K4;ADAM9
prerank,cholesterol biosynthetic process (GO:0006695),0.1995979595273885,0.5208061267573723,0.9830917874396136,1.0,1.0,9/31,27.15%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.24399757895579133,0.5200462512002727,0.963963963963964,1.0,1.0,2/10,19.01%,PRKCH;NUMA1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.17867077505490261,0.5182564540415261,0.9955056179775281,1.0,1.0,13/64,24.27%,ASAH2;ACADL;ACSL5;ABCD1;EPHX2;FADS2;DAGLA;ACOX1;GPX4;PNPLA3;PNPLA8;AIG1;ACSL3
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2485894355456053,0.5175310509904444,0.9618441971383148,1.0,1.0,3/10,25.22%,GALNT1;GALNT13;MGAT5B
prerank,negative regulation of vascular permeability (GO:0043116),-0.19776798016056713,-0.5171686897859358,0.9834437086092715,1.0,1.0,5/12,35.27%,DDAH1;CEACAM1;PDE2A;RAMP2;CLDN5
prerank,regulation of dopamine secretion (GO:0014059),0.20323031315844778,0.5164126110674889,0.9773584905660377,1.0,1.0,5/25,18.35%,SYT7;SYT3;GDNF;CHRNB2;DTNBP1
prerank,long-chain fatty acid transport (GO:0015909),0.1954317668611542,0.5126119886374441,0.989937106918239,1.0,1.0,3/30,12.38%,SLC27A1;ABCD1;APOE
prerank,regulation of T cell differentiation (GO:0045580),0.19436728682926302,0.5124951146431874,0.9901356350184957,1.0,1.0,6/33,22.11%,RUNX1;NFATC2;XBP1;MDK;RHOH;PRDM1
prerank,nuclear membrane disassembly (GO:0051081),0.23127252956475572,0.5099755611735305,0.9738751814223512,1.0,1.0,2/14,11.88%,NEK9;NEK6
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.23410351362844012,0.5097899379588842,0.9762611275964391,1.0,1.0,3/12,20.63%,MDK;FUT9;LCK
prerank,glycerophospholipid catabolic process (GO:0046475),0.197464777861358,0.5084033671258996,0.9861111111111112,1.0,1.0,6/27,21.72%,LIPC;PNPLA6;ENPP6;PLA2G4E;PLA2G6;PNPLA8
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.17384222263654087,-0.505444237447141,0.993127147766323,1.0,1.0,8/16,37.75%,SALL1;MYC;PAX8;BMP2;BMP4;FOXD1;SHH;NPNT
prerank,striated muscle contraction (GO:0006941),0.17661644171820612,0.49874606154017365,0.997737556561086,1.0,1.0,8/53,22.04%,SLC8A1;TNNC1;ARHGEF11;SCN1B;STAC3;TNNI2;RCSD1;MYH14
prerank,tRNA 5'-leader removal (GO:0001682),0.22002328481068234,0.4978217729779611,0.9664804469273743,1.0,1.0,4/13,23.01%,RPP30;RPP14;RPP25L;RPP21
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.22638776077295175,0.49513928646453986,0.9714285714285714,1.0,1.0,2/12,14.21%,STX4;SNAP23
prerank,hematopoietic stem cell differentiation (GO:0060218),0.23550579747515665,0.4935112762534975,0.9804804804804805,1.0,1.0,2/10,15.19%,LMBR1L;MLLT3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.20166245960675291,0.49284129693815026,0.9934725848563969,1.0,1.0,7/20,26.46%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23;PMPCB;STOML2
prerank,protein acetylation (GO:0006473),0.1891749487467269,0.49281047605450856,0.9890643985419199,1.0,1.0,7/30,23.88%,NAA50;NAA35;NAT9;ING5;KAT6A;KAT5;KAT2B
prerank,negative regulation of establishment of protein localization (GO:1904950),0.23432753544961749,0.4927379966028115,0.9748892171344166,1.0,1.0,4/10,26.75%,PPM1F;SNX12;NDFIP1;DNAJA1
prerank,aorta development (GO:0035904),0.21336769463986038,0.4890151933431831,0.9786931818181818,1.0,1.0,2/14,17.22%,TFAP2B;HECTD1
prerank,inner mitochondrial membrane organization (GO:0007007),0.17398581425647158,0.4885792876131721,0.9988505747126437,1.0,1.0,10/47,23.49%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO;GHITM;MTX1;ATP5F1B;OPA1;TIMM29
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.206255277100378,0.48816556268681144,0.9817671809256662,1.0,1.0,2/17,13.15%,SOX9;BAD
prerank,cytosolic calcium ion transport (GO:0060401),0.18691572741056345,0.4867203825172449,0.9975124378109452,1.0,1.0,3/28,13.22%,SLC8A1;MCUR1;MICU2
prerank,regulation of cellular pH (GO:0030641),-0.13678232121280856,-0.4865546477724273,0.9950248756218906,1.0,1.0,15/29,41.46%,SLC9A9;SLC4A8;CLN3;SLC9A8;SLC26A6;SLC4A3;SLC4A9;SLC4A7;SLC4A10;ATP6AP1;SLC9A4;SLC9B1;SLC9A3;SLC4A1;SLC4A5
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.1648248147683034,-0.4839079240310007,0.996415770609319,1.0,1.0,16/16,83.54%,TRAF6;RHOA;ITGB2;ST3GAL4;FUT4;ETS1;ALOX5;SELE;SELP;FUT7;IL6;RELA;NFAT5;TNF;MDK;IRAK1
prerank,cell differentiation in hindbrain (GO:0021533),0.22172509110373073,0.48209033236683874,0.9800285306704708,1.0,1.0,2/11,16.33%,PROX1;OPHN1
prerank,positive regulation of behavior (GO:0048520),0.22708818909420136,0.4816957753792032,0.9851851851851852,1.0,1.0,2/10,23.72%,CFAP20;AGRP
prerank,amino sugar biosynthetic process (GO:0046349),-0.18282593736120362,-0.48113886796913696,0.9848942598187311,1.0,1.0,6/12,32.32%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2;NANP
prerank,establishment of apical/basal cell polarity (GO:0035089),0.21101144524557225,0.47785951533406834,0.9886524822695035,1.0,1.0,4/14,22.74%,SH3BP1;OPHN1;RAP2A;MSN
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.21256211318232468,0.47613397876547175,0.9868804664723032,1.0,1.0,4/13,23.04%,AK4;AK3;ENTPD7;OPA1
prerank,negative regulation of ion transport (GO:0043271),0.18738265718611613,0.47587267858116006,0.9853723404255319,1.0,1.0,5/24,24.77%,ACTN2;INPP5K;CD33;SYT11;WNK3
prerank,rRNA pseudouridine synthesis (GO:0031118),0.22461125809299576,0.4755924527531706,0.9681335356600911,1.0,1.0,3/10,24.60%,GAR1;RPUSD1;NHP2
prerank,cardiac myofibril assembly (GO:0055003),0.20465180941977515,0.4749483171004425,0.9814285714285714,1.0,1.0,3/15,22.79%,PROX1;MEF2A;NRAP
prerank,regulation of biosynthetic process (GO:0009889),0.2191877430794535,0.472025302607242,0.9883720930232558,1.0,1.0,1/11,10.01%,SPHK2
prerank,negative regulation of calcium ion transport (GO:0051926),0.20367347346741732,0.4706988081082313,0.9829059829059829,1.0,1.0,3/15,19.81%,SLC30A1;INPP5K;CD33
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.18429458994690953,-0.4700726430863199,1.0,1.0,1.0,5/11,30.29%,MIF;NBL1;CCN3;GREM1;DUSP1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.17669237974157614,-0.4652092562720909,0.9967845659163987,0.9997763902523715,1.0,4/12,26.55%,VANGL2;SCRIB;FUZ;TRAF3IP1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.1996096938846165,0.465109548113104,0.990728476821192,1.0,1.0,4/17,27.01%,AKAP9;SCN1B;ANK2;SCN4B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.19318456241943083,0.46358101281122105,0.9918918918918919,1.0,1.0,6/18,28.79%,CHCHD10;BAX;SLC35F6;FZD9;BID;MPV17L
prerank,potassium ion transport (GO:0006813),0.15150917423037435,0.4627560322299124,1.0,1.0,1.0,7/120,11.84%,KCNMB3;ATP1B3;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,sensory organ development (GO:0007423),0.1635182236228031,0.4590013373003548,1.0,1.0,1.0,12/51,26.58%,CHD7;MEIS3;SOX2;SH3PXD2B;SIPA1L3;ADAMTS18;SMCHD1;PBX4;ECE1;ATF6;ZDHHC16;SHROOM2
prerank,negative regulation of secretion (GO:0051048),0.21346316553421787,0.4562969527032588,0.9880774962742176,1.0,1.0,1/10,8.40%,PTGER3
prerank,positive regulation of response to wounding (GO:1903036),0.18033127686626516,0.45562167956515576,0.9962406015037594,1.0,1.0,7/24,28.50%,KANK1;PRKCE;MDK;INSL3;GRN;ITGB1;ARFGEF1
prerank,dendrite self-avoidance (GO:0070593),0.1953751458764918,0.45351524057582765,0.9831697054698457,1.0,1.0,3/16,16.20%,NPTN;DSCAM;DSCAML1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.17930217583817246,-0.45187985286145804,0.9911504424778761,0.9994109136089584,1.0,5/11,29.95%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2
prerank,regulation of keratinocyte migration (GO:0051547),0.20130056207219799,0.4451427668065076,0.9925705794947994,1.0,1.0,4/12,26.55%,MTOR;IQSEC1;MAPRE2;PTEN
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.20723981374663264,0.4435513118454234,0.9910313901345291,1.0,1.0,2/10,19.21%,MYD88;CD68
prerank,positive regulation of calcium ion import (GO:0090280),0.19502918268605035,0.43769039914638413,0.998587570621469,1.0,1.0,1/12,10.01%,SPHK2
prerank,mitochondrial protein processing (GO:0034982),0.19886979837097107,0.4354703946712056,0.9970588235294118,1.0,1.0,5/11,31.99%,MIPEP;PMPCB;STOML2;ATP23;IMMP2L
prerank,negative regulation of cation channel activity (GO:2001258),0.17023327322506565,0.4335726150144633,1.0,1.0,1.0,3/26,15.26%,UBQLN1;GPR35;CALM3
prerank,regulation of membrane repolarization (GO:0060306),0.19495483347243114,0.4331928513242473,0.9943899018232819,1.0,1.0,3/13,24.51%,AKAP9;KCNJ2;YWHAE
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.20339870267268612,0.43237121112547705,0.9880239520958084,1.0,1.0,4/10,26.57%,ZNHIT3;RUVBL2;PIH1D1;RUVBL1
prerank,peptidyl-amino acid modification (GO:0018193),0.20725583730856154,0.4323189075672565,0.9953560371517027,0.9999834644892185,1.0,10/10,79.29%,METAP2;FKBP7;ATP7A;APOA1;APOA2;METAP1D;PDF;FKBP10;METAP1;TTLL4
prerank,negative regulation of blood coagulation (GO:0030195),0.15706740442655936,0.4240300520929104,0.9976190476190476,1.0,1.0,38/38,84.33%,APOE;PLAUR;F3;F8;PLAT;SERPING1;SERPINE1;KNG1;NOS3;FGG;CPB2;F2;GP1BA;KRT1;C1QTNF1;PROC;SERPINE2;PDGFA;EDN1;PDGFB;HRG;F12;PLG;KLKB1;F11;SERPINB2;TFPI;ADTRP;SERPINF2;APOH;F10;PLAU;CD34;F7;THBD;PDGFRA;A2M;VTN
prerank,striated muscle cell differentiation (GO:0051146),0.17903957203251308,0.41553255049024945,0.9972677595628415,1.0,1.0,2/16,13.24%,SIK1;AKAP13
prerank,cardiac ventricle development (GO:0003231),-0.13308629569149605,-0.41397960592138006,0.9959349593495935,0.9995263803586999,1.0,20/20,86.71%,SALL1;PDE2A;HEY1;HEY2;GATA3;HES1;MDM4;HEYL;DLL4;GJA5;ENG;STRA6;TMEM65;SCN5A;GATA4;TBX5;DAND5;NOTCH1;HECTD1;MATR3
prerank,lipoprotein biosynthetic process (GO:0042158),0.19182744170698324,0.4055253384350929,0.998546511627907,1.0,1.0,1/11,12.38%,APOE
prerank,intracellular lipid transport (GO:0032365),0.16636550878782214,0.40350318656804623,0.996078431372549,1.0,1.0,5/21,24.47%,ABCD1;NPC2;ABCD4;CERT1;PRKAB2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.15178375380425305,0.3954973224773127,1.0,1.0,1.0,2/31,8.87%,FGFR2;HOXA9
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.17133933398069306,0.38668651129455106,0.9972565157750343,1.0,1.0,2/14,15.61%,LIMS1;PHACTR4
prerank,cardiac muscle tissue development (GO:0048738),0.12794723804561953,0.3594274449605832,1.0,1.0,1.0,4/50,15.05%,BMPR2;SIK1;AKAP13;BMPR1A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.15718278622128723,0.3519836255682141,0.9986033519553073,1.0,1.0,5/13,29.76%,FBN1;CD46;DAND5;FSTL1;CHRDL1
prerank,regulation of ion transmembrane transport (GO:0034765),0.1285019043537935,0.3415809251526426,1.0,0.9998878317987447,1.0,7/33,27.66%,AHCYL1;AKAP9;KCNJ2;YWHAE;WNK3;CHRM3;KCNJ9
